{
 "documentInfo": {
  "documentType": "https://xbrl.org/2021/xbrl-json",
  "features": {
   "xbrl:canonicalValues": true
  },
  "namespaces": {
   "ifrs-full": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
   "iso4217": "http://www.xbrl.org/2003/iso4217",
   "photocure": "https://home.photocure.com",
   "scheme": "http://standards.iso.org/iso/17442",
   "xbrl": "https://xbrl.org/2021",
   "xbrli": "http://www.xbrl.org/2003/instance"
  },
  "taxonomy": [
   "https://home.photocure.com/5967007LIEEXZXG8OW35-2022-12-31.xsd"
  ]
 },
 "facts": {
  "f2942": {
   "value": "374474000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:RevenueFromContractsWithCustomers",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2944": {
   "value": "354124000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:RevenueFromContractsWithCustomers",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2950": {
   "value": "18658000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:SigningFeesAndMilestoneRevenues",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2952": {
   "value": "6416000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:SigningFeesAndMilestoneRevenues",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2957": {
   "value": "393132000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Revenue",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2959": {
   "value": "360540000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Revenue",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2965": {
   "value": "22697000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CostOfSales",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2967": {
   "value": "24050000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CostOfSales",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2972": {
   "value": "370434000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:GrossProfit",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2974": {
   "value": "336490000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:GrossProfit",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2985": {
   "value": "15371000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Indirectmanufacturingexpenses",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2987": {
   "value": "14828000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Indirectmanufacturingexpenses",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2993": {
   "value": "3342000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ResearchAndDevelopmentExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f2995": {
   "value": "4322000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ResearchAndDevelopmentExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3001": {
   "value": "303434000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:SalesAndMarketingExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3003": {
   "value": "259867000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:SalesAndMarketingExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3009": {
   "value": "97290000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:MiscellaneousOtherOperatingExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3011": {
   "value": "63299000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:MiscellaneousOtherOperatingExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3016": {
   "value": "-419437000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherOperatingIncomeExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3018": {
   "value": "-342316000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherOperatingIncomeExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3023": {
   "value": "-49003000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossFromOperatingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3025": {
   "value": "-5826000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossFromOperatingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3031": {
   "value": "9218000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3033": {
   "value": "26212000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3039": {
   "value": "30591000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:FinanceCosts",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3041": {
   "value": "34822000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:FinanceCosts",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3047": {
   "value": "-758000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseInFairValueMeasurementLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3049": {
   "value": "-17220000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseInFairValueMeasurementLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3054": {
   "value": "-22131000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncomeCost",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3056": {
   "value": "-25830000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:FinanceIncomeCost",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3061": {
   "value": "-71134000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3063": {
   "value": "-31656000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3069": {
   "value": "723000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3071": {
   "value": "-759000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3076": {
   "value": "-71857000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3078": {
   "value": "-30897000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3081": {
   "value": "2202000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3083": {
   "value": "-1311000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3089": {
   "value": "2202000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3091": {
   "value": "-1311000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3096": {
   "value": "-69654000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3098": {
   "value": "-32208000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3104": {
   "value": "-266",
   "decimals": 0,
   "dimensions": {
    "concept": "ifrs-full:BasicEarningsLossPerShare",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK/xbrli:shares"
   }
  },
  "f3106": {
   "value": "-115",
   "decimals": 0,
   "dimensions": {
    "concept": "ifrs-full:BasicEarningsLossPerShare",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK/xbrli:shares"
   }
  },
  "f3109": {
   "value": "-266",
   "decimals": 0,
   "dimensions": {
    "concept": "ifrs-full:DilutedEarningsLossPerShare",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK/xbrli:shares"
   }
  },
  "f3111": {
   "value": "-115",
   "decimals": 0,
   "dimensions": {
    "concept": "ifrs-full:DilutedEarningsLossPerShare",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK/xbrli:shares"
   }
  },
  "f3133": {
   "value": "129209000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:CustomerRelations",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3135": {
   "value": "145881000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:CustomerRelations",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3141": {
   "value": "144000000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Goodwill",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3143": {
   "value": "144000000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Goodwill",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3149": {
   "value": "32479000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PropertyPlantAndEquipment",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3151": {
   "value": "33575000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PropertyPlantAndEquipment",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3169": {
   "value": "55120000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:DeferredTaxAssets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3171": {
   "value": "53003000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:DeferredTaxAssets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3176": {
   "value": "360808000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentAssets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3178": {
   "value": "376459000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentAssets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3184": {
   "value": "26534000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:InventoriesTotal",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3186": {
   "value": "27534000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:InventoriesTotal",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3192": {
   "value": "47164000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentTradeReceivables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3194": {
   "value": "47980000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentTradeReceivables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3200": {
   "value": "16455000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentReceivables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3202": {
   "value": "14780000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentReceivables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3208": {
   "value": "268073000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3210": {
   "value": "322895000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3215": {
   "value": "358226000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentAssets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3217": {
   "value": "413189000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentAssets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3222": {
   "value": "719034000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Assets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3224": {
   "value": "789648000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Assets",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3248": {
   "value": "13560000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IssuedCapital",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3250": {
   "value": "13487000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IssuedCapital",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3255": {
   "value": "440415000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:OtherPaidInCapital",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3257": {
   "value": "410734000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:OtherPaidInCapital",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3262": {
   "value": "8758000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:RetainedEarnings",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3264": {
   "value": "78412000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:RetainedEarnings",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3269": {
   "value": "462733000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3271": {
   "value": "502633000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3277": {
   "value": "126233000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentFinancialLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3279": {
   "value": "133600000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentFinancialLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3285": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Longtermborrowings",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3287": {
   "value": "12500000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Longtermborrowings",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3293": {
   "value": "4755000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentProvisionsForEmployeeBenefits",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3295": {
   "value": "3520000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentProvisionsForEmployeeBenefits",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3301": {
   "value": "21256000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLeaseLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3303": {
   "value": "23813000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLeaseLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3308": {
   "value": "152245000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3310": {
   "value": "173433000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:NoncurrentLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3316": {
   "value": "21281000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:TradeAndOtherCurrentPayables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3318": {
   "value": "23648000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:TradeAndOtherCurrentPayables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3324": {
   "value": "4587000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3326": {
   "value": "3001000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3332": {
   "value": "27382000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentPortionOfLongtermBorrowings",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3334": {
   "value": "36580000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentPortionOfLongtermBorrowings",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3340": {
   "value": "50807000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3342": {
   "value": "50354000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherCurrentLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3347": {
   "value": "104056000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3349": {
   "value": "113583000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CurrentLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3354": {
   "value": "256301000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Liabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3356": {
   "value": "287016000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Liabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3361": {
   "value": "719034000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:EquityAndLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3363": {
   "value": "789648000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:EquityAndLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3397": {
   "value": "-71134000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3399": {
   "value": "-31656000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLossBeforeTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3405": {
   "value": "24378000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3407": {
   "value": "24127000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3413": {
   "value": "22176000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForSharebasedPayments",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3415": {
   "value": "12665000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForSharebasedPayments",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3421": {
   "value": "1235000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3423": {
   "value": "921000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3429": {
   "value": "2147000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForInterestIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3431": {
   "value": "1807000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForInterestIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3437": {
   "value": "25804000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForInterestExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3439": {
   "value": "23826000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForInterestExpense",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3445": {
   "value": "758000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3447": {
   "value": "17220000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3458": {
   "value": "763000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3460": {
   "value": "-14870000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3465": {
   "value": "-893000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherAdjustmentsForNoncashItems",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3467": {
   "value": "-2528000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherAdjustmentsForNoncashItems",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3473": {
   "value": "1000000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3475": {
   "value": "2144000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3480": {
   "value": "-859000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3482": {
   "value": "-15080000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3487": {
   "value": "-782000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3489": {
   "value": "-1954000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3494": {
   "value": "460000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForProvisions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3496": {
   "value": "11668000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:AdjustmentsForProvisions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3506": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Settlementemployeebenefits",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3508": {
   "value": "-476000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Settlementemployeebenefits",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3514": {
   "value": "-2777000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3516": {
   "value": "-314000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3521": {
   "value": "-2018000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3523": {
   "value": "23886000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3528": {
   "value": "2147000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:InterestReceivedClassifiedAsInvestingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3530": {
   "value": "1807000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:InterestReceivedClassifiedAsInvestingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3547": {
   "value": "3609000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3549": {
   "value": "3703000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3554": {
   "value": "-1462000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3556": {
   "value": "-1896000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3562": {
   "value": "3164000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3564": {
   "value": "5306000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3570": {
   "value": "-25000000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3572": {
   "value": "-12500000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3577": {
   "value": "1368000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3579": {
   "value": "1401000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3585": {
   "value": "29390000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Earnoutliability",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3587": {
   "value": "28818000",
   "decimals": -3,
   "dimensions": {
    "concept": "photocure:Earnoutliability",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3592": {
   "value": "7580000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3594": {
   "value": "14042000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProceedsFromExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3599": {
   "value": "-51342000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3601": {
   "value": "-33983000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3606": {
   "value": "-54822000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3608": {
   "value": "-11993000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3613": {
   "value": "322895000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3615": {
   "value": "334887000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3620": {
   "value": "268073000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3622": {
   "value": "322895000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:CashAndCashEquivalents",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3772": {
   "value": "13359000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3774": {
   "value": "-408000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3776": {
   "value": "384834000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3778": {
   "value": "-773000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3780": {
   "value": "111121000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3782": {
   "value": "508132000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3786": {
   "value": "-30897000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3788": {
   "value": "-30897000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3792": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3794": {
   "value": "-1311000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3796": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3798": {
   "value": "-1311000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3801": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3803": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3805": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3807": {
   "value": "-1311000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3809": {
   "value": "-30897000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3811": {
   "value": "-32208000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3815": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IssueOfEquity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3818": {
   "value": "186000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:SaleOrIssueOfTreasuryShares",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3820": {
   "value": "186000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:SaleOrIssueOfTreasuryShares",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3823": {
   "value": "-89000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3825": {
   "value": "-89000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3828": {
   "value": "128000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3830": {
   "value": "26211000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3832": {
   "value": "271000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3834": {
   "value": "26611000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3837": {
   "value": "128000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3839": {
   "value": "98000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3841": {
   "value": "26211000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3843": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3845": {
   "value": "271000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3847": {
   "value": "26709000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2021-01-01T00:00:00/2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3850": {
   "value": "13487000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3852": {
   "value": "-310000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3854": {
   "value": "411045000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3856": {
   "value": "-2084000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3858": {
   "value": "80495000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3860": {
   "value": "502633000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3864": {
   "value": "-71857000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3866": {
   "value": "-71857000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ProfitLoss",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3870": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3872": {
   "value": "2202000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3874": {
   "value": "2202000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3877": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3879": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3881": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3883": {
   "value": "2202000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3885": {
   "value": "-71857000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3887": {
   "value": "-69654000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:ComprehensiveIncome",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3891": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2020-01-01T00:00:00/2021-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3894": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:SaleOrIssueOfTreasuryShares",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3897": {
   "value": "-3685000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3899": {
   "value": "-3685000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3902": {
   "value": "74000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3904": {
   "value": "3695000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3906": {
   "value": "29671000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3908": {
   "value": "33440000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughExerciseOfOptions",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3911": {
   "value": "74000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3913": {
   "value": "10000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3915": {
   "value": "29671000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3917": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3919": {
   "value": "0",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3921": {
   "value": "29755000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3924": {
   "value": "13560000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3926": {
   "value": "-300000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:TreasurySharesMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3928": {
   "value": "440717000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:AdditionalPaidinCapitalMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3930": {
   "value": "118000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3932": {
   "value": "8638000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember",
    "unit": "iso4217:NOK"
   }
  },
  "f3934": {
   "value": "462733000",
   "decimals": -3,
   "dimensions": {
    "concept": "ifrs-full:Equity",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2023-01-01T00:00:00",
    "unit": "iso4217:NOK"
   }
  },
  "f3943": {
   "value": "<span class=\"SCB3 S9 S2\" id=\"t4_36\">Accounting </span><span class=\"SCB4 S9 S2\" id=\"t5_36\">principles 2022 </span><span class=\"SCB5 S47 S2\" id=\"t6_36\">I. General information </span><span class=\"SCB6 S46 S2\" id=\"t7_36\">The annual accounts for 2022 </span><span class=\"SCB7 S46 S2\" id=\"t8_36\">for Photocure Group (Photocure) </span><span class=\"SCB8 S46 S2\" id=\"t9_36\">comprises Photocure ASA and the four </span><span class=\"SCB9 S46 S2\" id=\"ta_36\">wholly owned subsidiaries; Photocure </span><span class=\"SCBA S46 S2\" id=\"tb_36\">Inc. registered in U.S, Photocure GmbH </span><span class=\"SCBB S46 S2\" id=\"tc_36\">registered in Germany, Photocure SAS </span><span class=\"SCBC S46 S2\" id=\"td_36\">registered in France and Photocure </span><span class=\"SCBD S46 S2\" id=\"te_36\">Canada Inc. registered in Canada. The </span><span class=\"SCBE S46 S2\" id=\"tf_36\">annual accounts for Photocure were </span><span class=\"SCBF S46 S2\" id=\"tg_36\">approved for publication by the Board </span><span class=\"SCC0 S46 S2\" id=\"th_36\">of Directors on 11 April 2023. </span><span class=\"SCC1 S46 S2\" id=\"ti_36\">Photocure ASA is a public limited </span><span class=\"SCC2 S46 S2\" id=\"tj_36\">company domiciled in Norway. The </span><span class=\"SCC3 S46 S2\" id=\"tk_36\">business of the Group is associated </span><span class=\"SCC4 S46 S2\" id=\"tl_36\">with research, development, </span><span class=\"SCC5 S46 S2\" id=\"tm_36\">production, distribution, marketing </span><span class=\"SCC6 S46 S2\" id=\"tn_36\">and sales of pharmaceutical products. </span><span class=\"SCC7 S46 S2\" id=\"to_36\">The Company\u2019s shares are listed </span><span class=\"SCC8 S46 S2\" id=\"tp_36\">on the Oslo Stock Exchange. The </span><span class=\"SCC9 S46 S2\" id=\"tq_36\">Parent Company\u2019s registered o\ufb03ce is </span><span class=\"SCCA S46 S2\" id=\"tr_36\">Ho\ufb00sveien 4, NO-0275 Oslo, Norway. </span><span class=\"SCCB S47 S2\" id=\"ts_36\">II. Basis for preparation of </span><span class=\"SCCC S47 S2\" id=\"tt_36\">the annual accounts </span><span class=\"SCCD S46 S2\" id=\"tu_36\">The annual accounts for the Group </span><span class=\"SCCE S46 S2\" id=\"tv_36\">and the Parent Company have been </span><span class=\"SCCF S46 S2\" id=\"tw_36\">prepared on the basis of historical cost, </span><span class=\"SCD0 S46 S2\" id=\"tx_36\">with the exception of money market </span><span class=\"SCD1 S46 S2\" id=\"ty_36\">funds and earnout liability that are </span><span class=\"SCD2 S46 S2\" id=\"tz_36\">valued at fair value. </span><span class=\"SCD3 S46 S362 S2\" id=\"t10_36\">The Group and the Parent Company\u2019s </span><span class=\"SCD4 S46 S362 S2\" id=\"t11_36\">annual accounts are prepared in </span><span class=\"SCD5 S46 S362 S2\" id=\"t12_36\">accordance with International Financial </span><span class=\"SCD6 S46 S362 S2\" id=\"t13_36\">Reporting Standards (IFRS) as speci\ufb01ed </span><span class=\"SCD7 S46 S362 S2\" id=\"t14_36\">by the International Accounting </span><span class=\"SCD8 S46 S362 S2\" id=\"t15_36\">Standards Board as adopted by </span><span class=\"SCD9 S46 S362 S2\" id=\"t16_36\">the European Union (EU) as per 31 </span><span class=\"SCDA S46 S362 S2\" id=\"t17_36\">December 2022. </span><span class=\"SCDB S46 S362 S2\" id=\"t18_36\">Photocure ASA has NOK (Norwegian </span><span class=\"SCDC S46 S362 S2\" id=\"t19_36\">kroner) as its functional currency and </span><span class=\"SCDD S46 S362 S2\" id=\"t1a_36\">presentation currency. In the absence </span><span class=\"SCDE S46 S362 S2\" id=\"t1b_36\">of any statement to the contrary, all </span><span class=\"SCDF S46 S362 S2\" id=\"t1c_36\">\ufb01nancial information is reported in </span><span class=\"SCE0 S46 S362 S2\" id=\"t1d_36\">whole thousands. As a result of rounding </span><span class=\"SCE1 S46 S362 S2\" id=\"t1e_36\">adjustments, the \ufb01gures in the \ufb01nancial </span><span class=\"SCE2 S46 S362 S2\" id=\"t1f_36\">statements may not add up to the totals. </span><span class=\"SCE3 S46 S362 S2\" id=\"t1g_36\">Photocure performs the sales and </span><span class=\"SCE4 S46 S362 S2\" id=\"t1h_36\">distribution of Hexvix in the European </span><span class=\"SCE5 S46 S362 S2\" id=\"t1i_36\">markets. Photocure has established </span><span class=\"SCE6 S46 S362 S2\" id=\"t1j_36\">wholly owned subsidiaries in Germany </span><span class=\"SCE7 S46 S362 S2\" id=\"t1k_36\">(Photocure GmbH) and France </span><span class=\"SCE8 S46 S362 S2\" id=\"t1l_36\">(Photocure SAS) that provide marketing </span><span class=\"SCE9 S46 S362 S2\" id=\"t1m_36\">and promotion services. These entities </span><span class=\"SCEA S46 S362 S2\" id=\"t1n_36\">have Euro (EUR) as functional currency. </span><span class=\"SCEB S46 S362 S2\" id=\"t1o_36\">The sales, marketing and distribution </span><span class=\"SCEC S46 S362 S2\" id=\"t1p_36\">in North America is in U.S. performed </span><span class=\"SCED S46 S362 S2\" id=\"t1q_36\">through Photocure\u2019s wholly owned </span><span class=\"SCEE S46 S362 S2\" id=\"t1r_36\">subsidiary Photocure Inc. and in Canada </span><span class=\"SCEF S46 S362 S2\" id=\"t1s_36\">though Photocure\u2019s wholly owned </span><span class=\"SCF0 S46 S362 S2\" id=\"t1t_36\">subsidiary Photocure Canada Inc., in </span><span class=\"SCF1 S46 S362 S2\" id=\"t1u_36\">both countries under the trade name </span><span class=\"SCF2 S46 S362 S2\" id=\"t1v_36\">Cysview. Photocure Inc. has U.S. dollars </span><span class=\"SCF3 S46 S362 S2\" id=\"t1w_36\">(USD) as functional currency while </span><span class=\"SCF4 S46 S362 S2\" id=\"t1x_36\">Photocure Canada Inc. has </span><span class=\"SCF5 S46 S2\" id=\"t1y_36\">Canadian </span><span class=\"SCF6 S46 S2\" id=\"t1z_36\">dollars (CAD) as functional currency. </span><div class=\"S0\" id=\"p37\" style=\"content-visibility: auto;\"><div class=\"S1\" id=\"pg37Overlay\"></div><div id=\"pg37\" style=\"-webkit-user-select: none;\"><img alt=\"\" src=\"data:image/svg+xml;base64,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\" style=\"width:909px; height:1286px; transform:scale(1); z-index: 0;\"/></div><div class=\"S3\"><span class=\"SCF7 S49 S2\" id=\"t1_37\">37 </span><span class=\"SCF8 S47 S2\" id=\"t2_37\">III. Changes in signi\ufb01cant </span><span class=\"SCF9 S47 S2\" id=\"t3_37\">accounting policies </span><span class=\"SCFA S46 S2\" id=\"t4_37\">There are no signi\ufb01cant new IFRS </span><span class=\"SCFB S46 S2\" id=\"t5_37\">standards made e\ufb00ective in 2022 </span><span class=\"SCFC S46 S2\" id=\"t6_37\">that e\ufb00ect the group accounts for </span><span class=\"SCFD S46 S2\" id=\"t7_37\">Photocure. </span><span class=\"SCFE S47 S2\" id=\"t8_37\">IV. Disclosures regarding </span><span class=\"SCFF S47 S2\" id=\"t9_37\">new standards not yet </span><span class=\"SD00 S47 S2\" id=\"ta_37\">e\ufb00ective </span><span class=\"SD01 S46 S2\" id=\"tb_37\">There are no IFRS or IFRIC </span><span class=\"SD02 S46 S2\" id=\"tc_37\">interpretations that are not yet </span><span class=\"SD03 S46 S2\" id=\"td_37\">e\ufb00ective that would be expected to </span><span class=\"SD04 S46 S2\" id=\"te_37\">have a material impact on the Group. </span><span class=\"SD05 S46 S2\" id=\"tf_37\">The new and amended standards </span><span class=\"SD06 S46 S2\" id=\"tg_37\">and interpretations from IFRS that </span><span class=\"SD07 S46 S2\" id=\"th_37\">were adopted by the EU with e\ufb00ect </span><span class=\"SD08 S46 S2\" id=\"ti_37\">from 2022 did not have any signi\ufb01cant </span><span class=\"SD09 S46 S2\" id=\"tj_37\">impact on the reporting in 2022. </span><span class=\"SD0A S47 S2\" id=\"tk_37\">V. Use of judgements and </span><span class=\"SD0B S47 S2\" id=\"tl_37\">estimates </span><span class=\"SD0C S46 S2\" id=\"tm_37\">In preparation of these consolidated </span><span class=\"SD0D S46 S2\" id=\"tn_37\">\ufb01nancial statements, management </span><span class=\"SD0E S46 S2\" id=\"to_37\">has made judgments, estimates and </span><span class=\"SD0F S46 S2\" id=\"tp_37\">assumptions that a\ufb00ect the application </span><span class=\"SD10 S46 S2\" id=\"tq_37\">of the Group\u2019s accounting policies </span><span class=\"SD11 S46 S2\" id=\"tr_37\">and the reported amounts of assets, </span><span class=\"SD12 S46 S2\" id=\"ts_37\">liabilities, income and expenses. Actual </span><span class=\"SD13 S46 S2\" id=\"tt_37\">results may di\ufb00er from these estimates. </span><span class=\"SD14 S46 S2\" id=\"tu_37\">Estimates and underlying assumptions </span><span class=\"SD15 S46 S2\" id=\"tv_37\">are reviewed on an ongoing basis. </span><span class=\"SD16 S46 S2\" id=\"tw_37\">Revisions to estimates are recognized </span><span class=\"SD17 S46 S2\" id=\"tx_37\">prospectively. Information about </span><span class=\"SD18 S46 S2\" id=\"ty_37\">judgements made in applying </span><span class=\"SD19 S46 S2\" id=\"tz_37\">accounting policies that have the </span><span class=\"SD1A S46 S2\" id=\"t10_37\">most signi\ufb01cant e\ufb00ects on the </span><span class=\"SD1B S46 S2\" id=\"t11_37\">amounts recognized, and information </span><span class=\"SD1C S46 S2\" id=\"t12_37\">about assumptions and estimation </span><span class=\"SD1D S46 S2\" id=\"t13_37\">uncertainties that have signi\ufb01cant risk </span><span class=\"SD1E S46 S2\" id=\"t14_37\">of resulting in a material adjustment </span><span class=\"SD1F S46 S2\" id=\"t15_37\">in the \ufb01nancial statements as of 31 </span><span class=\"SD20 S46 S2\" id=\"t16_37\">December 2022, are included in the </span><span class=\"SD21 S46 S2\" id=\"t17_37\">following notes: </span><span class=\"SD22 S46 S2\" id=\"t18_37\">Note 13 and 22 Goodwill and </span><span class=\"SD23 S46 S2\" id=\"t19_37\">customer relations: the assumptions </span><span class=\"SD24 S46 S2\" id=\"t1a_37\">in the application of IFRS 36 of </span><span class=\"SD25 S46 S2\" id=\"t1b_37\">the annual goodwill impairment </span><span class=\"SD26 S46 S2\" id=\"t1c_37\">analysis, and the remeasurement of </span><span class=\"SD27 S46 S2\" id=\"t1d_37\">the fair value of the earnout liability </span><span class=\"SD28 S46 S2\" id=\"t1e_37\">according to IFRS 9. </span><span class=\"SD29 S46 S2\" id=\"t1f_37\">Note 11 Recognition of deferred tax </span><span class=\"SD2A S46 S2\" id=\"t1g_37\">asset: available future taxable pro\ufb01t </span><span class=\"SD2B S46 S2\" id=\"t1h_37\">against which tax losses carried </span><span class=\"SD2C S46 S2\" id=\"t1i_37\">forward can be used. </span><span class=\"SD2D S46 S2\" id=\"t1j_37\">Note 9 and 10 Long term loan </span><span class=\"SD2E S46 S2\" id=\"t1k_37\">subsidiary: impairment and key </span><span class=\"SD2F S46 S2\" id=\"t1l_37\">assumptions underlying the balance </span><span class=\"SD30 S46 S2\" id=\"t1m_37\">sheet value in Parent company. </span><span class=\"SD31 S47 S2\" id=\"t1n_37\">VI. Summary of important </span><span class=\"SD32 S47 S2\" id=\"t1o_37\">guidelines for accounting </span><span class=\"SD33 S47 S2\" id=\"t1p_37\">for the Group </span><span class=\"SD34 S202 S2\" id=\"t1q_37\">A. Classi\ufb01cation </span><span class=\"SD35 S46 S2\" id=\"t1r_37\">Assets/liabilities are classi\ufb01ed as </span><span class=\"SD36 S46 S2\" id=\"t1s_37\">current assets/current liabilities when </span><span class=\"SD37 S46 S2\" id=\"t1t_37\">they meet one of the following criteria: </span><span class=\"SD38 S46 S2\" id=\"t1u_37\">They are expected to be realized in </span><span class=\"SD39 S46 S2\" id=\"t1v_37\">the Group\u2019s ordinary operating cycle </span><span class=\"SD3A S46 S2\" id=\"t1w_37\">or are kept for sale or consumption; </span><span class=\"SD3B S46 S2\" id=\"t1x_37\">They are expected to be realized </span><span class=\"SD3C S46 S2\" id=\"t1y_37\">within 12 months of the balance </span><span class=\"SD3D S46 S2\" id=\"t1z_37\">sheet date; or </span><span class=\"SD3E S46 S2\" id=\"t20_37\">They are in the form of cash or a </span><span class=\"SD3F S46 S2\" id=\"t21_37\">cash equivalent. </span><span class=\"SD40 S46 S29E S2\" id=\"t22_37\">All other assets/liabilities are </span><span class=\"SD41 S46 S29E S2\" id=\"t23_37\">classi\ufb01ed as \ufb01xed assets/long-term </span><span class=\"SD42 S46 S29E S2\" id=\"t24_37\">liabilities </span><span class=\"SD43 S202 S2\" id=\"t25_37\">B. Currency </span><span class=\"SD44 S46 S2\" id=\"t26_37\">Monetary items in foreign currencies </span><span class=\"SD45 S46 S2\" id=\"t27_37\">are converted at closing rate of </span><span class=\"SD46 S46 S2\" id=\"t28_37\">exchange. In the absence of any </span><span class=\"SD47 S46 S2\" id=\"t29_37\">statement to the contrary, realized </span><span class=\"SD48 S46 S2\" id=\"t2a_37\">and unrealized exchange rate gains </span><span class=\"SD49 S46 S2\" id=\"t2b_37\">and losses are included in \ufb01nancial </span><span class=\"SD4A S46 S2\" id=\"t2c_37\">income or expenses. Transactions </span><span class=\"SD4B S46 S2\" id=\"t2d_37\">in foreign currencies are recorded </span><span class=\"SD4C S46 S2\" id=\"t2e_37\">at the exchange rate on the date of </span><span class=\"SD4D S46 S2\" id=\"t2f_37\">transaction. Assets and liabilities in </span><span class=\"SD4E S46 S2\" id=\"t2g_37\">foreign currencies are translated into </span><span class=\"SD4F S46 S2\" id=\"t2h_37\">NOK at the exchange rate applicable on </span><span class=\"SD50 S46 S2\" id=\"t2i_37\">the balance sheet date. </span><span class=\"SD51 S46 S2\" id=\"t2j_37\">Income and expenses in foreign </span><span class=\"SD52 S46 S2\" id=\"t2k_37\">subsidiaries are translated into NOK </span><span class=\"SD53 S46 S2\" id=\"t2l_37\">at the average exchange rate for the </span><span class=\"SD54 S46 S2\" id=\"t2m_37\">\ufb01nancial statement period. The assets </span><span class=\"SD55 S46 S2\" id=\"t2n_37\">and liabilities of the foreign subsidiaries </span><span class=\"SD56 S46 S2\" id=\"t2o_37\">are translated to NOK at exchange rates </span><span class=\"SD57 S46 S2\" id=\"t2p_37\">at the reporting date </span><span class=\"SD58 S202 S2\" id=\"t2q_37\">C. Property, plant, </span><span class=\"SD59 S202 S2\" id=\"t2r_37\">equipment and intangible </span><span class=\"SD5A S202 S2\" id=\"t2s_37\">assets </span><span class=\"SD5B S46 S2\" id=\"t2t_37\">Property, plant and equipment (PPE) </span><span class=\"SD5C S46 S2\" id=\"t2u_37\">are recognized at cost less deductions </span><span class=\"SD5D S46 S2\" id=\"t2v_37\">for accumulated depreciation and </span><span class=\"SD5E S46 S2\" id=\"t2w_37\">accumulated impairment losses. PPE </span><span class=\"SD5F S46 S2\" id=\"t2x_37\">are depreciated over the expected </span><span class=\"SD60 S46 S2\" id=\"t2y_37\">useful life of the assets taking any </span><span class=\"SD61 S46 S2\" id=\"t2z_37\">residual value into consideration. Costs </span><span class=\"SD62 S46 S2\" id=\"t30_37\">incurred for major replacements and </span><span class=\"SD63 S46 S2\" id=\"t31_37\">upgrades of PPE are added to cost if it </span><span class=\"SD64 S46 S2\" id=\"t32_37\">is probable that the costs will generate </span><span class=\"SD65 S46 S2\" id=\"t33_37\">future economic bene\ufb01ts for the </span><span class=\"SD66 S46 S2\" id=\"t34_37\">Group and if the costs can be reliably </span><span class=\"SD67 S46 S2\" id=\"t35_37\">measured. Ordinary maintenance is </span><span class=\"SD68 S46 S2\" id=\"t36_37\">expensed as incurred. </span><span class=\"SD69 S46 S2\" id=\"t37_37\">PPE are depreciated on a straight-line </span><span class=\"SD6A S46 S2\" id=\"t38_37\">basis over the estimated useful life of </span><span class=\"SD6B S46 S2\" id=\"t39_37\">the asset as follows: </span><span class=\"SD6C S46 S2\" id=\"t3a_37\">Production and test </span><span class=\"SD6D S46 S2\" id=\"t3b_37\">equipment </span><span class=\"SD6E S46 S2\" id=\"t3c_37\">5 years </span><span class=\"SD6F S46 S2\" id=\"t3d_37\">Furniture and o\ufb03ce </span><span class=\"SD70 S46 S2\" id=\"t3e_37\">equipment </span><span class=\"SD71 S46 S2\" id=\"t3f_37\">3\u20135 years </span><span class=\"SD72 S46 S2\" id=\"t3g_37\">Intangible development expenditures </span><span class=\"SD73 S46 S2\" id=\"t3h_37\">are amortized on a straight-line basis in </span><span class=\"SD74 S46 S2\" id=\"t3i_37\">the pro\ufb01t and loss over the remaining </span><span class=\"SD75 S46 S2\" id=\"t3j_37\">patent period for the approved product </span><span class=\"SD76 S46 S2\" id=\"t3k_37\">and indication as follows: </span><span class=\"SD77 S46 S2\" id=\"t3l_37\">Product development </span><span class=\"SD78 S46 S2\" id=\"t3m_37\">4 - 10 years </span><span class=\"SD79 S46 S2\" id=\"t3n_37\">Customer relations </span><span class=\"SD7A S46 S2\" id=\"t3o_37\">10 years </span><span class=\"SD7B S202 S2\" id=\"t3p_37\">D. Impairment </span><span class=\"SD7C S46 S2\" id=\"t3q_37\">Non-current &amp; intangible assets that </span><span class=\"SD7D S46 S2\" id=\"t3r_37\">are recognized in the balance sheet, </span><span class=\"SD7E S46 S2\" id=\"t3s_37\">are tested for impairment if there are </span><span class=\"SD7F S46 S2\" id=\"t3t_37\">indications of a </span><span class=\"SD80 S46 S2\" id=\"t3u_37\">loss in value. If the </span><span class=\"SD81 S46 S2\" id=\"t3v_37\">book value of an asset is higher than </span><span class=\"SD82 S46 S2\" id=\"t3w_37\">the recoverable value of the asset, </span><span class=\"SD83 S46 S2\" id=\"t3x_37\">the loss in value is recognized in pro\ufb01t </span><span class=\"SD84 S46 S2\" id=\"t3y_37\">and loss. The recoverable value is the </span></div></div><div class=\"S0\" id=\"p38\" style=\"content-visibility: auto;\"><div class=\"S1\" id=\"pg38Overlay\"></div><div id=\"pg38\" style=\"-webkit-user-select: none;\"><img alt=\"\" src=\"data:image/svg+xml;base64,﻿<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"[]>
<svg viewBox="0 0 909 1286" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <clipPath id="c0_38">
      <path d="M55,1186.6V789.3H799.7v397.3Z" />
    </clipPath>
    <style type="text/css"><![CDATA[
.g0_38{
fill: none;
stroke: #1E1051;
stroke-width: 0.381;
stroke-linecap: butt;
stroke-linejoin: miter;
}
.g1_38{
fill: #776D9C;
}
.g2_38{
fill: #CBD5DB;
}
]]></style>
  </defs>
  <path d="M110,109.3H854.4" class="g0_38" />
  <path d="M567.1,267.1c2.3,0,4.2,-1.9,4.2,-4.2c0,-2.3,-1.9,-4.2,-4.2,-4.2c-2.3,0,-4.2,1.9,-4.2,4.2c0,2.3,1.9,4.2,4.2,4.2Z" class="g1_38" />
  <path d="M567.1,377.1c2.3,0,4.2,-1.9,4.2,-4.2c0,-2.3,-1.9,-4.2,-4.2,-4.2c-2.3,0,-4.2,1.9,-4.2,4.2c0,2.3,1.9,4.2,4.2,4.2Z" class="g1_38" />
  <path d="M55,1186.6H799.7V775.2H55v411.4Z" class="g2_38" />
  <image clip-path="url(#c0_38)" preserveAspectRatio="none" x="53" y="789" width="748" height="399" xlink:href="data:image/jpg;base64,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" />
</svg>\" style=\"width:909px; height:1286px; transform:scale(1); z-index: 0;\"/></div><div class=\"S3\"><span class=\"SD85 S49 S2\" id=\"t1_38\">38 </span><span class=\"S4B S47 S2\" id=\"t2_38\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_38\">\u2013 Results 2022 </span><span class=\"SD86 S46 S2\" id=\"t4_38\">highest of net sales value and the value </span><span class=\"SD87 S46 S2\" id=\"t5_38\">in use of the asset. Assets are grouped </span><span class=\"SD88 S46 S2\" id=\"t6_38\">and measured at the lowest level for </span><span class=\"SD89 S46 S2\" id=\"t7_38\">determining loss in value. </span><span class=\"SD8A S46 S2\" id=\"t8_38\">Previous impairment losses are </span><span class=\"SD8B S46 S2\" id=\"t9_38\">reversed to the extent that the assets </span><span class=\"SD8C S46 S2\" id=\"ta_38\">carrying amount does not exceed the </span><span class=\"SD8D S46 S2\" id=\"tb_38\">carrying amount that would have been </span><span class=\"SD8E S46 S2\" id=\"tc_38\">determined, net of depreciation and </span><span class=\"SD8F S46 S2\" id=\"td_38\">amortization, if no impairment loss had </span><span class=\"SD90 S46 S2\" id=\"te_38\">been recognized or taken place. </span><span class=\"SD91 S46 S2\" id=\"tf_38\">Goodwill is tested annually for </span><span class=\"SD92 S46 S2\" id=\"tg_38\">impairment. For impairment testing, </span><span class=\"SD93 S46 S2\" id=\"th_38\">assets are grouped that generate cash </span><span class=\"SD94 S46 S2\" id=\"ti_38\">in\ufb02ows from continuing use that are </span><span class=\"SD95 S46 S2\" id=\"tj_38\">largely independent from the cash </span><span class=\"SD96 S46 S2\" id=\"tk_38\">in\ufb02ows from other assets or cash </span><span class=\"SD97 S46 S2\" id=\"tl_38\">generating units (CGU). Goodwill that </span><span class=\"SD98 S46 S2\" id=\"tm_38\">are arising from a business combination </span><span class=\"SD99 S46 S2\" id=\"tn_38\">is allocated to CGUs or group of CGUs </span><span class=\"SD9A S46 S2\" id=\"to_38\">that are expected to bene\ufb01t from the </span><span class=\"SD9B S46 S2\" id=\"tp_38\">synergies of the combination. The </span><span class=\"SD9C S46 S2\" id=\"tq_38\">recoverable value of the asset is the </span><span class=\"SD9D S46 S2\" id=\"tr_38\">greater of value in use and its fair value </span><span class=\"SD9E S46 S2\" id=\"ts_38\">less cost of disposal. Value in use is </span><span class=\"SD9F S46 S2\" id=\"tt_38\">based on estimated future cash \ufb02ows, </span><span class=\"SDA0 S46 S2\" id=\"tu_38\">discounted to their present value using </span><span class=\"SDA1 S46 S2\" id=\"tv_38\">a pre-tax discount rate that re\ufb02ects </span><span class=\"SDA2 S46 S2\" id=\"tw_38\">current market assessments of the time </span><span class=\"SDA3 S46 S2\" id=\"tx_38\">value of money and the risks speci\ufb01c to </span><span class=\"SDA4 S46 S2\" id=\"ty_38\">the asset. </span><span class=\"SDA5 S46 S2\" id=\"tz_38\">An impairment loss is allocated \ufb01rst to </span><span class=\"SDA6 S46 S2\" id=\"t10_38\">reduce the book value of the goodwill </span><span class=\"SDA7 S46 S2\" id=\"t11_38\">related to the CGU and then to reduce </span><span class=\"SDA8 S46 S2\" id=\"t12_38\">the carrying amount of the other assets </span><span class=\"SDA9 S46 S2\" id=\"t13_38\">in the CGU on a pro rata basis. An </span><span class=\"SDAA S46 S2\" id=\"t14_38\">impairment loss in respect of goodwill </span><span class=\"SDAB S46 S2\" id=\"t15_38\">is not reversed. </span><span class=\"SDAC S202 S2\" id=\"t16_38\">E. Research and </span><span class=\"SDAD S202 S2\" id=\"t17_38\">development costs </span><span class=\"SDAE S46 SDD8 S2\" id=\"t18_38\">Research costs are expensed as incurred. </span><span class=\"SDAF S46 SDD8 S2\" id=\"t19_38\">Development costs are recognized in </span><span class=\"SDB0 S46 SDD8 S2\" id=\"t1a_38\">the balance sheet as intangible assets </span><span class=\"SDB1 S46 SDD8 S2\" id=\"t1b_38\">only if there is an identi\ufb01able asset that </span><span class=\"SDB2 S46 SDD8 S2\" id=\"t1c_38\">is expected to generate future \ufb01nancial </span><span class=\"SDB3 S46 SDD8 S2\" id=\"t1d_38\">bene\ufb01ts, and when the costs of such </span><span class=\"SDB4 S46 SDD8 S2\" id=\"t1e_38\">an asset can be reliably measured.. </span><span class=\"SDB5 S46 SDD8 S2\" id=\"t1f_38\">Development costs that have been </span><span class=\"SDB6 S46 SDD8 S2\" id=\"t1g_38\">expensed in previous accounting periods </span><span class=\"SDB7 S46 SDD8 S2\" id=\"t1h_38\">cannot be recognized in the balance </span><span class=\"SDB8 S46 SDD8 S2\" id=\"t1i_38\">sheet at a later date. Cost-sharing of </span><span class=\"SDB9 S46 SDD8 S2\" id=\"t1j_38\">research and development expenses </span><span class=\"SDBA S46 SDD8 S2\" id=\"t1k_38\">with license partners is booked as a </span><span class=\"SDBB S46 SDD8 S2\" id=\"t1l_38\">reduction in costs. </span><span class=\"SDBC S46 S2\" id=\"t1m_38\">The work of the regulatory function </span><span class=\"SDBD S46 S2\" id=\"t1n_38\">and services provided are related to </span><span class=\"SDBE S46 S2\" id=\"t1o_38\">both market expansion and product </span><span class=\"SDBF S46 S2\" id=\"t1p_38\">development. Photocure classi\ufb01es for </span><span class=\"SDC0 S46 S2\" id=\"t1q_38\">this reason the regulatory function into </span><span class=\"SDC1 S46 S2\" id=\"t1r_38\">the following two categories: </span><span class=\"SDC2 S46 S2\" id=\"t1s_38\">Regulatory work and services </span><span class=\"SDC3 S46 S2\" id=\"t1t_38\">related to new products or product </span><span class=\"SDC4 S46 S2\" id=\"t1u_38\">development based on new clinical </span><span class=\"SDC5 S46 S2\" id=\"t1v_38\">trials up to and including phase 3, </span><span class=\"SDC6 S46 S2\" id=\"t1w_38\">are classi\ufb01ed as R&amp;D costs </span><span class=\"SDC7 S46 S2\" id=\"t1x_38\">Regulatory work and services for </span><span class=\"SDC8 S46 S2\" id=\"t1y_38\">new markets based on existing </span><span class=\"SDC9 S46 S2\" id=\"t1z_38\">clinical data are classi\ufb01ed as </span><span class=\"SDCA S46 S2\" id=\"t20_38\">marketing costs </span><span class=\"SDCB S202 S2\" id=\"t21_38\">F. Investment in subsidiary </span><span class=\"SDCC S202 S2\" id=\"t22_38\">companies </span><span class=\"SDCD S46 S2\" id=\"t23_38\">Shares and investments with the aim </span><span class=\"SDCE S46 S2\" id=\"t24_38\">of long-term ownership are booked </span><span class=\"SDCF S46 S2\" id=\"t25_38\">in the balance sheet as long-term </span><span class=\"SDD0 S46 S2\" id=\"t26_38\">investments and are valued at the lower </span><span class=\"SDD1 S46 S2\" id=\"t27_38\">of cost and fair value. Write-downs for </span><span class=\"SDD2 S46 S2\" id=\"t28_38\">permanent declines in value are made </span><span class=\"SDD3 S46 S2\" id=\"t29_38\">on the basis of individual evaluations. </span><span class=\"SDD4 S46 S2\" id=\"t2a_38\">Any realized and unrealized pro\ufb01ts/ </span><span class=\"SDD5 S46 S2\" id=\"t2b_38\">losses and any write-downs related to </span><span class=\"SDD6 S46 S2\" id=\"t2c_38\">these investments will be booked in the </span><span class=\"SDD7 S46 S2\" id=\"t2d_38\">income statement as \ufb01nancial items. </span></div></div><span class=\"SDDA S202 S2\" id=\"t2_39\">G. Inventories </span><span class=\"SDDB S46 S2\" id=\"t3_39\">Raw materials are valued at the lower of </span><span class=\"SDDC S46 S2\" id=\"t4_39\">cost and net sales value in accordance </span><span class=\"SDDD S46 S2\" id=\"t5_39\">with the \ufb01rst-in, \ufb01rst-out principle (FIFO). </span><span class=\"SDDE S46 S2\" id=\"t6_39\">Semi-\ufb01nished and \ufb01nished goods are </span><span class=\"SDDF S46 S2\" id=\"t7_39\">valued at production cost including a </span><span class=\"SDE0 S46 S2\" id=\"t8_39\">mark-up for their share of the indirect </span><span class=\"SDE1 S46 S2\" id=\"t9_39\">production costs based on the FIFO </span><span class=\"SDE2 S46 S2\" id=\"ta_39\">principle. </span><span class=\"SDE3 S202 S2\" id=\"tb_39\">H. Financial assets and </span><span class=\"SDE4 S202 S2\" id=\"tc_39\">liabilities </span><span class=\"SDE5 S49 S2\" id=\"td_39\">Recognition and measurement </span><span class=\"SDE6 S46 S2\" id=\"te_39\">Trade receivables are initially recognized </span><span class=\"SDE7 S46 S2\" id=\"tf_39\">when they are originated. All other </span><span class=\"SDE8 S46 S2\" id=\"tg_39\">\ufb01nancial assets and \ufb01nancial liabilities </span><span class=\"SDE9 S46 S2\" id=\"th_39\">are initially recognized when the Group </span><span class=\"SDEA S46 S2\" id=\"ti_39\">becomes a party to the contractual </span><span class=\"SDEB S46 S2\" id=\"tj_39\">provisions of the instrument. A trade </span><span class=\"SDEC S46 S2\" id=\"tk_39\">receivable without a signi\ufb01cant \ufb01nancing </span><span class=\"SDED S46 S2\" id=\"tl_39\">component is initially measured at the </span><span class=\"SDEE S46 S2\" id=\"tm_39\">transaction price. All other \ufb01nancial </span><span class=\"SDEF S46 S2\" id=\"tn_39\">assets are initially measured at fair value </span><span class=\"SDF0 S46 S2\" id=\"to_39\">plus, for an item not at fair value through, </span><span class=\"SDF1 S46 S2\" id=\"tp_39\">transaction costs that are directly </span><span class=\"SDF2 S46 S2\" id=\"tq_39\">attributable. </span><span class=\"SDF3 S46 S2\" id=\"tr_39\">A \ufb01nancial asset is subsequently </span><span class=\"SDF4 S46 S2\" id=\"ts_39\">measured at amortized cost if it meets </span><span class=\"SDF5 S46 S2\" id=\"tt_39\">both of the following criteria and is not </span><span class=\"SDF6 S46 S2\" id=\"tu_39\">designated as at Fair Value Through </span><span class=\"SDF7 S46 S2\" id=\"tv_39\">Pro\ufb01t and Loss (FVTPL): </span><span class=\"SDF8 S46 S2\" id=\"tw_39\">it is held within a business model </span><span class=\"SDF9 S46 S2\" id=\"tx_39\">whose objective is to hold assets to </span><span class=\"SDFA S46 S2\" id=\"ty_39\">collect contractual cash \ufb02ows; and </span><span class=\"SDFB S46 S2\" id=\"tz_39\">its contractual terms give rise on </span><span class=\"SDFC S46 S2\" id=\"t10_39\">speci\ufb01ed dates to cash \ufb02ows that </span><span class=\"SDFD S46 S2\" id=\"t11_39\">are solely payments of principal and </span><span class=\"SDFE S46 S2\" id=\"t12_39\">interest on the principal amount </span><span class=\"SDFF S46 S2\" id=\"t13_39\">outstanding. </span><span class=\"SE00 S46 S2\" id=\"t14_39\">Trade receivables, loan to group </span><span class=\"SE01 S46 S2\" id=\"t15_39\">companies, and other receivables meet </span><span class=\"SE02 S46 S2\" id=\"t16_39\">both of these criteria and are measured </span><span class=\"SE03 S46 S2\" id=\"t17_39\">at amortized cost using e\ufb00ective </span><span class=\"SE04 S46 S2\" id=\"t18_39\">interest rate method. </span><span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span><span class=\"SE16 S46 S2\" id=\"t1q_39\">e\ufb00ective interest rate method. </span><span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span><span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span><span class=\"SE46 S46 S167 S2\" id=\"t32_39\">interest rate of the \ufb01nancial asset. </span><span class=\"SE47 S202 S2\" id=\"t33_39\">I. Revenue recognition </span><span class=\"SE48 S46 S2\" id=\"t34_39\">The core principle in IFRS 15 is revenue </span><span class=\"SE49 S46 S2\" id=\"t35_39\">should be recognized dependent </span><span class=\"SE4A S46 S2\" id=\"t36_39\">on the transfer of promised goods </span><span class=\"SE4B S46 S2\" id=\"t37_39\">or services to the customer for an </span><span class=\"SE4C S46 S2\" id=\"t38_39\">amount that re\ufb02ects the consideration </span><span class=\"SE4D S46 S2\" id=\"t39_39\">which should be received in exchange </span><span class=\"SE4E S46 S2\" id=\"t3a_39\">for those goods or services. The </span><span class=\"SE4F S46 S2\" id=\"t3b_39\">objective is to provide a \ufb01ve-step </span><span class=\"SE50 S46 S2\" id=\"t3c_39\">approach to revenue recognition that </span><span class=\"SE51 S46 S2\" id=\"t3d_39\">includes identifying contracts with </span><span class=\"SE52 S46 S2\" id=\"t3e_39\">customers, identifying performance </span><span class=\"SE53 S46 S2\" id=\"t3f_39\">obligations, determining transaction </span><span class=\"SE54 S46 S2\" id=\"t3g_39\">prices, allocating transaction prices </span><span class=\"SE55 S46 S2\" id=\"t3h_39\">to performance obligations, and </span><span class=\"SE56 S46 S2\" id=\"t3i_39\">recognizing revenue when or as </span><span class=\"SE57 S46 S2\" id=\"t3j_39\">performance obligations are satis\ufb01ed. </span><span class=\"SE58 S46 S2\" id=\"t3k_39\">In Photocure\u2019s customer contracts </span><span class=\"SE59 S46 S2\" id=\"t3l_39\">which are regarded to be within the </span><span class=\"SE5A S46 S2\" id=\"t3m_39\">scope of IFRS 15, the up-front fees not </span><span class=\"SE5B S46 S2\" id=\"t3n_39\">related to a separate performance </span><span class=\"SE5C S46 S2\" id=\"t3o_39\">obligation will be recognized over the </span><span class=\"SE5D S46 S2\" id=\"t3p_39\">term of the contract upon the delivery </span><span class=\"SE5E S46 S2\" id=\"t3q_39\">of goods. </span><span class=\"SE5F S46 S2\" id=\"t3r_39\">If the promise to grant the license is </span><span class=\"SE60 S46 S2\" id=\"t3s_39\">distinct from other promised goods or </span><span class=\"SE61 S46 S2\" id=\"t3t_39\">services in the contract, the promise </span><span class=\"SE62 S46 S2\" id=\"t3u_39\">to grant the license is a separate </span><span class=\"SE63 S46 S2\" id=\"t3v_39\">performance obligation. A license </span><span class=\"SE64 S46 S2\" id=\"t3w_39\">contract with a customer is a right to </span><span class=\"SE65 S46 S2\" id=\"t3x_39\">use Photocure\u2019s intellectual property as </span><span class=\"SE66 S46 S2\" id=\"t3y_39\">it exists at the point in time at which the </span><span class=\"SE67 S46 S2\" id=\"t3z_39\">license is granted. </span><span class=\"SE68 S46 S2\" id=\"t40_39\">The total transaction price is allocated </span><span class=\"SE69 S46 S2\" id=\"t41_39\">between the performance obligations </span><span class=\"SE6A S46 S2\" id=\"t42_39\">based on the relative stand-alone </span><span class=\"SE6B S46 S2\" id=\"t43_39\">selling price. The transaction price </span><span class=\"SE6C S46 S2\" id=\"t44_39\">allocated to the license may consist </span><span class=\"SE6D S46 S2\" id=\"t45_39\">of up-front fee, di\ufb00erent milestone </span><span class=\"SE6E S46 S2\" id=\"t46_39\">payments and sales based royalty </span><span class=\"SE6F S46 S2\" id=\"t4_40\">payments. The part of the transaction </span><span class=\"SE70 S46 S2\" id=\"t5_40\">price related to variable milestone </span><span class=\"SE71 S46 S2\" id=\"t6_40\">payments are estimated as the most </span><span class=\"SE72 S46 S2\" id=\"t7_40\">likely amount but constrained which </span><span class=\"SE73 S46 S2\" id=\"t8_40\">currently means that these revenues </span><span class=\"SE74 S46 S2\" id=\"t9_40\">will be recognized if and when the </span><span class=\"SE75 S46 S2\" id=\"ta_40\">relevant milestone are achieved. Sales </span><span class=\"SE76 S46 S2\" id=\"tb_40\">based royalty is recognized when the </span><span class=\"SE77 S46 S2\" id=\"tc_40\">subsequent sales occur. </span><span class=\"SE78 S46 S2\" id=\"td_40\">Revenues for the sale of products are </span><span class=\"SE79 S46 S2\" id=\"te_40\">recorded on the date of delivery, when </span><span class=\"SE7A S46 S2\" id=\"tf_40\">both control and risk essentially have </span><span class=\"SE7B S46 S2\" id=\"tg_40\">been transferred to the buyer. </span><span class=\"SE7C S46 S2\" id=\"th_40\">License agreements that give the right </span><span class=\"SE7D S46 S2\" id=\"ti_40\">to a guaranteed minimum royalty are </span><span class=\"SE7E S46 S2\" id=\"tj_40\">booked as revenue at the time the </span><span class=\"SD96 S46 S2\" id=\"tk_40\">prerequisite is ful\ufb01lled. Royalty revenue </span><span class=\"SE7F S46 S2\" id=\"tl_40\">is booked as Sales revenue in line with </span><span class=\"SE80 S46 S2\" id=\"tm_40\">the licensee\u2019s sale of licensed products. </span><span class=\"SE81 S202 S2\" id=\"tn_40\">J. Government grants </span><span class=\"SE82 S46 S2\" id=\"to_40\">Government grants are booked at </span><span class=\"SE83 S46 S2\" id=\"tp_40\">the same time as the income that it </span><span class=\"SE84 S46 S2\" id=\"tq_40\">shall generate or the cost that it shall </span><span class=\"SE85 S46 S2\" id=\"tr_40\">reduce. Grants received for product </span><span class=\"SE86 S46 S2\" id=\"ts_40\">development or manufacture are \ufb01rst </span><span class=\"SE87 S46 S2\" id=\"tt_40\">booked as reduction of costs when </span><span class=\"SE88 S46 S2\" id=\"tu_40\">the conditions for the grant in question </span><span class=\"SE89 S46 S2\" id=\"tv_40\">have been met and the applications are </span><span class=\"SE8A S46 S2\" id=\"tw_40\">granted. Grants received for product </span><span class=\"SE8B S46 S2\" id=\"tx_40\">development that are capitalized, </span><span class=\"SE8C S46 S2\" id=\"ty_40\">are reported as reduction of gross </span><span class=\"SE8D S46 S2\" id=\"tz_40\">expenditures and the net expenditures </span><span class=\"SE8E S46 S2\" id=\"t10_40\">are regarded as the intangible assets. </span><span class=\"SE8F S202 S2\" id=\"t11_40\">K. Pensions </span><span class=\"SE90 S46 S2\" id=\"t12_40\">The Company\u2019s payment of </span><span class=\"SE91 S46 S2\" id=\"t13_40\">contributions is expensed in the period </span><span class=\"SE92 S46 S2\" id=\"t14_40\">it is accrued. Any prepayments made to </span><span class=\"SE93 S46 S2\" id=\"t15_40\">the contribution fund are recognized in </span><span class=\"SE94 S46 S2\" id=\"t16_40\">the balance sheet. </span><span class=\"SE95 S46 S2\" id=\"t17_40\">Employees residing in the United </span><span class=\"SE96 S46 S2\" id=\"t18_40\">States participate in a 401(k), a tax- </span><span class=\"SE97 S46 S2\" id=\"t19_40\">quali\ufb01ed, de\ufb01ned-contribution pension </span><span class=\"SE98 S46 S2\" id=\"t1a_40\">account de\ufb01ned in subsection 401(k) </span><span class=\"SE99 S46 S2\" id=\"t1b_40\">of the Internal Revenue Code The </span><span class=\"S8FD S46 S2\" id=\"t1c_40\">401k plan is not interest-bearing, the </span><span class=\"SE9A S46 S2\" id=\"t1d_40\">employee chooses from an investment </span><span class=\"SE9B S46 S2\" id=\"t1e_40\">line up of diversi\ufb01ed mutual funds, </span><span class=\"SE9C S46 S2\" id=\"t1f_40\">which can generate gains or losses. </span><span class=\"SE9D S46 S2\" id=\"t1g_40\">Employees in Germany that were part </span><span class=\"SE9E S46 S2\" id=\"t1h_40\">of the acquisition from Ipsen have </span><span class=\"SE9F S46 S2\" id=\"t1i_40\">a de\ufb01ned bene\ufb01t pension plan that </span><span class=\"SEA0 S46 S2\" id=\"t1j_40\">has been transferred to Photocure </span><span class=\"SEA1 S46 S2\" id=\"t1k_40\">GmbH as part of the TUPE regulations. </span><span class=\"SEA2 S46 S2\" id=\"t1l_40\">Photocure GmbH has entered a </span><span class=\"SEA3 S46 S2\" id=\"t1m_40\">re-assurance agreement with an </span><span class=\"SEA4 S46 S2\" id=\"t1n_40\">assurance company that balance </span><span class=\"SDAA S46 S2\" id=\"t1o_40\">the pension liability. New employees </span><span class=\"SEA5 S46 S2\" id=\"t1p_40\">in Germany are o\ufb00ered a de\ufb01ned </span><span class=\"SEA6 S46 S2\" id=\"t1q_40\">contribution pension plan. </span><span class=\"SEA7 S46 S2\" id=\"t1r_40\">Salary to senior management </span><span class=\"SEA8 S46 S2\" id=\"t1s_40\">employees in Photocure ASA above 12 x </span><span class=\"SEA9 S46 S2\" id=\"t1t_40\">G is subject to agreements concerning </span><span class=\"SEAA S46 S2\" id=\"t1u_40\">operational coverage of pensions for </span><span class=\"SEAB S46 S2\" id=\"t1v_40\">salary above this level in the form of </span><span class=\"SEAC S46 S2\" id=\"t1w_40\">contribution-based pensions. The </span><span class=\"S7F7 S46 S2\" id=\"t1x_40\">calculated contribution constitutes </span><span class=\"SEAD S46 S2\" id=\"t1y_40\">16% of the employee\u2019s salary above 12 </span><span class=\"SEAE S46 S2\" id=\"t1z_40\">x G. </span><span class=\"SEAF S46 S2\" id=\"t20_40\">Photocure Inc has established an </span><span class=\"SEB0 S46 S2\" id=\"t21_40\">additional unfunded pension coverage </span><span class=\"SEB1 S46 S2\" id=\"t22_40\">for senior managers accruing annually </span><span class=\"SEB2 S46 S2\" id=\"t23_40\">an amount equal to 4% of salary and </span><span class=\"SEB3 S46 S2\" id=\"t24_40\">earned bonus. </span><span class=\"SEB4 S46 S2\" id=\"t25_40\">The calculated pension obligation </span><span class=\"SEB5 S46 S2\" id=\"t26_40\">pursuant to these schemes are </span><span class=\"SEB6 S46 S2\" id=\"t27_40\">interest-bearing. </span><span class=\"SEB7 S202 S2\" id=\"t28_40\">L. Share remuneration and </span><span class=\"SEB8 S202 S2\" id=\"t29_40\">other bene\ufb01ts related to </span><span class=\"SEB9 S202 S2\" id=\"t2a_40\">share based remuneration </span><span class=\"SEBA S46 S206 S2\" id=\"t2b_40\">Employees have been o\ufb00ered share </span><span class=\"SEBB S46 S206 S2\" id=\"t2c_40\">options to the Company\u2019s shares as </span><span class=\"SEBC S46 S206 S2\" id=\"t2d_40\">an element of the Group\u2019s employee </span><span class=\"SEBD S46 S206 S2\" id=\"t2e_40\">incentive policy. If the Group has own </span><span class=\"S50D S46 S206 S2\" id=\"t2f_40\">shares, the Group may allot own shares </span><span class=\"SEBE S46 S206 S2\" id=\"t2g_40\">instead of issuing new shares when share </span><span class=\"SEBF S46 S206 S2\" id=\"t2h_40\">options are exercised. All share options </span><span class=\"SEC0 S46 S206 S2\" id=\"t2i_40\">are o\ufb00ered at strike prices that re\ufb02ect </span><span class=\"SEC1 S46 S206 S2\" id=\"t2j_40\">the market price +10% of the shares at </span><span class=\"SEC2 S46 S206 S2\" id=\"t2k_40\">the time of allotment of the rights. </span><span class=\"SEC3 S46 S2\" id=\"t2l_40\">The fair value is expensed over the </span><span class=\"SEC4 S46 S2\" id=\"t2m_40\">share options vesting period and </span><span class=\"SEC5 S46 S2\" id=\"t2n_40\">the Company\u2019s equity is increased </span><span class=\"SEC6 S46 S2\" id=\"t2o_40\">correspondingly. The fair value of share </span><span class=\"SEC7 S46 S2\" id=\"t2p_40\">options is calculated according to the </span><span class=\"SEC8 S46 S2\" id=\"t2q_40\">Black-Scholes model. Each program </span><span class=\"SEC9 S46 S2\" id=\"t2r_40\">is calculated separately with the </span><span class=\"SECA S46 S2\" id=\"t2s_40\">actual strike price and duration of the </span><span class=\"SECB S46 S2\" id=\"t2t_40\">program. The share options cease to be </span><span class=\"SECC S46 S2\" id=\"t2u_40\">valid when the employee\u2019s is leaving the </span><span class=\"SECD S46 S2\" id=\"t2v_40\">Company. </span><span class=\"SECE S46 S2\" id=\"t2w_40\">Employer\u2019s social security contributions </span><span class=\"SECF S46 S2\" id=\"t2x_40\">on outstanding share options are </span><span class=\"SED0 S46 S2\" id=\"t2y_40\">accrued as personnel costs based on </span><span class=\"SED1 S46 S2\" id=\"t2z_40\">the intrinsic value of the rights. </span><span class=\"SED2 S202 S2\" id=\"t30_40\">M. Tax </span><span class=\"SED3 S46 S2\" id=\"t31_40\">The tax expense in the income </span><span class=\"SED4 S46 S2\" id=\"t32_40\">statement includes both the income </span><span class=\"SED5 S46 S2\" id=\"t33_40\">tax payable for the period and changes </span><span class=\"SED6 S46 S2\" id=\"t34_40\">in deferred tax. Deferred tax in Norway </span><span class=\"SED7 S46 S2\" id=\"t35_40\">is calculated at rate of 22% and in the </span><span class=\"SED8 S46 S2\" id=\"t36_40\">USA at a total rate of 28% on the basis </span><span class=\"SED9 S46 S2\" id=\"t37_40\">of the temporary di\ufb00erences that exist </span><span class=\"SEDA S46 S2\" id=\"t38_40\">between the tax value of the assets and </span><span class=\"SEDB S46 S2\" id=\"t39_40\">liabilities, and their book value. </span><span class=\"SEDC S46 S2\" id=\"t3a_40\">Liabilities for deferred tax are included </span><span class=\"SEDD S46 S2\" id=\"t3b_40\">for all temporary di\ufb00erences that </span><span class=\"SEDE S46 S2\" id=\"t3c_40\">increase tax, except when the asset in </span><span class=\"SEDF S46 S2\" id=\"t3d_40\">connection with deferred tax arises as </span><span class=\"SEE0 S46 S2\" id=\"t3e_40\">a result of the \ufb01rst-time inclusion of an </span><span class=\"SEE1 S46 S2\" id=\"t3f_40\">asset or liability in a transaction that </span><span class=\"SEE2 S46 S2\" id=\"t3g_40\">is not in a business combination and </span><span class=\"SEE3 S46 S2\" id=\"t3h_40\">a\ufb00ects neither the accounting nor the </span><span class=\"SEE4 S46 S2\" id=\"t3i_40\">taxable pro\ufb01t or loss at the time of the </span><span class=\"SEE5 S46 S2\" id=\"t3j_40\">transaction. </span><span class=\"SEE6 S46 S2\" id=\"t3k_40\">Assets in connection with deferred </span><span class=\"SEE7 S46 S2\" id=\"t3l_40\">tax are included for all tax-reducing </span><span class=\"SEE8 S46 S2\" id=\"t3m_40\">temporary di\ufb00erences, carry forward </span><span class=\"SEE9 S46 S2\" id=\"t3n_40\">of tax deductions and tax losses in the </span><span class=\"SEEA S46 S2\" id=\"t3o_40\">extent that there is objective proof that </span><span class=\"SEEB S46 S2\" id=\"t3p_40\">there will be su\ufb03cient taxable pro\ufb01ts </span><span class=\"SEEC S46 S2\" id=\"t3q_40\">against which to o\ufb00set tax-reducing </span><span class=\"SEED S46 S2\" id=\"t3r_40\">temporary di\ufb00erences, and carry </span><span class=\"SEEE S46 S2\" id=\"t3s_40\">forward of unused tax deductions and </span><span class=\"SEEF S46 S2\" id=\"t3t_40\">tax losses. </span><span class=\"SEF0 S46 S2\" id=\"t3u_40\">In the US the tax years 2017 and </span><span class=\"SEF1 S46 S2\" id=\"t3v_40\">prior, businesses were able to o\ufb00set </span><span class=\"SE64 S46 S2\" id=\"t3w_40\">current taxable income by claiming </span><span class=\"SEF2 S46 S2\" id=\"t3x_40\">net operating losses (NOLs), generally </span><span class=\"SEF3 S46 S2\" id=\"t3y_40\">eligible for a two-year carryback and </span><span class=\"SEF4 S46 S2\" id=\"t3z_40\">20-year carryforward. Starting in tax </span><span class=\"SEF5 S46 S2\" id=\"t40_40\">year 2018, NOLs cannot be carried </span><span class=\"SEF6 S46 S2\" id=\"t41_40\">back, but can be inde\ufb01nitely carried </span><span class=\"SEF7 S46 S2\" id=\"t42_40\">forward. In addition, NOLs for tax </span><span class=\"SEF8 S46 S2\" id=\"t43_40\">years beginning in 2018 will be subject </span><span class=\"SEF9 S46 S2\" id=\"t44_40\">to an 80-percent limitation. </span><span class=\"SEFA S46 S2\" id=\"t45_40\">The 80 </span><span class=\"SEFB S46 S2\" id=\"t46_40\">percent limitation on NOL deductions </span><span class=\"SEFD S46 S2\" id=\"t2_41\">applies to losses generated in tax </span><span class=\"SEFE S46 S2\" id=\"t3_41\">years beginning after December 31, </span><span class=\"SEFF S46 S2\" id=\"t4_41\">2017. </span><span class=\"SF00 S46 S2\" id=\"t5_41\">NOLs </span><span class=\"SF01 S46 S167 S2\" id=\"t6_41\">generated in 2017 and </span><span class=\"SF02 S46 S167 S2\" id=\"t7_41\">earlier would retain their 20-year life </span><span class=\"SF03 S46 S167 S2\" id=\"t8_41\">and be available to o\ufb00set 100 percent </span><span class=\"SF04 S46 S167 S2\" id=\"t9_41\">of taxable income, subject to certain </span><span class=\"SF05 S46 S167 S2\" id=\"ta_41\">limitations. </span><span class=\"SF06 S46 S167 S2\" id=\"tb_41\">Companies will have to </span><span class=\"SF07 S46 S167 S2\" id=\"tc_41\">track their NOLs in di\ufb00erent buckets </span><span class=\"SF08 S46 S167 S2\" id=\"td_41\">based on date (pre and post December </span><span class=\"SF09 S46 S167 S2\" id=\"te_41\">31, 2017). The Coronavirus Aid, Relief, </span><span class=\"SF0A S46 S167 S2\" id=\"tf_41\">and Economic Security (\u201cCARES \u201c) Act </span><span class=\"SF0B S46 S167 S2\" id=\"tg_41\">changed those rules temporarily by </span><span class=\"SF0C S46 S167 S2\" id=\"th_41\">permitting NOLs incurred in 2018, 2019, </span><span class=\"SD91 S46 S167 S2\" id=\"ti_41\">or 2020 to be carried back for \ufb01ve years </span><span class=\"SF0D S46 S167 S2\" id=\"tj_41\">to the earliest year \ufb01rst and suspending </span><span class=\"SF0E S46 S167 S2\" id=\"tk_41\">the 80% taxable income limitation </span><span class=\"SF0F S46 S167 S2\" id=\"tl_41\">through 2020. </span><span class=\"SF10 S46 S2\" id=\"tm_41\">The book value of assets in connection </span><span class=\"SF11 S46 S2\" id=\"tn_41\">with deferred tax is reviewed on every </span><span class=\"SF12 S46 S2\" id=\"to_41\">balance sheet date and is reduced </span><span class=\"SF13 S46 S2\" id=\"tp_41\">to the degree that there is no longer </span><span class=\"SF14 S46 S2\" id=\"tq_41\">any objective proof that there will be </span><span class=\"SF15 S46 S2\" id=\"tr_41\">su\ufb03cient taxable pro\ufb01ts to utilize all </span><span class=\"SF16 S46 S2\" id=\"ts_41\">or parts of assets in connection with </span><span class=\"SF17 S46 S2\" id=\"tt_41\">deferred tax. Non-recognized assets </span><span class=\"SF18 S46 S2\" id=\"tu_41\">in connection with deferred tax are </span><span class=\"SF19 S46 S2\" id=\"tv_41\">reviewed every balance sheet date </span><span class=\"SF1A S46 S2\" id=\"tw_41\">and are included to the degree that it </span><span class=\"SF1B S46 S2\" id=\"tx_41\">is probable that future taxable pro\ufb01ts </span><span class=\"SF1C S46 S2\" id=\"ty_41\">will allow the recovery of assets in </span><span class=\"SF1D S46 S2\" id=\"tz_41\">connection with deferred tax. Each </span><span class=\"SF1E S46 S2\" id=\"t10_41\">taxable entity in the Group are treated </span><span class=\"SF1F S46 S2\" id=\"t11_41\">separately. </span><span class=\"SF20 S202 S2\" id=\"t12_41\">N. Earnings per share </span><span class=\"SF21 S46 S2\" id=\"t13_41\">Earnings per share is calculated on </span><span class=\"SF22 S46 S2\" id=\"t14_41\">the basis of the pro\ufb01ts for the </span><span class=\"SF23 S46 S2\" id=\"t15_41\">period after tax but before \u201cOther </span><span class=\"SF24 S46 S2\" id=\"t16_41\">comprehensive income\u201d, divided </span><span class=\"SF25 S46 S2\" id=\"t17_41\">by a weighted average number of </span><span class=\"SF26 S46 S2\" id=\"t18_41\">outstanding shares in the period and </span><span class=\"SF27 S46 S2\" id=\"t19_41\">adjusted for the treasury shares. </span><span class=\"SF28 S46 S2\" id=\"t1a_41\">The diluted earnings per share </span><span class=\"SF29 S46 S2\" id=\"t1b_41\">are calculated by adjusting the </span><span class=\"SF2A S46 S2\" id=\"t1c_41\">denominator for amounts outstanding </span><span class=\"SF2B S46 S2\" id=\"t1d_41\">on option programs. Anti-dilution </span><span class=\"SF2C S46 S2\" id=\"t1e_41\">e\ufb00ects are not taken into consideration. </span><span class=\"SF2D S202 S2\" id=\"t1f_41\">O. Provisions </span><span class=\"SF2E S46 S2\" id=\"t1g_41\">Provisions are booked when the Group </span><span class=\"SF2F S46 S2\" id=\"t1h_41\">has a liability associated with an event, </span><span class=\"SF30 S46 S2\" id=\"t1i_41\">when it is probable that the liability will </span><span class=\"SF31 S46 S2\" id=\"t1j_41\">have to be settled and when the liability </span><span class=\"SF32 S46 S2\" id=\"t1k_41\">can be measured or estimated. </span><span class=\"SF33 S46 S2\" id=\"t1l_41\">When the Group expects that all or </span><span class=\"SF34 S46 S2\" id=\"t1m_41\">parts of the liability can be charged on </span><span class=\"SF35 S46 S2\" id=\"t1n_41\">to another party, this recharge will be </span><span class=\"SF36 S46 S2\" id=\"t1o_41\">recorded as an account receivable if </span><span class=\"SF37 S46 S2\" id=\"t1p_41\">there is virtual certain that the other </span><span class=\"SF38 S46 S2\" id=\"t1q_41\">party will pay. The cost associated with </span><span class=\"SF39 S46 S2\" id=\"t1r_41\">a provision will be recorded net in the </span><span class=\"SF3A S46 S2\" id=\"t1s_41\">income statement after deduction for </span>the recharge<span class=\"SF3C S202 S2\" id=\"t4_42\">P. Contingent liabilities </span><span class=\"SF3D S202 S2\" id=\"t5_42\">and assets </span><span class=\"SF3E S46 S2\" id=\"t6_42\">Contingent liabilities are de\ufb01ned as: </span><span class=\"SF3F S46 S2\" id=\"t7_42\">Possible liabilities as a result of </span><span class=\"SF40 S46 S2\" id=\"t8_42\">earlier events where their existence </span><span class=\"SF41 S46 S2\" id=\"t9_42\">depends on future events; </span><span class=\"SF42 S46 S2\" id=\"ta_42\">Liabilities that are not included </span><span class=\"SF43 S46 S2\" id=\"tb_42\">because it is not probable that they </span><span class=\"SF44 S46 S2\" id=\"tc_42\">will lead to an out\ufb02ow of resources </span><span class=\"SF45 S46 S2\" id=\"td_42\">from the Group; </span><span class=\"SF46 S46 S2\" id=\"te_42\">Liabilities that cannot be measured </span><span class=\"SF47 S46 S2\" id=\"tf_42\">with su\ufb03cient reliability. </span><span class=\"SF48 S46 S2\" id=\"tg_42\">Contingent liabilities are not included </span><span class=\"SF49 S46 S2\" id=\"th_42\">in the annual accounts. Notes on </span><span class=\"SF4A S46 S2\" id=\"ti_42\">signi\ufb01cant contingent liabilities </span><span class=\"SF4B S46 S2\" id=\"tj_42\">are provided, with the exception </span><span class=\"SF4C S46 S2\" id=\"tk_42\">of contingent liabilities with little </span><span class=\"SF4D S46 S2\" id=\"tl_42\">probability of occurring. </span><span class=\"SF4E S46 S2\" id=\"tm_42\">Contingent assets are not included in </span><span class=\"SF4F S46 S2\" id=\"tn_42\">the annual accounts, but are reported </span><span class=\"SF50 S46 S2\" id=\"to_42\">in cases in which there is a certain </span><span class=\"SF51 S46 S2\" id=\"tp_42\">likelihood of their resulting in a bene\ufb01t </span><span class=\"SF52 S46 S2\" id=\"tq_42\">to the Group. </span><span class=\"SF53 S202 S2\" id=\"tr_42\">Q. Cash \ufb02ow statement </span><span class=\"SF54 S46 S2\" id=\"ts_42\">The cash \ufb02ow statement has been </span><span class=\"SF55 S46 S2\" id=\"tt_42\">prepared in accordance with the </span><span class=\"SF56 S46 S2\" id=\"tu_42\">indirect method. Cash and cash </span><span class=\"SF57 S46 S2\" id=\"tv_42\">equivalents consist of cash, bank </span><span class=\"SF58 S46 S2\" id=\"tw_42\">deposits and other current investments </span><span class=\"SF59 S46 S2\" id=\"tx_42\">like money market funds. </span><span class=\"SF5A S202 S2\" id=\"ty_42\">R. Lease agreements </span><span class=\"SF5B S46 S2\" id=\"tz_42\">The main rule is that the leased assets </span><span class=\"SF5C S46 S2\" id=\"t10_42\">are recognized in the balance sheet as </span><span class=\"SF5D S46 S2\" id=\"t11_42\">a \ufb01xed asset or in a disclosure note for </span><span class=\"SF5E S46 S2\" id=\"t12_42\">\ufb01xed assets. Leased assets are shown </span><span class=\"SF5F S46 S2\" id=\"t13_42\">separately from other \ufb01xed assets </span><span class=\"SF60 S46 S2\" id=\"t14_42\">owned by the company as \u201cRight of use </span><span class=\"SF61 S46 S2\" id=\"t15_42\">assets\u201d in the related disclosure note. </span><span class=\"SF62 S46 S2\" id=\"t16_42\">Although a lease is a right to use an </span><span class=\"SF63 S46 S2\" id=\"t17_42\">asset and not a purchase of an asset, </span><span class=\"SF64 S46 S2\" id=\"t18_42\">the classi\ufb01cation in the balance sheet </span><span class=\"SF65 S46 S2\" id=\"t19_42\">follows the leased asset. </span><span class=\"SF66 S46 S2\" id=\"t1a_42\">The net present value of the lease </span><span class=\"SF67 S46 S2\" id=\"t1b_42\">liability is calculated by discounting </span><span class=\"SF68 S46 S2\" id=\"t1c_42\">the rental payments with the implicit </span><span class=\"SF69 S46 S2\" id=\"t1d_42\">interest rate of the lease, or the </span><span class=\"SF6A S46 S2\" id=\"t1e_42\">business\u2019s marginal borrowing rate if </span><span class=\"SF6B S46 S2\" id=\"t1f_42\">the implicit interest rate is unknown. </span><span class=\"SF6C S46 S2\" id=\"t1g_42\">According to IFRS 16 depreciation is </span><span class=\"SF6D S46 S2\" id=\"t1h_42\">calculated for the right of use assets. </span><span class=\"SF6E S46 S2\" id=\"t1i_42\">Depreciation is presented together with </span><span class=\"SF6F S46 S2\" id=\"t1j_42\">other depreciation, while interest cost </span><span class=\"SF70 S46 S2\" id=\"t1k_42\">is included in \ufb01nancial expenses in the </span><span class=\"SF71 S46 S2\" id=\"t1l_42\">income statement. </span><span class=\"SF72 S46 S2\" id=\"t1m_42\">The leased assets are depreciated over </span><span class=\"SF73 S46 S2\" id=\"t1n_42\">their useful lives. This is the shorter </span><span class=\"SF74 S46 S2\" id=\"t1o_42\">of the rental period and the assets </span><span class=\"SF75 S46 S2\" id=\"t1p_42\">economic life. </span><span class=\"SF77 S202 S2\" id=\"t2_43\">S. Segment reporting </span><span class=\"SF78 S46 S2\" id=\"t3_43\">Segments are reported similarly as the </span><span class=\"SF79 S46 S2\" id=\"t4_43\">internal reporting to the Group\u2019s Chief </span><span class=\"SF7A S46 S2\" id=\"t5_43\">Operating Decision Maker (CODM) </span><span class=\"SF7B S46 S2\" id=\"t6_43\">s. CODM are de\ufb01ned as the Group\u2019s </span><span class=\"SF7C S46 S2\" id=\"t7_43\">Senior management. </span><span class=\"SF7D S202 S2\" id=\"t8_43\">T. Business combinations </span><span class=\"SF7E S46 S2\" id=\"t9_43\">A business acquisition can be regarded </span><span class=\"SF7F S46 S2\" id=\"ta_43\">as a business combination using the </span><span class=\"SF80 S46 S2\" id=\"tb_43\">acquisition method when the acquired </span><span class=\"SF81 S46 S2\" id=\"tc_43\">set of activities and assets meets the </span><span class=\"SF82 S46 S2\" id=\"td_43\">de\ufb01nition of a business and control is </span><span class=\"SF83 S46 S2\" id=\"te_43\">transferred. In determining whether a </span><span class=\"SF84 S46 S2\" id=\"tf_43\">particular set of activities and assets </span><span class=\"SF85 S46 S2\" id=\"tg_43\">is a business, Photocure will assessed </span><span class=\"SF86 S46 S2\" id=\"th_43\">whether the set of assets and activities </span><span class=\"SF87 S46 S2\" id=\"ti_43\">acquired includes, at a minimum, an </span><span class=\"SF88 S46 S2\" id=\"tj_43\">input and substantive process and </span><span class=\"SF89 S46 S2\" id=\"tk_43\">whether the acquired set has the ability </span><span class=\"SF8A S46 S2\" id=\"tl_43\">to produce outputs. </span><span class=\"SF8B S46 S29E S2\" id=\"tm_43\">Based on the agreement including </span><span class=\"SF8C S46 S29E S2\" id=\"tn_43\">the transfer of distribution contracts, </span><span class=\"SF8D S46 S29E S2\" id=\"to_43\">employees and inventory, the </span><span class=\"SF8E S46 S29E S2\" id=\"tp_43\">transaction has been de\ufb01ned as a </span><span class=\"SF8F S46 S29E S2\" id=\"tq_43\">business combination and is thus </span><span class=\"SF90 S46 S29E S2\" id=\"tr_43\">accounted for in accordance with IFRS 3. </span><span class=\"SF91 S46 S167 S2\" id=\"ts_43\">The consideration transferred in the </span><span class=\"SF92 S46 S167 S2\" id=\"tt_43\">acquisition is generally measured at </span><span class=\"SF93 S46 S167 S2\" id=\"tu_43\">fair value, as are the identi\ufb01able net </span><span class=\"SF94 S46 S167 S2\" id=\"tv_43\">assets acquired. The residual value in </span><span class=\"SF95 S46 S167 S2\" id=\"tw_43\">the acquisition constitutes goodwill and </span><span class=\"SF96 S46 S167 S2\" id=\"tx_43\">is tested annually for impairment. Any </span><span class=\"SF97 S46 S167 S2\" id=\"ty_43\">contingent consideration is measured </span><span class=\"SF98 S46 S167 S2\" id=\"tz_43\">at fair value at the date of acquisition </span><span class=\"SF99 S46 S167 S2\" id=\"t10_43\">and remeasured at fair value at each </span><span class=\"SE90 S46 S167 S2\" id=\"t11_43\">reporting date and subsequent changes </span><span class=\"SF9A S46 S167 S2\" id=\"t12_43\">in the fair value are recognized in pro\ufb01t </span><span class=\"SF9B S46 S167 S2\" id=\"t13_43\">or loss as \ufb01nancial income or cost. </span><span class=\"SF28 S46 S2\" id=\"t14_43\">Customer relationships meet </span><span class=\"SF9C S46 S2\" id=\"t15_43\">the contractual legal criterion for </span><span class=\"SF9D S46 S2\" id=\"t16_43\">identi\ufb01cation as intangible assets </span><span class=\"SF9E S46 S2\" id=\"t17_43\">for an entity that has a practice </span><span class=\"SF9F S46 S2\" id=\"t18_43\">of establishing contracts with its </span><span class=\"SFA0 S46 S2\" id=\"t19_43\">customers, regardless of whether </span><span class=\"SFA1 S46 S2\" id=\"t1a_43\">a contract exist at the date of the </span><span class=\"SFA2 S46 S2\" id=\"t1b_43\">acquisition. A customer relationship </span><span class=\"SFA3 S46 S2\" id=\"t1c_43\">may also arise through means other </span><span class=\"SFA4 S46 S2\" id=\"t1d_43\">than contracts, such as through </span><span class=\"SFA5 S46 S2\" id=\"t1e_43\">regular contact by sales or service </span><span class=\"SFA6 S46 S2\" id=\"t1f_43\">representatives. Furthermore, IFRS 3\u2019s </span><span class=\"SFA7 S46 S2\" id=\"t1g_43\">illustrative examples on \u201ccustomer- </span><span class=\"SFA8 S46 S2\" id=\"t1h_43\">related intangible assets\u201d sets forth </span><span class=\"SFA9 S46 S2\" id=\"t1i_43\">that customer relationships meet the </span><span class=\"SFAA S46 S2\" id=\"t1j_43\">criteria of an intangible asset if the </span><span class=\"SFAB S46 S2\" id=\"t1k_43\">company has recurring customers, </span><span class=\"SFAC S46 S2\" id=\"t1l_43\">even if the company does not have </span><span class=\"SFAD S46 S2\" id=\"t1m_43\">any open purchase orders or contracts </span><span class=\"SFAE S46 S2\" id=\"t1n_43\">with those. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3946": {
   "value": "<span class=\"SCB5 S47 S2\" id=\"t6_36\">I. General information </span><span class=\"SCB6 S46 S2\" id=\"t7_36\">The annual accounts for 2022 </span><span class=\"SCB7 S46 S2\" id=\"t8_36\">for Photocure Group (Photocure) </span><span class=\"SCB8 S46 S2\" id=\"t9_36\">comprises Photocure ASA and the four </span><span class=\"SCB9 S46 S2\" id=\"ta_36\">wholly owned subsidiaries; Photocure </span><span class=\"SCBA S46 S2\" id=\"tb_36\">Inc. registered in U.S, Photocure GmbH </span><span class=\"SCBB S46 S2\" id=\"tc_36\">registered in Germany, Photocure SAS </span><span class=\"SCBC S46 S2\" id=\"td_36\">registered in France and Photocure </span><span class=\"SCBD S46 S2\" id=\"te_36\">Canada Inc. registered in Canada. The </span><span class=\"SCBE S46 S2\" id=\"tf_36\">annual accounts for Photocure were </span><span class=\"SCBF S46 S2\" id=\"tg_36\">approved for publication by the Board </span><span class=\"SCC0 S46 S2\" id=\"th_36\">of Directors on 11 April 2023. </span><span class=\"SCC1 S46 S2\" id=\"ti_36\">Photocure ASA is a public limited </span><span class=\"SCC2 S46 S2\" id=\"tj_36\">company domiciled in Norway. The </span><span class=\"SCC3 S46 S2\" id=\"tk_36\">business of the Group is associated </span><span class=\"SCC4 S46 S2\" id=\"tl_36\">with research, development, </span><span class=\"SCC5 S46 S2\" id=\"tm_36\">production, distribution, marketing </span><span class=\"SCC6 S46 S2\" id=\"tn_36\">and sales of pharmaceutical products. </span><span class=\"SCC7 S46 S2\" id=\"to_36\">The Company\u2019s shares are listed </span><span class=\"SCC8 S46 S2\" id=\"tp_36\">on the Oslo Stock Exchange. The </span><span class=\"SCC9 S46 S2\" id=\"tq_36\">Parent Company\u2019s registered o\ufb03ce is </span><span class=\"SCCA S46 S2\" id=\"tr_36\">Ho\ufb00sveien 4, NO-0275 Oslo, Norway. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3948": {
   "value": "<span class=\"SCB6 S46 S2\" id=\"t7_36\">The annual accounts for 2022 </span><span class=\"SCB7 S46 S2\" id=\"t8_36\">for Photocure Group (Photocure) </span><span class=\"SCB8 S46 S2\" id=\"t9_36\">comprises Photocure ASA and the four </span><span class=\"SCB9 S46 S2\" id=\"ta_36\">wholly owned subsidiaries; Photocure </span><span class=\"SCBA S46 S2\" id=\"tb_36\">Inc. registered in U.S, Photocure GmbH </span><span class=\"SCBB S46 S2\" id=\"tc_36\">registered in Germany, Photocure SAS </span><span class=\"SCBC S46 S2\" id=\"td_36\">registered in France and Photocure </span><span class=\"SCBD S46 S2\" id=\"te_36\">Canada Inc. registered in Canada. The </span><span class=\"SCBE S46 S2\" id=\"tf_36\">annual accounts for Photocure were </span><span class=\"SCBF S46 S2\" id=\"tg_36\">approved for publication by the Board </span>of Directors on 11 April 2023",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3951": {
   "value": "Photocure Group",
   "dimensions": {
    "concept": "ifrs-full:NameOfReportingEntityOrOtherMeansOfIdentification",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3953": {
   "value": "Photocure ASA",
   "dimensions": {
    "concept": "ifrs-full:NameOfParentEntity",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3964": {
   "value": "public limited company",
   "dimensions": {
    "concept": "ifrs-full:LegalFormOfEntity",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3967": {
   "value": " Norway",
   "dimensions": {
    "concept": "ifrs-full:CountryOfIncorporation",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3970": {
   "value": "research, development, <span class=\"SCC5 S46 S2\" id=\"tm_36\">production, distribution, marketing </span><span class=\"SCC6 S46 S2\" id=\"tn_36\">and sales of pharmaceutical products. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3978": {
   "value": "Ho\ufb00sveien 4, NO-0275 Oslo",
   "dimensions": {
    "concept": "ifrs-full:AddressOfRegisteredOfficeOfEntity",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3979": {
   "value": "Norway",
   "dimensions": {
    "concept": "ifrs-full:DomicileOfEntity",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3981": {
   "value": "I. Basis for preparation of <span class=\"SCCC S47 S2\" id=\"tt_36\">the annual accounts </span><span class=\"SCCD S46 S2\" id=\"tu_36\">The annual accounts for the Group </span><span class=\"SCCE S46 S2\" id=\"tv_36\">and the Parent Company have been </span><span class=\"SCCF S46 S2\" id=\"tw_36\">prepared on the basis of historical cost, </span><span class=\"SCD0 S46 S2\" id=\"tx_36\">with the exception of money market </span><span class=\"SCD1 S46 S2\" id=\"ty_36\">funds and earnout liability that are </span><span class=\"SCD2 S46 S2\" id=\"tz_36\">valued at fair value. </span><span class=\"SCD3 S46 S362 S2\" id=\"t10_36\">The Group and the Parent Company\u2019s </span><span class=\"SCD4 S46 S362 S2\" id=\"t11_36\">annual accounts are prepared in </span><span class=\"SCD5 S46 S362 S2\" id=\"t12_36\">accordance with International Financial </span><span class=\"SCD6 S46 S362 S2\" id=\"t13_36\">Reporting Standards (IFRS) as speci\ufb01ed </span><span class=\"SCD7 S46 S362 S2\" id=\"t14_36\">by the International Accounting </span><span class=\"SCD8 S46 S362 S2\" id=\"t15_36\">Standards Board as adopted by </span><span class=\"SCD9 S46 S362 S2\" id=\"t16_36\">the European Union (EU) as per 31 </span><span class=\"SCDA S46 S362 S2\" id=\"t17_36\">December 2022. </span><span class=\"SCDB S46 S362 S2\" id=\"t18_36\">Photocure ASA has NOK (Norwegian </span><span class=\"SCDC S46 S362 S2\" id=\"t19_36\">kroner) as its functional currency and </span><span class=\"SCDD S46 S362 S2\" id=\"t1a_36\">presentation currency. In the absence </span><span class=\"SCDE S46 S362 S2\" id=\"t1b_36\">of any statement to the contrary, all </span><span class=\"SCDF S46 S362 S2\" id=\"t1c_36\">\ufb01nancial information is reported in </span><span class=\"SCE0 S46 S362 S2\" id=\"t1d_36\">whole thousands. As a result of rounding </span><span class=\"SCE1 S46 S362 S2\" id=\"t1e_36\">adjustments, the \ufb01gures in the \ufb01nancial </span><span class=\"SCE2 S46 S362 S2\" id=\"t1f_36\">statements may not add up to the totals. </span><span class=\"SCE3 S46 S362 S2\" id=\"t1g_36\">Photocure performs the sales and </span><span class=\"SCE4 S46 S362 S2\" id=\"t1h_36\">distribution of Hexvix in the European </span><span class=\"SCE5 S46 S362 S2\" id=\"t1i_36\">markets. Photocure has established </span><span class=\"SCE6 S46 S362 S2\" id=\"t1j_36\">wholly owned subsidiaries in Germany </span><span class=\"SCE7 S46 S362 S2\" id=\"t1k_36\">(Photocure GmbH) and France </span><span class=\"SCE8 S46 S362 S2\" id=\"t1l_36\">(Photocure SAS) that provide marketing </span><span class=\"SCE9 S46 S362 S2\" id=\"t1m_36\">and promotion services. These entities </span><span class=\"SCEA S46 S362 S2\" id=\"t1n_36\">have Euro (EUR) as functional currency. </span><span class=\"SCEB S46 S362 S2\" id=\"t1o_36\">The sales, marketing and distribution </span><span class=\"SCEC S46 S362 S2\" id=\"t1p_36\">in North America is in U.S. performed </span><span class=\"SCED S46 S362 S2\" id=\"t1q_36\">through Photocure\u2019s wholly owned </span><span class=\"SCEE S46 S362 S2\" id=\"t1r_36\">subsidiary Photocure Inc. and in Canada </span><span class=\"SCEF S46 S362 S2\" id=\"t1s_36\">though Photocure\u2019s wholly owned </span><span class=\"SCF0 S46 S362 S2\" id=\"t1t_36\">subsidiary Photocure Canada Inc., in </span><span class=\"SCF1 S46 S362 S2\" id=\"t1u_36\">both countries under the trade name </span><span class=\"SCF2 S46 S362 S2\" id=\"t1v_36\">Cysview. Photocure Inc. has U.S. dollars </span><span class=\"SCF3 S46 S362 S2\" id=\"t1w_36\">(USD) as functional currency while </span><span class=\"SCF4 S46 S362 S2\" id=\"t1x_36\">Photocure Canada Inc. has </span><span class=\"SCF5 S46 S2\" id=\"t1y_36\">Canadian </span><span class=\"SCF6 S46 S2\" id=\"t1z_36\">dollars (CAD) as functional currency. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f3990": {
   "value": "<span class=\"SCD3 S46 S362 S2\" id=\"t10_36\">The Group and the Parent Company\u2019s </span><span class=\"SCD4 S46 S362 S2\" id=\"t11_36\">annual accounts are prepared in </span><span class=\"SCD5 S46 S362 S2\" id=\"t12_36\">accordance with International Financial </span><span class=\"SCD6 S46 S362 S2\" id=\"t13_36\">Reporting Standards (IFRS) as speci\ufb01ed </span><span class=\"SCD7 S46 S362 S2\" id=\"t14_36\">by the International Accounting </span><span class=\"SCD8 S46 S362 S2\" id=\"t15_36\">Standards Board as adopted by </span><span class=\"SCD9 S46 S362 S2\" id=\"t16_36\">the European Union (EU) as per 31 </span><span class=\"SCDA S46 S362 S2\" id=\"t17_36\">December 2022. </span>",
   "dimensions": {
    "concept": "ifrs-full:StatementOfIFRSCompliance",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4007": {
   "value": "<span class=\"SCE3 S46 S362 S2\" id=\"t1g_36\">Photocure performs the sales and </span><span class=\"SCE4 S46 S362 S2\" id=\"t1h_36\">distribution of Hexvix in the European </span><span class=\"SCE5 S46 S362 S2\" id=\"t1i_36\">markets. Photocure has established </span><span class=\"SCE6 S46 S362 S2\" id=\"t1j_36\">wholly owned subsidiaries in Germany </span><span class=\"SCE7 S46 S362 S2\" id=\"t1k_36\">(Photocure GmbH) and France </span><span class=\"SCE8 S46 S362 S2\" id=\"t1l_36\">(Photocure SAS) that provide marketing </span><span class=\"SCE9 S46 S362 S2\" id=\"t1m_36\">and promotion services. These entities </span><span class=\"SCEA S46 S362 S2\" id=\"t1n_36\">have Euro (EUR) as functional currency. </span><span class=\"SCEB S46 S362 S2\" id=\"t1o_36\">The sales, marketing and distribution </span><span class=\"SCEC S46 S362 S2\" id=\"t1p_36\">in North America is in U.S. performed </span><span class=\"SCED S46 S362 S2\" id=\"t1q_36\">through Photocure\u2019s wholly owned </span><span class=\"SCEE S46 S362 S2\" id=\"t1r_36\">subsidiary Photocure Inc. and in Canada </span><span class=\"SCEF S46 S362 S2\" id=\"t1s_36\">though Photocure\u2019s wholly owned </span><span class=\"SCF0 S46 S362 S2\" id=\"t1t_36\">subsidiary Photocure Canada Inc., in </span><span class=\"SCF1 S46 S362 S2\" id=\"t1u_36\">both countries under the trade name </span>Cysview.",
   "dimensions": {
    "concept": "ifrs-full:PrincipalPlaceOfBusiness",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4037": {
   "value": "II. Changes in signi\ufb01cant <span class=\"SCF9 S47 S2\" id=\"t3_37\">accounting policies </span><span class=\"SCFA S46 S2\" id=\"t4_37\">There are no signi\ufb01cant new IFRS </span><span class=\"SCFB S46 S2\" id=\"t5_37\">standards made e\ufb00ective in 2022 </span><span class=\"SCFC S46 S2\" id=\"t6_37\">that e\ufb00ect the group accounts for </span><span class=\"SCFD S46 S2\" id=\"t7_37\">Photocure. </span><span class=\"SCFE S47 S2\" id=\"t8_37\">IV. Disclosures regarding </span><span class=\"SCFF S47 S2\" id=\"t9_37\">new standards not yet </span><span class=\"SD00 S47 S2\" id=\"ta_37\">e\ufb00ective </span><span class=\"SD01 S46 S2\" id=\"tb_37\">There are no IFRS or IFRIC </span><span class=\"SD02 S46 S2\" id=\"tc_37\">interpretations that are not yet </span><span class=\"SD03 S46 S2\" id=\"td_37\">e\ufb00ective that would be expected to </span><span class=\"SD04 S46 S2\" id=\"te_37\">have a material impact on the Group. </span><span class=\"SD05 S46 S2\" id=\"tf_37\">The new and amended standards </span><span class=\"SD06 S46 S2\" id=\"tg_37\">and interpretations from IFRS that </span><span class=\"SD07 S46 S2\" id=\"th_37\">were adopted by the EU with e\ufb00ect </span><span class=\"SD08 S46 S2\" id=\"ti_37\">from 2022 did not have any signi\ufb01cant </span><span class=\"SD09 S46 S2\" id=\"tj_37\">impact on the reporting in 2022. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4038": {
   "value": "II. Changes in signi\ufb01cant <span class=\"SCF9 S47 S2\" id=\"t3_37\">accounting policies </span><span class=\"SCFA S46 S2\" id=\"t4_37\">There are no signi\ufb01cant new IFRS </span><span class=\"SCFB S46 S2\" id=\"t5_37\">standards made e\ufb00ective in 2022 </span><span class=\"SCFC S46 S2\" id=\"t6_37\">that e\ufb00ect the group accounts for </span><span class=\"SCFD S46 S2\" id=\"t7_37\">Photocure. </span><span class=\"SCFE S47 S2\" id=\"t8_37\">IV. Disclosures regarding </span><span class=\"SCFF S47 S2\" id=\"t9_37\">new standards not yet </span><span class=\"SD00 S47 S2\" id=\"ta_37\">e\ufb00ective </span><span class=\"SD01 S46 S2\" id=\"tb_37\">There are no IFRS or IFRIC </span><span class=\"SD02 S46 S2\" id=\"tc_37\">interpretations that are not yet </span><span class=\"SD03 S46 S2\" id=\"td_37\">e\ufb00ective that would be expected to </span><span class=\"SD04 S46 S2\" id=\"te_37\">have a material impact on the Group. </span><span class=\"SD05 S46 S2\" id=\"tf_37\">The new and amended standards </span><span class=\"SD06 S46 S2\" id=\"tg_37\">and interpretations from IFRS that </span><span class=\"SD07 S46 S2\" id=\"th_37\">were adopted by the EU with e\ufb00ect </span><span class=\"SD08 S46 S2\" id=\"ti_37\">from 2022 did not have any signi\ufb01cant </span><span class=\"SD09 S46 S2\" id=\"tj_37\">impact on the reporting in 2022. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4058": {
   "value": "<span class=\"SD0A S47 S2\" id=\"tk_37\">V. Use of judgements and </span><span class=\"SD0B S47 S2\" id=\"tl_37\">estimates </span><span class=\"SD0C S46 S2\" id=\"tm_37\">In preparation of these consolidated </span><span class=\"SD0D S46 S2\" id=\"tn_37\">\ufb01nancial statements, management </span><span class=\"SD0E S46 S2\" id=\"to_37\">has made judgments, estimates and </span><span class=\"SD0F S46 S2\" id=\"tp_37\">assumptions that a\ufb00ect the application </span><span class=\"SD10 S46 S2\" id=\"tq_37\">of the Group\u2019s accounting policies </span><span class=\"SD11 S46 S2\" id=\"tr_37\">and the reported amounts of assets, </span><span class=\"SD12 S46 S2\" id=\"ts_37\">liabilities, income and expenses. Actual </span><span class=\"SD13 S46 S2\" id=\"tt_37\">results may di\ufb00er from these estimates. </span><span class=\"SD14 S46 S2\" id=\"tu_37\">Estimates and underlying assumptions </span><span class=\"SD15 S46 S2\" id=\"tv_37\">are reviewed on an ongoing basis. </span><span class=\"SD16 S46 S2\" id=\"tw_37\">Revisions to estimates are recognized </span><span class=\"SD17 S46 S2\" id=\"tx_37\">prospectively. Information about </span><span class=\"SD18 S46 S2\" id=\"ty_37\">judgements made in applying </span><span class=\"SD19 S46 S2\" id=\"tz_37\">accounting policies that have the </span><span class=\"SD1A S46 S2\" id=\"t10_37\">most signi\ufb01cant e\ufb00ects on the </span><span class=\"SD1B S46 S2\" id=\"t11_37\">amounts recognized, and information </span><span class=\"SD1C S46 S2\" id=\"t12_37\">about assumptions and estimation </span><span class=\"SD1D S46 S2\" id=\"t13_37\">uncertainties that have signi\ufb01cant risk </span><span class=\"SD1E S46 S2\" id=\"t14_37\">of resulting in a material adjustment </span><span class=\"SD1F S46 S2\" id=\"t15_37\">in the \ufb01nancial statements as of 31 </span><span class=\"SD20 S46 S2\" id=\"t16_37\">December 2022, are included in the </span><span class=\"SD21 S46 S2\" id=\"t17_37\">following notes: </span><span class=\"SD22 S46 S2\" id=\"t18_37\">Note 13 and 22 Goodwill and </span><span class=\"SD23 S46 S2\" id=\"t19_37\">customer relations: the assumptions </span><span class=\"SD24 S46 S2\" id=\"t1a_37\">in the application of IFRS 36 of </span><span class=\"SD25 S46 S2\" id=\"t1b_37\">the annual goodwill impairment </span><span class=\"SD26 S46 S2\" id=\"t1c_37\">analysis, and the remeasurement of </span><span class=\"SD27 S46 S2\" id=\"t1d_37\">the fair value of the earnout liability </span><span class=\"SD28 S46 S2\" id=\"t1e_37\">according to IFRS 9. </span><span class=\"SD29 S46 S2\" id=\"t1f_37\">Note 11 Recognition of deferred tax </span><span class=\"SD2A S46 S2\" id=\"t1g_37\">asset: available future taxable pro\ufb01t </span><span class=\"SD2B S46 S2\" id=\"t1h_37\">against which tax losses carried </span><span class=\"SD2C S46 S2\" id=\"t1i_37\">forward can be used. </span><span class=\"SD2D S46 S2\" id=\"t1j_37\">Note 9 and 10 Long term loan </span><span class=\"SD2E S46 S2\" id=\"t1k_37\">subsidiary: impairment and key </span><span class=\"SD2F S46 S2\" id=\"t1l_37\">assumptions underlying the balance </span><span class=\"SD30 S46 S2\" id=\"t1m_37\">sheet value in Parent company. </span>",
   "dimensions": {
    "concept": "ifrs-full:ExplanationOfMethodMainParametersAndAssumptionsUnderlyingInformationProvidedSensitivityAnalysisOtherThanSpecifiedInParagraph128aOfIFRS17Explanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4059": {
   "value": "<span class=\"SD0A S47 S2\" id=\"tk_37\">V. Use of judgements and </span><span class=\"SD0B S47 S2\" id=\"tl_37\">estimates </span><span class=\"SD0C S46 S2\" id=\"tm_37\">In preparation of these consolidated </span><span class=\"SD0D S46 S2\" id=\"tn_37\">\ufb01nancial statements, management </span><span class=\"SD0E S46 S2\" id=\"to_37\">has made judgments, estimates and </span><span class=\"SD0F S46 S2\" id=\"tp_37\">assumptions that a\ufb00ect the application </span><span class=\"SD10 S46 S2\" id=\"tq_37\">of the Group\u2019s accounting policies </span><span class=\"SD11 S46 S2\" id=\"tr_37\">and the reported amounts of assets, </span><span class=\"SD12 S46 S2\" id=\"ts_37\">liabilities, income and expenses. Actual </span><span class=\"SD13 S46 S2\" id=\"tt_37\">results may di\ufb00er from these estimates. </span><span class=\"SD14 S46 S2\" id=\"tu_37\">Estimates and underlying assumptions </span><span class=\"SD15 S46 S2\" id=\"tv_37\">are reviewed on an ongoing basis. </span><span class=\"SD16 S46 S2\" id=\"tw_37\">Revisions to estimates are recognized </span><span class=\"SD17 S46 S2\" id=\"tx_37\">prospectively. Information about </span><span class=\"SD18 S46 S2\" id=\"ty_37\">judgements made in applying </span><span class=\"SD19 S46 S2\" id=\"tz_37\">accounting policies that have the </span><span class=\"SD1A S46 S2\" id=\"t10_37\">most signi\ufb01cant e\ufb00ects on the </span><span class=\"SD1B S46 S2\" id=\"t11_37\">amounts recognized, and information </span><span class=\"SD1C S46 S2\" id=\"t12_37\">about assumptions and estimation </span><span class=\"SD1D S46 S2\" id=\"t13_37\">uncertainties that have signi\ufb01cant risk </span><span class=\"SD1E S46 S2\" id=\"t14_37\">of resulting in a material adjustment </span><span class=\"SD1F S46 S2\" id=\"t15_37\">in the \ufb01nancial statements as of 31 </span><span class=\"SD20 S46 S2\" id=\"t16_37\">December 2022, are included in the </span><span class=\"SD21 S46 S2\" id=\"t17_37\">following notes: </span><span class=\"SD22 S46 S2\" id=\"t18_37\">Note 13 and 22 Goodwill and </span><span class=\"SD23 S46 S2\" id=\"t19_37\">customer relations: the assumptions </span><span class=\"SD24 S46 S2\" id=\"t1a_37\">in the application of IFRS 36 of </span><span class=\"SD25 S46 S2\" id=\"t1b_37\">the annual goodwill impairment </span><span class=\"SD26 S46 S2\" id=\"t1c_37\">analysis, and the remeasurement of </span><span class=\"SD27 S46 S2\" id=\"t1d_37\">the fair value of the earnout liability </span><span class=\"SD28 S46 S2\" id=\"t1e_37\">according to IFRS 9. </span><span class=\"SD29 S46 S2\" id=\"t1f_37\">Note 11 Recognition of deferred tax </span><span class=\"SD2A S46 S2\" id=\"t1g_37\">asset: available future taxable pro\ufb01t </span><span class=\"SD2B S46 S2\" id=\"t1h_37\">against which tax losses carried </span><span class=\"SD2C S46 S2\" id=\"t1i_37\">forward can be used. </span><span class=\"SD2D S46 S2\" id=\"t1j_37\">Note 9 and 10 Long term loan </span><span class=\"SD2E S46 S2\" id=\"t1k_37\">subsidiary: impairment and key </span><span class=\"SD2F S46 S2\" id=\"t1l_37\">assumptions underlying the balance </span><span class=\"SD30 S46 S2\" id=\"t1m_37\">sheet value in Parent company. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAssetsAndLiabilitiesWithSignificantRiskOfMaterialAdjustmentExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4060": {
   "value": "<span class=\"SD0A S47 S2\" id=\"tk_37\">V. Use of judgements and </span><span class=\"SD0B S47 S2\" id=\"tl_37\">estimates </span><span class=\"SD0C S46 S2\" id=\"tm_37\">In preparation of these consolidated </span><span class=\"SD0D S46 S2\" id=\"tn_37\">\ufb01nancial statements, management </span><span class=\"SD0E S46 S2\" id=\"to_37\">has made judgments, estimates and </span><span class=\"SD0F S46 S2\" id=\"tp_37\">assumptions that a\ufb00ect the application </span><span class=\"SD10 S46 S2\" id=\"tq_37\">of the Group\u2019s accounting policies </span><span class=\"SD11 S46 S2\" id=\"tr_37\">and the reported amounts of assets, </span><span class=\"SD12 S46 S2\" id=\"ts_37\">liabilities, income and expenses. Actual </span><span class=\"SD13 S46 S2\" id=\"tt_37\">results may di\ufb00er from these estimates. </span><span class=\"SD14 S46 S2\" id=\"tu_37\">Estimates and underlying assumptions </span><span class=\"SD15 S46 S2\" id=\"tv_37\">are reviewed on an ongoing basis. </span><span class=\"SD16 S46 S2\" id=\"tw_37\">Revisions to estimates are recognized </span><span class=\"SD17 S46 S2\" id=\"tx_37\">prospectively. Information about </span><span class=\"SD18 S46 S2\" id=\"ty_37\">judgements made in applying </span><span class=\"SD19 S46 S2\" id=\"tz_37\">accounting policies that have the </span><span class=\"SD1A S46 S2\" id=\"t10_37\">most signi\ufb01cant e\ufb00ects on the </span><span class=\"SD1B S46 S2\" id=\"t11_37\">amounts recognized, and information </span><span class=\"SD1C S46 S2\" id=\"t12_37\">about assumptions and estimation </span><span class=\"SD1D S46 S2\" id=\"t13_37\">uncertainties that have signi\ufb01cant risk </span><span class=\"SD1E S46 S2\" id=\"t14_37\">of resulting in a material adjustment </span><span class=\"SD1F S46 S2\" id=\"t15_37\">in the \ufb01nancial statements as of 31 </span><span class=\"SD20 S46 S2\" id=\"t16_37\">December 2022, are included in the </span><span class=\"SD21 S46 S2\" id=\"t17_37\">following notes: </span><span class=\"SD22 S46 S2\" id=\"t18_37\">Note 13 and 22 Goodwill and </span><span class=\"SD23 S46 S2\" id=\"t19_37\">customer relations: the assumptions </span><span class=\"SD24 S46 S2\" id=\"t1a_37\">in the application of IFRS 36 of </span><span class=\"SD25 S46 S2\" id=\"t1b_37\">the annual goodwill impairment </span><span class=\"SD26 S46 S2\" id=\"t1c_37\">analysis, and the remeasurement of </span><span class=\"SD27 S46 S2\" id=\"t1d_37\">the fair value of the earnout liability </span><span class=\"SD28 S46 S2\" id=\"t1e_37\">according to IFRS 9. </span><span class=\"SD29 S46 S2\" id=\"t1f_37\">Note 11 Recognition of deferred tax </span><span class=\"SD2A S46 S2\" id=\"t1g_37\">asset: available future taxable pro\ufb01t </span><span class=\"SD2B S46 S2\" id=\"t1h_37\">against which tax losses carried </span><span class=\"SD2C S46 S2\" id=\"t1i_37\">forward can be used. </span><span class=\"SD2D S46 S2\" id=\"t1j_37\">Note 9 and 10 Long term loan </span><span class=\"SD2E S46 S2\" id=\"t1k_37\">subsidiary: impairment and key </span><span class=\"SD2F S46 S2\" id=\"t1l_37\">assumptions underlying the balance </span><span class=\"SD30 S46 S2\" id=\"t1m_37\">sheet value in Parent company. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4100": {
   "value": "<span class=\"SD31 S47 S2\" id=\"t1n_37\">VI. Summary of important </span><span class=\"SD32 S47 S2\" id=\"t1o_37\">guidelines for accounting </span><span class=\"SD33 S47 S2\" id=\"t1p_37\">for the Group </span><span class=\"SD34 S202 S2\" id=\"t1q_37\">A. Classi\ufb01cation </span><span class=\"SD35 S46 S2\" id=\"t1r_37\">Assets/liabilities are classi\ufb01ed as </span><span class=\"SD36 S46 S2\" id=\"t1s_37\">current assets/current liabilities when </span><span class=\"SD37 S46 S2\" id=\"t1t_37\">they meet one of the following criteria: </span><span class=\"SD38 S46 S2\" id=\"t1u_37\">They are expected to be realized in </span><span class=\"SD39 S46 S2\" id=\"t1v_37\">the Group\u2019s ordinary operating cycle </span><span class=\"SD3A S46 S2\" id=\"t1w_37\">or are kept for sale or consumption; </span><span class=\"SD3B S46 S2\" id=\"t1x_37\">They are expected to be realized </span><span class=\"SD3C S46 S2\" id=\"t1y_37\">within 12 months of the balance </span><span class=\"SD3D S46 S2\" id=\"t1z_37\">sheet date; or </span><span class=\"SD3E S46 S2\" id=\"t20_37\">They are in the form of cash or a </span><span class=\"SD3F S46 S2\" id=\"t21_37\">cash equivalent. </span><span class=\"SD40 S46 S29E S2\" id=\"t22_37\">All other assets/liabilities are </span><span class=\"SD41 S46 S29E S2\" id=\"t23_37\">classi\ufb01ed as \ufb01xed assets/long-term </span><span class=\"SD42 S46 S29E S2\" id=\"t24_37\">liabilities </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4119": {
   "value": "<span class=\"SD43 S202 S2\" id=\"t25_37\">B. Currency </span><span class=\"SD44 S46 S2\" id=\"t26_37\">Monetary items in foreign currencies </span><span class=\"SD45 S46 S2\" id=\"t27_37\">are converted at closing rate of </span><span class=\"SD46 S46 S2\" id=\"t28_37\">exchange. In the absence of any </span><span class=\"SD47 S46 S2\" id=\"t29_37\">statement to the contrary, realized </span><span class=\"SD48 S46 S2\" id=\"t2a_37\">and unrealized exchange rate gains </span><span class=\"SD49 S46 S2\" id=\"t2b_37\">and losses are included in \ufb01nancial </span><span class=\"SD4A S46 S2\" id=\"t2c_37\">income or expenses. Transactions </span><span class=\"SD4B S46 S2\" id=\"t2d_37\">in foreign currencies are recorded </span><span class=\"SD4C S46 S2\" id=\"t2e_37\">at the exchange rate on the date of </span><span class=\"SD4D S46 S2\" id=\"t2f_37\">transaction. Assets and liabilities in </span><span class=\"SD4E S46 S2\" id=\"t2g_37\">foreign currencies are translated into </span><span class=\"SD4F S46 S2\" id=\"t2h_37\">NOK at the exchange rate applicable on </span><span class=\"SD50 S46 S2\" id=\"t2i_37\">the balance sheet date. </span><span class=\"SD51 S46 S2\" id=\"t2j_37\">Income and expenses in foreign </span><span class=\"SD52 S46 S2\" id=\"t2k_37\">subsidiaries are translated into NOK </span><span class=\"SD53 S46 S2\" id=\"t2l_37\">at the average exchange rate for the </span><span class=\"SD54 S46 S2\" id=\"t2m_37\">\ufb01nancial statement period. The assets </span><span class=\"SD55 S46 S2\" id=\"t2n_37\">and liabilities of the foreign subsidiaries </span><span class=\"SD56 S46 S2\" id=\"t2o_37\">are translated to NOK at exchange rates </span><span class=\"SD57 S46 S2\" id=\"t2p_37\">at the reporting date </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4141": {
   "value": "<span class=\"SD58 S202 S2\" id=\"t2q_37\">C. Property, plant, </span><span class=\"SD59 S202 S2\" id=\"t2r_37\">equipment and intangible </span><span class=\"SD5A S202 S2\" id=\"t2s_37\">assets </span><span class=\"SD5B S46 S2\" id=\"t2t_37\">Property, plant and equipment (PPE) </span><span class=\"SD5C S46 S2\" id=\"t2u_37\">are recognized at cost less deductions </span><span class=\"SD5D S46 S2\" id=\"t2v_37\">for accumulated depreciation and </span><span class=\"SD5E S46 S2\" id=\"t2w_37\">accumulated impairment losses. PPE </span><span class=\"SD5F S46 S2\" id=\"t2x_37\">are depreciated over the expected </span><span class=\"SD60 S46 S2\" id=\"t2y_37\">useful life of the assets taking any </span><span class=\"SD61 S46 S2\" id=\"t2z_37\">residual value into consideration. Costs </span><span class=\"SD62 S46 S2\" id=\"t30_37\">incurred for major replacements and </span><span class=\"SD63 S46 S2\" id=\"t31_37\">upgrades of PPE are added to cost if it </span><span class=\"SD64 S46 S2\" id=\"t32_37\">is probable that the costs will generate </span><span class=\"SD65 S46 S2\" id=\"t33_37\">future economic bene\ufb01ts for the </span><span class=\"SD66 S46 S2\" id=\"t34_37\">Group and if the costs can be reliably </span><span class=\"SD67 S46 S2\" id=\"t35_37\">measured. Ordinary maintenance is </span><span class=\"SD68 S46 S2\" id=\"t36_37\">expensed as incurred. </span><span class=\"SD69 S46 S2\" id=\"t37_37\">PPE are depreciated on a straight-line </span><span class=\"SD6A S46 S2\" id=\"t38_37\">basis over the estimated useful life of </span><span class=\"SD6B S46 S2\" id=\"t39_37\">the asset as follows: </span><span class=\"SD6C S46 S2\" id=\"t3a_37\">Production and test </span><span class=\"SD6D S46 S2\" id=\"t3b_37\">equipment </span><span class=\"SD6E S46 S2\" id=\"t3c_37\">5 years </span><span class=\"SD6F S46 S2\" id=\"t3d_37\">Furniture and o\ufb03ce </span><span class=\"SD70 S46 S2\" id=\"t3e_37\">equipment </span><span class=\"SD71 S46 S2\" id=\"t3f_37\">3\u20135 years </span><span class=\"SD72 S46 S2\" id=\"t3g_37\">Intangible development expenditures </span><span class=\"SD73 S46 S2\" id=\"t3h_37\">are amortized on a straight-line basis in </span><span class=\"SD74 S46 S2\" id=\"t3i_37\">the pro\ufb01t and loss over the remaining </span><span class=\"SD75 S46 S2\" id=\"t3j_37\">patent period for the approved product </span><span class=\"SD76 S46 S2\" id=\"t3k_37\">and indication as follows: </span><span class=\"SD77 S46 S2\" id=\"t3l_37\">Product development </span><span class=\"SD78 S46 S2\" id=\"t3m_37\">4 - 10 years </span><span class=\"SD79 S46 S2\" id=\"t3n_37\">Customer relations </span><span class=\"SD7A S46 S2\" id=\"t3o_37\">10 years </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4160": {
   "value": "PE are depreciated on a straight-line <span class=\"SD6A S46 S2\" id=\"t38_37\">basis over the estimated useful life of </span><span class=\"SD6B S46 S2\" id=\"t39_37\">the asset as follows: </span><span class=\"SD6C S46 S2\" id=\"t3a_37\">Production and test </span><span class=\"SD6D S46 S2\" id=\"t3b_37\">equipment </span><span class=\"SD6E S46 S2\" id=\"t3c_37\">5 years </span><span class=\"SD6F S46 S2\" id=\"t3d_37\">Furniture and o\ufb03ce </span><span class=\"SD70 S46 S2\" id=\"t3e_37\">equipment </span><span class=\"SD71 S46 S2\" id=\"t3f_37\">3\u20135 years </span><span class=\"SD72 S46 S2\" id=\"t3g_37\">Intangible development expenditures </span><span class=\"SD73 S46 S2\" id=\"t3h_37\">are amortized on a straight-line basis in </span><span class=\"SD74 S46 S2\" id=\"t3i_37\">the pro\ufb01t and loss over the remaining </span><span class=\"SD75 S46 S2\" id=\"t3j_37\">patent period for the approved product </span><span class=\"SD76 S46 S2\" id=\"t3k_37\">and indication as follows: </span><span class=\"SD77 S46 S2\" id=\"t3l_37\">Product development </span><span class=\"SD78 S46 S2\" id=\"t3m_37\">4 - 10 years </span><span class=\"SD79 S46 S2\" id=\"t3n_37\">Customer relations </span><span class=\"SD7A S46 S2\" id=\"t3o_37\">10 years </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForDepreciationExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4179": {
   "value": "<span class=\"SD7B S202 S2\" id=\"t3p_37\">D. Impairment </span><span class=\"SD7C S46 S2\" id=\"t3q_37\">Non-current &amp; intangible assets that </span><span class=\"SD7D S46 S2\" id=\"t3r_37\">are recognized in the balance sheet, </span><span class=\"SD7E S46 S2\" id=\"t3s_37\">are tested for impairment if there are </span><span class=\"SD7F S46 S2\" id=\"t3t_37\">indications of a </span><span class=\"SD80 S46 S2\" id=\"t3u_37\">loss in value. If the </span><span class=\"SD81 S46 S2\" id=\"t3v_37\">book value of an asset is higher than </span><span class=\"SD82 S46 S2\" id=\"t3w_37\">the recoverable value of the asset, </span><span class=\"SD83 S46 S2\" id=\"t3x_37\">the loss in value is recognized in pro\ufb01t </span><span class=\"SD84 S46 S2\" id=\"t3y_37\">and loss. The recoverable value is the </span><span class=\"SD85 S49 S2\" id=\"t1_38\">38 </span><span class=\"S4B S47 S2\" id=\"t2_38\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_38\">\u2013 Results 2022 </span><span class=\"SD86 S46 S2\" id=\"t4_38\">highest of net sales value and the value </span><span class=\"SD87 S46 S2\" id=\"t5_38\">in use of the asset. Assets are grouped </span><span class=\"SD88 S46 S2\" id=\"t6_38\">and measured at the lowest level for </span><span class=\"SD89 S46 S2\" id=\"t7_38\">determining loss in value. </span><span class=\"SD8A S46 S2\" id=\"t8_38\">Previous impairment losses are </span><span class=\"SD8B S46 S2\" id=\"t9_38\">reversed to the extent that the assets </span><span class=\"SD8C S46 S2\" id=\"ta_38\">carrying amount does not exceed the </span><span class=\"SD8D S46 S2\" id=\"tb_38\">carrying amount that would have been </span><span class=\"SD8E S46 S2\" id=\"tc_38\">determined, net of depreciation and </span><span class=\"SD8F S46 S2\" id=\"td_38\">amortization, if no impairment loss had </span><span class=\"SD90 S46 S2\" id=\"te_38\">been recognized or taken place. </span><span class=\"SD91 S46 S2\" id=\"tf_38\">Goodwill is tested annually for </span><span class=\"SD92 S46 S2\" id=\"tg_38\">impairment. For impairment testing, </span><span class=\"SD93 S46 S2\" id=\"th_38\">assets are grouped that generate cash </span><span class=\"SD94 S46 S2\" id=\"ti_38\">in\ufb02ows from continuing use that are </span><span class=\"SD95 S46 S2\" id=\"tj_38\">largely independent from the cash </span><span class=\"SD96 S46 S2\" id=\"tk_38\">in\ufb02ows from other assets or cash </span><span class=\"SD97 S46 S2\" id=\"tl_38\">generating units (CGU). Goodwill that </span><span class=\"SD98 S46 S2\" id=\"tm_38\">are arising from a business combination </span><span class=\"SD99 S46 S2\" id=\"tn_38\">is allocated to CGUs or group of CGUs </span><span class=\"SD9A S46 S2\" id=\"to_38\">that are expected to bene\ufb01t from the </span><span class=\"SD9B S46 S2\" id=\"tp_38\">synergies of the combination. The </span><span class=\"SD9C S46 S2\" id=\"tq_38\">recoverable value of the asset is the </span><span class=\"SD9D S46 S2\" id=\"tr_38\">greater of value in use and its fair value </span><span class=\"SD9E S46 S2\" id=\"ts_38\">less cost of disposal. Value in use is </span><span class=\"SD9F S46 S2\" id=\"tt_38\">based on estimated future cash \ufb02ows, </span><span class=\"SDA0 S46 S2\" id=\"tu_38\">discounted to their present value using </span><span class=\"SDA1 S46 S2\" id=\"tv_38\">a pre-tax discount rate that re\ufb02ects </span><span class=\"SDA2 S46 S2\" id=\"tw_38\">current market assessments of the time </span><span class=\"SDA3 S46 S2\" id=\"tx_38\">value of money and the risks speci\ufb01c to </span><span class=\"SDA4 S46 S2\" id=\"ty_38\">the asset. </span><span class=\"SDA5 S46 S2\" id=\"tz_38\">An impairment loss is allocated \ufb01rst to </span><span class=\"SDA6 S46 S2\" id=\"t10_38\">reduce the book value of the goodwill </span><span class=\"SDA7 S46 S2\" id=\"t11_38\">related to the CGU and then to reduce </span><span class=\"SDA8 S46 S2\" id=\"t12_38\">the carrying amount of the other assets </span><span class=\"SDA9 S46 S2\" id=\"t13_38\">in the CGU on a pro rata basis. An </span><span class=\"SDAA S46 S2\" id=\"t14_38\">impairment loss in respect of goodwill </span>is not reversed",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4180": {
   "value": "<span class=\"SD7B S202 S2\" id=\"t3p_37\">D. Impairment </span><span class=\"SD7C S46 S2\" id=\"t3q_37\">Non-current &amp; intangible assets that </span><span class=\"SD7D S46 S2\" id=\"t3r_37\">are recognized in the balance sheet, </span><span class=\"SD7E S46 S2\" id=\"t3s_37\">are tested for impairment if there are </span><span class=\"SD7F S46 S2\" id=\"t3t_37\">indications of a </span><span class=\"SD80 S46 S2\" id=\"t3u_37\">loss in value. If the </span><span class=\"SD81 S46 S2\" id=\"t3v_37\">book value of an asset is higher than </span><span class=\"SD82 S46 S2\" id=\"t3w_37\">the recoverable value of the asset, </span><span class=\"SD83 S46 S2\" id=\"t3x_37\">the loss in value is recognized in pro\ufb01t </span><span class=\"SD84 S46 S2\" id=\"t3y_37\">and loss. The recoverable value is the </span><span class=\"SD85 S49 S2\" id=\"t1_38\">38 </span><span class=\"S4B S47 S2\" id=\"t2_38\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_38\">\u2013 Results 2022 </span><span class=\"SD86 S46 S2\" id=\"t4_38\">highest of net sales value and the value </span><span class=\"SD87 S46 S2\" id=\"t5_38\">in use of the asset. Assets are grouped </span><span class=\"SD88 S46 S2\" id=\"t6_38\">and measured at the lowest level for </span><span class=\"SD89 S46 S2\" id=\"t7_38\">determining loss in value. </span><span class=\"SD8A S46 S2\" id=\"t8_38\">Previous impairment losses are </span><span class=\"SD8B S46 S2\" id=\"t9_38\">reversed to the extent that the assets </span><span class=\"SD8C S46 S2\" id=\"ta_38\">carrying amount does not exceed the </span><span class=\"SD8D S46 S2\" id=\"tb_38\">carrying amount that would have been </span><span class=\"SD8E S46 S2\" id=\"tc_38\">determined, net of depreciation and </span><span class=\"SD8F S46 S2\" id=\"td_38\">amortization, if no impairment loss had </span><span class=\"SD90 S46 S2\" id=\"te_38\">been recognized or taken place. </span><span class=\"SD91 S46 S2\" id=\"tf_38\">Goodwill is tested annually for </span><span class=\"SD92 S46 S2\" id=\"tg_38\">impairment. For impairment testing, </span><span class=\"SD93 S46 S2\" id=\"th_38\">assets are grouped that generate cash </span><span class=\"SD94 S46 S2\" id=\"ti_38\">in\ufb02ows from continuing use that are </span><span class=\"SD95 S46 S2\" id=\"tj_38\">largely independent from the cash </span><span class=\"SD96 S46 S2\" id=\"tk_38\">in\ufb02ows from other assets or cash </span><span class=\"SD97 S46 S2\" id=\"tl_38\">generating units (CGU). Goodwill that </span><span class=\"SD98 S46 S2\" id=\"tm_38\">are arising from a business combination </span><span class=\"SD99 S46 S2\" id=\"tn_38\">is allocated to CGUs or group of CGUs </span><span class=\"SD9A S46 S2\" id=\"to_38\">that are expected to bene\ufb01t from the </span><span class=\"SD9B S46 S2\" id=\"tp_38\">synergies of the combination. The </span><span class=\"SD9C S46 S2\" id=\"tq_38\">recoverable value of the asset is the </span><span class=\"SD9D S46 S2\" id=\"tr_38\">greater of value in use and its fair value </span><span class=\"SD9E S46 S2\" id=\"ts_38\">less cost of disposal. Value in use is </span><span class=\"SD9F S46 S2\" id=\"tt_38\">based on estimated future cash \ufb02ows, </span><span class=\"SDA0 S46 S2\" id=\"tu_38\">discounted to their present value using </span><span class=\"SDA1 S46 S2\" id=\"tv_38\">a pre-tax discount rate that re\ufb02ects </span><span class=\"SDA2 S46 S2\" id=\"tw_38\">current market assessments of the time </span><span class=\"SDA3 S46 S2\" id=\"tx_38\">value of money and the risks speci\ufb01c to </span><span class=\"SDA4 S46 S2\" id=\"ty_38\">the asset. </span><span class=\"SDA5 S46 S2\" id=\"tz_38\">An impairment loss is allocated \ufb01rst to </span><span class=\"SDA6 S46 S2\" id=\"t10_38\">reduce the book value of the goodwill </span><span class=\"SDA7 S46 S2\" id=\"t11_38\">related to the CGU and then to reduce </span><span class=\"SDA8 S46 S2\" id=\"t12_38\">the carrying amount of the other assets </span><span class=\"SDA9 S46 S2\" id=\"t13_38\">in the CGU on a pro rata basis. An </span><span class=\"SDAA S46 S2\" id=\"t14_38\">impairment loss in respect of goodwill </span>is not reversed",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4181": {
   "value": "<span class=\"SD7B S202 S2\" id=\"t3p_37\">D. Impairment </span><span class=\"SD7C S46 S2\" id=\"t3q_37\">Non-current &amp; intangible assets that </span><span class=\"SD7D S46 S2\" id=\"t3r_37\">are recognized in the balance sheet, </span><span class=\"SD7E S46 S2\" id=\"t3s_37\">are tested for impairment if there are </span><span class=\"SD7F S46 S2\" id=\"t3t_37\">indications of a </span><span class=\"SD80 S46 S2\" id=\"t3u_37\">loss in value. If the </span><span class=\"SD81 S46 S2\" id=\"t3v_37\">book value of an asset is higher than </span><span class=\"SD82 S46 S2\" id=\"t3w_37\">the recoverable value of the asset, </span><span class=\"SD83 S46 S2\" id=\"t3x_37\">the loss in value is recognized in pro\ufb01t </span><span class=\"SD84 S46 S2\" id=\"t3y_37\">and loss. The recoverable value is the </span><span class=\"SD85 S49 S2\" id=\"t1_38\">38 </span><span class=\"S4B S47 S2\" id=\"t2_38\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_38\">\u2013 Results 2022 </span><span class=\"SD86 S46 S2\" id=\"t4_38\">highest of net sales value and the value </span><span class=\"SD87 S46 S2\" id=\"t5_38\">in use of the asset. Assets are grouped </span><span class=\"SD88 S46 S2\" id=\"t6_38\">and measured at the lowest level for </span><span class=\"SD89 S46 S2\" id=\"t7_38\">determining loss in value. </span><span class=\"SD8A S46 S2\" id=\"t8_38\">Previous impairment losses are </span><span class=\"SD8B S46 S2\" id=\"t9_38\">reversed to the extent that the assets </span><span class=\"SD8C S46 S2\" id=\"ta_38\">carrying amount does not exceed the </span><span class=\"SD8D S46 S2\" id=\"tb_38\">carrying amount that would have been </span><span class=\"SD8E S46 S2\" id=\"tc_38\">determined, net of depreciation and </span><span class=\"SD8F S46 S2\" id=\"td_38\">amortization, if no impairment loss had </span><span class=\"SD90 S46 S2\" id=\"te_38\">been recognized or taken place. </span><span class=\"SD91 S46 S2\" id=\"tf_38\">Goodwill is tested annually for </span><span class=\"SD92 S46 S2\" id=\"tg_38\">impairment. For impairment testing, </span><span class=\"SD93 S46 S2\" id=\"th_38\">assets are grouped that generate cash </span><span class=\"SD94 S46 S2\" id=\"ti_38\">in\ufb02ows from continuing use that are </span><span class=\"SD95 S46 S2\" id=\"tj_38\">largely independent from the cash </span><span class=\"SD96 S46 S2\" id=\"tk_38\">in\ufb02ows from other assets or cash </span><span class=\"SD97 S46 S2\" id=\"tl_38\">generating units (CGU). Goodwill that </span><span class=\"SD98 S46 S2\" id=\"tm_38\">are arising from a business combination </span><span class=\"SD99 S46 S2\" id=\"tn_38\">is allocated to CGUs or group of CGUs </span><span class=\"SD9A S46 S2\" id=\"to_38\">that are expected to bene\ufb01t from the </span><span class=\"SD9B S46 S2\" id=\"tp_38\">synergies of the combination. The </span><span class=\"SD9C S46 S2\" id=\"tq_38\">recoverable value of the asset is the </span><span class=\"SD9D S46 S2\" id=\"tr_38\">greater of value in use and its fair value </span><span class=\"SD9E S46 S2\" id=\"ts_38\">less cost of disposal. Value in use is </span><span class=\"SD9F S46 S2\" id=\"tt_38\">based on estimated future cash \ufb02ows, </span><span class=\"SDA0 S46 S2\" id=\"tu_38\">discounted to their present value using </span><span class=\"SDA1 S46 S2\" id=\"tv_38\">a pre-tax discount rate that re\ufb02ects </span><span class=\"SDA2 S46 S2\" id=\"tw_38\">current market assessments of the time </span><span class=\"SDA3 S46 S2\" id=\"tx_38\">value of money and the risks speci\ufb01c to </span><span class=\"SDA4 S46 S2\" id=\"ty_38\">the asset. </span><span class=\"SDA5 S46 S2\" id=\"tz_38\">An impairment loss is allocated \ufb01rst to </span><span class=\"SDA6 S46 S2\" id=\"t10_38\">reduce the book value of the goodwill </span><span class=\"SDA7 S46 S2\" id=\"t11_38\">related to the CGU and then to reduce </span><span class=\"SDA8 S46 S2\" id=\"t12_38\">the carrying amount of the other assets </span><span class=\"SDA9 S46 S2\" id=\"t13_38\">in the CGU on a pro rata basis. An </span><span class=\"SDAA S46 S2\" id=\"t14_38\">impairment loss in respect of goodwill </span>is not reversed<span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span><span class=\"SE46 S46 S167 S2\" id=\"t32_39\">interest rate of the \ufb01nancial asset. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4182": {
   "value": "<span class=\"SD7B S202 S2\" id=\"t3p_37\">D. Impairment </span><span class=\"SD7C S46 S2\" id=\"t3q_37\">Non-current &amp; intangible assets that </span><span class=\"SD7D S46 S2\" id=\"t3r_37\">are recognized in the balance sheet, </span><span class=\"SD7E S46 S2\" id=\"t3s_37\">are tested for impairment if there are </span><span class=\"SD7F S46 S2\" id=\"t3t_37\">indications of a </span><span class=\"SD80 S46 S2\" id=\"t3u_37\">loss in value. If the </span><span class=\"SD81 S46 S2\" id=\"t3v_37\">book value of an asset is higher than </span><span class=\"SD82 S46 S2\" id=\"t3w_37\">the recoverable value of the asset, </span><span class=\"SD83 S46 S2\" id=\"t3x_37\">the loss in value is recognized in pro\ufb01t </span><span class=\"SD84 S46 S2\" id=\"t3y_37\">and loss. The recoverable value is the </span><span class=\"SD85 S49 S2\" id=\"t1_38\">38 </span><span class=\"S4B S47 S2\" id=\"t2_38\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_38\">\u2013 Results 2022 </span><span class=\"SD86 S46 S2\" id=\"t4_38\">highest of net sales value and the value </span><span class=\"SD87 S46 S2\" id=\"t5_38\">in use of the asset. Assets are grouped </span><span class=\"SD88 S46 S2\" id=\"t6_38\">and measured at the lowest level for </span><span class=\"SD89 S46 S2\" id=\"t7_38\">determining loss in value. </span><span class=\"SD8A S46 S2\" id=\"t8_38\">Previous impairment losses are </span><span class=\"SD8B S46 S2\" id=\"t9_38\">reversed to the extent that the assets </span><span class=\"SD8C S46 S2\" id=\"ta_38\">carrying amount does not exceed the </span><span class=\"SD8D S46 S2\" id=\"tb_38\">carrying amount that would have been </span><span class=\"SD8E S46 S2\" id=\"tc_38\">determined, net of depreciation and </span><span class=\"SD8F S46 S2\" id=\"td_38\">amortization, if no impairment loss had </span><span class=\"SD90 S46 S2\" id=\"te_38\">been recognized or taken place. </span><span class=\"SD91 S46 S2\" id=\"tf_38\">Goodwill is tested annually for </span><span class=\"SD92 S46 S2\" id=\"tg_38\">impairment. For impairment testing, </span><span class=\"SD93 S46 S2\" id=\"th_38\">assets are grouped that generate cash </span><span class=\"SD94 S46 S2\" id=\"ti_38\">in\ufb02ows from continuing use that are </span><span class=\"SD95 S46 S2\" id=\"tj_38\">largely independent from the cash </span><span class=\"SD96 S46 S2\" id=\"tk_38\">in\ufb02ows from other assets or cash </span><span class=\"SD97 S46 S2\" id=\"tl_38\">generating units (CGU). Goodwill that </span><span class=\"SD98 S46 S2\" id=\"tm_38\">are arising from a business combination </span><span class=\"SD99 S46 S2\" id=\"tn_38\">is allocated to CGUs or group of CGUs </span><span class=\"SD9A S46 S2\" id=\"to_38\">that are expected to bene\ufb01t from the </span><span class=\"SD9B S46 S2\" id=\"tp_38\">synergies of the combination. The </span><span class=\"SD9C S46 S2\" id=\"tq_38\">recoverable value of the asset is the </span><span class=\"SD9D S46 S2\" id=\"tr_38\">greater of value in use and its fair value </span><span class=\"SD9E S46 S2\" id=\"ts_38\">less cost of disposal. Value in use is </span><span class=\"SD9F S46 S2\" id=\"tt_38\">based on estimated future cash \ufb02ows, </span><span class=\"SDA0 S46 S2\" id=\"tu_38\">discounted to their present value using </span><span class=\"SDA1 S46 S2\" id=\"tv_38\">a pre-tax discount rate that re\ufb02ects </span><span class=\"SDA2 S46 S2\" id=\"tw_38\">current market assessments of the time </span><span class=\"SDA3 S46 S2\" id=\"tx_38\">value of money and the risks speci\ufb01c to </span><span class=\"SDA4 S46 S2\" id=\"ty_38\">the asset. </span><span class=\"SDA5 S46 S2\" id=\"tz_38\">An impairment loss is allocated \ufb01rst to </span><span class=\"SDA6 S46 S2\" id=\"t10_38\">reduce the book value of the goodwill </span><span class=\"SDA7 S46 S2\" id=\"t11_38\">related to the CGU and then to reduce </span><span class=\"SDA8 S46 S2\" id=\"t12_38\">the carrying amount of the other assets </span><span class=\"SDA9 S46 S2\" id=\"t13_38\">in the CGU on a pro rata basis. An </span><span class=\"SDAA S46 S2\" id=\"t14_38\">impairment loss in respect of goodwill </span>is not reversed",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4183": {
   "value": "<span class=\"SD7B S202 S2\" id=\"t3p_37\">D. Impairment </span><span class=\"SD7C S46 S2\" id=\"t3q_37\">Non-current &amp; intangible assets that </span><span class=\"SD7D S46 S2\" id=\"t3r_37\">are recognized in the balance sheet, </span><span class=\"SD7E S46 S2\" id=\"t3s_37\">are tested for impairment if there are </span><span class=\"SD7F S46 S2\" id=\"t3t_37\">indications of a </span><span class=\"SD80 S46 S2\" id=\"t3u_37\">loss in value. If the </span><span class=\"SD81 S46 S2\" id=\"t3v_37\">book value of an asset is higher than </span><span class=\"SD82 S46 S2\" id=\"t3w_37\">the recoverable value of the asset, </span><span class=\"SD83 S46 S2\" id=\"t3x_37\">the loss in value is recognized in pro\ufb01t </span><span class=\"SD84 S46 S2\" id=\"t3y_37\">and loss. The recoverable value is the </span><span class=\"SD85 S49 S2\" id=\"t1_38\">38 </span><span class=\"S4B S47 S2\" id=\"t2_38\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_38\">\u2013 Results 2022 </span><span class=\"SD86 S46 S2\" id=\"t4_38\">highest of net sales value and the value </span><span class=\"SD87 S46 S2\" id=\"t5_38\">in use of the asset. Assets are grouped </span><span class=\"SD88 S46 S2\" id=\"t6_38\">and measured at the lowest level for </span><span class=\"SD89 S46 S2\" id=\"t7_38\">determining loss in value. </span><span class=\"SD8A S46 S2\" id=\"t8_38\">Previous impairment losses are </span><span class=\"SD8B S46 S2\" id=\"t9_38\">reversed to the extent that the assets </span><span class=\"SD8C S46 S2\" id=\"ta_38\">carrying amount does not exceed the </span><span class=\"SD8D S46 S2\" id=\"tb_38\">carrying amount that would have been </span><span class=\"SD8E S46 S2\" id=\"tc_38\">determined, net of depreciation and </span><span class=\"SD8F S46 S2\" id=\"td_38\">amortization, if no impairment loss had </span><span class=\"SD90 S46 S2\" id=\"te_38\">been recognized or taken place. </span><span class=\"SD91 S46 S2\" id=\"tf_38\">Goodwill is tested annually for </span><span class=\"SD92 S46 S2\" id=\"tg_38\">impairment. For impairment testing, </span><span class=\"SD93 S46 S2\" id=\"th_38\">assets are grouped that generate cash </span><span class=\"SD94 S46 S2\" id=\"ti_38\">in\ufb02ows from continuing use that are </span><span class=\"SD95 S46 S2\" id=\"tj_38\">largely independent from the cash </span><span class=\"SD96 S46 S2\" id=\"tk_38\">in\ufb02ows from other assets or cash </span><span class=\"SD97 S46 S2\" id=\"tl_38\">generating units (CGU). Goodwill that </span><span class=\"SD98 S46 S2\" id=\"tm_38\">are arising from a business combination </span><span class=\"SD99 S46 S2\" id=\"tn_38\">is allocated to CGUs or group of CGUs </span><span class=\"SD9A S46 S2\" id=\"to_38\">that are expected to bene\ufb01t from the </span><span class=\"SD9B S46 S2\" id=\"tp_38\">synergies of the combination. The </span><span class=\"SD9C S46 S2\" id=\"tq_38\">recoverable value of the asset is the </span><span class=\"SD9D S46 S2\" id=\"tr_38\">greater of value in use and its fair value </span><span class=\"SD9E S46 S2\" id=\"ts_38\">less cost of disposal. Value in use is </span><span class=\"SD9F S46 S2\" id=\"tt_38\">based on estimated future cash \ufb02ows, </span><span class=\"SDA0 S46 S2\" id=\"tu_38\">discounted to their present value using </span><span class=\"SDA1 S46 S2\" id=\"tv_38\">a pre-tax discount rate that re\ufb02ects </span><span class=\"SDA2 S46 S2\" id=\"tw_38\">current market assessments of the time </span><span class=\"SDA3 S46 S2\" id=\"tx_38\">value of money and the risks speci\ufb01c to </span><span class=\"SDA4 S46 S2\" id=\"ty_38\">the asset. </span><span class=\"SDA5 S46 S2\" id=\"tz_38\">An impairment loss is allocated \ufb01rst to </span><span class=\"SDA6 S46 S2\" id=\"t10_38\">reduce the book value of the goodwill </span><span class=\"SDA7 S46 S2\" id=\"t11_38\">related to the CGU and then to reduce </span><span class=\"SDA8 S46 S2\" id=\"t12_38\">the carrying amount of the other assets </span><span class=\"SDA9 S46 S2\" id=\"t13_38\">in the CGU on a pro rata basis. An </span><span class=\"SDAA S46 S2\" id=\"t14_38\">impairment loss in respect of goodwill </span><span class=\"SDAB S46 S2\" id=\"t15_38\">is not reversed. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4249": {
   "value": "<span class=\"SDAC S202 S2\" id=\"t16_38\">E. Research and </span><span class=\"SDAD S202 S2\" id=\"t17_38\">development costs </span><span class=\"SDAE S46 SDD8 S2\" id=\"t18_38\">Research costs are expensed as incurred. </span><span class=\"SDAF S46 SDD8 S2\" id=\"t19_38\">Development costs are recognized in </span><span class=\"SDB0 S46 SDD8 S2\" id=\"t1a_38\">the balance sheet as intangible assets </span><span class=\"SDB1 S46 SDD8 S2\" id=\"t1b_38\">only if there is an identi\ufb01able asset that </span><span class=\"SDB2 S46 SDD8 S2\" id=\"t1c_38\">is expected to generate future \ufb01nancial </span><span class=\"SDB3 S46 SDD8 S2\" id=\"t1d_38\">bene\ufb01ts, and when the costs of such </span><span class=\"SDB4 S46 SDD8 S2\" id=\"t1e_38\">an asset can be reliably measured.. </span><span class=\"SDB5 S46 SDD8 S2\" id=\"t1f_38\">Development costs that have been </span><span class=\"SDB6 S46 SDD8 S2\" id=\"t1g_38\">expensed in previous accounting periods </span><span class=\"SDB7 S46 SDD8 S2\" id=\"t1h_38\">cannot be recognized in the balance </span><span class=\"SDB8 S46 SDD8 S2\" id=\"t1i_38\">sheet at a later date. Cost-sharing of </span><span class=\"SDB9 S46 SDD8 S2\" id=\"t1j_38\">research and development expenses </span><span class=\"SDBA S46 SDD8 S2\" id=\"t1k_38\">with license partners is booked as a </span><span class=\"SDBB S46 SDD8 S2\" id=\"t1l_38\">reduction in costs. </span><span class=\"SDBC S46 S2\" id=\"t1m_38\">The work of the regulatory function </span><span class=\"SDBD S46 S2\" id=\"t1n_38\">and services provided are related to </span><span class=\"SDBE S46 S2\" id=\"t1o_38\">both market expansion and product </span><span class=\"SDBF S46 S2\" id=\"t1p_38\">development. Photocure classi\ufb01es for </span><span class=\"SDC0 S46 S2\" id=\"t1q_38\">this reason the regulatory function into </span><span class=\"SDC1 S46 S2\" id=\"t1r_38\">the following two categories: </span><span class=\"SDC2 S46 S2\" id=\"t1s_38\">Regulatory work and services </span><span class=\"SDC3 S46 S2\" id=\"t1t_38\">related to new products or product </span><span class=\"SDC4 S46 S2\" id=\"t1u_38\">development based on new clinical </span><span class=\"SDC5 S46 S2\" id=\"t1v_38\">trials up to and including phase 3, </span><span class=\"SDC6 S46 S2\" id=\"t1w_38\">are classi\ufb01ed as R&amp;D costs </span><span class=\"SDC7 S46 S2\" id=\"t1x_38\">Regulatory work and services for </span><span class=\"SDC8 S46 S2\" id=\"t1y_38\">new markets based on existing </span><span class=\"SDC9 S46 S2\" id=\"t1z_38\">clinical data are classi\ufb01ed as </span><span class=\"SDCA S46 S2\" id=\"t20_38\">marketing costs </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4281": {
   "value": "<span class=\"SDCB S202 S2\" id=\"t21_38\">F. Investment in subsidiary </span><span class=\"SDCC S202 S2\" id=\"t22_38\">companies </span><span class=\"SDCD S46 S2\" id=\"t23_38\">Shares and investments with the aim </span><span class=\"SDCE S46 S2\" id=\"t24_38\">of long-term ownership are booked </span><span class=\"SDCF S46 S2\" id=\"t25_38\">in the balance sheet as long-term </span><span class=\"SDD0 S46 S2\" id=\"t26_38\">investments and are valued at the lower </span><span class=\"SDD1 S46 S2\" id=\"t27_38\">of cost and fair value. Write-downs for </span><span class=\"SDD2 S46 S2\" id=\"t28_38\">permanent declines in value are made </span><span class=\"SDD3 S46 S2\" id=\"t29_38\">on the basis of individual evaluations. </span><span class=\"SDD4 S46 S2\" id=\"t2a_38\">Any realized and unrealized pro\ufb01ts/ </span><span class=\"SDD5 S46 S2\" id=\"t2b_38\">losses and any write-downs related to </span><span class=\"SDD6 S46 S2\" id=\"t2c_38\">these investments will be booked in the </span><span class=\"SDD7 S46 S2\" id=\"t2d_38\">income statement as \ufb01nancial items. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForSubsidiariesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4302": {
   "value": "<span class=\"SDDA S202 S2\" id=\"t2_39\">G. Inventories </span><span class=\"SDDB S46 S2\" id=\"t3_39\">Raw materials are valued at the lower of </span><span class=\"SDDC S46 S2\" id=\"t4_39\">cost and net sales value in accordance </span><span class=\"SDDD S46 S2\" id=\"t5_39\">with the \ufb01rst-in, \ufb01rst-out principle (FIFO). </span><span class=\"SDDE S46 S2\" id=\"t6_39\">Semi-\ufb01nished and \ufb01nished goods are </span><span class=\"SDDF S46 S2\" id=\"t7_39\">valued at production cost including a </span><span class=\"SDE0 S46 S2\" id=\"t8_39\">mark-up for their share of the indirect </span><span class=\"SDE1 S46 S2\" id=\"t9_39\">production costs based on the FIFO </span><span class=\"SDE2 S46 S2\" id=\"ta_39\">principle. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4312": {
   "value": "<span class=\"SDE3 S202 S2\" id=\"tb_39\">H. Financial assets and </span><span class=\"SDE4 S202 S2\" id=\"tc_39\">liabilities </span><span class=\"SDE5 S49 S2\" id=\"td_39\">Recognition and measurement </span><span class=\"SDE6 S46 S2\" id=\"te_39\">Trade receivables are initially recognized </span><span class=\"SDE7 S46 S2\" id=\"tf_39\">when they are originated. All other </span><span class=\"SDE8 S46 S2\" id=\"tg_39\">\ufb01nancial assets and \ufb01nancial liabilities </span><span class=\"SDE9 S46 S2\" id=\"th_39\">are initially recognized when the Group </span><span class=\"SDEA S46 S2\" id=\"ti_39\">becomes a party to the contractual </span><span class=\"SDEB S46 S2\" id=\"tj_39\">provisions of the instrument. A trade </span><span class=\"SDEC S46 S2\" id=\"tk_39\">receivable without a signi\ufb01cant \ufb01nancing </span><span class=\"SDED S46 S2\" id=\"tl_39\">component is initially measured at the </span><span class=\"SDEE S46 S2\" id=\"tm_39\">transaction price. All other \ufb01nancial </span><span class=\"SDEF S46 S2\" id=\"tn_39\">assets are initially measured at fair value </span><span class=\"SDF0 S46 S2\" id=\"to_39\">plus, for an item not at fair value through, </span><span class=\"SDF1 S46 S2\" id=\"tp_39\">transaction costs that are directly </span><span class=\"SDF2 S46 S2\" id=\"tq_39\">attributable. </span><span class=\"SDF3 S46 S2\" id=\"tr_39\">A \ufb01nancial asset is subsequently </span><span class=\"SDF4 S46 S2\" id=\"ts_39\">measured at amortized cost if it meets </span><span class=\"SDF5 S46 S2\" id=\"tt_39\">both of the following criteria and is not </span><span class=\"SDF6 S46 S2\" id=\"tu_39\">designated as at Fair Value Through </span><span class=\"SDF7 S46 S2\" id=\"tv_39\">Pro\ufb01t and Loss (FVTPL): </span><span class=\"SDF8 S46 S2\" id=\"tw_39\">it is held within a business model </span><span class=\"SDF9 S46 S2\" id=\"tx_39\">whose objective is to hold assets to </span><span class=\"SDFA S46 S2\" id=\"ty_39\">collect contractual cash \ufb02ows; and </span><span class=\"SDFB S46 S2\" id=\"tz_39\">its contractual terms give rise on </span><span class=\"SDFC S46 S2\" id=\"t10_39\">speci\ufb01ed dates to cash \ufb02ows that </span><span class=\"SDFD S46 S2\" id=\"t11_39\">are solely payments of principal and </span><span class=\"SDFE S46 S2\" id=\"t12_39\">interest on the principal amount </span><span class=\"SDFF S46 S2\" id=\"t13_39\">outstanding. </span><span class=\"SE00 S46 S2\" id=\"t14_39\">Trade receivables, loan to group </span><span class=\"SE01 S46 S2\" id=\"t15_39\">companies, and other receivables meet </span><span class=\"SE02 S46 S2\" id=\"t16_39\">both of these criteria and are measured </span><span class=\"SE03 S46 S2\" id=\"t17_39\">at amortized cost using e\ufb00ective </span><span class=\"SE04 S46 S2\" id=\"t18_39\">interest rate method. </span><span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span><span class=\"SE16 S46 S2\" id=\"t1q_39\">e\ufb00ective interest rate method. </span><span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span><span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span><span class=\"SE46 S46 S167 S2\" id=\"t32_39\">interest rate of the \ufb01nancial asset. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4313": {
   "value": "<span class=\"SDE3 S202 S2\" id=\"tb_39\">H. Financial assets and </span><span class=\"SDE4 S202 S2\" id=\"tc_39\">liabilities </span><span class=\"SDE5 S49 S2\" id=\"td_39\">Recognition and measurement </span><span class=\"SDE6 S46 S2\" id=\"te_39\">Trade receivables are initially recognized </span><span class=\"SDE7 S46 S2\" id=\"tf_39\">when they are originated. All other </span><span class=\"SDE8 S46 S2\" id=\"tg_39\">\ufb01nancial assets and \ufb01nancial liabilities </span><span class=\"SDE9 S46 S2\" id=\"th_39\">are initially recognized when the Group </span><span class=\"SDEA S46 S2\" id=\"ti_39\">becomes a party to the contractual </span><span class=\"SDEB S46 S2\" id=\"tj_39\">provisions of the instrument. A trade </span><span class=\"SDEC S46 S2\" id=\"tk_39\">receivable without a signi\ufb01cant \ufb01nancing </span><span class=\"SDED S46 S2\" id=\"tl_39\">component is initially measured at the </span><span class=\"SDEE S46 S2\" id=\"tm_39\">transaction price. All other \ufb01nancial </span><span class=\"SDEF S46 S2\" id=\"tn_39\">assets are initially measured at fair value </span><span class=\"SDF0 S46 S2\" id=\"to_39\">plus, for an item not at fair value through, </span><span class=\"SDF1 S46 S2\" id=\"tp_39\">transaction costs that are directly </span><span class=\"SDF2 S46 S2\" id=\"tq_39\">attributable. </span><span class=\"SDF3 S46 S2\" id=\"tr_39\">A \ufb01nancial asset is subsequently </span><span class=\"SDF4 S46 S2\" id=\"ts_39\">measured at amortized cost if it meets </span><span class=\"SDF5 S46 S2\" id=\"tt_39\">both of the following criteria and is not </span><span class=\"SDF6 S46 S2\" id=\"tu_39\">designated as at Fair Value Through </span><span class=\"SDF7 S46 S2\" id=\"tv_39\">Pro\ufb01t and Loss (FVTPL): </span><span class=\"SDF8 S46 S2\" id=\"tw_39\">it is held within a business model </span><span class=\"SDF9 S46 S2\" id=\"tx_39\">whose objective is to hold assets to </span><span class=\"SDFA S46 S2\" id=\"ty_39\">collect contractual cash \ufb02ows; and </span><span class=\"SDFB S46 S2\" id=\"tz_39\">its contractual terms give rise on </span><span class=\"SDFC S46 S2\" id=\"t10_39\">speci\ufb01ed dates to cash \ufb02ows that </span><span class=\"SDFD S46 S2\" id=\"t11_39\">are solely payments of principal and </span><span class=\"SDFE S46 S2\" id=\"t12_39\">interest on the principal amount </span><span class=\"SDFF S46 S2\" id=\"t13_39\">outstanding. </span><span class=\"SE00 S46 S2\" id=\"t14_39\">Trade receivables, loan to group </span><span class=\"SE01 S46 S2\" id=\"t15_39\">companies, and other receivables meet </span><span class=\"SE02 S46 S2\" id=\"t16_39\">both of these criteria and are measured </span><span class=\"SE03 S46 S2\" id=\"t17_39\">at amortized cost using e\ufb00ective </span><span class=\"SE04 S46 S2\" id=\"t18_39\">interest rate method. </span><span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span><span class=\"SE16 S46 S2\" id=\"t1q_39\">e\ufb00ective interest rate method. </span><span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span><span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span><span class=\"SE46 S46 S167 S2\" id=\"t32_39\">interest rate of the \ufb01nancial asset. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4314": {
   "value": "<span class=\"SDE3 S202 S2\" id=\"tb_39\">H. Financial assets and </span><span class=\"SDE4 S202 S2\" id=\"tc_39\">liabilities </span><span class=\"SDE5 S49 S2\" id=\"td_39\">Recognition and measurement </span><span class=\"SDE6 S46 S2\" id=\"te_39\">Trade receivables are initially recognized </span><span class=\"SDE7 S46 S2\" id=\"tf_39\">when they are originated. All other </span><span class=\"SDE8 S46 S2\" id=\"tg_39\">\ufb01nancial assets and \ufb01nancial liabilities </span><span class=\"SDE9 S46 S2\" id=\"th_39\">are initially recognized when the Group </span><span class=\"SDEA S46 S2\" id=\"ti_39\">becomes a party to the contractual </span><span class=\"SDEB S46 S2\" id=\"tj_39\">provisions of the instrument. A trade </span><span class=\"SDEC S46 S2\" id=\"tk_39\">receivable without a signi\ufb01cant \ufb01nancing </span><span class=\"SDED S46 S2\" id=\"tl_39\">component is initially measured at the </span><span class=\"SDEE S46 S2\" id=\"tm_39\">transaction price. All other \ufb01nancial </span><span class=\"SDEF S46 S2\" id=\"tn_39\">assets are initially measured at fair value </span><span class=\"SDF0 S46 S2\" id=\"to_39\">plus, for an item not at fair value through, </span><span class=\"SDF1 S46 S2\" id=\"tp_39\">transaction costs that are directly </span><span class=\"SDF2 S46 S2\" id=\"tq_39\">attributable. </span><span class=\"SDF3 S46 S2\" id=\"tr_39\">A \ufb01nancial asset is subsequently </span><span class=\"SDF4 S46 S2\" id=\"ts_39\">measured at amortized cost if it meets </span><span class=\"SDF5 S46 S2\" id=\"tt_39\">both of the following criteria and is not </span><span class=\"SDF6 S46 S2\" id=\"tu_39\">designated as at Fair Value Through </span><span class=\"SDF7 S46 S2\" id=\"tv_39\">Pro\ufb01t and Loss (FVTPL): </span><span class=\"SDF8 S46 S2\" id=\"tw_39\">it is held within a business model </span><span class=\"SDF9 S46 S2\" id=\"tx_39\">whose objective is to hold assets to </span><span class=\"SDFA S46 S2\" id=\"ty_39\">collect contractual cash \ufb02ows; and </span><span class=\"SDFB S46 S2\" id=\"tz_39\">its contractual terms give rise on </span><span class=\"SDFC S46 S2\" id=\"t10_39\">speci\ufb01ed dates to cash \ufb02ows that </span><span class=\"SDFD S46 S2\" id=\"t11_39\">are solely payments of principal and </span><span class=\"SDFE S46 S2\" id=\"t12_39\">interest on the principal amount </span><span class=\"SDFF S46 S2\" id=\"t13_39\">outstanding. </span><span class=\"SE00 S46 S2\" id=\"t14_39\">Trade receivables, loan to group </span><span class=\"SE01 S46 S2\" id=\"t15_39\">companies, and other receivables meet </span><span class=\"SE02 S46 S2\" id=\"t16_39\">both of these criteria and are measured </span><span class=\"SE03 S46 S2\" id=\"t17_39\">at amortized cost using e\ufb00ective </span><span class=\"SE04 S46 S2\" id=\"t18_39\">interest rate method. </span><span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span><span class=\"SE16 S46 S2\" id=\"t1q_39\">e\ufb00ective interest rate method. </span><span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span><span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span><span class=\"SE46 S46 S167 S2\" id=\"t32_39\">interest rate of the \ufb01nancial asset. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4315": {
   "value": "<span class=\"SDE3 S202 S2\" id=\"tb_39\">H. Financial assets and </span><span class=\"SDE4 S202 S2\" id=\"tc_39\">liabilities </span><span class=\"SDE5 S49 S2\" id=\"td_39\">Recognition and measurement </span><span class=\"SDE6 S46 S2\" id=\"te_39\">Trade receivables are initially recognized </span><span class=\"SDE7 S46 S2\" id=\"tf_39\">when they are originated. All other </span><span class=\"SDE8 S46 S2\" id=\"tg_39\">\ufb01nancial assets and \ufb01nancial liabilities </span><span class=\"SDE9 S46 S2\" id=\"th_39\">are initially recognized when the Group </span><span class=\"SDEA S46 S2\" id=\"ti_39\">becomes a party to the contractual </span><span class=\"SDEB S46 S2\" id=\"tj_39\">provisions of the instrument. A trade </span><span class=\"SDEC S46 S2\" id=\"tk_39\">receivable without a signi\ufb01cant \ufb01nancing </span><span class=\"SDED S46 S2\" id=\"tl_39\">component is initially measured at the </span><span class=\"SDEE S46 S2\" id=\"tm_39\">transaction price. All other \ufb01nancial </span><span class=\"SDEF S46 S2\" id=\"tn_39\">assets are initially measured at fair value </span><span class=\"SDF0 S46 S2\" id=\"to_39\">plus, for an item not at fair value through, </span><span class=\"SDF1 S46 S2\" id=\"tp_39\">transaction costs that are directly </span><span class=\"SDF2 S46 S2\" id=\"tq_39\">attributable. </span><span class=\"SDF3 S46 S2\" id=\"tr_39\">A \ufb01nancial asset is subsequently </span><span class=\"SDF4 S46 S2\" id=\"ts_39\">measured at amortized cost if it meets </span><span class=\"SDF5 S46 S2\" id=\"tt_39\">both of the following criteria and is not </span><span class=\"SDF6 S46 S2\" id=\"tu_39\">designated as at Fair Value Through </span><span class=\"SDF7 S46 S2\" id=\"tv_39\">Pro\ufb01t and Loss (FVTPL): </span><span class=\"SDF8 S46 S2\" id=\"tw_39\">it is held within a business model </span><span class=\"SDF9 S46 S2\" id=\"tx_39\">whose objective is to hold assets to </span><span class=\"SDFA S46 S2\" id=\"ty_39\">collect contractual cash \ufb02ows; and </span><span class=\"SDFB S46 S2\" id=\"tz_39\">its contractual terms give rise on </span><span class=\"SDFC S46 S2\" id=\"t10_39\">speci\ufb01ed dates to cash \ufb02ows that </span><span class=\"SDFD S46 S2\" id=\"t11_39\">are solely payments of principal and </span><span class=\"SDFE S46 S2\" id=\"t12_39\">interest on the principal amount </span><span class=\"SDFF S46 S2\" id=\"t13_39\">outstanding. </span><span class=\"SE00 S46 S2\" id=\"t14_39\">Trade receivables, loan to group </span><span class=\"SE01 S46 S2\" id=\"t15_39\">companies, and other receivables meet </span><span class=\"SE02 S46 S2\" id=\"t16_39\">both of these criteria and are measured </span><span class=\"SE03 S46 S2\" id=\"t17_39\">at amortized cost using e\ufb00ective </span><span class=\"SE04 S46 S2\" id=\"t18_39\">interest rate method. </span><span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span><span class=\"SE16 S46 S2\" id=\"t1q_39\">e\ufb00ective interest rate method. </span><span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span><span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span><span class=\"SE46 S46 S167 S2\" id=\"t32_39\">interest rate of the \ufb01nancial asset. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4319": {
   "value": "<span class=\"SDE6 S46 S2\" id=\"te_39\">Trade receivables are initially recognized </span><span class=\"SDE7 S46 S2\" id=\"tf_39\">when they are originated. All other </span><span class=\"SDE8 S46 S2\" id=\"tg_39\">\ufb01nancial assets and \ufb01nancial liabilities </span><span class=\"SDE9 S46 S2\" id=\"th_39\">are initially recognized when the Group </span><span class=\"SDEA S46 S2\" id=\"ti_39\">becomes a party to the contractual </span><span class=\"SDEB S46 S2\" id=\"tj_39\">provisions of the instrument. A trade </span><span class=\"SDEC S46 S2\" id=\"tk_39\">receivable without a signi\ufb01cant \ufb01nancing </span><span class=\"SDED S46 S2\" id=\"tl_39\">component is initially measured at the </span><span class=\"SDEE S46 S2\" id=\"tm_39\">transaction price. All other \ufb01nancial </span><span class=\"SDEF S46 S2\" id=\"tn_39\">assets are initially measured at fair value </span><span class=\"SDF0 S46 S2\" id=\"to_39\">plus, for an item not at fair value through, </span><span class=\"SDF1 S46 S2\" id=\"tp_39\">transaction costs that are directly </span><span class=\"SDF2 S46 S2\" id=\"tq_39\">attributable. </span><span class=\"SDF3 S46 S2\" id=\"tr_39\">A \ufb01nancial asset is subsequently </span><span class=\"SDF4 S46 S2\" id=\"ts_39\">measured at amortized cost if it meets </span><span class=\"SDF5 S46 S2\" id=\"tt_39\">both of the following criteria and is not </span><span class=\"SDF6 S46 S2\" id=\"tu_39\">designated as at Fair Value Through </span><span class=\"SDF7 S46 S2\" id=\"tv_39\">Pro\ufb01t and Loss (FVTPL): </span><span class=\"SDF8 S46 S2\" id=\"tw_39\">it is held within a business model </span><span class=\"SDF9 S46 S2\" id=\"tx_39\">whose objective is to hold assets to </span><span class=\"SDFA S46 S2\" id=\"ty_39\">collect contractual cash \ufb02ows; and </span><span class=\"SDFB S46 S2\" id=\"tz_39\">its contractual terms give rise on </span><span class=\"SDFC S46 S2\" id=\"t10_39\">speci\ufb01ed dates to cash \ufb02ows that </span><span class=\"SDFD S46 S2\" id=\"t11_39\">are solely payments of principal and </span><span class=\"SDFE S46 S2\" id=\"t12_39\">interest on the principal amount </span><span class=\"SDFF S46 S2\" id=\"t13_39\">outstanding. </span><span class=\"SE00 S46 S2\" id=\"t14_39\">Trade receivables, loan to group </span><span class=\"SE01 S46 S2\" id=\"t15_39\">companies, and other receivables meet </span><span class=\"SE02 S46 S2\" id=\"t16_39\">both of these criteria and are measured </span><span class=\"SE03 S46 S2\" id=\"t17_39\">at amortized cost using e\ufb00ective </span><span class=\"SE04 S46 S2\" id=\"t18_39\">interest rate method. </span><span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span><span class=\"SE16 S46 S2\" id=\"t1q_39\">e\ufb00ective interest rate method. </span><span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span><span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span>interest rate of the \ufb01nancial asset",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4351": {
   "value": "<span class=\"SE05 S46 S2\" id=\"t19_39\">All \ufb01nancial assets not classi\ufb01ed as </span><span class=\"SE06 S46 S2\" id=\"t1a_39\">measured at amortized cost or FVOCI </span><span class=\"SE07 S46 S2\" id=\"t1b_39\">as described above are subsequently </span><span class=\"SE08 S46 S2\" id=\"t1c_39\">measured at FVTPL. Photocure\u2019s </span><span class=\"SE09 S46 S2\" id=\"t1d_39\">investments in money market funds are </span><span class=\"SE0A S46 S2\" id=\"t1e_39\">measured at FVTPL. </span><span class=\"SE0B S46 S2\" id=\"t1f_39\">The earnout liability is measured at </span><span class=\"SE0C S46 S2\" id=\"t1g_39\">fair value at the date of acquisition </span><span class=\"SE0D S46 S2\" id=\"t1h_39\">and remeasured at fair value at each </span><span class=\"SE0E S46 S2\" id=\"t1i_39\">reporting date and subsequent </span><span class=\"SE0F S46 S2\" id=\"t1j_39\">changes in the fair value are recognized </span><span class=\"SE10 S46 S2\" id=\"t1k_39\">in pro\ufb01t or loss </span><span class=\"SE11 S46 S2\" id=\"t1l_39\">Interest bearing liabilities are </span><span class=\"SE12 S46 S2\" id=\"t1m_39\">recognized at fair value at the time of </span><span class=\"SE13 S46 S2\" id=\"t1n_39\">recognition. In subsequent periods, </span><span class=\"SE14 S46 S2\" id=\"t1o_39\">interest-bearing liabilities are booked </span><span class=\"SE15 S46 S2\" id=\"t1p_39\">at amortized cost according to the </span>e\ufb00ective interest rate method",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4371": {
   "value": "<span class=\"SE17 S46 S2\" id=\"t1r_39\">Financial income consists of interest </span><span class=\"SE18 S46 S2\" id=\"t1s_39\">income on bank balances and money </span><span class=\"SE19 S46 S2\" id=\"t1t_39\">market fund as well as exchange rate </span><span class=\"SE1A S46 S2\" id=\"t1u_39\">gains from currency items. Financial </span><span class=\"SE1B S46 S2\" id=\"t1v_39\">expense consists of interest expense </span><span class=\"SE1C S46 S2\" id=\"t1w_39\">on borrowing and exchange rate losses </span><span class=\"SE1D S46 S2\" id=\"t1x_39\">from currency items. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4380": {
   "value": "<span class=\"SE1E S49 S2\" id=\"t1y_39\">Impairment </span><span class=\"SE1F S46 S2\" id=\"t1z_39\">The Group recognizes loss allowances for </span><span class=\"SE20 S46 S2\" id=\"t20_39\">expected credit losses (ECLs) on \ufb01nancial </span><span class=\"SE21 S46 S2\" id=\"t21_39\">assets measured at amortized cost. </span><span class=\"SE22 S46 S2\" id=\"t22_39\">The Group measures loss allowances at </span><span class=\"SE23 S46 S2\" id=\"t23_39\">an amount equal to lifetime ECLs, except </span><span class=\"SE24 S46 S2\" id=\"t24_39\">for the following, which are measured at </span><span class=\"SE25 S46 S2\" id=\"t25_39\">12-month ECLs: </span><span class=\"SE26 S46 S2\" id=\"t26_39\">debt securities that are determined </span><span class=\"SE27 S46 S2\" id=\"t27_39\">to have low credit risk at the </span><span class=\"SE28 S46 S2\" id=\"t28_39\">reporting date; and </span><span class=\"SE29 S46 S2\" id=\"t29_39\">other debt securities and bank </span><span class=\"SE2A S46 S2\" id=\"t2a_39\">balances for which credit risk (i.e. </span><span class=\"SE2B S46 S2\" id=\"t2b_39\">the risk of default occurring over </span><span class=\"SE2C S46 S2\" id=\"t2c_39\">the expected life of the \ufb01nancial </span><span class=\"SE2D S46 S2\" id=\"t2d_39\">instrument) has not increased </span><span class=\"SE2E S46 S2\" id=\"t2e_39\">signi\ufb01cantly since initial recognition. </span><span class=\"SE2F S46 S2\" id=\"t2f_39\">The Group assumes that the credit </span><span class=\"SE30 S46 S2\" id=\"t2g_39\">risk on a \ufb01nancial asset has increased </span><span class=\"SE31 S46 S2\" id=\"t2h_39\">signi\ufb01cantly if it is more than 30 days </span><span class=\"SE32 S46 S2\" id=\"t2i_39\">past due. Lifetime ECLs are the ECLs </span><span class=\"SE33 S46 S2\" id=\"t2j_39\">that result from all possible default </span><span class=\"SE34 S46 S2\" id=\"t2k_39\">events over the expected life of a </span><span class=\"SE35 S46 S2\" id=\"t2l_39\">\ufb01nancial instrument. 12-month ECLs </span><span class=\"SE36 S46 S2\" id=\"t2m_39\">are the portion of ECLs that result from </span><span class=\"SE37 S46 S2\" id=\"t2n_39\">default events that are possible within </span><span class=\"SE38 S46 S2\" id=\"t2o_39\">the 12 months after the reporting date </span><span class=\"SE39 S46 S2\" id=\"t2p_39\">(or a shorter period if the expected </span><span class=\"SE3A S46 S2\" id=\"t2q_39\">life of the instrument is less than 12 </span><span class=\"SE3B S46 S2\" id=\"t2r_39\">months). </span><span class=\"SE3C S46 S167 S2\" id=\"t2s_39\">Loss allowances for trade receivables </span><span class=\"SE3D S46 S167 S2\" id=\"t2t_39\">and contract assets are always </span><span class=\"SE3E S46 S167 S2\" id=\"t2u_39\">measured at an amount equal to </span><span class=\"SE3F S46 S167 S2\" id=\"t2v_39\">lifetime ECLs. The Group uses an </span><span class=\"SE40 S46 S167 S2\" id=\"t2w_39\">allowance matrix based on historical </span><span class=\"SE41 S46 S167 S2\" id=\"t2x_39\">losses adjusted for forward-looking </span><span class=\"SE42 S46 S167 S2\" id=\"t2y_39\">information. For other \ufb01nancial assets </span><span class=\"SE43 S46 S167 S2\" id=\"t2z_39\">measured at amortized cost the ECLs </span><span class=\"SE44 S46 S167 S2\" id=\"t30_39\">are probability-weighted estimates of </span><span class=\"SE45 S46 S167 S2\" id=\"t31_39\">credit losses discounted at the e\ufb00ective </span>interest rate of the \ufb01nancial asset",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4425": {
   "value": "<span class=\"SE47 S202 S2\" id=\"t33_39\">I. Revenue recognition </span><span class=\"SE48 S46 S2\" id=\"t34_39\">The core principle in IFRS 15 is revenue </span><span class=\"SE49 S46 S2\" id=\"t35_39\">should be recognized dependent </span><span class=\"SE4A S46 S2\" id=\"t36_39\">on the transfer of promised goods </span><span class=\"SE4B S46 S2\" id=\"t37_39\">or services to the customer for an </span><span class=\"SE4C S46 S2\" id=\"t38_39\">amount that re\ufb02ects the consideration </span><span class=\"SE4D S46 S2\" id=\"t39_39\">which should be received in exchange </span><span class=\"SE4E S46 S2\" id=\"t3a_39\">for those goods or services. The </span><span class=\"SE4F S46 S2\" id=\"t3b_39\">objective is to provide a \ufb01ve-step </span><span class=\"SE50 S46 S2\" id=\"t3c_39\">approach to revenue recognition that </span><span class=\"SE51 S46 S2\" id=\"t3d_39\">includes identifying contracts with </span><span class=\"SE52 S46 S2\" id=\"t3e_39\">customers, identifying performance </span><span class=\"SE53 S46 S2\" id=\"t3f_39\">obligations, determining transaction </span><span class=\"SE54 S46 S2\" id=\"t3g_39\">prices, allocating transaction prices </span><span class=\"SE55 S46 S2\" id=\"t3h_39\">to performance obligations, and </span><span class=\"SE56 S46 S2\" id=\"t3i_39\">recognizing revenue when or as </span><span class=\"SE57 S46 S2\" id=\"t3j_39\">performance obligations are satis\ufb01ed. </span><span class=\"SE58 S46 S2\" id=\"t3k_39\">In Photocure\u2019s customer contracts </span><span class=\"SE59 S46 S2\" id=\"t3l_39\">which are regarded to be within the </span><span class=\"SE5A S46 S2\" id=\"t3m_39\">scope of IFRS 15, the up-front fees not </span><span class=\"SE5B S46 S2\" id=\"t3n_39\">related to a separate performance </span><span class=\"SE5C S46 S2\" id=\"t3o_39\">obligation will be recognized over the </span><span class=\"SE5D S46 S2\" id=\"t3p_39\">term of the contract upon the delivery </span><span class=\"SE5E S46 S2\" id=\"t3q_39\">of goods. </span><span class=\"SE5F S46 S2\" id=\"t3r_39\">If the promise to grant the license is </span><span class=\"SE60 S46 S2\" id=\"t3s_39\">distinct from other promised goods or </span><span class=\"SE61 S46 S2\" id=\"t3t_39\">services in the contract, the promise </span><span class=\"SE62 S46 S2\" id=\"t3u_39\">to grant the license is a separate </span><span class=\"SE63 S46 S2\" id=\"t3v_39\">performance obligation. A license </span><span class=\"SE64 S46 S2\" id=\"t3w_39\">contract with a customer is a right to </span><span class=\"SE65 S46 S2\" id=\"t3x_39\">use Photocure\u2019s intellectual property as </span><span class=\"SE66 S46 S2\" id=\"t3y_39\">it exists at the point in time at which the </span><span class=\"SE67 S46 S2\" id=\"t3z_39\">license is granted. </span><span class=\"SE68 S46 S2\" id=\"t40_39\">The total transaction price is allocated </span><span class=\"SE69 S46 S2\" id=\"t41_39\">between the performance obligations </span><span class=\"SE6A S46 S2\" id=\"t42_39\">based on the relative stand-alone </span><span class=\"SE6B S46 S2\" id=\"t43_39\">selling price. The transaction price </span><span class=\"SE6C S46 S2\" id=\"t44_39\">allocated to the license may consist </span><span class=\"SE6D S46 S2\" id=\"t45_39\">of up-front fee, di\ufb00erent milestone </span><span class=\"SE6E S46 S2\" id=\"t46_39\">payments and sales based royalty </span><span class=\"SE6F S46 S2\" id=\"t4_40\">payments. The part of the transaction </span><span class=\"SE70 S46 S2\" id=\"t5_40\">price related to variable milestone </span><span class=\"SE71 S46 S2\" id=\"t6_40\">payments are estimated as the most </span><span class=\"SE72 S46 S2\" id=\"t7_40\">likely amount but constrained which </span><span class=\"SE73 S46 S2\" id=\"t8_40\">currently means that these revenues </span><span class=\"SE74 S46 S2\" id=\"t9_40\">will be recognized if and when the </span><span class=\"SE75 S46 S2\" id=\"ta_40\">relevant milestone are achieved. Sales </span><span class=\"SE76 S46 S2\" id=\"tb_40\">based royalty is recognized when the </span><span class=\"SE77 S46 S2\" id=\"tc_40\">subsequent sales occur. </span><span class=\"SE78 S46 S2\" id=\"td_40\">Revenues for the sale of products are </span><span class=\"SE79 S46 S2\" id=\"te_40\">recorded on the date of delivery, when </span><span class=\"SE7A S46 S2\" id=\"tf_40\">both control and risk essentially have </span><span class=\"SE7B S46 S2\" id=\"tg_40\">been transferred to the buyer. </span><span class=\"SE7C S46 S2\" id=\"th_40\">License agreements that give the right </span><span class=\"SE7D S46 S2\" id=\"ti_40\">to a guaranteed minimum royalty are </span><span class=\"SE7E S46 S2\" id=\"tj_40\">booked as revenue at the time the </span><span class=\"SD96 S46 S2\" id=\"tk_40\">prerequisite is ful\ufb01lled. Royalty revenue </span><span class=\"SE7F S46 S2\" id=\"tl_40\">is booked as Sales revenue in line with </span>the licensee\u2019s sale of licensed products",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4496": {
   "value": "<span class=\"SE81 S202 S2\" id=\"tn_40\">J. Government grants </span><span class=\"SE82 S46 S2\" id=\"to_40\">Government grants are booked at </span><span class=\"SE83 S46 S2\" id=\"tp_40\">the same time as the income that it </span><span class=\"SE84 S46 S2\" id=\"tq_40\">shall generate or the cost that it shall </span><span class=\"SE85 S46 S2\" id=\"tr_40\">reduce. Grants received for product </span><span class=\"SE86 S46 S2\" id=\"ts_40\">development or manufacture are \ufb01rst </span><span class=\"SE87 S46 S2\" id=\"tt_40\">booked as reduction of costs when </span><span class=\"SE88 S46 S2\" id=\"tu_40\">the conditions for the grant in question </span><span class=\"SE89 S46 S2\" id=\"tv_40\">have been met and the applications are </span><span class=\"SE8A S46 S2\" id=\"tw_40\">granted. Grants received for product </span><span class=\"SE8B S46 S2\" id=\"tx_40\">development that are capitalized, </span><span class=\"SE8C S46 S2\" id=\"ty_40\">are reported as reduction of gross </span><span class=\"SE8D S46 S2\" id=\"tz_40\">expenditures and the net expenditures </span><span class=\"SE8E S46 S2\" id=\"t10_40\">are regarded as the intangible assets. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4511": {
   "value": "<span class=\"SE8F S202 S2\" id=\"t11_40\">K. Pensions </span><span class=\"SE90 S46 S2\" id=\"t12_40\">The Company\u2019s payment of </span><span class=\"SE91 S46 S2\" id=\"t13_40\">contributions is expensed in the period </span><span class=\"SE92 S46 S2\" id=\"t14_40\">it is accrued. Any prepayments made to </span><span class=\"SE93 S46 S2\" id=\"t15_40\">the contribution fund are recognized in </span><span class=\"SE94 S46 S2\" id=\"t16_40\">the balance sheet. </span><span class=\"SE95 S46 S2\" id=\"t17_40\">Employees residing in the United </span><span class=\"SE96 S46 S2\" id=\"t18_40\">States participate in a 401(k), a tax- </span><span class=\"SE97 S46 S2\" id=\"t19_40\">quali\ufb01ed, de\ufb01ned-contribution pension </span><span class=\"SE98 S46 S2\" id=\"t1a_40\">account de\ufb01ned in subsection 401(k) </span><span class=\"SE99 S46 S2\" id=\"t1b_40\">of the Internal Revenue Code The </span><span class=\"S8FD S46 S2\" id=\"t1c_40\">401k plan is not interest-bearing, the </span><span class=\"SE9A S46 S2\" id=\"t1d_40\">employee chooses from an investment </span><span class=\"SE9B S46 S2\" id=\"t1e_40\">line up of diversi\ufb01ed mutual funds, </span><span class=\"SE9C S46 S2\" id=\"t1f_40\">which can generate gains or losses. </span><span class=\"SE9D S46 S2\" id=\"t1g_40\">Employees in Germany that were part </span><span class=\"SE9E S46 S2\" id=\"t1h_40\">of the acquisition from Ipsen have </span><span class=\"SE9F S46 S2\" id=\"t1i_40\">a de\ufb01ned bene\ufb01t pension plan that </span><span class=\"SEA0 S46 S2\" id=\"t1j_40\">has been transferred to Photocure </span><span class=\"SEA1 S46 S2\" id=\"t1k_40\">GmbH as part of the TUPE regulations. </span><span class=\"SEA2 S46 S2\" id=\"t1l_40\">Photocure GmbH has entered a </span><span class=\"SEA3 S46 S2\" id=\"t1m_40\">re-assurance agreement with an </span><span class=\"SEA4 S46 S2\" id=\"t1n_40\">assurance company that balance </span><span class=\"SDAA S46 S2\" id=\"t1o_40\">the pension liability. New employees </span><span class=\"SEA5 S46 S2\" id=\"t1p_40\">in Germany are o\ufb00ered a de\ufb01ned </span><span class=\"SEA6 S46 S2\" id=\"t1q_40\">contribution pension plan. </span><span class=\"SEA7 S46 S2\" id=\"t1r_40\">Salary to senior management </span><span class=\"SEA8 S46 S2\" id=\"t1s_40\">employees in Photocure ASA above 12 x </span><span class=\"SEA9 S46 S2\" id=\"t1t_40\">G is subject to agreements concerning </span><span class=\"SEAA S46 S2\" id=\"t1u_40\">operational coverage of pensions for </span><span class=\"SEAB S46 S2\" id=\"t1v_40\">salary above this level in the form of </span><span class=\"SEAC S46 S2\" id=\"t1w_40\">contribution-based pensions. The </span><span class=\"S7F7 S46 S2\" id=\"t1x_40\">calculated contribution constitutes </span><span class=\"SEAD S46 S2\" id=\"t1y_40\">16% of the employee\u2019s salary above 12 </span><span class=\"SEAE S46 S2\" id=\"t1z_40\">x G. </span><span class=\"SEAF S46 S2\" id=\"t20_40\">Photocure Inc has established an </span><span class=\"SEB0 S46 S2\" id=\"t21_40\">additional unfunded pension coverage </span><span class=\"SEB1 S46 S2\" id=\"t22_40\">for senior managers accruing annually </span><span class=\"SEB2 S46 S2\" id=\"t23_40\">an amount equal to 4% of salary and </span><span class=\"SEB3 S46 S2\" id=\"t24_40\">earned bonus. </span><span class=\"SEB4 S46 S2\" id=\"t25_40\">The calculated pension obligation </span><span class=\"SEB5 S46 S2\" id=\"t26_40\">pursuant to these schemes are </span><span class=\"SEB6 S46 S2\" id=\"t27_40\">interest-bearing. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4555": {
   "value": "<span class=\"SEB7 S202 S2\" id=\"t28_40\">L. Share remuneration and </span><span class=\"SEB8 S202 S2\" id=\"t29_40\">other bene\ufb01ts related to </span><span class=\"SEB9 S202 S2\" id=\"t2a_40\">share based remuneration </span><span class=\"SEBA S46 S206 S2\" id=\"t2b_40\">Employees have been o\ufb00ered share </span><span class=\"SEBB S46 S206 S2\" id=\"t2c_40\">options to the Company\u2019s shares as </span><span class=\"SEBC S46 S206 S2\" id=\"t2d_40\">an element of the Group\u2019s employee </span><span class=\"SEBD S46 S206 S2\" id=\"t2e_40\">incentive policy. If the Group has own </span><span class=\"S50D S46 S206 S2\" id=\"t2f_40\">shares, the Group may allot own shares </span><span class=\"SEBE S46 S206 S2\" id=\"t2g_40\">instead of issuing new shares when share </span><span class=\"SEBF S46 S206 S2\" id=\"t2h_40\">options are exercised. All share options </span><span class=\"SEC0 S46 S206 S2\" id=\"t2i_40\">are o\ufb00ered at strike prices that re\ufb02ect </span><span class=\"SEC1 S46 S206 S2\" id=\"t2j_40\">the market price +10% of the shares at </span><span class=\"SEC2 S46 S206 S2\" id=\"t2k_40\">the time of allotment of the rights. </span><span class=\"SEC3 S46 S2\" id=\"t2l_40\">The fair value is expensed over the </span><span class=\"SEC4 S46 S2\" id=\"t2m_40\">share options vesting period and </span><span class=\"SEC5 S46 S2\" id=\"t2n_40\">the Company\u2019s equity is increased </span><span class=\"SEC6 S46 S2\" id=\"t2o_40\">correspondingly. The fair value of share </span><span class=\"SEC7 S46 S2\" id=\"t2p_40\">options is calculated according to the </span><span class=\"SEC8 S46 S2\" id=\"t2q_40\">Black-Scholes model. Each program </span><span class=\"SEC9 S46 S2\" id=\"t2r_40\">is calculated separately with the </span><span class=\"SECA S46 S2\" id=\"t2s_40\">actual strike price and duration of the </span><span class=\"SECB S46 S2\" id=\"t2t_40\">program. The share options cease to be </span><span class=\"SECC S46 S2\" id=\"t2u_40\">valid when the employee\u2019s is leaving the </span><span class=\"SECD S46 S2\" id=\"t2v_40\">Company. </span><span class=\"SECE S46 S2\" id=\"t2w_40\">Employer\u2019s social security contributions </span><span class=\"SECF S46 S2\" id=\"t2x_40\">on outstanding share options are </span><span class=\"SED0 S46 S2\" id=\"t2y_40\">accrued as personnel costs based on </span><span class=\"SED1 S46 S2\" id=\"t2z_40\">the intrinsic value of the rights. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4584": {
   "value": "<span class=\"SED2 S202 S2\" id=\"t30_40\">M. Tax </span><span class=\"SED3 S46 S2\" id=\"t31_40\">The tax expense in the income </span><span class=\"SED4 S46 S2\" id=\"t32_40\">statement includes both the income </span><span class=\"SED5 S46 S2\" id=\"t33_40\">tax payable for the period and changes </span><span class=\"SED6 S46 S2\" id=\"t34_40\">in deferred tax. Deferred tax in Norway </span><span class=\"SED7 S46 S2\" id=\"t35_40\">is calculated at rate of 22% and in the </span><span class=\"SED8 S46 S2\" id=\"t36_40\">USA at a total rate of 28% on the basis </span><span class=\"SED9 S46 S2\" id=\"t37_40\">of the temporary di\ufb00erences that exist </span><span class=\"SEDA S46 S2\" id=\"t38_40\">between the tax value of the assets and </span><span class=\"SEDB S46 S2\" id=\"t39_40\">liabilities, and their book value. </span><span class=\"SEDC S46 S2\" id=\"t3a_40\">Liabilities for deferred tax are included </span><span class=\"SEDD S46 S2\" id=\"t3b_40\">for all temporary di\ufb00erences that </span><span class=\"SEDE S46 S2\" id=\"t3c_40\">increase tax, except when the asset in </span><span class=\"SEDF S46 S2\" id=\"t3d_40\">connection with deferred tax arises as </span><span class=\"SEE0 S46 S2\" id=\"t3e_40\">a result of the \ufb01rst-time inclusion of an </span><span class=\"SEE1 S46 S2\" id=\"t3f_40\">asset or liability in a transaction that </span><span class=\"SEE2 S46 S2\" id=\"t3g_40\">is not in a business combination and </span><span class=\"SEE3 S46 S2\" id=\"t3h_40\">a\ufb00ects neither the accounting nor the </span><span class=\"SEE4 S46 S2\" id=\"t3i_40\">taxable pro\ufb01t or loss at the time of the </span><span class=\"SEE5 S46 S2\" id=\"t3j_40\">transaction. </span><span class=\"SEE6 S46 S2\" id=\"t3k_40\">Assets in connection with deferred </span><span class=\"SEE7 S46 S2\" id=\"t3l_40\">tax are included for all tax-reducing </span><span class=\"SEE8 S46 S2\" id=\"t3m_40\">temporary di\ufb00erences, carry forward </span><span class=\"SEE9 S46 S2\" id=\"t3n_40\">of tax deductions and tax losses in the </span><span class=\"SEEA S46 S2\" id=\"t3o_40\">extent that there is objective proof that </span><span class=\"SEEB S46 S2\" id=\"t3p_40\">there will be su\ufb03cient taxable pro\ufb01ts </span><span class=\"SEEC S46 S2\" id=\"t3q_40\">against which to o\ufb00set tax-reducing </span><span class=\"SEED S46 S2\" id=\"t3r_40\">temporary di\ufb00erences, and carry </span><span class=\"SEEE S46 S2\" id=\"t3s_40\">forward of unused tax deductions and </span><span class=\"SEEF S46 S2\" id=\"t3t_40\">tax losses. </span><span class=\"SEF0 S46 S2\" id=\"t3u_40\">In the US the tax years 2017 and </span><span class=\"SEF1 S46 S2\" id=\"t3v_40\">prior, businesses were able to o\ufb00set </span><span class=\"SE64 S46 S2\" id=\"t3w_40\">current taxable income by claiming </span><span class=\"SEF2 S46 S2\" id=\"t3x_40\">net operating losses (NOLs), generally </span><span class=\"SEF3 S46 S2\" id=\"t3y_40\">eligible for a two-year carryback and </span><span class=\"SEF4 S46 S2\" id=\"t3z_40\">20-year carryforward. Starting in tax </span><span class=\"SEF5 S46 S2\" id=\"t40_40\">year 2018, NOLs cannot be carried </span><span class=\"SEF6 S46 S2\" id=\"t41_40\">back, but can be inde\ufb01nitely carried </span><span class=\"SEF7 S46 S2\" id=\"t42_40\">forward. In addition, NOLs for tax </span><span class=\"SEF8 S46 S2\" id=\"t43_40\">years beginning in 2018 will be subject </span><span class=\"SEF9 S46 S2\" id=\"t44_40\">to an 80-percent limitation. </span><span class=\"SEFA S46 S2\" id=\"t45_40\">The 80 </span><span class=\"SEFB S46 S2\" id=\"t46_40\">percent limitation on NOL deductions </span><span class=\"SEFD S46 S2\" id=\"t2_41\">applies to losses generated in tax </span><span class=\"SEFE S46 S2\" id=\"t3_41\">years beginning after December 31, </span><span class=\"SEFF S46 S2\" id=\"t4_41\">2017. </span><span class=\"SF00 S46 S2\" id=\"t5_41\">NOLs </span><span class=\"SF01 S46 S167 S2\" id=\"t6_41\">generated in 2017 and </span><span class=\"SF02 S46 S167 S2\" id=\"t7_41\">earlier would retain their 20-year life </span><span class=\"SF03 S46 S167 S2\" id=\"t8_41\">and be available to o\ufb00set 100 percent </span><span class=\"SF04 S46 S167 S2\" id=\"t9_41\">of taxable income, subject to certain </span><span class=\"SF05 S46 S167 S2\" id=\"ta_41\">limitations. </span><span class=\"SF06 S46 S167 S2\" id=\"tb_41\">Companies will have to </span><span class=\"SF07 S46 S167 S2\" id=\"tc_41\">track their NOLs in di\ufb00erent buckets </span><span class=\"SF08 S46 S167 S2\" id=\"td_41\">based on date (pre and post December </span><span class=\"SF09 S46 S167 S2\" id=\"te_41\">31, 2017). The Coronavirus Aid, Relief, </span><span class=\"SF0A S46 S167 S2\" id=\"tf_41\">and Economic Security (\u201cCARES \u201c) Act </span><span class=\"SF0B S46 S167 S2\" id=\"tg_41\">changed those rules temporarily by </span><span class=\"SF0C S46 S167 S2\" id=\"th_41\">permitting NOLs incurred in 2018, 2019, </span><span class=\"SD91 S46 S167 S2\" id=\"ti_41\">or 2020 to be carried back for \ufb01ve years </span><span class=\"SF0D S46 S167 S2\" id=\"tj_41\">to the earliest year \ufb01rst and suspending </span><span class=\"SF0E S46 S167 S2\" id=\"tk_41\">the 80% taxable income limitation </span><span class=\"SF0F S46 S167 S2\" id=\"tl_41\">through 2020. </span><span class=\"SF10 S46 S2\" id=\"tm_41\">The book value of assets in connection </span><span class=\"SF11 S46 S2\" id=\"tn_41\">with deferred tax is reviewed on every </span><span class=\"SF12 S46 S2\" id=\"to_41\">balance sheet date and is reduced </span><span class=\"SF13 S46 S2\" id=\"tp_41\">to the degree that there is no longer </span><span class=\"SF14 S46 S2\" id=\"tq_41\">any objective proof that there will be </span><span class=\"SF15 S46 S2\" id=\"tr_41\">su\ufb03cient taxable pro\ufb01ts to utilize all </span><span class=\"SF16 S46 S2\" id=\"ts_41\">or parts of assets in connection with </span><span class=\"SF17 S46 S2\" id=\"tt_41\">deferred tax. Non-recognized assets </span><span class=\"SF18 S46 S2\" id=\"tu_41\">in connection with deferred tax are </span><span class=\"SF19 S46 S2\" id=\"tv_41\">reviewed every balance sheet date </span><span class=\"SF1A S46 S2\" id=\"tw_41\">and are included to the degree that it </span><span class=\"SF1B S46 S2\" id=\"tx_41\">is probable that future taxable pro\ufb01ts </span><span class=\"SF1C S46 S2\" id=\"ty_41\">will allow the recovery of assets in </span><span class=\"SF1D S46 S2\" id=\"tz_41\">connection with deferred tax. Each </span><span class=\"SF1E S46 S2\" id=\"t10_41\">taxable entity in the Group are treated </span><span class=\"SF1F S46 S2\" id=\"t11_41\">separately. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4585": {
   "value": "<span class=\"SED2 S202 S2\" id=\"t30_40\">M. Tax </span><span class=\"SED3 S46 S2\" id=\"t31_40\">The tax expense in the income </span><span class=\"SED4 S46 S2\" id=\"t32_40\">statement includes both the income </span><span class=\"SED5 S46 S2\" id=\"t33_40\">tax payable for the period and changes </span><span class=\"SED6 S46 S2\" id=\"t34_40\">in deferred tax. Deferred tax in Norway </span><span class=\"SED7 S46 S2\" id=\"t35_40\">is calculated at rate of 22% and in the </span><span class=\"SED8 S46 S2\" id=\"t36_40\">USA at a total rate of 28% on the basis </span><span class=\"SED9 S46 S2\" id=\"t37_40\">of the temporary di\ufb00erences that exist </span><span class=\"SEDA S46 S2\" id=\"t38_40\">between the tax value of the assets and </span><span class=\"SEDB S46 S2\" id=\"t39_40\">liabilities, and their book value. </span><span class=\"SEDC S46 S2\" id=\"t3a_40\">Liabilities for deferred tax are included </span><span class=\"SEDD S46 S2\" id=\"t3b_40\">for all temporary di\ufb00erences that </span><span class=\"SEDE S46 S2\" id=\"t3c_40\">increase tax, except when the asset in </span><span class=\"SEDF S46 S2\" id=\"t3d_40\">connection with deferred tax arises as </span><span class=\"SEE0 S46 S2\" id=\"t3e_40\">a result of the \ufb01rst-time inclusion of an </span><span class=\"SEE1 S46 S2\" id=\"t3f_40\">asset or liability in a transaction that </span><span class=\"SEE2 S46 S2\" id=\"t3g_40\">is not in a business combination and </span><span class=\"SEE3 S46 S2\" id=\"t3h_40\">a\ufb00ects neither the accounting nor the </span><span class=\"SEE4 S46 S2\" id=\"t3i_40\">taxable pro\ufb01t or loss at the time of the </span><span class=\"SEE5 S46 S2\" id=\"t3j_40\">transaction. </span><span class=\"SEE6 S46 S2\" id=\"t3k_40\">Assets in connection with deferred </span><span class=\"SEE7 S46 S2\" id=\"t3l_40\">tax are included for all tax-reducing </span><span class=\"SEE8 S46 S2\" id=\"t3m_40\">temporary di\ufb00erences, carry forward </span><span class=\"SEE9 S46 S2\" id=\"t3n_40\">of tax deductions and tax losses in the </span><span class=\"SEEA S46 S2\" id=\"t3o_40\">extent that there is objective proof that </span><span class=\"SEEB S46 S2\" id=\"t3p_40\">there will be su\ufb03cient taxable pro\ufb01ts </span><span class=\"SEEC S46 S2\" id=\"t3q_40\">against which to o\ufb00set tax-reducing </span><span class=\"SEED S46 S2\" id=\"t3r_40\">temporary di\ufb00erences, and carry </span><span class=\"SEEE S46 S2\" id=\"t3s_40\">forward of unused tax deductions and </span><span class=\"SEEF S46 S2\" id=\"t3t_40\">tax losses. </span><span class=\"SEF0 S46 S2\" id=\"t3u_40\">In the US the tax years 2017 and </span><span class=\"SEF1 S46 S2\" id=\"t3v_40\">prior, businesses were able to o\ufb00set </span><span class=\"SE64 S46 S2\" id=\"t3w_40\">current taxable income by claiming </span><span class=\"SEF2 S46 S2\" id=\"t3x_40\">net operating losses (NOLs), generally </span><span class=\"SEF3 S46 S2\" id=\"t3y_40\">eligible for a two-year carryback and </span><span class=\"SEF4 S46 S2\" id=\"t3z_40\">20-year carryforward. Starting in tax </span><span class=\"SEF5 S46 S2\" id=\"t40_40\">year 2018, NOLs cannot be carried </span><span class=\"SEF6 S46 S2\" id=\"t41_40\">back, but can be inde\ufb01nitely carried </span><span class=\"SEF7 S46 S2\" id=\"t42_40\">forward. In addition, NOLs for tax </span><span class=\"SEF8 S46 S2\" id=\"t43_40\">years beginning in 2018 will be subject </span><span class=\"SEF9 S46 S2\" id=\"t44_40\">to an 80-percent limitation. </span><span class=\"SEFA S46 S2\" id=\"t45_40\">The 80 </span><span class=\"SEFB S46 S2\" id=\"t46_40\">percent limitation on NOL deductions </span><span class=\"SEFD S46 S2\" id=\"t2_41\">applies to losses generated in tax </span><span class=\"SEFE S46 S2\" id=\"t3_41\">years beginning after December 31, </span><span class=\"SEFF S46 S2\" id=\"t4_41\">2017. </span><span class=\"SF00 S46 S2\" id=\"t5_41\">NOLs </span><span class=\"SF01 S46 S167 S2\" id=\"t6_41\">generated in 2017 and </span><span class=\"SF02 S46 S167 S2\" id=\"t7_41\">earlier would retain their 20-year life </span><span class=\"SF03 S46 S167 S2\" id=\"t8_41\">and be available to o\ufb00set 100 percent </span><span class=\"SF04 S46 S167 S2\" id=\"t9_41\">of taxable income, subject to certain </span><span class=\"SF05 S46 S167 S2\" id=\"ta_41\">limitations. </span><span class=\"SF06 S46 S167 S2\" id=\"tb_41\">Companies will have to </span><span class=\"SF07 S46 S167 S2\" id=\"tc_41\">track their NOLs in di\ufb00erent buckets </span><span class=\"SF08 S46 S167 S2\" id=\"td_41\">based on date (pre and post December </span><span class=\"SF09 S46 S167 S2\" id=\"te_41\">31, 2017). The Coronavirus Aid, Relief, </span><span class=\"SF0A S46 S167 S2\" id=\"tf_41\">and Economic Security (\u201cCARES \u201c) Act </span><span class=\"SF0B S46 S167 S2\" id=\"tg_41\">changed those rules temporarily by </span><span class=\"SF0C S46 S167 S2\" id=\"th_41\">permitting NOLs incurred in 2018, 2019, </span><span class=\"SD91 S46 S167 S2\" id=\"ti_41\">or 2020 to be carried back for \ufb01ve years </span><span class=\"SF0D S46 S167 S2\" id=\"tj_41\">to the earliest year \ufb01rst and suspending </span><span class=\"SF0E S46 S167 S2\" id=\"tk_41\">the 80% taxable income limitation </span><span class=\"SF0F S46 S167 S2\" id=\"tl_41\">through 2020. </span><span class=\"SF10 S46 S2\" id=\"tm_41\">The book value of assets in connection </span><span class=\"SF11 S46 S2\" id=\"tn_41\">with deferred tax is reviewed on every </span><span class=\"SF12 S46 S2\" id=\"to_41\">balance sheet date and is reduced </span><span class=\"SF13 S46 S2\" id=\"tp_41\">to the degree that there is no longer </span><span class=\"SF14 S46 S2\" id=\"tq_41\">any objective proof that there will be </span><span class=\"SF15 S46 S2\" id=\"tr_41\">su\ufb03cient taxable pro\ufb01ts to utilize all </span><span class=\"SF16 S46 S2\" id=\"ts_41\">or parts of assets in connection with </span><span class=\"SF17 S46 S2\" id=\"tt_41\">deferred tax. Non-recognized assets </span><span class=\"SF18 S46 S2\" id=\"tu_41\">in connection with deferred tax are </span><span class=\"SF19 S46 S2\" id=\"tv_41\">reviewed every balance sheet date </span><span class=\"SF1A S46 S2\" id=\"tw_41\">and are included to the degree that it </span><span class=\"SF1B S46 S2\" id=\"tx_41\">is probable that future taxable pro\ufb01ts </span><span class=\"SF1C S46 S2\" id=\"ty_41\">will allow the recovery of assets in </span><span class=\"SF1D S46 S2\" id=\"tz_41\">connection with deferred tax. Each </span><span class=\"SF1E S46 S2\" id=\"t10_41\">taxable entity in the Group are treated </span><span class=\"SF1F S46 S2\" id=\"t11_41\">separately. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4674": {
   "value": "<span class=\"SF20 S202 S2\" id=\"t12_41\">N. Earnings per share </span><span class=\"SF21 S46 S2\" id=\"t13_41\">Earnings per share is calculated on </span><span class=\"SF22 S46 S2\" id=\"t14_41\">the basis of the pro\ufb01ts for the </span><span class=\"SF23 S46 S2\" id=\"t15_41\">period after tax but before \u201cOther </span><span class=\"SF24 S46 S2\" id=\"t16_41\">comprehensive income\u201d, divided </span><span class=\"SF25 S46 S2\" id=\"t17_41\">by a weighted average number of </span><span class=\"SF26 S46 S2\" id=\"t18_41\">outstanding shares in the period and </span><span class=\"SF27 S46 S2\" id=\"t19_41\">adjusted for the treasury shares. </span><span class=\"SF28 S46 S2\" id=\"t1a_41\">The diluted earnings per share </span><span class=\"SF29 S46 S2\" id=\"t1b_41\">are calculated by adjusting the </span><span class=\"SF2A S46 S2\" id=\"t1c_41\">denominator for amounts outstanding </span><span class=\"SF2B S46 S2\" id=\"t1d_41\">on option programs. Anti-dilution </span>e\ufb00ects are not taken into consideration",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4690": {
   "value": ". Provisions <span class=\"SF2E S46 S2\" id=\"t1g_41\">Provisions are booked when the Group </span><span class=\"SF2F S46 S2\" id=\"t1h_41\">has a liability associated with an event, </span><span class=\"SF30 S46 S2\" id=\"t1i_41\">when it is probable that the liability will </span><span class=\"SF31 S46 S2\" id=\"t1j_41\">have to be settled and when the liability </span><span class=\"SF32 S46 S2\" id=\"t1k_41\">can be measured or estimated. </span><span class=\"SF33 S46 S2\" id=\"t1l_41\">When the Group expects that all or </span><span class=\"SF34 S46 S2\" id=\"t1m_41\">parts of the liability can be charged on </span><span class=\"SF35 S46 S2\" id=\"t1n_41\">to another party, this recharge will be </span><span class=\"SF36 S46 S2\" id=\"t1o_41\">recorded as an account receivable if </span><span class=\"SF37 S46 S2\" id=\"t1p_41\">there is virtual certain that the other </span><span class=\"SF38 S46 S2\" id=\"t1q_41\">party will pay. The cost associated with </span><span class=\"SF39 S46 S2\" id=\"t1r_41\">a provision will be recorded net in the </span><span class=\"SF3A S46 S2\" id=\"t1s_41\">income statement after deduction for </span>the recharge",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4717": {
   "value": "<span class=\"SF3C S202 S2\" id=\"t4_42\">P. Contingent liabilities </span><span class=\"SF3D S202 S2\" id=\"t5_42\">and assets </span><span class=\"SF3E S46 S2\" id=\"t6_42\">Contingent liabilities are de\ufb01ned as: </span><span class=\"SF3F S46 S2\" id=\"t7_42\">Possible liabilities as a result of </span><span class=\"SF40 S46 S2\" id=\"t8_42\">earlier events where their existence </span><span class=\"SF41 S46 S2\" id=\"t9_42\">depends on future events; </span><span class=\"SF42 S46 S2\" id=\"ta_42\">Liabilities that are not included </span><span class=\"SF43 S46 S2\" id=\"tb_42\">because it is not probable that they </span><span class=\"SF44 S46 S2\" id=\"tc_42\">will lead to an out\ufb02ow of resources </span><span class=\"SF45 S46 S2\" id=\"td_42\">from the Group; </span><span class=\"SF46 S46 S2\" id=\"te_42\">Liabilities that cannot be measured </span><span class=\"SF47 S46 S2\" id=\"tf_42\">with su\ufb03cient reliability. </span><span class=\"SF48 S46 S2\" id=\"tg_42\">Contingent liabilities are not included </span><span class=\"SF49 S46 S2\" id=\"th_42\">in the annual accounts. Notes on </span><span class=\"SF4A S46 S2\" id=\"ti_42\">signi\ufb01cant contingent liabilities </span><span class=\"SF4B S46 S2\" id=\"tj_42\">are provided, with the exception </span><span class=\"SF4C S46 S2\" id=\"tk_42\">of contingent liabilities with little </span><span class=\"SF4D S46 S2\" id=\"tl_42\">probability of occurring. </span><span class=\"SF4E S46 S2\" id=\"tm_42\">Contingent assets are not included in </span><span class=\"SF4F S46 S2\" id=\"tn_42\">the annual accounts, but are reported </span><span class=\"SF50 S46 S2\" id=\"to_42\">in cases in which there is a certain </span><span class=\"SF51 S46 S2\" id=\"tp_42\">likelihood of their resulting in a bene\ufb01t </span><span class=\"SF52 S46 S2\" id=\"tq_42\">to the Group. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4741": {
   "value": "<span class=\"SF53 S202 S2\" id=\"tr_42\">Q. Cash \ufb02ow statement </span><span class=\"SF54 S46 S2\" id=\"ts_42\">The cash \ufb02ow statement has been </span><span class=\"SF55 S46 S2\" id=\"tt_42\">prepared in accordance with the </span><span class=\"SF56 S46 S2\" id=\"tu_42\">indirect method. Cash and cash </span><span class=\"SF57 S46 S2\" id=\"tv_42\">equivalents consist of cash, bank </span><span class=\"SF58 S46 S2\" id=\"tw_42\">deposits and other current investments </span><span class=\"SF59 S46 S2\" id=\"tx_42\">like money market funds. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4742": {
   "value": "<span class=\"SF53 S202 S2\" id=\"tr_42\">Q. Cash \ufb02ow statement </span><span class=\"SF54 S46 S2\" id=\"ts_42\">The cash \ufb02ow statement has been </span><span class=\"SF55 S46 S2\" id=\"tt_42\">prepared in accordance with the </span><span class=\"SF56 S46 S2\" id=\"tu_42\">indirect method. Cash and cash </span><span class=\"SF57 S46 S2\" id=\"tv_42\">equivalents consist of cash, bank </span><span class=\"SF58 S46 S2\" id=\"tw_42\">deposits and other current investments </span><span class=\"SF59 S46 S2\" id=\"tx_42\">like money market funds. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4750": {
   "value": "<span class=\"SF5A S202 S2\" id=\"ty_42\">R. Lease agreements </span><span class=\"SF5B S46 S2\" id=\"tz_42\">The main rule is that the leased assets </span><span class=\"SF5C S46 S2\" id=\"t10_42\">are recognized in the balance sheet as </span><span class=\"SF5D S46 S2\" id=\"t11_42\">a \ufb01xed asset or in a disclosure note for </span><span class=\"SF5E S46 S2\" id=\"t12_42\">\ufb01xed assets. Leased assets are shown </span><span class=\"SF5F S46 S2\" id=\"t13_42\">separately from other \ufb01xed assets </span><span class=\"SF60 S46 S2\" id=\"t14_42\">owned by the company as \u201cRight of use </span><span class=\"SF61 S46 S2\" id=\"t15_42\">assets\u201d in the related disclosure note. </span><span class=\"SF62 S46 S2\" id=\"t16_42\">Although a lease is a right to use an </span><span class=\"SF63 S46 S2\" id=\"t17_42\">asset and not a purchase of an asset, </span><span class=\"SF64 S46 S2\" id=\"t18_42\">the classi\ufb01cation in the balance sheet </span><span class=\"SF65 S46 S2\" id=\"t19_42\">follows the leased asset. </span><span class=\"SF66 S46 S2\" id=\"t1a_42\">The net present value of the lease </span><span class=\"SF67 S46 S2\" id=\"t1b_42\">liability is calculated by discounting </span><span class=\"SF68 S46 S2\" id=\"t1c_42\">the rental payments with the implicit </span><span class=\"SF69 S46 S2\" id=\"t1d_42\">interest rate of the lease, or the </span><span class=\"SF6A S46 S2\" id=\"t1e_42\">business\u2019s marginal borrowing rate if </span><span class=\"SF6B S46 S2\" id=\"t1f_42\">the implicit interest rate is unknown. </span><span class=\"SF6C S46 S2\" id=\"t1g_42\">According to IFRS 16 depreciation is </span><span class=\"SF6D S46 S2\" id=\"t1h_42\">calculated for the right of use assets. </span><span class=\"SF6E S46 S2\" id=\"t1i_42\">Depreciation is presented together with </span><span class=\"SF6F S46 S2\" id=\"t1j_42\">other depreciation, while interest cost </span><span class=\"SF70 S46 S2\" id=\"t1k_42\">is included in \ufb01nancial expenses in the </span><span class=\"SF71 S46 S2\" id=\"t1l_42\">income statement. </span><span class=\"SF72 S46 S2\" id=\"t1m_42\">The leased assets are depreciated over </span><span class=\"SF73 S46 S2\" id=\"t1n_42\">their useful lives. This is the shorter </span><span class=\"SF74 S46 S2\" id=\"t1o_42\">of the rental period and the assets </span><span class=\"SF75 S46 S2\" id=\"t1p_42\">economic life. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4786": {
   "value": "<span class=\"SF77 S202 S2\" id=\"t2_43\">S. Segment reporting </span><span class=\"SF78 S46 S2\" id=\"t3_43\">Segments are reported similarly as the </span><span class=\"SF79 S46 S2\" id=\"t4_43\">internal reporting to the Group\u2019s Chief </span><span class=\"SF7A S46 S2\" id=\"t5_43\">Operating Decision Maker (CODM) </span><span class=\"SF7B S46 S2\" id=\"t6_43\">s. CODM are de\ufb01ned as the Group\u2019s </span><span class=\"SF7C S46 S2\" id=\"t7_43\">Senior management. </span>T.",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4793": {
   "value": "<span class=\"SF7D S202 S2\" id=\"t8_43\">T. Business combinations </span><span class=\"SF7E S46 S2\" id=\"t9_43\">A business acquisition can be regarded </span><span class=\"SF7F S46 S2\" id=\"ta_43\">as a business combination using the </span><span class=\"SF80 S46 S2\" id=\"tb_43\">acquisition method when the acquired </span><span class=\"SF81 S46 S2\" id=\"tc_43\">set of activities and assets meets the </span><span class=\"SF82 S46 S2\" id=\"td_43\">de\ufb01nition of a business and control is </span><span class=\"SF83 S46 S2\" id=\"te_43\">transferred. In determining whether a </span><span class=\"SF84 S46 S2\" id=\"tf_43\">particular set of activities and assets </span><span class=\"SF85 S46 S2\" id=\"tg_43\">is a business, Photocure will assessed </span><span class=\"SF86 S46 S2\" id=\"th_43\">whether the set of assets and activities </span><span class=\"SF87 S46 S2\" id=\"ti_43\">acquired includes, at a minimum, an </span><span class=\"SF88 S46 S2\" id=\"tj_43\">input and substantive process and </span><span class=\"SF89 S46 S2\" id=\"tk_43\">whether the acquired set has the ability </span><span class=\"SF8A S46 S2\" id=\"tl_43\">to produce outputs. </span><span class=\"SF8B S46 S29E S2\" id=\"tm_43\">Based on the agreement including </span><span class=\"SF8C S46 S29E S2\" id=\"tn_43\">the transfer of distribution contracts, </span><span class=\"SF8D S46 S29E S2\" id=\"to_43\">employees and inventory, the </span><span class=\"SF8E S46 S29E S2\" id=\"tp_43\">transaction has been de\ufb01ned as a </span><span class=\"SF8F S46 S29E S2\" id=\"tq_43\">business combination and is thus </span><span class=\"SF90 S46 S29E S2\" id=\"tr_43\">accounted for in accordance with IFRS 3. </span><span class=\"SF91 S46 S167 S2\" id=\"ts_43\">The consideration transferred in the </span><span class=\"SF92 S46 S167 S2\" id=\"tt_43\">acquisition is generally measured at </span><span class=\"SF93 S46 S167 S2\" id=\"tu_43\">fair value, as are the identi\ufb01able net </span><span class=\"SF94 S46 S167 S2\" id=\"tv_43\">assets acquired. The residual value in </span><span class=\"SF95 S46 S167 S2\" id=\"tw_43\">the acquisition constitutes goodwill and </span><span class=\"SF96 S46 S167 S2\" id=\"tx_43\">is tested annually for impairment. Any </span><span class=\"SF97 S46 S167 S2\" id=\"ty_43\">contingent consideration is measured </span><span class=\"SF98 S46 S167 S2\" id=\"tz_43\">at fair value at the date of acquisition </span><span class=\"SF99 S46 S167 S2\" id=\"t10_43\">and remeasured at fair value at each </span><span class=\"SE90 S46 S167 S2\" id=\"t11_43\">reporting date and subsequent changes </span><span class=\"SF9A S46 S167 S2\" id=\"t12_43\">in the fair value are recognized in pro\ufb01t </span><span class=\"SF9B S46 S167 S2\" id=\"t13_43\">or loss as \ufb01nancial income or cost. </span><span class=\"SF28 S46 S2\" id=\"t14_43\">Customer relationships meet </span><span class=\"SF9C S46 S2\" id=\"t15_43\">the contractual legal criterion for </span><span class=\"SF9D S46 S2\" id=\"t16_43\">identi\ufb01cation as intangible assets </span><span class=\"SF9E S46 S2\" id=\"t17_43\">for an entity that has a practice </span><span class=\"SF9F S46 S2\" id=\"t18_43\">of establishing contracts with its </span><span class=\"SFA0 S46 S2\" id=\"t19_43\">customers, regardless of whether </span><span class=\"SFA1 S46 S2\" id=\"t1a_43\">a contract exist at the date of the </span><span class=\"SFA2 S46 S2\" id=\"t1b_43\">acquisition. A customer relationship </span><span class=\"SFA3 S46 S2\" id=\"t1c_43\">may also arise through means other </span><span class=\"SFA4 S46 S2\" id=\"t1d_43\">than contracts, such as through </span><span class=\"SFA5 S46 S2\" id=\"t1e_43\">regular contact by sales or service </span><span class=\"SFA6 S46 S2\" id=\"t1f_43\">representatives. Furthermore, IFRS 3\u2019s </span><span class=\"SFA7 S46 S2\" id=\"t1g_43\">illustrative examples on \u201ccustomer- </span><span class=\"SFA8 S46 S2\" id=\"t1h_43\">related intangible assets\u201d sets forth </span><span class=\"SFA9 S46 S2\" id=\"t1i_43\">that customer relationships meet the </span><span class=\"SFAA S46 S2\" id=\"t1j_43\">criteria of an intangible asset if the </span><span class=\"SFAB S46 S2\" id=\"t1k_43\">company has recurring customers, </span><span class=\"SFAC S46 S2\" id=\"t1l_43\">even if the company does not have </span><span class=\"SFAD S46 S2\" id=\"t1m_43\">any open purchase orders or contracts </span><span class=\"SFAE S46 S2\" id=\"t1n_43\">with those. </span>",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4794": {
   "value": "<span class=\"SF7D S202 S2\" id=\"t8_43\">T. Business combinations </span><span class=\"SF7E S46 S2\" id=\"t9_43\">A business acquisition can be regarded </span><span class=\"SF7F S46 S2\" id=\"ta_43\">as a business combination using the </span><span class=\"SF80 S46 S2\" id=\"tb_43\">acquisition method when the acquired </span><span class=\"SF81 S46 S2\" id=\"tc_43\">set of activities and assets meets the </span><span class=\"SF82 S46 S2\" id=\"td_43\">de\ufb01nition of a business and control is </span><span class=\"SF83 S46 S2\" id=\"te_43\">transferred. In determining whether a </span><span class=\"SF84 S46 S2\" id=\"tf_43\">particular set of activities and assets </span><span class=\"SF85 S46 S2\" id=\"tg_43\">is a business, Photocure will assessed </span><span class=\"SF86 S46 S2\" id=\"th_43\">whether the set of assets and activities </span><span class=\"SF87 S46 S2\" id=\"ti_43\">acquired includes, at a minimum, an </span><span class=\"SF88 S46 S2\" id=\"tj_43\">input and substantive process and </span><span class=\"SF89 S46 S2\" id=\"tk_43\">whether the acquired set has the ability </span><span class=\"SF8A S46 S2\" id=\"tl_43\">to produce outputs. </span><span class=\"SF8B S46 S29E S2\" id=\"tm_43\">Based on the agreement including </span><span class=\"SF8C S46 S29E S2\" id=\"tn_43\">the transfer of distribution contracts, </span><span class=\"SF8D S46 S29E S2\" id=\"to_43\">employees and inventory, the </span><span class=\"SF8E S46 S29E S2\" id=\"tp_43\">transaction has been de\ufb01ned as a </span><span class=\"SF8F S46 S29E S2\" id=\"tq_43\">business combination and is thus </span><span class=\"SF90 S46 S29E S2\" id=\"tr_43\">accounted for in accordance with IFRS 3. </span><span class=\"SF91 S46 S167 S2\" id=\"ts_43\">The consideration transferred in the </span><span class=\"SF92 S46 S167 S2\" id=\"tt_43\">acquisition is generally measured at </span><span class=\"SF93 S46 S167 S2\" id=\"tu_43\">fair value, as are the identi\ufb01able net </span><span class=\"SF94 S46 S167 S2\" id=\"tv_43\">assets acquired. The residual value in </span><span class=\"SF95 S46 S167 S2\" id=\"tw_43\">the acquisition constitutes goodwill and </span><span class=\"SF96 S46 S167 S2\" id=\"tx_43\">is tested annually for impairment. Any </span><span class=\"SF97 S46 S167 S2\" id=\"ty_43\">contingent consideration is measured </span><span class=\"SF98 S46 S167 S2\" id=\"tz_43\">at fair value at the date of acquisition </span><span class=\"SF99 S46 S167 S2\" id=\"t10_43\">and remeasured at fair value at each </span><span class=\"SE90 S46 S167 S2\" id=\"t11_43\">reporting date and subsequent changes </span><span class=\"SF9A S46 S167 S2\" id=\"t12_43\">in the fair value are recognized in pro\ufb01t </span><span class=\"SF9B S46 S167 S2\" id=\"t13_43\">or loss as \ufb01nancial income or cost. </span><span class=\"SF28 S46 S2\" id=\"t14_43\">Customer relationships meet </span><span class=\"SF9C S46 S2\" id=\"t15_43\">the contractual legal criterion for </span><span class=\"SF9D S46 S2\" id=\"t16_43\">identi\ufb01cation as intangible assets </span><span class=\"SF9E S46 S2\" id=\"t17_43\">for an entity that has a practice </span><span class=\"SF9F S46 S2\" id=\"t18_43\">of establishing contracts with its </span><span class=\"SFA0 S46 S2\" id=\"t19_43\">customers, regardless of whether </span><span class=\"SFA1 S46 S2\" id=\"t1a_43\">a contract exist at the date of the </span><span class=\"SFA2 S46 S2\" id=\"t1b_43\">acquisition. A customer relationship </span><span class=\"SFA3 S46 S2\" id=\"t1c_43\">may also arise through means other </span><span class=\"SFA4 S46 S2\" id=\"t1d_43\">than contracts, such as through </span><span class=\"SFA5 S46 S2\" id=\"t1e_43\">regular contact by sales or service </span><span class=\"SFA6 S46 S2\" id=\"t1f_43\">representatives. Furthermore, IFRS 3\u2019s </span><span class=\"SFA7 S46 S2\" id=\"t1g_43\">illustrative examples on \u201ccustomer- </span><span class=\"SFA8 S46 S2\" id=\"t1h_43\">related intangible assets\u201d sets forth </span><span class=\"SFA9 S46 S2\" id=\"t1i_43\">that customer relationships meet the </span><span class=\"SFAA S46 S2\" id=\"t1j_43\">criteria of an intangible asset if the </span><span class=\"SFAB S46 S2\" id=\"t1k_43\">company has recurring customers, </span><span class=\"SFAC S46 S2\" id=\"t1l_43\">even if the company does not have </span><span class=\"SFAD S46 S2\" id=\"t1m_43\">any open purchase orders or contracts </span>with those",
   "dimensions": {
    "concept": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4863": {
   "value": "<span class=\"SFB0 S9 S2\" id=\"t2_45\">Notes to the </span><span class=\"SFB1 S9 S2\" id=\"t3_45\">Financial </span><span class=\"SFB2 S9 S2\" id=\"t4_45\">Statements </span><span class=\"SFB3 S9 S2\" id=\"t5_45\">for 2022 </span><span class=\"SFB4 S47 S2\" id=\"t6_45\">Photocure ASA </span><span class=\"SFB5 S9EF S2\" id=\"t7_45\">1 </span><span class=\"SFB6 S9EF S2\" id=\"t8_45\">PARTNERSHIPS </span><span class=\"SFB7 S9EF S2\" id=\"t9_45\">2 </span><span class=\"SFB8 S9EF S2\" id=\"ta_45\">OPERATING SEGMENTS </span><span class=\"SFB9 S9EF S2\" id=\"tb_45\">3 </span><span class=\"SFBA S9EF S2\" id=\"tc_45\">REVENUES FROM CONTRACT WITH CUSTOMERS </span><span class=\"SFBB S9EF S2\" id=\"td_45\">4 </span><span class=\"SFBC S9EF S2\" id=\"te_45\">COST OF GOODS SOLD </span><span class=\"SFBD S9EF S2\" id=\"tf_45\">5 </span><span class=\"SFBE S9EF S2\" id=\"tg_45\">INCOME STATEMENT CLASSIFIED BY NATURE </span><span class=\"SFBF S9EF S2\" id=\"th_45\">6 </span><span class=\"SFC0 S9EF S2\" id=\"ti_45\">PERSONNEL EXPENSES </span><span class=\"SFC1 S9EF S2\" id=\"tj_45\">7 </span><span class=\"SFC2 S9EF S2\" id=\"tk_45\">REMUNERATION OF MANAGEMENT AND </span><span class=\"SFC3 S9EF S2\" id=\"tl_45\">BOARD OF DIRECTORS </span><span class=\"SFC4 S9EF S2\" id=\"tm_45\">8 </span><span class=\"SFC5 S9EF S2\" id=\"tn_45\">PENSION COSTS </span><span class=\"SFC6 S9EF S2\" id=\"to_45\">9 </span><span class=\"SFC7 S9EF S2\" id=\"tp_45\">FINANCIAL INCOME AND EXPENSE </span><span class=\"SFC8 S9EF S2\" id=\"tq_45\">10 </span><span class=\"SFC9 S9EF S2\" id=\"tr_45\">RELATED PARTY </span><span class=\"SFCA S9EF S2\" id=\"ts_45\">11 </span><span class=\"SFCB S9EF S2\" id=\"tt_45\">TAX </span><span class=\"SFCC S9EF S2\" id=\"tu_45\">12 </span><span class=\"SFCD S9EF S2\" id=\"tv_45\">EARNINGS PER SHARE </span><span class=\"SFCE S9EF S2\" id=\"tw_45\">13 </span><span class=\"SFCF S9EF S2\" id=\"tx_45\">GOODWILL AND CUSTOMER RELATIONS </span><span class=\"SFD0 S9EF S2\" id=\"ty_45\">14 </span><span class=\"SFD1 S9EF S2\" id=\"tz_45\">PROPERTY, PLANT, EQUIPMENT AND </span><span class=\"SFD2 S9EF S2\" id=\"t10_45\">OTHER ASSETS </span><span class=\"SFD3 S9EF S2\" id=\"t11_45\">15 </span><span class=\"SFD4 S9EF S2\" id=\"t12_45\">SUBSIDIARIES </span><span class=\"SFD5 S9EF S2\" id=\"t13_45\">16 </span><span class=\"SFD6 S9EF S2\" id=\"t14_45\">INVENTORIES </span><span class=\"SFD7 S9EF S2\" id=\"t15_45\">17 </span><span class=\"SFD8 S9EF S2\" id=\"t16_45\">FINANCIAL RISK </span><span class=\"SFD9 S9EF S2\" id=\"t17_45\">18 </span><span class=\"SFDA S9EF S2\" id=\"t18_45\">FAIR VALUE </span><span class=\"SFDB S9EF S2\" id=\"t19_45\">19 </span><span class=\"SFDC S9EF S2\" id=\"t1a_45\">RECEIVABLES </span><span class=\"SFDD S9EF S2\" id=\"t1b_45\">20 </span><span class=\"SFDE S9EF S2\" id=\"t1c_45\">CASH AND SHORT TERM DEPOSITS </span><span class=\"SFDF S9EF S2\" id=\"t1d_45\">21 </span><span class=\"SFE0 S9EF S2\" id=\"t1e_45\">SHARE CAPITAL </span><span class=\"SFE1 S9EF S2\" id=\"t1f_45\">22 </span><span class=\"SFE2 S9EF S2\" id=\"t1g_45\">LOAN TERMS AND REPAYMENT </span><span class=\"SFE3 S9EF S2\" id=\"t1h_45\">23 </span><span class=\"SFE4 S9EF S2\" id=\"t1i_45\">ACCOUNTS PAYABLE AND OTHER </span><span class=\"SFE5 S9EF S2\" id=\"t1j_45\">CURRENT LIABILITIES </span><span class=\"SFE6 S9EF S2\" id=\"t1k_45\">24 </span><span class=\"SFE7 S9EF S2\" id=\"t1l_45\">SUBSEQUENT EVENTS </span><span class=\"SACA S49 S2\" id=\"t1_46\">46 </span><span class=\"S4B S47 S2\" id=\"t2_46\">Annual Report Photocure </span><span class=\"S4C S48 S2\" id=\"t3_46\">\u2013 Results 2022 </span><span class=\"SFE8 S106F S2\" id=\"t4_46\">1. PARTNERSHIPS </span><span class=\"SFE9 S1070 S2\" id=\"t5_46\">Photocure entered in July 2019 into a license agreement providing Asieris MediTech Co with a world-wide license to develop and </span><span class=\"SFEA S1070 S2\" id=\"t6_46\">commercialize Cevira\u00ae for the treatment of HPV induced cervical precancerous lesions. Under the agreement, Photocure will receive </span><span class=\"SFEB S1070 S2\" id=\"t7_46\">signing fees, development- and approval milestones, in addition to sales royalties. </span><span class=\"SFEC S1070 S2\" id=\"t8_46\">Photocure entered in January 2021 into a license agreement providing Asieris MediTech Co with a license to commercialize Hexvix in </span><span class=\"SFED S1070 S2\" id=\"t9_46\">mainland China and Taiwan. Under this agreement, Photocure will receive signing fees and approval milestones, in addition to sales </span><span class=\"SFEE S1070 S2\" id=\"ta_46\">royalties. </span><span class=\"SFEF S106F S2\" id=\"tb_46\">2. OPERATING SEGMENTS </span><span class=\"SFF0 S1070 S2\" id=\"tc_46\">Photocure has two segments: Commercial Franchise and Development Portfolio. Commercial Franchise includes Hexvix/Cysview </span><span class=\"SFF1 S1070 S2\" id=\"td_46\">by geography (North America and Europe) and other sales (partners and other products including sales revenues for Hivec). </span><span class=\"SFF2 S1070 S2\" id=\"te_46\">Development Portfolio includes development of pipeline products. North America 2022 results includes U.S. and Canada while </span><span class=\"SFF3 S1070 S2\" id=\"tf_46\">2021 and earlier results include U.S. only as sales in Canada were through a partner. Total 2021 revenue for Photocure from this </span><span class=\"SFF4 S1070 S2\" id=\"tg_46\">partner was NOK 0.4 million. Sales revenue Europe in the Commercial segment consists of Hexvix direct sale to hospitals, wholesalers </span><span class=\"SFF5 S1070 S2\" id=\"th_46\">and pharmacies. </span><span class=\"SFF6 S1070 S2\" id=\"ti_46\">The Development segment is split by development of Cevira and other pipeline products. </span><span class=\"SFF7 S1070 S2\" id=\"tj_46\">Operating costs are charged directly to the respective segment involved if directly related. Indirect manufacturing costs are </span><span class=\"SFF8 S1070 S2\" id=\"tk_46\">allocated based on sales within the commercial segment and other indirect costs are allocated based on time and resources utilized </span><span class=\"SFF9 S1070 S2\" id=\"tl_46\">within the di\ufb00erent subsegments. </span><span class=\"SFFA S1070 S2\" id=\"tm_46\">Segment assets and liabilities are not reported to the Chief Operating Decision Makers (CODM) and therefore not allocated to </span><span class=\"SFFB S1070 S2\" id=\"tn_46\">reportable segments. </span><span class=\"SFFC S1071 S2\" id=\"to_46\">1 Jan - 31 December 2022 </span><span class=\"SFFD S1071 S2\" id=\"tp_46\">Commercial Franchise </span><span class=\"SFFE S1071 S2\" id=\"tq_46\">Development Portfolio </span><span class=\"SFFF S1070 S2\" id=\"tr_46\">(Amounts in NOK 1,000) </span><span class=\"S1000 S1071 S2\" id=\"ts_46\">North Am. </span><span class=\"S1001 S1071 S2\" id=\"tt_46\">Cysview </span><span class=\"S1002 S1071 S2\" id=\"tu_46\">Europe </span><span class=\"S1003 S1071 S2\" id=\"tv_46\">Hexvix </span><span class=\"S1004 S1071 S2\" id=\"tw_46\">Other </span><span class=\"S1005 S1071 S2\" id=\"tx_46\">Sales </span><span class=\"S1006 S1071 S2\" id=\"ty_46\">Total </span><span class=\"S1007 S1071 S2\" id=\"tz_46\">Sales </span><span class=\"S1008 S1071 S2\" id=\"t10_46\">Cevira </span><span class=\"S1009 S1071 S2\" id=\"t11_46\">PDT &amp; </span><span class=\"S100A S1071 S2\" id=\"t12_46\">Explorativ </span><span class=\"S100B S1071 S2\" id=\"t13_46\">Total </span><span class=\"S100C S1071 S2\" id=\"t14_46\">R&amp;D </span><span class=\"S100D S1071 S2\" id=\"t15_46\">Grand </span><span class=\"S100E S1071 S2\" id=\"t16_46\">Total </span><span class=\"S100F S1070 S2\" id=\"t17_46\">Revenues from contract </span><span class=\"S1010 S1070 S2\" id=\"t18_46\">with customers </span><span class=\"S1011 S1070 S2\" id=\"t19_46\">150 784 </span><span class=\"S1012 S1070 S2\" id=\"t1a_46\">221 826 </span><span class=\"S1013 S1070 S2\" id=\"t1b_46\">1 863 </span><span class=\"S1014 S1070 S2\" id=\"t1c_46\">374 474 </span><span class=\"S1015 S1070 S2\" id=\"t1d_46\">- </span><span class=\"S1016 S1070 S2\" id=\"t1e_46\">- </span><span class=\"S1017 S1070 S2\" id=\"t1f_46\">- </span><span class=\"S1018 S1070 S2\" id=\"t1g_46\">374 474 </span><span class=\"S1019 S1070 S2\" id=\"t1h_46\">Signing fees and milestone </span><span class=\"S101A S1070 S2\" id=\"t1i_46\">revenues </span><span class=\"S101B S1070 S2\" id=\"t1j_46\">- </span><span class=\"S101C S1070 S2\" id=\"t1k_46\">- </span><span class=\"S101D S1070 S2\" id=\"t1l_46\">152 </span><span class=\"S101E S1070 S2\" id=\"t1m_46\">152 </span><span class=\"S101F S1070 S2\" id=\"t1n_46\">18 506 </span><span class=\"S1020 S1070 S2\" id=\"t1o_46\">- </span><span class=\"S1021 S1070 S2\" id=\"t1p_46\">18 506 </span><span class=\"S1022 S1070 S2\" id=\"t1q_46\">18 658 </span><span class=\"S1023 S1070 S2\" id=\"t1r_46\">Cost of goods sold </span><span class=\"S1024 S1070 S2\" id=\"t1s_46\">-4 835 </span><span class=\"S1025 S1070 S2\" id=\"t1t_46\">-16 810 </span><span class=\"S1026 S1070 S2\" id=\"t1u_46\">-1 052 </span><span class=\"S1027 S1070 S2\" id=\"t1v_46\">-22 697 </span><span class=\"S1028 S1070 S2\" id=\"t1w_46\">- </span><span class=\"S1029 S1070 S2\" id=\"t1x_46\">- </span><span class=\"S102A S1070 S2\" id=\"t1y_46\">- </span><span class=\"S102B S1070 S2\" id=\"t1z_46\">-22 697 </span><span class=\"S102C S1071 S2\" id=\"t20_46\">Gross pro\ufb01t </span><span class=\"S102D S1071 S2\" id=\"t21_46\">145 950 </span><span class=\"S102E S1071 S2\" id=\"t22_46\">205 016 </span><span class=\"S102F S1071 S2\" id=\"t23_46\">963 </span><span class=\"S1030 S1071 S2\" id=\"t24_46\">351 929 </span><span class=\"S1031 S1071 S2\" id=\"t25_46\">18 506 </span><span class=\"S1032 S1071 S2\" id=\"t26_46\">- </span><span class=\"S1033 S1071 S2\" id=\"t27_46\">18 506 </span><span class=\"S1034 S1071 S2\" id=\"t28_46\">370 435 </span><span class=\"S1035 S1070 S2\" id=\"t29_46\">Gross pro\ufb01t of sales % </span><span class=\"S1036 S1070 S2\" id=\"t2a_46\">97 % </span><span class=\"S1037 S1070 S2\" id=\"t2b_46\">92 % </span><span class=\"S1038 S1070 S2\" id=\"t2c_46\">44 % </span><span class=\"S1039 S1070 S2\" id=\"t2d_46\">94 % </span><span class=\"S103A S1070 S2\" id=\"t2e_46\">94 % </span><span class=\"S103B S1070 S2\" id=\"t2f_46\">R&amp;D </span><span class=\"S103C S1070 S2\" id=\"t2g_46\">-322 </span><span class=\"S103D S1070 S2\" id=\"t2h_46\">-1 211 </span><span class=\"S103E S1070 S2\" id=\"t2i_46\">- </span><span class=\"S103F S1070 S2\" id=\"t2j_46\">-1 533 </span><span class=\"S1040 S1070 S2\" id=\"t2k_46\">-739 </span><span class=\"S1041 S1070 S2\" id=\"t2l_46\">-1 070 </span><span class=\"S1042 S1070 S2\" id=\"t2m_46\">-1 809 </span><span class=\"S1043 S1070 S2\" id=\"t2n_46\">-3 342 </span><span class=\"S1044 S1070 S2\" id=\"t2o_46\">Sales &amp; marketing </span><span class=\"S1045 S1070 S2\" id=\"t2p_46\">-163 706 </span><span class=\"S1046 S1070 S2\" id=\"t2q_46\">-118 563 </span><span class=\"S1047 S1070 S2\" id=\"t2r_46\">-3 619 </span><span class=\"S1048 S1070 S2\" id=\"t2s_46\">-285 888 </span><span class=\"S1049 S1070 S2\" id=\"t2t_46\">-645 </span><span class=\"S104A S1070 S2\" id=\"t2u_46\">- </span><span class=\"S104B S1070 S2\" id=\"t2v_46\">-645 </span><span class=\"S104C S1070 S2\" id=\"t2w_46\">-286 533 </span><span class=\"S104D S1070 S2\" id=\"t2x_46\">Other &amp; allocations </span><span class=\"S104E S1070 S2\" id=\"t2y_46\">-38 214 </span><span class=\"S104F S1070 S2\" id=\"t2z_46\">-52 758 </span><span class=\"S1050 S1070 S2\" id=\"t30_46\">-8 177 </span><span class=\"S1051 S1070 S2\" id=\"t31_46\">-99 149 </span><span class=\"S1052 S1070 S2\" id=\"t32_46\">-1 933 </span><span class=\"S1053 S1070 S2\" id=\"t33_46\">-4 106 </span><span class=\"S1054 S1070 S2\" id=\"t34_46\">-6 038 </span><span class=\"S1055 S1070 S2\" id=\"t35_46\">-105 187 </span><span class=\"S1056 S1071 S2\" id=\"t36_46\">Operating expenses </span><span class=\"S1057 S1071 S2\" id=\"t37_46\">-202 242 </span><span class=\"S1058 S1071 S2\" id=\"t38_46\">-172 532  -11 795 </span><span class=\"S1059 S1071 S2\" id=\"t39_46\">-386 570 </span><span class=\"S105A S1071 S2\" id=\"t3a_46\">-3 317 </span><span class=\"S105B S1071 S2\" id=\"t3b_46\">-5 176 </span><span class=\"S105C S1071 S2\" id=\"t3c_46\">-8 492 </span><span class=\"S105D S1071 S2\" id=\"t3d_46\">-395 062 </span><span class=\"S105E S1071 S2\" id=\"t3e_46\">EBITDA before restructuring </span><span class=\"S105F S1071 S2\" id=\"t3f_46\">-56 292 </span><span class=\"S1060 S1071 S2\" id=\"t3g_46\">32 484 </span><span class=\"S1061 S1071 S1072 S2\" id=\"t3h_46\">-10 832 </span><span class=\"S1062 S1071 S2\" id=\"t3i_46\">-34 641 </span><span class=\"S1063 S1071 S2\" id=\"t3j_46\">15 189 </span><span class=\"S1064 S1071 S2\" id=\"t3k_46\">-5 176 </span><span class=\"S1065 S1071 S2\" id=\"t3l_46\">10 013 </span><span class=\"S1066 S1071 S2\" id=\"t3m_46\">-24 627 </span><span class=\"S1067 S1071 S2\" id=\"t3n_46\">Depreciation and Amortization </span><span class=\"S1068 S1071 S2\" id=\"t3o_46\">-24 231 </span><span class=\"S1069 S1071 S2\" id=\"t3p_46\">-147 </span><span class=\"S106A S1071 S2\" id=\"t3q_46\">-24 378 </span><span class=\"S106B S1071 S2\" id=\"t3r_46\">EBIT before restructuring </span><span class=\"S106C S1071 S2\" id=\"t3s_46\">-58 872 </span><span class=\"S106D S1071 S2\" id=\"t3t_46\">9 866 </span><span class=\"S1074 S1071 S2\" id=\"t2_47\">1 Jan - 31 December 2021 </span><span class=\"S1075 S1071 S2\" id=\"t3_47\">Commercial Franchise </span><span class=\"S1076 S1071 S2\" id=\"t4_47\">Development Portfolio </span><span class=\"S1077 S1070 S2\" id=\"t5_47\">(Amounts in NOK 1,000) </span><span class=\"S1078 S1071 S2\" id=\"t6_47\">U.S. </span><span class=\"S1079 S1071 S2\" id=\"t7_47\">Cysview </span><span class=\"S107A S1071 S2\" id=\"t8_47\">Europe </span><span class=\"S107B S1071 S2\" id=\"t9_47\">Hexvix </span><span class=\"S107C S1071 S2\" id=\"ta_47\">Other </span><span class=\"S107D S1071 S2\" id=\"tb_47\">Sales </span><span class=\"S107E S1071 S2\" id=\"tc_47\">Total </span><span class=\"S107F S1071 S2\" id=\"td_47\">Sales </span><span class=\"S1080 S1071 S2\" id=\"te_47\">Cevira </span><span class=\"S1081 S1071 S2\" id=\"tf_47\">PDT &amp; </span><span class=\"S1082 S1071 S2\" id=\"tg_47\">Explorativ </span><span class=\"S1083 S1071 S2\" id=\"th_47\">Total </span><span class=\"S1084 S1071 S2\" id=\"ti_47\">R&amp;D </span><span class=\"S1085 S1071 S2\" id=\"tj_47\">Grand </span><span class=\"S1086 S1071 S2\" id=\"tk_47\">Total </span><span class=\"S1087 S1070 S2\" id=\"tl_47\">Revenues from contract </span><span class=\"S1088 S1070 S2\" id=\"tm_47\">with customers </span><span class=\"S1089 S1070 S2\" id=\"tn_47\">125 232 </span><span class=\"S108A S1070 S2\" id=\"to_47\">225 751 </span><span class=\"S108B S1070 S2\" id=\"tp_47\">1 306 </span><span class=\"S108C S1070 S2\" id=\"tq_47\">352 289 </span><span class=\"S108D S1070 S2\" id=\"tr_47\">1 836 </span><span class=\"S108E S1070 S2\" id=\"ts_47\">- </span><span class=\"S108F S1070 S2\" id=\"tt_47\">1 836 </span><span class=\"S1090 S1070 S2\" id=\"tu_47\">354 125 </span><span class=\"S1091 S1070 S2\" id=\"tv_47\">Signing fees and milestone </span><span class=\"S1092 S1070 S2\" id=\"tw_47\">revenues </span><span class=\"S1093 S1070 S2\" id=\"tx_47\">- </span><span class=\"S1094 S1070 S2\" id=\"ty_47\">- </span><span class=\"S1095 S1070 S2\" id=\"tz_47\">6 416 </span><span class=\"S1096 S1070 S2\" id=\"t10_47\">6 416 </span><span class=\"S1097 S1070 S2\" id=\"t11_47\">- </span><span class=\"S1098 S1070 S2\" id=\"t12_47\">- </span><span class=\"S1099 S1070 S2\" id=\"t13_47\">- </span><span class=\"S109A S1070 S2\" id=\"t14_47\">6 416 </span><span class=\"S109B S1070 S2\" id=\"t15_47\">Cost of goods sold </span><span class=\"S109C S1070 S2\" id=\"t16_47\">-3 901 </span><span class=\"S109D S1070 S2\" id=\"t17_47\">-18 454 </span><span class=\"S109E S1070 S2\" id=\"t18_47\">-521 </span><span class=\"S109F S1070 S2\" id=\"t19_47\">-22 876 </span><span class=\"S10A0 S1070 S2\" id=\"t1a_47\">-1 175 </span><span class=\"S10A1 S1070 S2\" id=\"t1b_47\">- </span><span class=\"S10A2 S1070 S2\" id=\"t1c_47\">-1 175 </span><span class=\"S10A3 S1070 S2\" id=\"t1d_47\">-24 051 </span><span class=\"S10A4 S1071 S2\" id=\"t1e_47\">Gross pro\ufb01t </span><span class=\"S10A5 S1071 S2\" id=\"t1f_47\">121 331 </span><span class=\"S10A6 S1071 S2\" id=\"t1g_47\">207 297 </span><span class=\"S10A7 S1071 S2\" id=\"t1h_47\">7 201 </span><span class=\"S10A8 S1071 S2\" id=\"t1i_47\">335 829 </span><span class=\"S10A9 S1071 S2\" id=\"t1j_47\">661 </span><span class=\"S10AA S1071 S2\" id=\"t1k_47\">- </span><span class=\"S10AB S1071 S2\" id=\"t1l_47\">661 </span><span class=\"S10AC S1071 S2\" id=\"t1m_47\">336 490 </span><span class=\"S10AD S1070 S2\" id=\"t1n_47\">Gross pro\ufb01t of sales % </span><span class=\"S10AE S1070 S2\" id=\"t1o_47\">97 % </span><span class=\"S10AF S1070 S2\" id=\"t1p_47\">92 % </span><span class=\"S10B0 S1070 S2\" id=\"t1q_47\">60 % </span><span class=\"S10B1 S1070 S2\" id=\"t1r_47\">94 % </span><span class=\"S10B2 S1070 S2\" id=\"t1s_47\">36 % </span><span class=\"S10B3 S1070 S2\" id=\"t1t_47\">36 % </span><span class=\"S10B4 S1070 S2\" id=\"t1u_47\">93 % </span><span class=\"S10B5 S1070 S2\" id=\"t1v_47\">R&amp;D </span><span class=\"S10B6 S1070 S2\" id=\"t1w_47\">-386 </span><span class=\"S10B7 S1070 S2\" id=\"t1x_47\">-1 279 </span><span class=\"S10B8 S1070 S2\" id=\"t1y_47\">- </span><span class=\"S10B9 S1070 S2\" id=\"t1z_47\">-1 665 </span><span class=\"S10BA S1070 S2\" id=\"t20_47\">-390 </span><span class=\"S10BB S1070 S2\" id=\"t21_47\">-2 267 </span><span class=\"S10BC S1070 S2\" id=\"t22_47\">-2 657 </span><span class=\"S10BD S1070 S2\" id=\"t23_47\">-4 322 </span><span class=\"S10BE S1070 S2\" id=\"t24_47\">Sales &amp; marketing </span><span class=\"S10BF S1070 S2\" id=\"t25_47\">-131 251 </span><span class=\"S10C0 S1070 S2\" id=\"t26_47\">-105 127 </span><span class=\"S10C1 S1070 S2\" id=\"t27_47\">-5 976 </span><span class=\"S10C2 S1070 S2\" id=\"t28_47\">-242 354 </span><span class=\"S10C3 S1070 S2\" id=\"t29_47\">-612 </span><span class=\"S10C4 S1070 S2\" id=\"t2a_47\">- </span><span class=\"S10C5 S1070 S2\" id=\"t2b_47\">-612 </span><span class=\"S10C6 S1070 S2\" id=\"t2c_47\">-242 966 </span><span class=\"S10C7 S1070 S2\" id=\"t2d_47\">Other &amp; allocations </span><span class=\"S10C8 S1070 S2\" id=\"t2e_47\">-24 920 </span><span class=\"S10C9 S1070 S2\" id=\"t2f_47\">-37 083 </span><span class=\"S10CA S1070 S2\" id=\"t2g_47\">-5 317 </span><span class=\"S10CB S1070 S2\" id=\"t2h_47\">-67 320 </span><span class=\"S10CC S1070 S2\" id=\"t2i_47\">-1 141 </span><span class=\"S10CD S1070 S2\" id=\"t2j_47\">-2 440 </span><span class=\"S10CE S1070 S2\" id=\"t2k_47\">-3 581 </span><span class=\"S10CF S1070 S2\" id=\"t2l_47\">-70 901 </span><span class=\"S10D0 S1071 S2\" id=\"t2m_47\">Operating expenses </span><span class=\"S10D1 S1071 S2\" id=\"t2n_47\">-156 557 </span><span class=\"S10D2 S1071 S2\" id=\"t2o_47\">-143 489  -11 293 </span><span class=\"S10D3 S1071 S2\" id=\"t2p_47\">-311 339 </span><span class=\"S10D4 S1071 S2\" id=\"t2q_47\">-2 143 </span><span class=\"S10D5 S1071 S2\" id=\"t2r_47\">-4 707 </span><span class=\"S10D6 S1071 S2\" id=\"t2s_47\">-6 850 </span><span class=\"S10D7 S1071 S2\" id=\"t2t_47\">-318 189 </span><span class=\"S10D8 S1071 S2\" id=\"t2u_47\">EBITDA before restructuring </span><span class=\"S10D9 S1071 S2\" id=\"t2v_47\">-35 226 </span><span class=\"S10DA S1071 S2\" id=\"t2w_47\">63 808 </span><span class=\"S10DB S1071 S2\" id=\"t2x_47\">-4 092 </span><span class=\"S10DC S1071 S2\" id=\"t2y_47\">24 490 </span><span class=\"S10DD S1071 S2\" id=\"t2z_47\">-1 482 </span><span class=\"S10DE S1071 S2\" id=\"t30_47\">-4 707 </span><span class=\"S10DF S1071 S2\" id=\"t31_47\">-6 189 </span><span class=\"S10E0 S1071 S2\" id=\"t32_47\">18 301 </span><span class=\"S10E1 S1071 S2\" id=\"t33_47\">Depreciation and Amortization </span><span class=\"S10E2 S1071 S2\" id=\"t34_47\">-23 889 </span><span class=\"S10E3 S1071 S2\" id=\"t35_47\">-238 </span><span class=\"S10E4 S1071 S2\" id=\"t36_47\">-24 127 </span><span class=\"S10E5 S1071 S2\" id=\"t37_47\">EBIT before restructuring </span><span class=\"S10E6 S1071 S2\" id=\"t38_47\">601 </span><span class=\"S10E7 S1071 S2\" id=\"t39_47\">-6 427 </span><span class=\"S10E8 S1071 S2\" id=\"t3a_47\">-5 826 </span><span class=\"S10E9 S1070 S2\" id=\"t3b_47\">The de\ufb01nition of EBITDA is \u201cEarnings Before Interest, Tax, Depreciation and Amortization\u201d. </span><span class=\"S10EA S106F S2\" id=\"t3c_47\">3. REVENUES FROM CONTRACT WITH CUSTOMERS </span><span class=\"S10EB S1071 S2\" id=\"t3d_47\">Performance obligation product deliveries </span><span class=\"S10EC S1070 S2\" id=\"t3e_47\">For the general supply of products Photocure satisfy the contractual performance obligation upon delivery of products according to </span><span class=\"S10ED S1070 S2\" id=\"t3f_47\">the delivery terms agreed. Invoices are issued at that point in time and the payment term is usually within 30 days. No discounts were </span><span class=\"S10EE S1070 S2\" id=\"t3g_47\">provided to the customers and no return of products were accepted within the expiry of the products. </span><span class=\"S10EF S1071 S2\" id=\"t3h_47\">Performance obligation license </span><span class=\"S10F0 S1070 S2\" id=\"t3i_47\">Photocure entered a license agreement with Asieris for the development and commercialization of product Cevira in July 2019. </span><span class=\"S10F1 S1070 S2\" id=\"t3j_47\">The agreement is based on a \u201cready for Phase 3 study\u201d concept and this study will be carried out by Asieris in China from 2020. </span><span class=\"S10F2 S1070 S2\" id=\"t3k_47\">Photocure has in the agreement with Asieris agreed to transfer the rights for the development and commercialization of Cevira </span><span class=\"S10F3 S1070 S2\" id=\"t3l_47\">(license) and to deliver the active substance for the phase 3 study. Asieris will be responsible for the remaining development of Cevira </span><span class=\"S10F4 S1070 S2\" id=\"t3m_47\">and pay all the costs. The license is a right to use Photocure\u2019s intellectual property as it existed at the contract date. The active </span><span class=\"S10F5 S1070 S2\" id=\"t3n_47\">substance will not be further developed or changed by Photocure for use by Asieris. The transfer of the license and the delivery of </span><span class=\"S10F6 S1070 S2\" id=\"t3o_47\">the active substance are by Photocure regarded as two separate performance obligations. </span><span class=\"S10F7 S1070 S2\" id=\"t3p_47\">Asieris has in 2022 paid one milestone of USD 2.0 million related to the phase 3 study and accumulated paid USD 10 million in </span><span class=\"S10F8 S1070 S2\" id=\"t3q_47\">milestones for Cevira. The agreement include additional milestones and potential sales royalty if a commercial product is approved, </span><span class=\"S10F9 S1070 S2\" id=\"t3r_47\">this will depend on the outcome of the ongoing phase 3 study. The transaction price allocated to the license consist of signing fee, </span><span class=\"S10FA S1070 S2\" id=\"t3s_47\">di\ufb00erent milestone payments and sales based royalty payments. The part of the transaction price related to milestone payments are </span><span class=\"S10FB S1070 S2\" id=\"t3t_47\">estimated as the most likely amount, but constrained which currently means that these revenues will be recognized if and when the </span><span class=\"S10FC S1070 S2\" id=\"t3u_47\">relevant milestone are achieved. </span><span class=\"S10FD S1070 S2\" id=\"t3v_47\">Revenue for the sale of active substance is recognized when the customer takes control of the goods, which is at the time of </span><span class=\"S10FE S1070 S2\" id=\"t3w_47\">shipment. </span><span class=\"S10FF S1070 S2\" id=\"t3x_47\">Photocure has in January 2021 entered into a partnership agreement with Asieris whereby Asieris has obtained exclusive rights </span><span class=\"S1100 S1070 S2\" id=\"t3y_47\">to register and commercialize Hexvix[\u00ae] in Mainland China and Taiwan. Based on the agreement, Photocure received an upfront </span><span class=\"S1101 S1070 S2\" id=\"t3z_47\">payment of USD 750,000 from Asieris for the rights to Hexvix in the designated territories as a non-refundable payment. Asieris will </span><span class=\"S1102 S1070 S2\" id=\"t40_47\">fund all costs to secure required clinical studies and to regulatory approvals of Hexvix in Mainland China and Taiwan. </span><span class=\"S1103 S1070 S2\" id=\"t41_47\">The license of the Groups intellectual property are under all current licensing agreement considered distinct from the delivery of </span><span class=\"S1104 S1070 S2\" id=\"t42_47\">goods and thus a separate performance obligation. Furthermore the licenses are considered to be a right to use the company\u2019s </span><span class=\"S1105 S1070 S2\" id=\"t43_47\">intellectual property as is, and therefore revenue allocated to the license is recognized at point in time taking into consideration the </span><span class=\"S1106 S1070 S2\" id=\"t44_47\">variable constraint for milestone payments that have not yet occurred and sales based royalty. Milestone payments related to future </span>events and sales based royalties are recognized when the events and sales actually occur<span class=\"S1109 S1071 S2\" id=\"t4_48\">Geographical information </span><span class=\"S110A S1070 S2\" id=\"t5_48\">(Amounts in NOK 1,000) </span><span class=\"S110B S1071 S2\" id=\"t6_48\">Group revenues from contract with customers </span><span class=\"S110C S1071 S2\" id=\"t7_48\">2022 </span><span class=\"S110D S1071 S2\" id=\"t8_48\">2021 </span><span class=\"S110E S1070 S2\" id=\"t9_48\">Nordic countries </span><span class=\"S110F S1070 S2\" id=\"ta_48\">22 647 </span><span class=\"S1110 S1070 S2\" id=\"tb_48\">31 882 </span><span class=\"S1111 S1070 S2\" id=\"tc_48\">Germany </span><span class=\"S1112 S1070 S2\" id=\"td_48\">148 936 </span><span class=\"S1113 S1070 S2\" id=\"te_48\">141 920 </span><span class=\"S1114 S1070 S2\" id=\"tf_48\">France </span><span class=\"S1115 S1070 S2\" id=\"tg_48\">27 032 </span><span class=\"S1116 S1070 S2\" id=\"th_48\">29 021 </span><span class=\"S1117 S1070 S2\" id=\"ti_48\">Austria </span><span class=\"S1118 S1070 S2\" id=\"tj_48\">9 500 </span><span class=\"S1119 S1070 S2\" id=\"tk_48\">8 983 </span><span class=\"S111A S1070 S2\" id=\"tl_48\">UK </span><span class=\"S111B S1070 S2\" id=\"tm_48\">2 147 </span><span class=\"S111C S1070 S2\" id=\"tn_48\">3 448 </span><span class=\"S111D S1070 S2\" id=\"to_48\">BeNeLux </span><span class=\"S111E S1070 S2\" id=\"tp_48\">4 597 </span><span class=\"S111F S1070 S2\" id=\"tq_48\">6 927 </span><span class=\"S1120 S1070 S2\" id=\"tr_48\">Italy </span><span class=\"S1121 S1070 S2\" id=\"ts_48\">4 368 </span><span class=\"S1122 S1070 S2\" id=\"tt_48\">1 700 </span><span class=\"S1123 S1070 S2\" id=\"tu_48\">Other European countries </span><span class=\"S1124 S1070 S2\" id=\"tv_48\">3 905 </span><span class=\"S1125 S1070 S2\" id=\"tw_48\">2 778 </span><span class=\"S1126 S1070 S2\" id=\"tx_48\">United States </span><span class=\"S1127 S1070 S2\" id=\"ty_48\">149 045 </span><span class=\"S1128 S1070 S2\" id=\"tz_48\">125 232 </span><span class=\"S1129 S1070 S2\" id=\"t10_48\">Canada </span><span class=\"S112A S1070 S2\" id=\"t11_48\">1 740 </span><span class=\"S112B S1071 S2\" id=\"t12_48\">Own sales </span><span class=\"S112C S1071 S2\" id=\"t13_48\">373 917 </span><span class=\"S112D S1071 S2\" id=\"t14_48\">351 891 </span><span class=\"S112E S1070 S2\" id=\"t15_48\">Partner countries rest of world </span><span class=\"S112F S1070 S2\" id=\"t16_48\">557 </span><span class=\"S1130 S1070 S2\" id=\"t17_48\">2 233 </span><span class=\"S1131 S1071 S2\" id=\"t18_48\">374 474 </span><span class=\"S1132 S1071 S2\" id=\"t19_48\">354 124 </span><span class=\"S1133 S1070 S2\" id=\"t1a_48\">The geographical revenue in all countries except North America are in the parent company. The geographical revenue information is </span><span class=\"S1134 S1070 S2\" id=\"t1b_48\">based on the location of the end customers. </span><span class=\"S1135 S1070 S2\" id=\"t1c_48\">The signing fees and milestone revenue are not included in the table above. </span><span class=\"S1136 S1071 S2\" id=\"t1d_48\">Revenue recognition by segments </span><span class=\"S1137 S1071 S2\" id=\"t1e_48\">1 Jan - 31 December 2022 </span><span class=\"S1138 S1071 S2\" id=\"t1f_48\">Commercial Franchise </span><span class=\"S1139 S1071 S2\" id=\"t1g_48\">Development Portfolio </span><span class=\"S113A S1071 S2\" id=\"t1h_48\">Grand </span><span class=\"S113B S1071 S2\" id=\"t1i_48\">Total </span><span class=\"S113C S1071 S2\" id=\"t1j_48\">Hexvix/Cysview </span><span class=\"S113D S1070 S2\" id=\"t1k_48\">(Amounts in NOK 1,000) </span><span class=\"S113E S1071 S2\" id=\"t1l_48\">Own sales </span><span class=\"S113F S1071 S2\" id=\"t1m_48\">Partner </span><span class=\"S1140 S1071 S2\" id=\"t1n_48\">Other </span><span class=\"S1141 S1071 S2\" id=\"t1o_48\">Sales </span><span class=\"S1142 S1071 S2\" id=\"t1p_48\">Total </span><span class=\"S1143 S1071 S2\" id=\"t1q_48\">Sales </span><span class=\"S1144 S1071 S2\" id=\"t1r_48\">Pipeline </span><span class=\"S1145 S1071 S2\" id=\"t1s_48\">Total </span><span class=\"S1146 S1071 S2\" id=\"t1t_48\">R&amp;D </span><span class=\"S1147 S1070 S2\" id=\"t1u_48\">Contract revenue at point in time </span><span class=\"S1148 S1070 S2\" id=\"t1v_48\">430 </span><span class=\"S1149 S1070 S2\" id=\"t1w_48\">128 </span><span class=\"S114A S1071 S2\" id=\"t1x_48\">558 </span><span class=\"S114B S1070 S2\" id=\"t1y_48\">0 </span><span class=\"S114C S1070 S2\" id=\"t1z_48\">0 </span><span class=\"S114D S1071 S2\" id=\"t20_48\">558 </span><span class=\"S114E S1070 S2\" id=\"t21_48\">Contract revenue over time </span><span class=\"S114F S1071 S2\" id=\"t22_48\">0 </span><span class=\"S1150 S1070 S2\" id=\"t23_48\">0 </span><span class=\"S1151 S1071 S2\" id=\"t24_48\">0 </span><span class=\"S1152 S1070 S2\" id=\"t25_48\">Signing fees and milestone </span><span class=\"S1153 S1070 S2\" id=\"t26_48\">revenues at point in time </span><span class=\"S1154 S1070 S2\" id=\"t27_48\">152 </span><span class=\"S1155 S1071 S2\" id=\"t28_48\">152 </span><span class=\"S1156 S1070 S2\" id=\"t29_48\">18 506 </span><span class=\"S1157 S1070 S2\" id=\"t2a_48\">18 506 </span><span class=\"S1158 S1071 S2\" id=\"t2b_48\">18 658 </span><span class=\"S1159 S1071 S2\" id=\"t2c_48\">Sales order revenue at point </span><span class=\"S115A S1071 S2\" id=\"t2d_48\">in time </span><span class=\"S115B S1070 S2\" id=\"t2e_48\">372 611 </span><span class=\"S115C S1070 S2\" id=\"t2f_48\">1 306 </span><span class=\"S115D S1071 S2\" id=\"t2g_48\">373 917 </span><span class=\"S115E S1070 S2\" id=\"t2h_48\">0 </span><span class=\"S115F S1071 S2\" id=\"t2i_48\">373 917 </span><span class=\"S1160 S1071 S2\" id=\"t2j_48\">372 611 </span><span class=\"S1161 S1071 S2\" id=\"t2k_48\">582 </span><span class=\"S1162 S1071 S2\" id=\"t2l_48\">1 434 </span><span class=\"S1163 S1071 S2\" id=\"t2m_48\">374 627 </span><span class=\"S1164 S1071 S2\" id=\"t2n_48\">18 506 </span><span class=\"S1165 S1071 S2\" id=\"t2o_48\">18 506 </span><span class=\"S1166 S1071 S2\" id=\"t2p_48\">393 132 </span><span class=\"S1167 S1071 S2\" id=\"t2q_48\">Revenue recognition by segments </span><span class=\"S1168 S1071 S2\" id=\"t2r_48\">1 Jan - 31 December 2021 </span><span class=\"S1169 S1071 S2\" id=\"t2s_48\">Commercial Franchise </span><span class=\"S116A S1071 S2\" id=\"t2t_48\">Development Portfolio </span><span class=\"S116B S1071 S2\" id=\"t2u_48\">Grand </span><span class=\"S116C S1071 S2\" id=\"t2v_48\">Total </span><span class=\"S116D S1071 S2\" id=\"t2w_48\">Hexvix/Cysview </span><span class=\"S116E S1070 S2\" id=\"t2x_48\">(Amounts in NOK 1,000) </span><span class=\"S116F S1071 S2\" id=\"t2y_48\">Own sales </span><span class=\"S1170 S1071 S2\" id=\"t2z_48\">Partner </span><span class=\"S1171 S1071 S2\" id=\"t30_48\">Other </span><span class=\"S1172 S1071 S2\" id=\"t31_48\">Sales </span><span class=\"S1173 S1071 S2\" id=\"t32_48\">Total </span><span class=\"S1174 S1071 S2\" id=\"t33_48\">Sales </span><span class=\"S1175 S1071 S2\" id=\"t34_48\">Pipeline </span><span class=\"S1176 S1071 S2\" id=\"t35_48\">Total </span><span class=\"S1177 S1071 S2\" id=\"t36_48\">R&amp;D </span><span class=\"S1178 S1070 S2\" id=\"t37_48\">Contract revenue at point in time </span><span class=\"S1179 S1071 S2\" id=\"t38_48\">- </span><span class=\"S117A S1070 S2\" id=\"t39_48\">1 832 </span><span class=\"S117B S1070 S2\" id=\"t3a_48\">1 832 </span><span class=\"S117C S1071 S2\" id=\"t3b_48\">1 832 </span><span class=\"S117D S1070 S2\" id=\"t3c_48\">Contract revenue over time </span><span class=\"S117E S1070 S2\" id=\"t3d_48\">397 </span><span class=\"S117F S1071 S2\" id=\"t3e_48\">397 </span><span class=\"S1180 S1070 S2\" id=\"t3f_48\">0 </span><span class=\"S1181 S1071 S2\" id=\"t3g_48\">397 </span><span class=\"S1182 S1070 S2\" id=\"t3h_48\">Signing fees and milestone </span><span class=\"S1183 S1070 S2\" id=\"t3i_48\">revenues at point in time </span><span class=\"S1184 S1070 S2\" id=\"t3j_48\">6 416 </span><span class=\"S1185 S1071 S2\" id=\"t3k_48\">6 416 </span><span class=\"S1186 S1070 S2\" id=\"t3l_48\">0 </span><span class=\"S1187 S1071 S2\" id=\"t3m_48\">6 416 </span><span class=\"S1188 S1071 S2\" id=\"t3n_48\">Sales order revenue </span><span class=\"S1189 S1071 S2\" id=\"t3o_48\">at point in time </span><span class=\"S118A S1070 S2\" id=\"t3p_48\">350 983 </span><span class=\"S118B S1070 S2\" id=\"t3q_48\">913 </span><span class=\"S118C S1071 S2\" id=\"t3r_48\">351 896 </span><span class=\"S118D S1070 S2\" id=\"t3s_48\">0 </span><span class=\"S118E S1071 S2\" id=\"t3t_48\">351 896 </span><span class=\"S118F S1071 S2\" id=\"t3u_48\">350 983 </span><span class=\"S1190 S1071 S2\" id=\"t3v_48\">6 813 </span><span class=\"S1191 S1071 S2\" id=\"t3w_48\">913 </span><span class=\"S1192 S1071 S2\" id=\"t3x_48\">358 709 </span><span class=\"S1193 S1071 S2\" id=\"t3y_48\">1 832 </span><span class=\"S1194 S1071 S2\" id=\"t3z_48\">1 832 </span><span class=\"S1195 S1071 S2\" id=\"t40_48\">360 540 </span><span class=\"S1197 S106F S2\" id=\"t2_49\">4. COST OF GOODS SOLD </span><span class=\"S1198 S1070 S2\" id=\"t3_49\">Total cost of goods sold includes direct materials, services provided by contract manufacturers and packaging suppliers, products </span><span class=\"S1199 S1070 S2\" id=\"t4_49\">freights and distribution costs. </span><span class=\"S119A S106F S2\" id=\"t5_49\">5. INCOME STATEMENT CLASSIFIED BY NATURE </span><span class=\"S119B S1070 S2\" id=\"t6_49\">(Amounts in NOK 1,000) </span><span class=\"S119C S1071 S2\" id=\"t7_49\">Group </span><span class=\"S119D S1071 S2\" id=\"t8_49\">Parent </span><span class=\"S119E S1071 S2\" id=\"t9_49\">Note </span><span class=\"S119F S1071 S2\" id=\"ta_49\">2022 </span><span class=\"S11A0 S1071 S2\" id=\"tb_49\">2021 </span><span class=\"S11A1 S1071 S2\" id=\"tc_49\">2022 </span><span class=\"S11A2 S1071 S2\" id=\"td_49\">2021 </span><span class=\"S11A3 S1070 S2\" id=\"te_49\">Revenues from contract with customers </span><span class=\"S11A4 S1070 S2\" id=\"tf_49\">2 </span><span class=\"S11A5 S1070 S2\" id=\"tg_49\">374 474 </span><span class=\"S11A6 S1070 S2\" id=\"th_49\">354 124 </span><span class=\"S11A7 S1070 S2\" id=\"ti_49\">236 550 </span><span class=\"S11A8 S1070 S2\" id=\"tj_49\">236 380 </span><span class=\"S11A9 S1070 S2\" id=\"tk_49\">Signing fees and milestone revenues </span><span class=\"S11AA S1070 S2\" id=\"tl_49\">2 </span><span class=\"S11AB S1070 S2\" id=\"tm_49\">18 658 </span><span class=\"S11AC S1070 S2\" id=\"tn_49\">6 416 </span><span class=\"S11AD S1070 S2\" id=\"to_49\">18 658 </span><span class=\"S11AE S1070 S2\" id=\"tp_49\">6 416 </span><span class=\"S11AF S1070 S2\" id=\"tq_49\">Cost of goods sold </span><span class=\"S11B0 S1070 S2\" id=\"tr_49\">-22 697 </span><span class=\"S11B1 S1070 S2\" id=\"ts_49\">-24 050 </span><span class=\"S11B2 S1070 S2\" id=\"tt_49\">-23 269 </span><span class=\"S11B3 S1070 S2\" id=\"tu_49\">-23 012 </span><span class=\"S11B4 S1071 S2\" id=\"tv_49\">Gross pro\ufb01t </span><span class=\"S11B5 S1071 S2\" id=\"tw_49\">370 435 </span><span class=\"S11B6 S1071 S2\" id=\"tx_49\">336 490 </span><span class=\"S11B7 S1071 S2\" id=\"ty_49\">231 939 </span><span class=\"S11B8 S1071 S2\" id=\"tz_49\">219 784 </span><span class=\"S11B9 S1070 S2\" id=\"t10_49\">Other income </span><span class=\"S11BA S1070 S2\" id=\"t11_49\">0 </span><span class=\"S11BB S1070 S2\" id=\"t12_49\">0 </span><span class=\"S11BC S1070 S2\" id=\"t13_49\">899 </span><span class=\"S11BD S1070 S2\" id=\"t14_49\">999 </span><span class=\"S11BE S1070 S2\" id=\"t15_49\">Payroll expenses </span><span class=\"S11BF S1070 S2\" id=\"t16_49\">6, 7 </span><span class=\"S11C0 S1070 S2\" id=\"t17_49\">-244 881 </span><span class=\"S11C1 S1070 S2\" id=\"t18_49\">-210 552 </span><span class=\"S11C2 S1070 S2\" id=\"t19_49\">-102 315 </span><span class=\"S11C3 S1070 S2\" id=\"t1a_49\">-86 906 </span><span class=\"S11C4 S1070 S2\" id=\"t1b_49\">R&amp;D costs excluding payroll expenses/other operating expenses </span><span class=\"S11C5 S1070 S2\" id=\"t1c_49\">-1 809 </span><span class=\"S11C6 S1070 S2\" id=\"t1d_49\">-2 657 </span><span class=\"S11C7 S1070 S2\" id=\"t1e_49\">-1 809 </span><span class=\"S11C8 S1070 S2\" id=\"t1f_49\">-2 657 </span><span class=\"S11C9 S1070 S2\" id=\"t1g_49\">Ordinary depreciation and amortisation </span><span class=\"S11CA S1070 S2\" id=\"t1h_49\">13, 14 </span><span class=\"S11CB S1070 S2\" id=\"t1i_49\">-24 378 </span><span class=\"S11CC S1070 S2\" id=\"t1j_49\">-24 127 </span><span class=\"S11CD S1070 S2\" id=\"t1k_49\">-20 051 </span><span class=\"S11CE S1070 S2\" id=\"t1l_49\">-20 753 </span><span class=\"S11CF S1070 S2\" id=\"t1m_49\">Other operating expenses </span><span class=\"S11D0 S1070 S2\" id=\"t1n_49\">-148 370 </span><span class=\"S11D1 S1070 S2\" id=\"t1o_49\">-104 979 </span><span class=\"S11D2 S1070 S2\" id=\"t1p_49\">-158 016 </span><span class=\"S11D3 S1070 S2\" id=\"t1q_49\">-112 108 </span><span class=\"S11D4 S1071 S2\" id=\"t1r_49\">Total operating expenses </span><span class=\"S11D5 S1071 S2\" id=\"t1s_49\">-419 438 </span><span class=\"S11D6 S1071 S2\" id=\"t1t_49\">-342 315 </span><span class=\"S11D7 S1071 S2\" id=\"t1u_49\">-281 292 </span><span class=\"S11D8 S1071 S2\" id=\"t1v_49\">-221 425 </span><span class=\"S11D9 S1071 S2\" id=\"t1w_49\">Operating pro\ufb01t / loss (-) </span><span class=\"S11DA S1071 S2\" id=\"t1x_49\">-49 003 </span><span class=\"S11DB S1071 S2\" id=\"t1y_49\">-5 825 </span><span class=\"S11DC S1071 S2\" id=\"t1z_49\">-49 353 </span><span class=\"S11DD S1071 S2\" id=\"t20_49\">-1 641 </span><span class=\"S11DE S1071 S2\" id=\"t21_49\">Speci\ufb01cation of Other operating expenses: </span><span class=\"S11DF S1071 S2\" id=\"t22_49\">2022 </span><span class=\"S11E0 S1071 S2\" id=\"t23_49\">2021 </span><span class=\"S11E1 S1071 S2\" id=\"t24_49\">2022 </span><span class=\"S11E2 S1071 S2\" id=\"t25_49\">2021 </span><span class=\"S11E3 S1070 S2\" id=\"t26_49\">Marketing expenses </span><span class=\"S11E4 S1070 S2\" id=\"t27_49\">45 162 </span><span class=\"S11E5 S1070 S2\" id=\"t28_49\">33 140 </span><span class=\"S11E6 S1070 S2\" id=\"t29_49\">16 087 </span><span class=\"S11E7 S1070 S2\" id=\"t2a_49\">15 908 </span><span class=\"S11E8 S1070 S2\" id=\"t2b_49\">Pro\ufb01t split coverage US </span><span class=\"S11E9 S1070 S2\" id=\"t2c_49\">- </span><span class=\"S11EA S1070 S2\" id=\"t2d_49\">- </span><span class=\"S11EB S1070 S2\" id=\"t2e_49\">17 888 </span><span class=\"S11EC S1070 S2\" id=\"t2f_49\">7 269 </span><span class=\"S11ED S1070 S2\" id=\"t2g_49\">Sales and marketing costs Europe </span><span class=\"S11EE S1070 S2\" id=\"t2h_49\">- </span><span class=\"S11EF S1070 S2\" id=\"t2i_49\">- </span><span class=\"S11F0 S1070 S2\" id=\"t2j_49\">54 719 </span><span class=\"S11F1 S1070 S2\" id=\"t2k_49\">48 060 </span><span class=\"S11F2 S1070 S2\" id=\"t2l_49\">Travel expenses </span><span class=\"S11F3 S1070 S2\" id=\"t2m_49\">19 108 </span><span class=\"S11F4 S1070 S2\" id=\"t2n_49\">10 522 </span><span class=\"S11F5 S1070 S2\" id=\"t2o_49\">5 308 </span><span class=\"S11F6 S1070 S2\" id=\"t2p_49\">1 724 </span><span class=\"S11F7 S1070 S2\" id=\"t2q_49\">Patent costs, legal and other fees </span><span class=\"S11F8 S1070 S2\" id=\"t2r_49\">55 848 </span><span class=\"S11F9 S1070 S2\" id=\"t2s_49\">38 938 </span><span class=\"S11FA S1070 S2\" id=\"t2t_49\">41 317 </span><span class=\"S11FB S1070 S2\" id=\"t2u_49\">25 854 </span><span class=\"S11FC S1070 S2\" id=\"t2v_49\">Other expenses </span><span class=\"S11FD S1070 S2\" id=\"t2w_49\">28 253 </span><span class=\"S11FE S1070 S2\" id=\"t2x_49\">22 380 </span><span class=\"S11FF S1070 S2\" id=\"t2y_49\">22 698 </span><span class=\"S1200 S1070 S2\" id=\"t2z_49\">13 294 </span><span class=\"S1201 S1071 S2\" id=\"t30_49\">Total other operating expenses </span><span class=\"S1202 S1071 S2\" id=\"t31_49\">148 370 </span><span class=\"S1203 S1071 S2\" id=\"t32_49\">104 979 </span><span class=\"S1204 S1071 S2\" id=\"t33_49\">158 016 </span><span class=\"S1205 S1071 S2\" id=\"t34_49\">112 108 </span><span class=\"S1206 S106F S2\" id=\"t35_49\">6. PERSONNEL EXPENSES </span><span class=\"S1207 S1070 S2\" id=\"t36_49\">(Amounts in NOK 1,000) </span><span class=\"S1208 S1071 S2\" id=\"t37_49\">Group </span><span class=\"S1209 S1071 S2\" id=\"t38_49\">Parent </span><span class=\"S120A S1071 S2\" id=\"t39_49\">Note </span><span class=\"S120B S1071 S2\" id=\"t3a_49\">2022 </span><span class=\"S120C S1071 S2\" id=\"t3b_49\">2021 </span><span class=\"S120D S1071 S2\" id=\"t3c_49\">2022 </span><span class=\"S120E S1071 S2\" id=\"t3d_49\">2021 </span><span class=\"S120F S1070 S2\" id=\"t3e_49\">Salaries </span><span class=\"S1210 S1070 S2\" id=\"t3f_49\">175 991 </span><span class=\"S1211 S1070 S2\" id=\"t3g_49\">156 914 </span><span class=\"S1212 S1070 S2\" id=\"t3h_49\">66 879 </span><span class=\"S1213 S1070 S2\" id=\"t3i_49\">60 780 </span><span class=\"S1214 S1070 S2\" id=\"t3j_49\">Employer\u2019s social security contributions on salaries, etc. </span><span class=\"S1215 S1070 S2\" id=\"t3k_49\">20 855 </span><span class=\"S1216 S1070 S2\" id=\"t3l_49\">18 736 </span><span class=\"S1217 S1070 S2\" id=\"t3m_49\">8 144 </span><span class=\"S1218 S1070 S2\" id=\"t3n_49\">8 297 </span><span class=\"S1219 S1070 S2\" id=\"t3o_49\">Option costs incl employer's social security contributions </span><span class=\"S121A S1070 S2\" id=\"t3p_49\">21 674 </span><span class=\"S121B S1070 S2\" id=\"t3q_49\">13 225 </span><span class=\"S121C S1070 S2\" id=\"t3r_49\">16 406 </span><span class=\"S121D S1070 S2\" id=\"t3s_49\">10 229 </span><span class=\"S121E S1070 S2\" id=\"t3t_49\">Pension costs </span><span class=\"S121F S1070 S2\" id=\"t3u_49\">8 </span><span class=\"S1220 S1070 S2\" id=\"t3v_49\">13 101 </span><span class=\"S1221 S1070 S2\" id=\"t3w_49\">11 372 </span><span class=\"S1222 S1070 S2\" id=\"t3x_49\">5 682 </span><span class=\"S1223 S1070 S2\" id=\"t3y_49\">4 902 </span><span class=\"S1224 S1070 S2\" id=\"t3z_49\">Other bene\ufb01ts </span><span class=\"S1225 S1070 S2\" id=\"t40_49\">13 260 </span><span class=\"S1226 S1070 S2\" id=\"t41_49\">10 305 </span><span class=\"S1227 S1070 S2\" id=\"t42_49\">5 205 </span><span class=\"S1228 S1070 S2\" id=\"t43_49\">2 699 </span><span class=\"S1229 S1071 S2\" id=\"t44_49\">Total payroll expenses </span><span class=\"S122A S1071 S2\" id=\"t45_49\">244 881 </span><span class=\"S122B S1071 S2\" id=\"t46_49\">210 552 </span><span class=\"S122C S1071 S2\" id=\"t47_49\">102 315 </span><span class=\"S122D S1071 S2\" id=\"t48_49\">86 906 </span><span class=\"S122E S1070 S2\" id=\"t49_49\">No. of full-time equivalent positions </span><span class=\"S122F S1070 S2\" id=\"t4a_49\">106 </span><span class=\"S1230 S1070 S2\" id=\"t4b_49\">98 </span><span class=\"S1231 S1070 S2\" id=\"t4c_49\">37 </span><span class=\"S1232 S1070 S2\" id=\"t4d_49\">32 </span><span class=\"S1233 S1071 S2\" id=\"t4e_49\">Share-based remuneration </span><span class=\"S1234 S1070 S2\" id=\"t4f_49\">As part of the company\u2019s incentive policy, employees have been o\ufb00ered share options to the company\u2019s shares (the term \u2018options\u2019 is </span><span class=\"S1235 S1070 S2\" id=\"t4g_49\">also used). Allocated share options are vested over three years, 25% after \ufb01rst year, 25% second year and 50% third year. The rights </span><span class=\"S1236 S1070 S2\" id=\"t4h_49\">are no longer valid after \ufb01ve years or on termination of the employee. </span>he number of employee share options and average exercise prices for Photocure, and developments during the year: <span class=\"S1238 S1071 S2\" id=\"t5_50\">2022 </span><span class=\"S1239 S1071 S2\" id=\"t6_50\">2021 </span><span class=\"S123A S1071 S2\" id=\"t7_50\">Number </span><span class=\"S123B S1071 S2\" id=\"t8_50\">Average exercise </span><span class=\"S123C S1071 S2\" id=\"t9_50\">price (NOK) </span><span class=\"S123D S1071 S2\" id=\"ta_50\">Number </span><span class=\"S123E S1071 S2\" id=\"tb_50\">Average exercise </span><span class=\"S123F S1071 S2\" id=\"tc_50\">price (NOK) </span><span class=\"S1240 S1070 S2\" id=\"td_50\">Outstanding at start of year </span><span class=\"S1241 S1070 S2\" id=\"te_50\">1 355 750 </span><span class=\"S1242 S1070 S2\" id=\"tf_50\">109.61 </span><span class=\"S1243 S1070 S2\" id=\"tg_50\">981 534 </span><span class=\"S1244 S1070 S2\" id=\"th_50\">66.28 </span><span class=\"S1245 S1070 S2\" id=\"ti_50\">Granted during the year </span><span class=\"S1246 S1070 S2\" id=\"tj_50\">716 028 </span><span class=\"S1247 S1070 S2\" id=\"tk_50\">114.90 </span><span class=\"S1248 S1070 S2\" id=\"tl_50\">756 000 </span><span class=\"S1249 S1070 S2\" id=\"tm_50\">142.57 </span><span class=\"S124A S1070 S2\" id=\"tn_50\">Become invalid during the year </span><span class=\"S124B S1070 S2\" id=\"to_50\">2 000 </span><span class=\"S124C S1070 S2\" id=\"tp_50\">87.39 </span><span class=\"S124D S1070 S2\" id=\"tq_50\">125 500 </span><span class=\"S124E S1070 S2\" id=\"tr_50\">81.99 </span><span class=\"S124F S1070 S2\" id=\"ts_50\">Exercised during the year </span><span class=\"S1250 S1070 S2\" id=\"tt_50\">147 000 </span><span class=\"S1251 S1070 S2\" id=\"tu_50\">51.49 </span><span class=\"S1252 S1070 S2\" id=\"tv_50\">256 284 </span><span class=\"S1253 S1070 S2\" id=\"tw_50\">54.41 </span><span class=\"S1254 S1070 S2\" id=\"tx_50\">Expired during the year </span><span class=\"S1255 S1070 S2\" id=\"ty_50\">- </span><span class=\"S1256 S1070 S2\" id=\"tz_50\">0.00 </span><span class=\"S1257 S1070 S2\" id=\"t10_50\">- </span><span class=\"S1258 S1070 S2\" id=\"t11_50\">0.00 </span><span class=\"S1259 S1070 S2\" id=\"t12_50\">Outstanding at end of year </span><span class=\"S125A S1070 S2\" id=\"t13_50\">1 922 778 </span><span class=\"S125B S1070 S2\" id=\"t14_50\">116.04 </span><span class=\"S125C S1070 S2\" id=\"t15_50\">1 355 750 </span><span class=\"S125D S1070 S2\" id=\"t16_50\">109.61 </span><span class=\"S125E S1070 S2\" id=\"t17_50\">Exercisable options as per 31 December </span><span class=\"S125F S1070 S2\" id=\"t18_50\">448 000 </span><span class=\"S1260 S1070 S2\" id=\"t19_50\">101.30 </span><span class=\"S1261 S1070 S2\" id=\"t1a_50\">90 375 </span><span class=\"S1262 S1070 S2\" id=\"t1b_50\">77.66 </span><span class=\"S1263 S1070 S2\" id=\"t1c_50\">The average weighted life of outstanding share options was 3.7 years at 31 December 2022 and 4.0 years at 31 December 2021. </span><span class=\"S1264 S1070 S2\" id=\"t1d_50\">The exercise prices and the average life of outstanding share options as per 31 December 2022 were as follows: </span><span class=\"S1265 S1071 S2\" id=\"t1e_50\">Average remaining life </span><span class=\"S1266 S1071 S2\" id=\"t1f_50\">No. of options </span><span class=\"S1267 S1071 S2\" id=\"t1g_50\">Exercise price </span><span class=\"S1268 S1071 S2\" id=\"t1h_50\">NOK </span><span class=\"S1269 S1070 S2\" id=\"t1i_50\">1 year </span><span class=\"S126A S1070 S2\" id=\"t1j_50\">84 500 </span><span class=\"S126B S1070 S2\" id=\"t1k_50\">50.72-56.83 </span><span class=\"S126C S1070 S2\" id=\"t1l_50\">3 year </span><span class=\"S126D S1070 S2\" id=\"t1m_50\">424 750 </span><span class=\"S126E S1070 S2\" id=\"t1n_50\">78.65-139.41 </span><span class=\"S126F S1070 S2\" id=\"t1o_50\">4 year </span><span class=\"S1270 S1070 S2\" id=\"t1p_50\">697 500 </span><span class=\"S1271 S1070 S2\" id=\"t1q_50\">123.34-145.27 </span><span class=\"S1272 S1070 S2\" id=\"t1r_50\">5 year </span><span class=\"S1273 S1070 S2\" id=\"t1s_50\">716 028 </span><span class=\"S1274 S1070 S2\" id=\"t1t_50\">114.89-115.70 </span><span class=\"S1275 S1071 S2\" id=\"t1u_50\">Total </span><span class=\"S1276 S1071 S2\" id=\"t1v_50\">1 922 778 </span><span class=\"S1277 S1071 S2\" id=\"t1w_50\">Calculation method for market value of employee share options: </span><span class=\"S1278 S1070 S2\" id=\"t1x_50\">The market value of share options is calculated according to the Black-Scholes method. Volatility is calculated on the basis of the </span><span class=\"S1279 S1070 S2\" id=\"t1y_50\">development in the historical share price equal to the lifetime of the options. This assumes that historical volatility indicates future </span><span class=\"S127A S1070 S2\" id=\"t1z_50\">volatility, which is not necessarily the case. Strike prices are set as the listed price plus 10% at the time of allocation. Risk-free </span><span class=\"S127B S1070 S2\" id=\"t20_50\">interest is based on the interest for Norwegian government bonds. Each option program is calculated separately with the actual </span><span class=\"S127C S1070 S2\" id=\"t21_50\">exercise price and duration of the program. The exercise date for the options is calculated on the basis of historical experience in the </span><span class=\"S127D S1070 S2\" id=\"t22_50\">company and is di\ufb00erentiated between senior management and other employees. The interest advantage is insigni\ufb01cant and has not </span><span class=\"S127E S1070 S2\" id=\"t23_50\">been included in the accounts. The table below shows the values that have been used in the model. </span><span class=\"S127F S1071 S2\" id=\"t24_50\">2022 </span><span class=\"S1280 SFE S2\" id=\"t25_50\">* </span><span class=\"S1281 S1071 S2\" id=\"t26_50\">2021 </span><span class=\"S1282 SFE S2\" id=\"t27_50\">* </span><span class=\"S1283 S1070 S2\" id=\"t28_50\">Dividends (NOK) </span><span class=\"S1284 S1070 S2\" id=\"t29_50\">0.00 </span><span class=\"S1285 S1070 S2\" id=\"t2a_50\">0.00 </span><span class=\"S1286 S1070 S2\" id=\"t2b_50\">Expected volatility (%) </span><span class=\"S1287 S1070 S2\" id=\"t2c_50\">50.98 </span><span class=\"S1288 S1070 S2\" id=\"t2d_50\">57.63 </span><span class=\"S1289 S1070 S2\" id=\"t2e_50\">Historical volatility (%) </span><span class=\"S128A S1070 S2\" id=\"t2f_50\">50.98 </span><span class=\"S128B S1070 S2\" id=\"t2g_50\">57.63 </span><span class=\"S128C S1070 S2\" id=\"t2h_50\">Risk-free interest (%) </span><span class=\"S128D S1070 S2\" id=\"t2i_50\">2.89 </span><span class=\"S128E S1070 S2\" id=\"t2j_50\">0.92 </span><span class=\"S128F S1070 S2\" id=\"t2k_50\">Expected life of options (years) </span><span class=\"S1290 S1070 S2\" id=\"t2l_50\">3.24 </span><span class=\"S1291 S1070 S2\" id=\"t2m_50\">3.25 </span><span class=\"S1292 S1294 S2\" id=\"t2n_50\">* </span><span class=\"S1293 S1295 S2\" id=\"t2o_50\">Weighted average parameters at grant of instrument </span><span class=\"S1297 S106F S2\" id=\"t2_51\">7. REMUNERATION OF MANAGEMENT AND BOARD OF DIRECTORS </span><span class=\"S1298 S1070 S2\" id=\"t3_51\">(Amounts in NOK 1,000) </span><span class=\"S1299 S1071 S2\" id=\"t4_51\">Directors\u2019 </span><span class=\"S129A S1071 S2\" id=\"t5_51\">fees paid </span><span class=\"S129B S1071 S2\" id=\"t6_51\">Salaries </span><span class=\"S129C S1071 S2\" id=\"t7_51\">paid </span><span class=\"S129D S1071 S2\" id=\"t8_51\">Bonuses </span><span class=\"S129E S1071 S2\" id=\"t9_51\">accrued </span><span class=\"S129F S1071 S2\" id=\"ta_51\">Bene\ufb01ts </span><span class=\"S12A0 S1071 S2\" id=\"tb_51\">in kind </span><span class=\"S12A1 S1071 S2\" id=\"tc_51\">Pension </span><span class=\"S12A2 S1071 S2\" id=\"td_51\">cost </span><span class=\"S12A3 S1071 S2\" id=\"te_51\">Total </span><span class=\"S12A4 S1071 S2\" id=\"tf_51\">Senior management 2022 </span><span class=\"S12A5 S1070 S2\" id=\"tg_51\">President and CEO </span><span class=\"S12A6 S1070 S2\" id=\"th_51\">6 013 </span><span class=\"S12A7 S1070 S2\" id=\"ti_51\">2 812 </span><span class=\"S12A8 S1070 S2\" id=\"tj_51\">754 </span><span class=\"S12A9 S1070 S2\" id=\"tk_51\">494 </span><span class=\"S12AA S1070 S2\" id=\"tl_51\">10 073 </span><span class=\"S12AB S1070 S2\" id=\"tm_51\">Chief Financial O\ufb03cer </span><span class=\"S12AC S1070 S2\" id=\"tn_51\">2 629 </span><span class=\"S12AD S1070 S2\" id=\"to_51\">595 </span><span class=\"S12AE S1070 S2\" id=\"tp_51\">18 </span><span class=\"S12AF S1070 S2\" id=\"tq_51\">343 </span><span class=\"S12B0 S1070 S2\" id=\"tr_51\">3 585 </span><span class=\"S12B1 S1070 S2\" id=\"ts_51\">VP and General Manager North America </span><span class=\"S12B2 S1070 S2\" id=\"tt_51\">3 848 </span><span class=\"S12B3 S1070 S2\" id=\"tu_51\">857 </span><span class=\"S12B4 S1070 S2\" id=\"tv_51\">419 </span><span class=\"S12B5 S1070 S2\" id=\"tw_51\">319 </span><span class=\"S12B6 S1070 S2\" id=\"tx_51\">5 444 </span><span class=\"S12B7 S1070 S2\" id=\"ty_51\">VP and General Manager Europe </span><span class=\"S12B8 S1070 S2\" id=\"tz_51\">2 935 </span><span class=\"S12B9 S1070 S2\" id=\"t10_51\">586 </span><span class=\"S12BA S1070 S2\" id=\"t11_51\">427 </span><span class=\"S12BB S1070 S2\" id=\"t12_51\">3 948 </span><span class=\"S12BC S1070 S2\" id=\"t13_51\">VP Global Strategic Marketing &amp; BD </span><span class=\"S12BD S1070 S2\" id=\"t14_51\">1 754 </span><span class=\"S12BE S1070 S2\" id=\"t15_51\">196 </span><span class=\"S12BF S1070 S2\" id=\"t16_51\">88 </span><span class=\"S12C0 S1070 S2\" id=\"t17_51\">221 </span><span class=\"S12C1 S1070 S2\" id=\"t18_51\">2 259 </span><span class=\"S12C2 S1070 S2\" id=\"t19_51\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S12C3 S1070 S2\" id=\"t1a_51\">2 071 </span><span class=\"S12C4 S1070 S2\" id=\"t1b_51\">431 </span><span class=\"S12C5 S1070 S2\" id=\"t1c_51\">91 </span><span class=\"S12C6 S1070 S2\" id=\"t1d_51\">360 </span><span class=\"S12C7 S1070 S2\" id=\"t1e_51\">2 952 </span><span class=\"S12C8 S1070 S2\" id=\"t1f_51\">VP Global Human Resources </span><span class=\"S12C9 S1070 S2\" id=\"t1g_51\">2 672 </span><span class=\"S12CA S1070 S2\" id=\"t1h_51\">310 </span><span class=\"S12CB S1070 S2\" id=\"t1i_51\">7 </span><span class=\"S12CC S1070 S2\" id=\"t1j_51\">242 </span><span class=\"S12CD S1070 S2\" id=\"t1k_51\">3 232 </span><span class=\"S12CE S1071 S2\" id=\"t1l_51\">Total senior management </span><span class=\"S12CF S1071 S2\" id=\"t1m_51\">21 921 </span><span class=\"S12D0 S1071 S2\" id=\"t1n_51\">5 788 </span><span class=\"S12D1 S1071 S2\" id=\"t1o_51\">1 803 </span><span class=\"S12D2 S1071 S2\" id=\"t1p_51\">1 979 </span><span class=\"S12D3 S1071 S2\" id=\"t1q_51\">31 491 </span><span class=\"S12D4 S1071 S2\" id=\"t1r_51\">Board of Directors 2022 </span><span class=\"S12D5 S1070 S2\" id=\"t1s_51\">Chairperson of the Board </span><span class=\"S12D6 S1070 S2\" id=\"t1t_51\">620 </span><span class=\"S12D7 S1070 S2\" id=\"t1u_51\">620 </span><span class=\"S12D8 S1070 S2\" id=\"t1v_51\">Members of the Board </span><span class=\"S12D9 S1070 S2\" id=\"t1w_51\">1 440 </span><span class=\"S12DA S1070 S2\" id=\"t1x_51\">1 440 </span><span class=\"S12DB S1071 S2\" id=\"t1y_51\">Total remuneration </span><span class=\"S12DC S1071 S2\" id=\"t1z_51\">2 060 </span><span class=\"S12DD S1071 S2\" id=\"t20_51\">21 921 </span><span class=\"S12DE S1071 S2\" id=\"t21_51\">5 788 </span><span class=\"S12DF S1071 S2\" id=\"t22_51\">1 803 </span><span class=\"S12E0 S1071 S2\" id=\"t23_51\">1 979 </span><span class=\"S12E1 S1071 S2\" id=\"t24_51\">33 551 </span><span class=\"S12E2 S1070 S2\" id=\"t25_51\">(Amounts in NOK 1,000) </span><span class=\"S12E3 S1071 S2\" id=\"t26_51\">Directors\u2019 </span><span class=\"S12E4 S1071 S2\" id=\"t27_51\">fees paid </span><span class=\"S12E5 S1071 S2\" id=\"t28_51\">Salaries </span><span class=\"S12E6 S1071 S2\" id=\"t29_51\">paid </span><span class=\"S12E7 S1071 S2\" id=\"t2a_51\">Bonuses </span><span class=\"S12E8 S1071 S2\" id=\"t2b_51\">accrued </span><span class=\"S12E9 S1071 S2\" id=\"t2c_51\">Bene\ufb01ts </span><span class=\"S12EA S1071 S2\" id=\"t2d_51\">in kind </span><span class=\"S12EB S1071 S2\" id=\"t2e_51\">Pension </span><span class=\"S12EC S1071 S2\" id=\"t2f_51\">cost </span><span class=\"S12ED S1071 S2\" id=\"t2g_51\">Total </span><span class=\"S12EE S1071 S2\" id=\"t2h_51\">Senior management 2021 </span><span class=\"S12EF S1070 S2\" id=\"t2i_51\">President and CEO </span><span class=\"S12F0 S1070 S2\" id=\"t2j_51\">4 760 </span><span class=\"S12F1 S1070 S2\" id=\"t2k_51\">2 571 </span><span class=\"S12F2 S1070 S2\" id=\"t2l_51\">177 </span><span class=\"S12F3 S1070 S2\" id=\"t2m_51\">382 </span><span class=\"S12F4 S1070 S2\" id=\"t2n_51\">7 889 </span><span class=\"S12F5 S1070 S2\" id=\"t2o_51\">Chief Financial O\ufb03cer </span><span class=\"S12F6 S1070 S2\" id=\"t2p_51\">2 007 </span><span class=\"S12F7 S1070 S2\" id=\"t2q_51\">513 </span><span class=\"S12F8 S1070 S2\" id=\"t2r_51\">18 </span><span class=\"S12F9 S1070 S2\" id=\"t2s_51\">284 </span><span class=\"S12FA S1070 S2\" id=\"t2t_51\">2 822 </span><span class=\"S12FB S1070 S2\" id=\"t2u_51\">VP and General Manager US Operations </span><span class=\"S12FC S1070 S2\" id=\"t2v_51\">2 989 </span><span class=\"S12FD S1070 S2\" id=\"t2w_51\">877 </span><span class=\"S12FE S1070 S2\" id=\"t2x_51\">287 </span><span class=\"S12FF S1070 S2\" id=\"t2y_51\">258 </span><span class=\"S1300 S1070 S2\" id=\"t2z_51\">4 410 </span><span class=\"S1301 S1070 S2\" id=\"t30_51\">VP and General Manager Europe </span><span class=\"S1302 S1070 S2\" id=\"t31_51\">2 807 </span><span class=\"S1303 S1070 S2\" id=\"t32_51\">661 </span><span class=\"S1304 S1070 S2\" id=\"t33_51\">150 </span><span class=\"S1305 S1070 S2\" id=\"t34_51\">250 </span><span class=\"S1306 S1070 S2\" id=\"t35_51\">3 868 </span><span class=\"S1307 S1070 S2\" id=\"t36_51\">VP Global Strategic Marketing &amp; BD </span><span class=\"S1308 S1070 S2\" id=\"t37_51\">1 694 </span><span class=\"S1309 S1070 S2\" id=\"t38_51\">219 </span><span class=\"S130A S1070 S2\" id=\"t39_51\">88 </span><span class=\"S130B S1070 S2\" id=\"t3a_51\">231 </span><span class=\"S130C S1070 S2\" id=\"t3b_51\">2 232 </span><span class=\"S130D S1070 S2\" id=\"t3c_51\">VP Technical Development and Operations to April </span><span class=\"S130E S1070 S2\" id=\"t3d_51\">916 </span><span class=\"S130F S1070 S2\" id=\"t3e_51\">- </span><span class=\"S1310 S1070 S2\" id=\"t3f_51\">5 </span><span class=\"S1311 S1070 S2\" id=\"t3g_51\">56 </span><span class=\"S1312 S1070 S2\" id=\"t3h_51\">976 </span><span class=\"S1313 S1070 S2\" id=\"t3i_51\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1314 S1070 S2\" id=\"t3j_51\">from September </span><span class=\"S1315 S1070 S2\" id=\"t3k_51\">647 </span><span class=\"S1316 S1070 S2\" id=\"t3l_51\">104 </span><span class=\"S1317 S1070 S2\" id=\"t3m_51\">113 </span><span class=\"S1318 S1070 S2\" id=\"t3n_51\">864 </span><span class=\"S1319 S1070 S2\" id=\"t3o_51\">VP Global Medical to August </span><span class=\"S131A S1070 S2\" id=\"t3p_51\">1 275 </span><span class=\"S131B S1070 S2\" id=\"t3q_51\">- </span><span class=\"S131C S1070 S2\" id=\"t3r_51\">14 </span><span class=\"S131D S1070 S2\" id=\"t3s_51\">151 </span><span class=\"S131E S1070 S2\" id=\"t3t_51\">1 440 </span><span class=\"S131F S1070 S2\" id=\"t3u_51\">VP Global Human Resources </span><span class=\"S1320 S1070 S2\" id=\"t3v_51\">2 353 </span><span class=\"S1321 S1070 S2\" id=\"t3w_51\">320 </span><span class=\"S1322 S1070 S2\" id=\"t3x_51\">6 </span><span class=\"S1323 S1070 S2\" id=\"t3y_51\">186 </span><span class=\"S1324 S1070 S2\" id=\"t3z_51\">2 865 </span><span class=\"S1325 S1071 S2\" id=\"t40_51\">Total senior management </span><span class=\"S1326 S1071 S2\" id=\"t41_51\">19 448 </span><span class=\"S1327 S1071 S2\" id=\"t42_51\">5 265 </span><span class=\"S1328 S1071 S2\" id=\"t43_51\">743 </span><span class=\"S1329 S1071 S2\" id=\"t44_51\">1 910 </span><span class=\"S132A S1071 S2\" id=\"t45_51\">27 365 </span><span class=\"S132B S1071 S2\" id=\"t46_51\">Board of Directors 2020 </span><span class=\"S132C S1070 S2\" id=\"t47_51\">Chairperson of the Board </span><span class=\"S132D S1070 S2\" id=\"t48_51\">620 </span><span class=\"S132E S1070 S2\" id=\"t49_51\">620 </span><span class=\"S132F S1070 S2\" id=\"t4a_51\">Members of the Board </span><span class=\"S1330 S1070 S2\" id=\"t4b_51\">1 440 </span><span class=\"S1331 S1070 S2\" id=\"t4c_51\">1 440 </span><span class=\"S1332 S1071 S2\" id=\"t4d_51\">Total remuneration </span><span class=\"S1333 S1071 S2\" id=\"t4e_51\">2 060 </span><span class=\"S1334 S1071 S2\" id=\"t4f_51\">19 448 </span><span class=\"S1335 S1071 S2\" id=\"t4g_51\">5 265 </span><span class=\"S1336 S1071 S2\" id=\"t4h_51\">743 </span><span class=\"S1337 S1071 S2\" id=\"t4i_51\">1 910 </span><span class=\"S1338 S1071 S2\" id=\"t4j_51\">29 425 </span><span class=\"S133A S1071 S2\" id=\"t4_52\">Share options senior management </span><span class=\"S133B S1070 S2\" id=\"t5_52\">Senior managers\u2019 holdings of shares in Photocure ASA are stated in the note concerning share capital. Allocation and exercise of </span><span class=\"S133C S1070 S2\" id=\"t6_52\">share options and holdings of share options for senior managers are presented in the following overview: </span><span class=\"S133D S1071 S2\" id=\"t7_52\">Share options for senior management 2022 </span><span class=\"S133E S1071 S2\" id=\"t8_52\">Share </span><span class=\"S133F S1071 S2\" id=\"t9_52\">options </span><span class=\"S1340 S1071 S2\" id=\"ta_52\">awarded </span><span class=\"S1341 S1071 S2\" id=\"tb_52\">Expired </span><span class=\"S1342 S1071 S2\" id=\"tc_52\">share </span><span class=\"S1343 S1071 S2\" id=\"td_52\">options </span><span class=\"S1344 S1071 S2\" id=\"te_52\">Share </span><span class=\"S1345 S1071 S2\" id=\"tf_52\">options </span><span class=\"S1346 S1071 S2\" id=\"tg_52\">exercised </span><span class=\"S1347 S1071 S2\" id=\"th_52\">Holding of </span><span class=\"S1348 S1071 S2\" id=\"ti_52\">share options </span><span class=\"S1349 S1071 S2\" id=\"tj_52\">at 31 December </span><span class=\"S134A S1071 S2\" id=\"tk_52\">2022 </span><span class=\"S134B S1071 S2\" id=\"tl_52\">Average </span><span class=\"S134C S1071 S2\" id=\"tm_52\">exercise </span><span class=\"S134D S1071 S2\" id=\"tn_52\">price </span><span class=\"S134E S1070 S2\" id=\"to_52\">President &amp; CEO </span><span class=\"S134F S1070 S2\" id=\"tp_52\">130 000 </span><span class=\"S1350 S1070 S2\" id=\"tq_52\">- </span><span class=\"S1351 S1070 S2\" id=\"tr_52\">100 000 </span><span class=\"S1352 S1070 S2\" id=\"ts_52\">325 000 </span><span class=\"S1353 S1070 S2\" id=\"tt_52\">121.33 </span><span class=\"S1354 S1070 S2\" id=\"tu_52\">Chief Financial O\ufb03cer </span><span class=\"S1355 S1070 S2\" id=\"tv_52\">90 000 </span><span class=\"S1356 S1070 S2\" id=\"tw_52\">- </span><span class=\"S1357 S1070 S2\" id=\"tx_52\">20 000 </span><span class=\"S1358 S1070 S2\" id=\"ty_52\">192 500 </span><span class=\"S1359 S1070 S2\" id=\"tz_52\">119.46 </span><span class=\"S135A S1070 S2\" id=\"t10_52\">VP and General Manager North America </span><span class=\"S135B S1070 S2\" id=\"t11_52\">65 000 </span><span class=\"S135C S1070 S2\" id=\"t12_52\">- </span><span class=\"S135D S1070 S2\" id=\"t13_52\">- </span><span class=\"S135E S1070 S2\" id=\"t14_52\">212 500 </span><span class=\"S135F S1070 S2\" id=\"t15_52\">106.73 </span><span class=\"S1360 S1070 S2\" id=\"t16_52\">VP and General Manager Europe </span><span class=\"S1361 S1070 S2\" id=\"t17_52\">65 000 </span><span class=\"S1362 S1070 S2\" id=\"t18_52\">- </span><span class=\"S1363 S1070 S2\" id=\"t19_52\">- </span><span class=\"S1364 S1070 S2\" id=\"t1a_52\">200 000 </span><span class=\"S1365 S1070 S2\" id=\"t1b_52\">113.84 </span><span class=\"S1366 S1070 S2\" id=\"t1c_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S1367 S1070 S2\" id=\"t1d_52\">35 000 </span><span class=\"S1368 S1070 S2\" id=\"t1e_52\">- </span><span class=\"S1369 S1070 S2\" id=\"t1f_52\">- </span><span class=\"S136A S1070 S2\" id=\"t1g_52\">112 500 </span><span class=\"S136B S1070 S2\" id=\"t1h_52\">111.12 </span><span class=\"S136C S1070 S2\" id=\"t1i_52\">VP Global Human Resources </span><span class=\"S136D S1070 S2\" id=\"t1j_52\">- </span><span class=\"S136E S1070 S2\" id=\"t1k_52\">- </span><span class=\"S136F S1070 S2\" id=\"t1l_52\">- </span><span class=\"S1370 S1070 S2\" id=\"t1m_52\">80 000 </span><span class=\"S1371 S1070 S2\" id=\"t1n_52\">113.34 </span><span class=\"S1372 S1070 S2\" id=\"t1o_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1373 S1070 S2\" id=\"t1p_52\">60 000 </span><span class=\"S1374 S1070 S2\" id=\"t1q_52\">- </span><span class=\"S1375 S1070 S2\" id=\"t1r_52\">- </span><span class=\"S1376 S1070 S2\" id=\"t1s_52\">88 000 </span><span class=\"S1377 S1070 S2\" id=\"t1t_52\">122.56 </span><span class=\"S1378 S1071 S2\" id=\"t1u_52\">Total </span><span class=\"S1379 S1071 S2\" id=\"t1v_52\">445 000 </span><span class=\"S137A S1071 S2\" id=\"t1w_52\">- </span><span class=\"S137B S1071 S2\" id=\"t1x_52\">120 000 </span><span class=\"S137C S1071 S2\" id=\"t1y_52\">1 210 500 </span><span class=\"S137D S1071 S2\" id=\"t1z_52\">Share options for senior management 2021 </span><span class=\"S137E S1071 S2\" id=\"t20_52\">Share </span><span class=\"S137F S1071 S2\" id=\"t21_52\">options </span><span class=\"S1380 S1071 S2\" id=\"t22_52\">awarded </span><span class=\"S1381 S1071 S2\" id=\"t23_52\">Expired </span><span class=\"S1382 S1071 S2\" id=\"t24_52\">share </span><span class=\"S1383 S1071 S2\" id=\"t25_52\">options </span><span class=\"S1384 S1071 S2\" id=\"t26_52\">Share </span><span class=\"S1385 S1071 S2\" id=\"t27_52\">options </span><span class=\"S1386 S1071 S2\" id=\"t28_52\">exercised </span><span class=\"S1387 S1071 S2\" id=\"t29_52\">Holding of </span><span class=\"S1388 S1071 S2\" id=\"t2a_52\">share options </span><span class=\"S1389 S1071 S2\" id=\"t2b_52\">at 31 December </span><span class=\"S138A S1071 S2\" id=\"t2c_52\">2021 </span><span class=\"S138B S1071 S2\" id=\"t2d_52\">Average </span><span class=\"S138C S1071 S2\" id=\"t2e_52\">exercise </span><span class=\"S138D S1071 S2\" id=\"t2f_52\">price </span><span class=\"S138E S1070 S2\" id=\"t2g_52\">President &amp; CEO </span><span class=\"S138F S1070 S2\" id=\"t2h_52\">135 000 </span><span class=\"S1390 S1070 S2\" id=\"t2i_52\">- </span><span class=\"S1391 S1070 S2\" id=\"t2j_52\">100 000 </span><span class=\"S1392 S1070 S2\" id=\"t2k_52\">295 000 </span><span class=\"S1393 S1070 S2\" id=\"t2l_52\">100.23 </span><span class=\"S1394 S1070 S2\" id=\"t2m_52\">Chief Financial O\ufb03cer </span><span class=\"S1395 S1070 S2\" id=\"t2n_52\">67 500 </span><span class=\"S1396 S1070 S2\" id=\"t2o_52\">- </span><span class=\"S1397 S1070 S2\" id=\"t2p_52\">20 000 </span><span class=\"S1398 S1070 S2\" id=\"t2q_52\">122 500 </span><span class=\"S1399 S1070 S2\" id=\"t2r_52\">111.59 </span><span class=\"S139A S1070 S2\" id=\"t2s_52\">VP and General Manager US Operations </span><span class=\"S139B S1070 S2\" id=\"t2t_52\">67 500 </span><span class=\"S139C S1070 S2\" id=\"t2u_52\">- </span><span class=\"S139D S1070 S2\" id=\"t2v_52\">45 000 </span><span class=\"S139E S1070 S2\" id=\"t2w_52\">147 500 </span><span class=\"S139F S1070 S2\" id=\"t2x_52\">103.14 </span><span class=\"S13A0 S1070 S2\" id=\"t2y_52\">VP and General Manager Europe </span><span class=\"S13A1 S1070 S2\" id=\"t2z_52\">67 500 </span><span class=\"S13A2 S1070 S2\" id=\"t30_52\">- </span><span class=\"S13A3 S1070 S2\" id=\"t31_52\">22 500 </span><span class=\"S13A4 S1070 S2\" id=\"t32_52\">135 000 </span><span class=\"S13A5 S1070 S2\" id=\"t33_52\">113.34 </span><span class=\"S13A6 S1070 S2\" id=\"t34_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S13A7 S1070 S2\" id=\"t35_52\">40 000 </span><span class=\"S13A8 S1070 S2\" id=\"t36_52\">- </span><span class=\"S13A9 S1070 S2\" id=\"t37_52\">12 500 </span><span class=\"S13AA S1070 S2\" id=\"t38_52\">77 500 </span><span class=\"S13AB S1070 S2\" id=\"t39_52\">109.42 </span><span class=\"S13AC S1070 S2\" id=\"t3a_52\">VP Global Human Resources </span><span class=\"S13AD S1070 S2\" id=\"t3b_52\">40 000 </span><span class=\"S13AE S1070 S2\" id=\"t3c_52\">- </span><span class=\"S13AF S1070 S2\" id=\"t3d_52\">- </span><span class=\"S13B0 S1070 S2\" id=\"t3e_52\">80 000 </span><span class=\"S13B1 S1070 S2\" id=\"t3f_52\">113.34 </span><span class=\"S13B2 S1070 S2\" id=\"t3g_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S13B3 S1070 S2\" id=\"t3h_52\">28 000 </span><span class=\"S13B4 S1070 S2\" id=\"t3i_52\">- </span><span class=\"S13B5 S1070 S2\" id=\"t3j_52\">- </span><span class=\"S13B6 S1070 S2\" id=\"t3k_52\">28 000 </span><span class=\"S13B7 S1070 S2\" id=\"t3l_52\">139.00 </span><span class=\"S13B8 S1071 S2\" id=\"t3m_52\">Total </span><span class=\"S13B9 S1071 S2\" id=\"t3n_52\">445 500 </span><span class=\"S13BA S1071 S2\" id=\"t3o_52\">- </span><span class=\"S13BB S1071 S2\" id=\"t3p_52\">200 000 </span><span class=\"S13BC S1071 S2\" id=\"t3q_52\">885 500 </span><span class=\"S13BD S1071 S2\" id=\"t3r_52\">Auditing fees </span><span class=\"S13BE S1070 S2\" id=\"t3s_52\">(Amounts in NOK 1,000) </span><span class=\"S13BF S1071 S2\" id=\"t3t_52\">Group and parent </span><span class=\"S13C0 S1071 S2\" id=\"t3u_52\">2022 </span><span class=\"S13C1 S1071 S2\" id=\"t3v_52\">2021 </span><span class=\"S13C2 S1070 S2\" id=\"t3w_52\">Statutory auditing </span><span class=\"S13C3 S1070 S2\" id=\"t3x_52\">972 </span><span class=\"S13C4 S1070 S2\" id=\"t3y_52\">488 </span><span class=\"S13C5 S1070 S2\" id=\"t3z_52\">Other attestation services </span><span class=\"S13C6 S1070 S2\" id=\"t40_52\">138 </span><span class=\"S13C7 S1070 S2\" id=\"t41_52\">22 </span><span class=\"S13C8 S1070 S2\" id=\"t42_52\">Other services excluding auditing </span><span class=\"S13C9 S1070 S2\" id=\"t43_52\">42 </span><span class=\"S13CA S1070 S2\" id=\"t44_52\">0 </span><span class=\"S13CB S1070 S2\" id=\"t45_52\">Tax advice </span><span class=\"S13CC S1070 S2\" id=\"t46_52\">132 </span><span class=\"S13CD S1070 S2\" id=\"t47_52\">126 </span><span class=\"S13CE S1071 S2\" id=\"t48_52\">Total </span><span class=\"S13CF S1071 S2\" id=\"t49_52\">1 284 </span><span class=\"S13D0 S1071 S2\" id=\"t4a_52\">636 </span><span class=\"S13D2 S106F S2\" id=\"t2_53\">8. PENSION COSTS </span><span class=\"S13D3 S1070 S2\" id=\"t3_53\">Photocure ASA has an agreement with a life assurance company concerning contribution-based pensions for Photocure\u2019s </span><span class=\"S13D4 S1070 S2\" id=\"t4_53\">employees in Norway. The contribution plan match the revised national regulations for pension. The contributions are 6% of the </span><span class=\"S13D5 S1070 S2\" id=\"t5_53\">employee\u2019s ordinary salary up to 7.1 times the basic amount (G) of the Norwegian National Insurance scheme, and thereafter 16% up </span><span class=\"S13D6 S1070 S2\" id=\"t6_53\">to 12 x G. The national insurance cover pension for salaries to 7.1 G. Pension contributions are paid into the employee\u2019s contribution </span><span class=\"S13D7 S1070 S2\" id=\"t7_53\">account with the life assurance company. As of 31 December 2022 and 31 December 2021, the company had no deposits in the </span><span class=\"S13D8 S1070 S2\" id=\"t8_53\">premium and the contribution fund. </span><span class=\"S13D9 S1070 S2\" id=\"t9_53\">Photocure ASA employees in other European countries have individual de\ufb01ned contribution pension plans according to local </span><span class=\"S13DA S1070 S2\" id=\"ta_53\">regulations and </span><span class=\"S13DB S1070 S2\" id=\"tb_53\">their employment agreements. </span><span class=\"S13DC S1070 S2\" id=\"tc_53\">Photocure Inc matches its employee\u2019s contribution to the 401(k) plan dollar for dollar up to 4% of salary for the employees that elect </span><span class=\"S13DD S1070 S2\" id=\"td_53\">to join the plan. </span><span class=\"S13DE S1070 S2\" id=\"te_53\">There is a salary maximum set by the IRS, which was $305 000 in 2022. </span><span class=\"S13DF S1070 S2\" id=\"tf_53\">Employees in Photocure GmbH in Germany coming from Ipsen have de\ufb01ned bene\ufb01t pension plans through the </span><span class=\"S13E0 S1070 S2\" id=\"tg_53\">TUPE regulations in </span><span class=\"S13E1 S1070 S2\" id=\"th_53\">Germany. Photocure GmbH has a re-assurance agreement with an assurance company in Germany that balance the pension liability. </span><span class=\"S13E2 S1070 S2\" id=\"ti_53\">New employees in Photocure GmbH are o\ufb00ered a de\ufb01ned contribution plan. </span><span class=\"S13E3 S1070 S2\" id=\"tj_53\">Photocure has entered into pension agreements with senior management in the form of un-funded pensions for salaries exceeding </span><span class=\"S13E4 S1070 S2\" id=\"tk_53\">coverage by insurance. This un-funded pension liability is interest-bearing. </span><span class=\"S13E5 S1071 S2\" id=\"tl_53\">The pension cost for the year is calculated as follows: </span><span class=\"S13E6 S1070 S2\" id=\"tm_53\">(Amounts in NOK 1,000) </span><span class=\"S13E7 S1071 S2\" id=\"tn_53\">Group </span><span class=\"S13E8 S1071 S2\" id=\"to_53\">Parent </span><span class=\"S13E9 S1071 S2\" id=\"tp_53\">2022 </span><span class=\"S13EA S1071 S2\" id=\"tq_53\">2021 </span><span class=\"S13EB S1071 S2\" id=\"tr_53\">2022 </span><span class=\"S13EC S1071 S2\" id=\"ts_53\">2021 </span><span class=\"S13ED S1070 S2\" id=\"tt_53\">Total pension costs, contribution scheme in life assurance </span><span class=\"S13EE S1070 S2\" id=\"tu_53\">11 866 </span><span class=\"S13EF S1070 S2\" id=\"tv_53\">10 496 </span><span class=\"S13F0 S1070 S2\" id=\"tw_53\">5 339 </span><span class=\"S13F1 S1070 S2\" id=\"tx_53\">4 607 </span><span class=\"S13F2 S1070 S2\" id=\"ty_53\">Total pension costs, company scheme </span><span class=\"S13F3 S1070 S2\" id=\"tz_53\">1 235 </span><span class=\"S13F4 S1070 S2\" id=\"t10_53\">876 </span><span class=\"S13F5 S1070 S2\" id=\"t11_53\">343 </span><span class=\"S13F6 S1070 S2\" id=\"t12_53\">295 </span><span class=\"S13F7 S1071 S2\" id=\"t13_53\">Total </span><span class=\"S13F8 S1071 S2\" id=\"t14_53\">13 101 </span><span class=\"S13F9 S1071 S2\" id=\"t15_53\">11 372 </span><span class=\"S13FA S1071 S2\" id=\"t16_53\">5 682 </span><span class=\"S13FB S1071 S2\" id=\"t17_53\">4 902 </span><span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span><span class=\"S1445 S1070 SDD8 S2\" id=\"t24_54\">The parent company is committed to securing the operations in the U.S. </span><span class=\"S1447 S106F S2\" id=\"t2_55\">10. RELATED PARTIES - COMPANIES </span><span class=\"S1448 S1071 S2\" id=\"t3_55\">Subsidiaries </span><span class=\"S1449 S1070 S2\" id=\"t4_55\">The transfer price method implemented is the pro\ufb01t &amp; loss split method (PSM) for the sales in US and a residual pro\ufb01t model (RPM) </span><span class=\"S144A S1070 S2\" id=\"t5_55\">for the sales in Germany and France. </span><span class=\"S144B S1070 S2\" id=\"t6_55\">Both the PSM and the RPM divides the combined pro\ufb01t or loss between the transacting related entities based on what would be </span><span class=\"S144C S1070 S2\" id=\"t7_55\">anticipated if the entities had been transacting at arm\u2019s length. </span><span class=\"S144D S1070 S2\" id=\"t8_55\">A contribution analysis for sale of Cysview in US and sale of Hexvix in Germany and France compares the split of pro\ufb01t or loss </span><span class=\"S144E S1070 S2\" id=\"t9_55\">between the subsidiaries and Photocure ASA based on the value of the functions performed by each of the related parties, taking </span><span class=\"S144F S1070 S2\" id=\"ta_55\">into account the assets used and the risks assumed by both parties. </span><span class=\"S1450 S1070 S2\" id=\"tb_55\">Photocure has established a wholly owned subsidiary in the US, Photocure Inc, in order to carry out the sales and the marketing-, </span><span class=\"S1451 S1070 S2\" id=\"tc_55\">selling- and distribution activities for the Cysview product. Photocure ASA has the ownership to the patent rights and the trade mark </span><span class=\"S1452 S1070 S2\" id=\"td_55\">and is responsible in the Group for development and manufacturing of the product. Photocure Inc purchases the completed product </span><span class=\"S1453 S1070 S2\" id=\"te_55\">from the parent company and distributes in the United States. Photocure Inc has established its own marketing organization that is </span><span class=\"S1454 S1070 S2\" id=\"tf_55\">funded by a loan from its parent company in addition to its own revenues. The transactions between Photocure ASA and Photocure </span><span class=\"S1455 S1070 S2\" id=\"tg_55\">Inc are on terms at arm\u2019s length, except for the loan that is interest free until further notice. </span><span class=\"S1456 S1070 S2\" id=\"th_55\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table. This is based on a cash \ufb02ow model taking into account a </span><span class=\"S1457 S1070 S2\" id=\"ti_55\">balanced view of the market share for Cysview in the US compared to sales of Hexvix in Europe. The US sales and marketing force </span><span class=\"S1458 S1070 S2\" id=\"tj_55\">has been kept during the Covid pandemic and enables Photocure Inc to access the US market again </span><span class=\"S1459 S1070 S2\" id=\"tk_55\">after the pandemic has ended. </span><span class=\"S145A S1070 S2\" id=\"tl_55\">Photocure has established wholly owned subsidiaries in Germany and France. </span><span class=\"S145B S1070 S2\" id=\"tm_55\">Photocure ASA carries out the sales and distribution </span><span class=\"S145C S1070 S2\" id=\"tn_55\">in Europe for the Hexvix product. The marketing- and promotion activities for the Hexvix product in Continental Europe are carried </span><span class=\"S145D S1070 S2\" id=\"to_55\">out by Photocure GmbH and Photocure SAS. The residual pro\ufb01t in Germany and France are allocated to the subsidiaries. Mark up is </span><span class=\"S145E S1070 S2\" id=\"tp_55\">assumed on fully loaded local costs for the services rendered to parent company. </span><span class=\"S145F S1070 S2\" id=\"tq_55\">Photocure established from January 2022 a sales subsidiary in Canada to carry out the sales, marketing and distribution of Cysview </span><span class=\"S1460 S1070 S2\" id=\"tr_55\">in Canada. </span><span class=\"S1461 S1071 S2\" id=\"ts_55\">Transactions and intercompany balances: </span><span class=\"S1462 S1071 S2\" id=\"tt_55\">2022 </span><span class=\"S1463 S1071 S2\" id=\"tu_55\">2021 </span><span class=\"S1464 S1070 S2\" id=\"tv_55\">Sales of products </span><span class=\"S1465 S1070 S2\" id=\"tw_55\">12 986 </span><span class=\"S1466 S1070 S2\" id=\"tx_55\">7 488 </span><span class=\"S1467 S1070 S2\" id=\"ty_55\">Sales of services </span><span class=\"S1468 S1070 S2\" id=\"tz_55\">899 </span><span class=\"S1469 S1070 S2\" id=\"t10_55\">999 </span><span class=\"S146A S1071 S2\" id=\"t11_55\">Intercompany sales </span><span class=\"S146B S1071 S2\" id=\"t12_55\">13 885 </span><span class=\"S146C S1071 S2\" id=\"t13_55\">8 487 </span><span class=\"S146D S1071 S2\" id=\"t14_55\">Purchase of marketing and promotion services </span><span class=\"S146E S1071 S2\" id=\"t15_55\">-54 719 </span><span class=\"S146F S1071 S2\" id=\"t16_55\">-48 060 </span><span class=\"S1470 S1071 S2\" id=\"t17_55\">31-Dec-22 </span><span class=\"S1471 S1071 S2\" id=\"t18_55\">31-Dec-21 </span><span class=\"S1472 S1070 S2\" id=\"t19_55\">Accounts receivables and other storm-term receivables </span><span class=\"S1473 S1070 S2\" id=\"t1a_55\">4 733 </span><span class=\"S1474 S1070 S2\" id=\"t1b_55\">0 </span><span class=\"S1475 S1070 S2\" id=\"t1c_55\">Long term loan given </span><span class=\"S1476 S1070 S2\" id=\"t1d_55\">350 072 </span><span class=\"S1477 S1070 S2\" id=\"t1e_55\">308 390 </span><span class=\"S1478 S1070 S2\" id=\"t1f_55\">Accounts payables and other short-term liabilities </span><span class=\"S1479 S1070 S2\" id=\"t1g_55\">-17 436 </span><span class=\"S147A S1070 S2\" id=\"t1h_55\">-7 203 </span><span class=\"S147B S1071 S2\" id=\"t1i_55\">Total subsidiaries </span><span class=\"S147C S1071 S2\" id=\"t1j_55\">337 369 </span><span class=\"S147D S1071 S2\" id=\"t1k_55\">301 187 </span><span class=\"S147E S1071 S2\" id=\"t1l_55\">Guarantees to bank in favor of subsidiary for requested security </span><span class=\"S147F S1071 S2\" id=\"t1m_55\">2 724 </span><span class=\"S1480 S1071 S2\" id=\"t1n_55\">2 220 </span><span class=\"S1481 S1070 S2\" id=\"t1o_55\">These are for licenses with the States of Maryland, Mississippi, Nevada and California to sell Cysview and for the o\ufb03ce lease deposit </span>1. TAX <span class=\"S13FE S1070 S2\" id=\"t5_56\">(Amounts in NOK 1,000) </span><span class=\"S1483 S1071 S2\" id=\"t6_56\">Parent &amp; Group </span><span class=\"S1403 S1071 S2\" id=\"t7_56\">2022 </span><span class=\"S1404 S1071 S2\" id=\"t8_56\">2021 </span><span class=\"S1484 S1071 S2\" id=\"t9_56\">Income tax expense </span><span class=\"S1485 S1070 S2\" id=\"ta_56\">Tax payable </span><span class=\"S1486 S1070 S2\" id=\"tb_56\">2 840 </span><span class=\"S1487 S1070 S2\" id=\"tc_56\">2 365 </span><span class=\"S1488 S1070 S2\" id=\"td_56\">Changes in deferred tax </span><span class=\"S1489 S1070 S2\" id=\"te_56\">-2 117 </span><span class=\"S148A S1070 S2\" id=\"tf_56\">-3 124 </span><span class=\"S148B S1071 S2\" id=\"tg_56\">Total income tax expense </span><span class=\"S148C S1071 S2\" id=\"th_56\">723 </span><span class=\"S148D S1071 S2\" id=\"ti_56\">-759 </span><span class=\"S148E S1071 S2\" id=\"tj_56\">Tax base calculation parent </span><span class=\"S148F S1070 S2\" id=\"tk_56\">Pro\ufb01t(-loss) before income tax </span><span class=\"S1490 S1070 S2\" id=\"tl_56\">-61 021 </span><span class=\"S1491 S1070 S2\" id=\"tm_56\">-22 950 </span><span class=\"S1492 S1070 S2\" id=\"tn_56\">Permanent di\ufb00erences *) </span><span class=\"S1493 S1070 S2\" id=\"to_56\">49 534 </span><span class=\"S1494 S1070 S2\" id=\"tp_56\">8 346 </span><span class=\"S1495 S1070 S2\" id=\"tq_56\">Change in temporary di\ufb00erences </span><span class=\"S1496 S1070 S2\" id=\"tr_56\">-35 757 </span><span class=\"S1497 S1070 S2\" id=\"ts_56\">10 050 </span><span class=\"S1498 S1070 S2\" id=\"tt_56\">(Utilized)/Increased tax loss carried forward </span><span class=\"S1499 S1070 S2\" id=\"tu_56\">47 244 </span><span class=\"S149A S1070 S2\" id=\"tv_56\">4 554 </span><span class=\"S149B S1071 S2\" id=\"tw_56\">Tax base </span><span class=\"S149C S1071 S2\" id=\"tx_56\">-0 </span><span class=\"S149D S1071 S2\" id=\"ty_56\">0 </span><span class=\"S149E S1071 S2\" id=\"tz_56\">Temporary di\ufb00erences </span><span class=\"S149F S1070 S2\" id=\"t10_56\">Receivables </span><span class=\"S14A0 S1070 S2\" id=\"t11_56\">-551 </span><span class=\"S14A1 S1070 S2\" id=\"t12_56\">-551 </span><span class=\"S14A2 S1070 S2\" id=\"t13_56\">Inventories </span><span class=\"S14A3 S1070 S2\" id=\"t14_56\">4 003 </span><span class=\"S14A4 S1070 S2\" id=\"t15_56\">4 489 </span><span class=\"S14A5 S1070 S2\" id=\"t16_56\">Non current assets </span><span class=\"S14A6 S1070 S2\" id=\"t17_56\">32 041 </span><span class=\"S14A7 S1070 S2\" id=\"t18_56\">29 763 </span><span class=\"S14A8 S1070 S2\" id=\"t19_56\">Long term currency loans </span><span class=\"S14A9 S1070 S2\" id=\"t1a_56\">116 280 </span><span class=\"S14AA S1070 S2\" id=\"t1b_56\">77 622 </span><span class=\"S14AB S1070 S2\" id=\"t1c_56\">Earnout liability </span><span class=\"S14AC S1070 S2\" id=\"t1d_56\">-17 978 </span><span class=\"S14AD S1070 S2\" id=\"t1e_56\">-17 220 </span><span class=\"S14AE S1070 S2\" id=\"t1f_56\">Provisions </span><span class=\"S14AF S1070 S2\" id=\"t1g_56\">-1 024 </span><span class=\"S14B0 S1070 S2\" id=\"t1h_56\">-1 525 </span><span class=\"S14B1 S1070 S2\" id=\"t1i_56\">Pensions </span><span class=\"S14B2 S1070 S2\" id=\"t1j_56\">-2 523 </span><span class=\"S14B3 S1070 S2\" id=\"t1k_56\">-2 180 </span><span class=\"S14B4 S1070 S2\" id=\"t1l_56\">Gains and loss account </span><span class=\"S14B5 S1070 S2\" id=\"t1m_56\">16 109 </span><span class=\"S14B6 S1070 S2\" id=\"t1n_56\">20 136 </span><span class=\"S14B7 S1071 S2\" id=\"t1o_56\">Total </span><span class=\"S14B8 S1071 S2\" id=\"t1p_56\">146 356 </span><span class=\"S14B9 S1071 S2\" id=\"t1q_56\">110 533 </span><span class=\"S14BA S1070 S2\" id=\"t1r_56\">Tax loss carried forward </span><span class=\"S14BB S1070 S2\" id=\"t1s_56\">-396 901 </span><span class=\"S14BC S1070 S2\" id=\"t1t_56\">-351 456 </span><span class=\"S14BD S1071 S2\" id=\"t1u_56\">Net temporary di\ufb00erences </span><span class=\"S14BE S1071 S2\" id=\"t1v_56\">-250 545 </span><span class=\"S14BF S1071 S2\" id=\"t1w_56\">-240 923 </span><span class=\"S14C0 S1071 S2\" id=\"t1x_56\">Deferred tax liability (asset) </span><span class=\"S14C1 S1071 S2\" id=\"t1y_56\">-55 120 </span><span class=\"S14C2 S1071 S2\" id=\"t1z_56\">-53 003 </span><span class=\"S14C3 S1071 S2\" id=\"t20_56\">Parent &amp; Group </span><span class=\"S14C4 S1071 S2\" id=\"t21_56\">2022 </span><span class=\"S14C5 S1071 S2\" id=\"t22_56\">2021 </span><span class=\"S14C6 S1071 S2\" id=\"t23_56\">Reconciliation of e\ufb00ective tax rate </span><span class=\"S14C7 S1070 S2\" id=\"t24_56\">Expected income taxes at statutory tax rate </span><span class=\"S14C8 S1070 S2\" id=\"t25_56\">-13 425 </span><span class=\"S14C9 S1070 S2\" id=\"t26_56\">-5 049 </span><span class=\"S14CA S1070 S2\" id=\"t27_56\">Permanent di\ufb00erences </span><span class=\"S14CB S1070 S2\" id=\"t28_56\">10 897 </span><span class=\"S14CC S1070 S2\" id=\"t29_56\">1 836 </span><span class=\"S14CD S1070 S2\" id=\"t2a_56\">Change in temporary di\ufb00erences </span><span class=\"S14CE S1070 S2\" id=\"t2b_56\">-7 867 </span><span class=\"S14CF S1070 S2\" id=\"t2c_56\">Prior year adjustment </span><span class=\"S14D0 S1070 S2\" id=\"t2d_56\">111 </span><span class=\"S14D1 S1071 S2\" id=\"t2e_56\">Income tax expense </span><span class=\"S14D2 S1071 S2\" id=\"t2f_56\">-10 394 </span><span class=\"S14D3 S1071 S2\" id=\"t2g_56\">-3 102 </span><span class=\"S14D4 S1070 S2\" id=\"t2h_56\">E\ufb00ective tax rate in % </span><span class=\"S14D5 S204 S2\" id=\"t2i_56\">** </span><span class=\"S14D6 S1070 S2\" id=\"t2j_56\">) </span><span class=\"S14D7 S1070 S2\" id=\"t2k_56\">17.0 % </span><span class=\"S14D8 S1070 S2\" id=\"t2l_56\">13.5 % </span><span class=\"S14D9 S1070 S2\" id=\"t2m_56\">Temporary di\ufb00erences are recognized for the Parent company only and the note disclosure for the Group is of this reason identic to </span><span class=\"S14DA S1070 S2\" id=\"t2n_56\">the disclosure for the Parent company. </span><span class=\"S14DB S1070 S2\" id=\"t2o_56\">The tax payable is however due to the new subsidiaries in Europe that received a residual share of pro\ufb01t in Germany and France or a </span><span class=\"S14DC S1070 S2\" id=\"t2p_56\">minimum mark up of the costs incurred. </span><span class=\"S14DD S1294 S2\" id=\"t2q_56\">* </span><span class=\"S14DE S1295 S2\" id=\"t2r_56\">) </span><span class=\"S14DF S1295 S2\" id=\"t2s_56\">Permanent di\ufb00erences consist of non deductible costs, non taxable income and deduction for development cost through the SkatteFunn concept. </span><span class=\"S14E0 S1294 S2\" id=\"t2t_56\">** </span><span class=\"S14E1 S1295 S2\" id=\"t2u_56\">) Tax expense related to pro\ufb01t before tax. </span><span class=\"S14E3 S1070 S152D S2\" id=\"t2_57\">The parent company has a taxable loss in 2022 of NOK 47.2 million compared to a loss in 2021 of NOK 4.6 million. </span><span class=\"S14E4 S1070 S152D S2\" id=\"t3_57\">The deferred tax asset </span><span class=\"S14E5 S1070 S152D S2\" id=\"t4_57\">is of this reason and movements in other temporary di\ufb00erences increased to NOK 55.1 million compared to NOK 53.0 million as of 31 </span><span class=\"S14E6 S1070 S152D S2\" id=\"t5_57\">December 2021. </span><span class=\"S14E7 S1070 S152D S2\" id=\"t6_57\">Photocure apply a pro\ufb01t/loss split method for the business in US and a share of the US related revenue and expenses </span><span class=\"S14E8 S1070 S152D S2\" id=\"t7_57\">are included in the parent company. For the operations in Europe Photocure apply a residual pro\ufb01t share for Germany and France </span><span class=\"S14E9 S1070 S152D S2\" id=\"t8_57\">through our subsidiaries. The basis for recognition of a tax asset in Norway are the predicted future pro\ufb01t according to the business </span><span class=\"S14EA S1070 S152D S2\" id=\"t9_57\">plan for all major markets and that temporary di\ufb00erences for the coming years will be reversed. The remaining deferred tax asset is of </span><span class=\"S14EB S1070 S152D S2\" id=\"ta_57\">this reason maintained as of 31 December 2022. </span><span class=\"S14EC S1070 S152D S2\" id=\"tb_57\">European business contributes to Photocure pro\ufb01tability in 2022 and will continue to contribute going forward. The parent company is </span><span class=\"S14ED S1070 S152D S2\" id=\"tc_57\">the selling entity of the Hexvix product in all the European countries. The marketing and promotion activities in Germany and France are </span><span class=\"S14EE S1070 S152D S2\" id=\"td_57\">performed through the subsidiaries in those countries. </span><span class=\"S14EF S1070 S152D S2\" id=\"te_57\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table and this will contribute to the pre-tax result in the parent </span><span class=\"S14F0 S1070 S152D S2\" id=\"tf_57\">company through the pro\ufb01t/loss split method. This is based on a cash \ufb02ow model taking into account a balanced view of the market </span><span class=\"S14F1 S1070 S152D S2\" id=\"tg_57\">share for Cysview in the US compared to sales of Hexvix in Europe. The expanded US sales and marketing force has enabled Photocure </span><span class=\"S14F2 S1070 S152D S2\" id=\"th_57\">Inc to cover larger parts of the US market in order to gain further market shares. The installed base of blue light cystoscopes in US at </span><span class=\"S14F3 S1070 S152D S2\" id=\"ti_57\">the end of 2022 has increased 19% compared to last year end. </span><span class=\"S14F4 S1070 S152D S2\" id=\"tj_57\">Photocure continues to see growth opportunities in the European countries and particulary in several large untapped markets. With </span><span class=\"S14F5 S1070 S152D S2\" id=\"tk_57\">Photocure\u2019s own dedicated sales force in place in Europe, we believe this will further strengthen the sales. </span><span class=\"S14F6 S1070 S152D S2\" id=\"tl_57\">Several studies have been published highlighting and verifying key clinical bene\ufb01ts including the positive impact of Hexvix/Cysview on </span><span class=\"S14F7 S1070 S152D S2\" id=\"tm_57\">reduced disease progression, bladder cancer detection and the safety of repeated use of Hexvix/Cysview. The basis for the recognition </span><span class=\"S14F8 S1070 S152D S2\" id=\"tn_57\">of the tax asset is the assessment that there are convincing evidence that the deferred tax bene\ufb01t will be utilized. </span><span class=\"S14F9 S1070 S152D S2\" id=\"to_57\">There is no expiry on losses to be carried forward in Norway while it expires after 20 years in US according to tax legislation valid to end </span><span class=\"S14FA S1070 S152D S2\" id=\"tp_57\">of 2017. The new US tax legislation valid for taxable years from 2018 </span><span class=\"S14FB S1070 S152D S2\" id=\"tq_57\">have no expiry of loss carried forward but a 80% limit in utilization. </span><span class=\"S14FC S1070 S152D S2\" id=\"tr_57\">Deferred tax assets have not been recognised in respect of the following items in the US subsidiary due to no history of pre-tax pro\ufb01t at </span><span class=\"S14FD S1070 S152D S2\" id=\"ts_57\">this point in time : </span><span class=\"S14FE S1070 S2\" id=\"tt_57\">(Amounts in NOK 1,000) </span><span class=\"S14FF S1071 S2\" id=\"tu_57\">2022 </span><span class=\"S1500 S1071 S2\" id=\"tv_57\">2021 </span><span class=\"S1501 S1071 S2\" id=\"tw_57\">Unrecognised deferred tax assets </span><span class=\"S1502 S1071 S2\" id=\"tx_57\">Amount </span><span class=\"S1503 S1071 S2\" id=\"ty_57\">Tax e\ufb00ect </span><span class=\"S1504 S1071 S2\" id=\"tz_57\">Amount </span><span class=\"S1505 S1071 S2\" id=\"t10_57\">Tax e\ufb00ect </span><span class=\"S1506 S1070 S2\" id=\"t11_57\">Net deductible temporary di\ufb00erences </span><span class=\"S1507 S1070 S2\" id=\"t12_57\">-6 996 </span><span class=\"S1508 S1070 S2\" id=\"t13_57\">-1 969 </span><span class=\"S1509 S1070 S2\" id=\"t14_57\">-6 215 </span><span class=\"S150A S1070 S2\" id=\"t15_57\">-1 747 </span><span class=\"S150B S1070 S2\" id=\"t16_57\">Tax losses </span><span class=\"S150C S1070 S2\" id=\"t17_57\">183 930 </span><span class=\"S150D S1070 S2\" id=\"t18_57\">51 700 </span><span class=\"S150E S1070 S2\" id=\"t19_57\">158 734 </span><span class=\"S150F S1070 S2\" id=\"t1a_57\">44 620 </span><span class=\"S1510 S1071 S2\" id=\"t1b_57\">Net unrecognised deferred tax asset US </span><span class=\"S1511 S1071 S2\" id=\"t1c_57\">176 933 </span><span class=\"S1512 S1071 S2\" id=\"t1d_57\">49 731 </span><span class=\"S1513 S1071 S2\" id=\"t1e_57\">152 519 </span><span class=\"S1514 S1071 S2\" id=\"t1f_57\">42 873 </span><span class=\"S1515 S1070 S2\" id=\"t1g_57\">Tax losses for which no deferred tax asset was recognized, expire as follows: </span><span class=\"S1516 S1070 S2\" id=\"t1h_57\">(Amounts in NOK 1,000) </span><span class=\"S1517 S1071 S2\" id=\"t1i_57\">2022 </span><span class=\"S1518 S1071 S2\" id=\"t1j_57\">2021 </span><span class=\"S1519 S1071 S2\" id=\"t1k_57\">Amount </span><span class=\"S151A S1071 S2\" id=\"t1l_57\">Expiry date </span><span class=\"S151B S1071 S2\" id=\"t1m_57\">Amount </span><span class=\"S151C S1071 S2\" id=\"t1n_57\">Expiry date </span><span class=\"S151D S1070 S2\" id=\"t1o_57\">Expire Federal </span><span class=\"S151E S1070 S2\" id=\"t1p_57\">23 092 </span><span class=\"S151F S1070 S2\" id=\"t1q_57\">2030 - 2037 </span><span class=\"S1520 S1070 S2\" id=\"t1r_57\">20 599 </span><span class=\"S1521 S1070 S2\" id=\"t1s_57\">2030 - 2037 </span><span class=\"S1522 S1070 S2\" id=\"t1t_57\">Expire State </span><span class=\"S1523 S1070 S2\" id=\"t1u_57\">15 923 </span><span class=\"S1524 S1070 S2\" id=\"t1v_57\">2030 - 20412 </span><span class=\"S1525 S1070 S2\" id=\"t1w_57\">13 727 </span><span class=\"S1526 S1070 S2\" id=\"t1x_57\">2030 - 2041 </span><span class=\"S1527 S1070 S2\" id=\"t1y_57\">Never expire </span><span class=\"S1528 S1070 S2\" id=\"t1z_57\">10 718 </span><span class=\"S1529 S1070 S2\" id=\"t20_57\">8 547 </span><span class=\"S152A S1071 S2\" id=\"t21_57\">Total </span><span class=\"S152B S1071 S2\" id=\"t22_57\">49 733 </span><span class=\"S152C S1071 S2\" id=\"t23_57\">42 873 </span><span class=\"S152E S106F S2\" id=\"t4_58\">12. EARNINGS PER SHARE </span><span class=\"S152F S1070 S2\" id=\"t5_58\">Earnings per share are calculated on the basis of the pro\ufb01t/loss for the year after tax but excluding other comprehensive items. The </span><span class=\"S1530 S1070 S2\" id=\"t6_58\">result is divided by a weighted average number of outstanding shares over the year, reduced by acquisition of treasury shares. The </span><span class=\"S1531 S1070 S2\" id=\"t7_58\">diluted earnings per share is calculated by adjusting the average number of outstanding shares by the number of employee share </span><span class=\"S1532 S1070 S2\" id=\"t8_58\">options that can be exercised. Antidilution e\ufb00ects are not taken into consideration. </span><span class=\"S1533 S1071 S2\" id=\"t9_58\">2022 </span><span class=\"S1534 S1071 S2\" id=\"ta_58\">2021 </span><span class=\"S1535 S1071 S2\" id=\"tb_58\">Figures indicate the number of shares </span><span class=\"S1536 S1070 S2\" id=\"tc_58\">Ordinary shares 1 January </span><span class=\"S1537 S1070 S2\" id=\"td_58\">26 973 820 </span><span class=\"S1538 S1070 S2\" id=\"te_58\">26 717 536 </span><span class=\"S1539 S1070 S2\" id=\"tf_58\">E\ufb00ect of treasury shares </span><span class=\"S153A S1070 S2\" id=\"tg_58\">-20 861 </span><span class=\"S153B S1070 S2\" id=\"th_58\">-16 919 </span><span class=\"S153C S1070 S2\" id=\"ti_58\">E\ufb00ect of share options exercised </span><span class=\"S153D S1070 S2\" id=\"tj_58\">82 017 </span><span class=\"S153E S1070 S2\" id=\"tk_58\">142 718 </span><span class=\"S153F S1071 S2\" id=\"tl_58\">Weighted average number of shares, 31 December </span><span class=\"S1540 S1071 S2\" id=\"tm_58\">27 034 976 </span><span class=\"S1541 S1071 S2\" id=\"tn_58\">26 843 335 </span><span class=\"S1542 S1070 S2\" id=\"to_58\">E\ufb00ect of outstanding share options </span><span class=\"S1543 S1070 S2\" id=\"tp_58\">113 759 </span><span class=\"S1544 S1070 S2\" id=\"tq_58\">264 553 </span><span class=\"S1545 S1071 S2\" id=\"tr_58\">Weighted average number of diluted shares, 31 December </span><span class=\"S1546 S1071 S2\" id=\"ts_58\">27 148 735 </span><span class=\"S1547 S1071 S2\" id=\"tt_58\">27 107 888 </span><span class=\"S1548 S1071 S2\" id=\"tu_58\">Net pro\ufb01t/loss(-) </span><span class=\"S1549 S1071 S2\" id=\"tv_58\">-71 857 </span><span class=\"S154A S1071 S2\" id=\"tw_58\">-30 897 </span><span class=\"S154B S1070 S2\" id=\"tx_58\">(Amounts in NOK 1 000) </span><span class=\"S154C S1071 S2\" id=\"ty_58\">Earnings per share </span><span class=\"S154D S1071 S2\" id=\"tz_58\">2022 </span><span class=\"S154E S1071 S2\" id=\"t10_58\">2021 </span><span class=\"S154F S1070 S2\" id=\"t11_58\">Earnings per share in NOK basic </span><span class=\"S1550 S1070 S2\" id=\"t12_58\">-2.66 </span><span class=\"S1551 S1070 S2\" id=\"t13_58\">-1.15 </span><span class=\"S1552 S1070 S2\" id=\"t14_58\">Earnings per share in NOK diluted </span><span class=\"S1553 S1070 S2\" id=\"t15_58\">-2.66 </span><span class=\"S1554 S1070 S2\" id=\"t16_58\">-1.15 </span><span class=\"S1556 S106F S2\" id=\"t2_59\">13. GOODWILL AND CUSTOMER RELATIONS </span><span class=\"S1557 S1070 S2\" id=\"t3_59\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S1558 S1070 S2\" id=\"t4_59\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S1559 S1070 S2\" id=\"t5_59\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S155A S1070 S2\" id=\"t6_59\">sales (years 8-10) in the previous Ipsen major markets. </span><span class=\"S155B S1070 S2\" id=\"t7_59\">One intangible asset has been identi\ufb01ed, Customer relationships. The customer relationships relate to existing customers in Europe </span><span class=\"S155C S1070 S2\" id=\"t8_59\">which have previously been served by Ipsen. Customer relationships has been valued using a multiperiod excess earnings method </span><span class=\"S155D S1070 S2\" id=\"t9_59\">and the value at transaction date was NOK 166.7 million. Photocure has evaluated this asset to have an estimated value for 10 years </span><span class=\"S155E S1070 S2\" id=\"ta_59\">from transaction date and the intangible assets is depreciated on a straight-line basis over this period. The net book value </span><span class=\"S155F S1070 S2\" id=\"tb_59\">of the </span><span class=\"S1560 S1070 S2\" id=\"tc_59\">customer relations as of 31 December 2022 is NOK 129.2 million. </span><span class=\"S1561 S1070 S2\" id=\"td_59\">Goodwill amounts to NOK 144 million and this asset is not depreciated, but is tested against impairment as of end December 2022. </span><span class=\"S1562 S1070 S2\" id=\"te_59\">The impairment analysis carried out con\ufb01rms the goodwill value given the performance in 2022 and future growth opportunities that </span><span class=\"S1563 S1070 S2\" id=\"tf_59\">are expected to in line with forecasts prepared in connection with the transaction. </span><span class=\"S1564 S1071 S2\" id=\"tg_59\">Group and parent </span><span class=\"S1565 S1070 S2\" id=\"th_59\">(Amounts in NOK 1,000) </span><span class=\"S1566 S1071 S2\" id=\"ti_59\">Customer relations </span><span class=\"S1567 S1071 S2\" id=\"tj_59\">Goodwill </span><span class=\"S1568 S1070 S2\" id=\"tk_59\">Accumulated cost at 31 December 2020 </span><span class=\"S1569 S1070 S2\" id=\"tl_59\">166 720 </span><span class=\"S156A S1070 S2\" id=\"tm_59\">144 000 </span><span class=\"S156B S1070 S2\" id=\"tn_59\">Additions </span><span class=\"S156C S1070 S2\" id=\"to_59\">0 </span><span class=\"S156D S1070 S2\" id=\"tp_59\">0 </span><span class=\"S156E S1071 S2\" id=\"tq_59\">Accumulated cost at 31 December 2021 </span><span class=\"S156F S1071 S2\" id=\"tr_59\">166 720 </span><span class=\"S1570 S1071 S2\" id=\"ts_59\">144 000 </span><span class=\"S1571 S1070 S2\" id=\"tt_59\">Additions </span><span class=\"S1572 S1070 S2\" id=\"tu_59\">0 </span><span class=\"S1573 S1070 S2\" id=\"tv_59\">0 </span><span class=\"S1574 S1071 S2\" id=\"tw_59\">Accumulated cost at 31 December 2022 </span><span class=\"S1575 S1071 S2\" id=\"tx_59\">166 720 </span><span class=\"S1576 S1071 S2\" id=\"ty_59\">144 000 </span><span class=\"S1577 S1071 S2\" id=\"tz_59\">Accumulated depreciation at 31 December 2020 </span><span class=\"S1578 S1070 S2\" id=\"t10_59\">4 168 </span><span class=\"S1579 S1070 S2\" id=\"t11_59\">0 </span><span class=\"S157A S1070 S2\" id=\"t12_59\">Amortization and impairment </span><span class=\"S157B S1070 S2\" id=\"t13_59\">16 672 </span><span class=\"S157C S1070 S2\" id=\"t14_59\">0 </span><span class=\"S157D S1071 S2\" id=\"t15_59\">Accumulated depreciation at 31 December 2021 </span><span class=\"S157E S1071 S2\" id=\"t16_59\">20 840 </span><span class=\"S157F S1071 S2\" id=\"t17_59\">0 </span><span class=\"S1580 S1070 S2\" id=\"t18_59\">Amortization and impairment </span><span class=\"S1581 S1070 S2\" id=\"t19_59\">16 672 </span><span class=\"S1582 S1070 S2\" id=\"t1a_59\">0 </span><span class=\"S1583 S1071 S2\" id=\"t1b_59\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1584 S1071 S2\" id=\"t1c_59\">37 512 </span><span class=\"S1585 S1071 S2\" id=\"t1d_59\">0 </span><span class=\"S1586 S1071 S2\" id=\"t1e_59\">Book value at 31 December 2021 </span><span class=\"S1587 S1071 S2\" id=\"t1f_59\">145 880 </span><span class=\"S1588 S1071 S2\" id=\"t1g_59\">144 000 </span><span class=\"S1589 S1071 S2\" id=\"t1h_59\">Book value at 31 December 2022 </span><span class=\"S158A S1071 S2\" id=\"t1i_59\">129 209 </span><span class=\"S158B S1071 S2\" id=\"t1j_59\">144 000 </span><span class=\"S158C S1070 S2\" id=\"t1k_59\">Carrying amount of goodwill is allocated to the acquired business in Europe by NOK 144 million. The recoverable amount has been </span><span class=\"S158D S1070 S2\" id=\"t1l_59\">determined as value in use. </span><span class=\"S158E S1070 S2\" id=\"t1m_59\">The impairment test is based on cash \ufb02ow projections for the business related to the investment. The cash \ufb02ow projections is based </span><span class=\"S158F S1070 S2\" id=\"t1n_59\">on most recent \ufb01nancial forecast for the business. </span><span class=\"S1590 S1070 S2\" id=\"t1o_59\">Main assumptions are: </span><span class=\"S1591 S1070 S2\" id=\"t1p_59\">\u2022  Sales growth and related expenses is based on current penetration and future growth potential as per management assessment. </span><span class=\"S1592 S1070 S2\" id=\"t1q_59\">When assessing future growth and related expenses management has taken into consideration experiences from high growth </span><span class=\"S1593 S1070 S2\" id=\"t1r_59\">markets as well as more mature markets within the company portfolio. </span><span class=\"S1594 S1070 S2\" id=\"t1s_59\">\u2022  With minor exceptions the sales are in Euro. Assumed exchange rate in the forecast projection NOK/EUR is 10.20, this is at same </span><span class=\"S1595 S1070 S2\" id=\"t1t_59\">level as the average rate for 2022. </span><span class=\"S1596 S1070 S2\" id=\"t1u_59\">\u2022  The impairment test is based on a 8 year cash \ufb02ow projection including the terminal year. 8 year is applied as this re\ufb02ects the </span><span class=\"S1597 S1070 S2\" id=\"t1v_59\">change in hospital practices driven by the product as well as the low churn experienced in other markets. </span><span class=\"S1598 S1070 S2\" id=\"t1w_59\">\u2022  The applied discount rate is 18.0% post tax. An increase of discount rate with 2% or 4% will not change the conclusion of the </span><span class=\"S1599 S1070 S2\" id=\"t1x_59\">impairment test. Terminal </span><span class=\"S159A S1070 S2\" id=\"t1y_59\">growth rate is in the projection estimated to zero as a conservative approach. An increase of the terminal </span><span class=\"S159B S1070 S2\" id=\"t1z_59\">growth rate to 4% will have a positive impact on the fair value of the investment with NOK 40 million. </span><span class=\"S159C S1070 S2\" id=\"t20_59\">This percent re\ufb02ects the </span><span class=\"S159D S1070 S2\" id=\"t21_59\">expected in\ufb02ation and the growth in the aged population that has the highest prevalence of bladder cancer </span><span class=\"S159E S1070 S2\" id=\"t22_59\">\u2022  Applied tax rate is 22%. </span><span class=\"S15A0 S106F S2\" id=\"t4_60\">14. PROPERTY, PLANT, EQUIPMENT AND LEASE ASSETS </span><span class=\"S15A1 S1070 S2\" id=\"t5_60\">(Amounts in NOK 1,000) </span><span class=\"S15A2 S1071 S2\" id=\"t6_60\">Group </span><span class=\"S15A3 S1071 S2\" id=\"t7_60\">Intangible </span><span class=\"S15A4 S1071 S2\" id=\"t8_60\">assets </span><span class=\"S15A5 S1071 S2\" id=\"t9_60\">Right- </span><span class=\"S15A6 S1071 S2\" id=\"ta_60\">of-use </span><span class=\"S15A7 S1071 S2\" id=\"tb_60\">Machinery and </span><span class=\"S15A8 S1071 S2\" id=\"tc_60\">Equipment </span><span class=\"S15A9 S1071 S2\" id=\"td_60\">Product </span><span class=\"S15AA S1071 S2\" id=\"te_60\">Development </span><span class=\"S15AB S1071 S2\" id=\"tf_60\">Software </span><span class=\"S15AC S1071 S2\" id=\"tg_60\">Systems </span><span class=\"S15AD S1071 S2\" id=\"th_60\">O\ufb03ce </span><span class=\"S15AE S1071 S2\" id=\"ti_60\">Lease </span><span class=\"S15AF S1071 S2\" id=\"tj_60\">Medical </span><span class=\"S15B0 S1071 S2\" id=\"tk_60\">&amp; manu- </span><span class=\"S15B1 S1071 S2\" id=\"tl_60\">facture </span><span class=\"S15B2 S1071 S2\" id=\"tm_60\">O\ufb03ce </span><span class=\"S15B3 S1071 S2\" id=\"tn_60\">Total </span><span class=\"S134E S1071 S2\" id=\"to_60\">Accumulated cost at 31 December 2020 </span><span class=\"S15B4 S1070 S2\" id=\"tp_60\">51 069 </span><span class=\"S15B5 S1070 S2\" id=\"tq_60\">4 406 </span><span class=\"S15B6 S1070 S2\" id=\"tr_60\">10 900 </span><span class=\"S15B7 S1070 S2\" id=\"ts_60\">613 </span><span class=\"S15B8 S1070 S2\" id=\"tt_60\">7 006 </span><span class=\"S15B9 S1071 S2\" id=\"tu_60\">73 994 </span><span class=\"S15BA S1070 S2\" id=\"tv_60\">Additions </span><span class=\"S15BB S1070 S2\" id=\"tw_60\">527 </span><span class=\"S15BC S1070 S2\" id=\"tx_60\">31 062 </span><span class=\"S15BD S1070 S2\" id=\"ty_60\">163 </span><span class=\"S15BE S1070 S2\" id=\"tz_60\">2 342 </span><span class=\"S15BF S1071 S2\" id=\"t10_60\">34 095 </span><span class=\"S15C0 S1070 S2\" id=\"t11_60\">Disposals and lease expiry </span><span class=\"S15C1 S1070 S2\" id=\"t12_60\">-51 069 </span><span class=\"S15C2 S1070 S2\" id=\"t13_60\">-10 900 </span><span class=\"S15C3 S1071 S2\" id=\"t14_60\">-61 969 </span><span class=\"S15C4 S1071 S2\" id=\"t15_60\">Accumulated cost at 31 December 2021 </span><span class=\"S15C5 S1070 S2\" id=\"t16_60\">0 </span><span class=\"S15C6 S1070 S2\" id=\"t17_60\">4 933 </span><span class=\"S15C7 S1070 S2\" id=\"t18_60\">31 062 </span><span class=\"S15C8 S1070 S2\" id=\"t19_60\">776 </span><span class=\"S15C9 S1070 S2\" id=\"t1a_60\">9 348 </span><span class=\"S15CA S1071 S2\" id=\"t1b_60\">46 120 </span><span class=\"S15CB S1070 S2\" id=\"t1c_60\">Additions </span><span class=\"S15CC S1070 S2\" id=\"t1d_60\">1 133 </span><span class=\"S15CD S1070 S2\" id=\"t1e_60\">3 498 </span><span class=\"S15CE S1070 S2\" id=\"t1f_60\">78 </span><span class=\"S15CF S1070 S2\" id=\"t1g_60\">3 532 </span><span class=\"S15D0 S1071 S2\" id=\"t1h_60\">8 240 </span><span class=\"S15D1 S1070 S2\" id=\"t1i_60\">Disposals and lease expiry </span><span class=\"S15D2 S1070 S2\" id=\"t1j_60\">-83 </span><span class=\"S15D3 S1070 S2\" id=\"t1k_60\">-1 797 </span><span class=\"S15D4 S1071 S2\" id=\"t1l_60\">-1 880 </span><span class=\"S15D5 S1071 S2\" id=\"t1m_60\">Accumulated cost at 31 December 2022 </span><span class=\"S15D6 S1070 S2\" id=\"t1n_60\">0 </span><span class=\"S15D7 S1070 S2\" id=\"t1o_60\">6 066 </span><span class=\"S15D8 S1070 S2\" id=\"t1p_60\">34 477 </span><span class=\"S15D9 S1070 S2\" id=\"t1q_60\">854 </span><span class=\"S15DA S1070 S2\" id=\"t1r_60\">11 083 </span><span class=\"S15DB S1071 S2\" id=\"t1s_60\">52 479 </span><span class=\"S15DC S1071 S2\" id=\"t1t_60\">Accumulated depreciation at 31 December 2020 </span><span class=\"S15DD S1070 S2\" id=\"t1u_60\">51 069 </span><span class=\"S15DE S1070 S2\" id=\"t1v_60\">2 831 </span><span class=\"S15DF S1070 S2\" id=\"t1w_60\">7 046 </span><span class=\"S15E0 S1070 S2\" id=\"t1x_60\">272 </span><span class=\"S15E1 S1070 S2\" id=\"t1y_60\">5 407 </span><span class=\"S15E2 S1071 S2\" id=\"t1z_60\">66 625 </span><span class=\"S15E3 S1070 S2\" id=\"t20_60\">Amortization and depreciation </span><span class=\"S15E4 S1070 S2\" id=\"t21_60\">947 </span><span class=\"S15E5 S1070 S2\" id=\"t22_60\">5 392 </span><span class=\"S15E6 S1070 S2\" id=\"t23_60\">170 </span><span class=\"S15E7 S1070 S2\" id=\"t24_60\">946 </span><span class=\"S15E8 S1071 S2\" id=\"t25_60\">7 455 </span><span class=\"S15E9 S1070 S2\" id=\"t26_60\">Disposals and lease expiry </span><span class=\"S15EA S1070 S2\" id=\"t27_60\">-51 069 </span><span class=\"S15EB S1070 S2\" id=\"t28_60\">-10 067 </span><span class=\"S15EC S1070 S2\" id=\"t29_60\">-399 </span><span class=\"S15ED S1071 S2\" id=\"t2a_60\">-61 535 </span><span class=\"S15EE S1071 S2\" id=\"t2b_60\">Accumulated depreciation at 31 December 2021 </span><span class=\"S15EF S1070 S2\" id=\"t2c_60\">0 </span><span class=\"S15F0 S1070 S2\" id=\"t2d_60\">3 778 </span><span class=\"S15F1 S1070 S2\" id=\"t2e_60\">2 371 </span><span class=\"S15F2 S1070 S2\" id=\"t2f_60\">442 </span><span class=\"S15F3 S1070 S2\" id=\"t2g_60\">5 954 </span><span class=\"S15F4 S1071 S2\" id=\"t2h_60\">12 545 </span><span class=\"S15F5 S1070 S2\" id=\"t2i_60\">Amortization and depreciation </span><span class=\"S15F6 S1070 S2\" id=\"t2j_60\">615 </span><span class=\"S15F7 S1070 S2\" id=\"t2k_60\">5 779 </span><span class=\"S15F8 S1070 S2\" id=\"t2l_60\">161 </span><span class=\"S15F9 S1070 S2\" id=\"t2m_60\">1 151 </span><span class=\"S15FA S1071 S2\" id=\"t2n_60\">7 706 </span><span class=\"S15FB S1070 S2\" id=\"t2o_60\">Disposals and lease expiry </span><span class=\"S15FC S1070 S2\" id=\"t2p_60\">236 </span><span class=\"S15FD S1070 S2\" id=\"t2q_60\">-486 </span><span class=\"S15FE S1071 S2\" id=\"t2r_60\">-250 </span><span class=\"S15FF S1071 S2\" id=\"t2s_60\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1600 S1070 S2\" id=\"t2t_60\">0 </span><span class=\"S1601 S1070 S2\" id=\"t2u_60\">4 393 </span><span class=\"S1602 S1070 S2\" id=\"t2v_60\">8 386 </span><span class=\"S1603 S1070 S2\" id=\"t2w_60\">603 </span><span class=\"S1604 S1070 S2\" id=\"t2x_60\">6 619 </span><span class=\"S1605 S1071 S2\" id=\"t2y_60\">20 001 </span><span class=\"S1606 S1071 S2\" id=\"t2z_60\">Book value at 31 December 2021 </span><span class=\"S1607 S1070 S2\" id=\"t30_60\">0 </span><span class=\"S1608 S1070 S2\" id=\"t31_60\">1 156 </span><span class=\"S1609 S1070 S2\" id=\"t32_60\">28 691 </span><span class=\"S160A S1070 S2\" id=\"t33_60\">334 </span><span class=\"S160B S1070 S2\" id=\"t34_60\">3 394 </span><span class=\"S160C S1071 S2\" id=\"t35_60\">33 575 </span><span class=\"S160D S1071 S2\" id=\"t36_60\">Book value at 31 December 2022 </span><span class=\"S160E S1070 S2\" id=\"t37_60\">0 </span><span class=\"S160F S1070 S2\" id=\"t38_60\">1 673 </span><span class=\"S1610 S1070 S2\" id=\"t39_60\">26 091 </span><span class=\"S1611 S1070 S2\" id=\"t3a_60\">251 </span><span class=\"S1612 S1070 S2\" id=\"t3b_60\">4 464 </span><span class=\"S1613 S1071 S2\" id=\"t3c_60\">32 479 </span><span class=\"S1614 S1070 S2\" id=\"t3d_60\">PPE are depreciated on a straight-line basis over the estimated useful life of the asset as follows </span><span class=\"S1615 S1070 S2\" id=\"t3e_60\">Patent period </span><span class=\"S1616 S1070 S2\" id=\"t3f_60\">3 - 5 years </span><span class=\"S1617 S1070 S2\" id=\"t3g_60\">Contract </span><span class=\"S1618 S1070 S2\" id=\"t3h_60\">period </span><span class=\"S1619 S1070 S2\" id=\"t3i_60\">3 - 5 years </span><span class=\"S161A S1070 S2\" id=\"t3j_60\">3 - 5 years </span><span class=\"S161B S1070 S2\" id=\"t3k_60\">The note for the Parent company has immaterial di\ufb00erences to the Group and is not disclosed of this reason. </span><span class=\"S161C S1071 S2\" id=\"t3l_60\">Right-of-use assets (Lease) </span><span class=\"S161D S1071 S2\" id=\"t3m_60\">31-Dec-21 </span><span class=\"S161E S1071 S2\" id=\"t3n_60\">31-Dec-22 </span><span class=\"S161F S1070 S2\" id=\"t3o_60\">(Amounts in NOK 1,000) </span><span class=\"S1620 S1071 S2\" id=\"t3p_60\">Discount </span><span class=\"S1621 S1071 S2\" id=\"t3q_60\">rate </span><span class=\"S1622 S1071 S2\" id=\"t3r_60\">Contract </span><span class=\"S1623 S1071 S2\" id=\"t3s_60\">value </span><span class=\"S1624 S1071 S2\" id=\"t3t_60\">Expiry </span><span class=\"S1625 S1071 S2\" id=\"t3u_60\">New/ </span><span class=\"S1626 S1071 S2\" id=\"t3v_60\">increase </span><span class=\"S1627 S1071 S2\" id=\"t3w_60\">contracts </span><span class=\"S1628 S1071 S2\" id=\"t3x_60\">Remeasure </span><span class=\"S1629 S1071 S2\" id=\"t3y_60\">Contract </span><span class=\"S162A S1071 S2\" id=\"t3z_60\">value </span><span class=\"S162B S1070 S2\" id=\"t40_60\">Right-of-use o\ufb03ce contract Norway </span><span class=\"S162C S1070 S2\" id=\"t41_60\">3,15 % </span><span class=\"S162D S1070 S2\" id=\"t42_60\">13 008 </span><span class=\"S162E S1070 S2\" id=\"t43_60\">- </span><span class=\"S162F S1070 S2\" id=\"t44_60\">574 </span><span class=\"S1630 S1070 S2\" id=\"t45_60\">13 582 </span><span class=\"S1631 S1070 S2\" id=\"t46_60\">Right-of-use o\ufb03ce contract US </span><span class=\"S1632 S1070 S2\" id=\"t47_60\">3,70 % </span><span class=\"S1633 S1070 S2\" id=\"t48_60\">10 269 </span><span class=\"S1634 S1070 S2\" id=\"t49_60\">- </span><span class=\"S1635 S1070 S2\" id=\"t4a_60\">920 </span><span class=\"S1636 S1070 S2\" id=\"t4b_60\">11 189 </span><span class=\"S1637 S1070 S2\" id=\"t4c_60\">Right-of-use o\ufb03ce contract Germany </span><span class=\"S1638 S1070 S2\" id=\"t4d_60\">1,40 % </span><span class=\"S1639 S1070 S2\" id=\"t4e_60\">6 624 </span><span class=\"S163A S1070 S2\" id=\"t4f_60\">- </span><span class=\"S163B S1070 S2\" id=\"t4g_60\">298 </span><span class=\"S163C S1070 S2\" id=\"t4h_60\">387 </span><span class=\"S163D S1070 S2\" id=\"t4i_60\">7 309 </span><span class=\"S163E S1070 S2\" id=\"t4j_60\">Right-of-use o\ufb03ce company car </span><span class=\"S163F S1070 S2\" id=\"t4k_60\">\ufb02eet Germany </span><span class=\"S1640 S1070 S2\" id=\"t4l_60\">1,40 % </span><span class=\"S1641 S1070 S2\" id=\"t4m_60\">1 162 </span><span class=\"S1642 S1070 S2\" id=\"t4n_60\">(83) </span><span class=\"S1643 S1070 S2\" id=\"t4o_60\">1 120 </span><span class=\"S1644 S1070 S2\" id=\"t4p_60\">198 </span><span class=\"S1645 S1070 S2\" id=\"t4q_60\">2 397 </span><span class=\"S1646 S1071 S2\" id=\"t4r_60\">Total lease assets </span><span class=\"S1647 S1071 S2\" id=\"t4s_60\">31 063 </span><span class=\"S1648 S1071 S2\" id=\"t4t_60\">34 477 </span><span class=\"S1649 S1070 S2\" id=\"t4u_60\">The Right-of-use assets comprise the o\ufb03ce lease contracts covered by IFRS 16. In addition. In addition are the lease contracts for </span><span class=\"S164A S1070 S2\" id=\"t4v_60\">the company car \ufb02eet in the Germany included. </span><span class=\"S164B S1070 S2\" id=\"t4w_60\">The calculation of the lease asset is excluding utility services shared by the tenants. </span><span class=\"S164C S1070 S2\" id=\"t4x_60\">The Parent company has a 6-year rental agreement for o\ufb03ce premises at Ho\ufb00sveien 4 in Oslo starting 1 September 2021 and </span><span class=\"S164D S1070 S2\" id=\"t4y_60\">ending 31 August 2027. The agreement give Photocure an option to expand the rent period by 4 years. The </span><span class=\"S164E S1070 S2\" id=\"t4z_60\">rent amounts to NOK 2.8 </span><span class=\"S164F S1070 S2\" id=\"t50_60\">million for the period 1 January 2023 through 31 December 2023. The rent for the remaining period until the expiry of the agreement </span><span class=\"S1650 S1070 S2\" id=\"t51_60\">amounts to NOK 10.1 million. </span><span class=\"S1652 S1070 S2\" id=\"t2_61\">Photocure Inc rents o\ufb03ce premises at Carnegie Center, Princeton, New Jersey from 1 April 2011 through 10 December 2022. </span><span class=\"S1653 S1070 S2\" id=\"t3_61\">On </span><span class=\"S1654 S1070 S2\" id=\"t4_61\">December 13, 2021, Photocure Inc. signed a lease amendment to move to a new o\ufb03ce of 5,212 square fee in Carnegie Center and to </span><span class=\"S1655 S1070 S2\" id=\"t5_61\">extend the lease term by six years with an expiration date of December 31, 2028. </span><span class=\"S1656 S1070 S2\" id=\"t6_61\">The lease commitment is NOK 11.2 million ( USD 1.1 </span><span class=\"S1657 S1070 S2\" id=\"t7_61\">million ) at 3.7% discount rate. The rent commitment for the period 1 January 2023 to 31 December 2023 is NOK 1.9 million while the </span><span class=\"S1658 S1070 S2\" id=\"t8_61\">rent for the remaining period until the expiry of the agreement amounts to NOK 9.3 million. </span><span class=\"S1659 S1070 S2\" id=\"t9_61\">Photocure GmbH </span><span class=\"S165A S1070 S2\" id=\"ta_61\">rents o\ufb03ce premises in D\u00fcsseldorf, Marc-Chagall-Stra\u00dfe 2 from 1 April 2021 through 31 March 2026. The rent </span><span class=\"S165B S1070 S2\" id=\"tb_61\">commitment for the period 1 January 2023 to 31 December 2023 is EUR 151.1 thousand while the rent for the remaining period until </span><span class=\"S165C S1070 S2\" id=\"tc_61\">the expiry of the agreement amounts to EUR 340.1 thousand. </span><span class=\"S165D S1070 S2\" id=\"td_61\">The standard lease period for the car \ufb02eet in Germany is 36 months. As of 31.12.2022 Photocure GmbH had 6 lease agreements with </span><span class=\"S165E S1070 S2\" id=\"te_61\">an average remaining lease term of 21.5 months </span><span class=\"S165F S106F S2\" id=\"tf_61\">15. SUBSIDIARIES </span><span class=\"S1660 S1071 S2\" id=\"tg_61\">Company </span><span class=\"S1661 S1071 S2\" id=\"th_61\">Country </span><span class=\"S1662 S1071 S2\" id=\"ti_61\">Ownership </span><span class=\"S1663 S1071 S2\" id=\"tj_61\">Book value </span><span class=\"S1664 S1071 S2\" id=\"tk_61\">31-Dec-22 </span><span class=\"S1665 S1071 S2\" id=\"tl_61\">31-Dec-21 </span><span class=\"S1666 S1071 S2\" id=\"tm_61\">31-Dec-22 </span><span class=\"S1667 S1071 S2\" id=\"tn_61\">31-Dec-21 </span><span class=\"S1668 S1070 S2\" id=\"to_61\">Photocure Inc. </span><span class=\"S1669 S1070 S2\" id=\"tp_61\">USA </span><span class=\"S166A S1070 S2\" id=\"tq_61\">100 % </span><span class=\"S166B S1070 S2\" id=\"tr_61\">100 % </span><span class=\"S166C S1070 S2\" id=\"ts_61\">15 353 </span><span class=\"S166D S1070 S2\" id=\"tt_61\">11 018 </span><span class=\"S166E S1070 S2\" id=\"tu_61\">Photocure GmbH </span><span class=\"S166F S1070 S2\" id=\"tv_61\">Germany </span><span class=\"S1670 S1070 S2\" id=\"tw_61\">100 % </span><span class=\"S1671 S1070 S2\" id=\"tx_61\">100 % </span><span class=\"S1672 S1070 S2\" id=\"ty_61\">1 532 </span><span class=\"S1673 S1070 S2\" id=\"tz_61\">748 </span><span class=\"S1674 S1070 S2\" id=\"t10_61\">Photocure SAS </span><span class=\"S1675 S1070 S2\" id=\"t11_61\">France </span><span class=\"S1676 S1070 S2\" id=\"t12_61\">100 % </span><span class=\"S1677 S1070 S2\" id=\"t13_61\">100 % </span><span class=\"S1678 S1070 S2\" id=\"t14_61\">285 </span><span class=\"S1679 S1070 S2\" id=\"t15_61\">136 </span><span class=\"S167A S1070 S2\" id=\"t16_61\">Photocure Canada Inc. </span><span class=\"S167B S1070 S2\" id=\"t17_61\">Canada </span><span class=\"S167C S1070 S2\" id=\"t18_61\">100 % </span><span class=\"S167D S1070 S2\" id=\"t19_61\">100 % </span><span class=\"S167E S1070 S2\" id=\"t1a_61\">- </span><span class=\"S167F S1070 S2\" id=\"t1b_61\">- </span><span class=\"S1680 S1071 S2\" id=\"t1c_61\">Total subsidiaries </span><span class=\"S1681 S1071 S2\" id=\"t1d_61\">17 170 </span><span class=\"S1682 S1071 S2\" id=\"t1e_61\">11 902 </span><span class=\"S1683 S106F S2\" id=\"t1f_61\">16. INVENTORIES </span><span class=\"S1684 S1070 S2\" id=\"t1g_61\">(Amounts in NOK 1,000) </span><span class=\"S1685 S1071 S2\" id=\"t1h_61\">Group </span><span class=\"S1686 S1071 S2\" id=\"t1i_61\">Parent </span><span class=\"S1687 S1071 S2\" id=\"t1j_61\">31-Dec-22 </span><span class=\"S1688 S1071 S2\" id=\"t1k_61\">31-Dec-21 </span><span class=\"S1689 S1071 S2\" id=\"t1l_61\">31-Dec-22 </span><span class=\"S168A S1071 S2\" id=\"t1m_61\">31-Dec-21 </span><span class=\"S168B S1070 S2\" id=\"t1n_61\">Raw materials </span><span class=\"S168C S1070 S2\" id=\"t1o_61\">3 026 </span><span class=\"S168D S1070 S2\" id=\"t1p_61\">1 485 </span><span class=\"S168E S1070 S2\" id=\"t1q_61\">3 026 </span><span class=\"S168F S1070 S2\" id=\"t1r_61\">1 485 </span><span class=\"S1690 S1070 S2\" id=\"t1s_61\">Resale products </span><span class=\"S1691 S1070 S2\" id=\"t1t_61\">48 </span><span class=\"S1692 S1070 S2\" id=\"t1u_61\">176 </span><span class=\"S1693 S1070 S2\" id=\"t1v_61\">48 </span><span class=\"S1694 S1070 S2\" id=\"t1w_61\">176 </span><span class=\"S1695 S1070 S2\" id=\"t1x_61\">Semi-\ufb01nished and \ufb01nished goods </span><span class=\"S1696 S1070 S2\" id=\"t1y_61\">23 461 </span><span class=\"S1697 S1070 S2\" id=\"t1z_61\">25 874 </span><span class=\"S1698 S1070 S2\" id=\"t20_61\">21 339 </span><span class=\"S1699 S1070 S2\" id=\"t21_61\">25 000 </span><span class=\"S169A S1071 S2\" id=\"t22_61\">Total inventories </span><span class=\"S169B S1071 S2\" id=\"t23_61\">26 534 </span><span class=\"S169C S1071 S2\" id=\"t24_61\">27 534 </span><span class=\"S169D S1071 S2\" id=\"t25_61\">24 412 </span><span class=\"S169E S1071 S2\" id=\"t26_61\">26 660 </span><span class=\"S169F S1070 S2\" id=\"t27_61\">The raw materials inventory consists of active substances for the pharmaceutical products. Raw materials are valued at cost. </span><span class=\"S16A0 S1070 S2\" id=\"t28_61\">Finished and semi-\ufb01nished goods are valued at full manufacturing cost. Consumption is accounted in accordance with the FIFO </span><span class=\"S16A1 S1070 S2\" id=\"t29_61\">principle. Obsolete goods are written down to net realisable value. Provisions and write-downs of inventories are included in cost of </span><span class=\"S16A2 S1070 S2\" id=\"t2a_61\">goods sold in the income statement. </span><span class=\"S16A3 S106F S2\" id=\"t4_62\">17. FINANCIAL RISK </span><span class=\"S16A4 S1070 S2\" id=\"t5_62\">The note describes the Company\u2019s various \ufb01nancial risks and the management of same. In addition, numerical presentations of risk </span><span class=\"S16A5 S1070 S2\" id=\"t6_62\">associated with \ufb01nancial risks are included. </span><span class=\"S16A6 S1071 S2\" id=\"t7_62\">(I) Organisation of \ufb01nancial risk management </span><span class=\"S16A7 S1070 S2\" id=\"t8_62\">Photocure has an international business operation and is exposed to currency risk, interest rate risk, commodity price risk, liquidity </span><span class=\"S16A8 S1070 S2\" id=\"t9_62\">risk and credit risk. Responsibility for managing \ufb01nancial risk is placed with the management of the company, including \ufb01nancing, </span><span class=\"S16A9 S1070 S2\" id=\"ta_62\">interest rate and currency management as well as risk within the business areas and the risk associated with the company\u2019s business </span><span class=\"S16AA S1070 S2\" id=\"tb_62\">processes. Financial risk is also monitored by the Board of Directors. </span><span class=\"S16AB S16F9 S2\" id=\"tc_62\">Centralised risk management </span><span class=\"S16AC S1070 S2\" id=\"td_62\">Photocure has a centralised \ufb01nance department. This department ensures the company\u2019s \ufb01nancial freedom to act both long and </span><span class=\"S16AD S1070 S2\" id=\"te_62\">short term, and to monitor and manage \ufb01nancial risk in collaboration with the individual business units within the company. The </span><span class=\"S16AE S1070 S2\" id=\"tf_62\">\ufb01nance department maintains communication with the company\u2019s bank connections, and carries out hedging transactions regarding </span><span class=\"S16AF S1070 S2\" id=\"tg_62\">interest and currency. Required authorisations for borrowing and entering into derivative agreements are to be granted by the Board </span><span class=\"S16B0 S1070 S2\" id=\"th_62\">of Directors. All transactions involving \ufb01nancial instruments are backed by an underlying commercial hedging requirement.. </span><span class=\"S16B1 S16F9 S2\" id=\"ti_62\">Commercial operations \u2013 production, sales and marketing </span><span class=\"S16B2 S1070 S2\" id=\"tj_62\">Photocure manufactures, markets and sells the company\u2019s products through own sales organization in Europe and North America </span><span class=\"S16B3 S1070 S2\" id=\"tk_62\">and through license partners in other countries. Revenues from license partners consist of two elements: sales of products to </span><span class=\"S16B4 S1070 S2\" id=\"tl_62\">license partners and milestone revenues. Photocure manufactures the company\u2019s products by renowned contract manufacturers </span><span class=\"S16B5 S1070 S2\" id=\"tm_62\">in Italy, Spain, Netherland and Austria. Prices of raw materials is a risk factor. Photocure\u2019s commercial operations in the North </span><span class=\"S16B6 S1070 S2\" id=\"tn_62\">America expose Photocure for currency risk against USD/CAD as both revenues and expenses are in USD/CAD. The same applies </span><span class=\"S16B7 S1070 S2\" id=\"to_62\">for commercial operations in Europe which are mostly in Euros. Currency risks are partly naturally hedged by purchasing goods and </span><span class=\"S16B8 S1070 S2\" id=\"tp_62\">services in EUR and USD. </span><span class=\"S16B9 S1071 S2\" id=\"tq_62\">(II) Classes of \ufb01nancial risk </span><span class=\"S16BA S16F9 S2\" id=\"tr_62\">Interest rate risk </span><span class=\"S16BB S1070 S2\" id=\"ts_62\">Photocure has an interest bearing earnout liability from 2020 with interest rate equal to </span><span class=\"S16BC S1070 S2\" id=\"tt_62\">the internal rate of return for the investment </span><span class=\"S16BD S1070 S2\" id=\"tu_62\">project. In addition Photocure has interest bearing bank loan, leasing liability and pension liability. The long-term bank loan has a </span><span class=\"S16BE S1070 S2\" id=\"tv_62\">\ufb02oating interest and </span><span class=\"S16BF S1070 S2\" id=\"tw_62\">90% of the loan has a state guarantee. </span><span class=\"S16C0 S1070 S2\" id=\"tx_62\">The company\u2019s risk related to interest income is mainly associated with the company\u2019s holdings of cash and cash equivalents. The </span><span class=\"S16C1 S1070 S2\" id=\"ty_62\">main strategy is to diversify the risk and invest in money market funds and bond funds with low risk, high liquidity and short duration. </span><span class=\"S16C2 S1070 S2\" id=\"tz_62\">More than 90% of the investments are denominated in NOK and are not hedged. </span><span class=\"S16C3 S16F9 S2\" id=\"t10_62\">Liquidity and funding risk </span><span class=\"S16C4 S1070 S2\" id=\"t11_62\">The Company monitors its cash \ufb02ows from both long and short-term perspectives through planning and reporting. Photocure does </span><span class=\"S16C5 S1070 S2\" id=\"t12_62\">not have any loan agreements that involve covenants or other restrictions. Photocure uses a multi-currency consolidated bank </span><span class=\"S16C6 S1070 S2\" id=\"t13_62\">accounts system that provides \ufb02exibility in relation to drawing on multiple currencies. The company may require new capital in the </span><span class=\"S16C7 S1070 S2\" id=\"t14_62\">future. Adequate sources of capital funding may not be available when needed or may not be available on favorable terms. </span><span class=\"S16C8 S1070 S2\" id=\"t15_62\">A main objective of Photocure\u2019s \ufb01nancial policy is to ensure that the company has the \ufb01nancial freedom to act both short and long </span><span class=\"S16C9 S1070 S2\" id=\"t16_62\">term to achieve strategic and operational goals. Photocure\u2019s policy is to have su\ufb03cient funds to cover known capital requirements </span><span class=\"S16CA S1070 S2\" id=\"t17_62\">during the forthcoming 12 months in addition to a strategic reserve. Photocure follows a low risk investment strategy for its liquid </span><span class=\"S16CB S1070 S2\" id=\"t18_62\">funds. The return on the liquid funds depends on the rate of interest in the money markets and will therefore vary over time. </span><span class=\"S16CC S1071 S2\" id=\"t19_62\">Remaining period </span><span class=\"S16CD S1070 S2\" id=\"t1a_62\">(Amounts in NOK 1,000) </span><span class=\"S16CE S1071 S2\" id=\"t1b_62\">Less than 1 month </span><span class=\"S16CF S1071 S2\" id=\"t1c_62\">1\u20133 months </span><span class=\"S16D0 S1071 S2\" id=\"t1d_62\">3\u201312 months </span><span class=\"S16D1 S1071 S2\" id=\"t1e_62\">1\u20135 years </span><span class=\"S16D2 S1071 S2\" id=\"t1f_62\">Total </span><span class=\"S16D3 S1071 S2\" id=\"t1g_62\">31-Dec-22 </span><span class=\"S16D4 S1070 S2\" id=\"t1h_62\">Accounts payable </span><span class=\"S16D5 S1070 S2\" id=\"t1i_62\">18 091 </span><span class=\"S16D6 S1070 S2\" id=\"t1j_62\">3 190 </span><span class=\"S16D7 S1071 S2\" id=\"t1k_62\">21 281 </span><span class=\"S16D8 S1070 S2\" id=\"t1l_62\">Withholding tax and social securities </span><span class=\"S16D9 S1070 S2\" id=\"t1m_62\">2 440 </span><span class=\"S16DA S1070 S2\" id=\"t1n_62\">1 500 </span><span class=\"S16DB S1070 S2\" id=\"t1o_62\">647 </span><span class=\"S16DC S1071 S2\" id=\"t1p_62\">4 587 </span><span class=\"S16DD S1070 S2\" id=\"t1q_62\">Other current liabilities </span><span class=\"S16DE S1070 S2\" id=\"t1r_62\">20 630 </span><span class=\"S16DF S1070 S2\" id=\"t1s_62\">13 000 </span><span class=\"S16E0 S1070 S2\" id=\"t1t_62\">17 177 </span><span class=\"S16E1 S1071 S2\" id=\"t1u_62\">50 807 </span><span class=\"S16E2 S1070 S2\" id=\"t1v_62\">Loan and lease liabilities </span><span class=\"S16E3 S1070 S2\" id=\"t1w_62\">7 250 </span><span class=\"S16E4 S1070 S2\" id=\"t1x_62\">18 750 </span><span class=\"S16E5 S1070 S2\" id=\"t1y_62\">151 370 </span><span class=\"S16E6 S1071 S2\" id=\"t1z_62\">177 370 </span><span class=\"S16E7 S1071 S2\" id=\"t20_62\">31-Dec-21 </span><span class=\"S16E8 S1070 S2\" id=\"t21_62\">Accounts payable </span><span class=\"S16E9 S1070 S2\" id=\"t22_62\">19 748 </span><span class=\"S16EA S1070 S2\" id=\"t23_62\">3 900 </span><span class=\"S16EB S1071 S2\" id=\"t24_62\">23 648 </span><span class=\"S16EC S1070 S2\" id=\"t25_62\">Withholding tax and social securities </span><span class=\"S16ED S1070 S2\" id=\"t26_62\">771 </span><span class=\"S16EE S1070 S2\" id=\"t27_62\">2 230 </span><span class=\"S16EF S1071 S2\" id=\"t28_62\">3 001 </span><span class=\"S16F0 S1070 S2\" id=\"t29_62\">Other current liabilities </span><span class=\"S16F1 S1070 S2\" id=\"t2a_62\">3 500 </span><span class=\"S16F2 S1070 S2\" id=\"t2b_62\">28 000 </span><span class=\"S16F3 S1070 S2\" id=\"t2c_62\">18 854 </span><span class=\"S16F4 S1071 S2\" id=\"t2d_62\">50 354 </span><span class=\"S16F5 S1070 S2\" id=\"t2e_62\">Loan and lease liabilities </span><span class=\"S16F6 S1070 S2\" id=\"t2f_62\">36 580 </span><span class=\"S16F7 S1070 S2\" id=\"t2g_62\">169 913 </span><span class=\"S16F8 S1071 S2\" id=\"t2h_62\">206 493 </span><span class=\"S16FA S16F9 S2\" id=\"t2_63\">Credit risk </span><span class=\"S16FB S1070 S2\" id=\"t3_63\">Management of credit risk associated with accounts receivable and other operational receivables is dealt with as a part of the </span><span class=\"S16FC S1070 S2\" id=\"t4_63\">commercial risk and is followed up continuously as a part of normal operations. Photocure is primarily exposed to credit risk </span><span class=\"S16FD S1070 S2\" id=\"t5_63\">associated with accounts receivable and other short-term receivables. Photocure\u2019s sales is a mix of sales directly to hospitals, </span><span class=\"S16FE S1070 S2\" id=\"t6_63\">pharmacies and wholesalers in Europe and North America. The credit risk is limited as the customers are hospitals which are either </span><span class=\"S16FF S1070 S2\" id=\"t7_63\">publicly owned or \ufb01nanced by public funds or insurance companies. The same applies for the wholesalers customers. </span><span class=\"S1700 S1070 S2\" id=\"t8_63\">Photocure\u2019s </span><span class=\"S1701 S1070 S2\" id=\"t9_63\">credit risk is considered moderate and the Company does not use credit insurance. </span><span class=\"S1702 S16F9 S2\" id=\"ta_63\">Currency risk </span><span class=\"S1703 S1070 S152D S2\" id=\"tb_63\">As NOK is the Company\u2019s presentation currency, Photocure is exposed to translation risk associated with the company\u2019s foreign net </span><span class=\"S1704 S1070 S152D S2\" id=\"tc_63\">exposure. Photocure\u2019s revenues and costs are incurred in di\ufb00erent currencies, primarily EUR, USD, GBP and SEK. Photocure is therefore </span><span class=\"S1705 S1070 S152D S2\" id=\"td_63\">exposed to exchange rate \ufb02uctuations. The company regularly monitors the need for hedging of large transactions. Bank accounts in </span><span class=\"S1706 S1070 S152D S2\" id=\"te_63\">foreign currencies are used actively to reduce exposure to all the main currencies, and currency risk is to some degree naturally hedged </span><span class=\"S1707 S1070 S152D S2\" id=\"tf_63\">in EUR, USD and SEK by having both revenues and costs in the same currency. However, Photocure have in both 2022 and 2021 cash </span><span class=\"S1708 S1070 S152D S2\" id=\"tg_63\">surplus in EUR and a cash de\ufb01cit in USD. The Company has not entered into any currency hedging contracts during 2022. </span><span class=\"S1709 S1070 S2\" id=\"th_63\">The following table shows the Company\u2019s sensitivity for potential changes in the NOK exchange rate with all other factors constant. </span><span class=\"S170A S1070 S2\" id=\"ti_63\">The calculation is based on the same change in relation to all relevant currencies. The e\ufb00ect in the income statement comes from </span><span class=\"S170B S1070 S2\" id=\"tj_63\">changes in the value of monetary items. </span><span class=\"S170C S1070 S2\" id=\"tk_63\">(Amounts in NOK 1,000) </span><span class=\"S170D S1071 S2\" id=\"tl_63\">Change in the NOK exchange rate </span><span class=\"S170E S1071 S2\" id=\"tm_63\">E\ufb00ect on operating pro\ufb01t/loss </span><span class=\"S170F S1071 S2\" id=\"tn_63\">2022 </span><span class=\"S1710 S1070 S2\" id=\"to_63\">+ 10 % </span><span class=\"S1711 S1070 S2\" id=\"tp_63\">-2 270 </span><span class=\"S1712 S1071 S2\" id=\"tq_63\">2022 </span><span class=\"S1713 S1070 S2\" id=\"tr_63\">- 10 % </span><span class=\"S1714 S1070 S2\" id=\"ts_63\">2 270 </span><span class=\"S1715 S1071 S2\" id=\"tt_63\">2021 </span><span class=\"S1716 S1070 S2\" id=\"tu_63\">+ 10 % </span><span class=\"S1717 S1070 S2\" id=\"tv_63\">-7 187 </span><span class=\"S1718 S1071 S2\" id=\"tw_63\">2021 </span><span class=\"S1719 S1070 S2\" id=\"tx_63\">- 10 % </span><span class=\"S171A S1070 S2\" id=\"ty_63\">7 187 </span><span class=\"S171C S106F S2\" id=\"t4_64\">18. FAIR VALUE </span><span class=\"S171D S1070 S2\" id=\"t5_64\">The table below analyses \ufb01nancial assets recognised in the balance sheet at fair value according to the valuation method. </span><span class=\"S171E S1070 S2\" id=\"t6_64\">The di\ufb00erent levels have been de\ufb01ned as follows: </span><span class=\"S171F S1070 S2\" id=\"t7_64\">Level 1: </span><span class=\"S1720 S1070 S2\" id=\"t8_64\">Noted prices in active markets for corresponding assets or liabilities. </span><span class=\"S1721 S1070 S2\" id=\"t9_64\">Level 2: </span><span class=\"S1722 S1070 S2\" id=\"ta_64\">Available value measurements other than the noted prices classi\ufb01ed as Level 1, either directly observable in the form </span><span class=\"S1723 S1070 S2\" id=\"tb_64\">of agreed prices or indirectly as derived from the price of equivalent. </span><span class=\"S1724 S1070 S2\" id=\"tc_64\">Level 3: </span><span class=\"S1725 S1070 S2\" id=\"td_64\">Value measurements of assets or liabilities that are not based on observed market values. </span><span class=\"S1726 S1070 S2\" id=\"te_64\">(Amounts in NOK 1,000) </span><span class=\"S1727 S1071 S2\" id=\"tf_64\">Market value hierarchy </span><span class=\"S1728 S1071 S2\" id=\"tg_64\">Level 1 </span><span class=\"S1729 S1071 S2\" id=\"th_64\">Level 2 </span><span class=\"S172A S1071 S2\" id=\"ti_64\">Level 3 </span><span class=\"S172B S1071 S2\" id=\"tj_64\">Total </span><span class=\"S172C S1070 S2\" id=\"tk_64\">Money market funds </span><span class=\"S172D S1070 S2\" id=\"tl_64\">234 202 </span><span class=\"S172E S1070 S2\" id=\"tm_64\">234 202 </span><span class=\"S172F S1070 S2\" id=\"tn_64\">Earnout liability, ref note 22 </span><span class=\"S1730 S1070 S2\" id=\"to_64\">(135 333) </span><span class=\"S1731 S1070 S2\" id=\"tp_64\">(135 333) </span><span class=\"S1732 S1071 S2\" id=\"tq_64\">Total </span><span class=\"S1733 S1071 S2\" id=\"tr_64\">234 202 </span><span class=\"S1734 S1071 S2\" id=\"ts_64\">- </span><span class=\"S1735 S1071 S2\" id=\"tt_64\">(135 333) </span><span class=\"S1736 S1071 S2\" id=\"tu_64\">98 869 </span><span class=\"S1737 S106F S2\" id=\"tv_64\">19. RECEIVABLES </span><span class=\"S1738 S1071 S2\" id=\"tw_64\">Maximum credit risk </span><span class=\"S1739 S1070 S2\" id=\"tx_64\">The company\u2019s maximum credit risk associated with \ufb01nancial instruments corresponds to gross receivables. In a hypothetical </span><span class=\"S173A S1070 S2\" id=\"ty_64\">situations, where no receivables are actually paid, this would correspond to: </span><span class=\"S173B S1070 S2\" id=\"tz_64\">(Amounts in NOK 1,000) </span><span class=\"S173C S1071 S2\" id=\"t10_64\">Group </span><span class=\"S173D S1071 S2\" id=\"t11_64\">Parent </span><span class=\"S173E S1071 S2\" id=\"t12_64\">31-Dec-22 </span><span class=\"S173F S1071 S2\" id=\"t13_64\">31-Dec-21 </span><span class=\"S1740 S1071 S2\" id=\"t14_64\">31-Dec-22 </span><span class=\"S1741 S1071 S2\" id=\"t15_64\">31-Dec-21 </span><span class=\"S1742 S1070 S2\" id=\"t16_64\">Accounts receivable </span><span class=\"S1743 S1070 S2\" id=\"t17_64\">47 164 </span><span class=\"S1744 S1070 S2\" id=\"t18_64\">47 980 </span><span class=\"S1745 S1070 S2\" id=\"t19_64\">27 005 </span><span class=\"S1746 S1070 S2\" id=\"t1a_64\">29 610 </span><span class=\"S1747 S1070 S2\" id=\"t1b_64\">Accounts receivable intercompany </span><span class=\"S1748 S1070 S2\" id=\"t1c_64\">- </span><span class=\"S1749 S1070 S2\" id=\"t1d_64\">- </span><span class=\"S174A S1070 S2\" id=\"t1e_64\">4 733 </span><span class=\"S174B S1070 S2\" id=\"t1f_64\">0 </span><span class=\"S174C S1071 S2\" id=\"t1g_64\">Total </span><span class=\"S174D S1071 S2\" id=\"t1h_64\">47 164 </span><span class=\"S174E S1071 S2\" id=\"t1i_64\">47 980 </span><span class=\"S174F S1071 S2\" id=\"t1j_64\">31 738 </span><span class=\"S1750 S1071 S2\" id=\"t1k_64\">29 610 </span><span class=\"S1751 S1070 S2\" id=\"t1l_64\">Prepaid expenses </span><span class=\"S1752 S1070 S2\" id=\"t1m_64\">9 113 </span><span class=\"S1753 S1070 S2\" id=\"t1n_64\">9 852 </span><span class=\"S1754 S1070 S2\" id=\"t1o_64\">5 516 </span><span class=\"S1755 S1070 S2\" id=\"t1p_64\">4 697 </span><span class=\"S1756 S1070 S2\" id=\"t1q_64\">Other receivables and deposits </span><span class=\"S1757 S1070 S2\" id=\"t1r_64\">7 342 </span><span class=\"S1758 S1070 S2\" id=\"t1s_64\">4 928 </span><span class=\"S1759 S1070 S2\" id=\"t1t_64\">1 001 </span><span class=\"S175A S1070 S2\" id=\"t1u_64\">512 </span><span class=\"S175B S1071 S2\" id=\"t1v_64\">Total other receivables </span><span class=\"S175C S1071 S2\" id=\"t1w_64\">16 455 </span><span class=\"S175D S1071 S2\" id=\"t1x_64\">14 780 </span><span class=\"S175E S1071 S2\" id=\"t1y_64\">6 517 </span><span class=\"S175F S1071 S2\" id=\"t1z_64\">5 209 </span><span class=\"S1760 S1070 S2\" id=\"t20_64\">Loan to the subsidiary is disclosed in Note 10. </span><span class=\"S1761 S1071 S2\" id=\"t21_64\">Age breakdown of group accounts receivable </span><span class=\"S1762 S1071 S2\" id=\"t22_64\">Not yet </span><span class=\"S1763 S1071 S2\" id=\"t23_64\">due </span><span class=\"S1764 S1071 S2\" id=\"t24_64\">0\u201330 </span><span class=\"S1765 S1071 S2\" id=\"t25_64\">days </span><span class=\"S1766 S1071 S2\" id=\"t26_64\">30\u201360 </span><span class=\"S1767 S1071 S2\" id=\"t27_64\">days </span><span class=\"S1768 S1071 S2\" id=\"t28_64\">60\u201390 </span><span class=\"S1769 S1071 S2\" id=\"t29_64\">days </span><span class=\"S176A S1071 S2\" id=\"t2a_64\">Over 90 </span><span class=\"S176B S1071 S2\" id=\"t2b_64\">days </span><span class=\"S176C S1071 S2\" id=\"t2c_64\">Total </span><span class=\"S176D S1070 S2\" id=\"t2d_64\">31 December 2022 </span><span class=\"S176E S1070 S2\" id=\"t2e_64\">33 106 </span><span class=\"S176F S1070 S2\" id=\"t2f_64\">8 340 </span><span class=\"S1770 S1070 S2\" id=\"t2g_64\">3 679 </span><span class=\"S1771 S1070 S2\" id=\"t2h_64\">1 552 </span><span class=\"S1772 S1070 S2\" id=\"t2i_64\">487 </span><span class=\"S1773 S1071 S2\" id=\"t2j_64\">47 164 </span><span class=\"S1774 S1070 S2\" id=\"t2k_64\">31 December 2021 </span><span class=\"S1775 S1070 S2\" id=\"t2l_64\">37 641 </span><span class=\"S1776 S1070 S2\" id=\"t2m_64\">4 661 </span><span class=\"S1777 S1070 S2\" id=\"t2n_64\">4 705 </span><span class=\"S1778 S1070 S2\" id=\"t2o_64\">630 </span><span class=\"S1779 S1070 S2\" id=\"t2p_64\">342 </span><span class=\"S177A S1071 S2\" id=\"t2q_64\">47 980 </span><span class=\"S177B S1070 S2\" id=\"t2r_64\">Photocure\u2019s sales are mainly hospitals and pharmacies and wholesalers in Europe and North America. </span><span class=\"S177C S1070 S2\" id=\"t2s_64\">Photocure has implemented the expected loss model under IFRS 9 on trade receivables. The expected loss as of December 31, 2022 </span><span class=\"S177D S1070 S2\" id=\"t2t_64\">amounts to NOK 1.0 million. Realised bad debt loss\u2019 in 2022 and 2021 has been immaterial. Credit risk and foreign exchange risk in </span><span class=\"S177E S1070 S2\" id=\"t2u_64\">regard to trade accounts receivable are dealt with in more detail in Note 17. </span><span class=\"S1780 S106F S2\" id=\"t2_65\">20. CASH AND SHORT TERM DEPOSITS </span><span class=\"S1781 S1070 S2\" id=\"t3_65\">(Amounts in NOK 1,000) </span><span class=\"S1782 S1071 S2\" id=\"t4_65\">Group </span><span class=\"S1783 S1071 S2\" id=\"t5_65\">Parent </span><span class=\"S1784 S1071 S2\" id=\"t6_65\">31-Dec-22 </span><span class=\"S1785 S1071 S2\" id=\"t7_65\">31-Dec-21 </span><span class=\"S1786 S1071 S2\" id=\"t8_65\">31-Dec-22 </span><span class=\"S1787 S1071 S2\" id=\"t9_65\">31-Dec-21 </span><span class=\"S1788 S1070 S2\" id=\"ta_65\">Cash and cash equivalents, restricted </span><span class=\"S1789 S1070 S2\" id=\"tb_65\">3 422 </span><span class=\"S178A S1070 S2\" id=\"tc_65\">3 856 </span><span class=\"S178B S1070 S2\" id=\"td_65\">3 422 </span><span class=\"S178C S1070 S2\" id=\"te_65\">3 856 </span><span class=\"S178D S1070 S2\" id=\"tf_65\">Cash and cash equivalents, non-restricted </span><span class=\"S178E S1070 S2\" id=\"tg_65\">30 449 </span><span class=\"S178F S1070 S2\" id=\"th_65\">58 984 </span><span class=\"S1790 S1070 S2\" id=\"ti_65\">21 434 </span><span class=\"S1791 S1070 S2\" id=\"tj_65\">50 906 </span><span class=\"S1792 S1070 S2\" id=\"tk_65\">Money market funds, non-restricted </span><span class=\"S1793 S1070 S2\" id=\"tl_65\">234 202 </span><span class=\"S1794 S1070 S2\" id=\"tm_65\">260 055 </span><span class=\"S1795 S1070 S2\" id=\"tn_65\">234 202 </span><span class=\"S1796 S1070 S2\" id=\"to_65\">260 055 </span><span class=\"S1797 S1071 S2\" id=\"tp_65\">Total </span><span class=\"S1798 S1071 S2\" id=\"tq_65\">268 073 </span><span class=\"S1799 S1071 S2\" id=\"tr_65\">322 895 </span><span class=\"S179A S1071 S2\" id=\"ts_65\">259 058 </span><span class=\"S179B S1071 S2\" id=\"tt_65\">314 817 </span><span class=\"S179C S1070 S2\" id=\"tu_65\">Money market funds are considered as cash equivalents because they are readily convertible to known amounts of cash and are </span><span class=\"S179D S1070 S2\" id=\"tv_65\">held for the purpose of meeting short-term cash commitments. Restricted cash and cash equivalents at 31 December 2022 include </span><span class=\"S179E S1070 S2\" id=\"tw_65\">security for employees\u2019 withholding tax in of NOK 1.7 million, while the remaining amount refers to deposit for rent of o\ufb03ce. </span><span class=\"S179F S106F S2\" id=\"tx_65\">21. SHARE CAPITAL </span><span class=\"S17A0 S1070 S2\" id=\"ty_65\">Amounts that are distributed to or contributed by shareholders are included directly in the equity. The Group\u2019s equity is increased in </span><span class=\"S17A1 S1070 S2\" id=\"tz_65\">direct relation to the cost of share-based remuneration for employees. </span><span class=\"S17A2 S1070 S2\" id=\"t10_65\">1.  The nominal value of treasury shares is presented in the balance sheet as a negative equity element. The net purchase price is </span><span class=\"S17A3 S1070 S2\" id=\"t11_65\">entered as a reduction of other paid-in equity. Pro\ufb01ts or losses on transactions in treasury shares are not included in the income </span><span class=\"S17A4 S1070 S2\" id=\"t12_65\">statement. </span><span class=\"S17A5 S1070 S2\" id=\"t13_65\">2.  Transaction charges in connection with equity transactions are included directly in equity after deduction for tax. Only transaction </span><span class=\"S17A6 S1070 S2\" id=\"t14_65\">charges that are directly attributable to the equity transaction are included directly in equity. </span><span class=\"S17A7 S1070 S2\" id=\"t15_65\">Registered share capital in Photocure ASA amounted to: </span><span class=\"S17A8 S1071 S2\" id=\"t16_65\">No. of shares </span><span class=\"S17A9 S1071 S2\" id=\"t17_65\">Nominal value </span><span class=\"S17AA S1071 S2\" id=\"t18_65\">per share NOK </span><span class=\"S17AB S1071 S2\" id=\"t19_65\">Share capital </span><span class=\"S17AC S1071 S2\" id=\"t1a_65\">in NOK </span><span class=\"S17AD S1071 S2\" id=\"t1b_65\">Share capital at 31 December 2021 </span><span class=\"S17AE S1071 S2\" id=\"t1c_65\">26 973 820 </span><span class=\"S17AF S1071 S2\" id=\"t1d_65\">0.50 </span><span class=\"S17B0 S1071 S2\" id=\"t1e_65\">13 486 910 </span><span class=\"S17B1 S1071 S2\" id=\"t1f_65\">Share capital at 31 December 2022 </span><span class=\"S17B2 S1071 S2\" id=\"t1g_65\">27 120 820 </span><span class=\"S17B3 S1071 S2\" id=\"t1h_65\">0.50 </span><span class=\"S17B4 S1071 S2\" id=\"t1i_65\">13 560 410 </span><span class=\"S17B5 S1071 S2\" id=\"t1j_65\">Treasury shares: </span><span class=\"S17B6 S1071 S2\" id=\"t1k_65\">Holdings of treasury shares at 31 December 2020 </span><span class=\"S17B7 S1071 S2\" id=\"t1l_65\">15 666 </span><span class=\"S17B8 S1071 S2\" id=\"t1m_65\">7 833 </span><span class=\"S17B9 S1070 S2\" id=\"t1n_65\">Buy-back of restricted shares </span><span class=\"S17BA S1070 S2\" id=\"t1o_65\">6 306 </span><span class=\"S17BB S1070 S2\" id=\"t1p_65\">0.50 </span><span class=\"S17BC S1070 S2\" id=\"t1q_65\">3 153 </span><span class=\"S17BD S1070 S2\" id=\"t1r_65\">Share options exercised from treasury shares </span><span class=\"S17BE S1070 S2\" id=\"t1s_65\">-7 126 </span><span class=\"S17BF S1070 S2\" id=\"t1t_65\">0.50 </span><span class=\"S17C0 S1070 S2\" id=\"t1u_65\">-3 563 </span><span class=\"S17C1 S1071 S2\" id=\"t1v_65\">Holdings of treasury shares at 31 December 2021 </span><span class=\"S17C2 S1071 S2\" id=\"t1w_65\">14 846 </span><span class=\"S17C3 S1071 S2\" id=\"t1x_65\">7 423 </span><span class=\"S17C4 S1070 S2\" id=\"t1y_65\">Buy-back of restricted shares </span><span class=\"S17C5 S1070 S2\" id=\"t1z_65\">481 </span><span class=\"S17C6 S1070 S2\" id=\"t20_65\">0.50 </span><span class=\"S17C7 S1070 S2\" id=\"t21_65\">241 </span><span class=\"S17C8 S1070 S2\" id=\"t22_65\">Buy-back of treasury shares </span><span class=\"S17C9 S1070 S2\" id=\"t23_65\">36 000 </span><span class=\"S17CA S1070 S2\" id=\"t24_65\">0.50 </span><span class=\"S17CB S1070 S2\" id=\"t25_65\">18 000 </span><span class=\"S17CC S1070 S2\" id=\"t26_65\">Share options exercised from treasury shares </span><span class=\"S17CD S1070 S2\" id=\"t27_65\">-36 205 </span><span class=\"S17CE S1070 S2\" id=\"t28_65\">0.50 </span><span class=\"S17CF S1070 S2\" id=\"t29_65\">-18 103 </span><span class=\"S17D0 S1071 S2\" id=\"t2a_65\">Holdings of treasury shares at 31 December 2022 </span><span class=\"S17D1 S1071 S2\" id=\"t2b_65\">15 122 </span><span class=\"S17D2 S1071 S2\" id=\"t2c_65\">7 561 </span><span class=\"S17D3 S1070 S2\" id=\"t2d_65\">Restricted shares were o\ufb00ered to the employees according to the Board\u2019s discretion. </span><span class=\"S17D4 S1070 S2\" id=\"t2e_65\">The participant received the </span><span class=\"S17D5 S1070 S2\" id=\"t2f_65\">shares in the Company that have been subject to a three years\u2019 lock up period </span><span class=\"S17D6 S1070 S2\" id=\"t2g_65\">All shares have the same voting rights and otherwise the same rights in the Company. Ordinary shares are classi\ufb01ed as equity. </span><span class=\"S17D7 S1070 S2\" id=\"t2h_65\">Expenses that are directly attributable to the issue of ordinary shares are included as a reduction of equity. </span><span class=\"S17D8 S1070 S2\" id=\"t2i_65\">At the General Meeting 28 April 2022, the Board of Directors of Photocure ASA was granted authorisation to issue up to 6.1 million </span><span class=\"S17D9 S1070 S2\" id=\"t2j_65\">shares. Of this authorisation, (a) 5.4 million shares are linked to \ufb01nancing of the Company\u2019s development, while (b) 0.75 million shares </span><span class=\"S17DA S1070 S2\" id=\"t2k_65\">are associated with the issue of shares to the Company\u2019s employees. Subscription of shares under the incentive program shall </span><span class=\"S17DB S1070 S2\" id=\"t2l_65\">be subscribed at the market price with an addition of 10% at the time of allocation of the employee share options. At the General </span><span class=\"S17DC S1070 S2\" id=\"t2m_65\">Meeting the Board of Directors was granted authorisation to purchase treasury shares to 2.7 million shares. The basis for this </span><span class=\"S17DD S1070 S2\" id=\"t2n_65\">authorisation to purchase treasury shares is the desire by the Board of Directors to increase the liquidity of the Company\u2019s shares </span><span class=\"S17DE S1070 S2\" id=\"t2o_65\">and in connection with the incentive schemes. </span><span class=\"S17DF S1070 S2\" id=\"t2p_65\">All authorisations are valid up until the Ordinary General Meeting in 2023. Previously issued authorisations have expired. </span><span class=\"S17E0 S1070 S2\" id=\"t4_66\">The table below indicates the status of authorisations at 31 December 2022: </span><span class=\"S17E1 S1071 S2\" id=\"t5_66\">Purchase, </span><span class=\"S17E2 S1071 S2\" id=\"t6_66\">treasury shares </span><span class=\"S17E3 S1071 S2\" id=\"t7_66\">Ordinary </span><span class=\"S17E4 S1071 S2\" id=\"t8_66\">share issue </span><span class=\"S17E5 S1071 S2\" id=\"t9_66\">Employee </span><span class=\"S17E6 S1071 S2\" id=\"ta_66\">share issues </span><span class=\"S17E7 S1070 S2\" id=\"tb_66\">(Figures indicate the number of shares) </span><span class=\"S17E8 S1070 S2\" id=\"tc_66\">Authorisation issued at the General Meeting on 28 April 2022 </span><span class=\"S17E9 S1070 S2\" id=\"td_66\">2 697 657 </span><span class=\"S17EA S1070 S2\" id=\"te_66\">5 395 314 </span><span class=\"S17EB S1070 S2\" id=\"tf_66\">750 000 </span><span class=\"S17EC S1070 S2\" id=\"tg_66\">Share issues after the General Meeting on 28 April 2022 </span><span class=\"S17ED S1070 S2\" id=\"th_66\">0 </span><span class=\"S17EE S1070 S2\" id=\"ti_66\">0 </span><span class=\"S17EF S1070 S2\" id=\"tj_66\">144 250 </span><span class=\"S17F0 S1070 S2\" id=\"tk_66\">Purchase of treasury shares after the General Meeting 28 April 2022 </span><span class=\"S17F1 S1070 S2\" id=\"tl_66\">-36 000 </span><span class=\"S17F2 S1070 S2\" id=\"tm_66\">0 </span><span class=\"S17F3 S1070 S2\" id=\"tn_66\">0 </span><span class=\"S17F4 S1071 S2\" id=\"to_66\">Remaining under authorisations at 31 December 2022 </span><span class=\"S17F5 S1071 S2\" id=\"tp_66\">2 661 657 </span><span class=\"S17F6 S1071 S2\" id=\"tq_66\">5 395 314 </span><span class=\"S17F7 S1071 S2\" id=\"tr_66\">605 750 </span><span class=\"S17F8 S1070 S2\" id=\"ts_66\">1 922 778 share options have been allocated to employees 31 December 2022 (see note 6). </span><span class=\"S17F9 S1070 S2\" id=\"tt_66\">Photocure initiated a buyback of up to 36,000 of its own shares at 1 June 2022. The purpose of the buyback program was to acquire </span><span class=\"S17FA S1070 S2\" id=\"tu_66\">shares which was used as settlement in the Company\u2019s share-based incentive scheme. </span><span class=\"S17FB S1071 S2\" id=\"tv_66\">Ownership structure </span><span class=\"S17FC S1070 S2\" id=\"tw_66\">The major shareholders in Photocure as of 31 December 2022 were: </span><span class=\"S17FD S1071 S2\" id=\"tx_66\">Shares </span><span class=\"S17FE S1071 S2\" id=\"ty_66\">Shareholding </span><span class=\"S17FF S1070 S2\" id=\"tz_66\">Morgan Stanley &amp; Co. LLC </span><span class=\"S1800 S1070 S2\" id=\"t10_66\">4 160 945 </span><span class=\"S1801 S1070 S2\" id=\"t11_66\">15.3 % </span><span class=\"S1802 S1070 S2\" id=\"t12_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1803 S1070 S2\" id=\"t13_66\">1 138 000 </span><span class=\"S1804 S1070 S2\" id=\"t14_66\">4.2 % </span><span class=\"S1805 S1070 S2\" id=\"t15_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1806 S1070 S2\" id=\"t16_66\">1 117 101 </span><span class=\"S1807 S1070 S2\" id=\"t17_66\">4.1 % </span><span class=\"S1808 S1070 S2\" id=\"t18_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1809 S1070 S2\" id=\"t19_66\">720 644 </span><span class=\"S180A S1070 S2\" id=\"t1a_66\">2.7 % </span><span class=\"S180B S1070 S2\" id=\"t1b_66\">RADFORSK INVESTERINGSSTIFTELSE </span><span class=\"S180C S1070 S2\" id=\"t1c_66\">679 619 </span><span class=\"S180D S1070 S2\" id=\"t1d_66\">2.5 % </span><span class=\"S180E S1070 S2\" id=\"t1e_66\">The Bank of New York Mellon SA/NV </span><span class=\"S180F S1070 S2\" id=\"t1f_66\">581 018 </span><span class=\"S1810 S1070 S2\" id=\"t1g_66\">2.1 % </span><span class=\"S1811 S1070 S2\" id=\"t1h_66\">The Bank of New York Mellon SA/NV </span><span class=\"S1812 S1070 S2\" id=\"t1i_66\">515 000 </span><span class=\"S1813 S1070 S2\" id=\"t1j_66\">1.9 % </span><span class=\"S1814 S1070 S2\" id=\"t1k_66\">Nordnet Bank AB </span><span class=\"S1815 S1070 S2\" id=\"t1l_66\">511 441 </span><span class=\"S1816 S1070 S2\" id=\"t1m_66\">1.9 % </span><span class=\"S1817 S1070 S2\" id=\"t1n_66\">RBC Investor services bank S.A. </span><span class=\"S1818 S1070 S2\" id=\"t1o_66\">477 179 </span><span class=\"S1819 S1070 S2\" id=\"t1p_66\">1.8 % </span><span class=\"S181A S1070 S2\" id=\"t1q_66\">The Bank of New York Mellon </span><span class=\"S181B S1070 S2\" id=\"t1r_66\">473 494 </span><span class=\"S181C S1070 S2\" id=\"t1s_66\">1.7 % </span><span class=\"S181D S1070 S2\" id=\"t1t_66\">MP PENSJON PK </span><span class=\"S181E S1070 S2\" id=\"t1u_66\">440 178 </span><span class=\"S181F S1070 S2\" id=\"t1v_66\">1.6 % </span><span class=\"S1820 S1070 S2\" id=\"t1w_66\">The Northern Trust Comp, London Br </span><span class=\"S1821 S1070 S2\" id=\"t1x_66\">439 420 </span><span class=\"S1822 S1070 S2\" id=\"t1y_66\">1.6 % </span><span class=\"S1823 S1070 S2\" id=\"t1z_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1824 S1070 S2\" id=\"t20_66\">417 940 </span><span class=\"S1825 S1070 S2\" id=\"t21_66\">1.5 % </span><span class=\"S1826 S1070 S2\" id=\"t22_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1827 S1070 S2\" id=\"t23_66\">412 990 </span><span class=\"S1828 S1070 S2\" id=\"t24_66\">1.5 % </span><span class=\"S1829 S1070 S2\" id=\"t25_66\">The Bank of New York Mellon SA/NV </span><span class=\"S182A S1070 S2\" id=\"t26_66\">400 000 </span><span class=\"S182B S1070 S2\" id=\"t27_66\">1.5 % </span><span class=\"S182C S1070 S2\" id=\"t28_66\">JPMorgan Chase Bank, N.A., London </span><span class=\"S182D S1070 S2\" id=\"t29_66\">390 226 </span><span class=\"S182E S1070 S2\" id=\"t2a_66\">1.4 % </span><span class=\"S182F S1070 S2\" id=\"t2b_66\">VERDIPAPIRFONDET EQUINOR AKSJER NO </span><span class=\"S1830 S1070 S2\" id=\"t2c_66\">375 872 </span><span class=\"S1831 S1070 S2\" id=\"t2d_66\">1.4 % </span><span class=\"S1832 S1070 S2\" id=\"t2e_66\">VERDIPAPIRFONDET KLP AKSJENORGE </span><span class=\"S1833 S1070 S2\" id=\"t2f_66\">375 630 </span><span class=\"S1834 S1070 S2\" id=\"t2g_66\">1.4 % </span><span class=\"S1835 S1070 S2\" id=\"t2h_66\">Avanza Bank AB </span><span class=\"S1836 S1070 S2\" id=\"t2i_66\">372 126 </span><span class=\"S1837 S1070 S2\" id=\"t2j_66\">1.4 % </span><span class=\"S1838 S1070 S2\" id=\"t2k_66\">The Bank of New York Mellon </span><span class=\"S1839 S1070 S2\" id=\"t2l_66\">329 888 </span><span class=\"S183A S1070 S2\" id=\"t2m_66\">1.2 % </span><span class=\"S183B S1071 S2\" id=\"t2n_66\">Total of 20 largest shareholders </span><span class=\"S183C S1071 S2\" id=\"t2o_66\">14 328 711 </span><span class=\"S183D S1071 S2\" id=\"t2p_66\">52.8 % </span><span class=\"S183E S1070 S2\" id=\"t2q_66\">Treasury shares </span><span class=\"S183F S1070 S2\" id=\"t2r_66\">15 122 </span><span class=\"S1840 S1070 S2\" id=\"t2s_66\">0.1 % </span><span class=\"S1841 S1070 S2\" id=\"t2t_66\">Total other shareholders </span><span class=\"S1842 S1070 S2\" id=\"t2u_66\">12 776 987 </span><span class=\"S1843 S1070 S2\" id=\"t2v_66\">47.1 % </span><span class=\"S1844 S1071 S2\" id=\"t2w_66\">Total number of shares </span><span class=\"S1845 S1071 S2\" id=\"t2x_66\">27 120 820 </span><span class=\"S1846 S1071 S2\" id=\"t2y_66\">100.0 % </span><span class=\"S1847 S1070 S2\" id=\"t2_67\">Shares owned, directly or indirectly, by members of the Board of Directors, the President and CEO and senior management and their </span><span class=\"S1848 S1070 S2\" id=\"t3_67\">closely related associates as of 31 December 2022: </span><span class=\"S1849 S1071 S2\" id=\"t4_67\">Name </span><span class=\"S184A S1071 S2\" id=\"t5_67\">Position </span><span class=\"S184B S1071 S2\" id=\"t6_67\">No. of </span><span class=\"S184C S1071 S2\" id=\"t7_67\">shares </span><span class=\"S184D S1071 S2\" id=\"t8_67\">No. of share </span><span class=\"S184E S1071 S2\" id=\"t9_67\">options </span><span class=\"S184F SFE S2\" id=\"ta_67\">** </span><span class=\"S1850 S1070 S2\" id=\"tb_67\">Daniel Schneider </span><span class=\"S1851 S1070 S2\" id=\"tc_67\">President &amp; CEO </span><span class=\"S1852 S1070 S2\" id=\"td_67\">99 689 </span><span class=\"S1853 S1070 S2\" id=\"te_67\">325 000 </span><span class=\"S1854 S1070 S2\" id=\"tf_67\">Erik Dahl </span><span class=\"S1855 S1070 S2\" id=\"tg_67\">Chief Financial O\ufb03cer </span><span class=\"S1856 S1070 S2\" id=\"th_67\">32 750 </span><span class=\"S1857 S1070 S2\" id=\"ti_67\">192 500 </span><span class=\"S1858 S1070 S2\" id=\"tj_67\">Geo\ufb00rey Coy </span><span class=\"S1859 S1070 S2\" id=\"tk_67\">VP and General Manager North America </span><span class=\"S185A S1070 S2\" id=\"tl_67\">15 207 </span><span class=\"S185B S1070 S2\" id=\"tm_67\">212 500 </span><span class=\"S185C S1070 S2\" id=\"tn_67\">Susanne Strauss </span><span class=\"S185D S1070 S2\" id=\"to_67\">VP and General Manager Europe </span><span class=\"S185E S1070 S2\" id=\"tp_67\">1 392 </span><span class=\"S185F S1070 S2\" id=\"tq_67\">200 000 </span><span class=\"S1860 S1070 S2\" id=\"tr_67\">Grete Hogstad </span><span class=\"S1861 S1070 S2\" id=\"ts_67\">VP Global Strategic Marketing &amp; BD </span><span class=\"S1862 S1070 S2\" id=\"tt_67\">30 719 </span><span class=\"S1863 S1070 S2\" id=\"tu_67\">112 500 </span><span class=\"S1864 S1070 S2\" id=\"tv_67\">Patricia Kelly </span><span class=\"S1865 S1070 S2\" id=\"tw_67\">VP Global Human Resources </span><span class=\"S1866 S1070 S2\" id=\"tx_67\">- </span><span class=\"S1867 S1070 S2\" id=\"ty_67\">80 000 </span><span class=\"S1868 S1070 S2\" id=\"tz_67\">Anders Neijber </span><span class=\"S1869 S1070 S2\" id=\"t10_67\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S186A S1070 S2\" id=\"t11_67\">- </span><span class=\"S186B S1070 S2\" id=\"t12_67\">88 000 </span><span class=\"S186C S1070 S2\" id=\"t13_67\">Jan H. Egbert </span><span class=\"S186D S1070 S2\" id=\"t14_67\">Chairperson of the board </span><span class=\"S186E S1070 S2\" id=\"t15_67\">14 500 </span><span class=\"S186F S1070 S2\" id=\"t16_67\">1 312 </span><span class=\"S1870 S1070 S2\" id=\"t17_67\">Anders Tuv * </span><span class=\"S1871 S1070 S2\" id=\"t18_67\">Board member </span><span class=\"S1872 S1070 S2\" id=\"t19_67\">679 619 </span><span class=\"S1873 S1070 S2\" id=\"t1a_67\">804 </span><span class=\"S1874 S1070 S2\" id=\"t1b_67\">Anne Wors\u00f8e </span><span class=\"S1875 S1070 S2\" id=\"t1c_67\">Board member </span><span class=\"S1876 S1070 S2\" id=\"t1d_67\">- </span><span class=\"S1877 S1070 S2\" id=\"t1e_67\">804 </span><span class=\"S1878 S1070 S2\" id=\"t1f_67\">Johanna Holldack </span><span class=\"S1879 S1070 S2\" id=\"t1g_67\">Board member </span><span class=\"S187A S1070 S2\" id=\"t1h_67\">- </span><span class=\"S187B S1070 S2\" id=\"t1i_67\">804 </span><span class=\"S187C S1070 S2\" id=\"t1j_67\">Neal Shore </span><span class=\"S187D S1070 S2\" id=\"t1k_67\">Board member </span><span class=\"S187E S1070 S2\" id=\"t1l_67\">- </span><span class=\"S187F S1070 S2\" id=\"t1m_67\">804 </span><span class=\"S1880 S1294 S2\" id=\"t1n_67\">* </span><span class=\"S1881 S1295 S2\" id=\"t1o_67\">Anders Tuv represents RADFORSK Investeringsstiftelse. </span><span class=\"S1882 S1294 S2\" id=\"t1p_67\">** </span><span class=\"S1883 S1295 S2\" id=\"t1q_67\">See note 6 for additional information about the share options. </span><span class=\"S1884 S106F S2\" id=\"t1r_67\">22. LOAN TERMS AND REPAYMENT </span><span class=\"S1885 S1070 S2\" id=\"t1s_67\">(Amounts in NOK 1,000) </span><span class=\"S1886 S1071 S2\" id=\"t1t_67\">Currency </span><span class=\"S1887 S1071 S2\" id=\"t1u_67\">Nominell </span><span class=\"S1888 S1071 S2\" id=\"t1v_67\">interest </span><span class=\"S1889 S1071 S2\" id=\"t1w_67\">rate </span><span class=\"S188A S1071 S2\" id=\"t1x_67\">Year of </span><span class=\"S188B S1071 S2\" id=\"t1y_67\">maturity </span><span class=\"S188C S1071 S2\" id=\"t1z_67\">Loan </span><span class=\"S188D S1071 S2\" id=\"t20_67\">amount </span><span class=\"S188E S1071 S2\" id=\"t21_67\">01.01 </span><span class=\"S188F S1071 S2\" id=\"t22_67\">Instal- </span><span class=\"S1890 S1071 S2\" id=\"t23_67\">ments </span><span class=\"S1891 S1071 S2\" id=\"t24_67\">paid </span><span class=\"S1892 S1071 S2\" id=\"t25_67\">Book value </span><span class=\"S1893 S1071 S2\" id=\"t26_67\">31-Dec-22 </span><span class=\"S1894 S1071 S2\" id=\"t27_67\">1st year </span><span class=\"S1895 S1071 S2\" id=\"t28_67\">instal- </span><span class=\"S1896 S1071 S2\" id=\"t29_67\">ments </span><span class=\"S1897 S1070 S2\" id=\"t2a_67\">Bank loan secured through governmental </span><span class=\"S1898 S1070 S2\" id=\"t2b_67\">guarantee due to Covid-19 </span><span class=\"S1899 S1070 S2\" id=\"t2c_67\">NOK </span><span class=\"S189A S1070 S2\" id=\"t2d_67\">4.80 % </span><span class=\"S189B S1070 S2\" id=\"t2e_67\">2023 </span><span class=\"S189C S1070 S2\" id=\"t2f_67\">37 500 </span><span class=\"S189D S1070 S2\" id=\"t2g_67\">-25 000 </span><span class=\"S189E S1070 S2\" id=\"t2h_67\">12 500 </span><span class=\"S189F S1070 S2\" id=\"t2i_67\">12 500 </span><span class=\"S18A0 S1070 S2\" id=\"t2j_67\">Deferred consideration (Earnout) </span><span class=\"S18A1 S1070 S2\" id=\"t2k_67\">NOK/EUR </span><span class=\"S18A2 S1070 S2\" id=\"t2l_67\">2030 </span><span class=\"S18A3 S1070 S2\" id=\"t2m_67\">139 350 </span><span class=\"S18A4 S1070 S2\" id=\"t2n_67\">-5 714 </span><span class=\"S18A5 S1070 S2\" id=\"t2o_67\">135 333 </span><span class=\"S18A6 S1070 S2\" id=\"t2p_67\">9 100 </span><span class=\"S18A7 S1070 S2\" id=\"t2q_67\">Right-of-use o\ufb03ce contract Norway </span><span class=\"S18A8 S1070 S2\" id=\"t2r_67\">NOK </span><span class=\"S18A9 S1070 S2\" id=\"t2s_67\">3.15 % </span><span class=\"S18AA S1070 S2\" id=\"t2t_67\">2027 </span><span class=\"S18AB S1070 S2\" id=\"t2u_67\">13 052 </span><span class=\"S18AC S1070 S2\" id=\"t2v_67\">-2 193 </span><span class=\"S18AD S1070 S2\" id=\"t2w_67\">11 434 </span><span class=\"S18AE S1070 S2\" id=\"t2x_67\">2 302 </span><span class=\"S18AF S1070 S2\" id=\"t2y_67\">Right-of-use o\ufb03ce contract US </span><span class=\"S18B0 S1070 S2\" id=\"t2z_67\">USD </span><span class=\"S18B1 S1070 S2\" id=\"t30_67\">3.70 % </span><span class=\"S18B2 S1070 S2\" id=\"t31_67\">2028 </span><span class=\"S18B3 S1070 S2\" id=\"t32_67\">10 269 </span><span class=\"S18B4 S1070 S2\" id=\"t33_67\">-1 548 </span><span class=\"S18B5 S1070 S2\" id=\"t34_67\">9 591 </span><span class=\"S18B6 S1070 S2\" id=\"t35_67\">1 598 </span><span class=\"S18B7 S1070 S2\" id=\"t36_67\">Right-of-use o\ufb03ce contract Germany </span><span class=\"S18B8 S1070 S2\" id=\"t37_67\">EUR </span><span class=\"S18B9 S1070 S2\" id=\"t38_67\">1.40 % </span><span class=\"S18BA S1070 S2\" id=\"t39_67\">2026 </span><span class=\"S18BB S1070 S2\" id=\"t3a_67\">5 861 </span><span class=\"S18BC S1070 S2\" id=\"t3b_67\">-1 317 </span><span class=\"S18BD S1070 S2\" id=\"t3c_67\">5 064 </span><span class=\"S18BE S1070 S2\" id=\"t3d_67\">1 422 </span><span class=\"S18BF S1070 S2\" id=\"t3e_67\">Right-of-use o\ufb03ce company car \ufb02eet Germany * </span><span class=\"S18C0 S1070 S2\" id=\"t3f_67\">EUR </span><span class=\"S18C1 S1070 S2\" id=\"t3g_67\">1.40 % </span><span class=\"S18C2 S204 S2\" id=\"t3h_67\">2024 </span><span class=\"S18C3 S1070 S2\" id=\"t3i_67\">460 </span><span class=\"S18C4 S1070 S2\" id=\"t3j_67\">-708 </span><span class=\"S18C5 S1070 S2\" id=\"t3k_67\">949 </span><span class=\"S18C6 S1070 S2\" id=\"t3l_67\">460 </span><span class=\"S18C7 S18E0 S2\" id=\"t3m_67\">Total non-current liabilities </span><span class=\"S18C8 S1071 S2\" id=\"t3n_67\">174 871 </span><span class=\"S18C9 S1071 S2\" id=\"t3o_67\">27 382 </span><span class=\"S18CA S1294 S2\" id=\"t3p_67\">* </span><span class=\"S18CB S1295 S2\" id=\"t3q_67\">There are seperate lease agreements for each lease subject </span><span class=\"S18CC S1070 S2\" id=\"t3r_67\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S18CD S1070 S2\" id=\"t3s_67\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S18CE S1070 S2\" id=\"t3t_67\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S18CF S1070 S2\" id=\"t3u_67\">sales (years 8-10) in the previous Ipsen major markets. The deferred consideration is paid as quarterly earnout payments in EURO </span><span class=\"S18D0 S1070 S2\" id=\"t3v_67\">after the close of the quarter. </span><span class=\"S18D1 S1070 S2\" id=\"t3w_67\">The fair value of the deferred consideration is driven by future expected sales and is remeasured on a yearly basis. Photocure </span><span class=\"S18D2 S1070 S2\" id=\"t3x_67\">performed a new remeasurement as of 31 December 2022. </span><span class=\"S18D3 S1070 S2\" id=\"t3y_67\">The remeasurement resulted in a fair value of NOK 135.3 re\ufb02ecting </span><span class=\"S18D4 S1070 S2\" id=\"t3z_67\">an increase of fair value of NOK 0.8 million compared to remeasurement adjustment of NOK 17.2 in 2021. The increased fair value </span><span class=\"S18D5 S1070 S2\" id=\"t40_67\">has been recognized in pro\ufb01t or loss as a \ufb01nancial cost. To arrive at the remeasured fair value of NOK 135.3 million, Photocure has </span><span class=\"S18D6 S1070 S2\" id=\"t41_67\">discounted the estimated earnout payments by an IRR at level with the investment project. This IRR has been deemed appropriate </span><span class=\"S18D7 S1070 S2\" id=\"t42_67\">as a discount rate for the earnout payments since the level of the payments will be subject to the same risk factors as the cash </span><span class=\"S18D8 S1070 S2\" id=\"t43_67\">\ufb02ow prognosis for the acquisition as a whole. Future sales, given performance in 2022 and growth opportunities going forward, are </span><span class=\"S18D9 S1070 S2\" id=\"t44_67\">expected to be in line with forecasts prepared in connection with the transaction. </span><span class=\"S18DA S1070 S2\" id=\"t45_67\">Photocure has made the remeasurement of the earnout liability in NOK currency and based the forecasted cash\ufb02ow on a \ufb01xed </span><span class=\"S18DB S1070 S2\" id=\"t46_67\">exchange rate EUR/NOK of 10.2 and this is in line with the prior year remeasurement . </span><span class=\"S18DC S1070 S2\" id=\"t47_67\">The agreement with Ipsen determined a \ufb02oor revenue for the earnout from 2022 to the end of the forecast period and there is no </span><span class=\"S18DD S1070 S2\" id=\"t48_67\">upper cap of revenue. The total undiscounted amount of the earnout may be in the interval of NOK 187 - 306 million depending </span><span class=\"S18DE S1070 S2\" id=\"t49_67\">on revenue and development of the currency exchange rate between EUR and NOK. According to our sensitivity analysis the </span><span class=\"S18DF S1070 S2\" id=\"t4a_67\">corresponding net present value of the liability may decrease or increase by NOK 33 million. </span><span class=\"S18E2 S1071 S2\" id=\"t4_68\">Group </span><span class=\"S18E3 S1071 S2\" id=\"t5_68\">Earnout </span><span class=\"S18E4 S1071 S2\" id=\"t6_68\">liability </span><span class=\"S18E5 S1071 S2\" id=\"t7_68\">Financial </span><span class=\"S18E6 S1071 S2\" id=\"t8_68\">loan bank </span><span class=\"S18E7 S1071 S2\" id=\"t9_68\">O\ufb03ce </span><span class=\"S18E8 S1071 S2\" id=\"ta_68\">Lease </span><span class=\"S18E9 S1071 S2\" id=\"tb_68\">Oslo </span><span class=\"S18EA S1071 S2\" id=\"tc_68\">O\ufb03ce </span><span class=\"S18EB S1071 S2\" id=\"td_68\">Lease </span><span class=\"S18EC S1071 S2\" id=\"te_68\">Princeton </span><span class=\"S18ED S1071 S2\" id=\"tf_68\">O\ufb03ce and </span><span class=\"S18EE S1071 S2\" id=\"tg_68\">car Lease </span><span class=\"S18EF S1071 S2\" id=\"th_68\">Germany </span><span class=\"S18F0 S1071 S2\" id=\"ti_68\">Total </span><span class=\"S18F1 S1071 S2\" id=\"tj_68\">Accumulated 31 December 2020 </span><span class=\"S18F2 S1070 S2\" id=\"tk_68\">149 941 </span><span class=\"S18F3 S1070 S2\" id=\"tl_68\">50 000 </span><span class=\"S18F4 S1070 S2\" id=\"tm_68\">1 970 </span><span class=\"S18F5 S1070 S2\" id=\"tn_68\">1 917 </span><span class=\"S18F6 S1070 S2\" id=\"to_68\">0 </span><span class=\"S18F7 S1070 S2\" id=\"tp_68\">203 828 </span><span class=\"S18F8 S1070 S2\" id=\"tq_68\">Proceeds from loans and borrowing </span><span class=\"S18F9 S1070 S2\" id=\"tr_68\">0 </span><span class=\"S18FA S1070 S2\" id=\"ts_68\">Loan repayment and earnout </span><span class=\"S18FB S1070 S2\" id=\"tt_68\">-3 834 </span><span class=\"S18FC S1070 S2\" id=\"tu_68\">-12 500 </span><span class=\"S18FD S1070 S2\" id=\"tv_68\">-16 334 </span><span class=\"S18FE S1070 S2\" id=\"tw_68\">Payment of lease liabilities </span><span class=\"S18FF S1070 S2\" id=\"tx_68\">-1 970 </span><span class=\"S1900 S1070 S2\" id=\"ty_68\">-839 </span><span class=\"S1901 S1070 S2\" id=\"tz_68\">-1 134 </span><span class=\"S1902 S1070 S2\" id=\"t10_68\">-3 943 </span><span class=\"S1903 S1071 S2\" id=\"t11_68\">Total changes from \ufb01nancing </span><span class=\"S1904 S1071 S2\" id=\"t12_68\">-3 834 </span><span class=\"S1905 S1071 S2\" id=\"t13_68\">-12 500 </span><span class=\"S1906 S1071 S2\" id=\"t14_68\">-1 970 </span><span class=\"S1907 S1071 S2\" id=\"t15_68\">-839 </span><span class=\"S1908 S1071 S2\" id=\"t16_68\">-1 134 </span><span class=\"S1909 S1071 S2\" id=\"t17_68\">-20 277 </span><span class=\"S190A S1070 S2\" id=\"t18_68\">Change in fair value currency </span><span class=\"S190B S1070 S2\" id=\"t19_68\">-15 906 </span><span class=\"S190C S1070 S2\" id=\"t1a_68\">82 </span><span class=\"S190D S1070 S2\" id=\"t1b_68\">-15 824 </span><span class=\"S190E S1070 S2\" id=\"t1c_68\">Remeasurerd liability </span><span class=\"S190F S1070 S2\" id=\"t1d_68\">17 220 </span><span class=\"S1910 S1070 S2\" id=\"t1e_68\">17 220 </span><span class=\"S1911 S1070 S2\" id=\"t1f_68\">New lease liability </span><span class=\"S1912 S1070 S2\" id=\"t1g_68\">13 053 </span><span class=\"S1913 S1070 S2\" id=\"t1h_68\">9 110 </span><span class=\"S1914 S1070 S2\" id=\"t1i_68\">7 455 </span><span class=\"S1915 S1070 S2\" id=\"t1j_68\">29 617 </span><span class=\"S1916 S1070 S2\" id=\"t1k_68\">Interest expense </span><span class=\"S1917 S1070 S2\" id=\"t1l_68\">22 425 </span><span class=\"S1918 S1070 S2\" id=\"t1m_68\">1 065 </span><span class=\"S1919 S1070 S2\" id=\"t1n_68\">157 </span><span class=\"S191A S1070 S2\" id=\"t1o_68\">91 </span><span class=\"S191B S1070 S2\" id=\"t1p_68\">88 </span><span class=\"S191C S1070 S2\" id=\"t1q_68\">23 826 </span><span class=\"S191D S1070 S2\" id=\"t1r_68\">Interest paid </span><span class=\"S191E S1070 S2\" id=\"t1s_68\">-24 985 </span><span class=\"S191F S1070 S2\" id=\"t1t_68\">-1 065 </span><span class=\"S1920 S1070 S2\" id=\"t1u_68\">-157 </span><span class=\"S1921 S1070 S2\" id=\"t1v_68\">-91 </span><span class=\"S1922 S1070 S2\" id=\"t1w_68\">-88 </span><span class=\"S1923 S1070 S2\" id=\"t1x_68\">-26 386 </span><span class=\"S1924 S1071 S2\" id=\"t1y_68\">Total liability related changes </span><span class=\"S1925 S1071 S2\" id=\"t1z_68\">-1 246 </span><span class=\"S1926 S1071 S2\" id=\"t20_68\">0 </span><span class=\"S1927 S1071 S2\" id=\"t21_68\">13 053 </span><span class=\"S1928 S1071 S2\" id=\"t22_68\">9 192 </span><span class=\"S1929 S1071 S2\" id=\"t23_68\">7 455 </span><span class=\"S192A S1071 S2\" id=\"t24_68\">28 453 </span><span class=\"S192B S1070 S2\" id=\"t25_68\">1th year instalments </span><span class=\"S192C S1070 S2\" id=\"t26_68\">-5 750 </span><span class=\"S192D S1070 S2\" id=\"t27_68\">-25 000 </span><span class=\"S192E S1070 S2\" id=\"t28_68\">-2 400 </span><span class=\"S192F S1070 S2\" id=\"t29_68\">-1 549 </span><span class=\"S1930 S1070 S2\" id=\"t2a_68\">-1 882 </span><span class=\"S1931 S1070 S2\" id=\"t2b_68\">-36 581 </span><span class=\"S1932 S1071 S2\" id=\"t2c_68\">Accumulated 31 December 2021 </span><span class=\"S1933 S1070 S2\" id=\"t2d_68\">139 350 </span><span class=\"S1934 S1070 S2\" id=\"t2e_68\">37 500 </span><span class=\"S1935 S1070 S2\" id=\"t2f_68\">13 052 </span><span class=\"S1936 S1070 S2\" id=\"t2g_68\">10 269 </span><span class=\"S1937 S1070 S2\" id=\"t2h_68\">6 322 </span><span class=\"S1938 S1070 S2\" id=\"t2i_68\">206 492 </span><span class=\"S1939 S1070 S2\" id=\"t2j_68\">Proceeds from loans and borrowing </span><span class=\"S193A S1070 S2\" id=\"t2k_68\">0 </span><span class=\"S193B S1070 S2\" id=\"t2l_68\">Loan repayment and earnout instalments </span><span class=\"S193C S1070 S2\" id=\"t2m_68\">-5 714 </span><span class=\"S193D S1070 S2\" id=\"t2n_68\">-25 000 </span><span class=\"S193E S1070 S2\" id=\"t2o_68\">-30 714 </span><span class=\"S193F S1070 S2\" id=\"t2p_68\">Payment of lease liabilities </span><span class=\"S1940 S1070 S2\" id=\"t2q_68\">-2 193 </span><span class=\"S1941 S1070 S2\" id=\"t2r_68\">-1 548 </span><span class=\"S1942 S1070 S2\" id=\"t2s_68\">-1 889 </span><span class=\"S1943 S1070 S2\" id=\"t2t_68\">-5 630 </span><span class=\"S1944 S1071 S2\" id=\"t2u_68\">Total changes from \ufb01nancing </span><span class=\"S1945 S1071 S2\" id=\"t2v_68\">-5 714 </span><span class=\"S1946 S1071 S2\" id=\"t2w_68\">-25 000 </span><span class=\"S1947 S1071 S2\" id=\"t2x_68\">-2 193 </span><span class=\"S1948 S1071 S2\" id=\"t2y_68\">-1 548 </span><span class=\"S1949 S1071 S2\" id=\"t2z_68\">-1 889 </span><span class=\"S194A S1071 S2\" id=\"t30_68\">-36 344 </span><span class=\"S194B S1070 S2\" id=\"t31_68\">Remeasurerd liability </span><span class=\"S194C S1070 S2\" id=\"t32_68\">758 </span><span class=\"S194D S1070 S2\" id=\"t33_68\">574 </span><span class=\"S194E S1070 S2\" id=\"t34_68\">1 245 </span><span class=\"S194F S1070 S2\" id=\"t35_68\">410 </span><span class=\"S1950 S1070 S2\" id=\"t36_68\">2 988 </span><span class=\"S1951 S1070 S2\" id=\"t37_68\">New lease liability </span><span class=\"S1952 S1070 S2\" id=\"t38_68\">-324 </span><span class=\"S1953 S1070 S2\" id=\"t39_68\">1 170 </span><span class=\"S1954 S1070 S2\" id=\"t3a_68\">846 </span><span class=\"S1955 S1070 S2\" id=\"t3b_68\">Interest expense </span><span class=\"S1956 S1070 S2\" id=\"t3c_68\">24 383 </span><span class=\"S1957 S1070 S2\" id=\"t3d_68\">846 </span><span class=\"S1958 S1070 S2\" id=\"t3e_68\">249 </span><span class=\"S1959 S1070 S2\" id=\"t3f_68\">248 </span><span class=\"S195A S1070 S2\" id=\"t3g_68\">79 </span><span class=\"S195B S1070 S2\" id=\"t3h_68\">25 804 </span><span class=\"S195C S1070 S2\" id=\"t3i_68\">Interest paid </span><span class=\"S195D S1070 S2\" id=\"t3j_68\">-23 444 </span><span class=\"S195E S1070 S2\" id=\"t3k_68\">-846 </span><span class=\"S195F S1070 S2\" id=\"t3l_68\">-249 </span><span class=\"S1960 S1070 S2\" id=\"t3m_68\">-298 </span><span class=\"S1961 S1070 S2\" id=\"t3n_68\">-79 </span><span class=\"S1962 S1070 S2\" id=\"t3o_68\">-24 915 </span><span class=\"S1963 S1071 S2\" id=\"t3p_68\">Total liability related changes </span><span class=\"S1964 S1071 S2\" id=\"t3q_68\">1 697 </span><span class=\"S1965 S1071 S2\" id=\"t3r_68\">0 </span><span class=\"S1966 S1071 S2\" id=\"t3s_68\">574 </span><span class=\"S1967 S1071 S2\" id=\"t3t_68\">871 </span><span class=\"S1968 S1071 S2\" id=\"t3u_68\">1 580 </span><span class=\"S1969 S1071 S2\" id=\"t3v_68\">4 723 </span><span class=\"S196A S1071 S2\" id=\"t3w_68\">Accumulated 31 December 2022 </span><span class=\"S196B S1071 S2\" id=\"t3x_68\">135 333 </span><span class=\"S196C S1071 S2\" id=\"t3y_68\">12 500 </span><span class=\"S196D S1071 S2\" id=\"t3z_68\">11 433 </span><span class=\"S196E S1071 S2\" id=\"t40_68\">9 591 </span><span class=\"S196F S1071 S2\" id=\"t41_68\">6 014 </span><span class=\"S1970 S1071 S2\" id=\"t42_68\">174 871 </span><span class=\"S1971 S1070 S2\" id=\"t43_68\">1th year instalments </span><span class=\"S1972 S1070 S2\" id=\"t44_68\">-9 100 </span><span class=\"S1973 S1070 S2\" id=\"t45_68\">-12 500 </span><span class=\"S1974 S1070 S2\" id=\"t46_68\">-2 302 </span><span class=\"S1975 S1070 S2\" id=\"t47_68\">-1 598 </span><span class=\"S1976 S1070 S2\" id=\"t48_68\">-1 882 </span><span class=\"S1977 S1070 S2\" id=\"t49_68\">-27 382 </span><span class=\"S19AC S106F S2\" id=\"t1i_69\">24. SUBSEQUENT EVENTS </span><span class=\"S19AD S1070 S2\" id=\"t1j_69\">Post-period, on March 21, 2023, Photocure announced that Karl Storz due to component supply issues will discontinue the </span><span class=\"S19AE S1070 S2\" id=\"t1k_69\">production of its current \ufb02exible BLC equipment in the U.S. Karl Storz plans to service existing customers through the remainder of </span><span class=\"S19AF S1070 S2\" id=\"t1l_69\">the year. Karl Storz will explore the development of a next generation state-of-the-art \ufb02exible blue light system pending a positive </span><span class=\"S19B0 S1070 S2\" id=\"t1m_69\">reclassi\ufb01cation decision by the U.S. Food &amp; Drug Administration (FDA). The impact from a lack of new \ufb02exible BLC installations in FY </span><span class=\"S19B1 S1070 S2\" id=\"t1n_69\">2023 is estimated to be less than 2% of Photocure\u2019s total revenue. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfNotesAndOtherExplanatoryInformationExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4929": {
   "value": "<span class=\"SFE8 S106F S2\" id=\"t4_46\">1. PARTNERSHIPS </span><span class=\"SFE9 S1070 S2\" id=\"t5_46\">Photocure entered in July 2019 into a license agreement providing Asieris MediTech Co with a world-wide license to develop and </span><span class=\"SFEA S1070 S2\" id=\"t6_46\">commercialize Cevira\u00ae for the treatment of HPV induced cervical precancerous lesions. Under the agreement, Photocure will receive </span><span class=\"SFEB S1070 S2\" id=\"t7_46\">signing fees, development- and approval milestones, in addition to sales royalties. </span><span class=\"SFEC S1070 S2\" id=\"t8_46\">Photocure entered in January 2021 into a license agreement providing Asieris MediTech Co with a license to commercialize Hexvix in </span><span class=\"SFED S1070 S2\" id=\"t9_46\">mainland China and Taiwan. Under this agreement, Photocure will receive signing fees and approval milestones, in addition to sales </span><span class=\"SFEE S1070 S2\" id=\"ta_46\">royalties. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAdditionalInformationExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f4937": {
   "value": "<span class=\"SFEF S106F S2\" id=\"tb_46\">2. OPERATING SEGMENTS </span><span class=\"SFF0 S1070 S2\" id=\"tc_46\">Photocure has two segments: Commercial Franchise and Development Portfolio. Commercial Franchise includes Hexvix/Cysview </span><span class=\"SFF1 S1070 S2\" id=\"td_46\">by geography (North America and Europe) and other sales (partners and other products including sales revenues for Hivec). </span><span class=\"SFF2 S1070 S2\" id=\"te_46\">Development Portfolio includes development of pipeline products. North America 2022 results includes U.S. and Canada while </span><span class=\"SFF3 S1070 S2\" id=\"tf_46\">2021 and earlier results include U.S. only as sales in Canada were through a partner. Total 2021 revenue for Photocure from this </span><span class=\"SFF4 S1070 S2\" id=\"tg_46\">partner was NOK 0.4 million. Sales revenue Europe in the Commercial segment consists of Hexvix direct sale to hospitals, wholesalers </span><span class=\"SFF5 S1070 S2\" id=\"th_46\">and pharmacies. </span><span class=\"SFF6 S1070 S2\" id=\"ti_46\">The Development segment is split by development of Cevira and other pipeline products. </span><span class=\"SFF7 S1070 S2\" id=\"tj_46\">Operating costs are charged directly to the respective segment involved if directly related. Indirect manufacturing costs are </span><span class=\"SFF8 S1070 S2\" id=\"tk_46\">allocated based on sales within the commercial segment and other indirect costs are allocated based on time and resources utilized </span><span class=\"SFF9 S1070 S2\" id=\"tl_46\">within the di\ufb00erent subsegments. </span><span class=\"SFFA S1070 S2\" id=\"tm_46\">Segment assets and liabilities are not reported to the Chief Operating Decision Makers (CODM) and therefore not allocated to </span><span class=\"SFFB S1070 S2\" id=\"tn_46\">reportable segments. </span><span class=\"SFFC S1071 S2\" id=\"to_46\">1 Jan - 31 December 2022 </span><span class=\"SFFD S1071 S2\" id=\"tp_46\">Commercial Franchise </span><span class=\"SFFE S1071 S2\" id=\"tq_46\">Development Portfolio </span><span class=\"SFFF S1070 S2\" id=\"tr_46\">(Amounts in NOK 1,000) </span><span class=\"S1000 S1071 S2\" id=\"ts_46\">North Am. </span><span class=\"S1001 S1071 S2\" id=\"tt_46\">Cysview </span><span class=\"S1002 S1071 S2\" id=\"tu_46\">Europe </span><span class=\"S1003 S1071 S2\" id=\"tv_46\">Hexvix </span><span class=\"S1004 S1071 S2\" id=\"tw_46\">Other </span><span class=\"S1005 S1071 S2\" id=\"tx_46\">Sales </span><span class=\"S1006 S1071 S2\" id=\"ty_46\">Total </span><span class=\"S1007 S1071 S2\" id=\"tz_46\">Sales </span><span class=\"S1008 S1071 S2\" id=\"t10_46\">Cevira </span><span class=\"S1009 S1071 S2\" id=\"t11_46\">PDT &amp; </span><span class=\"S100A S1071 S2\" id=\"t12_46\">Explorativ </span><span class=\"S100B S1071 S2\" id=\"t13_46\">Total </span><span class=\"S100C S1071 S2\" id=\"t14_46\">R&amp;D </span><span class=\"S100D S1071 S2\" id=\"t15_46\">Grand </span><span class=\"S100E S1071 S2\" id=\"t16_46\">Total </span><span class=\"S100F S1070 S2\" id=\"t17_46\">Revenues from contract </span><span class=\"S1010 S1070 S2\" id=\"t18_46\">with customers </span><span class=\"S1011 S1070 S2\" id=\"t19_46\">150 784 </span><span class=\"S1012 S1070 S2\" id=\"t1a_46\">221 826 </span><span class=\"S1013 S1070 S2\" id=\"t1b_46\">1 863 </span><span class=\"S1014 S1070 S2\" id=\"t1c_46\">374 474 </span><span class=\"S1015 S1070 S2\" id=\"t1d_46\">- </span><span class=\"S1016 S1070 S2\" id=\"t1e_46\">- </span><span class=\"S1017 S1070 S2\" id=\"t1f_46\">- </span><span class=\"S1018 S1070 S2\" id=\"t1g_46\">374 474 </span><span class=\"S1019 S1070 S2\" id=\"t1h_46\">Signing fees and milestone </span><span class=\"S101A S1070 S2\" id=\"t1i_46\">revenues </span><span class=\"S101B S1070 S2\" id=\"t1j_46\">- </span><span class=\"S101C S1070 S2\" id=\"t1k_46\">- </span><span class=\"S101D S1070 S2\" id=\"t1l_46\">152 </span><span class=\"S101E S1070 S2\" id=\"t1m_46\">152 </span><span class=\"S101F S1070 S2\" id=\"t1n_46\">18 506 </span><span class=\"S1020 S1070 S2\" id=\"t1o_46\">- </span><span class=\"S1021 S1070 S2\" id=\"t1p_46\">18 506 </span><span class=\"S1022 S1070 S2\" id=\"t1q_46\">18 658 </span><span class=\"S1023 S1070 S2\" id=\"t1r_46\">Cost of goods sold </span><span class=\"S1024 S1070 S2\" id=\"t1s_46\">-4 835 </span><span class=\"S1025 S1070 S2\" id=\"t1t_46\">-16 810 </span><span class=\"S1026 S1070 S2\" id=\"t1u_46\">-1 052 </span><span class=\"S1027 S1070 S2\" id=\"t1v_46\">-22 697 </span><span class=\"S1028 S1070 S2\" id=\"t1w_46\">- </span><span class=\"S1029 S1070 S2\" id=\"t1x_46\">- </span><span class=\"S102A S1070 S2\" id=\"t1y_46\">- </span><span class=\"S102B S1070 S2\" id=\"t1z_46\">-22 697 </span><span class=\"S102C S1071 S2\" id=\"t20_46\">Gross pro\ufb01t </span><span class=\"S102D S1071 S2\" id=\"t21_46\">145 950 </span><span class=\"S102E S1071 S2\" id=\"t22_46\">205 016 </span><span class=\"S102F S1071 S2\" id=\"t23_46\">963 </span><span class=\"S1030 S1071 S2\" id=\"t24_46\">351 929 </span><span class=\"S1031 S1071 S2\" id=\"t25_46\">18 506 </span><span class=\"S1032 S1071 S2\" id=\"t26_46\">- </span><span class=\"S1033 S1071 S2\" id=\"t27_46\">18 506 </span><span class=\"S1034 S1071 S2\" id=\"t28_46\">370 435 </span><span class=\"S1035 S1070 S2\" id=\"t29_46\">Gross pro\ufb01t of sales % </span><span class=\"S1036 S1070 S2\" id=\"t2a_46\">97 % </span><span class=\"S1037 S1070 S2\" id=\"t2b_46\">92 % </span><span class=\"S1038 S1070 S2\" id=\"t2c_46\">44 % </span><span class=\"S1039 S1070 S2\" id=\"t2d_46\">94 % </span><span class=\"S103A S1070 S2\" id=\"t2e_46\">94 % </span><span class=\"S103B S1070 S2\" id=\"t2f_46\">R&amp;D </span><span class=\"S103C S1070 S2\" id=\"t2g_46\">-322 </span><span class=\"S103D S1070 S2\" id=\"t2h_46\">-1 211 </span><span class=\"S103E S1070 S2\" id=\"t2i_46\">- </span><span class=\"S103F S1070 S2\" id=\"t2j_46\">-1 533 </span><span class=\"S1040 S1070 S2\" id=\"t2k_46\">-739 </span><span class=\"S1041 S1070 S2\" id=\"t2l_46\">-1 070 </span><span class=\"S1042 S1070 S2\" id=\"t2m_46\">-1 809 </span><span class=\"S1043 S1070 S2\" id=\"t2n_46\">-3 342 </span><span class=\"S1044 S1070 S2\" id=\"t2o_46\">Sales &amp; marketing </span><span class=\"S1045 S1070 S2\" id=\"t2p_46\">-163 706 </span><span class=\"S1046 S1070 S2\" id=\"t2q_46\">-118 563 </span><span class=\"S1047 S1070 S2\" id=\"t2r_46\">-3 619 </span><span class=\"S1048 S1070 S2\" id=\"t2s_46\">-285 888 </span><span class=\"S1049 S1070 S2\" id=\"t2t_46\">-645 </span><span class=\"S104A S1070 S2\" id=\"t2u_46\">- </span><span class=\"S104B S1070 S2\" id=\"t2v_46\">-645 </span><span class=\"S104C S1070 S2\" id=\"t2w_46\">-286 533 </span><span class=\"S104D S1070 S2\" id=\"t2x_46\">Other &amp; allocations </span><span class=\"S104E S1070 S2\" id=\"t2y_46\">-38 214 </span><span class=\"S104F S1070 S2\" id=\"t2z_46\">-52 758 </span><span class=\"S1050 S1070 S2\" id=\"t30_46\">-8 177 </span><span class=\"S1051 S1070 S2\" id=\"t31_46\">-99 149 </span><span class=\"S1052 S1070 S2\" id=\"t32_46\">-1 933 </span><span class=\"S1053 S1070 S2\" id=\"t33_46\">-4 106 </span><span class=\"S1054 S1070 S2\" id=\"t34_46\">-6 038 </span><span class=\"S1055 S1070 S2\" id=\"t35_46\">-105 187 </span><span class=\"S1056 S1071 S2\" id=\"t36_46\">Operating expenses </span><span class=\"S1057 S1071 S2\" id=\"t37_46\">-202 242 </span><span class=\"S1058 S1071 S2\" id=\"t38_46\">-172 532  -11 795 </span><span class=\"S1059 S1071 S2\" id=\"t39_46\">-386 570 </span><span class=\"S105A S1071 S2\" id=\"t3a_46\">-3 317 </span><span class=\"S105B S1071 S2\" id=\"t3b_46\">-5 176 </span><span class=\"S105C S1071 S2\" id=\"t3c_46\">-8 492 </span><span class=\"S105D S1071 S2\" id=\"t3d_46\">-395 062 </span><span class=\"S105E S1071 S2\" id=\"t3e_46\">EBITDA before restructuring </span><span class=\"S105F S1071 S2\" id=\"t3f_46\">-56 292 </span><span class=\"S1060 S1071 S2\" id=\"t3g_46\">32 484 </span><span class=\"S1061 S1071 S1072 S2\" id=\"t3h_46\">-10 832 </span><span class=\"S1062 S1071 S2\" id=\"t3i_46\">-34 641 </span><span class=\"S1063 S1071 S2\" id=\"t3j_46\">15 189 </span><span class=\"S1064 S1071 S2\" id=\"t3k_46\">-5 176 </span><span class=\"S1065 S1071 S2\" id=\"t3l_46\">10 013 </span><span class=\"S1066 S1071 S2\" id=\"t3m_46\">-24 627 </span><span class=\"S1067 S1071 S2\" id=\"t3n_46\">Depreciation and Amortization </span><span class=\"S1068 S1071 S2\" id=\"t3o_46\">-24 231 </span><span class=\"S1069 S1071 S2\" id=\"t3p_46\">-147 </span><span class=\"S106A S1071 S2\" id=\"t3q_46\">-24 378 </span><span class=\"S106B S1071 S2\" id=\"t3r_46\">EBIT before restructuring </span><span class=\"S106C S1071 S2\" id=\"t3s_46\">-58 872 </span><span class=\"S106D S1071 S2\" id=\"t3t_46\">9 866 </span><span class=\"S1074 S1071 S2\" id=\"t2_47\">1 Jan - 31 December 2021 </span><span class=\"S1075 S1071 S2\" id=\"t3_47\">Commercial Franchise </span><span class=\"S1076 S1071 S2\" id=\"t4_47\">Development Portfolio </span><span class=\"S1077 S1070 S2\" id=\"t5_47\">(Amounts in NOK 1,000) </span><span class=\"S1078 S1071 S2\" id=\"t6_47\">U.S. </span><span class=\"S1079 S1071 S2\" id=\"t7_47\">Cysview </span><span class=\"S107A S1071 S2\" id=\"t8_47\">Europe </span><span class=\"S107B S1071 S2\" id=\"t9_47\">Hexvix </span><span class=\"S107C S1071 S2\" id=\"ta_47\">Other </span><span class=\"S107D S1071 S2\" id=\"tb_47\">Sales </span><span class=\"S107E S1071 S2\" id=\"tc_47\">Total </span><span class=\"S107F S1071 S2\" id=\"td_47\">Sales </span><span class=\"S1080 S1071 S2\" id=\"te_47\">Cevira </span><span class=\"S1081 S1071 S2\" id=\"tf_47\">PDT &amp; </span><span class=\"S1082 S1071 S2\" id=\"tg_47\">Explorativ </span><span class=\"S1083 S1071 S2\" id=\"th_47\">Total </span><span class=\"S1084 S1071 S2\" id=\"ti_47\">R&amp;D </span><span class=\"S1085 S1071 S2\" id=\"tj_47\">Grand </span><span class=\"S1086 S1071 S2\" id=\"tk_47\">Total </span><span class=\"S1087 S1070 S2\" id=\"tl_47\">Revenues from contract </span><span class=\"S1088 S1070 S2\" id=\"tm_47\">with customers </span><span class=\"S1089 S1070 S2\" id=\"tn_47\">125 232 </span><span class=\"S108A S1070 S2\" id=\"to_47\">225 751 </span><span class=\"S108B S1070 S2\" id=\"tp_47\">1 306 </span><span class=\"S108C S1070 S2\" id=\"tq_47\">352 289 </span><span class=\"S108D S1070 S2\" id=\"tr_47\">1 836 </span><span class=\"S108E S1070 S2\" id=\"ts_47\">- </span><span class=\"S108F S1070 S2\" id=\"tt_47\">1 836 </span><span class=\"S1090 S1070 S2\" id=\"tu_47\">354 125 </span><span class=\"S1091 S1070 S2\" id=\"tv_47\">Signing fees and milestone </span><span class=\"S1092 S1070 S2\" id=\"tw_47\">revenues </span><span class=\"S1093 S1070 S2\" id=\"tx_47\">- </span><span class=\"S1094 S1070 S2\" id=\"ty_47\">- </span><span class=\"S1095 S1070 S2\" id=\"tz_47\">6 416 </span><span class=\"S1096 S1070 S2\" id=\"t10_47\">6 416 </span><span class=\"S1097 S1070 S2\" id=\"t11_47\">- </span><span class=\"S1098 S1070 S2\" id=\"t12_47\">- </span><span class=\"S1099 S1070 S2\" id=\"t13_47\">- </span><span class=\"S109A S1070 S2\" id=\"t14_47\">6 416 </span><span class=\"S109B S1070 S2\" id=\"t15_47\">Cost of goods sold </span><span class=\"S109C S1070 S2\" id=\"t16_47\">-3 901 </span><span class=\"S109D S1070 S2\" id=\"t17_47\">-18 454 </span><span class=\"S109E S1070 S2\" id=\"t18_47\">-521 </span><span class=\"S109F S1070 S2\" id=\"t19_47\">-22 876 </span><span class=\"S10A0 S1070 S2\" id=\"t1a_47\">-1 175 </span><span class=\"S10A1 S1070 S2\" id=\"t1b_47\">- </span><span class=\"S10A2 S1070 S2\" id=\"t1c_47\">-1 175 </span><span class=\"S10A3 S1070 S2\" id=\"t1d_47\">-24 051 </span><span class=\"S10A4 S1071 S2\" id=\"t1e_47\">Gross pro\ufb01t </span><span class=\"S10A5 S1071 S2\" id=\"t1f_47\">121 331 </span><span class=\"S10A6 S1071 S2\" id=\"t1g_47\">207 297 </span><span class=\"S10A7 S1071 S2\" id=\"t1h_47\">7 201 </span><span class=\"S10A8 S1071 S2\" id=\"t1i_47\">335 829 </span><span class=\"S10A9 S1071 S2\" id=\"t1j_47\">661 </span><span class=\"S10AA S1071 S2\" id=\"t1k_47\">- </span><span class=\"S10AB S1071 S2\" id=\"t1l_47\">661 </span><span class=\"S10AC S1071 S2\" id=\"t1m_47\">336 490 </span><span class=\"S10AD S1070 S2\" id=\"t1n_47\">Gross pro\ufb01t of sales % </span><span class=\"S10AE S1070 S2\" id=\"t1o_47\">97 % </span><span class=\"S10AF S1070 S2\" id=\"t1p_47\">92 % </span><span class=\"S10B0 S1070 S2\" id=\"t1q_47\">60 % </span><span class=\"S10B1 S1070 S2\" id=\"t1r_47\">94 % </span><span class=\"S10B2 S1070 S2\" id=\"t1s_47\">36 % </span><span class=\"S10B3 S1070 S2\" id=\"t1t_47\">36 % </span><span class=\"S10B4 S1070 S2\" id=\"t1u_47\">93 % </span><span class=\"S10B5 S1070 S2\" id=\"t1v_47\">R&amp;D </span><span class=\"S10B6 S1070 S2\" id=\"t1w_47\">-386 </span><span class=\"S10B7 S1070 S2\" id=\"t1x_47\">-1 279 </span><span class=\"S10B8 S1070 S2\" id=\"t1y_47\">- </span><span class=\"S10B9 S1070 S2\" id=\"t1z_47\">-1 665 </span><span class=\"S10BA S1070 S2\" id=\"t20_47\">-390 </span><span class=\"S10BB S1070 S2\" id=\"t21_47\">-2 267 </span><span class=\"S10BC S1070 S2\" id=\"t22_47\">-2 657 </span><span class=\"S10BD S1070 S2\" id=\"t23_47\">-4 322 </span><span class=\"S10BE S1070 S2\" id=\"t24_47\">Sales &amp; marketing </span><span class=\"S10BF S1070 S2\" id=\"t25_47\">-131 251 </span><span class=\"S10C0 S1070 S2\" id=\"t26_47\">-105 127 </span><span class=\"S10C1 S1070 S2\" id=\"t27_47\">-5 976 </span><span class=\"S10C2 S1070 S2\" id=\"t28_47\">-242 354 </span><span class=\"S10C3 S1070 S2\" id=\"t29_47\">-612 </span><span class=\"S10C4 S1070 S2\" id=\"t2a_47\">- </span><span class=\"S10C5 S1070 S2\" id=\"t2b_47\">-612 </span><span class=\"S10C6 S1070 S2\" id=\"t2c_47\">-242 966 </span><span class=\"S10C7 S1070 S2\" id=\"t2d_47\">Other &amp; allocations </span><span class=\"S10C8 S1070 S2\" id=\"t2e_47\">-24 920 </span><span class=\"S10C9 S1070 S2\" id=\"t2f_47\">-37 083 </span><span class=\"S10CA S1070 S2\" id=\"t2g_47\">-5 317 </span><span class=\"S10CB S1070 S2\" id=\"t2h_47\">-67 320 </span><span class=\"S10CC S1070 S2\" id=\"t2i_47\">-1 141 </span><span class=\"S10CD S1070 S2\" id=\"t2j_47\">-2 440 </span><span class=\"S10CE S1070 S2\" id=\"t2k_47\">-3 581 </span><span class=\"S10CF S1070 S2\" id=\"t2l_47\">-70 901 </span><span class=\"S10D0 S1071 S2\" id=\"t2m_47\">Operating expenses </span><span class=\"S10D1 S1071 S2\" id=\"t2n_47\">-156 557 </span><span class=\"S10D2 S1071 S2\" id=\"t2o_47\">-143 489  -11 293 </span><span class=\"S10D3 S1071 S2\" id=\"t2p_47\">-311 339 </span><span class=\"S10D4 S1071 S2\" id=\"t2q_47\">-2 143 </span><span class=\"S10D5 S1071 S2\" id=\"t2r_47\">-4 707 </span><span class=\"S10D6 S1071 S2\" id=\"t2s_47\">-6 850 </span><span class=\"S10D7 S1071 S2\" id=\"t2t_47\">-318 189 </span><span class=\"S10D8 S1071 S2\" id=\"t2u_47\">EBITDA before restructuring </span><span class=\"S10D9 S1071 S2\" id=\"t2v_47\">-35 226 </span><span class=\"S10DA S1071 S2\" id=\"t2w_47\">63 808 </span><span class=\"S10DB S1071 S2\" id=\"t2x_47\">-4 092 </span><span class=\"S10DC S1071 S2\" id=\"t2y_47\">24 490 </span><span class=\"S10DD S1071 S2\" id=\"t2z_47\">-1 482 </span><span class=\"S10DE S1071 S2\" id=\"t30_47\">-4 707 </span><span class=\"S10DF S1071 S2\" id=\"t31_47\">-6 189 </span><span class=\"S10E0 S1071 S2\" id=\"t32_47\">18 301 </span><span class=\"S10E1 S1071 S2\" id=\"t33_47\">Depreciation and Amortization </span><span class=\"S10E2 S1071 S2\" id=\"t34_47\">-23 889 </span><span class=\"S10E3 S1071 S2\" id=\"t35_47\">-238 </span><span class=\"S10E4 S1071 S2\" id=\"t36_47\">-24 127 </span><span class=\"S10E5 S1071 S2\" id=\"t37_47\">EBIT before restructuring </span><span class=\"S10E6 S1071 S2\" id=\"t38_47\">601 </span><span class=\"S10E7 S1071 S2\" id=\"t39_47\">-6 427 </span><span class=\"S10E8 S1071 S2\" id=\"t3a_47\">-5 826 </span><span class=\"S10E9 S1070 S2\" id=\"t3b_47\">The de\ufb01nition of EBITDA is \u201cEarnings Before Interest, Tax, Depreciation and Amortization\u201d. </span><span class=\"S1109 S1071 S2\" id=\"t4_48\">Geographical information </span><span class=\"S110A S1070 S2\" id=\"t5_48\">(Amounts in NOK 1,000) </span><span class=\"S110B S1071 S2\" id=\"t6_48\">Group revenues from contract with customers </span><span class=\"S110C S1071 S2\" id=\"t7_48\">2022 </span><span class=\"S110D S1071 S2\" id=\"t8_48\">2021 </span><span class=\"S110E S1070 S2\" id=\"t9_48\">Nordic countries </span><span class=\"S110F S1070 S2\" id=\"ta_48\">22 647 </span><span class=\"S1110 S1070 S2\" id=\"tb_48\">31 882 </span><span class=\"S1111 S1070 S2\" id=\"tc_48\">Germany </span><span class=\"S1112 S1070 S2\" id=\"td_48\">148 936 </span><span class=\"S1113 S1070 S2\" id=\"te_48\">141 920 </span><span class=\"S1114 S1070 S2\" id=\"tf_48\">France </span><span class=\"S1115 S1070 S2\" id=\"tg_48\">27 032 </span><span class=\"S1116 S1070 S2\" id=\"th_48\">29 021 </span><span class=\"S1117 S1070 S2\" id=\"ti_48\">Austria </span><span class=\"S1118 S1070 S2\" id=\"tj_48\">9 500 </span><span class=\"S1119 S1070 S2\" id=\"tk_48\">8 983 </span><span class=\"S111A S1070 S2\" id=\"tl_48\">UK </span><span class=\"S111B S1070 S2\" id=\"tm_48\">2 147 </span><span class=\"S111C S1070 S2\" id=\"tn_48\">3 448 </span><span class=\"S111D S1070 S2\" id=\"to_48\">BeNeLux </span><span class=\"S111E S1070 S2\" id=\"tp_48\">4 597 </span><span class=\"S111F S1070 S2\" id=\"tq_48\">6 927 </span><span class=\"S1120 S1070 S2\" id=\"tr_48\">Italy </span><span class=\"S1121 S1070 S2\" id=\"ts_48\">4 368 </span><span class=\"S1122 S1070 S2\" id=\"tt_48\">1 700 </span><span class=\"S1123 S1070 S2\" id=\"tu_48\">Other European countries </span><span class=\"S1124 S1070 S2\" id=\"tv_48\">3 905 </span><span class=\"S1125 S1070 S2\" id=\"tw_48\">2 778 </span><span class=\"S1126 S1070 S2\" id=\"tx_48\">United States </span><span class=\"S1127 S1070 S2\" id=\"ty_48\">149 045 </span><span class=\"S1128 S1070 S2\" id=\"tz_48\">125 232 </span><span class=\"S1129 S1070 S2\" id=\"t10_48\">Canada </span><span class=\"S112A S1070 S2\" id=\"t11_48\">1 740 </span><span class=\"S112B S1071 S2\" id=\"t12_48\">Own sales </span><span class=\"S112C S1071 S2\" id=\"t13_48\">373 917 </span><span class=\"S112D S1071 S2\" id=\"t14_48\">351 891 </span><span class=\"S112E S1070 S2\" id=\"t15_48\">Partner countries rest of world </span><span class=\"S112F S1070 S2\" id=\"t16_48\">557 </span><span class=\"S1130 S1070 S2\" id=\"t17_48\">2 233 </span><span class=\"S1131 S1071 S2\" id=\"t18_48\">374 474 </span><span class=\"S1132 S1071 S2\" id=\"t19_48\">354 124 </span><span class=\"S1133 S1070 S2\" id=\"t1a_48\">The geographical revenue in all countries except North America are in the parent company. The geographical revenue information is </span><span class=\"S1134 S1070 S2\" id=\"t1b_48\">based on the location of the end customers. </span><span class=\"S1135 S1070 S2\" id=\"t1c_48\">The signing fees and milestone revenue are not included in the table above. </span><span class=\"S1136 S1071 S2\" id=\"t1d_48\">Revenue recognition by segments </span><span class=\"S1137 S1071 S2\" id=\"t1e_48\">1 Jan - 31 December 2022 </span><span class=\"S1138 S1071 S2\" id=\"t1f_48\">Commercial Franchise </span><span class=\"S1139 S1071 S2\" id=\"t1g_48\">Development Portfolio </span><span class=\"S113A S1071 S2\" id=\"t1h_48\">Grand </span><span class=\"S113B S1071 S2\" id=\"t1i_48\">Total </span><span class=\"S113C S1071 S2\" id=\"t1j_48\">Hexvix/Cysview </span><span class=\"S113D S1070 S2\" id=\"t1k_48\">(Amounts in NOK 1,000) </span><span class=\"S113E S1071 S2\" id=\"t1l_48\">Own sales </span><span class=\"S113F S1071 S2\" id=\"t1m_48\">Partner </span><span class=\"S1140 S1071 S2\" id=\"t1n_48\">Other </span><span class=\"S1141 S1071 S2\" id=\"t1o_48\">Sales </span><span class=\"S1142 S1071 S2\" id=\"t1p_48\">Total </span><span class=\"S1143 S1071 S2\" id=\"t1q_48\">Sales </span><span class=\"S1144 S1071 S2\" id=\"t1r_48\">Pipeline </span><span class=\"S1145 S1071 S2\" id=\"t1s_48\">Total </span><span class=\"S1146 S1071 S2\" id=\"t1t_48\">R&amp;D </span><span class=\"S1147 S1070 S2\" id=\"t1u_48\">Contract revenue at point in time </span><span class=\"S1148 S1070 S2\" id=\"t1v_48\">430 </span><span class=\"S1149 S1070 S2\" id=\"t1w_48\">128 </span><span class=\"S114A S1071 S2\" id=\"t1x_48\">558 </span><span class=\"S114B S1070 S2\" id=\"t1y_48\">0 </span><span class=\"S114C S1070 S2\" id=\"t1z_48\">0 </span><span class=\"S114D S1071 S2\" id=\"t20_48\">558 </span><span class=\"S114E S1070 S2\" id=\"t21_48\">Contract revenue over time </span><span class=\"S114F S1071 S2\" id=\"t22_48\">0 </span><span class=\"S1150 S1070 S2\" id=\"t23_48\">0 </span><span class=\"S1151 S1071 S2\" id=\"t24_48\">0 </span><span class=\"S1152 S1070 S2\" id=\"t25_48\">Signing fees and milestone </span><span class=\"S1153 S1070 S2\" id=\"t26_48\">revenues at point in time </span><span class=\"S1154 S1070 S2\" id=\"t27_48\">152 </span><span class=\"S1155 S1071 S2\" id=\"t28_48\">152 </span><span class=\"S1156 S1070 S2\" id=\"t29_48\">18 506 </span><span class=\"S1157 S1070 S2\" id=\"t2a_48\">18 506 </span><span class=\"S1158 S1071 S2\" id=\"t2b_48\">18 658 </span><span class=\"S1159 S1071 S2\" id=\"t2c_48\">Sales order revenue at point </span><span class=\"S115A S1071 S2\" id=\"t2d_48\">in time </span><span class=\"S115B S1070 S2\" id=\"t2e_48\">372 611 </span><span class=\"S115C S1070 S2\" id=\"t2f_48\">1 306 </span><span class=\"S115D S1071 S2\" id=\"t2g_48\">373 917 </span><span class=\"S115E S1070 S2\" id=\"t2h_48\">0 </span><span class=\"S115F S1071 S2\" id=\"t2i_48\">373 917 </span><span class=\"S1160 S1071 S2\" id=\"t2j_48\">372 611 </span><span class=\"S1161 S1071 S2\" id=\"t2k_48\">582 </span><span class=\"S1162 S1071 S2\" id=\"t2l_48\">1 434 </span><span class=\"S1163 S1071 S2\" id=\"t2m_48\">374 627 </span><span class=\"S1164 S1071 S2\" id=\"t2n_48\">18 506 </span><span class=\"S1165 S1071 S2\" id=\"t2o_48\">18 506 </span><span class=\"S1166 S1071 S2\" id=\"t2p_48\">393 132 </span><span class=\"S1167 S1071 S2\" id=\"t2q_48\">Revenue recognition by segments </span><span class=\"S1168 S1071 S2\" id=\"t2r_48\">1 Jan - 31 December 2021 </span><span class=\"S1169 S1071 S2\" id=\"t2s_48\">Commercial Franchise </span><span class=\"S116A S1071 S2\" id=\"t2t_48\">Development Portfolio </span><span class=\"S116B S1071 S2\" id=\"t2u_48\">Grand </span><span class=\"S116C S1071 S2\" id=\"t2v_48\">Total </span><span class=\"S116D S1071 S2\" id=\"t2w_48\">Hexvix/Cysview </span><span class=\"S116E S1070 S2\" id=\"t2x_48\">(Amounts in NOK 1,000) </span><span class=\"S116F S1071 S2\" id=\"t2y_48\">Own sales </span><span class=\"S1170 S1071 S2\" id=\"t2z_48\">Partner </span><span class=\"S1171 S1071 S2\" id=\"t30_48\">Other </span><span class=\"S1172 S1071 S2\" id=\"t31_48\">Sales </span><span class=\"S1173 S1071 S2\" id=\"t32_48\">Total </span><span class=\"S1174 S1071 S2\" id=\"t33_48\">Sales </span><span class=\"S1175 S1071 S2\" id=\"t34_48\">Pipeline </span><span class=\"S1176 S1071 S2\" id=\"t35_48\">Total </span><span class=\"S1177 S1071 S2\" id=\"t36_48\">R&amp;D </span><span class=\"S1178 S1070 S2\" id=\"t37_48\">Contract revenue at point in time </span><span class=\"S1179 S1071 S2\" id=\"t38_48\">- </span><span class=\"S117A S1070 S2\" id=\"t39_48\">1 832 </span><span class=\"S117B S1070 S2\" id=\"t3a_48\">1 832 </span><span class=\"S117C S1071 S2\" id=\"t3b_48\">1 832 </span><span class=\"S117D S1070 S2\" id=\"t3c_48\">Contract revenue over time </span><span class=\"S117E S1070 S2\" id=\"t3d_48\">397 </span><span class=\"S117F S1071 S2\" id=\"t3e_48\">397 </span><span class=\"S1180 S1070 S2\" id=\"t3f_48\">0 </span><span class=\"S1181 S1071 S2\" id=\"t3g_48\">397 </span><span class=\"S1182 S1070 S2\" id=\"t3h_48\">Signing fees and milestone </span><span class=\"S1183 S1070 S2\" id=\"t3i_48\">revenues at point in time </span><span class=\"S1184 S1070 S2\" id=\"t3j_48\">6 416 </span><span class=\"S1185 S1071 S2\" id=\"t3k_48\">6 416 </span><span class=\"S1186 S1070 S2\" id=\"t3l_48\">0 </span><span class=\"S1187 S1071 S2\" id=\"t3m_48\">6 416 </span><span class=\"S1188 S1071 S2\" id=\"t3n_48\">Sales order revenue </span><span class=\"S1189 S1071 S2\" id=\"t3o_48\">at point in time </span><span class=\"S118A S1070 S2\" id=\"t3p_48\">350 983 </span><span class=\"S118B S1070 S2\" id=\"t3q_48\">913 </span><span class=\"S118C S1071 S2\" id=\"t3r_48\">351 896 </span><span class=\"S118D S1070 S2\" id=\"t3s_48\">0 </span><span class=\"S118E S1071 S2\" id=\"t3t_48\">351 896 </span><span class=\"S118F S1071 S2\" id=\"t3u_48\">350 983 </span><span class=\"S1190 S1071 S2\" id=\"t3v_48\">6 813 </span><span class=\"S1191 S1071 S2\" id=\"t3w_48\">913 </span><span class=\"S1192 S1071 S2\" id=\"t3x_48\">358 709 </span><span class=\"S1193 S1071 S2\" id=\"t3y_48\">1 832 </span><span class=\"S1194 S1071 S2\" id=\"t3z_48\">1 832 </span><span class=\"S1195 S1071 S2\" id=\"t40_48\">360 540 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5192": {
   "value": "<span class=\"S10EA S106F S2\" id=\"t3c_47\">3. REVENUES FROM CONTRACT WITH CUSTOMERS </span><span class=\"S10EB S1071 S2\" id=\"t3d_47\">Performance obligation product deliveries </span><span class=\"S10EC S1070 S2\" id=\"t3e_47\">For the general supply of products Photocure satisfy the contractual performance obligation upon delivery of products according to </span><span class=\"S10ED S1070 S2\" id=\"t3f_47\">the delivery terms agreed. Invoices are issued at that point in time and the payment term is usually within 30 days. No discounts were </span><span class=\"S10EE S1070 S2\" id=\"t3g_47\">provided to the customers and no return of products were accepted within the expiry of the products. </span><span class=\"S10EF S1071 S2\" id=\"t3h_47\">Performance obligation license </span><span class=\"S10F0 S1070 S2\" id=\"t3i_47\">Photocure entered a license agreement with Asieris for the development and commercialization of product Cevira in July 2019. </span><span class=\"S10F1 S1070 S2\" id=\"t3j_47\">The agreement is based on a \u201cready for Phase 3 study\u201d concept and this study will be carried out by Asieris in China from 2020. </span><span class=\"S10F2 S1070 S2\" id=\"t3k_47\">Photocure has in the agreement with Asieris agreed to transfer the rights for the development and commercialization of Cevira </span><span class=\"S10F3 S1070 S2\" id=\"t3l_47\">(license) and to deliver the active substance for the phase 3 study. Asieris will be responsible for the remaining development of Cevira </span><span class=\"S10F4 S1070 S2\" id=\"t3m_47\">and pay all the costs. The license is a right to use Photocure\u2019s intellectual property as it existed at the contract date. The active </span><span class=\"S10F5 S1070 S2\" id=\"t3n_47\">substance will not be further developed or changed by Photocure for use by Asieris. The transfer of the license and the delivery of </span><span class=\"S10F6 S1070 S2\" id=\"t3o_47\">the active substance are by Photocure regarded as two separate performance obligations. </span><span class=\"S10F7 S1070 S2\" id=\"t3p_47\">Asieris has in 2022 paid one milestone of USD 2.0 million related to the phase 3 study and accumulated paid USD 10 million in </span><span class=\"S10F8 S1070 S2\" id=\"t3q_47\">milestones for Cevira. The agreement include additional milestones and potential sales royalty if a commercial product is approved, </span><span class=\"S10F9 S1070 S2\" id=\"t3r_47\">this will depend on the outcome of the ongoing phase 3 study. The transaction price allocated to the license consist of signing fee, </span><span class=\"S10FA S1070 S2\" id=\"t3s_47\">di\ufb00erent milestone payments and sales based royalty payments. The part of the transaction price related to milestone payments are </span><span class=\"S10FB S1070 S2\" id=\"t3t_47\">estimated as the most likely amount, but constrained which currently means that these revenues will be recognized if and when the </span><span class=\"S10FC S1070 S2\" id=\"t3u_47\">relevant milestone are achieved. </span><span class=\"S10FD S1070 S2\" id=\"t3v_47\">Revenue for the sale of active substance is recognized when the customer takes control of the goods, which is at the time of </span><span class=\"S10FE S1070 S2\" id=\"t3w_47\">shipment. </span><span class=\"S10FF S1070 S2\" id=\"t3x_47\">Photocure has in January 2021 entered into a partnership agreement with Asieris whereby Asieris has obtained exclusive rights </span><span class=\"S1100 S1070 S2\" id=\"t3y_47\">to register and commercialize Hexvix[\u00ae] in Mainland China and Taiwan. Based on the agreement, Photocure received an upfront </span><span class=\"S1101 S1070 S2\" id=\"t3z_47\">payment of USD 750,000 from Asieris for the rights to Hexvix in the designated territories as a non-refundable payment. Asieris will </span><span class=\"S1102 S1070 S2\" id=\"t40_47\">fund all costs to secure required clinical studies and to regulatory approvals of Hexvix in Mainland China and Taiwan. </span><span class=\"S1103 S1070 S2\" id=\"t41_47\">The license of the Groups intellectual property are under all current licensing agreement considered distinct from the delivery of </span><span class=\"S1104 S1070 S2\" id=\"t42_47\">goods and thus a separate performance obligation. Furthermore the licenses are considered to be a right to use the company\u2019s </span><span class=\"S1105 S1070 S2\" id=\"t43_47\">intellectual property as is, and therefore revenue allocated to the license is recognized at point in time taking into consideration the </span><span class=\"S1106 S1070 S2\" id=\"t44_47\">variable constraint for milestone payments that have not yet occurred and sales based royalty. Milestone payments related to future </span>events and sales based royalties are recognized when the events and sales actually occur<span class=\"S1109 S1071 S2\" id=\"t4_48\">Geographical information </span><span class=\"S110A S1070 S2\" id=\"t5_48\">(Amounts in NOK 1,000) </span><span class=\"S110B S1071 S2\" id=\"t6_48\">Group revenues from contract with customers </span><span class=\"S110C S1071 S2\" id=\"t7_48\">2022 </span><span class=\"S110D S1071 S2\" id=\"t8_48\">2021 </span><span class=\"S110E S1070 S2\" id=\"t9_48\">Nordic countries </span><span class=\"S110F S1070 S2\" id=\"ta_48\">22 647 </span><span class=\"S1110 S1070 S2\" id=\"tb_48\">31 882 </span><span class=\"S1111 S1070 S2\" id=\"tc_48\">Germany </span><span class=\"S1112 S1070 S2\" id=\"td_48\">148 936 </span><span class=\"S1113 S1070 S2\" id=\"te_48\">141 920 </span><span class=\"S1114 S1070 S2\" id=\"tf_48\">France </span><span class=\"S1115 S1070 S2\" id=\"tg_48\">27 032 </span><span class=\"S1116 S1070 S2\" id=\"th_48\">29 021 </span><span class=\"S1117 S1070 S2\" id=\"ti_48\">Austria </span><span class=\"S1118 S1070 S2\" id=\"tj_48\">9 500 </span><span class=\"S1119 S1070 S2\" id=\"tk_48\">8 983 </span><span class=\"S111A S1070 S2\" id=\"tl_48\">UK </span><span class=\"S111B S1070 S2\" id=\"tm_48\">2 147 </span><span class=\"S111C S1070 S2\" id=\"tn_48\">3 448 </span><span class=\"S111D S1070 S2\" id=\"to_48\">BeNeLux </span><span class=\"S111E S1070 S2\" id=\"tp_48\">4 597 </span><span class=\"S111F S1070 S2\" id=\"tq_48\">6 927 </span><span class=\"S1120 S1070 S2\" id=\"tr_48\">Italy </span><span class=\"S1121 S1070 S2\" id=\"ts_48\">4 368 </span><span class=\"S1122 S1070 S2\" id=\"tt_48\">1 700 </span><span class=\"S1123 S1070 S2\" id=\"tu_48\">Other European countries </span><span class=\"S1124 S1070 S2\" id=\"tv_48\">3 905 </span><span class=\"S1125 S1070 S2\" id=\"tw_48\">2 778 </span><span class=\"S1126 S1070 S2\" id=\"tx_48\">United States </span><span class=\"S1127 S1070 S2\" id=\"ty_48\">149 045 </span><span class=\"S1128 S1070 S2\" id=\"tz_48\">125 232 </span><span class=\"S1129 S1070 S2\" id=\"t10_48\">Canada </span><span class=\"S112A S1070 S2\" id=\"t11_48\">1 740 </span><span class=\"S112B S1071 S2\" id=\"t12_48\">Own sales </span><span class=\"S112C S1071 S2\" id=\"t13_48\">373 917 </span><span class=\"S112D S1071 S2\" id=\"t14_48\">351 891 </span><span class=\"S112E S1070 S2\" id=\"t15_48\">Partner countries rest of world </span><span class=\"S112F S1070 S2\" id=\"t16_48\">557 </span><span class=\"S1130 S1070 S2\" id=\"t17_48\">2 233 </span><span class=\"S1131 S1071 S2\" id=\"t18_48\">374 474 </span><span class=\"S1132 S1071 S2\" id=\"t19_48\">354 124 </span><span class=\"S1133 S1070 S2\" id=\"t1a_48\">The geographical revenue in all countries except North America are in the parent company. The geographical revenue information is </span><span class=\"S1134 S1070 S2\" id=\"t1b_48\">based on the location of the end customers. </span><span class=\"S1135 S1070 S2\" id=\"t1c_48\">The signing fees and milestone revenue are not included in the table above. </span><span class=\"S1136 S1071 S2\" id=\"t1d_48\">Revenue recognition by segments </span><span class=\"S1137 S1071 S2\" id=\"t1e_48\">1 Jan - 31 December 2022 </span><span class=\"S1138 S1071 S2\" id=\"t1f_48\">Commercial Franchise </span><span class=\"S1139 S1071 S2\" id=\"t1g_48\">Development Portfolio </span><span class=\"S113A S1071 S2\" id=\"t1h_48\">Grand </span><span class=\"S113B S1071 S2\" id=\"t1i_48\">Total </span><span class=\"S113C S1071 S2\" id=\"t1j_48\">Hexvix/Cysview </span><span class=\"S113D S1070 S2\" id=\"t1k_48\">(Amounts in NOK 1,000) </span><span class=\"S113E S1071 S2\" id=\"t1l_48\">Own sales </span><span class=\"S113F S1071 S2\" id=\"t1m_48\">Partner </span><span class=\"S1140 S1071 S2\" id=\"t1n_48\">Other </span><span class=\"S1141 S1071 S2\" id=\"t1o_48\">Sales </span><span class=\"S1142 S1071 S2\" id=\"t1p_48\">Total </span><span class=\"S1143 S1071 S2\" id=\"t1q_48\">Sales </span><span class=\"S1144 S1071 S2\" id=\"t1r_48\">Pipeline </span><span class=\"S1145 S1071 S2\" id=\"t1s_48\">Total </span><span class=\"S1146 S1071 S2\" id=\"t1t_48\">R&amp;D </span><span class=\"S1147 S1070 S2\" id=\"t1u_48\">Contract revenue at point in time </span><span class=\"S1148 S1070 S2\" id=\"t1v_48\">430 </span><span class=\"S1149 S1070 S2\" id=\"t1w_48\">128 </span><span class=\"S114A S1071 S2\" id=\"t1x_48\">558 </span><span class=\"S114B S1070 S2\" id=\"t1y_48\">0 </span><span class=\"S114C S1070 S2\" id=\"t1z_48\">0 </span><span class=\"S114D S1071 S2\" id=\"t20_48\">558 </span><span class=\"S114E S1070 S2\" id=\"t21_48\">Contract revenue over time </span><span class=\"S114F S1071 S2\" id=\"t22_48\">0 </span><span class=\"S1150 S1070 S2\" id=\"t23_48\">0 </span><span class=\"S1151 S1071 S2\" id=\"t24_48\">0 </span><span class=\"S1152 S1070 S2\" id=\"t25_48\">Signing fees and milestone </span><span class=\"S1153 S1070 S2\" id=\"t26_48\">revenues at point in time </span><span class=\"S1154 S1070 S2\" id=\"t27_48\">152 </span><span class=\"S1155 S1071 S2\" id=\"t28_48\">152 </span><span class=\"S1156 S1070 S2\" id=\"t29_48\">18 506 </span><span class=\"S1157 S1070 S2\" id=\"t2a_48\">18 506 </span><span class=\"S1158 S1071 S2\" id=\"t2b_48\">18 658 </span><span class=\"S1159 S1071 S2\" id=\"t2c_48\">Sales order revenue at point </span><span class=\"S115A S1071 S2\" id=\"t2d_48\">in time </span><span class=\"S115B S1070 S2\" id=\"t2e_48\">372 611 </span><span class=\"S115C S1070 S2\" id=\"t2f_48\">1 306 </span><span class=\"S115D S1071 S2\" id=\"t2g_48\">373 917 </span><span class=\"S115E S1070 S2\" id=\"t2h_48\">0 </span><span class=\"S115F S1071 S2\" id=\"t2i_48\">373 917 </span><span class=\"S1160 S1071 S2\" id=\"t2j_48\">372 611 </span><span class=\"S1161 S1071 S2\" id=\"t2k_48\">582 </span><span class=\"S1162 S1071 S2\" id=\"t2l_48\">1 434 </span><span class=\"S1163 S1071 S2\" id=\"t2m_48\">374 627 </span><span class=\"S1164 S1071 S2\" id=\"t2n_48\">18 506 </span><span class=\"S1165 S1071 S2\" id=\"t2o_48\">18 506 </span><span class=\"S1166 S1071 S2\" id=\"t2p_48\">393 132 </span><span class=\"S1167 S1071 S2\" id=\"t2q_48\">Revenue recognition by segments </span><span class=\"S1168 S1071 S2\" id=\"t2r_48\">1 Jan - 31 December 2021 </span><span class=\"S1169 S1071 S2\" id=\"t2s_48\">Commercial Franchise </span><span class=\"S116A S1071 S2\" id=\"t2t_48\">Development Portfolio </span><span class=\"S116B S1071 S2\" id=\"t2u_48\">Grand </span><span class=\"S116C S1071 S2\" id=\"t2v_48\">Total </span><span class=\"S116D S1071 S2\" id=\"t2w_48\">Hexvix/Cysview </span><span class=\"S116E S1070 S2\" id=\"t2x_48\">(Amounts in NOK 1,000) </span><span class=\"S116F S1071 S2\" id=\"t2y_48\">Own sales </span><span class=\"S1170 S1071 S2\" id=\"t2z_48\">Partner </span><span class=\"S1171 S1071 S2\" id=\"t30_48\">Other </span><span class=\"S1172 S1071 S2\" id=\"t31_48\">Sales </span><span class=\"S1173 S1071 S2\" id=\"t32_48\">Total </span><span class=\"S1174 S1071 S2\" id=\"t33_48\">Sales </span><span class=\"S1175 S1071 S2\" id=\"t34_48\">Pipeline </span><span class=\"S1176 S1071 S2\" id=\"t35_48\">Total </span><span class=\"S1177 S1071 S2\" id=\"t36_48\">R&amp;D </span><span class=\"S1178 S1070 S2\" id=\"t37_48\">Contract revenue at point in time </span><span class=\"S1179 S1071 S2\" id=\"t38_48\">- </span><span class=\"S117A S1070 S2\" id=\"t39_48\">1 832 </span><span class=\"S117B S1070 S2\" id=\"t3a_48\">1 832 </span><span class=\"S117C S1071 S2\" id=\"t3b_48\">1 832 </span><span class=\"S117D S1070 S2\" id=\"t3c_48\">Contract revenue over time </span><span class=\"S117E S1070 S2\" id=\"t3d_48\">397 </span><span class=\"S117F S1071 S2\" id=\"t3e_48\">397 </span><span class=\"S1180 S1070 S2\" id=\"t3f_48\">0 </span><span class=\"S1181 S1071 S2\" id=\"t3g_48\">397 </span><span class=\"S1182 S1070 S2\" id=\"t3h_48\">Signing fees and milestone </span><span class=\"S1183 S1070 S2\" id=\"t3i_48\">revenues at point in time </span><span class=\"S1184 S1070 S2\" id=\"t3j_48\">6 416 </span><span class=\"S1185 S1071 S2\" id=\"t3k_48\">6 416 </span><span class=\"S1186 S1070 S2\" id=\"t3l_48\">0 </span><span class=\"S1187 S1071 S2\" id=\"t3m_48\">6 416 </span><span class=\"S1188 S1071 S2\" id=\"t3n_48\">Sales order revenue </span><span class=\"S1189 S1071 S2\" id=\"t3o_48\">at point in time </span><span class=\"S118A S1070 S2\" id=\"t3p_48\">350 983 </span><span class=\"S118B S1070 S2\" id=\"t3q_48\">913 </span><span class=\"S118C S1071 S2\" id=\"t3r_48\">351 896 </span><span class=\"S118D S1070 S2\" id=\"t3s_48\">0 </span><span class=\"S118E S1071 S2\" id=\"t3t_48\">351 896 </span><span class=\"S118F S1071 S2\" id=\"t3u_48\">350 983 </span><span class=\"S1190 S1071 S2\" id=\"t3v_48\">6 813 </span><span class=\"S1191 S1071 S2\" id=\"t3w_48\">913 </span><span class=\"S1192 S1071 S2\" id=\"t3x_48\">358 709 </span><span class=\"S1193 S1071 S2\" id=\"t3y_48\">1 832 </span><span class=\"S1194 S1071 S2\" id=\"t3z_48\">1 832 </span><span class=\"S1195 S1071 S2\" id=\"t40_48\">360 540 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRevenueExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5193": {
   "value": "<span class=\"S10EA S106F S2\" id=\"t3c_47\">3. REVENUES FROM CONTRACT WITH CUSTOMERS </span><span class=\"S10EB S1071 S2\" id=\"t3d_47\">Performance obligation product deliveries </span><span class=\"S10EC S1070 S2\" id=\"t3e_47\">For the general supply of products Photocure satisfy the contractual performance obligation upon delivery of products according to </span><span class=\"S10ED S1070 S2\" id=\"t3f_47\">the delivery terms agreed. Invoices are issued at that point in time and the payment term is usually within 30 days. No discounts were </span><span class=\"S10EE S1070 S2\" id=\"t3g_47\">provided to the customers and no return of products were accepted within the expiry of the products. </span><span class=\"S10EF S1071 S2\" id=\"t3h_47\">Performance obligation license </span><span class=\"S10F0 S1070 S2\" id=\"t3i_47\">Photocure entered a license agreement with Asieris for the development and commercialization of product Cevira in July 2019. </span><span class=\"S10F1 S1070 S2\" id=\"t3j_47\">The agreement is based on a \u201cready for Phase 3 study\u201d concept and this study will be carried out by Asieris in China from 2020. </span><span class=\"S10F2 S1070 S2\" id=\"t3k_47\">Photocure has in the agreement with Asieris agreed to transfer the rights for the development and commercialization of Cevira </span><span class=\"S10F3 S1070 S2\" id=\"t3l_47\">(license) and to deliver the active substance for the phase 3 study. Asieris will be responsible for the remaining development of Cevira </span><span class=\"S10F4 S1070 S2\" id=\"t3m_47\">and pay all the costs. The license is a right to use Photocure\u2019s intellectual property as it existed at the contract date. The active </span><span class=\"S10F5 S1070 S2\" id=\"t3n_47\">substance will not be further developed or changed by Photocure for use by Asieris. The transfer of the license and the delivery of </span><span class=\"S10F6 S1070 S2\" id=\"t3o_47\">the active substance are by Photocure regarded as two separate performance obligations. </span><span class=\"S10F7 S1070 S2\" id=\"t3p_47\">Asieris has in 2022 paid one milestone of USD 2.0 million related to the phase 3 study and accumulated paid USD 10 million in </span><span class=\"S10F8 S1070 S2\" id=\"t3q_47\">milestones for Cevira. The agreement include additional milestones and potential sales royalty if a commercial product is approved, </span><span class=\"S10F9 S1070 S2\" id=\"t3r_47\">this will depend on the outcome of the ongoing phase 3 study. The transaction price allocated to the license consist of signing fee, </span><span class=\"S10FA S1070 S2\" id=\"t3s_47\">di\ufb00erent milestone payments and sales based royalty payments. The part of the transaction price related to milestone payments are </span><span class=\"S10FB S1070 S2\" id=\"t3t_47\">estimated as the most likely amount, but constrained which currently means that these revenues will be recognized if and when the </span><span class=\"S10FC S1070 S2\" id=\"t3u_47\">relevant milestone are achieved. </span><span class=\"S10FD S1070 S2\" id=\"t3v_47\">Revenue for the sale of active substance is recognized when the customer takes control of the goods, which is at the time of </span><span class=\"S10FE S1070 S2\" id=\"t3w_47\">shipment. </span><span class=\"S10FF S1070 S2\" id=\"t3x_47\">Photocure has in January 2021 entered into a partnership agreement with Asieris whereby Asieris has obtained exclusive rights </span><span class=\"S1100 S1070 S2\" id=\"t3y_47\">to register and commercialize Hexvix[\u00ae] in Mainland China and Taiwan. Based on the agreement, Photocure received an upfront </span><span class=\"S1101 S1070 S2\" id=\"t3z_47\">payment of USD 750,000 from Asieris for the rights to Hexvix in the designated territories as a non-refundable payment. Asieris will </span><span class=\"S1102 S1070 S2\" id=\"t40_47\">fund all costs to secure required clinical studies and to regulatory approvals of Hexvix in Mainland China and Taiwan. </span><span class=\"S1103 S1070 S2\" id=\"t41_47\">The license of the Groups intellectual property are under all current licensing agreement considered distinct from the delivery of </span><span class=\"S1104 S1070 S2\" id=\"t42_47\">goods and thus a separate performance obligation. Furthermore the licenses are considered to be a right to use the company\u2019s </span><span class=\"S1105 S1070 S2\" id=\"t43_47\">intellectual property as is, and therefore revenue allocated to the license is recognized at point in time taking into consideration the </span><span class=\"S1106 S1070 S2\" id=\"t44_47\">variable constraint for milestone payments that have not yet occurred and sales based royalty. Milestone payments related to future </span>events and sales based royalties are recognized when the events and sales actually occur<span class=\"S1109 S1071 S2\" id=\"t4_48\">Geographical information </span><span class=\"S110A S1070 S2\" id=\"t5_48\">(Amounts in NOK 1,000) </span><span class=\"S110B S1071 S2\" id=\"t6_48\">Group revenues from contract with customers </span><span class=\"S110C S1071 S2\" id=\"t7_48\">2022 </span><span class=\"S110D S1071 S2\" id=\"t8_48\">2021 </span><span class=\"S110E S1070 S2\" id=\"t9_48\">Nordic countries </span><span class=\"S110F S1070 S2\" id=\"ta_48\">22 647 </span><span class=\"S1110 S1070 S2\" id=\"tb_48\">31 882 </span><span class=\"S1111 S1070 S2\" id=\"tc_48\">Germany </span><span class=\"S1112 S1070 S2\" id=\"td_48\">148 936 </span><span class=\"S1113 S1070 S2\" id=\"te_48\">141 920 </span><span class=\"S1114 S1070 S2\" id=\"tf_48\">France </span><span class=\"S1115 S1070 S2\" id=\"tg_48\">27 032 </span><span class=\"S1116 S1070 S2\" id=\"th_48\">29 021 </span><span class=\"S1117 S1070 S2\" id=\"ti_48\">Austria </span><span class=\"S1118 S1070 S2\" id=\"tj_48\">9 500 </span><span class=\"S1119 S1070 S2\" id=\"tk_48\">8 983 </span><span class=\"S111A S1070 S2\" id=\"tl_48\">UK </span><span class=\"S111B S1070 S2\" id=\"tm_48\">2 147 </span><span class=\"S111C S1070 S2\" id=\"tn_48\">3 448 </span><span class=\"S111D S1070 S2\" id=\"to_48\">BeNeLux </span><span class=\"S111E S1070 S2\" id=\"tp_48\">4 597 </span><span class=\"S111F S1070 S2\" id=\"tq_48\">6 927 </span><span class=\"S1120 S1070 S2\" id=\"tr_48\">Italy </span><span class=\"S1121 S1070 S2\" id=\"ts_48\">4 368 </span><span class=\"S1122 S1070 S2\" id=\"tt_48\">1 700 </span><span class=\"S1123 S1070 S2\" id=\"tu_48\">Other European countries </span><span class=\"S1124 S1070 S2\" id=\"tv_48\">3 905 </span><span class=\"S1125 S1070 S2\" id=\"tw_48\">2 778 </span><span class=\"S1126 S1070 S2\" id=\"tx_48\">United States </span><span class=\"S1127 S1070 S2\" id=\"ty_48\">149 045 </span><span class=\"S1128 S1070 S2\" id=\"tz_48\">125 232 </span><span class=\"S1129 S1070 S2\" id=\"t10_48\">Canada </span><span class=\"S112A S1070 S2\" id=\"t11_48\">1 740 </span><span class=\"S112B S1071 S2\" id=\"t12_48\">Own sales </span><span class=\"S112C S1071 S2\" id=\"t13_48\">373 917 </span><span class=\"S112D S1071 S2\" id=\"t14_48\">351 891 </span><span class=\"S112E S1070 S2\" id=\"t15_48\">Partner countries rest of world </span><span class=\"S112F S1070 S2\" id=\"t16_48\">557 </span><span class=\"S1130 S1070 S2\" id=\"t17_48\">2 233 </span><span class=\"S1131 S1071 S2\" id=\"t18_48\">374 474 </span><span class=\"S1132 S1071 S2\" id=\"t19_48\">354 124 </span><span class=\"S1133 S1070 S2\" id=\"t1a_48\">The geographical revenue in all countries except North America are in the parent company. The geographical revenue information is </span><span class=\"S1134 S1070 S2\" id=\"t1b_48\">based on the location of the end customers. </span><span class=\"S1135 S1070 S2\" id=\"t1c_48\">The signing fees and milestone revenue are not included in the table above. </span><span class=\"S1136 S1071 S2\" id=\"t1d_48\">Revenue recognition by segments </span><span class=\"S1137 S1071 S2\" id=\"t1e_48\">1 Jan - 31 December 2022 </span><span class=\"S1138 S1071 S2\" id=\"t1f_48\">Commercial Franchise </span><span class=\"S1139 S1071 S2\" id=\"t1g_48\">Development Portfolio </span><span class=\"S113A S1071 S2\" id=\"t1h_48\">Grand </span><span class=\"S113B S1071 S2\" id=\"t1i_48\">Total </span><span class=\"S113C S1071 S2\" id=\"t1j_48\">Hexvix/Cysview </span><span class=\"S113D S1070 S2\" id=\"t1k_48\">(Amounts in NOK 1,000) </span><span class=\"S113E S1071 S2\" id=\"t1l_48\">Own sales </span><span class=\"S113F S1071 S2\" id=\"t1m_48\">Partner </span><span class=\"S1140 S1071 S2\" id=\"t1n_48\">Other </span><span class=\"S1141 S1071 S2\" id=\"t1o_48\">Sales </span><span class=\"S1142 S1071 S2\" id=\"t1p_48\">Total </span><span class=\"S1143 S1071 S2\" id=\"t1q_48\">Sales </span><span class=\"S1144 S1071 S2\" id=\"t1r_48\">Pipeline </span><span class=\"S1145 S1071 S2\" id=\"t1s_48\">Total </span><span class=\"S1146 S1071 S2\" id=\"t1t_48\">R&amp;D </span><span class=\"S1147 S1070 S2\" id=\"t1u_48\">Contract revenue at point in time </span><span class=\"S1148 S1070 S2\" id=\"t1v_48\">430 </span><span class=\"S1149 S1070 S2\" id=\"t1w_48\">128 </span><span class=\"S114A S1071 S2\" id=\"t1x_48\">558 </span><span class=\"S114B S1070 S2\" id=\"t1y_48\">0 </span><span class=\"S114C S1070 S2\" id=\"t1z_48\">0 </span><span class=\"S114D S1071 S2\" id=\"t20_48\">558 </span><span class=\"S114E S1070 S2\" id=\"t21_48\">Contract revenue over time </span><span class=\"S114F S1071 S2\" id=\"t22_48\">0 </span><span class=\"S1150 S1070 S2\" id=\"t23_48\">0 </span><span class=\"S1151 S1071 S2\" id=\"t24_48\">0 </span><span class=\"S1152 S1070 S2\" id=\"t25_48\">Signing fees and milestone </span><span class=\"S1153 S1070 S2\" id=\"t26_48\">revenues at point in time </span><span class=\"S1154 S1070 S2\" id=\"t27_48\">152 </span><span class=\"S1155 S1071 S2\" id=\"t28_48\">152 </span><span class=\"S1156 S1070 S2\" id=\"t29_48\">18 506 </span><span class=\"S1157 S1070 S2\" id=\"t2a_48\">18 506 </span><span class=\"S1158 S1071 S2\" id=\"t2b_48\">18 658 </span><span class=\"S1159 S1071 S2\" id=\"t2c_48\">Sales order revenue at point </span><span class=\"S115A S1071 S2\" id=\"t2d_48\">in time </span><span class=\"S115B S1070 S2\" id=\"t2e_48\">372 611 </span><span class=\"S115C S1070 S2\" id=\"t2f_48\">1 306 </span><span class=\"S115D S1071 S2\" id=\"t2g_48\">373 917 </span><span class=\"S115E S1070 S2\" id=\"t2h_48\">0 </span><span class=\"S115F S1071 S2\" id=\"t2i_48\">373 917 </span><span class=\"S1160 S1071 S2\" id=\"t2j_48\">372 611 </span><span class=\"S1161 S1071 S2\" id=\"t2k_48\">582 </span><span class=\"S1162 S1071 S2\" id=\"t2l_48\">1 434 </span><span class=\"S1163 S1071 S2\" id=\"t2m_48\">374 627 </span><span class=\"S1164 S1071 S2\" id=\"t2n_48\">18 506 </span><span class=\"S1165 S1071 S2\" id=\"t2o_48\">18 506 </span><span class=\"S1166 S1071 S2\" id=\"t2p_48\">393 132 </span><span class=\"S1167 S1071 S2\" id=\"t2q_48\">Revenue recognition by segments </span><span class=\"S1168 S1071 S2\" id=\"t2r_48\">1 Jan - 31 December 2021 </span><span class=\"S1169 S1071 S2\" id=\"t2s_48\">Commercial Franchise </span><span class=\"S116A S1071 S2\" id=\"t2t_48\">Development Portfolio </span><span class=\"S116B S1071 S2\" id=\"t2u_48\">Grand </span><span class=\"S116C S1071 S2\" id=\"t2v_48\">Total </span><span class=\"S116D S1071 S2\" id=\"t2w_48\">Hexvix/Cysview </span><span class=\"S116E S1070 S2\" id=\"t2x_48\">(Amounts in NOK 1,000) </span><span class=\"S116F S1071 S2\" id=\"t2y_48\">Own sales </span><span class=\"S1170 S1071 S2\" id=\"t2z_48\">Partner </span><span class=\"S1171 S1071 S2\" id=\"t30_48\">Other </span><span class=\"S1172 S1071 S2\" id=\"t31_48\">Sales </span><span class=\"S1173 S1071 S2\" id=\"t32_48\">Total </span><span class=\"S1174 S1071 S2\" id=\"t33_48\">Sales </span><span class=\"S1175 S1071 S2\" id=\"t34_48\">Pipeline </span><span class=\"S1176 S1071 S2\" id=\"t35_48\">Total </span><span class=\"S1177 S1071 S2\" id=\"t36_48\">R&amp;D </span><span class=\"S1178 S1070 S2\" id=\"t37_48\">Contract revenue at point in time </span><span class=\"S1179 S1071 S2\" id=\"t38_48\">- </span><span class=\"S117A S1070 S2\" id=\"t39_48\">1 832 </span><span class=\"S117B S1070 S2\" id=\"t3a_48\">1 832 </span><span class=\"S117C S1071 S2\" id=\"t3b_48\">1 832 </span><span class=\"S117D S1070 S2\" id=\"t3c_48\">Contract revenue over time </span><span class=\"S117E S1070 S2\" id=\"t3d_48\">397 </span><span class=\"S117F S1071 S2\" id=\"t3e_48\">397 </span><span class=\"S1180 S1070 S2\" id=\"t3f_48\">0 </span><span class=\"S1181 S1071 S2\" id=\"t3g_48\">397 </span><span class=\"S1182 S1070 S2\" id=\"t3h_48\">Signing fees and milestone </span><span class=\"S1183 S1070 S2\" id=\"t3i_48\">revenues at point in time </span><span class=\"S1184 S1070 S2\" id=\"t3j_48\">6 416 </span><span class=\"S1185 S1071 S2\" id=\"t3k_48\">6 416 </span><span class=\"S1186 S1070 S2\" id=\"t3l_48\">0 </span><span class=\"S1187 S1071 S2\" id=\"t3m_48\">6 416 </span><span class=\"S1188 S1071 S2\" id=\"t3n_48\">Sales order revenue </span><span class=\"S1189 S1071 S2\" id=\"t3o_48\">at point in time </span><span class=\"S118A S1070 S2\" id=\"t3p_48\">350 983 </span><span class=\"S118B S1070 S2\" id=\"t3q_48\">913 </span><span class=\"S118C S1071 S2\" id=\"t3r_48\">351 896 </span><span class=\"S118D S1070 S2\" id=\"t3s_48\">0 </span><span class=\"S118E S1071 S2\" id=\"t3t_48\">351 896 </span><span class=\"S118F S1071 S2\" id=\"t3u_48\">350 983 </span><span class=\"S1190 S1071 S2\" id=\"t3v_48\">6 813 </span><span class=\"S1191 S1071 S2\" id=\"t3w_48\">913 </span><span class=\"S1192 S1071 S2\" id=\"t3x_48\">358 709 </span><span class=\"S1193 S1071 S2\" id=\"t3y_48\">1 832 </span><span class=\"S1194 S1071 S2\" id=\"t3z_48\">1 832 </span><span class=\"S1195 S1071 S2\" id=\"t40_48\">360 540 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5387": {
   "value": "<span class=\"S1197 S106F S2\" id=\"t2_49\">4. COST OF GOODS SOLD </span><span class=\"S1198 S1070 S2\" id=\"t3_49\">Total cost of goods sold includes direct materials, services provided by contract manufacturers and packaging suppliers, products </span><span class=\"S1199 S1070 S2\" id=\"t4_49\">freights and distribution costs. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5391": {
   "value": "<span class=\"S119A S106F S2\" id=\"t5_49\">5. INCOME STATEMENT CLASSIFIED BY NATURE </span><span class=\"S119B S1070 S2\" id=\"t6_49\">(Amounts in NOK 1,000) </span><span class=\"S119C S1071 S2\" id=\"t7_49\">Group </span><span class=\"S119D S1071 S2\" id=\"t8_49\">Parent </span><span class=\"S119E S1071 S2\" id=\"t9_49\">Note </span><span class=\"S119F S1071 S2\" id=\"ta_49\">2022 </span><span class=\"S11A0 S1071 S2\" id=\"tb_49\">2021 </span><span class=\"S11A1 S1071 S2\" id=\"tc_49\">2022 </span><span class=\"S11A2 S1071 S2\" id=\"td_49\">2021 </span><span class=\"S11A3 S1070 S2\" id=\"te_49\">Revenues from contract with customers </span><span class=\"S11A4 S1070 S2\" id=\"tf_49\">2 </span><span class=\"S11A5 S1070 S2\" id=\"tg_49\">374 474 </span><span class=\"S11A6 S1070 S2\" id=\"th_49\">354 124 </span><span class=\"S11A7 S1070 S2\" id=\"ti_49\">236 550 </span><span class=\"S11A8 S1070 S2\" id=\"tj_49\">236 380 </span><span class=\"S11A9 S1070 S2\" id=\"tk_49\">Signing fees and milestone revenues </span><span class=\"S11AA S1070 S2\" id=\"tl_49\">2 </span><span class=\"S11AB S1070 S2\" id=\"tm_49\">18 658 </span><span class=\"S11AC S1070 S2\" id=\"tn_49\">6 416 </span><span class=\"S11AD S1070 S2\" id=\"to_49\">18 658 </span><span class=\"S11AE S1070 S2\" id=\"tp_49\">6 416 </span><span class=\"S11AF S1070 S2\" id=\"tq_49\">Cost of goods sold </span><span class=\"S11B0 S1070 S2\" id=\"tr_49\">-22 697 </span><span class=\"S11B1 S1070 S2\" id=\"ts_49\">-24 050 </span><span class=\"S11B2 S1070 S2\" id=\"tt_49\">-23 269 </span><span class=\"S11B3 S1070 S2\" id=\"tu_49\">-23 012 </span><span class=\"S11B4 S1071 S2\" id=\"tv_49\">Gross pro\ufb01t </span><span class=\"S11B5 S1071 S2\" id=\"tw_49\">370 435 </span><span class=\"S11B6 S1071 S2\" id=\"tx_49\">336 490 </span><span class=\"S11B7 S1071 S2\" id=\"ty_49\">231 939 </span><span class=\"S11B8 S1071 S2\" id=\"tz_49\">219 784 </span><span class=\"S11B9 S1070 S2\" id=\"t10_49\">Other income </span><span class=\"S11BA S1070 S2\" id=\"t11_49\">0 </span><span class=\"S11BB S1070 S2\" id=\"t12_49\">0 </span><span class=\"S11BC S1070 S2\" id=\"t13_49\">899 </span><span class=\"S11BD S1070 S2\" id=\"t14_49\">999 </span><span class=\"S11BE S1070 S2\" id=\"t15_49\">Payroll expenses </span><span class=\"S11BF S1070 S2\" id=\"t16_49\">6, 7 </span><span class=\"S11C0 S1070 S2\" id=\"t17_49\">-244 881 </span><span class=\"S11C1 S1070 S2\" id=\"t18_49\">-210 552 </span><span class=\"S11C2 S1070 S2\" id=\"t19_49\">-102 315 </span><span class=\"S11C3 S1070 S2\" id=\"t1a_49\">-86 906 </span><span class=\"S11C4 S1070 S2\" id=\"t1b_49\">R&amp;D costs excluding payroll expenses/other operating expenses </span><span class=\"S11C5 S1070 S2\" id=\"t1c_49\">-1 809 </span><span class=\"S11C6 S1070 S2\" id=\"t1d_49\">-2 657 </span><span class=\"S11C7 S1070 S2\" id=\"t1e_49\">-1 809 </span><span class=\"S11C8 S1070 S2\" id=\"t1f_49\">-2 657 </span><span class=\"S11C9 S1070 S2\" id=\"t1g_49\">Ordinary depreciation and amortisation </span><span class=\"S11CA S1070 S2\" id=\"t1h_49\">13, 14 </span><span class=\"S11CB S1070 S2\" id=\"t1i_49\">-24 378 </span><span class=\"S11CC S1070 S2\" id=\"t1j_49\">-24 127 </span><span class=\"S11CD S1070 S2\" id=\"t1k_49\">-20 051 </span><span class=\"S11CE S1070 S2\" id=\"t1l_49\">-20 753 </span><span class=\"S11CF S1070 S2\" id=\"t1m_49\">Other operating expenses </span><span class=\"S11D0 S1070 S2\" id=\"t1n_49\">-148 370 </span><span class=\"S11D1 S1070 S2\" id=\"t1o_49\">-104 979 </span><span class=\"S11D2 S1070 S2\" id=\"t1p_49\">-158 016 </span><span class=\"S11D3 S1070 S2\" id=\"t1q_49\">-112 108 </span><span class=\"S11D4 S1071 S2\" id=\"t1r_49\">Total operating expenses </span><span class=\"S11D5 S1071 S2\" id=\"t1s_49\">-419 438 </span><span class=\"S11D6 S1071 S2\" id=\"t1t_49\">-342 315 </span><span class=\"S11D7 S1071 S2\" id=\"t1u_49\">-281 292 </span><span class=\"S11D8 S1071 S2\" id=\"t1v_49\">-221 425 </span><span class=\"S11D9 S1071 S2\" id=\"t1w_49\">Operating pro\ufb01t / loss (-) </span><span class=\"S11DA S1071 S2\" id=\"t1x_49\">-49 003 </span><span class=\"S11DB S1071 S2\" id=\"t1y_49\">-5 825 </span><span class=\"S11DC S1071 S2\" id=\"t1z_49\">-49 353 </span><span class=\"S11DD S1071 S2\" id=\"t20_49\">-1 641 </span><span class=\"S11DE S1071 S2\" id=\"t21_49\">Speci\ufb01cation of Other operating expenses: </span><span class=\"S11DF S1071 S2\" id=\"t22_49\">2022 </span><span class=\"S11E0 S1071 S2\" id=\"t23_49\">2021 </span><span class=\"S11E1 S1071 S2\" id=\"t24_49\">2022 </span><span class=\"S11E2 S1071 S2\" id=\"t25_49\">2021 </span><span class=\"S11E3 S1070 S2\" id=\"t26_49\">Marketing expenses </span><span class=\"S11E4 S1070 S2\" id=\"t27_49\">45 162 </span><span class=\"S11E5 S1070 S2\" id=\"t28_49\">33 140 </span><span class=\"S11E6 S1070 S2\" id=\"t29_49\">16 087 </span><span class=\"S11E7 S1070 S2\" id=\"t2a_49\">15 908 </span><span class=\"S11E8 S1070 S2\" id=\"t2b_49\">Pro\ufb01t split coverage US </span><span class=\"S11E9 S1070 S2\" id=\"t2c_49\">- </span><span class=\"S11EA S1070 S2\" id=\"t2d_49\">- </span><span class=\"S11EB S1070 S2\" id=\"t2e_49\">17 888 </span><span class=\"S11EC S1070 S2\" id=\"t2f_49\">7 269 </span><span class=\"S11ED S1070 S2\" id=\"t2g_49\">Sales and marketing costs Europe </span><span class=\"S11EE S1070 S2\" id=\"t2h_49\">- </span><span class=\"S11EF S1070 S2\" id=\"t2i_49\">- </span><span class=\"S11F0 S1070 S2\" id=\"t2j_49\">54 719 </span><span class=\"S11F1 S1070 S2\" id=\"t2k_49\">48 060 </span><span class=\"S11F2 S1070 S2\" id=\"t2l_49\">Travel expenses </span><span class=\"S11F3 S1070 S2\" id=\"t2m_49\">19 108 </span><span class=\"S11F4 S1070 S2\" id=\"t2n_49\">10 522 </span><span class=\"S11F5 S1070 S2\" id=\"t2o_49\">5 308 </span><span class=\"S11F6 S1070 S2\" id=\"t2p_49\">1 724 </span><span class=\"S11F7 S1070 S2\" id=\"t2q_49\">Patent costs, legal and other fees </span><span class=\"S11F8 S1070 S2\" id=\"t2r_49\">55 848 </span><span class=\"S11F9 S1070 S2\" id=\"t2s_49\">38 938 </span><span class=\"S11FA S1070 S2\" id=\"t2t_49\">41 317 </span><span class=\"S11FB S1070 S2\" id=\"t2u_49\">25 854 </span><span class=\"S11FC S1070 S2\" id=\"t2v_49\">Other expenses </span><span class=\"S11FD S1070 S2\" id=\"t2w_49\">28 253 </span><span class=\"S11FE S1070 S2\" id=\"t2x_49\">22 380 </span><span class=\"S11FF S1070 S2\" id=\"t2y_49\">22 698 </span><span class=\"S1200 S1070 S2\" id=\"t2z_49\">13 294 </span><span class=\"S1201 S1071 S2\" id=\"t30_49\">Total other operating expenses </span><span class=\"S1202 S1071 S2\" id=\"t31_49\">148 370 </span><span class=\"S1203 S1071 S2\" id=\"t32_49\">104 979 </span><span class=\"S1204 S1071 S2\" id=\"t33_49\">158 016 </span><span class=\"S1205 S1071 S2\" id=\"t34_49\">112 108 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5392": {
   "value": "<span class=\"S119A S106F S2\" id=\"t5_49\">5. INCOME STATEMENT CLASSIFIED BY NATURE </span><span class=\"S119B S1070 S2\" id=\"t6_49\">(Amounts in NOK 1,000) </span><span class=\"S119C S1071 S2\" id=\"t7_49\">Group </span><span class=\"S119D S1071 S2\" id=\"t8_49\">Parent </span><span class=\"S119E S1071 S2\" id=\"t9_49\">Note </span><span class=\"S119F S1071 S2\" id=\"ta_49\">2022 </span><span class=\"S11A0 S1071 S2\" id=\"tb_49\">2021 </span><span class=\"S11A1 S1071 S2\" id=\"tc_49\">2022 </span><span class=\"S11A2 S1071 S2\" id=\"td_49\">2021 </span><span class=\"S11A3 S1070 S2\" id=\"te_49\">Revenues from contract with customers </span><span class=\"S11A4 S1070 S2\" id=\"tf_49\">2 </span><span class=\"S11A5 S1070 S2\" id=\"tg_49\">374 474 </span><span class=\"S11A6 S1070 S2\" id=\"th_49\">354 124 </span><span class=\"S11A7 S1070 S2\" id=\"ti_49\">236 550 </span><span class=\"S11A8 S1070 S2\" id=\"tj_49\">236 380 </span><span class=\"S11A9 S1070 S2\" id=\"tk_49\">Signing fees and milestone revenues </span><span class=\"S11AA S1070 S2\" id=\"tl_49\">2 </span><span class=\"S11AB S1070 S2\" id=\"tm_49\">18 658 </span><span class=\"S11AC S1070 S2\" id=\"tn_49\">6 416 </span><span class=\"S11AD S1070 S2\" id=\"to_49\">18 658 </span><span class=\"S11AE S1070 S2\" id=\"tp_49\">6 416 </span><span class=\"S11AF S1070 S2\" id=\"tq_49\">Cost of goods sold </span><span class=\"S11B0 S1070 S2\" id=\"tr_49\">-22 697 </span><span class=\"S11B1 S1070 S2\" id=\"ts_49\">-24 050 </span><span class=\"S11B2 S1070 S2\" id=\"tt_49\">-23 269 </span><span class=\"S11B3 S1070 S2\" id=\"tu_49\">-23 012 </span><span class=\"S11B4 S1071 S2\" id=\"tv_49\">Gross pro\ufb01t </span><span class=\"S11B5 S1071 S2\" id=\"tw_49\">370 435 </span><span class=\"S11B6 S1071 S2\" id=\"tx_49\">336 490 </span><span class=\"S11B7 S1071 S2\" id=\"ty_49\">231 939 </span><span class=\"S11B8 S1071 S2\" id=\"tz_49\">219 784 </span><span class=\"S11B9 S1070 S2\" id=\"t10_49\">Other income </span><span class=\"S11BA S1070 S2\" id=\"t11_49\">0 </span><span class=\"S11BB S1070 S2\" id=\"t12_49\">0 </span><span class=\"S11BC S1070 S2\" id=\"t13_49\">899 </span><span class=\"S11BD S1070 S2\" id=\"t14_49\">999 </span><span class=\"S11BE S1070 S2\" id=\"t15_49\">Payroll expenses </span><span class=\"S11BF S1070 S2\" id=\"t16_49\">6, 7 </span><span class=\"S11C0 S1070 S2\" id=\"t17_49\">-244 881 </span><span class=\"S11C1 S1070 S2\" id=\"t18_49\">-210 552 </span><span class=\"S11C2 S1070 S2\" id=\"t19_49\">-102 315 </span><span class=\"S11C3 S1070 S2\" id=\"t1a_49\">-86 906 </span><span class=\"S11C4 S1070 S2\" id=\"t1b_49\">R&amp;D costs excluding payroll expenses/other operating expenses </span><span class=\"S11C5 S1070 S2\" id=\"t1c_49\">-1 809 </span><span class=\"S11C6 S1070 S2\" id=\"t1d_49\">-2 657 </span><span class=\"S11C7 S1070 S2\" id=\"t1e_49\">-1 809 </span><span class=\"S11C8 S1070 S2\" id=\"t1f_49\">-2 657 </span><span class=\"S11C9 S1070 S2\" id=\"t1g_49\">Ordinary depreciation and amortisation </span><span class=\"S11CA S1070 S2\" id=\"t1h_49\">13, 14 </span><span class=\"S11CB S1070 S2\" id=\"t1i_49\">-24 378 </span><span class=\"S11CC S1070 S2\" id=\"t1j_49\">-24 127 </span><span class=\"S11CD S1070 S2\" id=\"t1k_49\">-20 051 </span><span class=\"S11CE S1070 S2\" id=\"t1l_49\">-20 753 </span><span class=\"S11CF S1070 S2\" id=\"t1m_49\">Other operating expenses </span><span class=\"S11D0 S1070 S2\" id=\"t1n_49\">-148 370 </span><span class=\"S11D1 S1070 S2\" id=\"t1o_49\">-104 979 </span><span class=\"S11D2 S1070 S2\" id=\"t1p_49\">-158 016 </span><span class=\"S11D3 S1070 S2\" id=\"t1q_49\">-112 108 </span><span class=\"S11D4 S1071 S2\" id=\"t1r_49\">Total operating expenses </span><span class=\"S11D5 S1071 S2\" id=\"t1s_49\">-419 438 </span><span class=\"S11D6 S1071 S2\" id=\"t1t_49\">-342 315 </span><span class=\"S11D7 S1071 S2\" id=\"t1u_49\">-281 292 </span><span class=\"S11D8 S1071 S2\" id=\"t1v_49\">-221 425 </span><span class=\"S11D9 S1071 S2\" id=\"t1w_49\">Operating pro\ufb01t / loss (-) </span><span class=\"S11DA S1071 S2\" id=\"t1x_49\">-49 003 </span><span class=\"S11DB S1071 S2\" id=\"t1y_49\">-5 825 </span><span class=\"S11DC S1071 S2\" id=\"t1z_49\">-49 353 </span><span class=\"S11DD S1071 S2\" id=\"t20_49\">-1 641 </span><span class=\"S11DE S1071 S2\" id=\"t21_49\">Speci\ufb01cation of Other operating expenses: </span><span class=\"S11DF S1071 S2\" id=\"t22_49\">2022 </span><span class=\"S11E0 S1071 S2\" id=\"t23_49\">2021 </span><span class=\"S11E1 S1071 S2\" id=\"t24_49\">2022 </span><span class=\"S11E2 S1071 S2\" id=\"t25_49\">2021 </span><span class=\"S11E3 S1070 S2\" id=\"t26_49\">Marketing expenses </span><span class=\"S11E4 S1070 S2\" id=\"t27_49\">45 162 </span><span class=\"S11E5 S1070 S2\" id=\"t28_49\">33 140 </span><span class=\"S11E6 S1070 S2\" id=\"t29_49\">16 087 </span><span class=\"S11E7 S1070 S2\" id=\"t2a_49\">15 908 </span><span class=\"S11E8 S1070 S2\" id=\"t2b_49\">Pro\ufb01t split coverage US </span><span class=\"S11E9 S1070 S2\" id=\"t2c_49\">- </span><span class=\"S11EA S1070 S2\" id=\"t2d_49\">- </span><span class=\"S11EB S1070 S2\" id=\"t2e_49\">17 888 </span><span class=\"S11EC S1070 S2\" id=\"t2f_49\">7 269 </span><span class=\"S11ED S1070 S2\" id=\"t2g_49\">Sales and marketing costs Europe </span><span class=\"S11EE S1070 S2\" id=\"t2h_49\">- </span><span class=\"S11EF S1070 S2\" id=\"t2i_49\">- </span><span class=\"S11F0 S1070 S2\" id=\"t2j_49\">54 719 </span><span class=\"S11F1 S1070 S2\" id=\"t2k_49\">48 060 </span><span class=\"S11F2 S1070 S2\" id=\"t2l_49\">Travel expenses </span><span class=\"S11F3 S1070 S2\" id=\"t2m_49\">19 108 </span><span class=\"S11F4 S1070 S2\" id=\"t2n_49\">10 522 </span><span class=\"S11F5 S1070 S2\" id=\"t2o_49\">5 308 </span><span class=\"S11F6 S1070 S2\" id=\"t2p_49\">1 724 </span><span class=\"S11F7 S1070 S2\" id=\"t2q_49\">Patent costs, legal and other fees </span><span class=\"S11F8 S1070 S2\" id=\"t2r_49\">55 848 </span><span class=\"S11F9 S1070 S2\" id=\"t2s_49\">38 938 </span><span class=\"S11FA S1070 S2\" id=\"t2t_49\">41 317 </span><span class=\"S11FB S1070 S2\" id=\"t2u_49\">25 854 </span><span class=\"S11FC S1070 S2\" id=\"t2v_49\">Other expenses </span><span class=\"S11FD S1070 S2\" id=\"t2w_49\">28 253 </span><span class=\"S11FE S1070 S2\" id=\"t2x_49\">22 380 </span><span class=\"S11FF S1070 S2\" id=\"t2y_49\">22 698 </span><span class=\"S1200 S1070 S2\" id=\"t2z_49\">13 294 </span><span class=\"S1201 S1071 S2\" id=\"t30_49\">Total other operating expenses </span><span class=\"S1202 S1071 S2\" id=\"t31_49\">148 370 </span><span class=\"S1203 S1071 S2\" id=\"t32_49\">104 979 </span><span class=\"S1204 S1071 S2\" id=\"t33_49\">158 016 </span><span class=\"S1205 S1071 S2\" id=\"t34_49\">112 108 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5393": {
   "value": "<span class=\"S119A S106F S2\" id=\"t5_49\">5. INCOME STATEMENT CLASSIFIED BY NATURE </span><span class=\"S119B S1070 S2\" id=\"t6_49\">(Amounts in NOK 1,000) </span><span class=\"S119C S1071 S2\" id=\"t7_49\">Group </span><span class=\"S119D S1071 S2\" id=\"t8_49\">Parent </span><span class=\"S119E S1071 S2\" id=\"t9_49\">Note </span><span class=\"S119F S1071 S2\" id=\"ta_49\">2022 </span><span class=\"S11A0 S1071 S2\" id=\"tb_49\">2021 </span><span class=\"S11A1 S1071 S2\" id=\"tc_49\">2022 </span><span class=\"S11A2 S1071 S2\" id=\"td_49\">2021 </span><span class=\"S11A3 S1070 S2\" id=\"te_49\">Revenues from contract with customers </span><span class=\"S11A4 S1070 S2\" id=\"tf_49\">2 </span><span class=\"S11A5 S1070 S2\" id=\"tg_49\">374 474 </span><span class=\"S11A6 S1070 S2\" id=\"th_49\">354 124 </span><span class=\"S11A7 S1070 S2\" id=\"ti_49\">236 550 </span><span class=\"S11A8 S1070 S2\" id=\"tj_49\">236 380 </span><span class=\"S11A9 S1070 S2\" id=\"tk_49\">Signing fees and milestone revenues </span><span class=\"S11AA S1070 S2\" id=\"tl_49\">2 </span><span class=\"S11AB S1070 S2\" id=\"tm_49\">18 658 </span><span class=\"S11AC S1070 S2\" id=\"tn_49\">6 416 </span><span class=\"S11AD S1070 S2\" id=\"to_49\">18 658 </span><span class=\"S11AE S1070 S2\" id=\"tp_49\">6 416 </span><span class=\"S11AF S1070 S2\" id=\"tq_49\">Cost of goods sold </span><span class=\"S11B0 S1070 S2\" id=\"tr_49\">-22 697 </span><span class=\"S11B1 S1070 S2\" id=\"ts_49\">-24 050 </span><span class=\"S11B2 S1070 S2\" id=\"tt_49\">-23 269 </span><span class=\"S11B3 S1070 S2\" id=\"tu_49\">-23 012 </span><span class=\"S11B4 S1071 S2\" id=\"tv_49\">Gross pro\ufb01t </span><span class=\"S11B5 S1071 S2\" id=\"tw_49\">370 435 </span><span class=\"S11B6 S1071 S2\" id=\"tx_49\">336 490 </span><span class=\"S11B7 S1071 S2\" id=\"ty_49\">231 939 </span><span class=\"S11B8 S1071 S2\" id=\"tz_49\">219 784 </span><span class=\"S11B9 S1070 S2\" id=\"t10_49\">Other income </span><span class=\"S11BA S1070 S2\" id=\"t11_49\">0 </span><span class=\"S11BB S1070 S2\" id=\"t12_49\">0 </span><span class=\"S11BC S1070 S2\" id=\"t13_49\">899 </span><span class=\"S11BD S1070 S2\" id=\"t14_49\">999 </span><span class=\"S11BE S1070 S2\" id=\"t15_49\">Payroll expenses </span><span class=\"S11BF S1070 S2\" id=\"t16_49\">6, 7 </span><span class=\"S11C0 S1070 S2\" id=\"t17_49\">-244 881 </span><span class=\"S11C1 S1070 S2\" id=\"t18_49\">-210 552 </span><span class=\"S11C2 S1070 S2\" id=\"t19_49\">-102 315 </span><span class=\"S11C3 S1070 S2\" id=\"t1a_49\">-86 906 </span><span class=\"S11C4 S1070 S2\" id=\"t1b_49\">R&amp;D costs excluding payroll expenses/other operating expenses </span><span class=\"S11C5 S1070 S2\" id=\"t1c_49\">-1 809 </span><span class=\"S11C6 S1070 S2\" id=\"t1d_49\">-2 657 </span><span class=\"S11C7 S1070 S2\" id=\"t1e_49\">-1 809 </span><span class=\"S11C8 S1070 S2\" id=\"t1f_49\">-2 657 </span><span class=\"S11C9 S1070 S2\" id=\"t1g_49\">Ordinary depreciation and amortisation </span><span class=\"S11CA S1070 S2\" id=\"t1h_49\">13, 14 </span><span class=\"S11CB S1070 S2\" id=\"t1i_49\">-24 378 </span><span class=\"S11CC S1070 S2\" id=\"t1j_49\">-24 127 </span><span class=\"S11CD S1070 S2\" id=\"t1k_49\">-20 051 </span><span class=\"S11CE S1070 S2\" id=\"t1l_49\">-20 753 </span><span class=\"S11CF S1070 S2\" id=\"t1m_49\">Other operating expenses </span><span class=\"S11D0 S1070 S2\" id=\"t1n_49\">-148 370 </span><span class=\"S11D1 S1070 S2\" id=\"t1o_49\">-104 979 </span><span class=\"S11D2 S1070 S2\" id=\"t1p_49\">-158 016 </span><span class=\"S11D3 S1070 S2\" id=\"t1q_49\">-112 108 </span><span class=\"S11D4 S1071 S2\" id=\"t1r_49\">Total operating expenses </span><span class=\"S11D5 S1071 S2\" id=\"t1s_49\">-419 438 </span><span class=\"S11D6 S1071 S2\" id=\"t1t_49\">-342 315 </span><span class=\"S11D7 S1071 S2\" id=\"t1u_49\">-281 292 </span><span class=\"S11D8 S1071 S2\" id=\"t1v_49\">-221 425 </span><span class=\"S11D9 S1071 S2\" id=\"t1w_49\">Operating pro\ufb01t / loss (-) </span><span class=\"S11DA S1071 S2\" id=\"t1x_49\">-49 003 </span><span class=\"S11DB S1071 S2\" id=\"t1y_49\">-5 825 </span><span class=\"S11DC S1071 S2\" id=\"t1z_49\">-49 353 </span><span class=\"S11DD S1071 S2\" id=\"t20_49\">-1 641 </span><span class=\"S11DE S1071 S2\" id=\"t21_49\">Speci\ufb01cation of Other operating expenses: </span><span class=\"S11DF S1071 S2\" id=\"t22_49\">2022 </span><span class=\"S11E0 S1071 S2\" id=\"t23_49\">2021 </span><span class=\"S11E1 S1071 S2\" id=\"t24_49\">2022 </span><span class=\"S11E2 S1071 S2\" id=\"t25_49\">2021 </span><span class=\"S11E3 S1070 S2\" id=\"t26_49\">Marketing expenses </span><span class=\"S11E4 S1070 S2\" id=\"t27_49\">45 162 </span><span class=\"S11E5 S1070 S2\" id=\"t28_49\">33 140 </span><span class=\"S11E6 S1070 S2\" id=\"t29_49\">16 087 </span><span class=\"S11E7 S1070 S2\" id=\"t2a_49\">15 908 </span><span class=\"S11E8 S1070 S2\" id=\"t2b_49\">Pro\ufb01t split coverage US </span><span class=\"S11E9 S1070 S2\" id=\"t2c_49\">- </span><span class=\"S11EA S1070 S2\" id=\"t2d_49\">- </span><span class=\"S11EB S1070 S2\" id=\"t2e_49\">17 888 </span><span class=\"S11EC S1070 S2\" id=\"t2f_49\">7 269 </span><span class=\"S11ED S1070 S2\" id=\"t2g_49\">Sales and marketing costs Europe </span><span class=\"S11EE S1070 S2\" id=\"t2h_49\">- </span><span class=\"S11EF S1070 S2\" id=\"t2i_49\">- </span><span class=\"S11F0 S1070 S2\" id=\"t2j_49\">54 719 </span><span class=\"S11F1 S1070 S2\" id=\"t2k_49\">48 060 </span><span class=\"S11F2 S1070 S2\" id=\"t2l_49\">Travel expenses </span><span class=\"S11F3 S1070 S2\" id=\"t2m_49\">19 108 </span><span class=\"S11F4 S1070 S2\" id=\"t2n_49\">10 522 </span><span class=\"S11F5 S1070 S2\" id=\"t2o_49\">5 308 </span><span class=\"S11F6 S1070 S2\" id=\"t2p_49\">1 724 </span><span class=\"S11F7 S1070 S2\" id=\"t2q_49\">Patent costs, legal and other fees </span><span class=\"S11F8 S1070 S2\" id=\"t2r_49\">55 848 </span><span class=\"S11F9 S1070 S2\" id=\"t2s_49\">38 938 </span><span class=\"S11FA S1070 S2\" id=\"t2t_49\">41 317 </span><span class=\"S11FB S1070 S2\" id=\"t2u_49\">25 854 </span><span class=\"S11FC S1070 S2\" id=\"t2v_49\">Other expenses </span><span class=\"S11FD S1070 S2\" id=\"t2w_49\">28 253 </span><span class=\"S11FE S1070 S2\" id=\"t2x_49\">22 380 </span><span class=\"S11FF S1070 S2\" id=\"t2y_49\">22 698 </span><span class=\"S1200 S1070 S2\" id=\"t2z_49\">13 294 </span><span class=\"S1201 S1071 S2\" id=\"t30_49\">Total other operating expenses </span><span class=\"S1202 S1071 S2\" id=\"t31_49\">148 370 </span><span class=\"S1203 S1071 S2\" id=\"t32_49\">104 979 </span><span class=\"S1204 S1071 S2\" id=\"t33_49\">158 016 </span><span class=\"S1205 S1071 S2\" id=\"t34_49\">112 108 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfExpensesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5462": {
   "value": "<span class=\"S11DE S1071 S2\" id=\"t21_49\">Speci\ufb01cation of Other operating expenses: </span><span class=\"S11DF S1071 S2\" id=\"t22_49\">2022 </span><span class=\"S11E0 S1071 S2\" id=\"t23_49\">2021 </span><span class=\"S11E1 S1071 S2\" id=\"t24_49\">2022 </span><span class=\"S11E2 S1071 S2\" id=\"t25_49\">2021 </span><span class=\"S11E3 S1070 S2\" id=\"t26_49\">Marketing expenses </span><span class=\"S11E4 S1070 S2\" id=\"t27_49\">45 162 </span><span class=\"S11E5 S1070 S2\" id=\"t28_49\">33 140 </span><span class=\"S11E6 S1070 S2\" id=\"t29_49\">16 087 </span><span class=\"S11E7 S1070 S2\" id=\"t2a_49\">15 908 </span><span class=\"S11E8 S1070 S2\" id=\"t2b_49\">Pro\ufb01t split coverage US </span><span class=\"S11E9 S1070 S2\" id=\"t2c_49\">- </span><span class=\"S11EA S1070 S2\" id=\"t2d_49\">- </span><span class=\"S11EB S1070 S2\" id=\"t2e_49\">17 888 </span><span class=\"S11EC S1070 S2\" id=\"t2f_49\">7 269 </span><span class=\"S11ED S1070 S2\" id=\"t2g_49\">Sales and marketing costs Europe </span><span class=\"S11EE S1070 S2\" id=\"t2h_49\">- </span><span class=\"S11EF S1070 S2\" id=\"t2i_49\">- </span><span class=\"S11F0 S1070 S2\" id=\"t2j_49\">54 719 </span><span class=\"S11F1 S1070 S2\" id=\"t2k_49\">48 060 </span><span class=\"S11F2 S1070 S2\" id=\"t2l_49\">Travel expenses </span><span class=\"S11F3 S1070 S2\" id=\"t2m_49\">19 108 </span><span class=\"S11F4 S1070 S2\" id=\"t2n_49\">10 522 </span><span class=\"S11F5 S1070 S2\" id=\"t2o_49\">5 308 </span><span class=\"S11F6 S1070 S2\" id=\"t2p_49\">1 724 </span><span class=\"S11F7 S1070 S2\" id=\"t2q_49\">Patent costs, legal and other fees </span><span class=\"S11F8 S1070 S2\" id=\"t2r_49\">55 848 </span><span class=\"S11F9 S1070 S2\" id=\"t2s_49\">38 938 </span><span class=\"S11FA S1070 S2\" id=\"t2t_49\">41 317 </span><span class=\"S11FB S1070 S2\" id=\"t2u_49\">25 854 </span><span class=\"S11FC S1070 S2\" id=\"t2v_49\">Other expenses </span><span class=\"S11FD S1070 S2\" id=\"t2w_49\">28 253 </span><span class=\"S11FE S1070 S2\" id=\"t2x_49\">22 380 </span><span class=\"S11FF S1070 S2\" id=\"t2y_49\">22 698 </span><span class=\"S1200 S1070 S2\" id=\"t2z_49\">13 294 </span><span class=\"S1201 S1071 S2\" id=\"t30_49\">Total other operating expenses </span><span class=\"S1202 S1071 S2\" id=\"t31_49\">148 370 </span><span class=\"S1203 S1071 S2\" id=\"t32_49\">104 979 </span><span class=\"S1204 S1071 S2\" id=\"t33_49\">158 016 </span><span class=\"S1205 S1071 S2\" id=\"t34_49\">112 108 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5503": {
   "value": "<span class=\"S1206 S106F S2\" id=\"t35_49\">6. PERSONNEL EXPENSES </span><span class=\"S1207 S1070 S2\" id=\"t36_49\">(Amounts in NOK 1,000) </span><span class=\"S1208 S1071 S2\" id=\"t37_49\">Group </span><span class=\"S1209 S1071 S2\" id=\"t38_49\">Parent </span><span class=\"S120A S1071 S2\" id=\"t39_49\">Note </span><span class=\"S120B S1071 S2\" id=\"t3a_49\">2022 </span><span class=\"S120C S1071 S2\" id=\"t3b_49\">2021 </span><span class=\"S120D S1071 S2\" id=\"t3c_49\">2022 </span><span class=\"S120E S1071 S2\" id=\"t3d_49\">2021 </span><span class=\"S120F S1070 S2\" id=\"t3e_49\">Salaries </span><span class=\"S1210 S1070 S2\" id=\"t3f_49\">175 991 </span><span class=\"S1211 S1070 S2\" id=\"t3g_49\">156 914 </span><span class=\"S1212 S1070 S2\" id=\"t3h_49\">66 879 </span><span class=\"S1213 S1070 S2\" id=\"t3i_49\">60 780 </span><span class=\"S1214 S1070 S2\" id=\"t3j_49\">Employer\u2019s social security contributions on salaries, etc. </span><span class=\"S1215 S1070 S2\" id=\"t3k_49\">20 855 </span><span class=\"S1216 S1070 S2\" id=\"t3l_49\">18 736 </span><span class=\"S1217 S1070 S2\" id=\"t3m_49\">8 144 </span><span class=\"S1218 S1070 S2\" id=\"t3n_49\">8 297 </span><span class=\"S1219 S1070 S2\" id=\"t3o_49\">Option costs incl employer's social security contributions </span><span class=\"S121A S1070 S2\" id=\"t3p_49\">21 674 </span><span class=\"S121B S1070 S2\" id=\"t3q_49\">13 225 </span><span class=\"S121C S1070 S2\" id=\"t3r_49\">16 406 </span><span class=\"S121D S1070 S2\" id=\"t3s_49\">10 229 </span><span class=\"S121E S1070 S2\" id=\"t3t_49\">Pension costs </span><span class=\"S121F S1070 S2\" id=\"t3u_49\">8 </span><span class=\"S1220 S1070 S2\" id=\"t3v_49\">13 101 </span><span class=\"S1221 S1070 S2\" id=\"t3w_49\">11 372 </span><span class=\"S1222 S1070 S2\" id=\"t3x_49\">5 682 </span><span class=\"S1223 S1070 S2\" id=\"t3y_49\">4 902 </span><span class=\"S1224 S1070 S2\" id=\"t3z_49\">Other bene\ufb01ts </span><span class=\"S1225 S1070 S2\" id=\"t40_49\">13 260 </span><span class=\"S1226 S1070 S2\" id=\"t41_49\">10 305 </span><span class=\"S1227 S1070 S2\" id=\"t42_49\">5 205 </span><span class=\"S1228 S1070 S2\" id=\"t43_49\">2 699 </span><span class=\"S1229 S1071 S2\" id=\"t44_49\">Total payroll expenses </span><span class=\"S122A S1071 S2\" id=\"t45_49\">244 881 </span><span class=\"S122B S1071 S2\" id=\"t46_49\">210 552 </span><span class=\"S122C S1071 S2\" id=\"t47_49\">102 315 </span><span class=\"S122D S1071 S2\" id=\"t48_49\">86 906 </span><span class=\"S122E S1070 S2\" id=\"t49_49\">No. of full-time equivalent positions </span><span class=\"S122F S1070 S2\" id=\"t4a_49\">106 </span><span class=\"S1230 S1070 S2\" id=\"t4b_49\">98 </span><span class=\"S1231 S1070 S2\" id=\"t4c_49\">37 </span><span class=\"S1232 S1070 S2\" id=\"t4d_49\">32 </span><span class=\"S1233 S1071 S2\" id=\"t4e_49\">Share-based remuneration </span><span class=\"S1234 S1070 S2\" id=\"t4f_49\">As part of the company\u2019s incentive policy, employees have been o\ufb00ered share options to the company\u2019s shares (the term \u2018options\u2019 is </span><span class=\"S1235 S1070 S2\" id=\"t4g_49\">also used). Allocated share options are vested over three years, 25% after \ufb01rst year, 25% second year and 50% third year. The rights </span><span class=\"S1236 S1070 S2\" id=\"t4h_49\">are no longer valid after \ufb01ve years or on termination of the employee. </span><span class=\"S1237 S1070 S2\" id=\"t4_50\">The number of employee share options and average exercise prices for Photocure, and developments during the year: </span><span class=\"S1238 S1071 S2\" id=\"t5_50\">2022 </span><span class=\"S1239 S1071 S2\" id=\"t6_50\">2021 </span><span class=\"S123A S1071 S2\" id=\"t7_50\">Number </span><span class=\"S123B S1071 S2\" id=\"t8_50\">Average exercise </span><span class=\"S123C S1071 S2\" id=\"t9_50\">price (NOK) </span><span class=\"S123D S1071 S2\" id=\"ta_50\">Number </span><span class=\"S123E S1071 S2\" id=\"tb_50\">Average exercise </span><span class=\"S123F S1071 S2\" id=\"tc_50\">price (NOK) </span><span class=\"S1240 S1070 S2\" id=\"td_50\">Outstanding at start of year </span><span class=\"S1241 S1070 S2\" id=\"te_50\">1 355 750 </span><span class=\"S1242 S1070 S2\" id=\"tf_50\">109.61 </span><span class=\"S1243 S1070 S2\" id=\"tg_50\">981 534 </span><span class=\"S1244 S1070 S2\" id=\"th_50\">66.28 </span><span class=\"S1245 S1070 S2\" id=\"ti_50\">Granted during the year </span><span class=\"S1246 S1070 S2\" id=\"tj_50\">716 028 </span><span class=\"S1247 S1070 S2\" id=\"tk_50\">114.90 </span><span class=\"S1248 S1070 S2\" id=\"tl_50\">756 000 </span><span class=\"S1249 S1070 S2\" id=\"tm_50\">142.57 </span><span class=\"S124A S1070 S2\" id=\"tn_50\">Become invalid during the year </span><span class=\"S124B S1070 S2\" id=\"to_50\">2 000 </span><span class=\"S124C S1070 S2\" id=\"tp_50\">87.39 </span><span class=\"S124D S1070 S2\" id=\"tq_50\">125 500 </span><span class=\"S124E S1070 S2\" id=\"tr_50\">81.99 </span><span class=\"S124F S1070 S2\" id=\"ts_50\">Exercised during the year </span><span class=\"S1250 S1070 S2\" id=\"tt_50\">147 000 </span><span class=\"S1251 S1070 S2\" id=\"tu_50\">51.49 </span><span class=\"S1252 S1070 S2\" id=\"tv_50\">256 284 </span><span class=\"S1253 S1070 S2\" id=\"tw_50\">54.41 </span><span class=\"S1254 S1070 S2\" id=\"tx_50\">Expired during the year </span><span class=\"S1255 S1070 S2\" id=\"ty_50\">- </span><span class=\"S1256 S1070 S2\" id=\"tz_50\">0.00 </span><span class=\"S1257 S1070 S2\" id=\"t10_50\">- </span><span class=\"S1258 S1070 S2\" id=\"t11_50\">0.00 </span><span class=\"S1259 S1070 S2\" id=\"t12_50\">Outstanding at end of year </span><span class=\"S125A S1070 S2\" id=\"t13_50\">1 922 778 </span><span class=\"S125B S1070 S2\" id=\"t14_50\">116.04 </span><span class=\"S125C S1070 S2\" id=\"t15_50\">1 355 750 </span><span class=\"S125D S1070 S2\" id=\"t16_50\">109.61 </span><span class=\"S125E S1070 S2\" id=\"t17_50\">Exercisable options as per 31 December </span><span class=\"S125F S1070 S2\" id=\"t18_50\">448 000 </span><span class=\"S1260 S1070 S2\" id=\"t19_50\">101.30 </span><span class=\"S1261 S1070 S2\" id=\"t1a_50\">90 375 </span><span class=\"S1262 S1070 S2\" id=\"t1b_50\">77.66 </span><span class=\"S1263 S1070 S2\" id=\"t1c_50\">The average weighted life of outstanding share options was 3.7 years at 31 December 2022 and 4.0 years at 31 December 2021. </span><span class=\"S1264 S1070 S2\" id=\"t1d_50\">The exercise prices and the average life of outstanding share options as per 31 December 2022 were as follows: </span><span class=\"S1265 S1071 S2\" id=\"t1e_50\">Average remaining life </span><span class=\"S1266 S1071 S2\" id=\"t1f_50\">No. of options </span><span class=\"S1267 S1071 S2\" id=\"t1g_50\">Exercise price </span><span class=\"S1268 S1071 S2\" id=\"t1h_50\">NOK </span><span class=\"S1269 S1070 S2\" id=\"t1i_50\">1 year </span><span class=\"S126A S1070 S2\" id=\"t1j_50\">84 500 </span><span class=\"S126B S1070 S2\" id=\"t1k_50\">50.72-56.83 </span><span class=\"S126C S1070 S2\" id=\"t1l_50\">3 year </span><span class=\"S126D S1070 S2\" id=\"t1m_50\">424 750 </span><span class=\"S126E S1070 S2\" id=\"t1n_50\">78.65-139.41 </span><span class=\"S126F S1070 S2\" id=\"t1o_50\">4 year </span><span class=\"S1270 S1070 S2\" id=\"t1p_50\">697 500 </span><span class=\"S1271 S1070 S2\" id=\"t1q_50\">123.34-145.27 </span><span class=\"S1272 S1070 S2\" id=\"t1r_50\">5 year </span><span class=\"S1273 S1070 S2\" id=\"t1s_50\">716 028 </span><span class=\"S1274 S1070 S2\" id=\"t1t_50\">114.89-115.70 </span><span class=\"S1275 S1071 S2\" id=\"t1u_50\">Total </span><span class=\"S1276 S1071 S2\" id=\"t1v_50\">1 922 778 </span><span class=\"S1277 S1071 S2\" id=\"t1w_50\">Calculation method for market value of employee share options: </span><span class=\"S1278 S1070 S2\" id=\"t1x_50\">The market value of share options is calculated according to the Black-Scholes method. Volatility is calculated on the basis of the </span><span class=\"S1279 S1070 S2\" id=\"t1y_50\">development in the historical share price equal to the lifetime of the options. This assumes that historical volatility indicates future </span><span class=\"S127A S1070 S2\" id=\"t1z_50\">volatility, which is not necessarily the case. Strike prices are set as the listed price plus 10% at the time of allocation. Risk-free </span><span class=\"S127B S1070 S2\" id=\"t20_50\">interest is based on the interest for Norwegian government bonds. Each option program is calculated separately with the actual </span><span class=\"S127C S1070 S2\" id=\"t21_50\">exercise price and duration of the program. The exercise date for the options is calculated on the basis of historical experience in the </span><span class=\"S127D S1070 S2\" id=\"t22_50\">company and is di\ufb00erentiated between senior management and other employees. The interest advantage is insigni\ufb01cant and has not </span><span class=\"S127E S1070 S2\" id=\"t23_50\">been included in the accounts. The table below shows the values that have been used in the model. </span><span class=\"S127F S1071 S2\" id=\"t24_50\">2022 </span><span class=\"S1280 SFE S2\" id=\"t25_50\">* </span><span class=\"S1281 S1071 S2\" id=\"t26_50\">2021 </span><span class=\"S1282 SFE S2\" id=\"t27_50\">* </span><span class=\"S1283 S1070 S2\" id=\"t28_50\">Dividends (NOK) </span><span class=\"S1284 S1070 S2\" id=\"t29_50\">0.00 </span><span class=\"S1285 S1070 S2\" id=\"t2a_50\">0.00 </span><span class=\"S1286 S1070 S2\" id=\"t2b_50\">Expected volatility (%) </span><span class=\"S1287 S1070 S2\" id=\"t2c_50\">50.98 </span><span class=\"S1288 S1070 S2\" id=\"t2d_50\">57.63 </span><span class=\"S1289 S1070 S2\" id=\"t2e_50\">Historical volatility (%) </span><span class=\"S128A S1070 S2\" id=\"t2f_50\">50.98 </span><span class=\"S128B S1070 S2\" id=\"t2g_50\">57.63 </span><span class=\"S128C S1070 S2\" id=\"t2h_50\">Risk-free interest (%) </span><span class=\"S128D S1070 S2\" id=\"t2i_50\">2.89 </span><span class=\"S128E S1070 S2\" id=\"t2j_50\">0.92 </span><span class=\"S128F S1070 S2\" id=\"t2k_50\">Expected life of options (years) </span><span class=\"S1290 S1070 S2\" id=\"t2l_50\">3.24 </span><span class=\"S1291 S1070 S2\" id=\"t2m_50\">3.25 </span><span class=\"S1292 S1294 S2\" id=\"t2n_50\">* </span><span class=\"S1293 S1295 S2\" id=\"t2o_50\">Weighted average parameters at grant of instrument </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5504": {
   "value": "<span class=\"S1206 S106F S2\" id=\"t35_49\">6. PERSONNEL EXPENSES </span><span class=\"S1207 S1070 S2\" id=\"t36_49\">(Amounts in NOK 1,000) </span><span class=\"S1208 S1071 S2\" id=\"t37_49\">Group </span><span class=\"S1209 S1071 S2\" id=\"t38_49\">Parent </span><span class=\"S120A S1071 S2\" id=\"t39_49\">Note </span><span class=\"S120B S1071 S2\" id=\"t3a_49\">2022 </span><span class=\"S120C S1071 S2\" id=\"t3b_49\">2021 </span><span class=\"S120D S1071 S2\" id=\"t3c_49\">2022 </span><span class=\"S120E S1071 S2\" id=\"t3d_49\">2021 </span><span class=\"S120F S1070 S2\" id=\"t3e_49\">Salaries </span><span class=\"S1210 S1070 S2\" id=\"t3f_49\">175 991 </span><span class=\"S1211 S1070 S2\" id=\"t3g_49\">156 914 </span><span class=\"S1212 S1070 S2\" id=\"t3h_49\">66 879 </span><span class=\"S1213 S1070 S2\" id=\"t3i_49\">60 780 </span><span class=\"S1214 S1070 S2\" id=\"t3j_49\">Employer\u2019s social security contributions on salaries, etc. </span><span class=\"S1215 S1070 S2\" id=\"t3k_49\">20 855 </span><span class=\"S1216 S1070 S2\" id=\"t3l_49\">18 736 </span><span class=\"S1217 S1070 S2\" id=\"t3m_49\">8 144 </span><span class=\"S1218 S1070 S2\" id=\"t3n_49\">8 297 </span><span class=\"S1219 S1070 S2\" id=\"t3o_49\">Option costs incl employer's social security contributions </span><span class=\"S121A S1070 S2\" id=\"t3p_49\">21 674 </span><span class=\"S121B S1070 S2\" id=\"t3q_49\">13 225 </span><span class=\"S121C S1070 S2\" id=\"t3r_49\">16 406 </span><span class=\"S121D S1070 S2\" id=\"t3s_49\">10 229 </span><span class=\"S121E S1070 S2\" id=\"t3t_49\">Pension costs </span><span class=\"S121F S1070 S2\" id=\"t3u_49\">8 </span><span class=\"S1220 S1070 S2\" id=\"t3v_49\">13 101 </span><span class=\"S1221 S1070 S2\" id=\"t3w_49\">11 372 </span><span class=\"S1222 S1070 S2\" id=\"t3x_49\">5 682 </span><span class=\"S1223 S1070 S2\" id=\"t3y_49\">4 902 </span><span class=\"S1224 S1070 S2\" id=\"t3z_49\">Other bene\ufb01ts </span><span class=\"S1225 S1070 S2\" id=\"t40_49\">13 260 </span><span class=\"S1226 S1070 S2\" id=\"t41_49\">10 305 </span><span class=\"S1227 S1070 S2\" id=\"t42_49\">5 205 </span><span class=\"S1228 S1070 S2\" id=\"t43_49\">2 699 </span><span class=\"S1229 S1071 S2\" id=\"t44_49\">Total payroll expenses </span><span class=\"S122A S1071 S2\" id=\"t45_49\">244 881 </span><span class=\"S122B S1071 S2\" id=\"t46_49\">210 552 </span><span class=\"S122C S1071 S2\" id=\"t47_49\">102 315 </span><span class=\"S122D S1071 S2\" id=\"t48_49\">86 906 </span><span class=\"S122E S1070 S2\" id=\"t49_49\">No. of full-time equivalent positions </span><span class=\"S122F S1070 S2\" id=\"t4a_49\">106 </span><span class=\"S1230 S1070 S2\" id=\"t4b_49\">98 </span><span class=\"S1231 S1070 S2\" id=\"t4c_49\">37 </span><span class=\"S1232 S1070 S2\" id=\"t4d_49\">32 </span><span class=\"S1233 S1071 S2\" id=\"t4e_49\">Share-based remuneration </span><span class=\"S1234 S1070 S2\" id=\"t4f_49\">As part of the company\u2019s incentive policy, employees have been o\ufb00ered share options to the company\u2019s shares (the term \u2018options\u2019 is </span><span class=\"S1235 S1070 S2\" id=\"t4g_49\">also used). Allocated share options are vested over three years, 25% after \ufb01rst year, 25% second year and 50% third year. The rights </span><span class=\"S1236 S1070 S2\" id=\"t4h_49\">are no longer valid after \ufb01ve years or on termination of the employee. </span><span class=\"S1237 S1070 S2\" id=\"t4_50\">The number of employee share options and average exercise prices for Photocure, and developments during the year: </span><span class=\"S1238 S1071 S2\" id=\"t5_50\">2022 </span><span class=\"S1239 S1071 S2\" id=\"t6_50\">2021 </span><span class=\"S123A S1071 S2\" id=\"t7_50\">Number </span><span class=\"S123B S1071 S2\" id=\"t8_50\">Average exercise </span><span class=\"S123C S1071 S2\" id=\"t9_50\">price (NOK) </span><span class=\"S123D S1071 S2\" id=\"ta_50\">Number </span><span class=\"S123E S1071 S2\" id=\"tb_50\">Average exercise </span><span class=\"S123F S1071 S2\" id=\"tc_50\">price (NOK) </span><span class=\"S1240 S1070 S2\" id=\"td_50\">Outstanding at start of year </span><span class=\"S1241 S1070 S2\" id=\"te_50\">1 355 750 </span><span class=\"S1242 S1070 S2\" id=\"tf_50\">109.61 </span><span class=\"S1243 S1070 S2\" id=\"tg_50\">981 534 </span><span class=\"S1244 S1070 S2\" id=\"th_50\">66.28 </span><span class=\"S1245 S1070 S2\" id=\"ti_50\">Granted during the year </span><span class=\"S1246 S1070 S2\" id=\"tj_50\">716 028 </span><span class=\"S1247 S1070 S2\" id=\"tk_50\">114.90 </span><span class=\"S1248 S1070 S2\" id=\"tl_50\">756 000 </span><span class=\"S1249 S1070 S2\" id=\"tm_50\">142.57 </span><span class=\"S124A S1070 S2\" id=\"tn_50\">Become invalid during the year </span><span class=\"S124B S1070 S2\" id=\"to_50\">2 000 </span><span class=\"S124C S1070 S2\" id=\"tp_50\">87.39 </span><span class=\"S124D S1070 S2\" id=\"tq_50\">125 500 </span><span class=\"S124E S1070 S2\" id=\"tr_50\">81.99 </span><span class=\"S124F S1070 S2\" id=\"ts_50\">Exercised during the year </span><span class=\"S1250 S1070 S2\" id=\"tt_50\">147 000 </span><span class=\"S1251 S1070 S2\" id=\"tu_50\">51.49 </span><span class=\"S1252 S1070 S2\" id=\"tv_50\">256 284 </span><span class=\"S1253 S1070 S2\" id=\"tw_50\">54.41 </span><span class=\"S1254 S1070 S2\" id=\"tx_50\">Expired during the year </span><span class=\"S1255 S1070 S2\" id=\"ty_50\">- </span><span class=\"S1256 S1070 S2\" id=\"tz_50\">0.00 </span><span class=\"S1257 S1070 S2\" id=\"t10_50\">- </span><span class=\"S1258 S1070 S2\" id=\"t11_50\">0.00 </span><span class=\"S1259 S1070 S2\" id=\"t12_50\">Outstanding at end of year </span><span class=\"S125A S1070 S2\" id=\"t13_50\">1 922 778 </span><span class=\"S125B S1070 S2\" id=\"t14_50\">116.04 </span><span class=\"S125C S1070 S2\" id=\"t15_50\">1 355 750 </span><span class=\"S125D S1070 S2\" id=\"t16_50\">109.61 </span><span class=\"S125E S1070 S2\" id=\"t17_50\">Exercisable options as per 31 December </span><span class=\"S125F S1070 S2\" id=\"t18_50\">448 000 </span><span class=\"S1260 S1070 S2\" id=\"t19_50\">101.30 </span><span class=\"S1261 S1070 S2\" id=\"t1a_50\">90 375 </span><span class=\"S1262 S1070 S2\" id=\"t1b_50\">77.66 </span><span class=\"S1263 S1070 S2\" id=\"t1c_50\">The average weighted life of outstanding share options was 3.7 years at 31 December 2022 and 4.0 years at 31 December 2021. </span><span class=\"S1264 S1070 S2\" id=\"t1d_50\">The exercise prices and the average life of outstanding share options as per 31 December 2022 were as follows: </span><span class=\"S1265 S1071 S2\" id=\"t1e_50\">Average remaining life </span><span class=\"S1266 S1071 S2\" id=\"t1f_50\">No. of options </span><span class=\"S1267 S1071 S2\" id=\"t1g_50\">Exercise price </span><span class=\"S1268 S1071 S2\" id=\"t1h_50\">NOK </span><span class=\"S1269 S1070 S2\" id=\"t1i_50\">1 year </span><span class=\"S126A S1070 S2\" id=\"t1j_50\">84 500 </span><span class=\"S126B S1070 S2\" id=\"t1k_50\">50.72-56.83 </span><span class=\"S126C S1070 S2\" id=\"t1l_50\">3 year </span><span class=\"S126D S1070 S2\" id=\"t1m_50\">424 750 </span><span class=\"S126E S1070 S2\" id=\"t1n_50\">78.65-139.41 </span><span class=\"S126F S1070 S2\" id=\"t1o_50\">4 year </span><span class=\"S1270 S1070 S2\" id=\"t1p_50\">697 500 </span><span class=\"S1271 S1070 S2\" id=\"t1q_50\">123.34-145.27 </span><span class=\"S1272 S1070 S2\" id=\"t1r_50\">5 year </span><span class=\"S1273 S1070 S2\" id=\"t1s_50\">716 028 </span><span class=\"S1274 S1070 S2\" id=\"t1t_50\">114.89-115.70 </span><span class=\"S1275 S1071 S2\" id=\"t1u_50\">Total </span><span class=\"S1276 S1071 S2\" id=\"t1v_50\">1 922 778 </span><span class=\"S1277 S1071 S2\" id=\"t1w_50\">Calculation method for market value of employee share options: </span><span class=\"S1278 S1070 S2\" id=\"t1x_50\">The market value of share options is calculated according to the Black-Scholes method. Volatility is calculated on the basis of the </span><span class=\"S1279 S1070 S2\" id=\"t1y_50\">development in the historical share price equal to the lifetime of the options. This assumes that historical volatility indicates future </span><span class=\"S127A S1070 S2\" id=\"t1z_50\">volatility, which is not necessarily the case. Strike prices are set as the listed price plus 10% at the time of allocation. Risk-free </span><span class=\"S127B S1070 S2\" id=\"t20_50\">interest is based on the interest for Norwegian government bonds. Each option program is calculated separately with the actual </span><span class=\"S127C S1070 S2\" id=\"t21_50\">exercise price and duration of the program. The exercise date for the options is calculated on the basis of historical experience in the </span><span class=\"S127D S1070 S2\" id=\"t22_50\">company and is di\ufb00erentiated between senior management and other employees. The interest advantage is insigni\ufb01cant and has not </span><span class=\"S127E S1070 S2\" id=\"t23_50\">been included in the accounts. The table below shows the values that have been used in the model. </span><span class=\"S127F S1071 S2\" id=\"t24_50\">2022 </span><span class=\"S1280 SFE S2\" id=\"t25_50\">* </span><span class=\"S1281 S1071 S2\" id=\"t26_50\">2021 </span><span class=\"S1282 SFE S2\" id=\"t27_50\">* </span><span class=\"S1283 S1070 S2\" id=\"t28_50\">Dividends (NOK) </span><span class=\"S1284 S1070 S2\" id=\"t29_50\">0.00 </span><span class=\"S1285 S1070 S2\" id=\"t2a_50\">0.00 </span><span class=\"S1286 S1070 S2\" id=\"t2b_50\">Expected volatility (%) </span><span class=\"S1287 S1070 S2\" id=\"t2c_50\">50.98 </span><span class=\"S1288 S1070 S2\" id=\"t2d_50\">57.63 </span><span class=\"S1289 S1070 S2\" id=\"t2e_50\">Historical volatility (%) </span><span class=\"S128A S1070 S2\" id=\"t2f_50\">50.98 </span><span class=\"S128B S1070 S2\" id=\"t2g_50\">57.63 </span><span class=\"S128C S1070 S2\" id=\"t2h_50\">Risk-free interest (%) </span><span class=\"S128D S1070 S2\" id=\"t2i_50\">2.89 </span><span class=\"S128E S1070 S2\" id=\"t2j_50\">0.92 </span><span class=\"S128F S1070 S2\" id=\"t2k_50\">Expected life of options (years) </span><span class=\"S1290 S1070 S2\" id=\"t2l_50\">3.24 </span><span class=\"S1291 S1070 S2\" id=\"t2m_50\">3.25 </span><span class=\"S1292 S1294 S2\" id=\"t2n_50\">* </span><span class=\"S1293 S1295 S2\" id=\"t2o_50\">Weighted average parameters at grant of instrument </span><span class=\"S13D2 S106F S2\" id=\"t2_53\">8. PENSION COSTS </span><span class=\"S13D3 S1070 S2\" id=\"t3_53\">Photocure ASA has an agreement with a life assurance company concerning contribution-based pensions for Photocure\u2019s </span><span class=\"S13D4 S1070 S2\" id=\"t4_53\">employees in Norway. The contribution plan match the revised national regulations for pension. The contributions are 6% of the </span><span class=\"S13D5 S1070 S2\" id=\"t5_53\">employee\u2019s ordinary salary up to 7.1 times the basic amount (G) of the Norwegian National Insurance scheme, and thereafter 16% up </span><span class=\"S13D6 S1070 S2\" id=\"t6_53\">to 12 x G. The national insurance cover pension for salaries to 7.1 G. Pension contributions are paid into the employee\u2019s contribution </span><span class=\"S13D7 S1070 S2\" id=\"t7_53\">account with the life assurance company. As of 31 December 2022 and 31 December 2021, the company had no deposits in the </span><span class=\"S13D8 S1070 S2\" id=\"t8_53\">premium and the contribution fund. </span><span class=\"S13D9 S1070 S2\" id=\"t9_53\">Photocure ASA employees in other European countries have individual de\ufb01ned contribution pension plans according to local </span><span class=\"S13DA S1070 S2\" id=\"ta_53\">regulations and </span><span class=\"S13DB S1070 S2\" id=\"tb_53\">their employment agreements. </span><span class=\"S13DC S1070 S2\" id=\"tc_53\">Photocure Inc matches its employee\u2019s contribution to the 401(k) plan dollar for dollar up to 4% of salary for the employees that elect </span><span class=\"S13DD S1070 S2\" id=\"td_53\">to join the plan. </span><span class=\"S13DE S1070 S2\" id=\"te_53\">There is a salary maximum set by the IRS, which was $305 000 in 2022. </span><span class=\"S13DF S1070 S2\" id=\"tf_53\">Employees in Photocure GmbH in Germany coming from Ipsen have de\ufb01ned bene\ufb01t pension plans through the </span><span class=\"S13E0 S1070 S2\" id=\"tg_53\">TUPE regulations in </span><span class=\"S13E1 S1070 S2\" id=\"th_53\">Germany. Photocure GmbH has a re-assurance agreement with an assurance company in Germany that balance the pension liability. </span><span class=\"S13E2 S1070 S2\" id=\"ti_53\">New employees in Photocure GmbH are o\ufb00ered a de\ufb01ned contribution plan. </span><span class=\"S13E3 S1070 S2\" id=\"tj_53\">Photocure has entered into pension agreements with senior management in the form of un-funded pensions for salaries exceeding </span><span class=\"S13E4 S1070 S2\" id=\"tk_53\">coverage by insurance. This un-funded pension liability is interest-bearing. </span><span class=\"S13E5 S1071 S2\" id=\"tl_53\">The pension cost for the year is calculated as follows: </span><span class=\"S13E6 S1070 S2\" id=\"tm_53\">(Amounts in NOK 1,000) </span><span class=\"S13E7 S1071 S2\" id=\"tn_53\">Group </span><span class=\"S13E8 S1071 S2\" id=\"to_53\">Parent </span><span class=\"S13E9 S1071 S2\" id=\"tp_53\">2022 </span><span class=\"S13EA S1071 S2\" id=\"tq_53\">2021 </span><span class=\"S13EB S1071 S2\" id=\"tr_53\">2022 </span><span class=\"S13EC S1071 S2\" id=\"ts_53\">2021 </span><span class=\"S13ED S1070 S2\" id=\"tt_53\">Total pension costs, contribution scheme in life assurance </span><span class=\"S13EE S1070 S2\" id=\"tu_53\">11 866 </span><span class=\"S13EF S1070 S2\" id=\"tv_53\">10 496 </span><span class=\"S13F0 S1070 S2\" id=\"tw_53\">5 339 </span><span class=\"S13F1 S1070 S2\" id=\"tx_53\">4 607 </span><span class=\"S13F2 S1070 S2\" id=\"ty_53\">Total pension costs, company scheme </span><span class=\"S13F3 S1070 S2\" id=\"tz_53\">1 235 </span><span class=\"S13F4 S1070 S2\" id=\"t10_53\">876 </span><span class=\"S13F5 S1070 S2\" id=\"t11_53\">343 </span><span class=\"S13F6 S1070 S2\" id=\"t12_53\">295 </span><span class=\"S13F7 S1071 S2\" id=\"t13_53\">Total </span><span class=\"S13F8 S1071 S2\" id=\"t14_53\">13 101 </span><span class=\"S13F9 S1071 S2\" id=\"t15_53\">11 372 </span><span class=\"S13FA S1071 S2\" id=\"t16_53\">5 682 </span><span class=\"S13FB S1071 S2\" id=\"t17_53\">4 902 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5550": {
   "value": "<span class=\"S1233 S1071 S2\" id=\"t4e_49\">Share-based remuneration </span><span class=\"S1234 S1070 S2\" id=\"t4f_49\">As part of the company\u2019s incentive policy, employees have been o\ufb00ered share options to the company\u2019s shares (the term \u2018options\u2019 is </span><span class=\"S1235 S1070 S2\" id=\"t4g_49\">also used). Allocated share options are vested over three years, 25% after \ufb01rst year, 25% second year and 50% third year. The rights </span><span class=\"S1236 S1070 S2\" id=\"t4h_49\">are no longer valid after \ufb01ve years or on termination of the employee. </span><span class=\"S1237 S1070 S2\" id=\"t4_50\">The number of employee share options and average exercise prices for Photocure, and developments during the year: </span><span class=\"S1238 S1071 S2\" id=\"t5_50\">2022 </span><span class=\"S1239 S1071 S2\" id=\"t6_50\">2021 </span><span class=\"S123A S1071 S2\" id=\"t7_50\">Number </span><span class=\"S123B S1071 S2\" id=\"t8_50\">Average exercise </span><span class=\"S123C S1071 S2\" id=\"t9_50\">price (NOK) </span><span class=\"S123D S1071 S2\" id=\"ta_50\">Number </span><span class=\"S123E S1071 S2\" id=\"tb_50\">Average exercise </span><span class=\"S123F S1071 S2\" id=\"tc_50\">price (NOK) </span><span class=\"S1240 S1070 S2\" id=\"td_50\">Outstanding at start of year </span><span class=\"S1241 S1070 S2\" id=\"te_50\">1 355 750 </span><span class=\"S1242 S1070 S2\" id=\"tf_50\">109.61 </span><span class=\"S1243 S1070 S2\" id=\"tg_50\">981 534 </span><span class=\"S1244 S1070 S2\" id=\"th_50\">66.28 </span><span class=\"S1245 S1070 S2\" id=\"ti_50\">Granted during the year </span><span class=\"S1246 S1070 S2\" id=\"tj_50\">716 028 </span><span class=\"S1247 S1070 S2\" id=\"tk_50\">114.90 </span><span class=\"S1248 S1070 S2\" id=\"tl_50\">756 000 </span><span class=\"S1249 S1070 S2\" id=\"tm_50\">142.57 </span><span class=\"S124A S1070 S2\" id=\"tn_50\">Become invalid during the year </span><span class=\"S124B S1070 S2\" id=\"to_50\">2 000 </span><span class=\"S124C S1070 S2\" id=\"tp_50\">87.39 </span><span class=\"S124D S1070 S2\" id=\"tq_50\">125 500 </span><span class=\"S124E S1070 S2\" id=\"tr_50\">81.99 </span><span class=\"S124F S1070 S2\" id=\"ts_50\">Exercised during the year </span><span class=\"S1250 S1070 S2\" id=\"tt_50\">147 000 </span><span class=\"S1251 S1070 S2\" id=\"tu_50\">51.49 </span><span class=\"S1252 S1070 S2\" id=\"tv_50\">256 284 </span><span class=\"S1253 S1070 S2\" id=\"tw_50\">54.41 </span><span class=\"S1254 S1070 S2\" id=\"tx_50\">Expired during the year </span><span class=\"S1255 S1070 S2\" id=\"ty_50\">- </span><span class=\"S1256 S1070 S2\" id=\"tz_50\">0.00 </span><span class=\"S1257 S1070 S2\" id=\"t10_50\">- </span><span class=\"S1258 S1070 S2\" id=\"t11_50\">0.00 </span><span class=\"S1259 S1070 S2\" id=\"t12_50\">Outstanding at end of year </span><span class=\"S125A S1070 S2\" id=\"t13_50\">1 922 778 </span><span class=\"S125B S1070 S2\" id=\"t14_50\">116.04 </span><span class=\"S125C S1070 S2\" id=\"t15_50\">1 355 750 </span><span class=\"S125D S1070 S2\" id=\"t16_50\">109.61 </span><span class=\"S125E S1070 S2\" id=\"t17_50\">Exercisable options as per 31 December </span><span class=\"S125F S1070 S2\" id=\"t18_50\">448 000 </span><span class=\"S1260 S1070 S2\" id=\"t19_50\">101.30 </span><span class=\"S1261 S1070 S2\" id=\"t1a_50\">90 375 </span><span class=\"S1262 S1070 S2\" id=\"t1b_50\">77.66 </span><span class=\"S1263 S1070 S2\" id=\"t1c_50\">The average weighted life of outstanding share options was 3.7 years at 31 December 2022 and 4.0 years at 31 December 2021. </span><span class=\"S1264 S1070 S2\" id=\"t1d_50\">The exercise prices and the average life of outstanding share options as per 31 December 2022 were as follows: </span><span class=\"S1265 S1071 S2\" id=\"t1e_50\">Average remaining life </span><span class=\"S1266 S1071 S2\" id=\"t1f_50\">No. of options </span><span class=\"S1267 S1071 S2\" id=\"t1g_50\">Exercise price </span><span class=\"S1268 S1071 S2\" id=\"t1h_50\">NOK </span><span class=\"S1269 S1070 S2\" id=\"t1i_50\">1 year </span><span class=\"S126A S1070 S2\" id=\"t1j_50\">84 500 </span><span class=\"S126B S1070 S2\" id=\"t1k_50\">50.72-56.83 </span><span class=\"S126C S1070 S2\" id=\"t1l_50\">3 year </span><span class=\"S126D S1070 S2\" id=\"t1m_50\">424 750 </span><span class=\"S126E S1070 S2\" id=\"t1n_50\">78.65-139.41 </span><span class=\"S126F S1070 S2\" id=\"t1o_50\">4 year </span><span class=\"S1270 S1070 S2\" id=\"t1p_50\">697 500 </span><span class=\"S1271 S1070 S2\" id=\"t1q_50\">123.34-145.27 </span><span class=\"S1272 S1070 S2\" id=\"t1r_50\">5 year </span><span class=\"S1273 S1070 S2\" id=\"t1s_50\">716 028 </span><span class=\"S1274 S1070 S2\" id=\"t1t_50\">114.89-115.70 </span><span class=\"S1275 S1071 S2\" id=\"t1u_50\">Total </span><span class=\"S1276 S1071 S2\" id=\"t1v_50\">1 922 778 </span><span class=\"S1277 S1071 S2\" id=\"t1w_50\">Calculation method for market value of employee share options: </span><span class=\"S1278 S1070 S2\" id=\"t1x_50\">The market value of share options is calculated according to the Black-Scholes method. Volatility is calculated on the basis of the </span><span class=\"S1279 S1070 S2\" id=\"t1y_50\">development in the historical share price equal to the lifetime of the options. This assumes that historical volatility indicates future </span><span class=\"S127A S1070 S2\" id=\"t1z_50\">volatility, which is not necessarily the case. Strike prices are set as the listed price plus 10% at the time of allocation. Risk-free </span><span class=\"S127B S1070 S2\" id=\"t20_50\">interest is based on the interest for Norwegian government bonds. Each option program is calculated separately with the actual </span><span class=\"S127C S1070 S2\" id=\"t21_50\">exercise price and duration of the program. The exercise date for the options is calculated on the basis of historical experience in the </span><span class=\"S127D S1070 S2\" id=\"t22_50\">company and is di\ufb00erentiated between senior management and other employees. The interest advantage is insigni\ufb01cant and has not </span><span class=\"S127E S1070 S2\" id=\"t23_50\">been included in the accounts. The table below shows the values that have been used in the model. </span><span class=\"S127F S1071 S2\" id=\"t24_50\">2022 </span><span class=\"S1280 SFE S2\" id=\"t25_50\">* </span><span class=\"S1281 S1071 S2\" id=\"t26_50\">2021 </span><span class=\"S1282 SFE S2\" id=\"t27_50\">* </span><span class=\"S1283 S1070 S2\" id=\"t28_50\">Dividends (NOK) </span><span class=\"S1284 S1070 S2\" id=\"t29_50\">0.00 </span><span class=\"S1285 S1070 S2\" id=\"t2a_50\">0.00 </span><span class=\"S1286 S1070 S2\" id=\"t2b_50\">Expected volatility (%) </span><span class=\"S1287 S1070 S2\" id=\"t2c_50\">50.98 </span><span class=\"S1288 S1070 S2\" id=\"t2d_50\">57.63 </span><span class=\"S1289 S1070 S2\" id=\"t2e_50\">Historical volatility (%) </span><span class=\"S128A S1070 S2\" id=\"t2f_50\">50.98 </span><span class=\"S128B S1070 S2\" id=\"t2g_50\">57.63 </span><span class=\"S128C S1070 S2\" id=\"t2h_50\">Risk-free interest (%) </span><span class=\"S128D S1070 S2\" id=\"t2i_50\">2.89 </span><span class=\"S128E S1070 S2\" id=\"t2j_50\">0.92 </span><span class=\"S128F S1070 S2\" id=\"t2k_50\">Expected life of options (years) </span><span class=\"S1290 S1070 S2\" id=\"t2l_50\">3.24 </span><span class=\"S1291 S1070 S2\" id=\"t2m_50\">3.25 </span><span class=\"S1292 S1294 S2\" id=\"t2n_50\">* </span><span class=\"S1293 S1295 S2\" id=\"t2o_50\">Weighted average parameters at grant of instrument </span><span class=\"S133A S1071 S2\" id=\"t4_52\">Share options senior management </span><span class=\"S133B S1070 S2\" id=\"t5_52\">Senior managers\u2019 holdings of shares in Photocure ASA are stated in the note concerning share capital. Allocation and exercise of </span><span class=\"S133C S1070 S2\" id=\"t6_52\">share options and holdings of share options for senior managers are presented in the following overview: </span><span class=\"S133D S1071 S2\" id=\"t7_52\">Share options for senior management 2022 </span><span class=\"S133E S1071 S2\" id=\"t8_52\">Share </span><span class=\"S133F S1071 S2\" id=\"t9_52\">options </span><span class=\"S1340 S1071 S2\" id=\"ta_52\">awarded </span><span class=\"S1341 S1071 S2\" id=\"tb_52\">Expired </span><span class=\"S1342 S1071 S2\" id=\"tc_52\">share </span><span class=\"S1343 S1071 S2\" id=\"td_52\">options </span><span class=\"S1344 S1071 S2\" id=\"te_52\">Share </span><span class=\"S1345 S1071 S2\" id=\"tf_52\">options </span><span class=\"S1346 S1071 S2\" id=\"tg_52\">exercised </span><span class=\"S1347 S1071 S2\" id=\"th_52\">Holding of </span><span class=\"S1348 S1071 S2\" id=\"ti_52\">share options </span><span class=\"S1349 S1071 S2\" id=\"tj_52\">at 31 December </span><span class=\"S134A S1071 S2\" id=\"tk_52\">2022 </span><span class=\"S134B S1071 S2\" id=\"tl_52\">Average </span><span class=\"S134C S1071 S2\" id=\"tm_52\">exercise </span><span class=\"S134D S1071 S2\" id=\"tn_52\">price </span><span class=\"S134E S1070 S2\" id=\"to_52\">President &amp; CEO </span><span class=\"S134F S1070 S2\" id=\"tp_52\">130 000 </span><span class=\"S1350 S1070 S2\" id=\"tq_52\">- </span><span class=\"S1351 S1070 S2\" id=\"tr_52\">100 000 </span><span class=\"S1352 S1070 S2\" id=\"ts_52\">325 000 </span><span class=\"S1353 S1070 S2\" id=\"tt_52\">121.33 </span><span class=\"S1354 S1070 S2\" id=\"tu_52\">Chief Financial O\ufb03cer </span><span class=\"S1355 S1070 S2\" id=\"tv_52\">90 000 </span><span class=\"S1356 S1070 S2\" id=\"tw_52\">- </span><span class=\"S1357 S1070 S2\" id=\"tx_52\">20 000 </span><span class=\"S1358 S1070 S2\" id=\"ty_52\">192 500 </span><span class=\"S1359 S1070 S2\" id=\"tz_52\">119.46 </span><span class=\"S135A S1070 S2\" id=\"t10_52\">VP and General Manager North America </span><span class=\"S135B S1070 S2\" id=\"t11_52\">65 000 </span><span class=\"S135C S1070 S2\" id=\"t12_52\">- </span><span class=\"S135D S1070 S2\" id=\"t13_52\">- </span><span class=\"S135E S1070 S2\" id=\"t14_52\">212 500 </span><span class=\"S135F S1070 S2\" id=\"t15_52\">106.73 </span><span class=\"S1360 S1070 S2\" id=\"t16_52\">VP and General Manager Europe </span><span class=\"S1361 S1070 S2\" id=\"t17_52\">65 000 </span><span class=\"S1362 S1070 S2\" id=\"t18_52\">- </span><span class=\"S1363 S1070 S2\" id=\"t19_52\">- </span><span class=\"S1364 S1070 S2\" id=\"t1a_52\">200 000 </span><span class=\"S1365 S1070 S2\" id=\"t1b_52\">113.84 </span><span class=\"S1366 S1070 S2\" id=\"t1c_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S1367 S1070 S2\" id=\"t1d_52\">35 000 </span><span class=\"S1368 S1070 S2\" id=\"t1e_52\">- </span><span class=\"S1369 S1070 S2\" id=\"t1f_52\">- </span><span class=\"S136A S1070 S2\" id=\"t1g_52\">112 500 </span><span class=\"S136B S1070 S2\" id=\"t1h_52\">111.12 </span><span class=\"S136C S1070 S2\" id=\"t1i_52\">VP Global Human Resources </span><span class=\"S136D S1070 S2\" id=\"t1j_52\">- </span><span class=\"S136E S1070 S2\" id=\"t1k_52\">- </span><span class=\"S136F S1070 S2\" id=\"t1l_52\">- </span><span class=\"S1370 S1070 S2\" id=\"t1m_52\">80 000 </span><span class=\"S1371 S1070 S2\" id=\"t1n_52\">113.34 </span><span class=\"S1372 S1070 S2\" id=\"t1o_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1373 S1070 S2\" id=\"t1p_52\">60 000 </span><span class=\"S1374 S1070 S2\" id=\"t1q_52\">- </span><span class=\"S1375 S1070 S2\" id=\"t1r_52\">- </span><span class=\"S1376 S1070 S2\" id=\"t1s_52\">88 000 </span><span class=\"S1377 S1070 S2\" id=\"t1t_52\">122.56 </span><span class=\"S1378 S1071 S2\" id=\"t1u_52\">Total </span><span class=\"S1379 S1071 S2\" id=\"t1v_52\">445 000 </span><span class=\"S137A S1071 S2\" id=\"t1w_52\">- </span><span class=\"S137B S1071 S2\" id=\"t1x_52\">120 000 </span><span class=\"S137C S1071 S2\" id=\"t1y_52\">1 210 500 </span><span class=\"S137D S1071 S2\" id=\"t1z_52\">Share options for senior management 2021 </span><span class=\"S137E S1071 S2\" id=\"t20_52\">Share </span><span class=\"S137F S1071 S2\" id=\"t21_52\">options </span><span class=\"S1380 S1071 S2\" id=\"t22_52\">awarded </span><span class=\"S1381 S1071 S2\" id=\"t23_52\">Expired </span><span class=\"S1382 S1071 S2\" id=\"t24_52\">share </span><span class=\"S1383 S1071 S2\" id=\"t25_52\">options </span><span class=\"S1384 S1071 S2\" id=\"t26_52\">Share </span><span class=\"S1385 S1071 S2\" id=\"t27_52\">options </span><span class=\"S1386 S1071 S2\" id=\"t28_52\">exercised </span><span class=\"S1387 S1071 S2\" id=\"t29_52\">Holding of </span><span class=\"S1388 S1071 S2\" id=\"t2a_52\">share options </span><span class=\"S1389 S1071 S2\" id=\"t2b_52\">at 31 December </span><span class=\"S138A S1071 S2\" id=\"t2c_52\">2021 </span><span class=\"S138B S1071 S2\" id=\"t2d_52\">Average </span><span class=\"S138C S1071 S2\" id=\"t2e_52\">exercise </span><span class=\"S138D S1071 S2\" id=\"t2f_52\">price </span><span class=\"S138E S1070 S2\" id=\"t2g_52\">President &amp; CEO </span><span class=\"S138F S1070 S2\" id=\"t2h_52\">135 000 </span><span class=\"S1390 S1070 S2\" id=\"t2i_52\">- </span><span class=\"S1391 S1070 S2\" id=\"t2j_52\">100 000 </span><span class=\"S1392 S1070 S2\" id=\"t2k_52\">295 000 </span><span class=\"S1393 S1070 S2\" id=\"t2l_52\">100.23 </span><span class=\"S1394 S1070 S2\" id=\"t2m_52\">Chief Financial O\ufb03cer </span><span class=\"S1395 S1070 S2\" id=\"t2n_52\">67 500 </span><span class=\"S1396 S1070 S2\" id=\"t2o_52\">- </span><span class=\"S1397 S1070 S2\" id=\"t2p_52\">20 000 </span><span class=\"S1398 S1070 S2\" id=\"t2q_52\">122 500 </span><span class=\"S1399 S1070 S2\" id=\"t2r_52\">111.59 </span><span class=\"S139A S1070 S2\" id=\"t2s_52\">VP and General Manager US Operations </span><span class=\"S139B S1070 S2\" id=\"t2t_52\">67 500 </span><span class=\"S139C S1070 S2\" id=\"t2u_52\">- </span><span class=\"S139D S1070 S2\" id=\"t2v_52\">45 000 </span><span class=\"S139E S1070 S2\" id=\"t2w_52\">147 500 </span><span class=\"S139F S1070 S2\" id=\"t2x_52\">103.14 </span><span class=\"S13A0 S1070 S2\" id=\"t2y_52\">VP and General Manager Europe </span><span class=\"S13A1 S1070 S2\" id=\"t2z_52\">67 500 </span><span class=\"S13A2 S1070 S2\" id=\"t30_52\">- </span><span class=\"S13A3 S1070 S2\" id=\"t31_52\">22 500 </span><span class=\"S13A4 S1070 S2\" id=\"t32_52\">135 000 </span><span class=\"S13A5 S1070 S2\" id=\"t33_52\">113.34 </span><span class=\"S13A6 S1070 S2\" id=\"t34_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S13A7 S1070 S2\" id=\"t35_52\">40 000 </span><span class=\"S13A8 S1070 S2\" id=\"t36_52\">- </span><span class=\"S13A9 S1070 S2\" id=\"t37_52\">12 500 </span><span class=\"S13AA S1070 S2\" id=\"t38_52\">77 500 </span><span class=\"S13AB S1070 S2\" id=\"t39_52\">109.42 </span><span class=\"S13AC S1070 S2\" id=\"t3a_52\">VP Global Human Resources </span><span class=\"S13AD S1070 S2\" id=\"t3b_52\">40 000 </span><span class=\"S13AE S1070 S2\" id=\"t3c_52\">- </span><span class=\"S13AF S1070 S2\" id=\"t3d_52\">- </span><span class=\"S13B0 S1070 S2\" id=\"t3e_52\">80 000 </span><span class=\"S13B1 S1070 S2\" id=\"t3f_52\">113.34 </span><span class=\"S13B2 S1070 S2\" id=\"t3g_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S13B3 S1070 S2\" id=\"t3h_52\">28 000 </span><span class=\"S13B4 S1070 S2\" id=\"t3i_52\">- </span><span class=\"S13B5 S1070 S2\" id=\"t3j_52\">- </span><span class=\"S13B6 S1070 S2\" id=\"t3k_52\">28 000 </span><span class=\"S13B7 S1070 S2\" id=\"t3l_52\">139.00 </span><span class=\"S13B8 S1071 S2\" id=\"t3m_52\">Total </span><span class=\"S13B9 S1071 S2\" id=\"t3n_52\">445 500 </span><span class=\"S13BA S1071 S2\" id=\"t3o_52\">- </span><span class=\"S13BB S1071 S2\" id=\"t3p_52\">200 000 </span><span class=\"S13BC S1071 S2\" id=\"t3q_52\">885 500 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5667": {
   "value": "<span class=\"S1297 S106F S2\" id=\"t2_51\">7. REMUNERATION OF MANAGEMENT AND BOARD OF DIRECTORS </span><span class=\"S1298 S1070 S2\" id=\"t3_51\">(Amounts in NOK 1,000) </span><span class=\"S1299 S1071 S2\" id=\"t4_51\">Directors\u2019 </span><span class=\"S129A S1071 S2\" id=\"t5_51\">fees paid </span><span class=\"S129B S1071 S2\" id=\"t6_51\">Salaries </span><span class=\"S129C S1071 S2\" id=\"t7_51\">paid </span><span class=\"S129D S1071 S2\" id=\"t8_51\">Bonuses </span><span class=\"S129E S1071 S2\" id=\"t9_51\">accrued </span><span class=\"S129F S1071 S2\" id=\"ta_51\">Bene\ufb01ts </span><span class=\"S12A0 S1071 S2\" id=\"tb_51\">in kind </span><span class=\"S12A1 S1071 S2\" id=\"tc_51\">Pension </span><span class=\"S12A2 S1071 S2\" id=\"td_51\">cost </span><span class=\"S12A3 S1071 S2\" id=\"te_51\">Total </span><span class=\"S12A4 S1071 S2\" id=\"tf_51\">Senior management 2022 </span><span class=\"S12A5 S1070 S2\" id=\"tg_51\">President and CEO </span><span class=\"S12A6 S1070 S2\" id=\"th_51\">6 013 </span><span class=\"S12A7 S1070 S2\" id=\"ti_51\">2 812 </span><span class=\"S12A8 S1070 S2\" id=\"tj_51\">754 </span><span class=\"S12A9 S1070 S2\" id=\"tk_51\">494 </span><span class=\"S12AA S1070 S2\" id=\"tl_51\">10 073 </span><span class=\"S12AB S1070 S2\" id=\"tm_51\">Chief Financial O\ufb03cer </span><span class=\"S12AC S1070 S2\" id=\"tn_51\">2 629 </span><span class=\"S12AD S1070 S2\" id=\"to_51\">595 </span><span class=\"S12AE S1070 S2\" id=\"tp_51\">18 </span><span class=\"S12AF S1070 S2\" id=\"tq_51\">343 </span><span class=\"S12B0 S1070 S2\" id=\"tr_51\">3 585 </span><span class=\"S12B1 S1070 S2\" id=\"ts_51\">VP and General Manager North America </span><span class=\"S12B2 S1070 S2\" id=\"tt_51\">3 848 </span><span class=\"S12B3 S1070 S2\" id=\"tu_51\">857 </span><span class=\"S12B4 S1070 S2\" id=\"tv_51\">419 </span><span class=\"S12B5 S1070 S2\" id=\"tw_51\">319 </span><span class=\"S12B6 S1070 S2\" id=\"tx_51\">5 444 </span><span class=\"S12B7 S1070 S2\" id=\"ty_51\">VP and General Manager Europe </span><span class=\"S12B8 S1070 S2\" id=\"tz_51\">2 935 </span><span class=\"S12B9 S1070 S2\" id=\"t10_51\">586 </span><span class=\"S12BA S1070 S2\" id=\"t11_51\">427 </span><span class=\"S12BB S1070 S2\" id=\"t12_51\">3 948 </span><span class=\"S12BC S1070 S2\" id=\"t13_51\">VP Global Strategic Marketing &amp; BD </span><span class=\"S12BD S1070 S2\" id=\"t14_51\">1 754 </span><span class=\"S12BE S1070 S2\" id=\"t15_51\">196 </span><span class=\"S12BF S1070 S2\" id=\"t16_51\">88 </span><span class=\"S12C0 S1070 S2\" id=\"t17_51\">221 </span><span class=\"S12C1 S1070 S2\" id=\"t18_51\">2 259 </span><span class=\"S12C2 S1070 S2\" id=\"t19_51\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S12C3 S1070 S2\" id=\"t1a_51\">2 071 </span><span class=\"S12C4 S1070 S2\" id=\"t1b_51\">431 </span><span class=\"S12C5 S1070 S2\" id=\"t1c_51\">91 </span><span class=\"S12C6 S1070 S2\" id=\"t1d_51\">360 </span><span class=\"S12C7 S1070 S2\" id=\"t1e_51\">2 952 </span><span class=\"S12C8 S1070 S2\" id=\"t1f_51\">VP Global Human Resources </span><span class=\"S12C9 S1070 S2\" id=\"t1g_51\">2 672 </span><span class=\"S12CA S1070 S2\" id=\"t1h_51\">310 </span><span class=\"S12CB S1070 S2\" id=\"t1i_51\">7 </span><span class=\"S12CC S1070 S2\" id=\"t1j_51\">242 </span><span class=\"S12CD S1070 S2\" id=\"t1k_51\">3 232 </span><span class=\"S12CE S1071 S2\" id=\"t1l_51\">Total senior management </span><span class=\"S12CF S1071 S2\" id=\"t1m_51\">21 921 </span><span class=\"S12D0 S1071 S2\" id=\"t1n_51\">5 788 </span><span class=\"S12D1 S1071 S2\" id=\"t1o_51\">1 803 </span><span class=\"S12D2 S1071 S2\" id=\"t1p_51\">1 979 </span><span class=\"S12D3 S1071 S2\" id=\"t1q_51\">31 491 </span><span class=\"S12D4 S1071 S2\" id=\"t1r_51\">Board of Directors 2022 </span><span class=\"S12D5 S1070 S2\" id=\"t1s_51\">Chairperson of the Board </span><span class=\"S12D6 S1070 S2\" id=\"t1t_51\">620 </span><span class=\"S12D7 S1070 S2\" id=\"t1u_51\">620 </span><span class=\"S12D8 S1070 S2\" id=\"t1v_51\">Members of the Board </span><span class=\"S12D9 S1070 S2\" id=\"t1w_51\">1 440 </span><span class=\"S12DA S1070 S2\" id=\"t1x_51\">1 440 </span><span class=\"S12DB S1071 S2\" id=\"t1y_51\">Total remuneration </span><span class=\"S12DC S1071 S2\" id=\"t1z_51\">2 060 </span><span class=\"S12DD S1071 S2\" id=\"t20_51\">21 921 </span><span class=\"S12DE S1071 S2\" id=\"t21_51\">5 788 </span><span class=\"S12DF S1071 S2\" id=\"t22_51\">1 803 </span><span class=\"S12E0 S1071 S2\" id=\"t23_51\">1 979 </span><span class=\"S12E1 S1071 S2\" id=\"t24_51\">33 551 </span><span class=\"S12E2 S1070 S2\" id=\"t25_51\">(Amounts in NOK 1,000) </span><span class=\"S12E3 S1071 S2\" id=\"t26_51\">Directors\u2019 </span><span class=\"S12E4 S1071 S2\" id=\"t27_51\">fees paid </span><span class=\"S12E5 S1071 S2\" id=\"t28_51\">Salaries </span><span class=\"S12E6 S1071 S2\" id=\"t29_51\">paid </span><span class=\"S12E7 S1071 S2\" id=\"t2a_51\">Bonuses </span><span class=\"S12E8 S1071 S2\" id=\"t2b_51\">accrued </span><span class=\"S12E9 S1071 S2\" id=\"t2c_51\">Bene\ufb01ts </span><span class=\"S12EA S1071 S2\" id=\"t2d_51\">in kind </span><span class=\"S12EB S1071 S2\" id=\"t2e_51\">Pension </span><span class=\"S12EC S1071 S2\" id=\"t2f_51\">cost </span><span class=\"S12ED S1071 S2\" id=\"t2g_51\">Total </span><span class=\"S12EE S1071 S2\" id=\"t2h_51\">Senior management 2021 </span><span class=\"S12EF S1070 S2\" id=\"t2i_51\">President and CEO </span><span class=\"S12F0 S1070 S2\" id=\"t2j_51\">4 760 </span><span class=\"S12F1 S1070 S2\" id=\"t2k_51\">2 571 </span><span class=\"S12F2 S1070 S2\" id=\"t2l_51\">177 </span><span class=\"S12F3 S1070 S2\" id=\"t2m_51\">382 </span><span class=\"S12F4 S1070 S2\" id=\"t2n_51\">7 889 </span><span class=\"S12F5 S1070 S2\" id=\"t2o_51\">Chief Financial O\ufb03cer </span><span class=\"S12F6 S1070 S2\" id=\"t2p_51\">2 007 </span><span class=\"S12F7 S1070 S2\" id=\"t2q_51\">513 </span><span class=\"S12F8 S1070 S2\" id=\"t2r_51\">18 </span><span class=\"S12F9 S1070 S2\" id=\"t2s_51\">284 </span><span class=\"S12FA S1070 S2\" id=\"t2t_51\">2 822 </span><span class=\"S12FB S1070 S2\" id=\"t2u_51\">VP and General Manager US Operations </span><span class=\"S12FC S1070 S2\" id=\"t2v_51\">2 989 </span><span class=\"S12FD S1070 S2\" id=\"t2w_51\">877 </span><span class=\"S12FE S1070 S2\" id=\"t2x_51\">287 </span><span class=\"S12FF S1070 S2\" id=\"t2y_51\">258 </span><span class=\"S1300 S1070 S2\" id=\"t2z_51\">4 410 </span><span class=\"S1301 S1070 S2\" id=\"t30_51\">VP and General Manager Europe </span><span class=\"S1302 S1070 S2\" id=\"t31_51\">2 807 </span><span class=\"S1303 S1070 S2\" id=\"t32_51\">661 </span><span class=\"S1304 S1070 S2\" id=\"t33_51\">150 </span><span class=\"S1305 S1070 S2\" id=\"t34_51\">250 </span><span class=\"S1306 S1070 S2\" id=\"t35_51\">3 868 </span><span class=\"S1307 S1070 S2\" id=\"t36_51\">VP Global Strategic Marketing &amp; BD </span><span class=\"S1308 S1070 S2\" id=\"t37_51\">1 694 </span><span class=\"S1309 S1070 S2\" id=\"t38_51\">219 </span><span class=\"S130A S1070 S2\" id=\"t39_51\">88 </span><span class=\"S130B S1070 S2\" id=\"t3a_51\">231 </span><span class=\"S130C S1070 S2\" id=\"t3b_51\">2 232 </span><span class=\"S130D S1070 S2\" id=\"t3c_51\">VP Technical Development and Operations to April </span><span class=\"S130E S1070 S2\" id=\"t3d_51\">916 </span><span class=\"S130F S1070 S2\" id=\"t3e_51\">- </span><span class=\"S1310 S1070 S2\" id=\"t3f_51\">5 </span><span class=\"S1311 S1070 S2\" id=\"t3g_51\">56 </span><span class=\"S1312 S1070 S2\" id=\"t3h_51\">976 </span><span class=\"S1313 S1070 S2\" id=\"t3i_51\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1314 S1070 S2\" id=\"t3j_51\">from September </span><span class=\"S1315 S1070 S2\" id=\"t3k_51\">647 </span><span class=\"S1316 S1070 S2\" id=\"t3l_51\">104 </span><span class=\"S1317 S1070 S2\" id=\"t3m_51\">113 </span><span class=\"S1318 S1070 S2\" id=\"t3n_51\">864 </span><span class=\"S1319 S1070 S2\" id=\"t3o_51\">VP Global Medical to August </span><span class=\"S131A S1070 S2\" id=\"t3p_51\">1 275 </span><span class=\"S131B S1070 S2\" id=\"t3q_51\">- </span><span class=\"S131C S1070 S2\" id=\"t3r_51\">14 </span><span class=\"S131D S1070 S2\" id=\"t3s_51\">151 </span><span class=\"S131E S1070 S2\" id=\"t3t_51\">1 440 </span><span class=\"S131F S1070 S2\" id=\"t3u_51\">VP Global Human Resources </span><span class=\"S1320 S1070 S2\" id=\"t3v_51\">2 353 </span><span class=\"S1321 S1070 S2\" id=\"t3w_51\">320 </span><span class=\"S1322 S1070 S2\" id=\"t3x_51\">6 </span><span class=\"S1323 S1070 S2\" id=\"t3y_51\">186 </span><span class=\"S1324 S1070 S2\" id=\"t3z_51\">2 865 </span><span class=\"S1325 S1071 S2\" id=\"t40_51\">Total senior management </span><span class=\"S1326 S1071 S2\" id=\"t41_51\">19 448 </span><span class=\"S1327 S1071 S2\" id=\"t42_51\">5 265 </span><span class=\"S1328 S1071 S2\" id=\"t43_51\">743 </span><span class=\"S1329 S1071 S2\" id=\"t44_51\">1 910 </span><span class=\"S132A S1071 S2\" id=\"t45_51\">27 365 </span><span class=\"S132B S1071 S2\" id=\"t46_51\">Board of Directors 2020 </span><span class=\"S132C S1070 S2\" id=\"t47_51\">Chairperson of the Board </span><span class=\"S132D S1070 S2\" id=\"t48_51\">620 </span><span class=\"S132E S1070 S2\" id=\"t49_51\">620 </span><span class=\"S132F S1070 S2\" id=\"t4a_51\">Members of the Board </span><span class=\"S1330 S1070 S2\" id=\"t4b_51\">1 440 </span><span class=\"S1331 S1070 S2\" id=\"t4c_51\">1 440 </span><span class=\"S1332 S1071 S2\" id=\"t4d_51\">Total remuneration </span><span class=\"S1333 S1071 S2\" id=\"t4e_51\">2 060 </span><span class=\"S1334 S1071 S2\" id=\"t4f_51\">19 448 </span><span class=\"S1335 S1071 S2\" id=\"t4g_51\">5 265 </span><span class=\"S1336 S1071 S2\" id=\"t4h_51\">743 </span><span class=\"S1337 S1071 S2\" id=\"t4i_51\">1 910 </span><span class=\"S1338 S1071 S2\" id=\"t4j_51\">29 425 </span><span class=\"S133A S1071 S2\" id=\"t4_52\">Share options senior management </span><span class=\"S133B S1070 S2\" id=\"t5_52\">Senior managers\u2019 holdings of shares in Photocure ASA are stated in the note concerning share capital. Allocation and exercise of </span><span class=\"S133C S1070 S2\" id=\"t6_52\">share options and holdings of share options for senior managers are presented in the following overview: </span><span class=\"S133D S1071 S2\" id=\"t7_52\">Share options for senior management 2022 </span><span class=\"S133E S1071 S2\" id=\"t8_52\">Share </span><span class=\"S133F S1071 S2\" id=\"t9_52\">options </span><span class=\"S1340 S1071 S2\" id=\"ta_52\">awarded </span><span class=\"S1341 S1071 S2\" id=\"tb_52\">Expired </span><span class=\"S1342 S1071 S2\" id=\"tc_52\">share </span><span class=\"S1343 S1071 S2\" id=\"td_52\">options </span><span class=\"S1344 S1071 S2\" id=\"te_52\">Share </span><span class=\"S1345 S1071 S2\" id=\"tf_52\">options </span><span class=\"S1346 S1071 S2\" id=\"tg_52\">exercised </span><span class=\"S1347 S1071 S2\" id=\"th_52\">Holding of </span><span class=\"S1348 S1071 S2\" id=\"ti_52\">share options </span><span class=\"S1349 S1071 S2\" id=\"tj_52\">at 31 December </span><span class=\"S134A S1071 S2\" id=\"tk_52\">2022 </span><span class=\"S134B S1071 S2\" id=\"tl_52\">Average </span><span class=\"S134C S1071 S2\" id=\"tm_52\">exercise </span><span class=\"S134D S1071 S2\" id=\"tn_52\">price </span><span class=\"S134E S1070 S2\" id=\"to_52\">President &amp; CEO </span><span class=\"S134F S1070 S2\" id=\"tp_52\">130 000 </span><span class=\"S1350 S1070 S2\" id=\"tq_52\">- </span><span class=\"S1351 S1070 S2\" id=\"tr_52\">100 000 </span><span class=\"S1352 S1070 S2\" id=\"ts_52\">325 000 </span><span class=\"S1353 S1070 S2\" id=\"tt_52\">121.33 </span><span class=\"S1354 S1070 S2\" id=\"tu_52\">Chief Financial O\ufb03cer </span><span class=\"S1355 S1070 S2\" id=\"tv_52\">90 000 </span><span class=\"S1356 S1070 S2\" id=\"tw_52\">- </span><span class=\"S1357 S1070 S2\" id=\"tx_52\">20 000 </span><span class=\"S1358 S1070 S2\" id=\"ty_52\">192 500 </span><span class=\"S1359 S1070 S2\" id=\"tz_52\">119.46 </span><span class=\"S135A S1070 S2\" id=\"t10_52\">VP and General Manager North America </span><span class=\"S135B S1070 S2\" id=\"t11_52\">65 000 </span><span class=\"S135C S1070 S2\" id=\"t12_52\">- </span><span class=\"S135D S1070 S2\" id=\"t13_52\">- </span><span class=\"S135E S1070 S2\" id=\"t14_52\">212 500 </span><span class=\"S135F S1070 S2\" id=\"t15_52\">106.73 </span><span class=\"S1360 S1070 S2\" id=\"t16_52\">VP and General Manager Europe </span><span class=\"S1361 S1070 S2\" id=\"t17_52\">65 000 </span><span class=\"S1362 S1070 S2\" id=\"t18_52\">- </span><span class=\"S1363 S1070 S2\" id=\"t19_52\">- </span><span class=\"S1364 S1070 S2\" id=\"t1a_52\">200 000 </span><span class=\"S1365 S1070 S2\" id=\"t1b_52\">113.84 </span><span class=\"S1366 S1070 S2\" id=\"t1c_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S1367 S1070 S2\" id=\"t1d_52\">35 000 </span><span class=\"S1368 S1070 S2\" id=\"t1e_52\">- </span><span class=\"S1369 S1070 S2\" id=\"t1f_52\">- </span><span class=\"S136A S1070 S2\" id=\"t1g_52\">112 500 </span><span class=\"S136B S1070 S2\" id=\"t1h_52\">111.12 </span><span class=\"S136C S1070 S2\" id=\"t1i_52\">VP Global Human Resources </span><span class=\"S136D S1070 S2\" id=\"t1j_52\">- </span><span class=\"S136E S1070 S2\" id=\"t1k_52\">- </span><span class=\"S136F S1070 S2\" id=\"t1l_52\">- </span><span class=\"S1370 S1070 S2\" id=\"t1m_52\">80 000 </span><span class=\"S1371 S1070 S2\" id=\"t1n_52\">113.34 </span><span class=\"S1372 S1070 S2\" id=\"t1o_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1373 S1070 S2\" id=\"t1p_52\">60 000 </span><span class=\"S1374 S1070 S2\" id=\"t1q_52\">- </span><span class=\"S1375 S1070 S2\" id=\"t1r_52\">- </span><span class=\"S1376 S1070 S2\" id=\"t1s_52\">88 000 </span><span class=\"S1377 S1070 S2\" id=\"t1t_52\">122.56 </span><span class=\"S1378 S1071 S2\" id=\"t1u_52\">Total </span><span class=\"S1379 S1071 S2\" id=\"t1v_52\">445 000 </span><span class=\"S137A S1071 S2\" id=\"t1w_52\">- </span><span class=\"S137B S1071 S2\" id=\"t1x_52\">120 000 </span><span class=\"S137C S1071 S2\" id=\"t1y_52\">1 210 500 </span><span class=\"S137D S1071 S2\" id=\"t1z_52\">Share options for senior management 2021 </span><span class=\"S137E S1071 S2\" id=\"t20_52\">Share </span><span class=\"S137F S1071 S2\" id=\"t21_52\">options </span><span class=\"S1380 S1071 S2\" id=\"t22_52\">awarded </span><span class=\"S1381 S1071 S2\" id=\"t23_52\">Expired </span><span class=\"S1382 S1071 S2\" id=\"t24_52\">share </span><span class=\"S1383 S1071 S2\" id=\"t25_52\">options </span><span class=\"S1384 S1071 S2\" id=\"t26_52\">Share </span><span class=\"S1385 S1071 S2\" id=\"t27_52\">options </span><span class=\"S1386 S1071 S2\" id=\"t28_52\">exercised </span><span class=\"S1387 S1071 S2\" id=\"t29_52\">Holding of </span><span class=\"S1388 S1071 S2\" id=\"t2a_52\">share options </span><span class=\"S1389 S1071 S2\" id=\"t2b_52\">at 31 December </span><span class=\"S138A S1071 S2\" id=\"t2c_52\">2021 </span><span class=\"S138B S1071 S2\" id=\"t2d_52\">Average </span><span class=\"S138C S1071 S2\" id=\"t2e_52\">exercise </span><span class=\"S138D S1071 S2\" id=\"t2f_52\">price </span><span class=\"S138E S1070 S2\" id=\"t2g_52\">President &amp; CEO </span><span class=\"S138F S1070 S2\" id=\"t2h_52\">135 000 </span><span class=\"S1390 S1070 S2\" id=\"t2i_52\">- </span><span class=\"S1391 S1070 S2\" id=\"t2j_52\">100 000 </span><span class=\"S1392 S1070 S2\" id=\"t2k_52\">295 000 </span><span class=\"S1393 S1070 S2\" id=\"t2l_52\">100.23 </span><span class=\"S1394 S1070 S2\" id=\"t2m_52\">Chief Financial O\ufb03cer </span><span class=\"S1395 S1070 S2\" id=\"t2n_52\">67 500 </span><span class=\"S1396 S1070 S2\" id=\"t2o_52\">- </span><span class=\"S1397 S1070 S2\" id=\"t2p_52\">20 000 </span><span class=\"S1398 S1070 S2\" id=\"t2q_52\">122 500 </span><span class=\"S1399 S1070 S2\" id=\"t2r_52\">111.59 </span><span class=\"S139A S1070 S2\" id=\"t2s_52\">VP and General Manager US Operations </span><span class=\"S139B S1070 S2\" id=\"t2t_52\">67 500 </span><span class=\"S139C S1070 S2\" id=\"t2u_52\">- </span><span class=\"S139D S1070 S2\" id=\"t2v_52\">45 000 </span><span class=\"S139E S1070 S2\" id=\"t2w_52\">147 500 </span><span class=\"S139F S1070 S2\" id=\"t2x_52\">103.14 </span><span class=\"S13A0 S1070 S2\" id=\"t2y_52\">VP and General Manager Europe </span><span class=\"S13A1 S1070 S2\" id=\"t2z_52\">67 500 </span><span class=\"S13A2 S1070 S2\" id=\"t30_52\">- </span><span class=\"S13A3 S1070 S2\" id=\"t31_52\">22 500 </span><span class=\"S13A4 S1070 S2\" id=\"t32_52\">135 000 </span><span class=\"S13A5 S1070 S2\" id=\"t33_52\">113.34 </span><span class=\"S13A6 S1070 S2\" id=\"t34_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S13A7 S1070 S2\" id=\"t35_52\">40 000 </span><span class=\"S13A8 S1070 S2\" id=\"t36_52\">- </span><span class=\"S13A9 S1070 S2\" id=\"t37_52\">12 500 </span><span class=\"S13AA S1070 S2\" id=\"t38_52\">77 500 </span><span class=\"S13AB S1070 S2\" id=\"t39_52\">109.42 </span><span class=\"S13AC S1070 S2\" id=\"t3a_52\">VP Global Human Resources </span><span class=\"S13AD S1070 S2\" id=\"t3b_52\">40 000 </span><span class=\"S13AE S1070 S2\" id=\"t3c_52\">- </span><span class=\"S13AF S1070 S2\" id=\"t3d_52\">- </span><span class=\"S13B0 S1070 S2\" id=\"t3e_52\">80 000 </span><span class=\"S13B1 S1070 S2\" id=\"t3f_52\">113.34 </span><span class=\"S13B2 S1070 S2\" id=\"t3g_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S13B3 S1070 S2\" id=\"t3h_52\">28 000 </span><span class=\"S13B4 S1070 S2\" id=\"t3i_52\">- </span><span class=\"S13B5 S1070 S2\" id=\"t3j_52\">- </span><span class=\"S13B6 S1070 S2\" id=\"t3k_52\">28 000 </span><span class=\"S13B7 S1070 S2\" id=\"t3l_52\">139.00 </span><span class=\"S13B8 S1071 S2\" id=\"t3m_52\">Total </span><span class=\"S13B9 S1071 S2\" id=\"t3n_52\">445 500 </span><span class=\"S13BA S1071 S2\" id=\"t3o_52\">- </span><span class=\"S13BB S1071 S2\" id=\"t3p_52\">200 000 </span><span class=\"S13BC S1071 S2\" id=\"t3q_52\">885 500 </span><span class=\"S1447 S106F S2\" id=\"t2_55\">10. RELATED PARTIES - COMPANIES </span><span class=\"S1448 S1071 S2\" id=\"t3_55\">Subsidiaries </span><span class=\"S1449 S1070 S2\" id=\"t4_55\">The transfer price method implemented is the pro\ufb01t &amp; loss split method (PSM) for the sales in US and a residual pro\ufb01t model (RPM) </span><span class=\"S144A S1070 S2\" id=\"t5_55\">for the sales in Germany and France. </span><span class=\"S144B S1070 S2\" id=\"t6_55\">Both the PSM and the RPM divides the combined pro\ufb01t or loss between the transacting related entities based on what would be </span><span class=\"S144C S1070 S2\" id=\"t7_55\">anticipated if the entities had been transacting at arm\u2019s length. </span><span class=\"S144D S1070 S2\" id=\"t8_55\">A contribution analysis for sale of Cysview in US and sale of Hexvix in Germany and France compares the split of pro\ufb01t or loss </span><span class=\"S144E S1070 S2\" id=\"t9_55\">between the subsidiaries and Photocure ASA based on the value of the functions performed by each of the related parties, taking </span><span class=\"S144F S1070 S2\" id=\"ta_55\">into account the assets used and the risks assumed by both parties. </span><span class=\"S1450 S1070 S2\" id=\"tb_55\">Photocure has established a wholly owned subsidiary in the US, Photocure Inc, in order to carry out the sales and the marketing-, </span><span class=\"S1451 S1070 S2\" id=\"tc_55\">selling- and distribution activities for the Cysview product. Photocure ASA has the ownership to the patent rights and the trade mark </span><span class=\"S1452 S1070 S2\" id=\"td_55\">and is responsible in the Group for development and manufacturing of the product. Photocure Inc purchases the completed product </span><span class=\"S1453 S1070 S2\" id=\"te_55\">from the parent company and distributes in the United States. Photocure Inc has established its own marketing organization that is </span><span class=\"S1454 S1070 S2\" id=\"tf_55\">funded by a loan from its parent company in addition to its own revenues. The transactions between Photocure ASA and Photocure </span><span class=\"S1455 S1070 S2\" id=\"tg_55\">Inc are on terms at arm\u2019s length, except for the loan that is interest free until further notice. </span><span class=\"S1456 S1070 S2\" id=\"th_55\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table. This is based on a cash \ufb02ow model taking into account a </span><span class=\"S1457 S1070 S2\" id=\"ti_55\">balanced view of the market share for Cysview in the US compared to sales of Hexvix in Europe. The US sales and marketing force </span><span class=\"S1458 S1070 S2\" id=\"tj_55\">has been kept during the Covid pandemic and enables Photocure Inc to access the US market again </span><span class=\"S1459 S1070 S2\" id=\"tk_55\">after the pandemic has ended. </span><span class=\"S145A S1070 S2\" id=\"tl_55\">Photocure has established wholly owned subsidiaries in Germany and France. </span><span class=\"S145B S1070 S2\" id=\"tm_55\">Photocure ASA carries out the sales and distribution </span><span class=\"S145C S1070 S2\" id=\"tn_55\">in Europe for the Hexvix product. The marketing- and promotion activities for the Hexvix product in Continental Europe are carried </span><span class=\"S145D S1070 S2\" id=\"to_55\">out by Photocure GmbH and Photocure SAS. The residual pro\ufb01t in Germany and France are allocated to the subsidiaries. Mark up is </span><span class=\"S145E S1070 S2\" id=\"tp_55\">assumed on fully loaded local costs for the services rendered to parent company. </span><span class=\"S145F S1070 S2\" id=\"tq_55\">Photocure established from January 2022 a sales subsidiary in Canada to carry out the sales, marketing and distribution of Cysview </span><span class=\"S1460 S1070 S2\" id=\"tr_55\">in Canada. </span><span class=\"S1461 S1071 S2\" id=\"ts_55\">Transactions and intercompany balances: </span><span class=\"S1462 S1071 S2\" id=\"tt_55\">2022 </span><span class=\"S1463 S1071 S2\" id=\"tu_55\">2021 </span><span class=\"S1464 S1070 S2\" id=\"tv_55\">Sales of products </span><span class=\"S1465 S1070 S2\" id=\"tw_55\">12 986 </span><span class=\"S1466 S1070 S2\" id=\"tx_55\">7 488 </span><span class=\"S1467 S1070 S2\" id=\"ty_55\">Sales of services </span><span class=\"S1468 S1070 S2\" id=\"tz_55\">899 </span><span class=\"S1469 S1070 S2\" id=\"t10_55\">999 </span><span class=\"S146A S1071 S2\" id=\"t11_55\">Intercompany sales </span><span class=\"S146B S1071 S2\" id=\"t12_55\">13 885 </span><span class=\"S146C S1071 S2\" id=\"t13_55\">8 487 </span><span class=\"S146D S1071 S2\" id=\"t14_55\">Purchase of marketing and promotion services </span><span class=\"S146E S1071 S2\" id=\"t15_55\">-54 719 </span><span class=\"S146F S1071 S2\" id=\"t16_55\">-48 060 </span><span class=\"S1470 S1071 S2\" id=\"t17_55\">31-Dec-22 </span><span class=\"S1471 S1071 S2\" id=\"t18_55\">31-Dec-21 </span><span class=\"S1472 S1070 S2\" id=\"t19_55\">Accounts receivables and other storm-term receivables </span><span class=\"S1473 S1070 S2\" id=\"t1a_55\">4 733 </span><span class=\"S1474 S1070 S2\" id=\"t1b_55\">0 </span><span class=\"S1475 S1070 S2\" id=\"t1c_55\">Long term loan given </span><span class=\"S1476 S1070 S2\" id=\"t1d_55\">350 072 </span><span class=\"S1477 S1070 S2\" id=\"t1e_55\">308 390 </span><span class=\"S1478 S1070 S2\" id=\"t1f_55\">Accounts payables and other short-term liabilities </span><span class=\"S1479 S1070 S2\" id=\"t1g_55\">-17 436 </span><span class=\"S147A S1070 S2\" id=\"t1h_55\">-7 203 </span><span class=\"S147B S1071 S2\" id=\"t1i_55\">Total subsidiaries </span><span class=\"S147C S1071 S2\" id=\"t1j_55\">337 369 </span><span class=\"S147D S1071 S2\" id=\"t1k_55\">301 187 </span><span class=\"S147E S1071 S2\" id=\"t1l_55\">Guarantees to bank in favor of subsidiary for requested security </span><span class=\"S147F S1071 S2\" id=\"t1m_55\">2 724 </span><span class=\"S1480 S1071 S2\" id=\"t1n_55\">2 220 </span><span class=\"S1481 S1070 S2\" id=\"t1o_55\">These are for licenses with the States of Maryland, Mississippi, Nevada and California to sell Cysview and for the o\ufb03ce lease deposit </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5668": {
   "value": "<span class=\"S1297 S106F S2\" id=\"t2_51\">7. REMUNERATION OF MANAGEMENT AND BOARD OF DIRECTORS </span><span class=\"S1298 S1070 S2\" id=\"t3_51\">(Amounts in NOK 1,000) </span><span class=\"S1299 S1071 S2\" id=\"t4_51\">Directors\u2019 </span><span class=\"S129A S1071 S2\" id=\"t5_51\">fees paid </span><span class=\"S129B S1071 S2\" id=\"t6_51\">Salaries </span><span class=\"S129C S1071 S2\" id=\"t7_51\">paid </span><span class=\"S129D S1071 S2\" id=\"t8_51\">Bonuses </span><span class=\"S129E S1071 S2\" id=\"t9_51\">accrued </span><span class=\"S129F S1071 S2\" id=\"ta_51\">Bene\ufb01ts </span><span class=\"S12A0 S1071 S2\" id=\"tb_51\">in kind </span><span class=\"S12A1 S1071 S2\" id=\"tc_51\">Pension </span><span class=\"S12A2 S1071 S2\" id=\"td_51\">cost </span><span class=\"S12A3 S1071 S2\" id=\"te_51\">Total </span><span class=\"S12A4 S1071 S2\" id=\"tf_51\">Senior management 2022 </span><span class=\"S12A5 S1070 S2\" id=\"tg_51\">President and CEO </span><span class=\"S12A6 S1070 S2\" id=\"th_51\">6 013 </span><span class=\"S12A7 S1070 S2\" id=\"ti_51\">2 812 </span><span class=\"S12A8 S1070 S2\" id=\"tj_51\">754 </span><span class=\"S12A9 S1070 S2\" id=\"tk_51\">494 </span><span class=\"S12AA S1070 S2\" id=\"tl_51\">10 073 </span><span class=\"S12AB S1070 S2\" id=\"tm_51\">Chief Financial O\ufb03cer </span><span class=\"S12AC S1070 S2\" id=\"tn_51\">2 629 </span><span class=\"S12AD S1070 S2\" id=\"to_51\">595 </span><span class=\"S12AE S1070 S2\" id=\"tp_51\">18 </span><span class=\"S12AF S1070 S2\" id=\"tq_51\">343 </span><span class=\"S12B0 S1070 S2\" id=\"tr_51\">3 585 </span><span class=\"S12B1 S1070 S2\" id=\"ts_51\">VP and General Manager North America </span><span class=\"S12B2 S1070 S2\" id=\"tt_51\">3 848 </span><span class=\"S12B3 S1070 S2\" id=\"tu_51\">857 </span><span class=\"S12B4 S1070 S2\" id=\"tv_51\">419 </span><span class=\"S12B5 S1070 S2\" id=\"tw_51\">319 </span><span class=\"S12B6 S1070 S2\" id=\"tx_51\">5 444 </span><span class=\"S12B7 S1070 S2\" id=\"ty_51\">VP and General Manager Europe </span><span class=\"S12B8 S1070 S2\" id=\"tz_51\">2 935 </span><span class=\"S12B9 S1070 S2\" id=\"t10_51\">586 </span><span class=\"S12BA S1070 S2\" id=\"t11_51\">427 </span><span class=\"S12BB S1070 S2\" id=\"t12_51\">3 948 </span><span class=\"S12BC S1070 S2\" id=\"t13_51\">VP Global Strategic Marketing &amp; BD </span><span class=\"S12BD S1070 S2\" id=\"t14_51\">1 754 </span><span class=\"S12BE S1070 S2\" id=\"t15_51\">196 </span><span class=\"S12BF S1070 S2\" id=\"t16_51\">88 </span><span class=\"S12C0 S1070 S2\" id=\"t17_51\">221 </span><span class=\"S12C1 S1070 S2\" id=\"t18_51\">2 259 </span><span class=\"S12C2 S1070 S2\" id=\"t19_51\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S12C3 S1070 S2\" id=\"t1a_51\">2 071 </span><span class=\"S12C4 S1070 S2\" id=\"t1b_51\">431 </span><span class=\"S12C5 S1070 S2\" id=\"t1c_51\">91 </span><span class=\"S12C6 S1070 S2\" id=\"t1d_51\">360 </span><span class=\"S12C7 S1070 S2\" id=\"t1e_51\">2 952 </span><span class=\"S12C8 S1070 S2\" id=\"t1f_51\">VP Global Human Resources </span><span class=\"S12C9 S1070 S2\" id=\"t1g_51\">2 672 </span><span class=\"S12CA S1070 S2\" id=\"t1h_51\">310 </span><span class=\"S12CB S1070 S2\" id=\"t1i_51\">7 </span><span class=\"S12CC S1070 S2\" id=\"t1j_51\">242 </span><span class=\"S12CD S1070 S2\" id=\"t1k_51\">3 232 </span><span class=\"S12CE S1071 S2\" id=\"t1l_51\">Total senior management </span><span class=\"S12CF S1071 S2\" id=\"t1m_51\">21 921 </span><span class=\"S12D0 S1071 S2\" id=\"t1n_51\">5 788 </span><span class=\"S12D1 S1071 S2\" id=\"t1o_51\">1 803 </span><span class=\"S12D2 S1071 S2\" id=\"t1p_51\">1 979 </span><span class=\"S12D3 S1071 S2\" id=\"t1q_51\">31 491 </span><span class=\"S12D4 S1071 S2\" id=\"t1r_51\">Board of Directors 2022 </span><span class=\"S12D5 S1070 S2\" id=\"t1s_51\">Chairperson of the Board </span><span class=\"S12D6 S1070 S2\" id=\"t1t_51\">620 </span><span class=\"S12D7 S1070 S2\" id=\"t1u_51\">620 </span><span class=\"S12D8 S1070 S2\" id=\"t1v_51\">Members of the Board </span><span class=\"S12D9 S1070 S2\" id=\"t1w_51\">1 440 </span><span class=\"S12DA S1070 S2\" id=\"t1x_51\">1 440 </span><span class=\"S12DB S1071 S2\" id=\"t1y_51\">Total remuneration </span><span class=\"S12DC S1071 S2\" id=\"t1z_51\">2 060 </span><span class=\"S12DD S1071 S2\" id=\"t20_51\">21 921 </span><span class=\"S12DE S1071 S2\" id=\"t21_51\">5 788 </span><span class=\"S12DF S1071 S2\" id=\"t22_51\">1 803 </span><span class=\"S12E0 S1071 S2\" id=\"t23_51\">1 979 </span><span class=\"S12E1 S1071 S2\" id=\"t24_51\">33 551 </span><span class=\"S12E2 S1070 S2\" id=\"t25_51\">(Amounts in NOK 1,000) </span><span class=\"S12E3 S1071 S2\" id=\"t26_51\">Directors\u2019 </span><span class=\"S12E4 S1071 S2\" id=\"t27_51\">fees paid </span><span class=\"S12E5 S1071 S2\" id=\"t28_51\">Salaries </span><span class=\"S12E6 S1071 S2\" id=\"t29_51\">paid </span><span class=\"S12E7 S1071 S2\" id=\"t2a_51\">Bonuses </span><span class=\"S12E8 S1071 S2\" id=\"t2b_51\">accrued </span><span class=\"S12E9 S1071 S2\" id=\"t2c_51\">Bene\ufb01ts </span><span class=\"S12EA S1071 S2\" id=\"t2d_51\">in kind </span><span class=\"S12EB S1071 S2\" id=\"t2e_51\">Pension </span><span class=\"S12EC S1071 S2\" id=\"t2f_51\">cost </span><span class=\"S12ED S1071 S2\" id=\"t2g_51\">Total </span><span class=\"S12EE S1071 S2\" id=\"t2h_51\">Senior management 2021 </span><span class=\"S12EF S1070 S2\" id=\"t2i_51\">President and CEO </span><span class=\"S12F0 S1070 S2\" id=\"t2j_51\">4 760 </span><span class=\"S12F1 S1070 S2\" id=\"t2k_51\">2 571 </span><span class=\"S12F2 S1070 S2\" id=\"t2l_51\">177 </span><span class=\"S12F3 S1070 S2\" id=\"t2m_51\">382 </span><span class=\"S12F4 S1070 S2\" id=\"t2n_51\">7 889 </span><span class=\"S12F5 S1070 S2\" id=\"t2o_51\">Chief Financial O\ufb03cer </span><span class=\"S12F6 S1070 S2\" id=\"t2p_51\">2 007 </span><span class=\"S12F7 S1070 S2\" id=\"t2q_51\">513 </span><span class=\"S12F8 S1070 S2\" id=\"t2r_51\">18 </span><span class=\"S12F9 S1070 S2\" id=\"t2s_51\">284 </span><span class=\"S12FA S1070 S2\" id=\"t2t_51\">2 822 </span><span class=\"S12FB S1070 S2\" id=\"t2u_51\">VP and General Manager US Operations </span><span class=\"S12FC S1070 S2\" id=\"t2v_51\">2 989 </span><span class=\"S12FD S1070 S2\" id=\"t2w_51\">877 </span><span class=\"S12FE S1070 S2\" id=\"t2x_51\">287 </span><span class=\"S12FF S1070 S2\" id=\"t2y_51\">258 </span><span class=\"S1300 S1070 S2\" id=\"t2z_51\">4 410 </span><span class=\"S1301 S1070 S2\" id=\"t30_51\">VP and General Manager Europe </span><span class=\"S1302 S1070 S2\" id=\"t31_51\">2 807 </span><span class=\"S1303 S1070 S2\" id=\"t32_51\">661 </span><span class=\"S1304 S1070 S2\" id=\"t33_51\">150 </span><span class=\"S1305 S1070 S2\" id=\"t34_51\">250 </span><span class=\"S1306 S1070 S2\" id=\"t35_51\">3 868 </span><span class=\"S1307 S1070 S2\" id=\"t36_51\">VP Global Strategic Marketing &amp; BD </span><span class=\"S1308 S1070 S2\" id=\"t37_51\">1 694 </span><span class=\"S1309 S1070 S2\" id=\"t38_51\">219 </span><span class=\"S130A S1070 S2\" id=\"t39_51\">88 </span><span class=\"S130B S1070 S2\" id=\"t3a_51\">231 </span><span class=\"S130C S1070 S2\" id=\"t3b_51\">2 232 </span><span class=\"S130D S1070 S2\" id=\"t3c_51\">VP Technical Development and Operations to April </span><span class=\"S130E S1070 S2\" id=\"t3d_51\">916 </span><span class=\"S130F S1070 S2\" id=\"t3e_51\">- </span><span class=\"S1310 S1070 S2\" id=\"t3f_51\">5 </span><span class=\"S1311 S1070 S2\" id=\"t3g_51\">56 </span><span class=\"S1312 S1070 S2\" id=\"t3h_51\">976 </span><span class=\"S1313 S1070 S2\" id=\"t3i_51\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1314 S1070 S2\" id=\"t3j_51\">from September </span><span class=\"S1315 S1070 S2\" id=\"t3k_51\">647 </span><span class=\"S1316 S1070 S2\" id=\"t3l_51\">104 </span><span class=\"S1317 S1070 S2\" id=\"t3m_51\">113 </span><span class=\"S1318 S1070 S2\" id=\"t3n_51\">864 </span><span class=\"S1319 S1070 S2\" id=\"t3o_51\">VP Global Medical to August </span><span class=\"S131A S1070 S2\" id=\"t3p_51\">1 275 </span><span class=\"S131B S1070 S2\" id=\"t3q_51\">- </span><span class=\"S131C S1070 S2\" id=\"t3r_51\">14 </span><span class=\"S131D S1070 S2\" id=\"t3s_51\">151 </span><span class=\"S131E S1070 S2\" id=\"t3t_51\">1 440 </span><span class=\"S131F S1070 S2\" id=\"t3u_51\">VP Global Human Resources </span><span class=\"S1320 S1070 S2\" id=\"t3v_51\">2 353 </span><span class=\"S1321 S1070 S2\" id=\"t3w_51\">320 </span><span class=\"S1322 S1070 S2\" id=\"t3x_51\">6 </span><span class=\"S1323 S1070 S2\" id=\"t3y_51\">186 </span><span class=\"S1324 S1070 S2\" id=\"t3z_51\">2 865 </span><span class=\"S1325 S1071 S2\" id=\"t40_51\">Total senior management </span><span class=\"S1326 S1071 S2\" id=\"t41_51\">19 448 </span><span class=\"S1327 S1071 S2\" id=\"t42_51\">5 265 </span><span class=\"S1328 S1071 S2\" id=\"t43_51\">743 </span><span class=\"S1329 S1071 S2\" id=\"t44_51\">1 910 </span><span class=\"S132A S1071 S2\" id=\"t45_51\">27 365 </span><span class=\"S132B S1071 S2\" id=\"t46_51\">Board of Directors 2020 </span><span class=\"S132C S1070 S2\" id=\"t47_51\">Chairperson of the Board </span><span class=\"S132D S1070 S2\" id=\"t48_51\">620 </span><span class=\"S132E S1070 S2\" id=\"t49_51\">620 </span><span class=\"S132F S1070 S2\" id=\"t4a_51\">Members of the Board </span><span class=\"S1330 S1070 S2\" id=\"t4b_51\">1 440 </span><span class=\"S1331 S1070 S2\" id=\"t4c_51\">1 440 </span><span class=\"S1332 S1071 S2\" id=\"t4d_51\">Total remuneration </span><span class=\"S1333 S1071 S2\" id=\"t4e_51\">2 060 </span><span class=\"S1334 S1071 S2\" id=\"t4f_51\">19 448 </span><span class=\"S1335 S1071 S2\" id=\"t4g_51\">5 265 </span><span class=\"S1336 S1071 S2\" id=\"t4h_51\">743 </span><span class=\"S1337 S1071 S2\" id=\"t4i_51\">1 910 </span><span class=\"S1338 S1071 S2\" id=\"t4j_51\">29 425 </span><span class=\"S133A S1071 S2\" id=\"t4_52\">Share options senior management </span><span class=\"S133B S1070 S2\" id=\"t5_52\">Senior managers\u2019 holdings of shares in Photocure ASA are stated in the note concerning share capital. Allocation and exercise of </span><span class=\"S133C S1070 S2\" id=\"t6_52\">share options and holdings of share options for senior managers are presented in the following overview: </span><span class=\"S133D S1071 S2\" id=\"t7_52\">Share options for senior management 2022 </span><span class=\"S133E S1071 S2\" id=\"t8_52\">Share </span><span class=\"S133F S1071 S2\" id=\"t9_52\">options </span><span class=\"S1340 S1071 S2\" id=\"ta_52\">awarded </span><span class=\"S1341 S1071 S2\" id=\"tb_52\">Expired </span><span class=\"S1342 S1071 S2\" id=\"tc_52\">share </span><span class=\"S1343 S1071 S2\" id=\"td_52\">options </span><span class=\"S1344 S1071 S2\" id=\"te_52\">Share </span><span class=\"S1345 S1071 S2\" id=\"tf_52\">options </span><span class=\"S1346 S1071 S2\" id=\"tg_52\">exercised </span><span class=\"S1347 S1071 S2\" id=\"th_52\">Holding of </span><span class=\"S1348 S1071 S2\" id=\"ti_52\">share options </span><span class=\"S1349 S1071 S2\" id=\"tj_52\">at 31 December </span><span class=\"S134A S1071 S2\" id=\"tk_52\">2022 </span><span class=\"S134B S1071 S2\" id=\"tl_52\">Average </span><span class=\"S134C S1071 S2\" id=\"tm_52\">exercise </span><span class=\"S134D S1071 S2\" id=\"tn_52\">price </span><span class=\"S134E S1070 S2\" id=\"to_52\">President &amp; CEO </span><span class=\"S134F S1070 S2\" id=\"tp_52\">130 000 </span><span class=\"S1350 S1070 S2\" id=\"tq_52\">- </span><span class=\"S1351 S1070 S2\" id=\"tr_52\">100 000 </span><span class=\"S1352 S1070 S2\" id=\"ts_52\">325 000 </span><span class=\"S1353 S1070 S2\" id=\"tt_52\">121.33 </span><span class=\"S1354 S1070 S2\" id=\"tu_52\">Chief Financial O\ufb03cer </span><span class=\"S1355 S1070 S2\" id=\"tv_52\">90 000 </span><span class=\"S1356 S1070 S2\" id=\"tw_52\">- </span><span class=\"S1357 S1070 S2\" id=\"tx_52\">20 000 </span><span class=\"S1358 S1070 S2\" id=\"ty_52\">192 500 </span><span class=\"S1359 S1070 S2\" id=\"tz_52\">119.46 </span><span class=\"S135A S1070 S2\" id=\"t10_52\">VP and General Manager North America </span><span class=\"S135B S1070 S2\" id=\"t11_52\">65 000 </span><span class=\"S135C S1070 S2\" id=\"t12_52\">- </span><span class=\"S135D S1070 S2\" id=\"t13_52\">- </span><span class=\"S135E S1070 S2\" id=\"t14_52\">212 500 </span><span class=\"S135F S1070 S2\" id=\"t15_52\">106.73 </span><span class=\"S1360 S1070 S2\" id=\"t16_52\">VP and General Manager Europe </span><span class=\"S1361 S1070 S2\" id=\"t17_52\">65 000 </span><span class=\"S1362 S1070 S2\" id=\"t18_52\">- </span><span class=\"S1363 S1070 S2\" id=\"t19_52\">- </span><span class=\"S1364 S1070 S2\" id=\"t1a_52\">200 000 </span><span class=\"S1365 S1070 S2\" id=\"t1b_52\">113.84 </span><span class=\"S1366 S1070 S2\" id=\"t1c_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S1367 S1070 S2\" id=\"t1d_52\">35 000 </span><span class=\"S1368 S1070 S2\" id=\"t1e_52\">- </span><span class=\"S1369 S1070 S2\" id=\"t1f_52\">- </span><span class=\"S136A S1070 S2\" id=\"t1g_52\">112 500 </span><span class=\"S136B S1070 S2\" id=\"t1h_52\">111.12 </span><span class=\"S136C S1070 S2\" id=\"t1i_52\">VP Global Human Resources </span><span class=\"S136D S1070 S2\" id=\"t1j_52\">- </span><span class=\"S136E S1070 S2\" id=\"t1k_52\">- </span><span class=\"S136F S1070 S2\" id=\"t1l_52\">- </span><span class=\"S1370 S1070 S2\" id=\"t1m_52\">80 000 </span><span class=\"S1371 S1070 S2\" id=\"t1n_52\">113.34 </span><span class=\"S1372 S1070 S2\" id=\"t1o_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S1373 S1070 S2\" id=\"t1p_52\">60 000 </span><span class=\"S1374 S1070 S2\" id=\"t1q_52\">- </span><span class=\"S1375 S1070 S2\" id=\"t1r_52\">- </span><span class=\"S1376 S1070 S2\" id=\"t1s_52\">88 000 </span><span class=\"S1377 S1070 S2\" id=\"t1t_52\">122.56 </span><span class=\"S1378 S1071 S2\" id=\"t1u_52\">Total </span><span class=\"S1379 S1071 S2\" id=\"t1v_52\">445 000 </span><span class=\"S137A S1071 S2\" id=\"t1w_52\">- </span><span class=\"S137B S1071 S2\" id=\"t1x_52\">120 000 </span><span class=\"S137C S1071 S2\" id=\"t1y_52\">1 210 500 </span><span class=\"S137D S1071 S2\" id=\"t1z_52\">Share options for senior management 2021 </span><span class=\"S137E S1071 S2\" id=\"t20_52\">Share </span><span class=\"S137F S1071 S2\" id=\"t21_52\">options </span><span class=\"S1380 S1071 S2\" id=\"t22_52\">awarded </span><span class=\"S1381 S1071 S2\" id=\"t23_52\">Expired </span><span class=\"S1382 S1071 S2\" id=\"t24_52\">share </span><span class=\"S1383 S1071 S2\" id=\"t25_52\">options </span><span class=\"S1384 S1071 S2\" id=\"t26_52\">Share </span><span class=\"S1385 S1071 S2\" id=\"t27_52\">options </span><span class=\"S1386 S1071 S2\" id=\"t28_52\">exercised </span><span class=\"S1387 S1071 S2\" id=\"t29_52\">Holding of </span><span class=\"S1388 S1071 S2\" id=\"t2a_52\">share options </span><span class=\"S1389 S1071 S2\" id=\"t2b_52\">at 31 December </span><span class=\"S138A S1071 S2\" id=\"t2c_52\">2021 </span><span class=\"S138B S1071 S2\" id=\"t2d_52\">Average </span><span class=\"S138C S1071 S2\" id=\"t2e_52\">exercise </span><span class=\"S138D S1071 S2\" id=\"t2f_52\">price </span><span class=\"S138E S1070 S2\" id=\"t2g_52\">President &amp; CEO </span><span class=\"S138F S1070 S2\" id=\"t2h_52\">135 000 </span><span class=\"S1390 S1070 S2\" id=\"t2i_52\">- </span><span class=\"S1391 S1070 S2\" id=\"t2j_52\">100 000 </span><span class=\"S1392 S1070 S2\" id=\"t2k_52\">295 000 </span><span class=\"S1393 S1070 S2\" id=\"t2l_52\">100.23 </span><span class=\"S1394 S1070 S2\" id=\"t2m_52\">Chief Financial O\ufb03cer </span><span class=\"S1395 S1070 S2\" id=\"t2n_52\">67 500 </span><span class=\"S1396 S1070 S2\" id=\"t2o_52\">- </span><span class=\"S1397 S1070 S2\" id=\"t2p_52\">20 000 </span><span class=\"S1398 S1070 S2\" id=\"t2q_52\">122 500 </span><span class=\"S1399 S1070 S2\" id=\"t2r_52\">111.59 </span><span class=\"S139A S1070 S2\" id=\"t2s_52\">VP and General Manager US Operations </span><span class=\"S139B S1070 S2\" id=\"t2t_52\">67 500 </span><span class=\"S139C S1070 S2\" id=\"t2u_52\">- </span><span class=\"S139D S1070 S2\" id=\"t2v_52\">45 000 </span><span class=\"S139E S1070 S2\" id=\"t2w_52\">147 500 </span><span class=\"S139F S1070 S2\" id=\"t2x_52\">103.14 </span><span class=\"S13A0 S1070 S2\" id=\"t2y_52\">VP and General Manager Europe </span><span class=\"S13A1 S1070 S2\" id=\"t2z_52\">67 500 </span><span class=\"S13A2 S1070 S2\" id=\"t30_52\">- </span><span class=\"S13A3 S1070 S2\" id=\"t31_52\">22 500 </span><span class=\"S13A4 S1070 S2\" id=\"t32_52\">135 000 </span><span class=\"S13A5 S1070 S2\" id=\"t33_52\">113.34 </span><span class=\"S13A6 S1070 S2\" id=\"t34_52\">VP Global Strategic Marketing &amp; Business Development </span><span class=\"S13A7 S1070 S2\" id=\"t35_52\">40 000 </span><span class=\"S13A8 S1070 S2\" id=\"t36_52\">- </span><span class=\"S13A9 S1070 S2\" id=\"t37_52\">12 500 </span><span class=\"S13AA S1070 S2\" id=\"t38_52\">77 500 </span><span class=\"S13AB S1070 S2\" id=\"t39_52\">109.42 </span><span class=\"S13AC S1070 S2\" id=\"t3a_52\">VP Global Human Resources </span><span class=\"S13AD S1070 S2\" id=\"t3b_52\">40 000 </span><span class=\"S13AE S1070 S2\" id=\"t3c_52\">- </span><span class=\"S13AF S1070 S2\" id=\"t3d_52\">- </span><span class=\"S13B0 S1070 S2\" id=\"t3e_52\">80 000 </span><span class=\"S13B1 S1070 S2\" id=\"t3f_52\">113.34 </span><span class=\"S13B2 S1070 S2\" id=\"t3g_52\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S13B3 S1070 S2\" id=\"t3h_52\">28 000 </span><span class=\"S13B4 S1070 S2\" id=\"t3i_52\">- </span><span class=\"S13B5 S1070 S2\" id=\"t3j_52\">- </span><span class=\"S13B6 S1070 S2\" id=\"t3k_52\">28 000 </span><span class=\"S13B7 S1070 S2\" id=\"t3l_52\">139.00 </span><span class=\"S13B8 S1071 S2\" id=\"t3m_52\">Total </span><span class=\"S13B9 S1071 S2\" id=\"t3n_52\">445 500 </span><span class=\"S13BA S1071 S2\" id=\"t3o_52\">- </span><span class=\"S13BB S1071 S2\" id=\"t3p_52\">200 000 </span><span class=\"S13BC S1071 S2\" id=\"t3q_52\">885 500 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f5975": {
   "value": "<span class=\"S13BD S1071 S2\" id=\"t3r_52\">Auditing fees </span><span class=\"S13BE S1070 S2\" id=\"t3s_52\">(Amounts in NOK 1,000) </span><span class=\"S13BF S1071 S2\" id=\"t3t_52\">Group and parent </span><span class=\"S13C0 S1071 S2\" id=\"t3u_52\">2022 </span><span class=\"S13C1 S1071 S2\" id=\"t3v_52\">2021 </span><span class=\"S13C2 S1070 S2\" id=\"t3w_52\">Statutory auditing </span><span class=\"S13C3 S1070 S2\" id=\"t3x_52\">972 </span><span class=\"S13C4 S1070 S2\" id=\"t3y_52\">488 </span><span class=\"S13C5 S1070 S2\" id=\"t3z_52\">Other attestation services </span><span class=\"S13C6 S1070 S2\" id=\"t40_52\">138 </span><span class=\"S13C7 S1070 S2\" id=\"t41_52\">22 </span><span class=\"S13C8 S1070 S2\" id=\"t42_52\">Other services excluding auditing </span><span class=\"S13C9 S1070 S2\" id=\"t43_52\">42 </span><span class=\"S13CA S1070 S2\" id=\"t44_52\">0 </span><span class=\"S13CB S1070 S2\" id=\"t45_52\">Tax advice </span><span class=\"S13CC S1070 S2\" id=\"t46_52\">132 </span><span class=\"S13CD S1070 S2\" id=\"t47_52\">126 </span><span class=\"S13CE S1071 S2\" id=\"t48_52\">Total </span><span class=\"S13CF S1071 S2\" id=\"t49_52\">1 284 </span><span class=\"S13D0 S1071 S2\" id=\"t4a_52\">636 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6054": {
   "value": "<span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span><span class=\"S1445 S1070 SDD8 S2\" id=\"t24_54\">The parent company is committed to securing the operations in the U.S. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6055": {
   "value": "<span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span><span class=\"S1445 S1070 SDD8 S2\" id=\"t24_54\">The parent company is committed to securing the operations in the U.S. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6057": {
   "value": "<span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span>The parent company is committed to securing the operations in the U.S",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6058": {
   "value": "<span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span>The parent company is committed to securing the operations in the U.S",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestIncomeExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6059": {
   "value": "<span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span>The parent company is committed to securing the operations in the U.S",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestIncomeExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6060": {
   "value": "<span class=\"S13FD S106F S2\" id=\"t4_54\">9. FINANCIAL INCOME AND EXPENSE </span><span class=\"S13FE S1070 S2\" id=\"t5_54\">(Amounts in NOK 1,000) </span><span class=\"S13FF S1071 S2\" id=\"t6_54\">Group </span><span class=\"S1400 S1071 S2\" id=\"t7_54\">Parent </span><span class=\"S1401 S1071 S2\" id=\"t8_54\">2022 </span><span class=\"S1402 S1071 S2\" id=\"t9_54\">2021 </span><span class=\"S1403 S1071 S2\" id=\"ta_54\">2022 </span><span class=\"S1404 S1071 S2\" id=\"tb_54\">2021 </span><span class=\"S1405 S1070 S2\" id=\"tc_54\">Interest income </span><span class=\"S1406 S1070 S2\" id=\"td_54\">2 336 </span><span class=\"S1407 S1070 S2\" id=\"te_54\">1 810 </span><span class=\"S1408 S1070 S2\" id=\"tf_54\">2 287 </span><span class=\"S1409 S1070 S2\" id=\"tg_54\">1 810 </span><span class=\"S140A S1070 S2\" id=\"th_54\">Foreign exchange gains </span><span class=\"S140B S1070 S2\" id=\"ti_54\">6 882 </span><span class=\"S140C S1070 S2\" id=\"tj_54\">23 778 </span><span class=\"S140D S1070 S2\" id=\"tk_54\">45 850 </span><span class=\"S140E S1070 S2\" id=\"tl_54\">34 379 </span><span class=\"S140F S1070 S2\" id=\"tm_54\">Other \ufb01nancial gains </span><span class=\"S1410 S1070 S2\" id=\"tn_54\">0 </span><span class=\"S1411 S1070 S2\" id=\"to_54\">624 </span><span class=\"S1412 S1070 S2\" id=\"tp_54\">0 </span><span class=\"S1413 S1070 S2\" id=\"tq_54\">624 </span><span class=\"S1414 S1071 S2\" id=\"tr_54\">Total \ufb01nancial income </span><span class=\"S1415 S1071 S2\" id=\"ts_54\">9 218 </span><span class=\"S1416 S1071 S2\" id=\"tt_54\">26 212 </span><span class=\"S1417 S1071 S2\" id=\"tu_54\">48 137 </span><span class=\"S1418 S1071 S2\" id=\"tv_54\">36 813 </span><span class=\"S1419 S1070 S2\" id=\"tw_54\">Interest costs long term liabilities and lease </span><span class=\"S141A S1070 S2\" id=\"tx_54\">1 421 </span><span class=\"S141B S1070 S2\" id=\"ty_54\">1 401 </span><span class=\"S141C S1070 S2\" id=\"tz_54\">1 095 </span><span class=\"S141D S1070 S2\" id=\"t10_54\">1 222 </span><span class=\"S141E S1070 S2\" id=\"t11_54\">Interest costs earnout </span><span class=\"S141F S1070 S2\" id=\"t12_54\">24 383 </span><span class=\"S1420 S1070 S2\" id=\"t13_54\">22 425 </span><span class=\"S1421 S1070 S2\" id=\"t14_54\">24 383 </span><span class=\"S1422 S1070 S2\" id=\"t15_54\">22 425 </span><span class=\"S1423 S1070 S2\" id=\"t16_54\">Foreign exchange losses </span><span class=\"S1424 S1070 S2\" id=\"t17_54\">4 588 </span><span class=\"S1425 S1070 S2\" id=\"t18_54\">10 472 </span><span class=\"S1426 S1070 S2\" id=\"t19_54\">4 564 </span><span class=\"S1427 S1070 S2\" id=\"t1a_54\">10 472 </span><span class=\"S1428 S1070 S2\" id=\"t1b_54\">Other \ufb01nancial expense </span><span class=\"S1429 S1070 S2\" id=\"t1c_54\">199 </span><span class=\"S142A S1070 S2\" id=\"t1d_54\">524 </span><span class=\"S142B S1070 S2\" id=\"t1e_54\">199 </span><span class=\"S142C S1070 S2\" id=\"t1f_54\">524 </span><span class=\"S142D S1070 S2\" id=\"t1g_54\">Loss allowance internal loan </span><span class=\"S142E S1070 S2\" id=\"t1h_54\">- </span><span class=\"S142F S1070 S2\" id=\"t1i_54\">- </span><span class=\"S1430 S1071 S2\" id=\"t1j_54\">Total \ufb01nancial expense </span><span class=\"S1431 S1071 S2\" id=\"t1k_54\">30 591 </span><span class=\"S1432 S1071 S2\" id=\"t1l_54\">34 822 </span><span class=\"S1433 S1071 S2\" id=\"t1m_54\">30 240 </span><span class=\"S1434 S1071 S2\" id=\"t1n_54\">34 643 </span><span class=\"S1435 S1071 S2\" id=\"t1o_54\">Remeasure \ufb01nancial balances </span><span class=\"S1436 S1071 S2\" id=\"t1p_54\">758 </span><span class=\"S1437 S1071 S2\" id=\"t1q_54\">17 720 </span><span class=\"S1438 S1071 S2\" id=\"t1r_54\">29 565 </span><span class=\"S1439 S1071 S2\" id=\"t1s_54\">23 479 </span><span class=\"S143A S1070 S2\" id=\"t1t_54\">The foreign exchange gain in the parent company 2022 include unrealised exchange gain of the long term loan to the subsidiary that </span><span class=\"S143B S1070 S2\" id=\"t1u_54\">is nominated in USD. </span><span class=\"S143C S1070 S2\" id=\"t1v_54\">The exchange rate NOK/USD increased to 9.90 as of December 31, 2022 compared to exchange rate of 8.84 at end of previous year. </span><span class=\"S143D S1070 S2\" id=\"t1w_54\">This is resulting in an unrealised gain of NOK 38.9 million in 2022 compared to a gain of NOK 10.6 million in 2021. </span><span class=\"S143E S1070 S29E S2\" id=\"t1x_54\">In the consolidated accounts the unrealised gain/loss is eliminated against the change in equity as part of other comprehensive income. </span><span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span>The parent company is committed to securing the operations in the U.S",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinanceCostExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6127": {
   "value": "<span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span><span class=\"S1445 S1070 SDD8 S2\" id=\"t24_54\">The parent company is committed to securing the operations in the U.S. </span><span class=\"S16B9 S1071 S2\" id=\"tq_62\">(II) Classes of \ufb01nancial risk </span><span class=\"S16BA S16F9 S2\" id=\"tr_62\">Interest rate risk </span><span class=\"S16BB S1070 S2\" id=\"ts_62\">Photocure has an interest bearing earnout liability from 2020 with interest rate equal to </span><span class=\"S16BC S1070 S2\" id=\"tt_62\">the internal rate of return for the investment </span><span class=\"S16BD S1070 S2\" id=\"tu_62\">project. In addition Photocure has interest bearing bank loan, leasing liability and pension liability. The long-term bank loan has a </span><span class=\"S16BE S1070 S2\" id=\"tv_62\">\ufb02oating interest and </span><span class=\"S16BF S1070 S2\" id=\"tw_62\">90% of the loan has a state guarantee. </span><span class=\"S16C0 S1070 S2\" id=\"tx_62\">The company\u2019s risk related to interest income is mainly associated with the company\u2019s holdings of cash and cash equivalents. The </span><span class=\"S16C1 S1070 S2\" id=\"ty_62\">main strategy is to diversify the risk and invest in money market funds and bond funds with low risk, high liquidity and short duration. </span><span class=\"S16C2 S1070 S2\" id=\"tz_62\">More than 90% of the investments are denominated in NOK and are not hedged. </span><span class=\"S16C3 S16F9 S2\" id=\"t10_62\">Liquidity and funding risk </span><span class=\"S16C4 S1070 S2\" id=\"t11_62\">The Company monitors its cash \ufb02ows from both long and short-term perspectives through planning and reporting. Photocure does </span><span class=\"S16C5 S1070 S2\" id=\"t12_62\">not have any loan agreements that involve covenants or other restrictions. Photocure uses a multi-currency consolidated bank </span><span class=\"S16C6 S1070 S2\" id=\"t13_62\">accounts system that provides \ufb02exibility in relation to drawing on multiple currencies. The company may require new capital in the </span><span class=\"S16C7 S1070 S2\" id=\"t14_62\">future. Adequate sources of capital funding may not be available when needed or may not be available on favorable terms. </span><span class=\"S16C8 S1070 S2\" id=\"t15_62\">A main objective of Photocure\u2019s \ufb01nancial policy is to ensure that the company has the \ufb01nancial freedom to act both short and long </span><span class=\"S16C9 S1070 S2\" id=\"t16_62\">term to achieve strategic and operational goals. Photocure\u2019s policy is to have su\ufb03cient funds to cover known capital requirements </span><span class=\"S16CA S1070 S2\" id=\"t17_62\">during the forthcoming 12 months in addition to a strategic reserve. Photocure follows a low risk investment strategy for its liquid </span><span class=\"S16CB S1070 S2\" id=\"t18_62\">funds. The return on the liquid funds depends on the rate of interest in the money markets and will therefore vary over time. </span><span class=\"S16CC S1071 S2\" id=\"t19_62\">Remaining period </span><span class=\"S16CD S1070 S2\" id=\"t1a_62\">(Amounts in NOK 1,000) </span><span class=\"S16CE S1071 S2\" id=\"t1b_62\">Less than 1 month </span><span class=\"S16CF S1071 S2\" id=\"t1c_62\">1\u20133 months </span><span class=\"S16D0 S1071 S2\" id=\"t1d_62\">3\u201312 months </span><span class=\"S16D1 S1071 S2\" id=\"t1e_62\">1\u20135 years </span><span class=\"S16D2 S1071 S2\" id=\"t1f_62\">Total </span><span class=\"S16D3 S1071 S2\" id=\"t1g_62\">31-Dec-22 </span><span class=\"S16D4 S1070 S2\" id=\"t1h_62\">Accounts payable </span><span class=\"S16D5 S1070 S2\" id=\"t1i_62\">18 091 </span><span class=\"S16D6 S1070 S2\" id=\"t1j_62\">3 190 </span><span class=\"S16D7 S1071 S2\" id=\"t1k_62\">21 281 </span><span class=\"S16D8 S1070 S2\" id=\"t1l_62\">Withholding tax and social securities </span><span class=\"S16D9 S1070 S2\" id=\"t1m_62\">2 440 </span><span class=\"S16DA S1070 S2\" id=\"t1n_62\">1 500 </span><span class=\"S16DB S1070 S2\" id=\"t1o_62\">647 </span><span class=\"S16DC S1071 S2\" id=\"t1p_62\">4 587 </span><span class=\"S16DD S1070 S2\" id=\"t1q_62\">Other current liabilities </span><span class=\"S16DE S1070 S2\" id=\"t1r_62\">20 630 </span><span class=\"S16DF S1070 S2\" id=\"t1s_62\">13 000 </span><span class=\"S16E0 S1070 S2\" id=\"t1t_62\">17 177 </span><span class=\"S16E1 S1071 S2\" id=\"t1u_62\">50 807 </span><span class=\"S16E2 S1070 S2\" id=\"t1v_62\">Loan and lease liabilities </span><span class=\"S16E3 S1070 S2\" id=\"t1w_62\">7 250 </span><span class=\"S16E4 S1070 S2\" id=\"t1x_62\">18 750 </span><span class=\"S16E5 S1070 S2\" id=\"t1y_62\">151 370 </span><span class=\"S16E6 S1071 S2\" id=\"t1z_62\">177 370 </span><span class=\"S16E7 S1071 S2\" id=\"t20_62\">31-Dec-21 </span><span class=\"S16E8 S1070 S2\" id=\"t21_62\">Accounts payable </span><span class=\"S16E9 S1070 S2\" id=\"t22_62\">19 748 </span><span class=\"S16EA S1070 S2\" id=\"t23_62\">3 900 </span><span class=\"S16EB S1071 S2\" id=\"t24_62\">23 648 </span><span class=\"S16EC S1070 S2\" id=\"t25_62\">Withholding tax and social securities </span><span class=\"S16ED S1070 S2\" id=\"t26_62\">771 </span><span class=\"S16EE S1070 S2\" id=\"t27_62\">2 230 </span><span class=\"S16EF S1071 S2\" id=\"t28_62\">3 001 </span><span class=\"S16F0 S1070 S2\" id=\"t29_62\">Other current liabilities </span><span class=\"S16F1 S1070 S2\" id=\"t2a_62\">3 500 </span><span class=\"S16F2 S1070 S2\" id=\"t2b_62\">28 000 </span><span class=\"S16F3 S1070 S2\" id=\"t2c_62\">18 854 </span><span class=\"S16F4 S1071 S2\" id=\"t2d_62\">50 354 </span><span class=\"S16F5 S1070 S2\" id=\"t2e_62\">Loan and lease liabilities </span><span class=\"S16F6 S1070 S2\" id=\"t2f_62\">36 580 </span><span class=\"S16F7 S1070 S2\" id=\"t2g_62\">169 913 </span><span class=\"S16F8 S1071 S2\" id=\"t2h_62\">206 493 </span><span class=\"S16FA S16F9 S2\" id=\"t2_63\">Credit risk </span><span class=\"S16FB S1070 S2\" id=\"t3_63\">Management of credit risk associated with accounts receivable and other operational receivables is dealt with as a part of the </span><span class=\"S16FC S1070 S2\" id=\"t4_63\">commercial risk and is followed up continuously as a part of normal operations. Photocure is primarily exposed to credit risk </span><span class=\"S16FD S1070 S2\" id=\"t5_63\">associated with accounts receivable and other short-term receivables. Photocure\u2019s sales is a mix of sales directly to hospitals, </span><span class=\"S16FE S1070 S2\" id=\"t6_63\">pharmacies and wholesalers in Europe and North America. The credit risk is limited as the customers are hospitals which are either </span><span class=\"S16FF S1070 S2\" id=\"t7_63\">publicly owned or \ufb01nanced by public funds or insurance companies. The same applies for the wholesalers customers. </span><span class=\"S1700 S1070 S2\" id=\"t8_63\">Photocure\u2019s </span><span class=\"S1701 S1070 S2\" id=\"t9_63\">credit risk is considered moderate and the Company does not use credit insurance. </span><span class=\"S1702 S16F9 S2\" id=\"ta_63\">Currency risk </span><span class=\"S1703 S1070 S152D S2\" id=\"tb_63\">As NOK is the Company\u2019s presentation currency, Photocure is exposed to translation risk associated with the company\u2019s foreign net </span><span class=\"S1704 S1070 S152D S2\" id=\"tc_63\">exposure. Photocure\u2019s revenues and costs are incurred in di\ufb00erent currencies, primarily EUR, USD, GBP and SEK. Photocure is therefore </span><span class=\"S1705 S1070 S152D S2\" id=\"td_63\">exposed to exchange rate \ufb02uctuations. The company regularly monitors the need for hedging of large transactions. Bank accounts in </span><span class=\"S1706 S1070 S152D S2\" id=\"te_63\">foreign currencies are used actively to reduce exposure to all the main currencies, and currency risk is to some degree naturally hedged </span><span class=\"S1707 S1070 S152D S2\" id=\"tf_63\">in EUR, USD and SEK by having both revenues and costs in the same currency. However, Photocure have in both 2022 and 2021 cash </span><span class=\"S1708 S1070 S152D S2\" id=\"tg_63\">surplus in EUR and a cash de\ufb01cit in USD. The Company has not entered into any currency hedging contracts during 2022. </span><span class=\"S1709 S1070 S2\" id=\"th_63\">The following table shows the Company\u2019s sensitivity for potential changes in the NOK exchange rate with all other factors constant. </span><span class=\"S170A S1070 S2\" id=\"ti_63\">The calculation is based on the same change in relation to all relevant currencies. The e\ufb00ect in the income statement comes from </span><span class=\"S170B S1070 S2\" id=\"tj_63\">changes in the value of monetary items. </span><span class=\"S170C S1070 S2\" id=\"tk_63\">(Amounts in NOK 1,000) </span><span class=\"S170D S1071 S2\" id=\"tl_63\">Change in the NOK exchange rate </span><span class=\"S170E S1071 S2\" id=\"tm_63\">E\ufb00ect on operating pro\ufb01t/loss </span><span class=\"S170F S1071 S2\" id=\"tn_63\">2022 </span><span class=\"S1710 S1070 S2\" id=\"to_63\">+ 10 % </span><span class=\"S1711 S1070 S2\" id=\"tp_63\">-2 270 </span><span class=\"S1712 S1071 S2\" id=\"tq_63\">2022 </span><span class=\"S1713 S1070 S2\" id=\"tr_63\">- 10 % </span><span class=\"S1714 S1070 S2\" id=\"ts_63\">2 270 </span><span class=\"S1715 S1071 S2\" id=\"tt_63\">2021 </span><span class=\"S1716 S1070 S2\" id=\"tu_63\">+ 10 % </span><span class=\"S1717 S1070 S2\" id=\"tv_63\">-7 187 </span><span class=\"S1718 S1071 S2\" id=\"tw_63\">2021 </span><span class=\"S1719 S1070 S2\" id=\"tx_63\">- 10 % </span><span class=\"S171A S1070 S2\" id=\"ty_63\">7 187 </span><span class=\"S171C S106F S2\" id=\"t4_64\">18. FAIR VALUE </span><span class=\"S171D S1070 S2\" id=\"t5_64\">The table below analyses \ufb01nancial assets recognised in the balance sheet at fair value according to the valuation method. </span><span class=\"S171E S1070 S2\" id=\"t6_64\">The di\ufb00erent levels have been de\ufb01ned as follows: </span><span class=\"S171F S1070 S2\" id=\"t7_64\">Level 1: </span><span class=\"S1720 S1070 S2\" id=\"t8_64\">Noted prices in active markets for corresponding assets or liabilities. </span><span class=\"S1721 S1070 S2\" id=\"t9_64\">Level 2: </span><span class=\"S1722 S1070 S2\" id=\"ta_64\">Available value measurements other than the noted prices classi\ufb01ed as Level 1, either directly observable in the form </span><span class=\"S1723 S1070 S2\" id=\"tb_64\">of agreed prices or indirectly as derived from the price of equivalent. </span><span class=\"S1724 S1070 S2\" id=\"tc_64\">Level 3: </span><span class=\"S1725 S1070 S2\" id=\"td_64\">Value measurements of assets or liabilities that are not based on observed market values. </span><span class=\"S1726 S1070 S2\" id=\"te_64\">(Amounts in NOK 1,000) </span><span class=\"S1727 S1071 S2\" id=\"tf_64\">Market value hierarchy </span><span class=\"S1728 S1071 S2\" id=\"tg_64\">Level 1 </span><span class=\"S1729 S1071 S2\" id=\"th_64\">Level 2 </span><span class=\"S172A S1071 S2\" id=\"ti_64\">Level 3 </span><span class=\"S172B S1071 S2\" id=\"tj_64\">Total </span><span class=\"S172C S1070 S2\" id=\"tk_64\">Money market funds </span><span class=\"S172D S1070 S2\" id=\"tl_64\">234 202 </span><span class=\"S172E S1070 S2\" id=\"tm_64\">234 202 </span><span class=\"S172F S1070 S2\" id=\"tn_64\">Earnout liability, ref note 22 </span><span class=\"S1730 S1070 S2\" id=\"to_64\">(135 333) </span><span class=\"S1731 S1070 S2\" id=\"tp_64\">(135 333) </span><span class=\"S1732 S1071 S2\" id=\"tq_64\">Total </span><span class=\"S1733 S1071 S2\" id=\"tr_64\">234 202 </span><span class=\"S1734 S1071 S2\" id=\"ts_64\">- </span><span class=\"S1735 S1071 S2\" id=\"tt_64\">(135 333) </span><span class=\"S1736 S1071 S2\" id=\"tu_64\">98 869 </span><span class=\"S1737 S106F S2\" id=\"tv_64\">19. RECEIVABLES </span><span class=\"S1738 S1071 S2\" id=\"tw_64\">Maximum credit risk </span><span class=\"S1739 S1070 S2\" id=\"tx_64\">The company\u2019s maximum credit risk associated with \ufb01nancial instruments corresponds to gross receivables. In a hypothetical </span><span class=\"S173A S1070 S2\" id=\"ty_64\">situations, where no receivables are actually paid, this would correspond to: </span><span class=\"S173B S1070 S2\" id=\"tz_64\">(Amounts in NOK 1,000) </span><span class=\"S173C S1071 S2\" id=\"t10_64\">Group </span><span class=\"S173D S1071 S2\" id=\"t11_64\">Parent </span><span class=\"S173E S1071 S2\" id=\"t12_64\">31-Dec-22 </span><span class=\"S173F S1071 S2\" id=\"t13_64\">31-Dec-21 </span><span class=\"S1740 S1071 S2\" id=\"t14_64\">31-Dec-22 </span><span class=\"S1741 S1071 S2\" id=\"t15_64\">31-Dec-21 </span><span class=\"S1742 S1070 S2\" id=\"t16_64\">Accounts receivable </span><span class=\"S1743 S1070 S2\" id=\"t17_64\">47 164 </span><span class=\"S1744 S1070 S2\" id=\"t18_64\">47 980 </span><span class=\"S1745 S1070 S2\" id=\"t19_64\">27 005 </span><span class=\"S1746 S1070 S2\" id=\"t1a_64\">29 610 </span><span class=\"S1747 S1070 S2\" id=\"t1b_64\">Accounts receivable intercompany </span><span class=\"S1748 S1070 S2\" id=\"t1c_64\">- </span><span class=\"S1749 S1070 S2\" id=\"t1d_64\">- </span><span class=\"S174A S1070 S2\" id=\"t1e_64\">4 733 </span><span class=\"S174B S1070 S2\" id=\"t1f_64\">0 </span><span class=\"S174C S1071 S2\" id=\"t1g_64\">Total </span><span class=\"S174D S1071 S2\" id=\"t1h_64\">47 164 </span><span class=\"S174E S1071 S2\" id=\"t1i_64\">47 980 </span><span class=\"S174F S1071 S2\" id=\"t1j_64\">31 738 </span><span class=\"S1750 S1071 S2\" id=\"t1k_64\">29 610 </span><span class=\"S1751 S1070 S2\" id=\"t1l_64\">Prepaid expenses </span><span class=\"S1752 S1070 S2\" id=\"t1m_64\">9 113 </span><span class=\"S1753 S1070 S2\" id=\"t1n_64\">9 852 </span><span class=\"S1754 S1070 S2\" id=\"t1o_64\">5 516 </span><span class=\"S1755 S1070 S2\" id=\"t1p_64\">4 697 </span><span class=\"S1756 S1070 S2\" id=\"t1q_64\">Other receivables and deposits </span><span class=\"S1757 S1070 S2\" id=\"t1r_64\">7 342 </span><span class=\"S1758 S1070 S2\" id=\"t1s_64\">4 928 </span><span class=\"S1759 S1070 S2\" id=\"t1t_64\">1 001 </span><span class=\"S175A S1070 S2\" id=\"t1u_64\">512 </span><span class=\"S175B S1071 S2\" id=\"t1v_64\">Total other receivables </span><span class=\"S175C S1071 S2\" id=\"t1w_64\">16 455 </span><span class=\"S175D S1071 S2\" id=\"t1x_64\">14 780 </span><span class=\"S175E S1071 S2\" id=\"t1y_64\">6 517 </span><span class=\"S175F S1071 S2\" id=\"t1z_64\">5 209 </span>2. LOAN TERMS AND REPAYMENT <span class=\"S1885 S1070 S2\" id=\"t1s_67\">(Amounts in NOK 1,000) </span><span class=\"S1886 S1071 S2\" id=\"t1t_67\">Currency </span><span class=\"S1887 S1071 S2\" id=\"t1u_67\">Nominell </span><span class=\"S1888 S1071 S2\" id=\"t1v_67\">interest </span><span class=\"S1889 S1071 S2\" id=\"t1w_67\">rate </span><span class=\"S188A S1071 S2\" id=\"t1x_67\">Year of </span><span class=\"S188B S1071 S2\" id=\"t1y_67\">maturity </span><span class=\"S188C S1071 S2\" id=\"t1z_67\">Loan </span><span class=\"S188D S1071 S2\" id=\"t20_67\">amount </span><span class=\"S188E S1071 S2\" id=\"t21_67\">01.01 </span><span class=\"S188F S1071 S2\" id=\"t22_67\">Instal- </span><span class=\"S1890 S1071 S2\" id=\"t23_67\">ments </span><span class=\"S1891 S1071 S2\" id=\"t24_67\">paid </span><span class=\"S1892 S1071 S2\" id=\"t25_67\">Book value </span><span class=\"S1893 S1071 S2\" id=\"t26_67\">31-Dec-22 </span><span class=\"S1894 S1071 S2\" id=\"t27_67\">1st year </span><span class=\"S1895 S1071 S2\" id=\"t28_67\">instal- </span><span class=\"S1896 S1071 S2\" id=\"t29_67\">ments </span><span class=\"S1897 S1070 S2\" id=\"t2a_67\">Bank loan secured through governmental </span><span class=\"S1898 S1070 S2\" id=\"t2b_67\">guarantee due to Covid-19 </span><span class=\"S1899 S1070 S2\" id=\"t2c_67\">NOK </span><span class=\"S189A S1070 S2\" id=\"t2d_67\">4.80 % </span><span class=\"S189B S1070 S2\" id=\"t2e_67\">2023 </span><span class=\"S189C S1070 S2\" id=\"t2f_67\">37 500 </span><span class=\"S189D S1070 S2\" id=\"t2g_67\">-25 000 </span><span class=\"S189E S1070 S2\" id=\"t2h_67\">12 500 </span><span class=\"S189F S1070 S2\" id=\"t2i_67\">12 500 </span><span class=\"S18A0 S1070 S2\" id=\"t2j_67\">Deferred consideration (Earnout) </span><span class=\"S18A1 S1070 S2\" id=\"t2k_67\">NOK/EUR </span><span class=\"S18A2 S1070 S2\" id=\"t2l_67\">2030 </span><span class=\"S18A3 S1070 S2\" id=\"t2m_67\">139 350 </span><span class=\"S18A4 S1070 S2\" id=\"t2n_67\">-5 714 </span><span class=\"S18A5 S1070 S2\" id=\"t2o_67\">135 333 </span><span class=\"S18A6 S1070 S2\" id=\"t2p_67\">9 100 </span><span class=\"S18A7 S1070 S2\" id=\"t2q_67\">Right-of-use o\ufb03ce contract Norway </span><span class=\"S18A8 S1070 S2\" id=\"t2r_67\">NOK </span><span class=\"S18A9 S1070 S2\" id=\"t2s_67\">3.15 % </span><span class=\"S18AA S1070 S2\" id=\"t2t_67\">2027 </span><span class=\"S18AB S1070 S2\" id=\"t2u_67\">13 052 </span><span class=\"S18AC S1070 S2\" id=\"t2v_67\">-2 193 </span><span class=\"S18AD S1070 S2\" id=\"t2w_67\">11 434 </span><span class=\"S18AE S1070 S2\" id=\"t2x_67\">2 302 </span><span class=\"S18AF S1070 S2\" id=\"t2y_67\">Right-of-use o\ufb03ce contract US </span><span class=\"S18B0 S1070 S2\" id=\"t2z_67\">USD </span><span class=\"S18B1 S1070 S2\" id=\"t30_67\">3.70 % </span><span class=\"S18B2 S1070 S2\" id=\"t31_67\">2028 </span><span class=\"S18B3 S1070 S2\" id=\"t32_67\">10 269 </span><span class=\"S18B4 S1070 S2\" id=\"t33_67\">-1 548 </span><span class=\"S18B5 S1070 S2\" id=\"t34_67\">9 591 </span><span class=\"S18B6 S1070 S2\" id=\"t35_67\">1 598 </span><span class=\"S18B7 S1070 S2\" id=\"t36_67\">Right-of-use o\ufb03ce contract Germany </span><span class=\"S18B8 S1070 S2\" id=\"t37_67\">EUR </span><span class=\"S18B9 S1070 S2\" id=\"t38_67\">1.40 % </span><span class=\"S18BA S1070 S2\" id=\"t39_67\">2026 </span><span class=\"S18BB S1070 S2\" id=\"t3a_67\">5 861 </span><span class=\"S18BC S1070 S2\" id=\"t3b_67\">-1 317 </span><span class=\"S18BD S1070 S2\" id=\"t3c_67\">5 064 </span><span class=\"S18BE S1070 S2\" id=\"t3d_67\">1 422 </span><span class=\"S18BF S1070 S2\" id=\"t3e_67\">Right-of-use o\ufb03ce company car \ufb02eet Germany * </span><span class=\"S18C0 S1070 S2\" id=\"t3f_67\">EUR </span><span class=\"S18C1 S1070 S2\" id=\"t3g_67\">1.40 % </span><span class=\"S18C2 S204 S2\" id=\"t3h_67\">2024 </span><span class=\"S18C3 S1070 S2\" id=\"t3i_67\">460 </span><span class=\"S18C4 S1070 S2\" id=\"t3j_67\">-708 </span><span class=\"S18C5 S1070 S2\" id=\"t3k_67\">949 </span><span class=\"S18C6 S1070 S2\" id=\"t3l_67\">460 </span><span class=\"S18C7 S18E0 S2\" id=\"t3m_67\">Total non-current liabilities </span><span class=\"S18C8 S1071 S2\" id=\"t3n_67\">174 871 </span><span class=\"S18C9 S1071 S2\" id=\"t3o_67\">27 382 </span><span class=\"S18CA S1294 S2\" id=\"t3p_67\">* </span><span class=\"S18CB S1295 S2\" id=\"t3q_67\">There are seperate lease agreements for each lease subject </span><span class=\"S18CC S1070 S2\" id=\"t3r_67\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S18CD S1070 S2\" id=\"t3s_67\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S18CE S1070 S2\" id=\"t3t_67\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S18CF S1070 S2\" id=\"t3u_67\">sales (years 8-10) in the previous Ipsen major markets. The deferred consideration is paid as quarterly earnout payments in EURO </span><span class=\"S18D0 S1070 S2\" id=\"t3v_67\">after the close of the quarter. </span><span class=\"S18D1 S1070 S2\" id=\"t3w_67\">The fair value of the deferred consideration is driven by future expected sales and is remeasured on a yearly basis. Photocure </span><span class=\"S18D2 S1070 S2\" id=\"t3x_67\">performed a new remeasurement as of 31 December 2022. </span><span class=\"S18D3 S1070 S2\" id=\"t3y_67\">The remeasurement resulted in a fair value of NOK 135.3 re\ufb02ecting </span><span class=\"S18D4 S1070 S2\" id=\"t3z_67\">an increase of fair value of NOK 0.8 million compared to remeasurement adjustment of NOK 17.2 in 2021. The increased fair value </span><span class=\"S18D5 S1070 S2\" id=\"t40_67\">has been recognized in pro\ufb01t or loss as a \ufb01nancial cost. To arrive at the remeasured fair value of NOK 135.3 million, Photocure has </span><span class=\"S18D6 S1070 S2\" id=\"t41_67\">discounted the estimated earnout payments by an IRR at level with the investment project. This IRR has been deemed appropriate </span><span class=\"S18D7 S1070 S2\" id=\"t42_67\">as a discount rate for the earnout payments since the level of the payments will be subject to the same risk factors as the cash </span><span class=\"S18D8 S1070 S2\" id=\"t43_67\">\ufb02ow prognosis for the acquisition as a whole. Future sales, given performance in 2022 and growth opportunities going forward, are </span><span class=\"S18D9 S1070 S2\" id=\"t44_67\">expected to be in line with forecasts prepared in connection with the transaction. </span><span class=\"S18DA S1070 S2\" id=\"t45_67\">Photocure has made the remeasurement of the earnout liability in NOK currency and based the forecasted cash\ufb02ow on a \ufb01xed </span><span class=\"S18DB S1070 S2\" id=\"t46_67\">exchange rate EUR/NOK of 10.2 and this is in line with the prior year remeasurement . </span><span class=\"S18DC S1070 S2\" id=\"t47_67\">The agreement with Ipsen determined a \ufb02oor revenue for the earnout from 2022 to the end of the forecast period and there is no </span><span class=\"S18DD S1070 S2\" id=\"t48_67\">upper cap of revenue. The total undiscounted amount of the earnout may be in the interval of NOK 187 - 306 million depending </span><span class=\"S18DE S1070 S2\" id=\"t49_67\">on revenue and development of the currency exchange rate between EUR and NOK. According to our sensitivity analysis the </span><span class=\"S18DF S1070 S2\" id=\"t4a_67\">corresponding net present value of the liability may decrease or increase by NOK 33 million. </span><span class=\"S18E2 S1071 S2\" id=\"t4_68\">Group </span><span class=\"S18E3 S1071 S2\" id=\"t5_68\">Earnout </span><span class=\"S18E4 S1071 S2\" id=\"t6_68\">liability </span><span class=\"S18E5 S1071 S2\" id=\"t7_68\">Financial </span><span class=\"S18E6 S1071 S2\" id=\"t8_68\">loan bank </span><span class=\"S18E7 S1071 S2\" id=\"t9_68\">O\ufb03ce </span><span class=\"S18E8 S1071 S2\" id=\"ta_68\">Lease </span><span class=\"S18E9 S1071 S2\" id=\"tb_68\">Oslo </span><span class=\"S18EA S1071 S2\" id=\"tc_68\">O\ufb03ce </span><span class=\"S18EB S1071 S2\" id=\"td_68\">Lease </span><span class=\"S18EC S1071 S2\" id=\"te_68\">Princeton </span><span class=\"S18ED S1071 S2\" id=\"tf_68\">O\ufb03ce and </span><span class=\"S18EE S1071 S2\" id=\"tg_68\">car Lease </span><span class=\"S18EF S1071 S2\" id=\"th_68\">Germany </span><span class=\"S18F0 S1071 S2\" id=\"ti_68\">Total </span><span class=\"S18F1 S1071 S2\" id=\"tj_68\">Accumulated 31 December 2020 </span><span class=\"S18F2 S1070 S2\" id=\"tk_68\">149 941 </span><span class=\"S18F3 S1070 S2\" id=\"tl_68\">50 000 </span><span class=\"S18F4 S1070 S2\" id=\"tm_68\">1 970 </span><span class=\"S18F5 S1070 S2\" id=\"tn_68\">1 917 </span><span class=\"S18F6 S1070 S2\" id=\"to_68\">0 </span><span class=\"S18F7 S1070 S2\" id=\"tp_68\">203 828 </span><span class=\"S18F8 S1070 S2\" id=\"tq_68\">Proceeds from loans and borrowing </span><span class=\"S18F9 S1070 S2\" id=\"tr_68\">0 </span><span class=\"S18FA S1070 S2\" id=\"ts_68\">Loan repayment and earnout </span><span class=\"S18FB S1070 S2\" id=\"tt_68\">-3 834 </span><span class=\"S18FC S1070 S2\" id=\"tu_68\">-12 500 </span><span class=\"S18FD S1070 S2\" id=\"tv_68\">-16 334 </span><span class=\"S18FE S1070 S2\" id=\"tw_68\">Payment of lease liabilities </span><span class=\"S18FF S1070 S2\" id=\"tx_68\">-1 970 </span><span class=\"S1900 S1070 S2\" id=\"ty_68\">-839 </span><span class=\"S1901 S1070 S2\" id=\"tz_68\">-1 134 </span><span class=\"S1902 S1070 S2\" id=\"t10_68\">-3 943 </span><span class=\"S1903 S1071 S2\" id=\"t11_68\">Total changes from \ufb01nancing </span><span class=\"S1904 S1071 S2\" id=\"t12_68\">-3 834 </span><span class=\"S1905 S1071 S2\" id=\"t13_68\">-12 500 </span><span class=\"S1906 S1071 S2\" id=\"t14_68\">-1 970 </span><span class=\"S1907 S1071 S2\" id=\"t15_68\">-839 </span><span class=\"S1908 S1071 S2\" id=\"t16_68\">-1 134 </span><span class=\"S1909 S1071 S2\" id=\"t17_68\">-20 277 </span><span class=\"S190A S1070 S2\" id=\"t18_68\">Change in fair value currency </span><span class=\"S190B S1070 S2\" id=\"t19_68\">-15 906 </span><span class=\"S190C S1070 S2\" id=\"t1a_68\">82 </span><span class=\"S190D S1070 S2\" id=\"t1b_68\">-15 824 </span><span class=\"S190E S1070 S2\" id=\"t1c_68\">Remeasurerd liability </span><span class=\"S190F S1070 S2\" id=\"t1d_68\">17 220 </span><span class=\"S1910 S1070 S2\" id=\"t1e_68\">17 220 </span><span class=\"S1911 S1070 S2\" id=\"t1f_68\">New lease liability </span><span class=\"S1912 S1070 S2\" id=\"t1g_68\">13 053 </span><span class=\"S1913 S1070 S2\" id=\"t1h_68\">9 110 </span><span class=\"S1914 S1070 S2\" id=\"t1i_68\">7 455 </span><span class=\"S1915 S1070 S2\" id=\"t1j_68\">29 617 </span><span class=\"S1916 S1070 S2\" id=\"t1k_68\">Interest expense </span><span class=\"S1917 S1070 S2\" id=\"t1l_68\">22 425 </span><span class=\"S1918 S1070 S2\" id=\"t1m_68\">1 065 </span><span class=\"S1919 S1070 S2\" id=\"t1n_68\">157 </span><span class=\"S191A S1070 S2\" id=\"t1o_68\">91 </span><span class=\"S191B S1070 S2\" id=\"t1p_68\">88 </span><span class=\"S191C S1070 S2\" id=\"t1q_68\">23 826 </span><span class=\"S191D S1070 S2\" id=\"t1r_68\">Interest paid </span><span class=\"S191E S1070 S2\" id=\"t1s_68\">-24 985 </span><span class=\"S191F S1070 S2\" id=\"t1t_68\">-1 065 </span><span class=\"S1920 S1070 S2\" id=\"t1u_68\">-157 </span><span class=\"S1921 S1070 S2\" id=\"t1v_68\">-91 </span><span class=\"S1922 S1070 S2\" id=\"t1w_68\">-88 </span><span class=\"S1923 S1070 S2\" id=\"t1x_68\">-26 386 </span><span class=\"S1924 S1071 S2\" id=\"t1y_68\">Total liability related changes </span><span class=\"S1925 S1071 S2\" id=\"t1z_68\">-1 246 </span><span class=\"S1926 S1071 S2\" id=\"t20_68\">0 </span><span class=\"S1927 S1071 S2\" id=\"t21_68\">13 053 </span><span class=\"S1928 S1071 S2\" id=\"t22_68\">9 192 </span><span class=\"S1929 S1071 S2\" id=\"t23_68\">7 455 </span><span class=\"S192A S1071 S2\" id=\"t24_68\">28 453 </span><span class=\"S192B S1070 S2\" id=\"t25_68\">1th year instalments </span><span class=\"S192C S1070 S2\" id=\"t26_68\">-5 750 </span><span class=\"S192D S1070 S2\" id=\"t27_68\">-25 000 </span><span class=\"S192E S1070 S2\" id=\"t28_68\">-2 400 </span><span class=\"S192F S1070 S2\" id=\"t29_68\">-1 549 </span><span class=\"S1930 S1070 S2\" id=\"t2a_68\">-1 882 </span><span class=\"S1931 S1070 S2\" id=\"t2b_68\">-36 581 </span><span class=\"S1932 S1071 S2\" id=\"t2c_68\">Accumulated 31 December 2021 </span><span class=\"S1933 S1070 S2\" id=\"t2d_68\">139 350 </span><span class=\"S1934 S1070 S2\" id=\"t2e_68\">37 500 </span><span class=\"S1935 S1070 S2\" id=\"t2f_68\">13 052 </span><span class=\"S1936 S1070 S2\" id=\"t2g_68\">10 269 </span><span class=\"S1937 S1070 S2\" id=\"t2h_68\">6 322 </span><span class=\"S1938 S1070 S2\" id=\"t2i_68\">206 492 </span><span class=\"S1939 S1070 S2\" id=\"t2j_68\">Proceeds from loans and borrowing </span><span class=\"S193A S1070 S2\" id=\"t2k_68\">0 </span><span class=\"S193B S1070 S2\" id=\"t2l_68\">Loan repayment and earnout instalments </span><span class=\"S193C S1070 S2\" id=\"t2m_68\">-5 714 </span><span class=\"S193D S1070 S2\" id=\"t2n_68\">-25 000 </span><span class=\"S193E S1070 S2\" id=\"t2o_68\">-30 714 </span><span class=\"S193F S1070 S2\" id=\"t2p_68\">Payment of lease liabilities </span><span class=\"S1940 S1070 S2\" id=\"t2q_68\">-2 193 </span><span class=\"S1941 S1070 S2\" id=\"t2r_68\">-1 548 </span><span class=\"S1942 S1070 S2\" id=\"t2s_68\">-1 889 </span><span class=\"S1943 S1070 S2\" id=\"t2t_68\">-5 630 </span><span class=\"S1944 S1071 S2\" id=\"t2u_68\">Total changes from \ufb01nancing </span><span class=\"S1945 S1071 S2\" id=\"t2v_68\">-5 714 </span><span class=\"S1946 S1071 S2\" id=\"t2w_68\">-25 000 </span><span class=\"S1947 S1071 S2\" id=\"t2x_68\">-2 193 </span><span class=\"S1948 S1071 S2\" id=\"t2y_68\">-1 548 </span><span class=\"S1949 S1071 S2\" id=\"t2z_68\">-1 889 </span><span class=\"S194A S1071 S2\" id=\"t30_68\">-36 344 </span><span class=\"S194B S1070 S2\" id=\"t31_68\">Remeasurerd liability </span><span class=\"S194C S1070 S2\" id=\"t32_68\">758 </span><span class=\"S194D S1070 S2\" id=\"t33_68\">574 </span><span class=\"S194E S1070 S2\" id=\"t34_68\">1 245 </span><span class=\"S194F S1070 S2\" id=\"t35_68\">410 </span><span class=\"S1950 S1070 S2\" id=\"t36_68\">2 988 </span><span class=\"S1951 S1070 S2\" id=\"t37_68\">New lease liability </span><span class=\"S1952 S1070 S2\" id=\"t38_68\">-324 </span><span class=\"S1953 S1070 S2\" id=\"t39_68\">1 170 </span><span class=\"S1954 S1070 S2\" id=\"t3a_68\">846 </span><span class=\"S1955 S1070 S2\" id=\"t3b_68\">Interest expense </span><span class=\"S1956 S1070 S2\" id=\"t3c_68\">24 383 </span><span class=\"S1957 S1070 S2\" id=\"t3d_68\">846 </span><span class=\"S1958 S1070 S2\" id=\"t3e_68\">249 </span><span class=\"S1959 S1070 S2\" id=\"t3f_68\">248 </span><span class=\"S195A S1070 S2\" id=\"t3g_68\">79 </span><span class=\"S195B S1070 S2\" id=\"t3h_68\">25 804 </span><span class=\"S195C S1070 S2\" id=\"t3i_68\">Interest paid </span><span class=\"S195D S1070 S2\" id=\"t3j_68\">-23 444 </span><span class=\"S195E S1070 S2\" id=\"t3k_68\">-846 </span><span class=\"S195F S1070 S2\" id=\"t3l_68\">-249 </span><span class=\"S1960 S1070 S2\" id=\"t3m_68\">-298 </span><span class=\"S1961 S1070 S2\" id=\"t3n_68\">-79 </span><span class=\"S1962 S1070 S2\" id=\"t3o_68\">-24 915 </span><span class=\"S1963 S1071 S2\" id=\"t3p_68\">Total liability related changes </span><span class=\"S1964 S1071 S2\" id=\"t3q_68\">1 697 </span><span class=\"S1965 S1071 S2\" id=\"t3r_68\">0 </span><span class=\"S1966 S1071 S2\" id=\"t3s_68\">574 </span><span class=\"S1967 S1071 S2\" id=\"t3t_68\">871 </span><span class=\"S1968 S1071 S2\" id=\"t3u_68\">1 580 </span><span class=\"S1969 S1071 S2\" id=\"t3v_68\">4 723 </span><span class=\"S196A S1071 S2\" id=\"t3w_68\">Accumulated 31 December 2022 </span><span class=\"S196B S1071 S2\" id=\"t3x_68\">135 333 </span><span class=\"S196C S1071 S2\" id=\"t3y_68\">12 500 </span><span class=\"S196D S1071 S2\" id=\"t3z_68\">11 433 </span><span class=\"S196E S1071 S2\" id=\"t40_68\">9 591 </span><span class=\"S196F S1071 S2\" id=\"t41_68\">6 014 </span><span class=\"S1970 S1071 S2\" id=\"t42_68\">174 871 </span><span class=\"S1971 S1070 S2\" id=\"t43_68\">1th year instalments </span><span class=\"S1972 S1070 S2\" id=\"t44_68\">-9 100 </span><span class=\"S1973 S1070 S2\" id=\"t45_68\">-12 500 </span><span class=\"S1974 S1070 S2\" id=\"t46_68\">-2 302 </span><span class=\"S1975 S1070 S2\" id=\"t47_68\">-1 598 </span><span class=\"S1976 S1070 S2\" id=\"t48_68\">-1 882 </span>-27",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6128": {
   "value": "<span class=\"S143F S1071 S2\" id=\"t1y_54\">Remeasure \ufb01nancial balances </span><span class=\"S1440 S1070 S2\" id=\"t1z_54\">Information regarding the remeasured value of the earnout liability is provided in note 22. </span><span class=\"S1441 S1070 SDD8 S2\" id=\"t20_54\">A loss allowance in the parent company loan to the US subsidiary has been recognized according to IFRS as a probability weighted estimate </span><span class=\"S1442 S1070 SDD8 S2\" id=\"t21_54\">of future loan repayments as of December 31, 2022. A loss allowance increase of NOK 28.8 million has been estimated in a downside </span><span class=\"S1443 S1070 SDD8 S2\" id=\"t22_54\">scenario as of 31, December 2022 compared the NOK 6.3 million allowance as of 31, December 2021. The total allowance on 31, December </span><span class=\"S1444 S1070 SDD8 S2\" id=\"t23_54\">2022 is NOK 31 million and the estimate is based on a probability weighted scenario in case the loan will not be paid back in full. </span><span class=\"S1445 S1070 SDD8 S2\" id=\"t24_54\">The parent company is committed to securing the operations in the U.S. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6150": {
   "value": "<span class=\"S1447 S106F S2\" id=\"t2_55\">10. RELATED PARTIES - COMPANIES </span><span class=\"S1448 S1071 S2\" id=\"t3_55\">Subsidiaries </span><span class=\"S1449 S1070 S2\" id=\"t4_55\">The transfer price method implemented is the pro\ufb01t &amp; loss split method (PSM) for the sales in US and a residual pro\ufb01t model (RPM) </span><span class=\"S144A S1070 S2\" id=\"t5_55\">for the sales in Germany and France. </span><span class=\"S144B S1070 S2\" id=\"t6_55\">Both the PSM and the RPM divides the combined pro\ufb01t or loss between the transacting related entities based on what would be </span><span class=\"S144C S1070 S2\" id=\"t7_55\">anticipated if the entities had been transacting at arm\u2019s length. </span><span class=\"S144D S1070 S2\" id=\"t8_55\">A contribution analysis for sale of Cysview in US and sale of Hexvix in Germany and France compares the split of pro\ufb01t or loss </span><span class=\"S144E S1070 S2\" id=\"t9_55\">between the subsidiaries and Photocure ASA based on the value of the functions performed by each of the related parties, taking </span><span class=\"S144F S1070 S2\" id=\"ta_55\">into account the assets used and the risks assumed by both parties. </span><span class=\"S1450 S1070 S2\" id=\"tb_55\">Photocure has established a wholly owned subsidiary in the US, Photocure Inc, in order to carry out the sales and the marketing-, </span><span class=\"S1451 S1070 S2\" id=\"tc_55\">selling- and distribution activities for the Cysview product. Photocure ASA has the ownership to the patent rights and the trade mark </span><span class=\"S1452 S1070 S2\" id=\"td_55\">and is responsible in the Group for development and manufacturing of the product. Photocure Inc purchases the completed product </span><span class=\"S1453 S1070 S2\" id=\"te_55\">from the parent company and distributes in the United States. Photocure Inc has established its own marketing organization that is </span><span class=\"S1454 S1070 S2\" id=\"tf_55\">funded by a loan from its parent company in addition to its own revenues. The transactions between Photocure ASA and Photocure </span><span class=\"S1455 S1070 S2\" id=\"tg_55\">Inc are on terms at arm\u2019s length, except for the loan that is interest free until further notice. </span><span class=\"S1456 S1070 S2\" id=\"th_55\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table. This is based on a cash \ufb02ow model taking into account a </span><span class=\"S1457 S1070 S2\" id=\"ti_55\">balanced view of the market share for Cysview in the US compared to sales of Hexvix in Europe. The US sales and marketing force </span><span class=\"S1458 S1070 S2\" id=\"tj_55\">has been kept during the Covid pandemic and enables Photocure Inc to access the US market again </span><span class=\"S1459 S1070 S2\" id=\"tk_55\">after the pandemic has ended. </span><span class=\"S145A S1070 S2\" id=\"tl_55\">Photocure has established wholly owned subsidiaries in Germany and France. </span><span class=\"S145B S1070 S2\" id=\"tm_55\">Photocure ASA carries out the sales and distribution </span><span class=\"S145C S1070 S2\" id=\"tn_55\">in Europe for the Hexvix product. The marketing- and promotion activities for the Hexvix product in Continental Europe are carried </span><span class=\"S145D S1070 S2\" id=\"to_55\">out by Photocure GmbH and Photocure SAS. The residual pro\ufb01t in Germany and France are allocated to the subsidiaries. Mark up is </span><span class=\"S145E S1070 S2\" id=\"tp_55\">assumed on fully loaded local costs for the services rendered to parent company. </span><span class=\"S145F S1070 S2\" id=\"tq_55\">Photocure established from January 2022 a sales subsidiary in Canada to carry out the sales, marketing and distribution of Cysview </span><span class=\"S1460 S1070 S2\" id=\"tr_55\">in Canada. </span><span class=\"S1461 S1071 S2\" id=\"ts_55\">Transactions and intercompany balances: </span><span class=\"S1462 S1071 S2\" id=\"tt_55\">2022 </span><span class=\"S1463 S1071 S2\" id=\"tu_55\">2021 </span><span class=\"S1464 S1070 S2\" id=\"tv_55\">Sales of products </span><span class=\"S1465 S1070 S2\" id=\"tw_55\">12 986 </span><span class=\"S1466 S1070 S2\" id=\"tx_55\">7 488 </span><span class=\"S1467 S1070 S2\" id=\"ty_55\">Sales of services </span><span class=\"S1468 S1070 S2\" id=\"tz_55\">899 </span><span class=\"S1469 S1070 S2\" id=\"t10_55\">999 </span><span class=\"S146A S1071 S2\" id=\"t11_55\">Intercompany sales </span><span class=\"S146B S1071 S2\" id=\"t12_55\">13 885 </span><span class=\"S146C S1071 S2\" id=\"t13_55\">8 487 </span><span class=\"S146D S1071 S2\" id=\"t14_55\">Purchase of marketing and promotion services </span><span class=\"S146E S1071 S2\" id=\"t15_55\">-54 719 </span><span class=\"S146F S1071 S2\" id=\"t16_55\">-48 060 </span><span class=\"S1470 S1071 S2\" id=\"t17_55\">31-Dec-22 </span><span class=\"S1471 S1071 S2\" id=\"t18_55\">31-Dec-21 </span><span class=\"S1472 S1070 S2\" id=\"t19_55\">Accounts receivables and other storm-term receivables </span><span class=\"S1473 S1070 S2\" id=\"t1a_55\">4 733 </span><span class=\"S1474 S1070 S2\" id=\"t1b_55\">0 </span><span class=\"S1475 S1070 S2\" id=\"t1c_55\">Long term loan given </span><span class=\"S1476 S1070 S2\" id=\"t1d_55\">350 072 </span><span class=\"S1477 S1070 S2\" id=\"t1e_55\">308 390 </span><span class=\"S1478 S1070 S2\" id=\"t1f_55\">Accounts payables and other short-term liabilities </span><span class=\"S1479 S1070 S2\" id=\"t1g_55\">-17 436 </span><span class=\"S147A S1070 S2\" id=\"t1h_55\">-7 203 </span><span class=\"S147B S1071 S2\" id=\"t1i_55\">Total subsidiaries </span><span class=\"S147C S1071 S2\" id=\"t1j_55\">337 369 </span><span class=\"S147D S1071 S2\" id=\"t1k_55\">301 187 </span><span class=\"S147E S1071 S2\" id=\"t1l_55\">Guarantees to bank in favor of subsidiary for requested security </span><span class=\"S147F S1071 S2\" id=\"t1m_55\">2 724 </span><span class=\"S1480 S1071 S2\" id=\"t1n_55\">2 220 </span><span class=\"S1481 S1070 S2\" id=\"t1o_55\">These are for licenses with the States of Maryland, Mississippi, Nevada and California to sell Cysview and for the o\ufb03ce lease deposit </span><span class=\"S165F S106F S2\" id=\"tf_61\">15. SUBSIDIARIES </span><span class=\"S1660 S1071 S2\" id=\"tg_61\">Company </span><span class=\"S1661 S1071 S2\" id=\"th_61\">Country </span><span class=\"S1662 S1071 S2\" id=\"ti_61\">Ownership </span><span class=\"S1663 S1071 S2\" id=\"tj_61\">Book value </span><span class=\"S1664 S1071 S2\" id=\"tk_61\">31-Dec-22 </span><span class=\"S1665 S1071 S2\" id=\"tl_61\">31-Dec-21 </span><span class=\"S1666 S1071 S2\" id=\"tm_61\">31-Dec-22 </span><span class=\"S1667 S1071 S2\" id=\"tn_61\">31-Dec-21 </span><span class=\"S1668 S1070 S2\" id=\"to_61\">Photocure Inc. </span><span class=\"S1669 S1070 S2\" id=\"tp_61\">USA </span><span class=\"S166A S1070 S2\" id=\"tq_61\">100 % </span><span class=\"S166B S1070 S2\" id=\"tr_61\">100 % </span><span class=\"S166C S1070 S2\" id=\"ts_61\">15 353 </span><span class=\"S166D S1070 S2\" id=\"tt_61\">11 018 </span><span class=\"S166E S1070 S2\" id=\"tu_61\">Photocure GmbH </span><span class=\"S166F S1070 S2\" id=\"tv_61\">Germany </span><span class=\"S1670 S1070 S2\" id=\"tw_61\">100 % </span><span class=\"S1671 S1070 S2\" id=\"tx_61\">100 % </span><span class=\"S1672 S1070 S2\" id=\"ty_61\">1 532 </span><span class=\"S1673 S1070 S2\" id=\"tz_61\">748 </span><span class=\"S1674 S1070 S2\" id=\"t10_61\">Photocure SAS </span><span class=\"S1675 S1070 S2\" id=\"t11_61\">France </span><span class=\"S1676 S1070 S2\" id=\"t12_61\">100 % </span><span class=\"S1677 S1070 S2\" id=\"t13_61\">100 % </span><span class=\"S1678 S1070 S2\" id=\"t14_61\">285 </span><span class=\"S1679 S1070 S2\" id=\"t15_61\">136 </span><span class=\"S167A S1070 S2\" id=\"t16_61\">Photocure Canada Inc. </span><span class=\"S167B S1070 S2\" id=\"t17_61\">Canada </span><span class=\"S167C S1070 S2\" id=\"t18_61\">100 % </span><span class=\"S167D S1070 S2\" id=\"t19_61\">100 % </span><span class=\"S167E S1070 S2\" id=\"t1a_61\">- </span><span class=\"S167F S1070 S2\" id=\"t1b_61\">- </span><span class=\"S1680 S1071 S2\" id=\"t1c_61\">Total subsidiaries </span><span class=\"S1681 S1071 S2\" id=\"t1d_61\">17 170 </span><span class=\"S1682 S1071 S2\" id=\"t1e_61\">11 902 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6154": {
   "value": "<span class=\"S1448 S1071 S2\" id=\"t3_55\">Subsidiaries </span><span class=\"S1449 S1070 S2\" id=\"t4_55\">The transfer price method implemented is the pro\ufb01t &amp; loss split method (PSM) for the sales in US and a residual pro\ufb01t model (RPM) </span><span class=\"S144A S1070 S2\" id=\"t5_55\">for the sales in Germany and France. </span><span class=\"S144B S1070 S2\" id=\"t6_55\">Both the PSM and the RPM divides the combined pro\ufb01t or loss between the transacting related entities based on what would be </span><span class=\"S144C S1070 S2\" id=\"t7_55\">anticipated if the entities had been transacting at arm\u2019s length. </span><span class=\"S144D S1070 S2\" id=\"t8_55\">A contribution analysis for sale of Cysview in US and sale of Hexvix in Germany and France compares the split of pro\ufb01t or loss </span><span class=\"S144E S1070 S2\" id=\"t9_55\">between the subsidiaries and Photocure ASA based on the value of the functions performed by each of the related parties, taking </span><span class=\"S144F S1070 S2\" id=\"ta_55\">into account the assets used and the risks assumed by both parties. </span><span class=\"S1450 S1070 S2\" id=\"tb_55\">Photocure has established a wholly owned subsidiary in the US, Photocure Inc, in order to carry out the sales and the marketing-, </span><span class=\"S1451 S1070 S2\" id=\"tc_55\">selling- and distribution activities for the Cysview product. Photocure ASA has the ownership to the patent rights and the trade mark </span><span class=\"S1452 S1070 S2\" id=\"td_55\">and is responsible in the Group for development and manufacturing of the product. Photocure Inc purchases the completed product </span><span class=\"S1453 S1070 S2\" id=\"te_55\">from the parent company and distributes in the United States. Photocure Inc has established its own marketing organization that is </span><span class=\"S1454 S1070 S2\" id=\"tf_55\">funded by a loan from its parent company in addition to its own revenues. The transactions between Photocure ASA and Photocure </span><span class=\"S1455 S1070 S2\" id=\"tg_55\">Inc are on terms at arm\u2019s length, except for the loan that is interest free until further notice. </span><span class=\"S1456 S1070 S2\" id=\"th_55\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table. This is based on a cash \ufb02ow model taking into account a </span><span class=\"S1457 S1070 S2\" id=\"ti_55\">balanced view of the market share for Cysview in the US compared to sales of Hexvix in Europe. The US sales and marketing force </span><span class=\"S1458 S1070 S2\" id=\"tj_55\">has been kept during the Covid pandemic and enables Photocure Inc to access the US market again </span><span class=\"S1459 S1070 S2\" id=\"tk_55\">after the pandemic has ended. </span><span class=\"S145A S1070 S2\" id=\"tl_55\">Photocure has established wholly owned subsidiaries in Germany and France. </span><span class=\"S145B S1070 S2\" id=\"tm_55\">Photocure ASA carries out the sales and distribution </span><span class=\"S145C S1070 S2\" id=\"tn_55\">in Europe for the Hexvix product. The marketing- and promotion activities for the Hexvix product in Continental Europe are carried </span><span class=\"S145D S1070 S2\" id=\"to_55\">out by Photocure GmbH and Photocure SAS. The residual pro\ufb01t in Germany and France are allocated to the subsidiaries. Mark up is </span><span class=\"S145E S1070 S2\" id=\"tp_55\">assumed on fully loaded local costs for the services rendered to parent company. </span><span class=\"S145F S1070 S2\" id=\"tq_55\">Photocure established from January 2022 a sales subsidiary in Canada to carry out the sales, marketing and distribution of Cysview </span><span class=\"S1460 S1070 S2\" id=\"tr_55\">in Canada. </span><span class=\"S1461 S1071 S2\" id=\"ts_55\">Transactions and intercompany balances: </span><span class=\"S1462 S1071 S2\" id=\"tt_55\">2022 </span><span class=\"S1463 S1071 S2\" id=\"tu_55\">2021 </span><span class=\"S1464 S1070 S2\" id=\"tv_55\">Sales of products </span><span class=\"S1465 S1070 S2\" id=\"tw_55\">12 986 </span><span class=\"S1466 S1070 S2\" id=\"tx_55\">7 488 </span><span class=\"S1467 S1070 S2\" id=\"ty_55\">Sales of services </span><span class=\"S1468 S1070 S2\" id=\"tz_55\">899 </span><span class=\"S1469 S1070 S2\" id=\"t10_55\">999 </span><span class=\"S146A S1071 S2\" id=\"t11_55\">Intercompany sales </span><span class=\"S146B S1071 S2\" id=\"t12_55\">13 885 </span><span class=\"S146C S1071 S2\" id=\"t13_55\">8 487 </span><span class=\"S146D S1071 S2\" id=\"t14_55\">Purchase of marketing and promotion services </span><span class=\"S146E S1071 S2\" id=\"t15_55\">-54 719 </span><span class=\"S146F S1071 S2\" id=\"t16_55\">-48 060 </span><span class=\"S1470 S1071 S2\" id=\"t17_55\">31-Dec-22 </span><span class=\"S1471 S1071 S2\" id=\"t18_55\">31-Dec-21 </span><span class=\"S1472 S1070 S2\" id=\"t19_55\">Accounts receivables and other storm-term receivables </span><span class=\"S1473 S1070 S2\" id=\"t1a_55\">4 733 </span><span class=\"S1474 S1070 S2\" id=\"t1b_55\">0 </span><span class=\"S1475 S1070 S2\" id=\"t1c_55\">Long term loan given </span><span class=\"S1476 S1070 S2\" id=\"t1d_55\">350 072 </span><span class=\"S1477 S1070 S2\" id=\"t1e_55\">308 390 </span><span class=\"S1478 S1070 S2\" id=\"t1f_55\">Accounts payables and other short-term liabilities </span><span class=\"S1479 S1070 S2\" id=\"t1g_55\">-17 436 </span><span class=\"S147A S1070 S2\" id=\"t1h_55\">-7 203 </span><span class=\"S147B S1071 S2\" id=\"t1i_55\">Total subsidiaries </span><span class=\"S147C S1071 S2\" id=\"t1j_55\">337 369 </span><span class=\"S147D S1071 S2\" id=\"t1k_55\">301 187 </span><span class=\"S147E S1071 S2\" id=\"t1l_55\">Guarantees to bank in favor of subsidiary for requested security </span><span class=\"S147F S1071 S2\" id=\"t1m_55\">2 724 </span><span class=\"S1480 S1071 S2\" id=\"t1n_55\">2 220 </span><span class=\"S1481 S1070 S2\" id=\"t1o_55\">These are for licenses with the States of Maryland, Mississippi, Nevada and California to sell Cysview and for the o\ufb03ce lease deposit </span><span class=\"S165F S106F S2\" id=\"tf_61\">15. SUBSIDIARIES </span><span class=\"S1660 S1071 S2\" id=\"tg_61\">Company </span><span class=\"S1661 S1071 S2\" id=\"th_61\">Country </span><span class=\"S1662 S1071 S2\" id=\"ti_61\">Ownership </span><span class=\"S1663 S1071 S2\" id=\"tj_61\">Book value </span><span class=\"S1664 S1071 S2\" id=\"tk_61\">31-Dec-22 </span><span class=\"S1665 S1071 S2\" id=\"tl_61\">31-Dec-21 </span><span class=\"S1666 S1071 S2\" id=\"tm_61\">31-Dec-22 </span><span class=\"S1667 S1071 S2\" id=\"tn_61\">31-Dec-21 </span><span class=\"S1668 S1070 S2\" id=\"to_61\">Photocure Inc. </span><span class=\"S1669 S1070 S2\" id=\"tp_61\">USA </span><span class=\"S166A S1070 S2\" id=\"tq_61\">100 % </span><span class=\"S166B S1070 S2\" id=\"tr_61\">100 % </span><span class=\"S166C S1070 S2\" id=\"ts_61\">15 353 </span><span class=\"S166D S1070 S2\" id=\"tt_61\">11 018 </span><span class=\"S166E S1070 S2\" id=\"tu_61\">Photocure GmbH </span><span class=\"S166F S1070 S2\" id=\"tv_61\">Germany </span><span class=\"S1670 S1070 S2\" id=\"tw_61\">100 % </span><span class=\"S1671 S1070 S2\" id=\"tx_61\">100 % </span><span class=\"S1672 S1070 S2\" id=\"ty_61\">1 532 </span><span class=\"S1673 S1070 S2\" id=\"tz_61\">748 </span><span class=\"S1674 S1070 S2\" id=\"t10_61\">Photocure SAS </span><span class=\"S1675 S1070 S2\" id=\"t11_61\">France </span><span class=\"S1676 S1070 S2\" id=\"t12_61\">100 % </span><span class=\"S1677 S1070 S2\" id=\"t13_61\">100 % </span><span class=\"S1678 S1070 S2\" id=\"t14_61\">285 </span><span class=\"S1679 S1070 S2\" id=\"t15_61\">136 </span><span class=\"S167A S1070 S2\" id=\"t16_61\">Photocure Canada Inc. </span><span class=\"S167B S1070 S2\" id=\"t17_61\">Canada </span><span class=\"S167C S1070 S2\" id=\"t18_61\">100 % </span><span class=\"S167D S1070 S2\" id=\"t19_61\">100 % </span><span class=\"S167E S1070 S2\" id=\"t1a_61\">- </span><span class=\"S167F S1070 S2\" id=\"t1b_61\">- </span>Total subsid",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6222": {
   "value": "1. TAX <span class=\"S13FE S1070 S2\" id=\"t5_56\">(Amounts in NOK 1,000) </span><span class=\"S1483 S1071 S2\" id=\"t6_56\">Parent &amp; Group </span><span class=\"S1403 S1071 S2\" id=\"t7_56\">2022 </span><span class=\"S1404 S1071 S2\" id=\"t8_56\">2021 </span><span class=\"S1484 S1071 S2\" id=\"t9_56\">Income tax expense </span><span class=\"S1485 S1070 S2\" id=\"ta_56\">Tax payable </span><span class=\"S1486 S1070 S2\" id=\"tb_56\">2 840 </span><span class=\"S1487 S1070 S2\" id=\"tc_56\">2 365 </span><span class=\"S1488 S1070 S2\" id=\"td_56\">Changes in deferred tax </span><span class=\"S1489 S1070 S2\" id=\"te_56\">-2 117 </span><span class=\"S148A S1070 S2\" id=\"tf_56\">-3 124 </span><span class=\"S148B S1071 S2\" id=\"tg_56\">Total income tax expense </span><span class=\"S148C S1071 S2\" id=\"th_56\">723 </span><span class=\"S148D S1071 S2\" id=\"ti_56\">-759 </span><span class=\"S148E S1071 S2\" id=\"tj_56\">Tax base calculation parent </span><span class=\"S148F S1070 S2\" id=\"tk_56\">Pro\ufb01t(-loss) before income tax </span><span class=\"S1490 S1070 S2\" id=\"tl_56\">-61 021 </span><span class=\"S1491 S1070 S2\" id=\"tm_56\">-22 950 </span><span class=\"S1492 S1070 S2\" id=\"tn_56\">Permanent di\ufb00erences *) </span><span class=\"S1493 S1070 S2\" id=\"to_56\">49 534 </span><span class=\"S1494 S1070 S2\" id=\"tp_56\">8 346 </span><span class=\"S1495 S1070 S2\" id=\"tq_56\">Change in temporary di\ufb00erences </span><span class=\"S1496 S1070 S2\" id=\"tr_56\">-35 757 </span><span class=\"S1497 S1070 S2\" id=\"ts_56\">10 050 </span><span class=\"S1498 S1070 S2\" id=\"tt_56\">(Utilized)/Increased tax loss carried forward </span><span class=\"S1499 S1070 S2\" id=\"tu_56\">47 244 </span><span class=\"S149A S1070 S2\" id=\"tv_56\">4 554 </span><span class=\"S149B S1071 S2\" id=\"tw_56\">Tax base </span><span class=\"S149C S1071 S2\" id=\"tx_56\">-0 </span><span class=\"S149D S1071 S2\" id=\"ty_56\">0 </span><span class=\"S149E S1071 S2\" id=\"tz_56\">Temporary di\ufb00erences </span><span class=\"S149F S1070 S2\" id=\"t10_56\">Receivables </span><span class=\"S14A0 S1070 S2\" id=\"t11_56\">-551 </span><span class=\"S14A1 S1070 S2\" id=\"t12_56\">-551 </span><span class=\"S14A2 S1070 S2\" id=\"t13_56\">Inventories </span><span class=\"S14A3 S1070 S2\" id=\"t14_56\">4 003 </span><span class=\"S14A4 S1070 S2\" id=\"t15_56\">4 489 </span><span class=\"S14A5 S1070 S2\" id=\"t16_56\">Non current assets </span><span class=\"S14A6 S1070 S2\" id=\"t17_56\">32 041 </span><span class=\"S14A7 S1070 S2\" id=\"t18_56\">29 763 </span><span class=\"S14A8 S1070 S2\" id=\"t19_56\">Long term currency loans </span><span class=\"S14A9 S1070 S2\" id=\"t1a_56\">116 280 </span><span class=\"S14AA S1070 S2\" id=\"t1b_56\">77 622 </span><span class=\"S14AB S1070 S2\" id=\"t1c_56\">Earnout liability </span><span class=\"S14AC S1070 S2\" id=\"t1d_56\">-17 978 </span><span class=\"S14AD S1070 S2\" id=\"t1e_56\">-17 220 </span><span class=\"S14AE S1070 S2\" id=\"t1f_56\">Provisions </span><span class=\"S14AF S1070 S2\" id=\"t1g_56\">-1 024 </span><span class=\"S14B0 S1070 S2\" id=\"t1h_56\">-1 525 </span><span class=\"S14B1 S1070 S2\" id=\"t1i_56\">Pensions </span><span class=\"S14B2 S1070 S2\" id=\"t1j_56\">-2 523 </span><span class=\"S14B3 S1070 S2\" id=\"t1k_56\">-2 180 </span><span class=\"S14B4 S1070 S2\" id=\"t1l_56\">Gains and loss account </span><span class=\"S14B5 S1070 S2\" id=\"t1m_56\">16 109 </span><span class=\"S14B6 S1070 S2\" id=\"t1n_56\">20 136 </span><span class=\"S14B7 S1071 S2\" id=\"t1o_56\">Total </span><span class=\"S14B8 S1071 S2\" id=\"t1p_56\">146 356 </span><span class=\"S14B9 S1071 S2\" id=\"t1q_56\">110 533 </span><span class=\"S14BA S1070 S2\" id=\"t1r_56\">Tax loss carried forward </span><span class=\"S14BB S1070 S2\" id=\"t1s_56\">-396 901 </span><span class=\"S14BC S1070 S2\" id=\"t1t_56\">-351 456 </span><span class=\"S14BD S1071 S2\" id=\"t1u_56\">Net temporary di\ufb00erences </span><span class=\"S14BE S1071 S2\" id=\"t1v_56\">-250 545 </span><span class=\"S14BF S1071 S2\" id=\"t1w_56\">-240 923 </span><span class=\"S14C0 S1071 S2\" id=\"t1x_56\">Deferred tax liability (asset) </span><span class=\"S14C1 S1071 S2\" id=\"t1y_56\">-55 120 </span><span class=\"S14C2 S1071 S2\" id=\"t1z_56\">-53 003 </span><span class=\"S14C3 S1071 S2\" id=\"t20_56\">Parent &amp; Group </span><span class=\"S14C4 S1071 S2\" id=\"t21_56\">2022 </span><span class=\"S14C5 S1071 S2\" id=\"t22_56\">2021 </span><span class=\"S14C6 S1071 S2\" id=\"t23_56\">Reconciliation of e\ufb00ective tax rate </span><span class=\"S14C7 S1070 S2\" id=\"t24_56\">Expected income taxes at statutory tax rate </span><span class=\"S14C8 S1070 S2\" id=\"t25_56\">-13 425 </span><span class=\"S14C9 S1070 S2\" id=\"t26_56\">-5 049 </span><span class=\"S14CA S1070 S2\" id=\"t27_56\">Permanent di\ufb00erences </span><span class=\"S14CB S1070 S2\" id=\"t28_56\">10 897 </span><span class=\"S14CC S1070 S2\" id=\"t29_56\">1 836 </span><span class=\"S14CD S1070 S2\" id=\"t2a_56\">Change in temporary di\ufb00erences </span><span class=\"S14CE S1070 S2\" id=\"t2b_56\">-7 867 </span><span class=\"S14CF S1070 S2\" id=\"t2c_56\">Prior year adjustment </span><span class=\"S14D0 S1070 S2\" id=\"t2d_56\">111 </span><span class=\"S14D1 S1071 S2\" id=\"t2e_56\">Income tax expense </span><span class=\"S14D2 S1071 S2\" id=\"t2f_56\">-10 394 </span><span class=\"S14D3 S1071 S2\" id=\"t2g_56\">-3 102 </span><span class=\"S14D4 S1070 S2\" id=\"t2h_56\">E\ufb00ective tax rate in % </span><span class=\"S14D5 S204 S2\" id=\"t2i_56\">** </span><span class=\"S14D6 S1070 S2\" id=\"t2j_56\">) </span><span class=\"S14D7 S1070 S2\" id=\"t2k_56\">17.0 % </span><span class=\"S14D8 S1070 S2\" id=\"t2l_56\">13.5 % </span><span class=\"S14D9 S1070 S2\" id=\"t2m_56\">Temporary di\ufb00erences are recognized for the Parent company only and the note disclosure for the Group is of this reason identic to </span><span class=\"S14DA S1070 S2\" id=\"t2n_56\">the disclosure for the Parent company. </span><span class=\"S14DB S1070 S2\" id=\"t2o_56\">The tax payable is however due to the new subsidiaries in Europe that received a residual share of pro\ufb01t in Germany and France or a </span><span class=\"S14DC S1070 S2\" id=\"t2p_56\">minimum mark up of the costs incurred. </span><span class=\"S14DD S1294 S2\" id=\"t2q_56\">* </span><span class=\"S14DE S1295 S2\" id=\"t2r_56\">) </span><span class=\"S14DF S1295 S2\" id=\"t2s_56\">Permanent di\ufb00erences consist of non deductible costs, non taxable income and deduction for development cost through the SkatteFunn concept. </span><span class=\"S14E0 S1294 S2\" id=\"t2t_56\">** </span><span class=\"S14E1 S1295 S2\" id=\"t2u_56\">) Tax expense related to pro\ufb01t before tax. </span><span class=\"S14E3 S1070 S152D S2\" id=\"t2_57\">The parent company has a taxable loss in 2022 of NOK 47.2 million compared to a loss in 2021 of NOK 4.6 million. </span><span class=\"S14E4 S1070 S152D S2\" id=\"t3_57\">The deferred tax asset </span><span class=\"S14E5 S1070 S152D S2\" id=\"t4_57\">is of this reason and movements in other temporary di\ufb00erences increased to NOK 55.1 million compared to NOK 53.0 million as of 31 </span><span class=\"S14E6 S1070 S152D S2\" id=\"t5_57\">December 2021. </span><span class=\"S14E7 S1070 S152D S2\" id=\"t6_57\">Photocure apply a pro\ufb01t/loss split method for the business in US and a share of the US related revenue and expenses </span><span class=\"S14E8 S1070 S152D S2\" id=\"t7_57\">are included in the parent company. For the operations in Europe Photocure apply a residual pro\ufb01t share for Germany and France </span><span class=\"S14E9 S1070 S152D S2\" id=\"t8_57\">through our subsidiaries. The basis for recognition of a tax asset in Norway are the predicted future pro\ufb01t according to the business </span><span class=\"S14EA S1070 S152D S2\" id=\"t9_57\">plan for all major markets and that temporary di\ufb00erences for the coming years will be reversed. The remaining deferred tax asset is of </span><span class=\"S14EB S1070 S152D S2\" id=\"ta_57\">this reason maintained as of 31 December 2022. </span><span class=\"S14EC S1070 S152D S2\" id=\"tb_57\">European business contributes to Photocure pro\ufb01tability in 2022 and will continue to contribute going forward. The parent company is </span><span class=\"S14ED S1070 S152D S2\" id=\"tc_57\">the selling entity of the Hexvix product in all the European countries. The marketing and promotion activities in Germany and France are </span><span class=\"S14EE S1070 S152D S2\" id=\"td_57\">performed through the subsidiaries in those countries. </span><span class=\"S14EF S1070 S152D S2\" id=\"te_57\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table and this will contribute to the pre-tax result in the parent </span><span class=\"S14F0 S1070 S152D S2\" id=\"tf_57\">company through the pro\ufb01t/loss split method. This is based on a cash \ufb02ow model taking into account a balanced view of the market </span><span class=\"S14F1 S1070 S152D S2\" id=\"tg_57\">share for Cysview in the US compared to sales of Hexvix in Europe. The expanded US sales and marketing force has enabled Photocure </span><span class=\"S14F2 S1070 S152D S2\" id=\"th_57\">Inc to cover larger parts of the US market in order to gain further market shares. The installed base of blue light cystoscopes in US at </span><span class=\"S14F3 S1070 S152D S2\" id=\"ti_57\">the end of 2022 has increased 19% compared to last year end. </span><span class=\"S14F4 S1070 S152D S2\" id=\"tj_57\">Photocure continues to see growth opportunities in the European countries and particulary in several large untapped markets. With </span><span class=\"S14F5 S1070 S152D S2\" id=\"tk_57\">Photocure\u2019s own dedicated sales force in place in Europe, we believe this will further strengthen the sales. </span><span class=\"S14F6 S1070 S152D S2\" id=\"tl_57\">Several studies have been published highlighting and verifying key clinical bene\ufb01ts including the positive impact of Hexvix/Cysview on </span><span class=\"S14F7 S1070 S152D S2\" id=\"tm_57\">reduced disease progression, bladder cancer detection and the safety of repeated use of Hexvix/Cysview. The basis for the recognition </span><span class=\"S14F8 S1070 S152D S2\" id=\"tn_57\">of the tax asset is the assessment that there are convincing evidence that the deferred tax bene\ufb01t will be utilized. </span><span class=\"S14F9 S1070 S152D S2\" id=\"to_57\">There is no expiry on losses to be carried forward in Norway while it expires after 20 years in US according to tax legislation valid to end </span><span class=\"S14FA S1070 S152D S2\" id=\"tp_57\">of 2017. The new US tax legislation valid for taxable years from 2018 </span><span class=\"S14FB S1070 S152D S2\" id=\"tq_57\">have no expiry of loss carried forward but a 80% limit in utilization. </span><span class=\"S14FC S1070 S152D S2\" id=\"tr_57\">Deferred tax assets have not been recognised in respect of the following items in the US subsidiary due to no history of pre-tax pro\ufb01t at </span><span class=\"S14FD S1070 S152D S2\" id=\"ts_57\">this point in time : </span><span class=\"S14FE S1070 S2\" id=\"tt_57\">(Amounts in NOK 1,000) </span><span class=\"S14FF S1071 S2\" id=\"tu_57\">2022 </span><span class=\"S1500 S1071 S2\" id=\"tv_57\">2021 </span><span class=\"S1501 S1071 S2\" id=\"tw_57\">Unrecognised deferred tax assets </span><span class=\"S1502 S1071 S2\" id=\"tx_57\">Amount </span><span class=\"S1503 S1071 S2\" id=\"ty_57\">Tax e\ufb00ect </span><span class=\"S1504 S1071 S2\" id=\"tz_57\">Amount </span><span class=\"S1505 S1071 S2\" id=\"t10_57\">Tax e\ufb00ect </span><span class=\"S1506 S1070 S2\" id=\"t11_57\">Net deductible temporary di\ufb00erences </span><span class=\"S1507 S1070 S2\" id=\"t12_57\">-6 996 </span><span class=\"S1508 S1070 S2\" id=\"t13_57\">-1 969 </span><span class=\"S1509 S1070 S2\" id=\"t14_57\">-6 215 </span><span class=\"S150A S1070 S2\" id=\"t15_57\">-1 747 </span><span class=\"S150B S1070 S2\" id=\"t16_57\">Tax losses </span><span class=\"S150C S1070 S2\" id=\"t17_57\">183 930 </span><span class=\"S150D S1070 S2\" id=\"t18_57\">51 700 </span><span class=\"S150E S1070 S2\" id=\"t19_57\">158 734 </span><span class=\"S150F S1070 S2\" id=\"t1a_57\">44 620 </span><span class=\"S1510 S1071 S2\" id=\"t1b_57\">Net unrecognised deferred tax asset US </span><span class=\"S1511 S1071 S2\" id=\"t1c_57\">176 933 </span><span class=\"S1512 S1071 S2\" id=\"t1d_57\">49 731 </span><span class=\"S1513 S1071 S2\" id=\"t1e_57\">152 519 </span><span class=\"S1514 S1071 S2\" id=\"t1f_57\">42 873 </span><span class=\"S1515 S1070 S2\" id=\"t1g_57\">Tax losses for which no deferred tax asset was recognized, expire as follows: </span><span class=\"S1516 S1070 S2\" id=\"t1h_57\">(Amounts in NOK 1,000) </span><span class=\"S1517 S1071 S2\" id=\"t1i_57\">2022 </span><span class=\"S1518 S1071 S2\" id=\"t1j_57\">2021 </span><span class=\"S1519 S1071 S2\" id=\"t1k_57\">Amount </span><span class=\"S151A S1071 S2\" id=\"t1l_57\">Expiry date </span><span class=\"S151B S1071 S2\" id=\"t1m_57\">Amount </span><span class=\"S151C S1071 S2\" id=\"t1n_57\">Expiry date </span><span class=\"S151D S1070 S2\" id=\"t1o_57\">Expire Federal </span><span class=\"S151E S1070 S2\" id=\"t1p_57\">23 092 </span><span class=\"S151F S1070 S2\" id=\"t1q_57\">2030 - 2037 </span><span class=\"S1520 S1070 S2\" id=\"t1r_57\">20 599 </span><span class=\"S1521 S1070 S2\" id=\"t1s_57\">2030 - 2037 </span><span class=\"S1522 S1070 S2\" id=\"t1t_57\">Expire State </span><span class=\"S1523 S1070 S2\" id=\"t1u_57\">15 923 </span><span class=\"S1524 S1070 S2\" id=\"t1v_57\">2030 - 20412 </span><span class=\"S1525 S1070 S2\" id=\"t1w_57\">13 727 </span><span class=\"S1526 S1070 S2\" id=\"t1x_57\">2030 - 2041 </span><span class=\"S1527 S1070 S2\" id=\"t1y_57\">Never expire </span><span class=\"S1528 S1070 S2\" id=\"t1z_57\">10 718 </span><span class=\"S1529 S1070 S2\" id=\"t20_57\">8 547 </span><span class=\"S152A S1071 S2\" id=\"t21_57\">Total </span><span class=\"S152B S1071 S2\" id=\"t22_57\">49 733 </span><span class=\"S152C S1071 S2\" id=\"t23_57\">42 873 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6223": {
   "value": "1. TAX <span class=\"S13FE S1070 S2\" id=\"t5_56\">(Amounts in NOK 1,000) </span><span class=\"S1483 S1071 S2\" id=\"t6_56\">Parent &amp; Group </span><span class=\"S1403 S1071 S2\" id=\"t7_56\">2022 </span><span class=\"S1404 S1071 S2\" id=\"t8_56\">2021 </span><span class=\"S1484 S1071 S2\" id=\"t9_56\">Income tax expense </span><span class=\"S1485 S1070 S2\" id=\"ta_56\">Tax payable </span><span class=\"S1486 S1070 S2\" id=\"tb_56\">2 840 </span><span class=\"S1487 S1070 S2\" id=\"tc_56\">2 365 </span><span class=\"S1488 S1070 S2\" id=\"td_56\">Changes in deferred tax </span><span class=\"S1489 S1070 S2\" id=\"te_56\">-2 117 </span><span class=\"S148A S1070 S2\" id=\"tf_56\">-3 124 </span><span class=\"S148B S1071 S2\" id=\"tg_56\">Total income tax expense </span><span class=\"S148C S1071 S2\" id=\"th_56\">723 </span><span class=\"S148D S1071 S2\" id=\"ti_56\">-759 </span><span class=\"S148E S1071 S2\" id=\"tj_56\">Tax base calculation parent </span><span class=\"S148F S1070 S2\" id=\"tk_56\">Pro\ufb01t(-loss) before income tax </span><span class=\"S1490 S1070 S2\" id=\"tl_56\">-61 021 </span><span class=\"S1491 S1070 S2\" id=\"tm_56\">-22 950 </span><span class=\"S1492 S1070 S2\" id=\"tn_56\">Permanent di\ufb00erences *) </span><span class=\"S1493 S1070 S2\" id=\"to_56\">49 534 </span><span class=\"S1494 S1070 S2\" id=\"tp_56\">8 346 </span><span class=\"S1495 S1070 S2\" id=\"tq_56\">Change in temporary di\ufb00erences </span><span class=\"S1496 S1070 S2\" id=\"tr_56\">-35 757 </span><span class=\"S1497 S1070 S2\" id=\"ts_56\">10 050 </span><span class=\"S1498 S1070 S2\" id=\"tt_56\">(Utilized)/Increased tax loss carried forward </span><span class=\"S1499 S1070 S2\" id=\"tu_56\">47 244 </span><span class=\"S149A S1070 S2\" id=\"tv_56\">4 554 </span><span class=\"S149B S1071 S2\" id=\"tw_56\">Tax base </span><span class=\"S149C S1071 S2\" id=\"tx_56\">-0 </span><span class=\"S149D S1071 S2\" id=\"ty_56\">0 </span><span class=\"S149E S1071 S2\" id=\"tz_56\">Temporary di\ufb00erences </span><span class=\"S149F S1070 S2\" id=\"t10_56\">Receivables </span><span class=\"S14A0 S1070 S2\" id=\"t11_56\">-551 </span><span class=\"S14A1 S1070 S2\" id=\"t12_56\">-551 </span><span class=\"S14A2 S1070 S2\" id=\"t13_56\">Inventories </span><span class=\"S14A3 S1070 S2\" id=\"t14_56\">4 003 </span><span class=\"S14A4 S1070 S2\" id=\"t15_56\">4 489 </span><span class=\"S14A5 S1070 S2\" id=\"t16_56\">Non current assets </span><span class=\"S14A6 S1070 S2\" id=\"t17_56\">32 041 </span><span class=\"S14A7 S1070 S2\" id=\"t18_56\">29 763 </span><span class=\"S14A8 S1070 S2\" id=\"t19_56\">Long term currency loans </span><span class=\"S14A9 S1070 S2\" id=\"t1a_56\">116 280 </span><span class=\"S14AA S1070 S2\" id=\"t1b_56\">77 622 </span><span class=\"S14AB S1070 S2\" id=\"t1c_56\">Earnout liability </span><span class=\"S14AC S1070 S2\" id=\"t1d_56\">-17 978 </span><span class=\"S14AD S1070 S2\" id=\"t1e_56\">-17 220 </span><span class=\"S14AE S1070 S2\" id=\"t1f_56\">Provisions </span><span class=\"S14AF S1070 S2\" id=\"t1g_56\">-1 024 </span><span class=\"S14B0 S1070 S2\" id=\"t1h_56\">-1 525 </span><span class=\"S14B1 S1070 S2\" id=\"t1i_56\">Pensions </span><span class=\"S14B2 S1070 S2\" id=\"t1j_56\">-2 523 </span><span class=\"S14B3 S1070 S2\" id=\"t1k_56\">-2 180 </span><span class=\"S14B4 S1070 S2\" id=\"t1l_56\">Gains and loss account </span><span class=\"S14B5 S1070 S2\" id=\"t1m_56\">16 109 </span><span class=\"S14B6 S1070 S2\" id=\"t1n_56\">20 136 </span><span class=\"S14B7 S1071 S2\" id=\"t1o_56\">Total </span><span class=\"S14B8 S1071 S2\" id=\"t1p_56\">146 356 </span><span class=\"S14B9 S1071 S2\" id=\"t1q_56\">110 533 </span><span class=\"S14BA S1070 S2\" id=\"t1r_56\">Tax loss carried forward </span><span class=\"S14BB S1070 S2\" id=\"t1s_56\">-396 901 </span><span class=\"S14BC S1070 S2\" id=\"t1t_56\">-351 456 </span><span class=\"S14BD S1071 S2\" id=\"t1u_56\">Net temporary di\ufb00erences </span><span class=\"S14BE S1071 S2\" id=\"t1v_56\">-250 545 </span><span class=\"S14BF S1071 S2\" id=\"t1w_56\">-240 923 </span><span class=\"S14C0 S1071 S2\" id=\"t1x_56\">Deferred tax liability (asset) </span><span class=\"S14C1 S1071 S2\" id=\"t1y_56\">-55 120 </span><span class=\"S14C2 S1071 S2\" id=\"t1z_56\">-53 003 </span><span class=\"S14C3 S1071 S2\" id=\"t20_56\">Parent &amp; Group </span><span class=\"S14C4 S1071 S2\" id=\"t21_56\">2022 </span><span class=\"S14C5 S1071 S2\" id=\"t22_56\">2021 </span><span class=\"S14C6 S1071 S2\" id=\"t23_56\">Reconciliation of e\ufb00ective tax rate </span><span class=\"S14C7 S1070 S2\" id=\"t24_56\">Expected income taxes at statutory tax rate </span><span class=\"S14C8 S1070 S2\" id=\"t25_56\">-13 425 </span><span class=\"S14C9 S1070 S2\" id=\"t26_56\">-5 049 </span><span class=\"S14CA S1070 S2\" id=\"t27_56\">Permanent di\ufb00erences </span><span class=\"S14CB S1070 S2\" id=\"t28_56\">10 897 </span><span class=\"S14CC S1070 S2\" id=\"t29_56\">1 836 </span><span class=\"S14CD S1070 S2\" id=\"t2a_56\">Change in temporary di\ufb00erences </span><span class=\"S14CE S1070 S2\" id=\"t2b_56\">-7 867 </span><span class=\"S14CF S1070 S2\" id=\"t2c_56\">Prior year adjustment </span><span class=\"S14D0 S1070 S2\" id=\"t2d_56\">111 </span><span class=\"S14D1 S1071 S2\" id=\"t2e_56\">Income tax expense </span><span class=\"S14D2 S1071 S2\" id=\"t2f_56\">-10 394 </span><span class=\"S14D3 S1071 S2\" id=\"t2g_56\">-3 102 </span><span class=\"S14D4 S1070 S2\" id=\"t2h_56\">E\ufb00ective tax rate in % </span><span class=\"S14D5 S204 S2\" id=\"t2i_56\">** </span><span class=\"S14D6 S1070 S2\" id=\"t2j_56\">) </span><span class=\"S14D7 S1070 S2\" id=\"t2k_56\">17.0 % </span><span class=\"S14D8 S1070 S2\" id=\"t2l_56\">13.5 % </span><span class=\"S14D9 S1070 S2\" id=\"t2m_56\">Temporary di\ufb00erences are recognized for the Parent company only and the note disclosure for the Group is of this reason identic to </span><span class=\"S14DA S1070 S2\" id=\"t2n_56\">the disclosure for the Parent company. </span><span class=\"S14DB S1070 S2\" id=\"t2o_56\">The tax payable is however due to the new subsidiaries in Europe that received a residual share of pro\ufb01t in Germany and France or a </span><span class=\"S14DC S1070 S2\" id=\"t2p_56\">minimum mark up of the costs incurred. </span><span class=\"S14DD S1294 S2\" id=\"t2q_56\">* </span><span class=\"S14DE S1295 S2\" id=\"t2r_56\">) </span><span class=\"S14DF S1295 S2\" id=\"t2s_56\">Permanent di\ufb00erences consist of non deductible costs, non taxable income and deduction for development cost through the SkatteFunn concept. </span><span class=\"S14E0 S1294 S2\" id=\"t2t_56\">** </span><span class=\"S14E1 S1295 S2\" id=\"t2u_56\">) Tax expense related to pro\ufb01t before tax. </span><span class=\"S14E3 S1070 S152D S2\" id=\"t2_57\">The parent company has a taxable loss in 2022 of NOK 47.2 million compared to a loss in 2021 of NOK 4.6 million. </span><span class=\"S14E4 S1070 S152D S2\" id=\"t3_57\">The deferred tax asset </span><span class=\"S14E5 S1070 S152D S2\" id=\"t4_57\">is of this reason and movements in other temporary di\ufb00erences increased to NOK 55.1 million compared to NOK 53.0 million as of 31 </span><span class=\"S14E6 S1070 S152D S2\" id=\"t5_57\">December 2021. </span><span class=\"S14E7 S1070 S152D S2\" id=\"t6_57\">Photocure apply a pro\ufb01t/loss split method for the business in US and a share of the US related revenue and expenses </span><span class=\"S14E8 S1070 S152D S2\" id=\"t7_57\">are included in the parent company. For the operations in Europe Photocure apply a residual pro\ufb01t share for Germany and France </span><span class=\"S14E9 S1070 S152D S2\" id=\"t8_57\">through our subsidiaries. The basis for recognition of a tax asset in Norway are the predicted future pro\ufb01t according to the business </span><span class=\"S14EA S1070 S152D S2\" id=\"t9_57\">plan for all major markets and that temporary di\ufb00erences for the coming years will be reversed. The remaining deferred tax asset is of </span><span class=\"S14EB S1070 S152D S2\" id=\"ta_57\">this reason maintained as of 31 December 2022. </span><span class=\"S14EC S1070 S152D S2\" id=\"tb_57\">European business contributes to Photocure pro\ufb01tability in 2022 and will continue to contribute going forward. The parent company is </span><span class=\"S14ED S1070 S152D S2\" id=\"tc_57\">the selling entity of the Hexvix product in all the European countries. The marketing and promotion activities in Germany and France are </span><span class=\"S14EE S1070 S152D S2\" id=\"td_57\">performed through the subsidiaries in those countries. </span><span class=\"S14EF S1070 S152D S2\" id=\"te_57\">It is Photocure\u2019s judgment that the operation in the US will be pro\ufb01table and this will contribute to the pre-tax result in the parent </span><span class=\"S14F0 S1070 S152D S2\" id=\"tf_57\">company through the pro\ufb01t/loss split method. This is based on a cash \ufb02ow model taking into account a balanced view of the market </span><span class=\"S14F1 S1070 S152D S2\" id=\"tg_57\">share for Cysview in the US compared to sales of Hexvix in Europe. The expanded US sales and marketing force has enabled Photocure </span><span class=\"S14F2 S1070 S152D S2\" id=\"th_57\">Inc to cover larger parts of the US market in order to gain further market shares. The installed base of blue light cystoscopes in US at </span><span class=\"S14F3 S1070 S152D S2\" id=\"ti_57\">the end of 2022 has increased 19% compared to last year end. </span><span class=\"S14F4 S1070 S152D S2\" id=\"tj_57\">Photocure continues to see growth opportunities in the European countries and particulary in several large untapped markets. With </span><span class=\"S14F5 S1070 S152D S2\" id=\"tk_57\">Photocure\u2019s own dedicated sales force in place in Europe, we believe this will further strengthen the sales. </span><span class=\"S14F6 S1070 S152D S2\" id=\"tl_57\">Several studies have been published highlighting and verifying key clinical bene\ufb01ts including the positive impact of Hexvix/Cysview on </span><span class=\"S14F7 S1070 S152D S2\" id=\"tm_57\">reduced disease progression, bladder cancer detection and the safety of repeated use of Hexvix/Cysview. The basis for the recognition </span><span class=\"S14F8 S1070 S152D S2\" id=\"tn_57\">of the tax asset is the assessment that there are convincing evidence that the deferred tax bene\ufb01t will be utilized. </span><span class=\"S14F9 S1070 S152D S2\" id=\"to_57\">There is no expiry on losses to be carried forward in Norway while it expires after 20 years in US according to tax legislation valid to end </span><span class=\"S14FA S1070 S152D S2\" id=\"tp_57\">of 2017. The new US tax legislation valid for taxable years from 2018 </span><span class=\"S14FB S1070 S152D S2\" id=\"tq_57\">have no expiry of loss carried forward but a 80% limit in utilization. </span><span class=\"S14FC S1070 S152D S2\" id=\"tr_57\">Deferred tax assets have not been recognised in respect of the following items in the US subsidiary due to no history of pre-tax pro\ufb01t at </span><span class=\"S14FD S1070 S152D S2\" id=\"ts_57\">this point in time : </span><span class=\"S14FE S1070 S2\" id=\"tt_57\">(Amounts in NOK 1,000) </span><span class=\"S14FF S1071 S2\" id=\"tu_57\">2022 </span><span class=\"S1500 S1071 S2\" id=\"tv_57\">2021 </span><span class=\"S1501 S1071 S2\" id=\"tw_57\">Unrecognised deferred tax assets </span><span class=\"S1502 S1071 S2\" id=\"tx_57\">Amount </span><span class=\"S1503 S1071 S2\" id=\"ty_57\">Tax e\ufb00ect </span><span class=\"S1504 S1071 S2\" id=\"tz_57\">Amount </span><span class=\"S1505 S1071 S2\" id=\"t10_57\">Tax e\ufb00ect </span><span class=\"S1506 S1070 S2\" id=\"t11_57\">Net deductible temporary di\ufb00erences </span><span class=\"S1507 S1070 S2\" id=\"t12_57\">-6 996 </span><span class=\"S1508 S1070 S2\" id=\"t13_57\">-1 969 </span><span class=\"S1509 S1070 S2\" id=\"t14_57\">-6 215 </span><span class=\"S150A S1070 S2\" id=\"t15_57\">-1 747 </span><span class=\"S150B S1070 S2\" id=\"t16_57\">Tax losses </span><span class=\"S150C S1070 S2\" id=\"t17_57\">183 930 </span><span class=\"S150D S1070 S2\" id=\"t18_57\">51 700 </span><span class=\"S150E S1070 S2\" id=\"t19_57\">158 734 </span><span class=\"S150F S1070 S2\" id=\"t1a_57\">44 620 </span><span class=\"S1510 S1071 S2\" id=\"t1b_57\">Net unrecognised deferred tax asset US </span><span class=\"S1511 S1071 S2\" id=\"t1c_57\">176 933 </span><span class=\"S1512 S1071 S2\" id=\"t1d_57\">49 731 </span><span class=\"S1513 S1071 S2\" id=\"t1e_57\">152 519 </span><span class=\"S1514 S1071 S2\" id=\"t1f_57\">42 873 </span><span class=\"S1515 S1070 S2\" id=\"t1g_57\">Tax losses for which no deferred tax asset was recognized, expire as follows: </span><span class=\"S1516 S1070 S2\" id=\"t1h_57\">(Amounts in NOK 1,000) </span><span class=\"S1517 S1071 S2\" id=\"t1i_57\">2022 </span><span class=\"S1518 S1071 S2\" id=\"t1j_57\">2021 </span><span class=\"S1519 S1071 S2\" id=\"t1k_57\">Amount </span><span class=\"S151A S1071 S2\" id=\"t1l_57\">Expiry date </span><span class=\"S151B S1071 S2\" id=\"t1m_57\">Amount </span><span class=\"S151C S1071 S2\" id=\"t1n_57\">Expiry date </span><span class=\"S151D S1070 S2\" id=\"t1o_57\">Expire Federal </span><span class=\"S151E S1070 S2\" id=\"t1p_57\">23 092 </span><span class=\"S151F S1070 S2\" id=\"t1q_57\">2030 - 2037 </span><span class=\"S1520 S1070 S2\" id=\"t1r_57\">20 599 </span><span class=\"S1521 S1070 S2\" id=\"t1s_57\">2030 - 2037 </span><span class=\"S1522 S1070 S2\" id=\"t1t_57\">Expire State </span><span class=\"S1523 S1070 S2\" id=\"t1u_57\">15 923 </span><span class=\"S1524 S1070 S2\" id=\"t1v_57\">2030 - 20412 </span><span class=\"S1525 S1070 S2\" id=\"t1w_57\">13 727 </span><span class=\"S1526 S1070 S2\" id=\"t1x_57\">2030 - 2041 </span><span class=\"S1527 S1070 S2\" id=\"t1y_57\">Never expire </span><span class=\"S1528 S1070 S2\" id=\"t1z_57\">10 718 </span><span class=\"S1529 S1070 S2\" id=\"t20_57\">8 547 </span><span class=\"S152A S1071 S2\" id=\"t21_57\">Total </span><span class=\"S152B S1071 S2\" id=\"t22_57\">49 733 </span><span class=\"S152C S1071 S2\" id=\"t23_57\">42 873 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6417": {
   "value": "<span class=\"S152E S106F S2\" id=\"t4_58\">12. EARNINGS PER SHARE </span><span class=\"S152F S1070 S2\" id=\"t5_58\">Earnings per share are calculated on the basis of the pro\ufb01t/loss for the year after tax but excluding other comprehensive items. The </span><span class=\"S1530 S1070 S2\" id=\"t6_58\">result is divided by a weighted average number of outstanding shares over the year, reduced by acquisition of treasury shares. The </span><span class=\"S1531 S1070 S2\" id=\"t7_58\">diluted earnings per share is calculated by adjusting the average number of outstanding shares by the number of employee share </span><span class=\"S1532 S1070 S2\" id=\"t8_58\">options that can be exercised. Antidilution e\ufb00ects are not taken into consideration. </span><span class=\"S1533 S1071 S2\" id=\"t9_58\">2022 </span><span class=\"S1534 S1071 S2\" id=\"ta_58\">2021 </span><span class=\"S1535 S1071 S2\" id=\"tb_58\">Figures indicate the number of shares </span><span class=\"S1536 S1070 S2\" id=\"tc_58\">Ordinary shares 1 January </span><span class=\"S1537 S1070 S2\" id=\"td_58\">26 973 820 </span><span class=\"S1538 S1070 S2\" id=\"te_58\">26 717 536 </span><span class=\"S1539 S1070 S2\" id=\"tf_58\">E\ufb00ect of treasury shares </span><span class=\"S153A S1070 S2\" id=\"tg_58\">-20 861 </span><span class=\"S153B S1070 S2\" id=\"th_58\">-16 919 </span><span class=\"S153C S1070 S2\" id=\"ti_58\">E\ufb00ect of share options exercised </span><span class=\"S153D S1070 S2\" id=\"tj_58\">82 017 </span><span class=\"S153E S1070 S2\" id=\"tk_58\">142 718 </span><span class=\"S153F S1071 S2\" id=\"tl_58\">Weighted average number of shares, 31 December </span><span class=\"S1540 S1071 S2\" id=\"tm_58\">27 034 976 </span><span class=\"S1541 S1071 S2\" id=\"tn_58\">26 843 335 </span><span class=\"S1542 S1070 S2\" id=\"to_58\">E\ufb00ect of outstanding share options </span><span class=\"S1543 S1070 S2\" id=\"tp_58\">113 759 </span><span class=\"S1544 S1070 S2\" id=\"tq_58\">264 553 </span><span class=\"S1545 S1071 S2\" id=\"tr_58\">Weighted average number of diluted shares, 31 December </span><span class=\"S1546 S1071 S2\" id=\"ts_58\">27 148 735 </span><span class=\"S1547 S1071 S2\" id=\"tt_58\">27 107 888 </span><span class=\"S1548 S1071 S2\" id=\"tu_58\">Net pro\ufb01t/loss(-) </span><span class=\"S1549 S1071 S2\" id=\"tv_58\">-71 857 </span><span class=\"S154A S1071 S2\" id=\"tw_58\">-30 897 </span><span class=\"S154B S1070 S2\" id=\"tx_58\">(Amounts in NOK 1 000) </span><span class=\"S154C S1071 S2\" id=\"ty_58\">Earnings per share </span><span class=\"S154D S1071 S2\" id=\"tz_58\">2022 </span><span class=\"S154E S1071 S2\" id=\"t10_58\">2021 </span><span class=\"S154F S1070 S2\" id=\"t11_58\">Earnings per share in NOK basic </span><span class=\"S1550 S1070 S2\" id=\"t12_58\">-2.66 </span><span class=\"S1551 S1070 S2\" id=\"t13_58\">-1.15 </span><span class=\"S1552 S1070 S2\" id=\"t14_58\">Earnings per share in NOK diluted </span><span class=\"S1553 S1070 S2\" id=\"t15_58\">-2.66 </span><span class=\"S1554 S1070 S2\" id=\"t16_58\">-1.15 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6465": {
   "value": "<span class=\"S1556 S106F S2\" id=\"t2_59\">13. GOODWILL AND CUSTOMER RELATIONS </span><span class=\"S1557 S1070 S2\" id=\"t3_59\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S1558 S1070 S2\" id=\"t4_59\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S1559 S1070 S2\" id=\"t5_59\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S155A S1070 S2\" id=\"t6_59\">sales (years 8-10) in the previous Ipsen major markets. </span><span class=\"S155B S1070 S2\" id=\"t7_59\">One intangible asset has been identi\ufb01ed, Customer relationships. The customer relationships relate to existing customers in Europe </span><span class=\"S155C S1070 S2\" id=\"t8_59\">which have previously been served by Ipsen. Customer relationships has been valued using a multiperiod excess earnings method </span><span class=\"S155D S1070 S2\" id=\"t9_59\">and the value at transaction date was NOK 166.7 million. Photocure has evaluated this asset to have an estimated value for 10 years </span><span class=\"S155E S1070 S2\" id=\"ta_59\">from transaction date and the intangible assets is depreciated on a straight-line basis over this period. The net book value </span><span class=\"S155F S1070 S2\" id=\"tb_59\">of the </span><span class=\"S1560 S1070 S2\" id=\"tc_59\">customer relations as of 31 December 2022 is NOK 129.2 million. </span><span class=\"S1561 S1070 S2\" id=\"td_59\">Goodwill amounts to NOK 144 million and this asset is not depreciated, but is tested against impairment as of end December 2022. </span><span class=\"S1562 S1070 S2\" id=\"te_59\">The impairment analysis carried out con\ufb01rms the goodwill value given the performance in 2022 and future growth opportunities that </span><span class=\"S1563 S1070 S2\" id=\"tf_59\">are expected to in line with forecasts prepared in connection with the transaction. </span><span class=\"S1564 S1071 S2\" id=\"tg_59\">Group and parent </span><span class=\"S1565 S1070 S2\" id=\"th_59\">(Amounts in NOK 1,000) </span><span class=\"S1566 S1071 S2\" id=\"ti_59\">Customer relations </span><span class=\"S1567 S1071 S2\" id=\"tj_59\">Goodwill </span><span class=\"S1568 S1070 S2\" id=\"tk_59\">Accumulated cost at 31 December 2020 </span><span class=\"S1569 S1070 S2\" id=\"tl_59\">166 720 </span><span class=\"S156A S1070 S2\" id=\"tm_59\">144 000 </span><span class=\"S156B S1070 S2\" id=\"tn_59\">Additions </span><span class=\"S156C S1070 S2\" id=\"to_59\">0 </span><span class=\"S156D S1070 S2\" id=\"tp_59\">0 </span><span class=\"S156E S1071 S2\" id=\"tq_59\">Accumulated cost at 31 December 2021 </span><span class=\"S156F S1071 S2\" id=\"tr_59\">166 720 </span><span class=\"S1570 S1071 S2\" id=\"ts_59\">144 000 </span><span class=\"S1571 S1070 S2\" id=\"tt_59\">Additions </span><span class=\"S1572 S1070 S2\" id=\"tu_59\">0 </span><span class=\"S1573 S1070 S2\" id=\"tv_59\">0 </span><span class=\"S1574 S1071 S2\" id=\"tw_59\">Accumulated cost at 31 December 2022 </span><span class=\"S1575 S1071 S2\" id=\"tx_59\">166 720 </span><span class=\"S1576 S1071 S2\" id=\"ty_59\">144 000 </span><span class=\"S1577 S1071 S2\" id=\"tz_59\">Accumulated depreciation at 31 December 2020 </span><span class=\"S1578 S1070 S2\" id=\"t10_59\">4 168 </span><span class=\"S1579 S1070 S2\" id=\"t11_59\">0 </span><span class=\"S157A S1070 S2\" id=\"t12_59\">Amortization and impairment </span><span class=\"S157B S1070 S2\" id=\"t13_59\">16 672 </span><span class=\"S157C S1070 S2\" id=\"t14_59\">0 </span><span class=\"S157D S1071 S2\" id=\"t15_59\">Accumulated depreciation at 31 December 2021 </span><span class=\"S157E S1071 S2\" id=\"t16_59\">20 840 </span><span class=\"S157F S1071 S2\" id=\"t17_59\">0 </span><span class=\"S1580 S1070 S2\" id=\"t18_59\">Amortization and impairment </span><span class=\"S1581 S1070 S2\" id=\"t19_59\">16 672 </span><span class=\"S1582 S1070 S2\" id=\"t1a_59\">0 </span><span class=\"S1583 S1071 S2\" id=\"t1b_59\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1584 S1071 S2\" id=\"t1c_59\">37 512 </span><span class=\"S1585 S1071 S2\" id=\"t1d_59\">0 </span><span class=\"S1586 S1071 S2\" id=\"t1e_59\">Book value at 31 December 2021 </span><span class=\"S1587 S1071 S2\" id=\"t1f_59\">145 880 </span><span class=\"S1588 S1071 S2\" id=\"t1g_59\">144 000 </span><span class=\"S1589 S1071 S2\" id=\"t1h_59\">Book value at 31 December 2022 </span><span class=\"S158A S1071 S2\" id=\"t1i_59\">129 209 </span><span class=\"S158B S1071 S2\" id=\"t1j_59\">144 000 </span><span class=\"S158C S1070 S2\" id=\"t1k_59\">Carrying amount of goodwill is allocated to the acquired business in Europe by NOK 144 million. The recoverable amount has been </span><span class=\"S158D S1070 S2\" id=\"t1l_59\">determined as value in use. </span><span class=\"S158E S1070 S2\" id=\"t1m_59\">The impairment test is based on cash \ufb02ow projections for the business related to the investment. The cash \ufb02ow projections is based </span><span class=\"S158F S1070 S2\" id=\"t1n_59\">on most recent \ufb01nancial forecast for the business. </span><span class=\"S1590 S1070 S2\" id=\"t1o_59\">Main assumptions are: </span><span class=\"S1591 S1070 S2\" id=\"t1p_59\">\u2022  Sales growth and related expenses is based on current penetration and future growth potential as per management assessment. </span><span class=\"S1592 S1070 S2\" id=\"t1q_59\">When assessing future growth and related expenses management has taken into consideration experiences from high growth </span><span class=\"S1593 S1070 S2\" id=\"t1r_59\">markets as well as more mature markets within the company portfolio. </span><span class=\"S1594 S1070 S2\" id=\"t1s_59\">\u2022  With minor exceptions the sales are in Euro. Assumed exchange rate in the forecast projection NOK/EUR is 10.20, this is at same </span><span class=\"S1595 S1070 S2\" id=\"t1t_59\">level as the average rate for 2022. </span><span class=\"S1596 S1070 S2\" id=\"t1u_59\">\u2022  The impairment test is based on a 8 year cash \ufb02ow projection including the terminal year. 8 year is applied as this re\ufb02ects the </span><span class=\"S1597 S1070 S2\" id=\"t1v_59\">change in hospital practices driven by the product as well as the low churn experienced in other markets. </span><span class=\"S1598 S1070 S2\" id=\"t1w_59\">\u2022  The applied discount rate is 18.0% post tax. An increase of discount rate with 2% or 4% will not change the conclusion of the </span><span class=\"S1599 S1070 S2\" id=\"t1x_59\">impairment test. Terminal </span><span class=\"S159A S1070 S2\" id=\"t1y_59\">growth rate is in the projection estimated to zero as a conservative approach. An increase of the terminal </span><span class=\"S159B S1070 S2\" id=\"t1z_59\">growth rate to 4% will have a positive impact on the fair value of the investment with NOK 40 million. </span><span class=\"S159C S1070 S2\" id=\"t20_59\">This percent re\ufb02ects the </span><span class=\"S159D S1070 S2\" id=\"t21_59\">expected in\ufb02ation and the growth in the aged population that has the highest prevalence of bladder cancer </span><span class=\"S159E S1070 S2\" id=\"t22_59\">\u2022  Applied tax rate is 22%. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfGoodwillExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6466": {
   "value": "<span class=\"S1556 S106F S2\" id=\"t2_59\">13. GOODWILL AND CUSTOMER RELATIONS </span><span class=\"S1557 S1070 S2\" id=\"t3_59\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S1558 S1070 S2\" id=\"t4_59\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S1559 S1070 S2\" id=\"t5_59\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S155A S1070 S2\" id=\"t6_59\">sales (years 8-10) in the previous Ipsen major markets. </span><span class=\"S155B S1070 S2\" id=\"t7_59\">One intangible asset has been identi\ufb01ed, Customer relationships. The customer relationships relate to existing customers in Europe </span><span class=\"S155C S1070 S2\" id=\"t8_59\">which have previously been served by Ipsen. Customer relationships has been valued using a multiperiod excess earnings method </span><span class=\"S155D S1070 S2\" id=\"t9_59\">and the value at transaction date was NOK 166.7 million. Photocure has evaluated this asset to have an estimated value for 10 years </span><span class=\"S155E S1070 S2\" id=\"ta_59\">from transaction date and the intangible assets is depreciated on a straight-line basis over this period. The net book value </span><span class=\"S155F S1070 S2\" id=\"tb_59\">of the </span><span class=\"S1560 S1070 S2\" id=\"tc_59\">customer relations as of 31 December 2022 is NOK 129.2 million. </span><span class=\"S1561 S1070 S2\" id=\"td_59\">Goodwill amounts to NOK 144 million and this asset is not depreciated, but is tested against impairment as of end December 2022. </span><span class=\"S1562 S1070 S2\" id=\"te_59\">The impairment analysis carried out con\ufb01rms the goodwill value given the performance in 2022 and future growth opportunities that </span><span class=\"S1563 S1070 S2\" id=\"tf_59\">are expected to in line with forecasts prepared in connection with the transaction. </span><span class=\"S1564 S1071 S2\" id=\"tg_59\">Group and parent </span><span class=\"S1565 S1070 S2\" id=\"th_59\">(Amounts in NOK 1,000) </span><span class=\"S1566 S1071 S2\" id=\"ti_59\">Customer relations </span><span class=\"S1567 S1071 S2\" id=\"tj_59\">Goodwill </span><span class=\"S1568 S1070 S2\" id=\"tk_59\">Accumulated cost at 31 December 2020 </span><span class=\"S1569 S1070 S2\" id=\"tl_59\">166 720 </span><span class=\"S156A S1070 S2\" id=\"tm_59\">144 000 </span><span class=\"S156B S1070 S2\" id=\"tn_59\">Additions </span><span class=\"S156C S1070 S2\" id=\"to_59\">0 </span><span class=\"S156D S1070 S2\" id=\"tp_59\">0 </span><span class=\"S156E S1071 S2\" id=\"tq_59\">Accumulated cost at 31 December 2021 </span><span class=\"S156F S1071 S2\" id=\"tr_59\">166 720 </span><span class=\"S1570 S1071 S2\" id=\"ts_59\">144 000 </span><span class=\"S1571 S1070 S2\" id=\"tt_59\">Additions </span><span class=\"S1572 S1070 S2\" id=\"tu_59\">0 </span><span class=\"S1573 S1070 S2\" id=\"tv_59\">0 </span><span class=\"S1574 S1071 S2\" id=\"tw_59\">Accumulated cost at 31 December 2022 </span><span class=\"S1575 S1071 S2\" id=\"tx_59\">166 720 </span><span class=\"S1576 S1071 S2\" id=\"ty_59\">144 000 </span><span class=\"S1577 S1071 S2\" id=\"tz_59\">Accumulated depreciation at 31 December 2020 </span><span class=\"S1578 S1070 S2\" id=\"t10_59\">4 168 </span><span class=\"S1579 S1070 S2\" id=\"t11_59\">0 </span><span class=\"S157A S1070 S2\" id=\"t12_59\">Amortization and impairment </span><span class=\"S157B S1070 S2\" id=\"t13_59\">16 672 </span><span class=\"S157C S1070 S2\" id=\"t14_59\">0 </span><span class=\"S157D S1071 S2\" id=\"t15_59\">Accumulated depreciation at 31 December 2021 </span><span class=\"S157E S1071 S2\" id=\"t16_59\">20 840 </span><span class=\"S157F S1071 S2\" id=\"t17_59\">0 </span><span class=\"S1580 S1070 S2\" id=\"t18_59\">Amortization and impairment </span><span class=\"S1581 S1070 S2\" id=\"t19_59\">16 672 </span><span class=\"S1582 S1070 S2\" id=\"t1a_59\">0 </span><span class=\"S1583 S1071 S2\" id=\"t1b_59\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1584 S1071 S2\" id=\"t1c_59\">37 512 </span><span class=\"S1585 S1071 S2\" id=\"t1d_59\">0 </span><span class=\"S1586 S1071 S2\" id=\"t1e_59\">Book value at 31 December 2021 </span><span class=\"S1587 S1071 S2\" id=\"t1f_59\">145 880 </span><span class=\"S1588 S1071 S2\" id=\"t1g_59\">144 000 </span><span class=\"S1589 S1071 S2\" id=\"t1h_59\">Book value at 31 December 2022 </span><span class=\"S158A S1071 S2\" id=\"t1i_59\">129 209 </span><span class=\"S158B S1071 S2\" id=\"t1j_59\">144 000 </span><span class=\"S158C S1070 S2\" id=\"t1k_59\">Carrying amount of goodwill is allocated to the acquired business in Europe by NOK 144 million. The recoverable amount has been </span><span class=\"S158D S1070 S2\" id=\"t1l_59\">determined as value in use. </span><span class=\"S158E S1070 S2\" id=\"t1m_59\">The impairment test is based on cash \ufb02ow projections for the business related to the investment. The cash \ufb02ow projections is based </span><span class=\"S158F S1070 S2\" id=\"t1n_59\">on most recent \ufb01nancial forecast for the business. </span><span class=\"S1590 S1070 S2\" id=\"t1o_59\">Main assumptions are: </span><span class=\"S1591 S1070 S2\" id=\"t1p_59\">\u2022  Sales growth and related expenses is based on current penetration and future growth potential as per management assessment. </span><span class=\"S1592 S1070 S2\" id=\"t1q_59\">When assessing future growth and related expenses management has taken into consideration experiences from high growth </span><span class=\"S1593 S1070 S2\" id=\"t1r_59\">markets as well as more mature markets within the company portfolio. </span><span class=\"S1594 S1070 S2\" id=\"t1s_59\">\u2022  With minor exceptions the sales are in Euro. Assumed exchange rate in the forecast projection NOK/EUR is 10.20, this is at same </span><span class=\"S1595 S1070 S2\" id=\"t1t_59\">level as the average rate for 2022. </span><span class=\"S1596 S1070 S2\" id=\"t1u_59\">\u2022  The impairment test is based on a 8 year cash \ufb02ow projection including the terminal year. 8 year is applied as this re\ufb02ects the </span><span class=\"S1597 S1070 S2\" id=\"t1v_59\">change in hospital practices driven by the product as well as the low churn experienced in other markets. </span><span class=\"S1598 S1070 S2\" id=\"t1w_59\">\u2022  The applied discount rate is 18.0% post tax. An increase of discount rate with 2% or 4% will not change the conclusion of the </span><span class=\"S1599 S1070 S2\" id=\"t1x_59\">impairment test. Terminal </span><span class=\"S159A S1070 S2\" id=\"t1y_59\">growth rate is in the projection estimated to zero as a conservative approach. An increase of the terminal </span><span class=\"S159B S1070 S2\" id=\"t1z_59\">growth rate to 4% will have a positive impact on the fair value of the investment with NOK 40 million. </span><span class=\"S159C S1070 S2\" id=\"t20_59\">This percent re\ufb02ects the </span><span class=\"S159D S1070 S2\" id=\"t21_59\">expected in\ufb02ation and the growth in the aged population that has the highest prevalence of bladder cancer </span><span class=\"S159E S1070 S2\" id=\"t22_59\">\u2022  Applied tax rate is 22%. </span><span class=\"S15A0 S106F S2\" id=\"t4_60\">14. PROPERTY, PLANT, EQUIPMENT AND LEASE ASSETS </span><span class=\"S15A1 S1070 S2\" id=\"t5_60\">(Amounts in NOK 1,000) </span><span class=\"S15A2 S1071 S2\" id=\"t6_60\">Group </span><span class=\"S15A3 S1071 S2\" id=\"t7_60\">Intangible </span><span class=\"S15A4 S1071 S2\" id=\"t8_60\">assets </span><span class=\"S15A5 S1071 S2\" id=\"t9_60\">Right- </span><span class=\"S15A6 S1071 S2\" id=\"ta_60\">of-use </span><span class=\"S15A7 S1071 S2\" id=\"tb_60\">Machinery and </span><span class=\"S15A8 S1071 S2\" id=\"tc_60\">Equipment </span><span class=\"S15A9 S1071 S2\" id=\"td_60\">Product </span><span class=\"S15AA S1071 S2\" id=\"te_60\">Development </span><span class=\"S15AB S1071 S2\" id=\"tf_60\">Software </span><span class=\"S15AC S1071 S2\" id=\"tg_60\">Systems </span><span class=\"S15AD S1071 S2\" id=\"th_60\">O\ufb03ce </span><span class=\"S15AE S1071 S2\" id=\"ti_60\">Lease </span><span class=\"S15AF S1071 S2\" id=\"tj_60\">Medical </span><span class=\"S15B0 S1071 S2\" id=\"tk_60\">&amp; manu- </span><span class=\"S15B1 S1071 S2\" id=\"tl_60\">facture </span><span class=\"S15B2 S1071 S2\" id=\"tm_60\">O\ufb03ce </span><span class=\"S15B3 S1071 S2\" id=\"tn_60\">Total </span><span class=\"S134E S1071 S2\" id=\"to_60\">Accumulated cost at 31 December 2020 </span><span class=\"S15B4 S1070 S2\" id=\"tp_60\">51 069 </span><span class=\"S15B5 S1070 S2\" id=\"tq_60\">4 406 </span><span class=\"S15B6 S1070 S2\" id=\"tr_60\">10 900 </span><span class=\"S15B7 S1070 S2\" id=\"ts_60\">613 </span><span class=\"S15B8 S1070 S2\" id=\"tt_60\">7 006 </span><span class=\"S15B9 S1071 S2\" id=\"tu_60\">73 994 </span><span class=\"S15BA S1070 S2\" id=\"tv_60\">Additions </span><span class=\"S15BB S1070 S2\" id=\"tw_60\">527 </span><span class=\"S15BC S1070 S2\" id=\"tx_60\">31 062 </span><span class=\"S15BD S1070 S2\" id=\"ty_60\">163 </span><span class=\"S15BE S1070 S2\" id=\"tz_60\">2 342 </span><span class=\"S15BF S1071 S2\" id=\"t10_60\">34 095 </span><span class=\"S15C0 S1070 S2\" id=\"t11_60\">Disposals and lease expiry </span><span class=\"S15C1 S1070 S2\" id=\"t12_60\">-51 069 </span><span class=\"S15C2 S1070 S2\" id=\"t13_60\">-10 900 </span><span class=\"S15C3 S1071 S2\" id=\"t14_60\">-61 969 </span><span class=\"S15C4 S1071 S2\" id=\"t15_60\">Accumulated cost at 31 December 2021 </span><span class=\"S15C5 S1070 S2\" id=\"t16_60\">0 </span><span class=\"S15C6 S1070 S2\" id=\"t17_60\">4 933 </span><span class=\"S15C7 S1070 S2\" id=\"t18_60\">31 062 </span><span class=\"S15C8 S1070 S2\" id=\"t19_60\">776 </span><span class=\"S15C9 S1070 S2\" id=\"t1a_60\">9 348 </span><span class=\"S15CA S1071 S2\" id=\"t1b_60\">46 120 </span><span class=\"S15CB S1070 S2\" id=\"t1c_60\">Additions </span><span class=\"S15CC S1070 S2\" id=\"t1d_60\">1 133 </span><span class=\"S15CD S1070 S2\" id=\"t1e_60\">3 498 </span><span class=\"S15CE S1070 S2\" id=\"t1f_60\">78 </span><span class=\"S15CF S1070 S2\" id=\"t1g_60\">3 532 </span><span class=\"S15D0 S1071 S2\" id=\"t1h_60\">8 240 </span><span class=\"S15D1 S1070 S2\" id=\"t1i_60\">Disposals and lease expiry </span><span class=\"S15D2 S1070 S2\" id=\"t1j_60\">-83 </span><span class=\"S15D3 S1070 S2\" id=\"t1k_60\">-1 797 </span><span class=\"S15D4 S1071 S2\" id=\"t1l_60\">-1 880 </span><span class=\"S15D5 S1071 S2\" id=\"t1m_60\">Accumulated cost at 31 December 2022 </span><span class=\"S15D6 S1070 S2\" id=\"t1n_60\">0 </span><span class=\"S15D7 S1070 S2\" id=\"t1o_60\">6 066 </span><span class=\"S15D8 S1070 S2\" id=\"t1p_60\">34 477 </span><span class=\"S15D9 S1070 S2\" id=\"t1q_60\">854 </span><span class=\"S15DA S1070 S2\" id=\"t1r_60\">11 083 </span><span class=\"S15DB S1071 S2\" id=\"t1s_60\">52 479 </span><span class=\"S15DC S1071 S2\" id=\"t1t_60\">Accumulated depreciation at 31 December 2020 </span><span class=\"S15DD S1070 S2\" id=\"t1u_60\">51 069 </span><span class=\"S15DE S1070 S2\" id=\"t1v_60\">2 831 </span><span class=\"S15DF S1070 S2\" id=\"t1w_60\">7 046 </span><span class=\"S15E0 S1070 S2\" id=\"t1x_60\">272 </span><span class=\"S15E1 S1070 S2\" id=\"t1y_60\">5 407 </span><span class=\"S15E2 S1071 S2\" id=\"t1z_60\">66 625 </span><span class=\"S15E3 S1070 S2\" id=\"t20_60\">Amortization and depreciation </span><span class=\"S15E4 S1070 S2\" id=\"t21_60\">947 </span><span class=\"S15E5 S1070 S2\" id=\"t22_60\">5 392 </span><span class=\"S15E6 S1070 S2\" id=\"t23_60\">170 </span><span class=\"S15E7 S1070 S2\" id=\"t24_60\">946 </span><span class=\"S15E8 S1071 S2\" id=\"t25_60\">7 455 </span><span class=\"S15E9 S1070 S2\" id=\"t26_60\">Disposals and lease expiry </span><span class=\"S15EA S1070 S2\" id=\"t27_60\">-51 069 </span><span class=\"S15EB S1070 S2\" id=\"t28_60\">-10 067 </span><span class=\"S15EC S1070 S2\" id=\"t29_60\">-399 </span><span class=\"S15ED S1071 S2\" id=\"t2a_60\">-61 535 </span><span class=\"S15EE S1071 S2\" id=\"t2b_60\">Accumulated depreciation at 31 December 2021 </span><span class=\"S15EF S1070 S2\" id=\"t2c_60\">0 </span><span class=\"S15F0 S1070 S2\" id=\"t2d_60\">3 778 </span><span class=\"S15F1 S1070 S2\" id=\"t2e_60\">2 371 </span><span class=\"S15F2 S1070 S2\" id=\"t2f_60\">442 </span><span class=\"S15F3 S1070 S2\" id=\"t2g_60\">5 954 </span><span class=\"S15F4 S1071 S2\" id=\"t2h_60\">12 545 </span><span class=\"S15F5 S1070 S2\" id=\"t2i_60\">Amortization and depreciation </span><span class=\"S15F6 S1070 S2\" id=\"t2j_60\">615 </span><span class=\"S15F7 S1070 S2\" id=\"t2k_60\">5 779 </span><span class=\"S15F8 S1070 S2\" id=\"t2l_60\">161 </span><span class=\"S15F9 S1070 S2\" id=\"t2m_60\">1 151 </span><span class=\"S15FA S1071 S2\" id=\"t2n_60\">7 706 </span><span class=\"S15FB S1070 S2\" id=\"t2o_60\">Disposals and lease expiry </span><span class=\"S15FC S1070 S2\" id=\"t2p_60\">236 </span><span class=\"S15FD S1070 S2\" id=\"t2q_60\">-486 </span><span class=\"S15FE S1071 S2\" id=\"t2r_60\">-250 </span><span class=\"S15FF S1071 S2\" id=\"t2s_60\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1600 S1070 S2\" id=\"t2t_60\">0 </span><span class=\"S1601 S1070 S2\" id=\"t2u_60\">4 393 </span><span class=\"S1602 S1070 S2\" id=\"t2v_60\">8 386 </span><span class=\"S1603 S1070 S2\" id=\"t2w_60\">603 </span><span class=\"S1604 S1070 S2\" id=\"t2x_60\">6 619 </span><span class=\"S1605 S1071 S2\" id=\"t2y_60\">20 001 </span><span class=\"S1606 S1071 S2\" id=\"t2z_60\">Book value at 31 December 2021 </span><span class=\"S1607 S1070 S2\" id=\"t30_60\">0 </span><span class=\"S1608 S1070 S2\" id=\"t31_60\">1 156 </span><span class=\"S1609 S1070 S2\" id=\"t32_60\">28 691 </span><span class=\"S160A S1070 S2\" id=\"t33_60\">334 </span><span class=\"S160B S1070 S2\" id=\"t34_60\">3 394 </span><span class=\"S160C S1071 S2\" id=\"t35_60\">33 575 </span><span class=\"S160D S1071 S2\" id=\"t36_60\">Book value at 31 December 2022 </span><span class=\"S160E S1070 S2\" id=\"t37_60\">0 </span><span class=\"S160F S1070 S2\" id=\"t38_60\">1 673 </span><span class=\"S1610 S1070 S2\" id=\"t39_60\">26 091 </span><span class=\"S1611 S1070 S2\" id=\"t3a_60\">251 </span><span class=\"S1612 S1070 S2\" id=\"t3b_60\">4 464 </span><span class=\"S1613 S1071 S2\" id=\"t3c_60\">32 479 </span><span class=\"S1614 S1070 S2\" id=\"t3d_60\">PPE are depreciated on a straight-line basis over the estimated useful life of the asset as follows </span><span class=\"S1615 S1070 S2\" id=\"t3e_60\">Patent period </span><span class=\"S1616 S1070 S2\" id=\"t3f_60\">3 - 5 years </span><span class=\"S1617 S1070 S2\" id=\"t3g_60\">Contract </span><span class=\"S1618 S1070 S2\" id=\"t3h_60\">period </span><span class=\"S1619 S1070 S2\" id=\"t3i_60\">3 - 5 years </span><span class=\"S161A S1070 S2\" id=\"t3j_60\">3 - 5 years </span><span class=\"S161B S1070 S2\" id=\"t3k_60\">The note for the Parent company has immaterial di\ufb00erences to the Group and is not disclosed of this reason. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6467": {
   "value": "<span class=\"S1556 S106F S2\" id=\"t2_59\">13. GOODWILL AND CUSTOMER RELATIONS </span><span class=\"S1557 S1070 S2\" id=\"t3_59\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S1558 S1070 S2\" id=\"t4_59\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S1559 S1070 S2\" id=\"t5_59\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S155A S1070 S2\" id=\"t6_59\">sales (years 8-10) in the previous Ipsen major markets. </span><span class=\"S155B S1070 S2\" id=\"t7_59\">One intangible asset has been identi\ufb01ed, Customer relationships. The customer relationships relate to existing customers in Europe </span><span class=\"S155C S1070 S2\" id=\"t8_59\">which have previously been served by Ipsen. Customer relationships has been valued using a multiperiod excess earnings method </span><span class=\"S155D S1070 S2\" id=\"t9_59\">and the value at transaction date was NOK 166.7 million. Photocure has evaluated this asset to have an estimated value for 10 years </span><span class=\"S155E S1070 S2\" id=\"ta_59\">from transaction date and the intangible assets is depreciated on a straight-line basis over this period. The net book value </span><span class=\"S155F S1070 S2\" id=\"tb_59\">of the </span><span class=\"S1560 S1070 S2\" id=\"tc_59\">customer relations as of 31 December 2022 is NOK 129.2 million. </span><span class=\"S1561 S1070 S2\" id=\"td_59\">Goodwill amounts to NOK 144 million and this asset is not depreciated, but is tested against impairment as of end December 2022. </span><span class=\"S1562 S1070 S2\" id=\"te_59\">The impairment analysis carried out con\ufb01rms the goodwill value given the performance in 2022 and future growth opportunities that </span><span class=\"S1563 S1070 S2\" id=\"tf_59\">are expected to in line with forecasts prepared in connection with the transaction. </span><span class=\"S1564 S1071 S2\" id=\"tg_59\">Group and parent </span><span class=\"S1565 S1070 S2\" id=\"th_59\">(Amounts in NOK 1,000) </span><span class=\"S1566 S1071 S2\" id=\"ti_59\">Customer relations </span><span class=\"S1567 S1071 S2\" id=\"tj_59\">Goodwill </span><span class=\"S1568 S1070 S2\" id=\"tk_59\">Accumulated cost at 31 December 2020 </span><span class=\"S1569 S1070 S2\" id=\"tl_59\">166 720 </span><span class=\"S156A S1070 S2\" id=\"tm_59\">144 000 </span><span class=\"S156B S1070 S2\" id=\"tn_59\">Additions </span><span class=\"S156C S1070 S2\" id=\"to_59\">0 </span><span class=\"S156D S1070 S2\" id=\"tp_59\">0 </span><span class=\"S156E S1071 S2\" id=\"tq_59\">Accumulated cost at 31 December 2021 </span><span class=\"S156F S1071 S2\" id=\"tr_59\">166 720 </span><span class=\"S1570 S1071 S2\" id=\"ts_59\">144 000 </span><span class=\"S1571 S1070 S2\" id=\"tt_59\">Additions </span><span class=\"S1572 S1070 S2\" id=\"tu_59\">0 </span><span class=\"S1573 S1070 S2\" id=\"tv_59\">0 </span><span class=\"S1574 S1071 S2\" id=\"tw_59\">Accumulated cost at 31 December 2022 </span><span class=\"S1575 S1071 S2\" id=\"tx_59\">166 720 </span><span class=\"S1576 S1071 S2\" id=\"ty_59\">144 000 </span><span class=\"S1577 S1071 S2\" id=\"tz_59\">Accumulated depreciation at 31 December 2020 </span><span class=\"S1578 S1070 S2\" id=\"t10_59\">4 168 </span><span class=\"S1579 S1070 S2\" id=\"t11_59\">0 </span><span class=\"S157A S1070 S2\" id=\"t12_59\">Amortization and impairment </span><span class=\"S157B S1070 S2\" id=\"t13_59\">16 672 </span><span class=\"S157C S1070 S2\" id=\"t14_59\">0 </span><span class=\"S157D S1071 S2\" id=\"t15_59\">Accumulated depreciation at 31 December 2021 </span><span class=\"S157E S1071 S2\" id=\"t16_59\">20 840 </span><span class=\"S157F S1071 S2\" id=\"t17_59\">0 </span><span class=\"S1580 S1070 S2\" id=\"t18_59\">Amortization and impairment </span><span class=\"S1581 S1070 S2\" id=\"t19_59\">16 672 </span><span class=\"S1582 S1070 S2\" id=\"t1a_59\">0 </span><span class=\"S1583 S1071 S2\" id=\"t1b_59\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1584 S1071 S2\" id=\"t1c_59\">37 512 </span><span class=\"S1585 S1071 S2\" id=\"t1d_59\">0 </span><span class=\"S1586 S1071 S2\" id=\"t1e_59\">Book value at 31 December 2021 </span><span class=\"S1587 S1071 S2\" id=\"t1f_59\">145 880 </span><span class=\"S1588 S1071 S2\" id=\"t1g_59\">144 000 </span><span class=\"S1589 S1071 S2\" id=\"t1h_59\">Book value at 31 December 2022 </span><span class=\"S158A S1071 S2\" id=\"t1i_59\">129 209 </span><span class=\"S158B S1071 S2\" id=\"t1j_59\">144 000 </span><span class=\"S158C S1070 S2\" id=\"t1k_59\">Carrying amount of goodwill is allocated to the acquired business in Europe by NOK 144 million. The recoverable amount has been </span><span class=\"S158D S1070 S2\" id=\"t1l_59\">determined as value in use. </span><span class=\"S158E S1070 S2\" id=\"t1m_59\">The impairment test is based on cash \ufb02ow projections for the business related to the investment. The cash \ufb02ow projections is based </span><span class=\"S158F S1070 S2\" id=\"t1n_59\">on most recent \ufb01nancial forecast for the business. </span><span class=\"S1590 S1070 S2\" id=\"t1o_59\">Main assumptions are: </span><span class=\"S1591 S1070 S2\" id=\"t1p_59\">\u2022  Sales growth and related expenses is based on current penetration and future growth potential as per management assessment. </span><span class=\"S1592 S1070 S2\" id=\"t1q_59\">When assessing future growth and related expenses management has taken into consideration experiences from high growth </span><span class=\"S1593 S1070 S2\" id=\"t1r_59\">markets as well as more mature markets within the company portfolio. </span><span class=\"S1594 S1070 S2\" id=\"t1s_59\">\u2022  With minor exceptions the sales are in Euro. Assumed exchange rate in the forecast projection NOK/EUR is 10.20, this is at same </span><span class=\"S1595 S1070 S2\" id=\"t1t_59\">level as the average rate for 2022. </span><span class=\"S1596 S1070 S2\" id=\"t1u_59\">\u2022  The impairment test is based on a 8 year cash \ufb02ow projection including the terminal year. 8 year is applied as this re\ufb02ects the </span><span class=\"S1597 S1070 S2\" id=\"t1v_59\">change in hospital practices driven by the product as well as the low churn experienced in other markets. </span><span class=\"S1598 S1070 S2\" id=\"t1w_59\">\u2022  The applied discount rate is 18.0% post tax. An increase of discount rate with 2% or 4% will not change the conclusion of the </span><span class=\"S1599 S1070 S2\" id=\"t1x_59\">impairment test. Terminal </span><span class=\"S159A S1070 S2\" id=\"t1y_59\">growth rate is in the projection estimated to zero as a conservative approach. An increase of the terminal </span><span class=\"S159B S1070 S2\" id=\"t1z_59\">growth rate to 4% will have a positive impact on the fair value of the investment with NOK 40 million. </span><span class=\"S159C S1070 S2\" id=\"t20_59\">This percent re\ufb02ects the </span><span class=\"S159D S1070 S2\" id=\"t21_59\">expected in\ufb02ation and the growth in the aged population that has the highest prevalence of bladder cancer </span>\u2022  Applied tax rate is 22%<span class=\"S15A0 S106F S2\" id=\"t4_60\">14. PROPERTY, PLANT, EQUIPMENT AND LEASE ASSETS </span><span class=\"S15A1 S1070 S2\" id=\"t5_60\">(Amounts in NOK 1,000) </span><span class=\"S15A2 S1071 S2\" id=\"t6_60\">Group </span><span class=\"S15A3 S1071 S2\" id=\"t7_60\">Intangible </span><span class=\"S15A4 S1071 S2\" id=\"t8_60\">assets </span><span class=\"S15A5 S1071 S2\" id=\"t9_60\">Right- </span><span class=\"S15A6 S1071 S2\" id=\"ta_60\">of-use </span><span class=\"S15A7 S1071 S2\" id=\"tb_60\">Machinery and </span><span class=\"S15A8 S1071 S2\" id=\"tc_60\">Equipment </span><span class=\"S15A9 S1071 S2\" id=\"td_60\">Product </span><span class=\"S15AA S1071 S2\" id=\"te_60\">Development </span><span class=\"S15AB S1071 S2\" id=\"tf_60\">Software </span><span class=\"S15AC S1071 S2\" id=\"tg_60\">Systems </span><span class=\"S15AD S1071 S2\" id=\"th_60\">O\ufb03ce </span><span class=\"S15AE S1071 S2\" id=\"ti_60\">Lease </span><span class=\"S15AF S1071 S2\" id=\"tj_60\">Medical </span><span class=\"S15B0 S1071 S2\" id=\"tk_60\">&amp; manu- </span><span class=\"S15B1 S1071 S2\" id=\"tl_60\">facture </span><span class=\"S15B2 S1071 S2\" id=\"tm_60\">O\ufb03ce </span><span class=\"S15B3 S1071 S2\" id=\"tn_60\">Total </span><span class=\"S134E S1071 S2\" id=\"to_60\">Accumulated cost at 31 December 2020 </span><span class=\"S15B4 S1070 S2\" id=\"tp_60\">51 069 </span><span class=\"S15B5 S1070 S2\" id=\"tq_60\">4 406 </span><span class=\"S15B6 S1070 S2\" id=\"tr_60\">10 900 </span><span class=\"S15B7 S1070 S2\" id=\"ts_60\">613 </span><span class=\"S15B8 S1070 S2\" id=\"tt_60\">7 006 </span><span class=\"S15B9 S1071 S2\" id=\"tu_60\">73 994 </span><span class=\"S15BA S1070 S2\" id=\"tv_60\">Additions </span><span class=\"S15BB S1070 S2\" id=\"tw_60\">527 </span><span class=\"S15BC S1070 S2\" id=\"tx_60\">31 062 </span><span class=\"S15BD S1070 S2\" id=\"ty_60\">163 </span><span class=\"S15BE S1070 S2\" id=\"tz_60\">2 342 </span><span class=\"S15BF S1071 S2\" id=\"t10_60\">34 095 </span><span class=\"S15C0 S1070 S2\" id=\"t11_60\">Disposals and lease expiry </span><span class=\"S15C1 S1070 S2\" id=\"t12_60\">-51 069 </span><span class=\"S15C2 S1070 S2\" id=\"t13_60\">-10 900 </span><span class=\"S15C3 S1071 S2\" id=\"t14_60\">-61 969 </span><span class=\"S15C4 S1071 S2\" id=\"t15_60\">Accumulated cost at 31 December 2021 </span><span class=\"S15C5 S1070 S2\" id=\"t16_60\">0 </span><span class=\"S15C6 S1070 S2\" id=\"t17_60\">4 933 </span><span class=\"S15C7 S1070 S2\" id=\"t18_60\">31 062 </span><span class=\"S15C8 S1070 S2\" id=\"t19_60\">776 </span><span class=\"S15C9 S1070 S2\" id=\"t1a_60\">9 348 </span><span class=\"S15CA S1071 S2\" id=\"t1b_60\">46 120 </span><span class=\"S15CB S1070 S2\" id=\"t1c_60\">Additions </span><span class=\"S15CC S1070 S2\" id=\"t1d_60\">1 133 </span><span class=\"S15CD S1070 S2\" id=\"t1e_60\">3 498 </span><span class=\"S15CE S1070 S2\" id=\"t1f_60\">78 </span><span class=\"S15CF S1070 S2\" id=\"t1g_60\">3 532 </span><span class=\"S15D0 S1071 S2\" id=\"t1h_60\">8 240 </span><span class=\"S15D1 S1070 S2\" id=\"t1i_60\">Disposals and lease expiry </span><span class=\"S15D2 S1070 S2\" id=\"t1j_60\">-83 </span><span class=\"S15D3 S1070 S2\" id=\"t1k_60\">-1 797 </span><span class=\"S15D4 S1071 S2\" id=\"t1l_60\">-1 880 </span><span class=\"S15D5 S1071 S2\" id=\"t1m_60\">Accumulated cost at 31 December 2022 </span><span class=\"S15D6 S1070 S2\" id=\"t1n_60\">0 </span><span class=\"S15D7 S1070 S2\" id=\"t1o_60\">6 066 </span><span class=\"S15D8 S1070 S2\" id=\"t1p_60\">34 477 </span><span class=\"S15D9 S1070 S2\" id=\"t1q_60\">854 </span><span class=\"S15DA S1070 S2\" id=\"t1r_60\">11 083 </span><span class=\"S15DB S1071 S2\" id=\"t1s_60\">52 479 </span><span class=\"S15DC S1071 S2\" id=\"t1t_60\">Accumulated depreciation at 31 December 2020 </span><span class=\"S15DD S1070 S2\" id=\"t1u_60\">51 069 </span><span class=\"S15DE S1070 S2\" id=\"t1v_60\">2 831 </span><span class=\"S15DF S1070 S2\" id=\"t1w_60\">7 046 </span><span class=\"S15E0 S1070 S2\" id=\"t1x_60\">272 </span><span class=\"S15E1 S1070 S2\" id=\"t1y_60\">5 407 </span><span class=\"S15E2 S1071 S2\" id=\"t1z_60\">66 625 </span><span class=\"S15E3 S1070 S2\" id=\"t20_60\">Amortization and depreciation </span><span class=\"S15E4 S1070 S2\" id=\"t21_60\">947 </span><span class=\"S15E5 S1070 S2\" id=\"t22_60\">5 392 </span><span class=\"S15E6 S1070 S2\" id=\"t23_60\">170 </span><span class=\"S15E7 S1070 S2\" id=\"t24_60\">946 </span><span class=\"S15E8 S1071 S2\" id=\"t25_60\">7 455 </span><span class=\"S15E9 S1070 S2\" id=\"t26_60\">Disposals and lease expiry </span><span class=\"S15EA S1070 S2\" id=\"t27_60\">-51 069 </span><span class=\"S15EB S1070 S2\" id=\"t28_60\">-10 067 </span><span class=\"S15EC S1070 S2\" id=\"t29_60\">-399 </span><span class=\"S15ED S1071 S2\" id=\"t2a_60\">-61 535 </span><span class=\"S15EE S1071 S2\" id=\"t2b_60\">Accumulated depreciation at 31 December 2021 </span><span class=\"S15EF S1070 S2\" id=\"t2c_60\">0 </span><span class=\"S15F0 S1070 S2\" id=\"t2d_60\">3 778 </span><span class=\"S15F1 S1070 S2\" id=\"t2e_60\">2 371 </span><span class=\"S15F2 S1070 S2\" id=\"t2f_60\">442 </span><span class=\"S15F3 S1070 S2\" id=\"t2g_60\">5 954 </span><span class=\"S15F4 S1071 S2\" id=\"t2h_60\">12 545 </span><span class=\"S15F5 S1070 S2\" id=\"t2i_60\">Amortization and depreciation </span><span class=\"S15F6 S1070 S2\" id=\"t2j_60\">615 </span><span class=\"S15F7 S1070 S2\" id=\"t2k_60\">5 779 </span><span class=\"S15F8 S1070 S2\" id=\"t2l_60\">161 </span><span class=\"S15F9 S1070 S2\" id=\"t2m_60\">1 151 </span><span class=\"S15FA S1071 S2\" id=\"t2n_60\">7 706 </span><span class=\"S15FB S1070 S2\" id=\"t2o_60\">Disposals and lease expiry </span><span class=\"S15FC S1070 S2\" id=\"t2p_60\">236 </span><span class=\"S15FD S1070 S2\" id=\"t2q_60\">-486 </span><span class=\"S15FE S1071 S2\" id=\"t2r_60\">-250 </span><span class=\"S15FF S1071 S2\" id=\"t2s_60\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1600 S1070 S2\" id=\"t2t_60\">0 </span><span class=\"S1601 S1070 S2\" id=\"t2u_60\">4 393 </span><span class=\"S1602 S1070 S2\" id=\"t2v_60\">8 386 </span><span class=\"S1603 S1070 S2\" id=\"t2w_60\">603 </span><span class=\"S1604 S1070 S2\" id=\"t2x_60\">6 619 </span><span class=\"S1605 S1071 S2\" id=\"t2y_60\">20 001 </span><span class=\"S1606 S1071 S2\" id=\"t2z_60\">Book value at 31 December 2021 </span><span class=\"S1607 S1070 S2\" id=\"t30_60\">0 </span><span class=\"S1608 S1070 S2\" id=\"t31_60\">1 156 </span><span class=\"S1609 S1070 S2\" id=\"t32_60\">28 691 </span><span class=\"S160A S1070 S2\" id=\"t33_60\">334 </span><span class=\"S160B S1070 S2\" id=\"t34_60\">3 394 </span><span class=\"S160C S1071 S2\" id=\"t35_60\">33 575 </span><span class=\"S160D S1071 S2\" id=\"t36_60\">Book value at 31 December 2022 </span><span class=\"S160E S1070 S2\" id=\"t37_60\">0 </span><span class=\"S160F S1070 S2\" id=\"t38_60\">1 673 </span><span class=\"S1610 S1070 S2\" id=\"t39_60\">26 091 </span><span class=\"S1611 S1070 S2\" id=\"t3a_60\">251 </span><span class=\"S1612 S1070 S2\" id=\"t3b_60\">4 464 </span><span class=\"S1613 S1071 S2\" id=\"t3c_60\">32 479 </span><span class=\"S1614 S1070 S2\" id=\"t3d_60\">PPE are depreciated on a straight-line basis over the estimated useful life of the asset as follows </span><span class=\"S1615 S1070 S2\" id=\"t3e_60\">Patent period </span><span class=\"S1616 S1070 S2\" id=\"t3f_60\">3 - 5 years </span><span class=\"S1617 S1070 S2\" id=\"t3g_60\">Contract </span><span class=\"S1618 S1070 S2\" id=\"t3h_60\">period </span><span class=\"S1619 S1070 S2\" id=\"t3i_60\">3 - 5 years </span><span class=\"S161A S1070 S2\" id=\"t3j_60\">3 - 5 years </span>The note for the Parent company has immaterial di\ufb00erences to the Group and is not disclosed of this reason",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6468": {
   "value": "<span class=\"S1556 S106F S2\" id=\"t2_59\">13. GOODWILL AND CUSTOMER RELATIONS </span><span class=\"S1557 S1070 S2\" id=\"t3_59\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S1558 S1070 S2\" id=\"t4_59\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S1559 S1070 S2\" id=\"t5_59\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S155A S1070 S2\" id=\"t6_59\">sales (years 8-10) in the previous Ipsen major markets. </span><span class=\"S155B S1070 S2\" id=\"t7_59\">One intangible asset has been identi\ufb01ed, Customer relationships. The customer relationships relate to existing customers in Europe </span><span class=\"S155C S1070 S2\" id=\"t8_59\">which have previously been served by Ipsen. Customer relationships has been valued using a multiperiod excess earnings method </span><span class=\"S155D S1070 S2\" id=\"t9_59\">and the value at transaction date was NOK 166.7 million. Photocure has evaluated this asset to have an estimated value for 10 years </span><span class=\"S155E S1070 S2\" id=\"ta_59\">from transaction date and the intangible assets is depreciated on a straight-line basis over this period. The net book value </span><span class=\"S155F S1070 S2\" id=\"tb_59\">of the </span><span class=\"S1560 S1070 S2\" id=\"tc_59\">customer relations as of 31 December 2022 is NOK 129.2 million. </span><span class=\"S1561 S1070 S2\" id=\"td_59\">Goodwill amounts to NOK 144 million and this asset is not depreciated, but is tested against impairment as of end December 2022. </span><span class=\"S1562 S1070 S2\" id=\"te_59\">The impairment analysis carried out con\ufb01rms the goodwill value given the performance in 2022 and future growth opportunities that </span><span class=\"S1563 S1070 S2\" id=\"tf_59\">are expected to in line with forecasts prepared in connection with the transaction. </span><span class=\"S1564 S1071 S2\" id=\"tg_59\">Group and parent </span><span class=\"S1565 S1070 S2\" id=\"th_59\">(Amounts in NOK 1,000) </span><span class=\"S1566 S1071 S2\" id=\"ti_59\">Customer relations </span><span class=\"S1567 S1071 S2\" id=\"tj_59\">Goodwill </span><span class=\"S1568 S1070 S2\" id=\"tk_59\">Accumulated cost at 31 December 2020 </span><span class=\"S1569 S1070 S2\" id=\"tl_59\">166 720 </span><span class=\"S156A S1070 S2\" id=\"tm_59\">144 000 </span><span class=\"S156B S1070 S2\" id=\"tn_59\">Additions </span><span class=\"S156C S1070 S2\" id=\"to_59\">0 </span><span class=\"S156D S1070 S2\" id=\"tp_59\">0 </span><span class=\"S156E S1071 S2\" id=\"tq_59\">Accumulated cost at 31 December 2021 </span><span class=\"S156F S1071 S2\" id=\"tr_59\">166 720 </span><span class=\"S1570 S1071 S2\" id=\"ts_59\">144 000 </span><span class=\"S1571 S1070 S2\" id=\"tt_59\">Additions </span><span class=\"S1572 S1070 S2\" id=\"tu_59\">0 </span><span class=\"S1573 S1070 S2\" id=\"tv_59\">0 </span><span class=\"S1574 S1071 S2\" id=\"tw_59\">Accumulated cost at 31 December 2022 </span><span class=\"S1575 S1071 S2\" id=\"tx_59\">166 720 </span><span class=\"S1576 S1071 S2\" id=\"ty_59\">144 000 </span><span class=\"S1577 S1071 S2\" id=\"tz_59\">Accumulated depreciation at 31 December 2020 </span><span class=\"S1578 S1070 S2\" id=\"t10_59\">4 168 </span><span class=\"S1579 S1070 S2\" id=\"t11_59\">0 </span><span class=\"S157A S1070 S2\" id=\"t12_59\">Amortization and impairment </span><span class=\"S157B S1070 S2\" id=\"t13_59\">16 672 </span><span class=\"S157C S1070 S2\" id=\"t14_59\">0 </span><span class=\"S157D S1071 S2\" id=\"t15_59\">Accumulated depreciation at 31 December 2021 </span><span class=\"S157E S1071 S2\" id=\"t16_59\">20 840 </span><span class=\"S157F S1071 S2\" id=\"t17_59\">0 </span><span class=\"S1580 S1070 S2\" id=\"t18_59\">Amortization and impairment </span><span class=\"S1581 S1070 S2\" id=\"t19_59\">16 672 </span><span class=\"S1582 S1070 S2\" id=\"t1a_59\">0 </span><span class=\"S1583 S1071 S2\" id=\"t1b_59\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1584 S1071 S2\" id=\"t1c_59\">37 512 </span><span class=\"S1585 S1071 S2\" id=\"t1d_59\">0 </span><span class=\"S1586 S1071 S2\" id=\"t1e_59\">Book value at 31 December 2021 </span><span class=\"S1587 S1071 S2\" id=\"t1f_59\">145 880 </span><span class=\"S1588 S1071 S2\" id=\"t1g_59\">144 000 </span><span class=\"S1589 S1071 S2\" id=\"t1h_59\">Book value at 31 December 2022 </span><span class=\"S158A S1071 S2\" id=\"t1i_59\">129 209 </span><span class=\"S158B S1071 S2\" id=\"t1j_59\">144 000 </span><span class=\"S15A0 S106F S2\" id=\"t4_60\">14. PROPERTY, PLANT, EQUIPMENT AND LEASE ASSETS </span><span class=\"S15A1 S1070 S2\" id=\"t5_60\">(Amounts in NOK 1,000) </span><span class=\"S15A2 S1071 S2\" id=\"t6_60\">Group </span><span class=\"S15A3 S1071 S2\" id=\"t7_60\">Intangible </span><span class=\"S15A4 S1071 S2\" id=\"t8_60\">assets </span><span class=\"S15A5 S1071 S2\" id=\"t9_60\">Right- </span><span class=\"S15A6 S1071 S2\" id=\"ta_60\">of-use </span><span class=\"S15A7 S1071 S2\" id=\"tb_60\">Machinery and </span><span class=\"S15A8 S1071 S2\" id=\"tc_60\">Equipment </span><span class=\"S15A9 S1071 S2\" id=\"td_60\">Product </span><span class=\"S15AA S1071 S2\" id=\"te_60\">Development </span><span class=\"S15AB S1071 S2\" id=\"tf_60\">Software </span><span class=\"S15AC S1071 S2\" id=\"tg_60\">Systems </span><span class=\"S15AD S1071 S2\" id=\"th_60\">O\ufb03ce </span><span class=\"S15AE S1071 S2\" id=\"ti_60\">Lease </span><span class=\"S15AF S1071 S2\" id=\"tj_60\">Medical </span><span class=\"S15B0 S1071 S2\" id=\"tk_60\">&amp; manu- </span><span class=\"S15B1 S1071 S2\" id=\"tl_60\">facture </span><span class=\"S15B2 S1071 S2\" id=\"tm_60\">O\ufb03ce </span><span class=\"S15B3 S1071 S2\" id=\"tn_60\">Total </span><span class=\"S134E S1071 S2\" id=\"to_60\">Accumulated cost at 31 December 2020 </span><span class=\"S15B4 S1070 S2\" id=\"tp_60\">51 069 </span><span class=\"S15B5 S1070 S2\" id=\"tq_60\">4 406 </span><span class=\"S15B6 S1070 S2\" id=\"tr_60\">10 900 </span><span class=\"S15B7 S1070 S2\" id=\"ts_60\">613 </span><span class=\"S15B8 S1070 S2\" id=\"tt_60\">7 006 </span><span class=\"S15B9 S1071 S2\" id=\"tu_60\">73 994 </span><span class=\"S15BA S1070 S2\" id=\"tv_60\">Additions </span><span class=\"S15BB S1070 S2\" id=\"tw_60\">527 </span><span class=\"S15BC S1070 S2\" id=\"tx_60\">31 062 </span><span class=\"S15BD S1070 S2\" id=\"ty_60\">163 </span><span class=\"S15BE S1070 S2\" id=\"tz_60\">2 342 </span><span class=\"S15BF S1071 S2\" id=\"t10_60\">34 095 </span><span class=\"S15C0 S1070 S2\" id=\"t11_60\">Disposals and lease expiry </span><span class=\"S15C1 S1070 S2\" id=\"t12_60\">-51 069 </span><span class=\"S15C2 S1070 S2\" id=\"t13_60\">-10 900 </span><span class=\"S15C3 S1071 S2\" id=\"t14_60\">-61 969 </span><span class=\"S15C4 S1071 S2\" id=\"t15_60\">Accumulated cost at 31 December 2021 </span><span class=\"S15C5 S1070 S2\" id=\"t16_60\">0 </span><span class=\"S15C6 S1070 S2\" id=\"t17_60\">4 933 </span><span class=\"S15C7 S1070 S2\" id=\"t18_60\">31 062 </span><span class=\"S15C8 S1070 S2\" id=\"t19_60\">776 </span><span class=\"S15C9 S1070 S2\" id=\"t1a_60\">9 348 </span><span class=\"S15CA S1071 S2\" id=\"t1b_60\">46 120 </span><span class=\"S15CB S1070 S2\" id=\"t1c_60\">Additions </span><span class=\"S15CC S1070 S2\" id=\"t1d_60\">1 133 </span><span class=\"S15CD S1070 S2\" id=\"t1e_60\">3 498 </span><span class=\"S15CE S1070 S2\" id=\"t1f_60\">78 </span><span class=\"S15CF S1070 S2\" id=\"t1g_60\">3 532 </span><span class=\"S15D0 S1071 S2\" id=\"t1h_60\">8 240 </span><span class=\"S15D1 S1070 S2\" id=\"t1i_60\">Disposals and lease expiry </span><span class=\"S15D2 S1070 S2\" id=\"t1j_60\">-83 </span><span class=\"S15D3 S1070 S2\" id=\"t1k_60\">-1 797 </span><span class=\"S15D4 S1071 S2\" id=\"t1l_60\">-1 880 </span><span class=\"S15D5 S1071 S2\" id=\"t1m_60\">Accumulated cost at 31 December 2022 </span><span class=\"S15D6 S1070 S2\" id=\"t1n_60\">0 </span><span class=\"S15D7 S1070 S2\" id=\"t1o_60\">6 066 </span><span class=\"S15D8 S1070 S2\" id=\"t1p_60\">34 477 </span><span class=\"S15D9 S1070 S2\" id=\"t1q_60\">854 </span><span class=\"S15DA S1070 S2\" id=\"t1r_60\">11 083 </span><span class=\"S15DB S1071 S2\" id=\"t1s_60\">52 479 </span><span class=\"S15DC S1071 S2\" id=\"t1t_60\">Accumulated depreciation at 31 December 2020 </span><span class=\"S15DD S1070 S2\" id=\"t1u_60\">51 069 </span><span class=\"S15DE S1070 S2\" id=\"t1v_60\">2 831 </span><span class=\"S15DF S1070 S2\" id=\"t1w_60\">7 046 </span><span class=\"S15E0 S1070 S2\" id=\"t1x_60\">272 </span><span class=\"S15E1 S1070 S2\" id=\"t1y_60\">5 407 </span><span class=\"S15E2 S1071 S2\" id=\"t1z_60\">66 625 </span><span class=\"S15E3 S1070 S2\" id=\"t20_60\">Amortization and depreciation </span><span class=\"S15E4 S1070 S2\" id=\"t21_60\">947 </span><span class=\"S15E5 S1070 S2\" id=\"t22_60\">5 392 </span><span class=\"S15E6 S1070 S2\" id=\"t23_60\">170 </span><span class=\"S15E7 S1070 S2\" id=\"t24_60\">946 </span><span class=\"S15E8 S1071 S2\" id=\"t25_60\">7 455 </span><span class=\"S15E9 S1070 S2\" id=\"t26_60\">Disposals and lease expiry </span><span class=\"S15EA S1070 S2\" id=\"t27_60\">-51 069 </span><span class=\"S15EB S1070 S2\" id=\"t28_60\">-10 067 </span><span class=\"S15EC S1070 S2\" id=\"t29_60\">-399 </span><span class=\"S15ED S1071 S2\" id=\"t2a_60\">-61 535 </span><span class=\"S15EE S1071 S2\" id=\"t2b_60\">Accumulated depreciation at 31 December 2021 </span><span class=\"S15EF S1070 S2\" id=\"t2c_60\">0 </span><span class=\"S15F0 S1070 S2\" id=\"t2d_60\">3 778 </span><span class=\"S15F1 S1070 S2\" id=\"t2e_60\">2 371 </span><span class=\"S15F2 S1070 S2\" id=\"t2f_60\">442 </span><span class=\"S15F3 S1070 S2\" id=\"t2g_60\">5 954 </span><span class=\"S15F4 S1071 S2\" id=\"t2h_60\">12 545 </span><span class=\"S15F5 S1070 S2\" id=\"t2i_60\">Amortization and depreciation </span><span class=\"S15F6 S1070 S2\" id=\"t2j_60\">615 </span><span class=\"S15F7 S1070 S2\" id=\"t2k_60\">5 779 </span><span class=\"S15F8 S1070 S2\" id=\"t2l_60\">161 </span><span class=\"S15F9 S1070 S2\" id=\"t2m_60\">1 151 </span><span class=\"S15FA S1071 S2\" id=\"t2n_60\">7 706 </span><span class=\"S15FB S1070 S2\" id=\"t2o_60\">Disposals and lease expiry </span><span class=\"S15FC S1070 S2\" id=\"t2p_60\">236 </span><span class=\"S15FD S1070 S2\" id=\"t2q_60\">-486 </span><span class=\"S15FE S1071 S2\" id=\"t2r_60\">-250 </span><span class=\"S15FF S1071 S2\" id=\"t2s_60\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1600 S1070 S2\" id=\"t2t_60\">0 </span><span class=\"S1601 S1070 S2\" id=\"t2u_60\">4 393 </span><span class=\"S1602 S1070 S2\" id=\"t2v_60\">8 386 </span><span class=\"S1603 S1070 S2\" id=\"t2w_60\">603 </span><span class=\"S1604 S1070 S2\" id=\"t2x_60\">6 619 </span><span class=\"S1605 S1071 S2\" id=\"t2y_60\">20 001 </span><span class=\"S1606 S1071 S2\" id=\"t2z_60\">Book value at 31 December 2021 </span><span class=\"S1607 S1070 S2\" id=\"t30_60\">0 </span><span class=\"S1608 S1070 S2\" id=\"t31_60\">1 156 </span><span class=\"S1609 S1070 S2\" id=\"t32_60\">28 691 </span><span class=\"S160A S1070 S2\" id=\"t33_60\">334 </span><span class=\"S160B S1070 S2\" id=\"t34_60\">3 394 </span><span class=\"S160C S1071 S2\" id=\"t35_60\">33 575 </span><span class=\"S160D S1071 S2\" id=\"t36_60\">Book value at 31 December 2022 </span><span class=\"S160E S1070 S2\" id=\"t37_60\">0 </span><span class=\"S160F S1070 S2\" id=\"t38_60\">1 673 </span><span class=\"S1610 S1070 S2\" id=\"t39_60\">26 091 </span><span class=\"S1611 S1070 S2\" id=\"t3a_60\">251 </span><span class=\"S1612 S1070 S2\" id=\"t3b_60\">4 464 </span><span class=\"S1613 S1071 S2\" id=\"t3c_60\">32 479 </span><span class=\"S1614 S1070 S2\" id=\"t3d_60\">PPE are depreciated on a straight-line basis over the estimated useful life of the asset as follows </span><span class=\"S1615 S1070 S2\" id=\"t3e_60\">Patent period </span><span class=\"S1616 S1070 S2\" id=\"t3f_60\">3 - 5 years </span><span class=\"S1617 S1070 S2\" id=\"t3g_60\">Contract </span><span class=\"S1618 S1070 S2\" id=\"t3h_60\">period </span><span class=\"S1619 S1070 S2\" id=\"t3i_60\">3 - 5 years </span><span class=\"S161A S1070 S2\" id=\"t3j_60\">3 - 5 years </span>The note for the Parent company has immaterial di\ufb00erences to the Group and is not disclosed of this reason",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6480": {
   "value": "<span class=\"S1561 S1070 S2\" id=\"td_59\">Goodwill amounts to NOK 144 million and this asset is not depreciated, but is tested against impairment as of end December 2022. </span><span class=\"S1562 S1070 S2\" id=\"te_59\">The impairment analysis carried out con\ufb01rms the goodwill value given the performance in 2022 and future growth opportunities that </span><span class=\"S1563 S1070 S2\" id=\"tf_59\">are expected to in line with forecasts prepared in connection with the transaction. </span><span class=\"S1564 S1071 S2\" id=\"tg_59\">Group and parent </span><span class=\"S1565 S1070 S2\" id=\"th_59\">(Amounts in NOK 1,000) </span><span class=\"S1566 S1071 S2\" id=\"ti_59\">Customer relations </span><span class=\"S1567 S1071 S2\" id=\"tj_59\">Goodwill </span><span class=\"S1568 S1070 S2\" id=\"tk_59\">Accumulated cost at 31 December 2020 </span><span class=\"S1569 S1070 S2\" id=\"tl_59\">166 720 </span><span class=\"S156A S1070 S2\" id=\"tm_59\">144 000 </span><span class=\"S156B S1070 S2\" id=\"tn_59\">Additions </span><span class=\"S156C S1070 S2\" id=\"to_59\">0 </span><span class=\"S156D S1070 S2\" id=\"tp_59\">0 </span><span class=\"S156E S1071 S2\" id=\"tq_59\">Accumulated cost at 31 December 2021 </span><span class=\"S156F S1071 S2\" id=\"tr_59\">166 720 </span><span class=\"S1570 S1071 S2\" id=\"ts_59\">144 000 </span><span class=\"S1571 S1070 S2\" id=\"tt_59\">Additions </span><span class=\"S1572 S1070 S2\" id=\"tu_59\">0 </span><span class=\"S1573 S1070 S2\" id=\"tv_59\">0 </span><span class=\"S1574 S1071 S2\" id=\"tw_59\">Accumulated cost at 31 December 2022 </span><span class=\"S1575 S1071 S2\" id=\"tx_59\">166 720 </span><span class=\"S1576 S1071 S2\" id=\"ty_59\">144 000 </span><span class=\"S1577 S1071 S2\" id=\"tz_59\">Accumulated depreciation at 31 December 2020 </span><span class=\"S1578 S1070 S2\" id=\"t10_59\">4 168 </span><span class=\"S1579 S1070 S2\" id=\"t11_59\">0 </span><span class=\"S157A S1070 S2\" id=\"t12_59\">Amortization and impairment </span><span class=\"S157B S1070 S2\" id=\"t13_59\">16 672 </span><span class=\"S157C S1070 S2\" id=\"t14_59\">0 </span><span class=\"S157D S1071 S2\" id=\"t15_59\">Accumulated depreciation at 31 December 2021 </span><span class=\"S157E S1071 S2\" id=\"t16_59\">20 840 </span><span class=\"S157F S1071 S2\" id=\"t17_59\">0 </span><span class=\"S1580 S1070 S2\" id=\"t18_59\">Amortization and impairment </span><span class=\"S1581 S1070 S2\" id=\"t19_59\">16 672 </span><span class=\"S1582 S1070 S2\" id=\"t1a_59\">0 </span><span class=\"S1583 S1071 S2\" id=\"t1b_59\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1584 S1071 S2\" id=\"t1c_59\">37 512 </span><span class=\"S1585 S1071 S2\" id=\"t1d_59\">0 </span><span class=\"S1586 S1071 S2\" id=\"t1e_59\">Book value at 31 December 2021 </span><span class=\"S1587 S1071 S2\" id=\"t1f_59\">145 880 </span><span class=\"S1588 S1071 S2\" id=\"t1g_59\">144 000 </span><span class=\"S1589 S1071 S2\" id=\"t1h_59\">Book value at 31 December 2022 </span><span class=\"S158A S1071 S2\" id=\"t1i_59\">129 209 </span><span class=\"S158B S1071 S2\" id=\"t1j_59\">144 000 </span><span class=\"S158C S1070 S2\" id=\"t1k_59\">Carrying amount of goodwill is allocated to the acquired business in Europe by NOK 144 million. The recoverable amount has been </span><span class=\"S158D S1070 S2\" id=\"t1l_59\">determined as value in use. </span><span class=\"S158E S1070 S2\" id=\"t1m_59\">The impairment test is based on cash \ufb02ow projections for the business related to the investment. The cash \ufb02ow projections is based </span><span class=\"S158F S1070 S2\" id=\"t1n_59\">on most recent \ufb01nancial forecast for the business. </span><span class=\"S1590 S1070 S2\" id=\"t1o_59\">Main assumptions are: </span><span class=\"S1591 S1070 S2\" id=\"t1p_59\">\u2022  Sales growth and related expenses is based on current penetration and future growth potential as per management assessment. </span><span class=\"S1592 S1070 S2\" id=\"t1q_59\">When assessing future growth and related expenses management has taken into consideration experiences from high growth </span><span class=\"S1593 S1070 S2\" id=\"t1r_59\">markets as well as more mature markets within the company portfolio. </span><span class=\"S1594 S1070 S2\" id=\"t1s_59\">\u2022  With minor exceptions the sales are in Euro. Assumed exchange rate in the forecast projection NOK/EUR is 10.20, this is at same </span><span class=\"S1595 S1070 S2\" id=\"t1t_59\">level as the average rate for 2022. </span><span class=\"S1596 S1070 S2\" id=\"t1u_59\">\u2022  The impairment test is based on a 8 year cash \ufb02ow projection including the terminal year. 8 year is applied as this re\ufb02ects the </span><span class=\"S1597 S1070 S2\" id=\"t1v_59\">change in hospital practices driven by the product as well as the low churn experienced in other markets. </span><span class=\"S1598 S1070 S2\" id=\"t1w_59\">\u2022  The applied discount rate is 18.0% post tax. An increase of discount rate with 2% or 4% will not change the conclusion of the </span><span class=\"S1599 S1070 S2\" id=\"t1x_59\">impairment test. Terminal </span><span class=\"S159A S1070 S2\" id=\"t1y_59\">growth rate is in the projection estimated to zero as a conservative approach. An increase of the terminal </span><span class=\"S159B S1070 S2\" id=\"t1z_59\">growth rate to 4% will have a positive impact on the fair value of the investment with NOK 40 million. </span><span class=\"S159C S1070 S2\" id=\"t20_59\">This percent re\ufb02ects the </span><span class=\"S159D S1070 S2\" id=\"t21_59\">expected in\ufb02ation and the growth in the aged population that has the highest prevalence of bladder cancer </span>\u2022  Applied tax rate is 22%",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6555": {
   "value": "<span class=\"S15A0 S106F S2\" id=\"t4_60\">14. PROPERTY, PLANT, EQUIPMENT AND LEASE ASSETS </span><span class=\"S15A1 S1070 S2\" id=\"t5_60\">(Amounts in NOK 1,000) </span><span class=\"S15A2 S1071 S2\" id=\"t6_60\">Group </span><span class=\"S15A3 S1071 S2\" id=\"t7_60\">Intangible </span><span class=\"S15A4 S1071 S2\" id=\"t8_60\">assets </span><span class=\"S15A5 S1071 S2\" id=\"t9_60\">Right- </span><span class=\"S15A6 S1071 S2\" id=\"ta_60\">of-use </span><span class=\"S15A7 S1071 S2\" id=\"tb_60\">Machinery and </span><span class=\"S15A8 S1071 S2\" id=\"tc_60\">Equipment </span><span class=\"S15A9 S1071 S2\" id=\"td_60\">Product </span><span class=\"S15AA S1071 S2\" id=\"te_60\">Development </span><span class=\"S15AB S1071 S2\" id=\"tf_60\">Software </span><span class=\"S15AC S1071 S2\" id=\"tg_60\">Systems </span><span class=\"S15AD S1071 S2\" id=\"th_60\">O\ufb03ce </span><span class=\"S15AE S1071 S2\" id=\"ti_60\">Lease </span><span class=\"S15AF S1071 S2\" id=\"tj_60\">Medical </span><span class=\"S15B0 S1071 S2\" id=\"tk_60\">&amp; manu- </span><span class=\"S15B1 S1071 S2\" id=\"tl_60\">facture </span><span class=\"S15B2 S1071 S2\" id=\"tm_60\">O\ufb03ce </span><span class=\"S15B3 S1071 S2\" id=\"tn_60\">Total </span><span class=\"S134E S1071 S2\" id=\"to_60\">Accumulated cost at 31 December 2020 </span><span class=\"S15B4 S1070 S2\" id=\"tp_60\">51 069 </span><span class=\"S15B5 S1070 S2\" id=\"tq_60\">4 406 </span><span class=\"S15B6 S1070 S2\" id=\"tr_60\">10 900 </span><span class=\"S15B7 S1070 S2\" id=\"ts_60\">613 </span><span class=\"S15B8 S1070 S2\" id=\"tt_60\">7 006 </span><span class=\"S15B9 S1071 S2\" id=\"tu_60\">73 994 </span><span class=\"S15BA S1070 S2\" id=\"tv_60\">Additions </span><span class=\"S15BB S1070 S2\" id=\"tw_60\">527 </span><span class=\"S15BC S1070 S2\" id=\"tx_60\">31 062 </span><span class=\"S15BD S1070 S2\" id=\"ty_60\">163 </span><span class=\"S15BE S1070 S2\" id=\"tz_60\">2 342 </span><span class=\"S15BF S1071 S2\" id=\"t10_60\">34 095 </span><span class=\"S15C0 S1070 S2\" id=\"t11_60\">Disposals and lease expiry </span><span class=\"S15C1 S1070 S2\" id=\"t12_60\">-51 069 </span><span class=\"S15C2 S1070 S2\" id=\"t13_60\">-10 900 </span><span class=\"S15C3 S1071 S2\" id=\"t14_60\">-61 969 </span><span class=\"S15C4 S1071 S2\" id=\"t15_60\">Accumulated cost at 31 December 2021 </span><span class=\"S15C5 S1070 S2\" id=\"t16_60\">0 </span><span class=\"S15C6 S1070 S2\" id=\"t17_60\">4 933 </span><span class=\"S15C7 S1070 S2\" id=\"t18_60\">31 062 </span><span class=\"S15C8 S1070 S2\" id=\"t19_60\">776 </span><span class=\"S15C9 S1070 S2\" id=\"t1a_60\">9 348 </span><span class=\"S15CA S1071 S2\" id=\"t1b_60\">46 120 </span><span class=\"S15CB S1070 S2\" id=\"t1c_60\">Additions </span><span class=\"S15CC S1070 S2\" id=\"t1d_60\">1 133 </span><span class=\"S15CD S1070 S2\" id=\"t1e_60\">3 498 </span><span class=\"S15CE S1070 S2\" id=\"t1f_60\">78 </span><span class=\"S15CF S1070 S2\" id=\"t1g_60\">3 532 </span><span class=\"S15D0 S1071 S2\" id=\"t1h_60\">8 240 </span><span class=\"S15D1 S1070 S2\" id=\"t1i_60\">Disposals and lease expiry </span><span class=\"S15D2 S1070 S2\" id=\"t1j_60\">-83 </span><span class=\"S15D3 S1070 S2\" id=\"t1k_60\">-1 797 </span><span class=\"S15D4 S1071 S2\" id=\"t1l_60\">-1 880 </span><span class=\"S15D5 S1071 S2\" id=\"t1m_60\">Accumulated cost at 31 December 2022 </span><span class=\"S15D6 S1070 S2\" id=\"t1n_60\">0 </span><span class=\"S15D7 S1070 S2\" id=\"t1o_60\">6 066 </span><span class=\"S15D8 S1070 S2\" id=\"t1p_60\">34 477 </span><span class=\"S15D9 S1070 S2\" id=\"t1q_60\">854 </span><span class=\"S15DA S1070 S2\" id=\"t1r_60\">11 083 </span><span class=\"S15DB S1071 S2\" id=\"t1s_60\">52 479 </span><span class=\"S15DC S1071 S2\" id=\"t1t_60\">Accumulated depreciation at 31 December 2020 </span><span class=\"S15DD S1070 S2\" id=\"t1u_60\">51 069 </span><span class=\"S15DE S1070 S2\" id=\"t1v_60\">2 831 </span><span class=\"S15DF S1070 S2\" id=\"t1w_60\">7 046 </span><span class=\"S15E0 S1070 S2\" id=\"t1x_60\">272 </span><span class=\"S15E1 S1070 S2\" id=\"t1y_60\">5 407 </span><span class=\"S15E2 S1071 S2\" id=\"t1z_60\">66 625 </span><span class=\"S15E3 S1070 S2\" id=\"t20_60\">Amortization and depreciation </span><span class=\"S15E4 S1070 S2\" id=\"t21_60\">947 </span><span class=\"S15E5 S1070 S2\" id=\"t22_60\">5 392 </span><span class=\"S15E6 S1070 S2\" id=\"t23_60\">170 </span><span class=\"S15E7 S1070 S2\" id=\"t24_60\">946 </span><span class=\"S15E8 S1071 S2\" id=\"t25_60\">7 455 </span><span class=\"S15E9 S1070 S2\" id=\"t26_60\">Disposals and lease expiry </span><span class=\"S15EA S1070 S2\" id=\"t27_60\">-51 069 </span><span class=\"S15EB S1070 S2\" id=\"t28_60\">-10 067 </span><span class=\"S15EC S1070 S2\" id=\"t29_60\">-399 </span><span class=\"S15ED S1071 S2\" id=\"t2a_60\">-61 535 </span><span class=\"S15EE S1071 S2\" id=\"t2b_60\">Accumulated depreciation at 31 December 2021 </span><span class=\"S15EF S1070 S2\" id=\"t2c_60\">0 </span><span class=\"S15F0 S1070 S2\" id=\"t2d_60\">3 778 </span><span class=\"S15F1 S1070 S2\" id=\"t2e_60\">2 371 </span><span class=\"S15F2 S1070 S2\" id=\"t2f_60\">442 </span><span class=\"S15F3 S1070 S2\" id=\"t2g_60\">5 954 </span><span class=\"S15F4 S1071 S2\" id=\"t2h_60\">12 545 </span><span class=\"S15F5 S1070 S2\" id=\"t2i_60\">Amortization and depreciation </span><span class=\"S15F6 S1070 S2\" id=\"t2j_60\">615 </span><span class=\"S15F7 S1070 S2\" id=\"t2k_60\">5 779 </span><span class=\"S15F8 S1070 S2\" id=\"t2l_60\">161 </span><span class=\"S15F9 S1070 S2\" id=\"t2m_60\">1 151 </span><span class=\"S15FA S1071 S2\" id=\"t2n_60\">7 706 </span><span class=\"S15FB S1070 S2\" id=\"t2o_60\">Disposals and lease expiry </span><span class=\"S15FC S1070 S2\" id=\"t2p_60\">236 </span><span class=\"S15FD S1070 S2\" id=\"t2q_60\">-486 </span><span class=\"S15FE S1071 S2\" id=\"t2r_60\">-250 </span><span class=\"S15FF S1071 S2\" id=\"t2s_60\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1600 S1070 S2\" id=\"t2t_60\">0 </span><span class=\"S1601 S1070 S2\" id=\"t2u_60\">4 393 </span><span class=\"S1602 S1070 S2\" id=\"t2v_60\">8 386 </span><span class=\"S1603 S1070 S2\" id=\"t2w_60\">603 </span><span class=\"S1604 S1070 S2\" id=\"t2x_60\">6 619 </span><span class=\"S1605 S1071 S2\" id=\"t2y_60\">20 001 </span><span class=\"S1606 S1071 S2\" id=\"t2z_60\">Book value at 31 December 2021 </span><span class=\"S1607 S1070 S2\" id=\"t30_60\">0 </span><span class=\"S1608 S1070 S2\" id=\"t31_60\">1 156 </span><span class=\"S1609 S1070 S2\" id=\"t32_60\">28 691 </span><span class=\"S160A S1070 S2\" id=\"t33_60\">334 </span><span class=\"S160B S1070 S2\" id=\"t34_60\">3 394 </span><span class=\"S160C S1071 S2\" id=\"t35_60\">33 575 </span><span class=\"S160D S1071 S2\" id=\"t36_60\">Book value at 31 December 2022 </span><span class=\"S160E S1070 S2\" id=\"t37_60\">0 </span><span class=\"S160F S1070 S2\" id=\"t38_60\">1 673 </span><span class=\"S1610 S1070 S2\" id=\"t39_60\">26 091 </span><span class=\"S1611 S1070 S2\" id=\"t3a_60\">251 </span><span class=\"S1612 S1070 S2\" id=\"t3b_60\">4 464 </span><span class=\"S1613 S1071 S2\" id=\"t3c_60\">32 479 </span><span class=\"S1614 S1070 S2\" id=\"t3d_60\">PPE are depreciated on a straight-line basis over the estimated useful life of the asset as follows </span><span class=\"S1615 S1070 S2\" id=\"t3e_60\">Patent period </span><span class=\"S1616 S1070 S2\" id=\"t3f_60\">3 - 5 years </span><span class=\"S1617 S1070 S2\" id=\"t3g_60\">Contract </span><span class=\"S1618 S1070 S2\" id=\"t3h_60\">period </span><span class=\"S1619 S1070 S2\" id=\"t3i_60\">3 - 5 years </span><span class=\"S161A S1070 S2\" id=\"t3j_60\">3 - 5 years </span><span class=\"S161B S1070 S2\" id=\"t3k_60\">The note for the Parent company has immaterial di\ufb00erences to the Group and is not disclosed of this reason. </span><span class=\"S161C S1071 S2\" id=\"t3l_60\">Right-of-use assets (Lease) </span><span class=\"S161D S1071 S2\" id=\"t3m_60\">31-Dec-21 </span><span class=\"S161E S1071 S2\" id=\"t3n_60\">31-Dec-22 </span><span class=\"S161F S1070 S2\" id=\"t3o_60\">(Amounts in NOK 1,000) </span><span class=\"S1620 S1071 S2\" id=\"t3p_60\">Discount </span><span class=\"S1621 S1071 S2\" id=\"t3q_60\">rate </span><span class=\"S1622 S1071 S2\" id=\"t3r_60\">Contract </span><span class=\"S1623 S1071 S2\" id=\"t3s_60\">value </span><span class=\"S1624 S1071 S2\" id=\"t3t_60\">Expiry </span><span class=\"S1625 S1071 S2\" id=\"t3u_60\">New/ </span><span class=\"S1626 S1071 S2\" id=\"t3v_60\">increase </span><span class=\"S1627 S1071 S2\" id=\"t3w_60\">contracts </span><span class=\"S1628 S1071 S2\" id=\"t3x_60\">Remeasure </span><span class=\"S1629 S1071 S2\" id=\"t3y_60\">Contract </span><span class=\"S162A S1071 S2\" id=\"t3z_60\">value </span><span class=\"S162B S1070 S2\" id=\"t40_60\">Right-of-use o\ufb03ce contract Norway </span><span class=\"S162C S1070 S2\" id=\"t41_60\">3,15 % </span><span class=\"S162D S1070 S2\" id=\"t42_60\">13 008 </span><span class=\"S162E S1070 S2\" id=\"t43_60\">- </span><span class=\"S162F S1070 S2\" id=\"t44_60\">574 </span><span class=\"S1630 S1070 S2\" id=\"t45_60\">13 582 </span><span class=\"S1631 S1070 S2\" id=\"t46_60\">Right-of-use o\ufb03ce contract US </span><span class=\"S1632 S1070 S2\" id=\"t47_60\">3,70 % </span><span class=\"S1633 S1070 S2\" id=\"t48_60\">10 269 </span><span class=\"S1634 S1070 S2\" id=\"t49_60\">- </span><span class=\"S1635 S1070 S2\" id=\"t4a_60\">920 </span><span class=\"S1636 S1070 S2\" id=\"t4b_60\">11 189 </span><span class=\"S1637 S1070 S2\" id=\"t4c_60\">Right-of-use o\ufb03ce contract Germany </span><span class=\"S1638 S1070 S2\" id=\"t4d_60\">1,40 % </span><span class=\"S1639 S1070 S2\" id=\"t4e_60\">6 624 </span><span class=\"S163A S1070 S2\" id=\"t4f_60\">- </span><span class=\"S163B S1070 S2\" id=\"t4g_60\">298 </span><span class=\"S163C S1070 S2\" id=\"t4h_60\">387 </span><span class=\"S163D S1070 S2\" id=\"t4i_60\">7 309 </span><span class=\"S163E S1070 S2\" id=\"t4j_60\">Right-of-use o\ufb03ce company car </span><span class=\"S163F S1070 S2\" id=\"t4k_60\">\ufb02eet Germany </span><span class=\"S1640 S1070 S2\" id=\"t4l_60\">1,40 % </span><span class=\"S1641 S1070 S2\" id=\"t4m_60\">1 162 </span><span class=\"S1642 S1070 S2\" id=\"t4n_60\">(83) </span><span class=\"S1643 S1070 S2\" id=\"t4o_60\">1 120 </span><span class=\"S1644 S1070 S2\" id=\"t4p_60\">198 </span><span class=\"S1645 S1070 S2\" id=\"t4q_60\">2 397 </span><span class=\"S1646 S1071 S2\" id=\"t4r_60\">Total lease assets </span><span class=\"S1647 S1071 S2\" id=\"t4s_60\">31 063 </span><span class=\"S1648 S1071 S2\" id=\"t4t_60\">34 477 </span><span class=\"S1649 S1070 S2\" id=\"t4u_60\">The Right-of-use assets comprise the o\ufb03ce lease contracts covered by IFRS 16. In addition. In addition are the lease contracts for </span><span class=\"S164A S1070 S2\" id=\"t4v_60\">the company car \ufb02eet in the Germany included. </span><span class=\"S164B S1070 S2\" id=\"t4w_60\">The calculation of the lease asset is excluding utility services shared by the tenants. </span><span class=\"S164C S1070 S2\" id=\"t4x_60\">The Parent company has a 6-year rental agreement for o\ufb03ce premises at Ho\ufb00sveien 4 in Oslo starting 1 September 2021 and </span><span class=\"S164D S1070 S2\" id=\"t4y_60\">ending 31 August 2027. The agreement give Photocure an option to expand the rent period by 4 years. The </span><span class=\"S164E S1070 S2\" id=\"t4z_60\">rent amounts to NOK 2.8 </span><span class=\"S164F S1070 S2\" id=\"t50_60\">million for the period 1 January 2023 through 31 December 2023. The rent for the remaining period until the expiry of the agreement </span>amounts to NOK 10.1 million<span class=\"S1652 S1070 S2\" id=\"t2_61\">Photocure Inc rents o\ufb03ce premises at Carnegie Center, Princeton, New Jersey from 1 April 2011 through 10 December 2022. </span><span class=\"S1653 S1070 S2\" id=\"t3_61\">On </span><span class=\"S1654 S1070 S2\" id=\"t4_61\">December 13, 2021, Photocure Inc. signed a lease amendment to move to a new o\ufb03ce of 5,212 square fee in Carnegie Center and to </span><span class=\"S1655 S1070 S2\" id=\"t5_61\">extend the lease term by six years with an expiration date of December 31, 2028. </span><span class=\"S1656 S1070 S2\" id=\"t6_61\">The lease commitment is NOK 11.2 million ( USD 1.1 </span><span class=\"S1657 S1070 S2\" id=\"t7_61\">million ) at 3.7% discount rate. The rent commitment for the period 1 January 2023 to 31 December 2023 is NOK 1.9 million while the </span><span class=\"S1658 S1070 S2\" id=\"t8_61\">rent for the remaining period until the expiry of the agreement amounts to NOK 9.3 million. </span><span class=\"S1659 S1070 S2\" id=\"t9_61\">Photocure GmbH </span><span class=\"S165A S1070 S2\" id=\"ta_61\">rents o\ufb03ce premises in D\u00fcsseldorf, Marc-Chagall-Stra\u00dfe 2 from 1 April 2021 through 31 March 2026. The rent </span><span class=\"S165B S1070 S2\" id=\"tb_61\">commitment for the period 1 January 2023 to 31 December 2023 is EUR 151.1 thousand while the rent for the remaining period until </span><span class=\"S165C S1070 S2\" id=\"tc_61\">the expiry of the agreement amounts to EUR 340.1 thousand. </span><span class=\"S165D S1070 S2\" id=\"td_61\">The standard lease period for the car \ufb02eet in Germany is 36 months. As of 31.12.2022 Photocure GmbH had 6 lease agreements with </span><span class=\"S165E S1070 S2\" id=\"te_61\">an average remaining lease term of 21.5 months </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfLeasesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6556": {
   "value": "<span class=\"S15A0 S106F S2\" id=\"t4_60\">14. PROPERTY, PLANT, EQUIPMENT AND LEASE ASSETS </span><span class=\"S15A1 S1070 S2\" id=\"t5_60\">(Amounts in NOK 1,000) </span><span class=\"S15A2 S1071 S2\" id=\"t6_60\">Group </span><span class=\"S15A3 S1071 S2\" id=\"t7_60\">Intangible </span><span class=\"S15A4 S1071 S2\" id=\"t8_60\">assets </span><span class=\"S15A5 S1071 S2\" id=\"t9_60\">Right- </span><span class=\"S15A6 S1071 S2\" id=\"ta_60\">of-use </span><span class=\"S15A7 S1071 S2\" id=\"tb_60\">Machinery and </span><span class=\"S15A8 S1071 S2\" id=\"tc_60\">Equipment </span><span class=\"S15A9 S1071 S2\" id=\"td_60\">Product </span><span class=\"S15AA S1071 S2\" id=\"te_60\">Development </span><span class=\"S15AB S1071 S2\" id=\"tf_60\">Software </span><span class=\"S15AC S1071 S2\" id=\"tg_60\">Systems </span><span class=\"S15AD S1071 S2\" id=\"th_60\">O\ufb03ce </span><span class=\"S15AE S1071 S2\" id=\"ti_60\">Lease </span><span class=\"S15AF S1071 S2\" id=\"tj_60\">Medical </span><span class=\"S15B0 S1071 S2\" id=\"tk_60\">&amp; manu- </span><span class=\"S15B1 S1071 S2\" id=\"tl_60\">facture </span><span class=\"S15B2 S1071 S2\" id=\"tm_60\">O\ufb03ce </span><span class=\"S15B3 S1071 S2\" id=\"tn_60\">Total </span><span class=\"S134E S1071 S2\" id=\"to_60\">Accumulated cost at 31 December 2020 </span><span class=\"S15B4 S1070 S2\" id=\"tp_60\">51 069 </span><span class=\"S15B5 S1070 S2\" id=\"tq_60\">4 406 </span><span class=\"S15B6 S1070 S2\" id=\"tr_60\">10 900 </span><span class=\"S15B7 S1070 S2\" id=\"ts_60\">613 </span><span class=\"S15B8 S1070 S2\" id=\"tt_60\">7 006 </span><span class=\"S15B9 S1071 S2\" id=\"tu_60\">73 994 </span><span class=\"S15BA S1070 S2\" id=\"tv_60\">Additions </span><span class=\"S15BB S1070 S2\" id=\"tw_60\">527 </span><span class=\"S15BC S1070 S2\" id=\"tx_60\">31 062 </span><span class=\"S15BD S1070 S2\" id=\"ty_60\">163 </span><span class=\"S15BE S1070 S2\" id=\"tz_60\">2 342 </span><span class=\"S15BF S1071 S2\" id=\"t10_60\">34 095 </span><span class=\"S15C0 S1070 S2\" id=\"t11_60\">Disposals and lease expiry </span><span class=\"S15C1 S1070 S2\" id=\"t12_60\">-51 069 </span><span class=\"S15C2 S1070 S2\" id=\"t13_60\">-10 900 </span><span class=\"S15C3 S1071 S2\" id=\"t14_60\">-61 969 </span><span class=\"S15C4 S1071 S2\" id=\"t15_60\">Accumulated cost at 31 December 2021 </span><span class=\"S15C5 S1070 S2\" id=\"t16_60\">0 </span><span class=\"S15C6 S1070 S2\" id=\"t17_60\">4 933 </span><span class=\"S15C7 S1070 S2\" id=\"t18_60\">31 062 </span><span class=\"S15C8 S1070 S2\" id=\"t19_60\">776 </span><span class=\"S15C9 S1070 S2\" id=\"t1a_60\">9 348 </span><span class=\"S15CA S1071 S2\" id=\"t1b_60\">46 120 </span><span class=\"S15CB S1070 S2\" id=\"t1c_60\">Additions </span><span class=\"S15CC S1070 S2\" id=\"t1d_60\">1 133 </span><span class=\"S15CD S1070 S2\" id=\"t1e_60\">3 498 </span><span class=\"S15CE S1070 S2\" id=\"t1f_60\">78 </span><span class=\"S15CF S1070 S2\" id=\"t1g_60\">3 532 </span><span class=\"S15D0 S1071 S2\" id=\"t1h_60\">8 240 </span><span class=\"S15D1 S1070 S2\" id=\"t1i_60\">Disposals and lease expiry </span><span class=\"S15D2 S1070 S2\" id=\"t1j_60\">-83 </span><span class=\"S15D3 S1070 S2\" id=\"t1k_60\">-1 797 </span><span class=\"S15D4 S1071 S2\" id=\"t1l_60\">-1 880 </span><span class=\"S15D5 S1071 S2\" id=\"t1m_60\">Accumulated cost at 31 December 2022 </span><span class=\"S15D6 S1070 S2\" id=\"t1n_60\">0 </span><span class=\"S15D7 S1070 S2\" id=\"t1o_60\">6 066 </span><span class=\"S15D8 S1070 S2\" id=\"t1p_60\">34 477 </span><span class=\"S15D9 S1070 S2\" id=\"t1q_60\">854 </span><span class=\"S15DA S1070 S2\" id=\"t1r_60\">11 083 </span><span class=\"S15DB S1071 S2\" id=\"t1s_60\">52 479 </span><span class=\"S15DC S1071 S2\" id=\"t1t_60\">Accumulated depreciation at 31 December 2020 </span><span class=\"S15DD S1070 S2\" id=\"t1u_60\">51 069 </span><span class=\"S15DE S1070 S2\" id=\"t1v_60\">2 831 </span><span class=\"S15DF S1070 S2\" id=\"t1w_60\">7 046 </span><span class=\"S15E0 S1070 S2\" id=\"t1x_60\">272 </span><span class=\"S15E1 S1070 S2\" id=\"t1y_60\">5 407 </span><span class=\"S15E2 S1071 S2\" id=\"t1z_60\">66 625 </span><span class=\"S15E3 S1070 S2\" id=\"t20_60\">Amortization and depreciation </span><span class=\"S15E4 S1070 S2\" id=\"t21_60\">947 </span><span class=\"S15E5 S1070 S2\" id=\"t22_60\">5 392 </span><span class=\"S15E6 S1070 S2\" id=\"t23_60\">170 </span><span class=\"S15E7 S1070 S2\" id=\"t24_60\">946 </span><span class=\"S15E8 S1071 S2\" id=\"t25_60\">7 455 </span><span class=\"S15E9 S1070 S2\" id=\"t26_60\">Disposals and lease expiry </span><span class=\"S15EA S1070 S2\" id=\"t27_60\">-51 069 </span><span class=\"S15EB S1070 S2\" id=\"t28_60\">-10 067 </span><span class=\"S15EC S1070 S2\" id=\"t29_60\">-399 </span><span class=\"S15ED S1071 S2\" id=\"t2a_60\">-61 535 </span><span class=\"S15EE S1071 S2\" id=\"t2b_60\">Accumulated depreciation at 31 December 2021 </span><span class=\"S15EF S1070 S2\" id=\"t2c_60\">0 </span><span class=\"S15F0 S1070 S2\" id=\"t2d_60\">3 778 </span><span class=\"S15F1 S1070 S2\" id=\"t2e_60\">2 371 </span><span class=\"S15F2 S1070 S2\" id=\"t2f_60\">442 </span><span class=\"S15F3 S1070 S2\" id=\"t2g_60\">5 954 </span><span class=\"S15F4 S1071 S2\" id=\"t2h_60\">12 545 </span><span class=\"S15F5 S1070 S2\" id=\"t2i_60\">Amortization and depreciation </span><span class=\"S15F6 S1070 S2\" id=\"t2j_60\">615 </span><span class=\"S15F7 S1070 S2\" id=\"t2k_60\">5 779 </span><span class=\"S15F8 S1070 S2\" id=\"t2l_60\">161 </span><span class=\"S15F9 S1070 S2\" id=\"t2m_60\">1 151 </span><span class=\"S15FA S1071 S2\" id=\"t2n_60\">7 706 </span><span class=\"S15FB S1070 S2\" id=\"t2o_60\">Disposals and lease expiry </span><span class=\"S15FC S1070 S2\" id=\"t2p_60\">236 </span><span class=\"S15FD S1070 S2\" id=\"t2q_60\">-486 </span><span class=\"S15FE S1071 S2\" id=\"t2r_60\">-250 </span><span class=\"S15FF S1071 S2\" id=\"t2s_60\">Accumulated depreciation at 31 December 2022 </span><span class=\"S1600 S1070 S2\" id=\"t2t_60\">0 </span><span class=\"S1601 S1070 S2\" id=\"t2u_60\">4 393 </span><span class=\"S1602 S1070 S2\" id=\"t2v_60\">8 386 </span><span class=\"S1603 S1070 S2\" id=\"t2w_60\">603 </span><span class=\"S1604 S1070 S2\" id=\"t2x_60\">6 619 </span><span class=\"S1605 S1071 S2\" id=\"t2y_60\">20 001 </span><span class=\"S1606 S1071 S2\" id=\"t2z_60\">Book value at 31 December 2021 </span><span class=\"S1607 S1070 S2\" id=\"t30_60\">0 </span><span class=\"S1608 S1070 S2\" id=\"t31_60\">1 156 </span><span class=\"S1609 S1070 S2\" id=\"t32_60\">28 691 </span><span class=\"S160A S1070 S2\" id=\"t33_60\">334 </span><span class=\"S160B S1070 S2\" id=\"t34_60\">3 394 </span><span class=\"S160C S1071 S2\" id=\"t35_60\">33 575 </span><span class=\"S160D S1071 S2\" id=\"t36_60\">Book value at 31 December 2022 </span><span class=\"S160E S1070 S2\" id=\"t37_60\">0 </span><span class=\"S160F S1070 S2\" id=\"t38_60\">1 673 </span><span class=\"S1610 S1070 S2\" id=\"t39_60\">26 091 </span><span class=\"S1611 S1070 S2\" id=\"t3a_60\">251 </span><span class=\"S1612 S1070 S2\" id=\"t3b_60\">4 464 </span><span class=\"S1613 S1071 S2\" id=\"t3c_60\">32 479 </span><span class=\"S1614 S1070 S2\" id=\"t3d_60\">PPE are depreciated on a straight-line basis over the estimated useful life of the asset as follows </span><span class=\"S1615 S1070 S2\" id=\"t3e_60\">Patent period </span><span class=\"S1616 S1070 S2\" id=\"t3f_60\">3 - 5 years </span><span class=\"S1617 S1070 S2\" id=\"t3g_60\">Contract </span><span class=\"S1618 S1070 S2\" id=\"t3h_60\">period </span><span class=\"S1619 S1070 S2\" id=\"t3i_60\">3 - 5 years </span><span class=\"S161A S1070 S2\" id=\"t3j_60\">3 - 5 years </span><span class=\"S161B S1070 S2\" id=\"t3k_60\">The note for the Parent company has immaterial di\ufb00erences to the Group and is not disclosed of this reason. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6801": {
   "value": "<span class=\"S1683 S106F S2\" id=\"t1f_61\">16. INVENTORIES </span><span class=\"S1684 S1070 S2\" id=\"t1g_61\">(Amounts in NOK 1,000) </span><span class=\"S1685 S1071 S2\" id=\"t1h_61\">Group </span><span class=\"S1686 S1071 S2\" id=\"t1i_61\">Parent </span><span class=\"S1687 S1071 S2\" id=\"t1j_61\">31-Dec-22 </span><span class=\"S1688 S1071 S2\" id=\"t1k_61\">31-Dec-21 </span><span class=\"S1689 S1071 S2\" id=\"t1l_61\">31-Dec-22 </span><span class=\"S168A S1071 S2\" id=\"t1m_61\">31-Dec-21 </span><span class=\"S168B S1070 S2\" id=\"t1n_61\">Raw materials </span><span class=\"S168C S1070 S2\" id=\"t1o_61\">3 026 </span><span class=\"S168D S1070 S2\" id=\"t1p_61\">1 485 </span><span class=\"S168E S1070 S2\" id=\"t1q_61\">3 026 </span><span class=\"S168F S1070 S2\" id=\"t1r_61\">1 485 </span><span class=\"S1690 S1070 S2\" id=\"t1s_61\">Resale products </span><span class=\"S1691 S1070 S2\" id=\"t1t_61\">48 </span><span class=\"S1692 S1070 S2\" id=\"t1u_61\">176 </span><span class=\"S1693 S1070 S2\" id=\"t1v_61\">48 </span><span class=\"S1694 S1070 S2\" id=\"t1w_61\">176 </span><span class=\"S1695 S1070 S2\" id=\"t1x_61\">Semi-\ufb01nished and \ufb01nished goods </span><span class=\"S1696 S1070 S2\" id=\"t1y_61\">23 461 </span><span class=\"S1697 S1070 S2\" id=\"t1z_61\">25 874 </span><span class=\"S1698 S1070 S2\" id=\"t20_61\">21 339 </span><span class=\"S1699 S1070 S2\" id=\"t21_61\">25 000 </span><span class=\"S169A S1071 S2\" id=\"t22_61\">Total inventories </span><span class=\"S169B S1071 S2\" id=\"t23_61\">26 534 </span><span class=\"S169C S1071 S2\" id=\"t24_61\">27 534 </span><span class=\"S169D S1071 S2\" id=\"t25_61\">24 412 </span><span class=\"S169E S1071 S2\" id=\"t26_61\">26 660 </span><span class=\"S169F S1070 S2\" id=\"t27_61\">The raw materials inventory consists of active substances for the pharmaceutical products. Raw materials are valued at cost. </span><span class=\"S16A0 S1070 S2\" id=\"t28_61\">Finished and semi-\ufb01nished goods are valued at full manufacturing cost. Consumption is accounted in accordance with the FIFO </span><span class=\"S16A1 S1070 S2\" id=\"t29_61\">principle. Obsolete goods are written down to net realisable value. Provisions and write-downs of inventories are included in cost of </span>goods sold in the income statement",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfInventoriesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6844": {
   "value": "<span class=\"S16A3 S106F S2\" id=\"t4_62\">17. FINANCIAL RISK </span><span class=\"S16A4 S1070 S2\" id=\"t5_62\">The note describes the Company\u2019s various \ufb01nancial risks and the management of same. In addition, numerical presentations of risk </span><span class=\"S16A5 S1070 S2\" id=\"t6_62\">associated with \ufb01nancial risks are included. </span><span class=\"S16A6 S1071 S2\" id=\"t7_62\">(I) Organisation of \ufb01nancial risk management </span><span class=\"S16A7 S1070 S2\" id=\"t8_62\">Photocure has an international business operation and is exposed to currency risk, interest rate risk, commodity price risk, liquidity </span><span class=\"S16A8 S1070 S2\" id=\"t9_62\">risk and credit risk. Responsibility for managing \ufb01nancial risk is placed with the management of the company, including \ufb01nancing, </span><span class=\"S16A9 S1070 S2\" id=\"ta_62\">interest rate and currency management as well as risk within the business areas and the risk associated with the company\u2019s business </span><span class=\"S16AA S1070 S2\" id=\"tb_62\">processes. Financial risk is also monitored by the Board of Directors. </span><span class=\"S16AB S16F9 S2\" id=\"tc_62\">Centralised risk management </span><span class=\"S16AC S1070 S2\" id=\"td_62\">Photocure has a centralised \ufb01nance department. This department ensures the company\u2019s \ufb01nancial freedom to act both long and </span><span class=\"S16AD S1070 S2\" id=\"te_62\">short term, and to monitor and manage \ufb01nancial risk in collaboration with the individual business units within the company. The </span><span class=\"S16AE S1070 S2\" id=\"tf_62\">\ufb01nance department maintains communication with the company\u2019s bank connections, and carries out hedging transactions regarding </span><span class=\"S16AF S1070 S2\" id=\"tg_62\">interest and currency. Required authorisations for borrowing and entering into derivative agreements are to be granted by the Board </span><span class=\"S16B0 S1070 S2\" id=\"th_62\">of Directors. All transactions involving \ufb01nancial instruments are backed by an underlying commercial hedging requirement.. </span><span class=\"S16B1 S16F9 S2\" id=\"ti_62\">Commercial operations \u2013 production, sales and marketing </span><span class=\"S16B2 S1070 S2\" id=\"tj_62\">Photocure manufactures, markets and sells the company\u2019s products through own sales organization in Europe and North America </span><span class=\"S16B3 S1070 S2\" id=\"tk_62\">and through license partners in other countries. Revenues from license partners consist of two elements: sales of products to </span><span class=\"S16B4 S1070 S2\" id=\"tl_62\">license partners and milestone revenues. Photocure manufactures the company\u2019s products by renowned contract manufacturers </span><span class=\"S16B5 S1070 S2\" id=\"tm_62\">in Italy, Spain, Netherland and Austria. Prices of raw materials is a risk factor. Photocure\u2019s commercial operations in the North </span><span class=\"S16B6 S1070 S2\" id=\"tn_62\">America expose Photocure for currency risk against USD/CAD as both revenues and expenses are in USD/CAD. The same applies </span><span class=\"S16B7 S1070 S2\" id=\"to_62\">for commercial operations in Europe which are mostly in Euros. Currency risks are partly naturally hedged by purchasing goods and </span><span class=\"S16B8 S1070 S2\" id=\"tp_62\">services in EUR and USD. </span><span class=\"S16B9 S1071 S2\" id=\"tq_62\">(II) Classes of \ufb01nancial risk </span><span class=\"S16BA S16F9 S2\" id=\"tr_62\">Interest rate risk </span><span class=\"S16BB S1070 S2\" id=\"ts_62\">Photocure has an interest bearing earnout liability from 2020 with interest rate equal to </span><span class=\"S16BC S1070 S2\" id=\"tt_62\">the internal rate of return for the investment </span><span class=\"S16BD S1070 S2\" id=\"tu_62\">project. In addition Photocure has interest bearing bank loan, leasing liability and pension liability. The long-term bank loan has a </span><span class=\"S16BE S1070 S2\" id=\"tv_62\">\ufb02oating interest and </span><span class=\"S16BF S1070 S2\" id=\"tw_62\">90% of the loan has a state guarantee. </span><span class=\"S16C0 S1070 S2\" id=\"tx_62\">The company\u2019s risk related to interest income is mainly associated with the company\u2019s holdings of cash and cash equivalents. The </span><span class=\"S16C1 S1070 S2\" id=\"ty_62\">main strategy is to diversify the risk and invest in money market funds and bond funds with low risk, high liquidity and short duration. </span><span class=\"S16C2 S1070 S2\" id=\"tz_62\">More than 90% of the investments are denominated in NOK and are not hedged. </span><span class=\"S16C3 S16F9 S2\" id=\"t10_62\">Liquidity and funding risk </span><span class=\"S16C4 S1070 S2\" id=\"t11_62\">The Company monitors its cash \ufb02ows from both long and short-term perspectives through planning and reporting. Photocure does </span><span class=\"S16C5 S1070 S2\" id=\"t12_62\">not have any loan agreements that involve covenants or other restrictions. Photocure uses a multi-currency consolidated bank </span><span class=\"S16C6 S1070 S2\" id=\"t13_62\">accounts system that provides \ufb02exibility in relation to drawing on multiple currencies. The company may require new capital in the </span><span class=\"S16C7 S1070 S2\" id=\"t14_62\">future. Adequate sources of capital funding may not be available when needed or may not be available on favorable terms. </span><span class=\"S16C8 S1070 S2\" id=\"t15_62\">A main objective of Photocure\u2019s \ufb01nancial policy is to ensure that the company has the \ufb01nancial freedom to act both short and long </span><span class=\"S16C9 S1070 S2\" id=\"t16_62\">term to achieve strategic and operational goals. Photocure\u2019s policy is to have su\ufb03cient funds to cover known capital requirements </span><span class=\"S16CA S1070 S2\" id=\"t17_62\">during the forthcoming 12 months in addition to a strategic reserve. Photocure follows a low risk investment strategy for its liquid </span><span class=\"S16CB S1070 S2\" id=\"t18_62\">funds. The return on the liquid funds depends on the rate of interest in the money markets and will therefore vary over time. </span><span class=\"S16CC S1071 S2\" id=\"t19_62\">Remaining period </span><span class=\"S16CD S1070 S2\" id=\"t1a_62\">(Amounts in NOK 1,000) </span><span class=\"S16CE S1071 S2\" id=\"t1b_62\">Less than 1 month </span><span class=\"S16CF S1071 S2\" id=\"t1c_62\">1\u20133 months </span><span class=\"S16D0 S1071 S2\" id=\"t1d_62\">3\u201312 months </span><span class=\"S16D1 S1071 S2\" id=\"t1e_62\">1\u20135 years </span><span class=\"S16D2 S1071 S2\" id=\"t1f_62\">Total </span><span class=\"S16D3 S1071 S2\" id=\"t1g_62\">31-Dec-22 </span><span class=\"S16D4 S1070 S2\" id=\"t1h_62\">Accounts payable </span><span class=\"S16D5 S1070 S2\" id=\"t1i_62\">18 091 </span><span class=\"S16D6 S1070 S2\" id=\"t1j_62\">3 190 </span><span class=\"S16D7 S1071 S2\" id=\"t1k_62\">21 281 </span><span class=\"S16D8 S1070 S2\" id=\"t1l_62\">Withholding tax and social securities </span><span class=\"S16D9 S1070 S2\" id=\"t1m_62\">2 440 </span><span class=\"S16DA S1070 S2\" id=\"t1n_62\">1 500 </span><span class=\"S16DB S1070 S2\" id=\"t1o_62\">647 </span><span class=\"S16DC S1071 S2\" id=\"t1p_62\">4 587 </span><span class=\"S16DD S1070 S2\" id=\"t1q_62\">Other current liabilities </span><span class=\"S16DE S1070 S2\" id=\"t1r_62\">20 630 </span><span class=\"S16DF S1070 S2\" id=\"t1s_62\">13 000 </span><span class=\"S16E0 S1070 S2\" id=\"t1t_62\">17 177 </span><span class=\"S16E1 S1071 S2\" id=\"t1u_62\">50 807 </span><span class=\"S16E2 S1070 S2\" id=\"t1v_62\">Loan and lease liabilities </span><span class=\"S16E3 S1070 S2\" id=\"t1w_62\">7 250 </span><span class=\"S16E4 S1070 S2\" id=\"t1x_62\">18 750 </span><span class=\"S16E5 S1070 S2\" id=\"t1y_62\">151 370 </span><span class=\"S16E6 S1071 S2\" id=\"t1z_62\">177 370 </span><span class=\"S16E7 S1071 S2\" id=\"t20_62\">31-Dec-21 </span><span class=\"S16E8 S1070 S2\" id=\"t21_62\">Accounts payable </span><span class=\"S16E9 S1070 S2\" id=\"t22_62\">19 748 </span><span class=\"S16EA S1070 S2\" id=\"t23_62\">3 900 </span><span class=\"S16EB S1071 S2\" id=\"t24_62\">23 648 </span><span class=\"S16EC S1070 S2\" id=\"t25_62\">Withholding tax and social securities </span><span class=\"S16ED S1070 S2\" id=\"t26_62\">771 </span><span class=\"S16EE S1070 S2\" id=\"t27_62\">2 230 </span><span class=\"S16EF S1071 S2\" id=\"t28_62\">3 001 </span><span class=\"S16F0 S1070 S2\" id=\"t29_62\">Other current liabilities </span><span class=\"S16F1 S1070 S2\" id=\"t2a_62\">3 500 </span><span class=\"S16F2 S1070 S2\" id=\"t2b_62\">28 000 </span><span class=\"S16F3 S1070 S2\" id=\"t2c_62\">18 854 </span><span class=\"S16F4 S1071 S2\" id=\"t2d_62\">50 354 </span><span class=\"S16F5 S1070 S2\" id=\"t2e_62\">Loan and lease liabilities </span><span class=\"S16F6 S1070 S2\" id=\"t2f_62\">36 580 </span><span class=\"S16F7 S1070 S2\" id=\"t2g_62\">169 913 </span><span class=\"S16F8 S1071 S2\" id=\"t2h_62\">206 493 </span><span class=\"S16FA S16F9 S2\" id=\"t2_63\">Credit risk </span><span class=\"S16FB S1070 S2\" id=\"t3_63\">Management of credit risk associated with accounts receivable and other operational receivables is dealt with as a part of the </span><span class=\"S16FC S1070 S2\" id=\"t4_63\">commercial risk and is followed up continuously as a part of normal operations. Photocure is primarily exposed to credit risk </span><span class=\"S16FD S1070 S2\" id=\"t5_63\">associated with accounts receivable and other short-term receivables. Photocure\u2019s sales is a mix of sales directly to hospitals, </span><span class=\"S16FE S1070 S2\" id=\"t6_63\">pharmacies and wholesalers in Europe and North America. The credit risk is limited as the customers are hospitals which are either </span><span class=\"S16FF S1070 S2\" id=\"t7_63\">publicly owned or \ufb01nanced by public funds or insurance companies. The same applies for the wholesalers customers. </span><span class=\"S1700 S1070 S2\" id=\"t8_63\">Photocure\u2019s </span><span class=\"S1701 S1070 S2\" id=\"t9_63\">credit risk is considered moderate and the Company does not use credit insurance. </span><span class=\"S1702 S16F9 S2\" id=\"ta_63\">Currency risk </span><span class=\"S1703 S1070 S152D S2\" id=\"tb_63\">As NOK is the Company\u2019s presentation currency, Photocure is exposed to translation risk associated with the company\u2019s foreign net </span><span class=\"S1704 S1070 S152D S2\" id=\"tc_63\">exposure. Photocure\u2019s revenues and costs are incurred in di\ufb00erent currencies, primarily EUR, USD, GBP and SEK. Photocure is therefore </span><span class=\"S1705 S1070 S152D S2\" id=\"td_63\">exposed to exchange rate \ufb02uctuations. The company regularly monitors the need for hedging of large transactions. Bank accounts in </span><span class=\"S1706 S1070 S152D S2\" id=\"te_63\">foreign currencies are used actively to reduce exposure to all the main currencies, and currency risk is to some degree naturally hedged </span><span class=\"S1707 S1070 S152D S2\" id=\"tf_63\">in EUR, USD and SEK by having both revenues and costs in the same currency. However, Photocure have in both 2022 and 2021 cash </span><span class=\"S1708 S1070 S152D S2\" id=\"tg_63\">surplus in EUR and a cash de\ufb01cit in USD. The Company has not entered into any currency hedging contracts during 2022. </span><span class=\"S1709 S1070 S2\" id=\"th_63\">The following table shows the Company\u2019s sensitivity for potential changes in the NOK exchange rate with all other factors constant. </span><span class=\"S170A S1070 S2\" id=\"ti_63\">The calculation is based on the same change in relation to all relevant currencies. The e\ufb00ect in the income statement comes from </span><span class=\"S170B S1070 S2\" id=\"tj_63\">changes in the value of monetary items. </span><span class=\"S170C S1070 S2\" id=\"tk_63\">(Amounts in NOK 1,000) </span><span class=\"S170D S1071 S2\" id=\"tl_63\">Change in the NOK exchange rate </span><span class=\"S170E S1071 S2\" id=\"tm_63\">E\ufb00ect on operating pro\ufb01t/loss </span><span class=\"S170F S1071 S2\" id=\"tn_63\">2022 </span><span class=\"S1710 S1070 S2\" id=\"to_63\">+ 10 % </span><span class=\"S1711 S1070 S2\" id=\"tp_63\">-2 270 </span><span class=\"S1712 S1071 S2\" id=\"tq_63\">2022 </span><span class=\"S1713 S1070 S2\" id=\"tr_63\">- 10 % </span><span class=\"S1714 S1070 S2\" id=\"ts_63\">2 270 </span><span class=\"S1715 S1071 S2\" id=\"tt_63\">2021 </span><span class=\"S1716 S1070 S2\" id=\"tu_63\">+ 10 % </span><span class=\"S1717 S1070 S2\" id=\"tv_63\">-7 187 </span><span class=\"S1718 S1071 S2\" id=\"tw_63\">2021 </span><span class=\"S1719 S1070 S2\" id=\"tx_63\">- 10 % </span><span class=\"S171A S1070 S2\" id=\"ty_63\">7 187 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6869": {
   "value": "<span class=\"S16BA S16F9 S2\" id=\"tr_62\">Interest rate risk </span><span class=\"S16BB S1070 S2\" id=\"ts_62\">Photocure has an interest bearing earnout liability from 2020 with interest rate equal to </span><span class=\"S16BC S1070 S2\" id=\"tt_62\">the internal rate of return for the investment </span><span class=\"S16BD S1070 S2\" id=\"tu_62\">project. In addition Photocure has interest bearing bank loan, leasing liability and pension liability. The long-term bank loan has a </span><span class=\"S16BE S1070 S2\" id=\"tv_62\">\ufb02oating interest and </span><span class=\"S16BF S1070 S2\" id=\"tw_62\">90% of the loan has a state guarantee. </span><span class=\"S16C0 S1070 S2\" id=\"tx_62\">The company\u2019s risk related to interest income is mainly associated with the company\u2019s holdings of cash and cash equivalents. The </span><span class=\"S16C1 S1070 S2\" id=\"ty_62\">main strategy is to diversify the risk and invest in money market funds and bond funds with low risk, high liquidity and short duration. </span><span class=\"S16C2 S1070 S2\" id=\"tz_62\">More than 90% of the investments are denominated in NOK and are not hedged. </span><span class=\"S1702 S16F9 S2\" id=\"ta_63\">Currency risk </span><span class=\"S1703 S1070 S152D S2\" id=\"tb_63\">As NOK is the Company\u2019s presentation currency, Photocure is exposed to translation risk associated with the company\u2019s foreign net </span><span class=\"S1704 S1070 S152D S2\" id=\"tc_63\">exposure. Photocure\u2019s revenues and costs are incurred in di\ufb00erent currencies, primarily EUR, USD, GBP and SEK. Photocure is therefore </span><span class=\"S1705 S1070 S152D S2\" id=\"td_63\">exposed to exchange rate \ufb02uctuations. The company regularly monitors the need for hedging of large transactions. Bank accounts in </span><span class=\"S1706 S1070 S152D S2\" id=\"te_63\">foreign currencies are used actively to reduce exposure to all the main currencies, and currency risk is to some degree naturally hedged </span><span class=\"S1707 S1070 S152D S2\" id=\"tf_63\">in EUR, USD and SEK by having both revenues and costs in the same currency. However, Photocure have in both 2022 and 2021 cash </span><span class=\"S1708 S1070 S152D S2\" id=\"tg_63\">surplus in EUR and a cash de\ufb01cit in USD. The Company has not entered into any currency hedging contracts during 2022. </span><span class=\"S1709 S1070 S2\" id=\"th_63\">The following table shows the Company\u2019s sensitivity for potential changes in the NOK exchange rate with all other factors constant. </span><span class=\"S170A S1070 S2\" id=\"ti_63\">The calculation is based on the same change in relation to all relevant currencies. The e\ufb00ect in the income statement comes from </span><span class=\"S170B S1070 S2\" id=\"tj_63\">changes in the value of monetary items. </span><span class=\"S170C S1070 S2\" id=\"tk_63\">(Amounts in NOK 1,000) </span><span class=\"S170D S1071 S2\" id=\"tl_63\">Change in the NOK exchange rate </span><span class=\"S170E S1071 S2\" id=\"tm_63\">E\ufb00ect on operating pro\ufb01t/loss </span><span class=\"S170F S1071 S2\" id=\"tn_63\">2022 </span><span class=\"S1710 S1070 S2\" id=\"to_63\">+ 10 % </span><span class=\"S1711 S1070 S2\" id=\"tp_63\">-2 270 </span><span class=\"S1712 S1071 S2\" id=\"tq_63\">2022 </span><span class=\"S1713 S1070 S2\" id=\"tr_63\">- 10 % </span><span class=\"S1714 S1070 S2\" id=\"ts_63\">2 270 </span><span class=\"S1715 S1071 S2\" id=\"tt_63\">2021 </span><span class=\"S1716 S1070 S2\" id=\"tu_63\">+ 10 % </span><span class=\"S1717 S1070 S2\" id=\"tv_63\">-7 187 </span><span class=\"S1718 S1071 S2\" id=\"tw_63\">2021 </span><span class=\"S1719 S1070 S2\" id=\"tx_63\">- 10 % </span><span class=\"S171A S1070 S2\" id=\"ty_63\">7 187 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfMarketRiskExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6879": {
   "value": "<span class=\"S16C3 S16F9 S2\" id=\"t10_62\">Liquidity and funding risk </span><span class=\"S16C4 S1070 S2\" id=\"t11_62\">The Company monitors its cash \ufb02ows from both long and short-term perspectives through planning and reporting. Photocure does </span><span class=\"S16C5 S1070 S2\" id=\"t12_62\">not have any loan agreements that involve covenants or other restrictions. Photocure uses a multi-currency consolidated bank </span><span class=\"S16C6 S1070 S2\" id=\"t13_62\">accounts system that provides \ufb02exibility in relation to drawing on multiple currencies. The company may require new capital in the </span><span class=\"S16C7 S1070 S2\" id=\"t14_62\">future. Adequate sources of capital funding may not be available when needed or may not be available on favorable terms. </span><span class=\"S16C8 S1070 S2\" id=\"t15_62\">A main objective of Photocure\u2019s \ufb01nancial policy is to ensure that the company has the \ufb01nancial freedom to act both short and long </span><span class=\"S16C9 S1070 S2\" id=\"t16_62\">term to achieve strategic and operational goals. Photocure\u2019s policy is to have su\ufb03cient funds to cover known capital requirements </span><span class=\"S16CA S1070 S2\" id=\"t17_62\">during the forthcoming 12 months in addition to a strategic reserve. Photocure follows a low risk investment strategy for its liquid </span><span class=\"S16CB S1070 S2\" id=\"t18_62\">funds. The return on the liquid funds depends on the rate of interest in the money markets and will therefore vary over time. </span><span class=\"S16CC S1071 S2\" id=\"t19_62\">Remaining period </span><span class=\"S16CD S1070 S2\" id=\"t1a_62\">(Amounts in NOK 1,000) </span><span class=\"S16CE S1071 S2\" id=\"t1b_62\">Less than 1 month </span><span class=\"S16CF S1071 S2\" id=\"t1c_62\">1\u20133 months </span><span class=\"S16D0 S1071 S2\" id=\"t1d_62\">3\u201312 months </span><span class=\"S16D1 S1071 S2\" id=\"t1e_62\">1\u20135 years </span><span class=\"S16D2 S1071 S2\" id=\"t1f_62\">Total </span><span class=\"S16D3 S1071 S2\" id=\"t1g_62\">31-Dec-22 </span><span class=\"S16D4 S1070 S2\" id=\"t1h_62\">Accounts payable </span><span class=\"S16D5 S1070 S2\" id=\"t1i_62\">18 091 </span><span class=\"S16D6 S1070 S2\" id=\"t1j_62\">3 190 </span><span class=\"S16D7 S1071 S2\" id=\"t1k_62\">21 281 </span><span class=\"S16D8 S1070 S2\" id=\"t1l_62\">Withholding tax and social securities </span><span class=\"S16D9 S1070 S2\" id=\"t1m_62\">2 440 </span><span class=\"S16DA S1070 S2\" id=\"t1n_62\">1 500 </span><span class=\"S16DB S1070 S2\" id=\"t1o_62\">647 </span><span class=\"S16DC S1071 S2\" id=\"t1p_62\">4 587 </span><span class=\"S16DD S1070 S2\" id=\"t1q_62\">Other current liabilities </span><span class=\"S16DE S1070 S2\" id=\"t1r_62\">20 630 </span><span class=\"S16DF S1070 S2\" id=\"t1s_62\">13 000 </span><span class=\"S16E0 S1070 S2\" id=\"t1t_62\">17 177 </span><span class=\"S16E1 S1071 S2\" id=\"t1u_62\">50 807 </span><span class=\"S16E2 S1070 S2\" id=\"t1v_62\">Loan and lease liabilities </span><span class=\"S16E3 S1070 S2\" id=\"t1w_62\">7 250 </span><span class=\"S16E4 S1070 S2\" id=\"t1x_62\">18 750 </span><span class=\"S16E5 S1070 S2\" id=\"t1y_62\">151 370 </span><span class=\"S16E6 S1071 S2\" id=\"t1z_62\">177 370 </span><span class=\"S16E7 S1071 S2\" id=\"t20_62\">31-Dec-21 </span><span class=\"S16E8 S1070 S2\" id=\"t21_62\">Accounts payable </span><span class=\"S16E9 S1070 S2\" id=\"t22_62\">19 748 </span><span class=\"S16EA S1070 S2\" id=\"t23_62\">3 900 </span><span class=\"S16EB S1071 S2\" id=\"t24_62\">23 648 </span><span class=\"S16EC S1070 S2\" id=\"t25_62\">Withholding tax and social securities </span><span class=\"S16ED S1070 S2\" id=\"t26_62\">771 </span><span class=\"S16EE S1070 S2\" id=\"t27_62\">2 230 </span><span class=\"S16EF S1071 S2\" id=\"t28_62\">3 001 </span><span class=\"S16F0 S1070 S2\" id=\"t29_62\">Other current liabilities </span><span class=\"S16F1 S1070 S2\" id=\"t2a_62\">3 500 </span><span class=\"S16F2 S1070 S2\" id=\"t2b_62\">28 000 </span><span class=\"S16F3 S1070 S2\" id=\"t2c_62\">18 854 </span><span class=\"S16F4 S1071 S2\" id=\"t2d_62\">50 354 </span><span class=\"S16F5 S1070 S2\" id=\"t2e_62\">Loan and lease liabilities </span><span class=\"S16F6 S1070 S2\" id=\"t2f_62\">36 580 </span><span class=\"S16F7 S1070 S2\" id=\"t2g_62\">169 913 </span><span class=\"S16F8 S1071 S2\" id=\"t2h_62\">206 493 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfLiquidityRiskExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6943": {
   "value": "<span class=\"S16FA S16F9 S2\" id=\"t2_63\">Credit risk </span><span class=\"S16FB S1070 S2\" id=\"t3_63\">Management of credit risk associated with accounts receivable and other operational receivables is dealt with as a part of the </span><span class=\"S16FC S1070 S2\" id=\"t4_63\">commercial risk and is followed up continuously as a part of normal operations. Photocure is primarily exposed to credit risk </span><span class=\"S16FD S1070 S2\" id=\"t5_63\">associated with accounts receivable and other short-term receivables. Photocure\u2019s sales is a mix of sales directly to hospitals, </span><span class=\"S16FE S1070 S2\" id=\"t6_63\">pharmacies and wholesalers in Europe and North America. The credit risk is limited as the customers are hospitals which are either </span><span class=\"S16FF S1070 S2\" id=\"t7_63\">publicly owned or \ufb01nanced by public funds or insurance companies. The same applies for the wholesalers customers. </span><span class=\"S1700 S1070 S2\" id=\"t8_63\">Photocure\u2019s </span><span class=\"S1701 S1070 S2\" id=\"t9_63\">credit risk is considered moderate and the Company does not use credit insurance. </span><span class=\"S1738 S1071 S2\" id=\"tw_64\">Maximum credit risk </span><span class=\"S1739 S1070 S2\" id=\"tx_64\">The company\u2019s maximum credit risk associated with \ufb01nancial instruments corresponds to gross receivables. In a hypothetical </span><span class=\"S173A S1070 S2\" id=\"ty_64\">situations, where no receivables are actually paid, this would correspond to: </span><span class=\"S173B S1070 S2\" id=\"tz_64\">(Amounts in NOK 1,000) </span><span class=\"S173C S1071 S2\" id=\"t10_64\">Group </span><span class=\"S173D S1071 S2\" id=\"t11_64\">Parent </span><span class=\"S173E S1071 S2\" id=\"t12_64\">31-Dec-22 </span><span class=\"S173F S1071 S2\" id=\"t13_64\">31-Dec-21 </span><span class=\"S1740 S1071 S2\" id=\"t14_64\">31-Dec-22 </span><span class=\"S1741 S1071 S2\" id=\"t15_64\">31-Dec-21 </span><span class=\"S1742 S1070 S2\" id=\"t16_64\">Accounts receivable </span><span class=\"S1743 S1070 S2\" id=\"t17_64\">47 164 </span><span class=\"S1744 S1070 S2\" id=\"t18_64\">47 980 </span><span class=\"S1745 S1070 S2\" id=\"t19_64\">27 005 </span><span class=\"S1746 S1070 S2\" id=\"t1a_64\">29 610 </span><span class=\"S1747 S1070 S2\" id=\"t1b_64\">Accounts receivable intercompany </span><span class=\"S1748 S1070 S2\" id=\"t1c_64\">- </span><span class=\"S1749 S1070 S2\" id=\"t1d_64\">- </span><span class=\"S174A S1070 S2\" id=\"t1e_64\">4 733 </span><span class=\"S174B S1070 S2\" id=\"t1f_64\">0 </span><span class=\"S174C S1071 S2\" id=\"t1g_64\">Total </span><span class=\"S174D S1071 S2\" id=\"t1h_64\">47 164 </span><span class=\"S174E S1071 S2\" id=\"t1i_64\">47 980 </span><span class=\"S174F S1071 S2\" id=\"t1j_64\">31 738 </span><span class=\"S1750 S1071 S2\" id=\"t1k_64\">29 610 </span><span class=\"S1751 S1070 S2\" id=\"t1l_64\">Prepaid expenses </span><span class=\"S1752 S1070 S2\" id=\"t1m_64\">9 113 </span><span class=\"S1753 S1070 S2\" id=\"t1n_64\">9 852 </span><span class=\"S1754 S1070 S2\" id=\"t1o_64\">5 516 </span><span class=\"S1755 S1070 S2\" id=\"t1p_64\">4 697 </span><span class=\"S1756 S1070 S2\" id=\"t1q_64\">Other receivables and deposits </span><span class=\"S1757 S1070 S2\" id=\"t1r_64\">7 342 </span><span class=\"S1758 S1070 S2\" id=\"t1s_64\">4 928 </span><span class=\"S1759 S1070 S2\" id=\"t1t_64\">1 001 </span><span class=\"S175A S1070 S2\" id=\"t1u_64\">512 </span><span class=\"S175B S1071 S2\" id=\"t1v_64\">Total other receivables </span><span class=\"S175C S1071 S2\" id=\"t1w_64\">16 455 </span><span class=\"S175D S1071 S2\" id=\"t1x_64\">14 780 </span><span class=\"S175E S1071 S2\" id=\"t1y_64\">6 517 </span><span class=\"S175F S1071 S2\" id=\"t1z_64\">5 209 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCreditRiskExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6952": {
   "value": "<span class=\"S1702 S16F9 S2\" id=\"ta_63\">Currency risk </span><span class=\"S1703 S1070 S152D S2\" id=\"tb_63\">As NOK is the Company\u2019s presentation currency, Photocure is exposed to translation risk associated with the company\u2019s foreign net </span><span class=\"S1704 S1070 S152D S2\" id=\"tc_63\">exposure. Photocure\u2019s revenues and costs are incurred in di\ufb00erent currencies, primarily EUR, USD, GBP and SEK. Photocure is therefore </span><span class=\"S1705 S1070 S152D S2\" id=\"td_63\">exposed to exchange rate \ufb02uctuations. The company regularly monitors the need for hedging of large transactions. Bank accounts in </span><span class=\"S1706 S1070 S152D S2\" id=\"te_63\">foreign currencies are used actively to reduce exposure to all the main currencies, and currency risk is to some degree naturally hedged </span><span class=\"S1707 S1070 S152D S2\" id=\"tf_63\">in EUR, USD and SEK by having both revenues and costs in the same currency. However, Photocure have in both 2022 and 2021 cash </span><span class=\"S1708 S1070 S152D S2\" id=\"tg_63\">surplus in EUR and a cash de\ufb01cit in USD. The Company has not entered into any currency hedging contracts during 2022. </span><span class=\"S1709 S1070 S2\" id=\"th_63\">The following table shows the Company\u2019s sensitivity for potential changes in the NOK exchange rate with all other factors constant. </span><span class=\"S170A S1070 S2\" id=\"ti_63\">The calculation is based on the same change in relation to all relevant currencies. The e\ufb00ect in the income statement comes from </span><span class=\"S170B S1070 S2\" id=\"tj_63\">changes in the value of monetary items. </span><span class=\"S170C S1070 S2\" id=\"tk_63\">(Amounts in NOK 1,000) </span><span class=\"S170D S1071 S2\" id=\"tl_63\">Change in the NOK exchange rate </span><span class=\"S170E S1071 S2\" id=\"tm_63\">E\ufb00ect on operating pro\ufb01t/loss </span><span class=\"S170F S1071 S2\" id=\"tn_63\">2022 </span><span class=\"S1710 S1070 S2\" id=\"to_63\">+ 10 % </span><span class=\"S1711 S1070 S2\" id=\"tp_63\">-2 270 </span><span class=\"S1712 S1071 S2\" id=\"tq_63\">2022 </span><span class=\"S1713 S1070 S2\" id=\"tr_63\">- 10 % </span><span class=\"S1714 S1070 S2\" id=\"ts_63\">2 270 </span><span class=\"S1715 S1071 S2\" id=\"tt_63\">2021 </span><span class=\"S1716 S1070 S2\" id=\"tu_63\">+ 10 % </span><span class=\"S1717 S1070 S2\" id=\"tv_63\">-7 187 </span><span class=\"S1718 S1071 S2\" id=\"tw_63\">2021 </span><span class=\"S1719 S1070 S2\" id=\"tx_63\">- 10 % </span><span class=\"S171A S1070 S2\" id=\"ty_63\">7 187 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6989": {
   "value": "<span class=\"S171C S106F S2\" id=\"t4_64\">18. FAIR VALUE </span><span class=\"S171D S1070 S2\" id=\"t5_64\">The table below analyses \ufb01nancial assets recognised in the balance sheet at fair value according to the valuation method. </span><span class=\"S171E S1070 S2\" id=\"t6_64\">The di\ufb00erent levels have been de\ufb01ned as follows: </span><span class=\"S171F S1070 S2\" id=\"t7_64\">Level 1: </span><span class=\"S1720 S1070 S2\" id=\"t8_64\">Noted prices in active markets for corresponding assets or liabilities. </span><span class=\"S1721 S1070 S2\" id=\"t9_64\">Level 2: </span><span class=\"S1722 S1070 S2\" id=\"ta_64\">Available value measurements other than the noted prices classi\ufb01ed as Level 1, either directly observable in the form </span><span class=\"S1723 S1070 S2\" id=\"tb_64\">of agreed prices or indirectly as derived from the price of equivalent. </span><span class=\"S1724 S1070 S2\" id=\"tc_64\">Level 3: </span><span class=\"S1725 S1070 S2\" id=\"td_64\">Value measurements of assets or liabilities that are not based on observed market values. </span><span class=\"S1726 S1070 S2\" id=\"te_64\">(Amounts in NOK 1,000) </span><span class=\"S1727 S1071 S2\" id=\"tf_64\">Market value hierarchy </span><span class=\"S1728 S1071 S2\" id=\"tg_64\">Level 1 </span><span class=\"S1729 S1071 S2\" id=\"th_64\">Level 2 </span><span class=\"S172A S1071 S2\" id=\"ti_64\">Level 3 </span><span class=\"S172B S1071 S2\" id=\"tj_64\">Total </span><span class=\"S172C S1070 S2\" id=\"tk_64\">Money market funds </span><span class=\"S172D S1070 S2\" id=\"tl_64\">234 202 </span><span class=\"S172E S1070 S2\" id=\"tm_64\">234 202 </span><span class=\"S172F S1070 S2\" id=\"tn_64\">Earnout liability, ref note 22 </span><span class=\"S1730 S1070 S2\" id=\"to_64\">(135 333) </span><span class=\"S1731 S1070 S2\" id=\"tp_64\">(135 333) </span><span class=\"S1732 S1071 S2\" id=\"tq_64\">Total </span><span class=\"S1733 S1071 S2\" id=\"tr_64\">234 202 </span><span class=\"S1734 S1071 S2\" id=\"ts_64\">- </span><span class=\"S1735 S1071 S2\" id=\"tt_64\">(135 333) </span><span class=\"S1736 S1071 S2\" id=\"tu_64\">98 869 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f6990": {
   "value": "<span class=\"S171C S106F S2\" id=\"t4_64\">18. FAIR VALUE </span><span class=\"S171D S1070 S2\" id=\"t5_64\">The table below analyses \ufb01nancial assets recognised in the balance sheet at fair value according to the valuation method. </span><span class=\"S171E S1070 S2\" id=\"t6_64\">The di\ufb00erent levels have been de\ufb01ned as follows: </span><span class=\"S171F S1070 S2\" id=\"t7_64\">Level 1: </span><span class=\"S1720 S1070 S2\" id=\"t8_64\">Noted prices in active markets for corresponding assets or liabilities. </span><span class=\"S1721 S1070 S2\" id=\"t9_64\">Level 2: </span><span class=\"S1722 S1070 S2\" id=\"ta_64\">Available value measurements other than the noted prices classi\ufb01ed as Level 1, either directly observable in the form </span><span class=\"S1723 S1070 S2\" id=\"tb_64\">of agreed prices or indirectly as derived from the price of equivalent. </span><span class=\"S1724 S1070 S2\" id=\"tc_64\">Level 3: </span><span class=\"S1725 S1070 S2\" id=\"td_64\">Value measurements of assets or liabilities that are not based on observed market values. </span><span class=\"S1726 S1070 S2\" id=\"te_64\">(Amounts in NOK 1,000) </span><span class=\"S1727 S1071 S2\" id=\"tf_64\">Market value hierarchy </span><span class=\"S1728 S1071 S2\" id=\"tg_64\">Level 1 </span><span class=\"S1729 S1071 S2\" id=\"th_64\">Level 2 </span><span class=\"S172A S1071 S2\" id=\"ti_64\">Level 3 </span><span class=\"S172B S1071 S2\" id=\"tj_64\">Total </span><span class=\"S172C S1070 S2\" id=\"tk_64\">Money market funds </span><span class=\"S172D S1070 S2\" id=\"tl_64\">234 202 </span><span class=\"S172E S1070 S2\" id=\"tm_64\">234 202 </span><span class=\"S172F S1070 S2\" id=\"tn_64\">Earnout liability, ref note 22 </span><span class=\"S1730 S1070 S2\" id=\"to_64\">(135 333) </span><span class=\"S1731 S1070 S2\" id=\"tp_64\">(135 333) </span><span class=\"S1732 S1071 S2\" id=\"tq_64\">Total </span><span class=\"S1733 S1071 S2\" id=\"tr_64\">234 202 </span><span class=\"S1734 S1071 S2\" id=\"ts_64\">- </span><span class=\"S1735 S1071 S2\" id=\"tt_64\">(135 333) </span><span class=\"S1736 S1071 S2\" id=\"tu_64\">98 869 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7018": {
   "value": "<span class=\"S1737 S106F S2\" id=\"tv_64\">19. RECEIVABLES </span><span class=\"S1738 S1071 S2\" id=\"tw_64\">Maximum credit risk </span><span class=\"S1739 S1070 S2\" id=\"tx_64\">The company\u2019s maximum credit risk associated with \ufb01nancial instruments corresponds to gross receivables. In a hypothetical </span><span class=\"S173A S1070 S2\" id=\"ty_64\">situations, where no receivables are actually paid, this would correspond to: </span><span class=\"S173B S1070 S2\" id=\"tz_64\">(Amounts in NOK 1,000) </span><span class=\"S173C S1071 S2\" id=\"t10_64\">Group </span><span class=\"S173D S1071 S2\" id=\"t11_64\">Parent </span><span class=\"S173E S1071 S2\" id=\"t12_64\">31-Dec-22 </span><span class=\"S173F S1071 S2\" id=\"t13_64\">31-Dec-21 </span><span class=\"S1740 S1071 S2\" id=\"t14_64\">31-Dec-22 </span><span class=\"S1741 S1071 S2\" id=\"t15_64\">31-Dec-21 </span><span class=\"S1742 S1070 S2\" id=\"t16_64\">Accounts receivable </span><span class=\"S1743 S1070 S2\" id=\"t17_64\">47 164 </span><span class=\"S1744 S1070 S2\" id=\"t18_64\">47 980 </span><span class=\"S1745 S1070 S2\" id=\"t19_64\">27 005 </span><span class=\"S1746 S1070 S2\" id=\"t1a_64\">29 610 </span><span class=\"S1747 S1070 S2\" id=\"t1b_64\">Accounts receivable intercompany </span><span class=\"S1748 S1070 S2\" id=\"t1c_64\">- </span><span class=\"S1749 S1070 S2\" id=\"t1d_64\">- </span><span class=\"S174A S1070 S2\" id=\"t1e_64\">4 733 </span><span class=\"S174B S1070 S2\" id=\"t1f_64\">0 </span><span class=\"S174C S1071 S2\" id=\"t1g_64\">Total </span><span class=\"S174D S1071 S2\" id=\"t1h_64\">47 164 </span><span class=\"S174E S1071 S2\" id=\"t1i_64\">47 980 </span><span class=\"S174F S1071 S2\" id=\"t1j_64\">31 738 </span><span class=\"S1750 S1071 S2\" id=\"t1k_64\">29 610 </span><span class=\"S1751 S1070 S2\" id=\"t1l_64\">Prepaid expenses </span><span class=\"S1752 S1070 S2\" id=\"t1m_64\">9 113 </span><span class=\"S1753 S1070 S2\" id=\"t1n_64\">9 852 </span><span class=\"S1754 S1070 S2\" id=\"t1o_64\">5 516 </span><span class=\"S1755 S1070 S2\" id=\"t1p_64\">4 697 </span><span class=\"S1756 S1070 S2\" id=\"t1q_64\">Other receivables and deposits </span><span class=\"S1757 S1070 S2\" id=\"t1r_64\">7 342 </span><span class=\"S1758 S1070 S2\" id=\"t1s_64\">4 928 </span><span class=\"S1759 S1070 S2\" id=\"t1t_64\">1 001 </span><span class=\"S175A S1070 S2\" id=\"t1u_64\">512 </span><span class=\"S175B S1071 S2\" id=\"t1v_64\">Total other receivables </span><span class=\"S175C S1071 S2\" id=\"t1w_64\">16 455 </span><span class=\"S175D S1071 S2\" id=\"t1x_64\">14 780 </span><span class=\"S175E S1071 S2\" id=\"t1y_64\">6 517 </span><span class=\"S175F S1071 S2\" id=\"t1z_64\">5 209 </span><span class=\"S1760 S1070 S2\" id=\"t20_64\">Loan to the subsidiary is disclosed in Note 10. </span><span class=\"S1761 S1071 S2\" id=\"t21_64\">Age breakdown of group accounts receivable </span><span class=\"S1762 S1071 S2\" id=\"t22_64\">Not yet </span><span class=\"S1763 S1071 S2\" id=\"t23_64\">due </span><span class=\"S1764 S1071 S2\" id=\"t24_64\">0\u201330 </span><span class=\"S1765 S1071 S2\" id=\"t25_64\">days </span><span class=\"S1766 S1071 S2\" id=\"t26_64\">30\u201360 </span><span class=\"S1767 S1071 S2\" id=\"t27_64\">days </span><span class=\"S1768 S1071 S2\" id=\"t28_64\">60\u201390 </span><span class=\"S1769 S1071 S2\" id=\"t29_64\">days </span><span class=\"S176A S1071 S2\" id=\"t2a_64\">Over 90 </span><span class=\"S176B S1071 S2\" id=\"t2b_64\">days </span><span class=\"S176C S1071 S2\" id=\"t2c_64\">Total </span><span class=\"S176D S1070 S2\" id=\"t2d_64\">31 December 2022 </span><span class=\"S176E S1070 S2\" id=\"t2e_64\">33 106 </span><span class=\"S176F S1070 S2\" id=\"t2f_64\">8 340 </span><span class=\"S1770 S1070 S2\" id=\"t2g_64\">3 679 </span><span class=\"S1771 S1070 S2\" id=\"t2h_64\">1 552 </span><span class=\"S1772 S1070 S2\" id=\"t2i_64\">487 </span><span class=\"S1773 S1071 S2\" id=\"t2j_64\">47 164 </span><span class=\"S1774 S1070 S2\" id=\"t2k_64\">31 December 2021 </span><span class=\"S1775 S1070 S2\" id=\"t2l_64\">37 641 </span><span class=\"S1776 S1070 S2\" id=\"t2m_64\">4 661 </span><span class=\"S1777 S1070 S2\" id=\"t2n_64\">4 705 </span><span class=\"S1778 S1070 S2\" id=\"t2o_64\">630 </span><span class=\"S1779 S1070 S2\" id=\"t2p_64\">342 </span><span class=\"S177A S1071 S2\" id=\"t2q_64\">47 980 </span><span class=\"S177B S1070 S2\" id=\"t2r_64\">Photocure\u2019s sales are mainly hospitals and pharmacies and wholesalers in Europe and North America. </span><span class=\"S177C S1070 S2\" id=\"t2s_64\">Photocure has implemented the expected loss model under IFRS 9 on trade receivables. The expected loss as of December 31, 2022 </span><span class=\"S177D S1070 S2\" id=\"t2t_64\">amounts to NOK 1.0 million. Realised bad debt loss\u2019 in 2022 and 2021 has been immaterial. Credit risk and foreign exchange risk in </span><span class=\"S177E S1070 S2\" id=\"t2u_64\">regard to trade accounts receivable are dealt with in more detail in Note 17. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7019": {
   "value": "<span class=\"S1737 S106F S2\" id=\"tv_64\">19. RECEIVABLES </span><span class=\"S1738 S1071 S2\" id=\"tw_64\">Maximum credit risk </span><span class=\"S1739 S1070 S2\" id=\"tx_64\">The company\u2019s maximum credit risk associated with \ufb01nancial instruments corresponds to gross receivables. In a hypothetical </span><span class=\"S173A S1070 S2\" id=\"ty_64\">situations, where no receivables are actually paid, this would correspond to: </span><span class=\"S173B S1070 S2\" id=\"tz_64\">(Amounts in NOK 1,000) </span><span class=\"S173C S1071 S2\" id=\"t10_64\">Group </span><span class=\"S173D S1071 S2\" id=\"t11_64\">Parent </span><span class=\"S173E S1071 S2\" id=\"t12_64\">31-Dec-22 </span><span class=\"S173F S1071 S2\" id=\"t13_64\">31-Dec-21 </span><span class=\"S1740 S1071 S2\" id=\"t14_64\">31-Dec-22 </span><span class=\"S1741 S1071 S2\" id=\"t15_64\">31-Dec-21 </span><span class=\"S1742 S1070 S2\" id=\"t16_64\">Accounts receivable </span><span class=\"S1743 S1070 S2\" id=\"t17_64\">47 164 </span><span class=\"S1744 S1070 S2\" id=\"t18_64\">47 980 </span><span class=\"S1745 S1070 S2\" id=\"t19_64\">27 005 </span><span class=\"S1746 S1070 S2\" id=\"t1a_64\">29 610 </span><span class=\"S1747 S1070 S2\" id=\"t1b_64\">Accounts receivable intercompany </span><span class=\"S1748 S1070 S2\" id=\"t1c_64\">- </span><span class=\"S1749 S1070 S2\" id=\"t1d_64\">- </span><span class=\"S174A S1070 S2\" id=\"t1e_64\">4 733 </span><span class=\"S174B S1070 S2\" id=\"t1f_64\">0 </span><span class=\"S174C S1071 S2\" id=\"t1g_64\">Total </span><span class=\"S174D S1071 S2\" id=\"t1h_64\">47 164 </span><span class=\"S174E S1071 S2\" id=\"t1i_64\">47 980 </span><span class=\"S174F S1071 S2\" id=\"t1j_64\">31 738 </span><span class=\"S1750 S1071 S2\" id=\"t1k_64\">29 610 </span><span class=\"S1751 S1070 S2\" id=\"t1l_64\">Prepaid expenses </span><span class=\"S1752 S1070 S2\" id=\"t1m_64\">9 113 </span><span class=\"S1753 S1070 S2\" id=\"t1n_64\">9 852 </span><span class=\"S1754 S1070 S2\" id=\"t1o_64\">5 516 </span><span class=\"S1755 S1070 S2\" id=\"t1p_64\">4 697 </span><span class=\"S1756 S1070 S2\" id=\"t1q_64\">Other receivables and deposits </span><span class=\"S1757 S1070 S2\" id=\"t1r_64\">7 342 </span><span class=\"S1758 S1070 S2\" id=\"t1s_64\">4 928 </span><span class=\"S1759 S1070 S2\" id=\"t1t_64\">1 001 </span><span class=\"S175A S1070 S2\" id=\"t1u_64\">512 </span><span class=\"S175B S1071 S2\" id=\"t1v_64\">Total other receivables </span><span class=\"S175C S1071 S2\" id=\"t1w_64\">16 455 </span><span class=\"S175D S1071 S2\" id=\"t1x_64\">14 780 </span><span class=\"S175E S1071 S2\" id=\"t1y_64\">6 517 </span><span class=\"S175F S1071 S2\" id=\"t1z_64\">5 209 </span><span class=\"S1760 S1070 S2\" id=\"t20_64\">Loan to the subsidiary is disclosed in Note 10. </span><span class=\"S1761 S1071 S2\" id=\"t21_64\">Age breakdown of group accounts receivable </span><span class=\"S1762 S1071 S2\" id=\"t22_64\">Not yet </span><span class=\"S1763 S1071 S2\" id=\"t23_64\">due </span><span class=\"S1764 S1071 S2\" id=\"t24_64\">0\u201330 </span><span class=\"S1765 S1071 S2\" id=\"t25_64\">days </span><span class=\"S1766 S1071 S2\" id=\"t26_64\">30\u201360 </span><span class=\"S1767 S1071 S2\" id=\"t27_64\">days </span><span class=\"S1768 S1071 S2\" id=\"t28_64\">60\u201390 </span><span class=\"S1769 S1071 S2\" id=\"t29_64\">days </span><span class=\"S176A S1071 S2\" id=\"t2a_64\">Over 90 </span><span class=\"S176B S1071 S2\" id=\"t2b_64\">days </span><span class=\"S176C S1071 S2\" id=\"t2c_64\">Total </span><span class=\"S176D S1070 S2\" id=\"t2d_64\">31 December 2022 </span><span class=\"S176E S1070 S2\" id=\"t2e_64\">33 106 </span><span class=\"S176F S1070 S2\" id=\"t2f_64\">8 340 </span><span class=\"S1770 S1070 S2\" id=\"t2g_64\">3 679 </span><span class=\"S1771 S1070 S2\" id=\"t2h_64\">1 552 </span><span class=\"S1772 S1070 S2\" id=\"t2i_64\">487 </span><span class=\"S1773 S1071 S2\" id=\"t2j_64\">47 164 </span><span class=\"S1774 S1070 S2\" id=\"t2k_64\">31 December 2021 </span><span class=\"S1775 S1070 S2\" id=\"t2l_64\">37 641 </span><span class=\"S1776 S1070 S2\" id=\"t2m_64\">4 661 </span><span class=\"S1777 S1070 S2\" id=\"t2n_64\">4 705 </span><span class=\"S1778 S1070 S2\" id=\"t2o_64\">630 </span><span class=\"S1779 S1070 S2\" id=\"t2p_64\">342 </span><span class=\"S177A S1071 S2\" id=\"t2q_64\">47 980 </span><span class=\"S177B S1070 S2\" id=\"t2r_64\">Photocure\u2019s sales are mainly hospitals and pharmacies and wholesalers in Europe and North America. </span><span class=\"S177C S1070 S2\" id=\"t2s_64\">Photocure has implemented the expected loss model under IFRS 9 on trade receivables. The expected loss as of December 31, 2022 </span><span class=\"S177D S1070 S2\" id=\"t2t_64\">amounts to NOK 1.0 million. Realised bad debt loss\u2019 in 2022 and 2021 has been immaterial. Credit risk and foreign exchange risk in </span><span class=\"S177E S1070 S2\" id=\"t2u_64\">regard to trade accounts receivable are dealt with in more detail in Note 17. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7101": {
   "value": "<span class=\"S1780 S106F S2\" id=\"t2_65\">20. CASH AND SHORT TERM DEPOSITS </span><span class=\"S1781 S1070 S2\" id=\"t3_65\">(Amounts in NOK 1,000) </span><span class=\"S1782 S1071 S2\" id=\"t4_65\">Group </span><span class=\"S1783 S1071 S2\" id=\"t5_65\">Parent </span><span class=\"S1784 S1071 S2\" id=\"t6_65\">31-Dec-22 </span><span class=\"S1785 S1071 S2\" id=\"t7_65\">31-Dec-21 </span><span class=\"S1786 S1071 S2\" id=\"t8_65\">31-Dec-22 </span><span class=\"S1787 S1071 S2\" id=\"t9_65\">31-Dec-21 </span><span class=\"S1788 S1070 S2\" id=\"ta_65\">Cash and cash equivalents, restricted </span><span class=\"S1789 S1070 S2\" id=\"tb_65\">3 422 </span><span class=\"S178A S1070 S2\" id=\"tc_65\">3 856 </span><span class=\"S178B S1070 S2\" id=\"td_65\">3 422 </span><span class=\"S178C S1070 S2\" id=\"te_65\">3 856 </span><span class=\"S178D S1070 S2\" id=\"tf_65\">Cash and cash equivalents, non-restricted </span><span class=\"S178E S1070 S2\" id=\"tg_65\">30 449 </span><span class=\"S178F S1070 S2\" id=\"th_65\">58 984 </span><span class=\"S1790 S1070 S2\" id=\"ti_65\">21 434 </span><span class=\"S1791 S1070 S2\" id=\"tj_65\">50 906 </span><span class=\"S1792 S1070 S2\" id=\"tk_65\">Money market funds, non-restricted </span><span class=\"S1793 S1070 S2\" id=\"tl_65\">234 202 </span><span class=\"S1794 S1070 S2\" id=\"tm_65\">260 055 </span><span class=\"S1795 S1070 S2\" id=\"tn_65\">234 202 </span><span class=\"S1796 S1070 S2\" id=\"to_65\">260 055 </span><span class=\"S1797 S1071 S2\" id=\"tp_65\">Total </span><span class=\"S1798 S1071 S2\" id=\"tq_65\">268 073 </span><span class=\"S1799 S1071 S2\" id=\"tr_65\">322 895 </span><span class=\"S179A S1071 S2\" id=\"ts_65\">259 058 </span><span class=\"S179B S1071 S2\" id=\"tt_65\">314 817 </span><span class=\"S179C S1070 S2\" id=\"tu_65\">Money market funds are considered as cash equivalents because they are readily convertible to known amounts of cash and are </span><span class=\"S179D S1070 S2\" id=\"tv_65\">held for the purpose of meeting short-term cash commitments. Restricted cash and cash equivalents at 31 December 2022 include </span><span class=\"S179E S1070 S2\" id=\"tw_65\">security for employees\u2019 withholding tax in of NOK 1.7 million, while the remaining amount refers to deposit for rent of o\ufb03ce. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7102": {
   "value": "<span class=\"S1780 S106F S2\" id=\"t2_65\">20. CASH AND SHORT TERM DEPOSITS </span><span class=\"S1781 S1070 S2\" id=\"t3_65\">(Amounts in NOK 1,000) </span><span class=\"S1782 S1071 S2\" id=\"t4_65\">Group </span><span class=\"S1783 S1071 S2\" id=\"t5_65\">Parent </span><span class=\"S1784 S1071 S2\" id=\"t6_65\">31-Dec-22 </span><span class=\"S1785 S1071 S2\" id=\"t7_65\">31-Dec-21 </span><span class=\"S1786 S1071 S2\" id=\"t8_65\">31-Dec-22 </span><span class=\"S1787 S1071 S2\" id=\"t9_65\">31-Dec-21 </span><span class=\"S1788 S1070 S2\" id=\"ta_65\">Cash and cash equivalents, restricted </span><span class=\"S1789 S1070 S2\" id=\"tb_65\">3 422 </span><span class=\"S178A S1070 S2\" id=\"tc_65\">3 856 </span><span class=\"S178B S1070 S2\" id=\"td_65\">3 422 </span><span class=\"S178C S1070 S2\" id=\"te_65\">3 856 </span><span class=\"S178D S1070 S2\" id=\"tf_65\">Cash and cash equivalents, non-restricted </span><span class=\"S178E S1070 S2\" id=\"tg_65\">30 449 </span><span class=\"S178F S1070 S2\" id=\"th_65\">58 984 </span><span class=\"S1790 S1070 S2\" id=\"ti_65\">21 434 </span><span class=\"S1791 S1070 S2\" id=\"tj_65\">50 906 </span><span class=\"S1792 S1070 S2\" id=\"tk_65\">Money market funds, non-restricted </span><span class=\"S1793 S1070 S2\" id=\"tl_65\">234 202 </span><span class=\"S1794 S1070 S2\" id=\"tm_65\">260 055 </span><span class=\"S1795 S1070 S2\" id=\"tn_65\">234 202 </span><span class=\"S1796 S1070 S2\" id=\"to_65\">260 055 </span><span class=\"S1797 S1071 S2\" id=\"tp_65\">Total </span><span class=\"S1798 S1071 S2\" id=\"tq_65\">268 073 </span><span class=\"S1799 S1071 S2\" id=\"tr_65\">322 895 </span><span class=\"S179A S1071 S2\" id=\"ts_65\">259 058 </span><span class=\"S179B S1071 S2\" id=\"tt_65\">314 817 </span><span class=\"S179C S1070 S2\" id=\"tu_65\">Money market funds are considered as cash equivalents because they are readily convertible to known amounts of cash and are </span><span class=\"S179D S1070 S2\" id=\"tv_65\">held for the purpose of meeting short-term cash commitments. Restricted cash and cash equivalents at 31 December 2022 include </span>security for employees\u2019 withholding tax in of NOK 1.7 million, while the remaining amount refers to deposit for rent of o\ufb03ce",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7135": {
   "value": "<span class=\"S179F S106F S2\" id=\"tx_65\">21. SHARE CAPITAL </span><span class=\"S17A0 S1070 S2\" id=\"ty_65\">Amounts that are distributed to or contributed by shareholders are included directly in the equity. The Group\u2019s equity is increased in </span><span class=\"S17A1 S1070 S2\" id=\"tz_65\">direct relation to the cost of share-based remuneration for employees. </span><span class=\"S17A2 S1070 S2\" id=\"t10_65\">1.  The nominal value of treasury shares is presented in the balance sheet as a negative equity element. The net purchase price is </span><span class=\"S17A3 S1070 S2\" id=\"t11_65\">entered as a reduction of other paid-in equity. Pro\ufb01ts or losses on transactions in treasury shares are not included in the income </span><span class=\"S17A4 S1070 S2\" id=\"t12_65\">statement. </span><span class=\"S17A5 S1070 S2\" id=\"t13_65\">2.  Transaction charges in connection with equity transactions are included directly in equity after deduction for tax. Only transaction </span><span class=\"S17A6 S1070 S2\" id=\"t14_65\">charges that are directly attributable to the equity transaction are included directly in equity. </span><span class=\"S17A7 S1070 S2\" id=\"t15_65\">Registered share capital in Photocure ASA amounted to: </span><span class=\"S17A8 S1071 S2\" id=\"t16_65\">No. of shares </span><span class=\"S17A9 S1071 S2\" id=\"t17_65\">Nominal value </span><span class=\"S17AA S1071 S2\" id=\"t18_65\">per share NOK </span><span class=\"S17AB S1071 S2\" id=\"t19_65\">Share capital </span><span class=\"S17AC S1071 S2\" id=\"t1a_65\">in NOK </span><span class=\"S17AD S1071 S2\" id=\"t1b_65\">Share capital at 31 December 2021 </span><span class=\"S17AE S1071 S2\" id=\"t1c_65\">26 973 820 </span><span class=\"S17AF S1071 S2\" id=\"t1d_65\">0.50 </span><span class=\"S17B0 S1071 S2\" id=\"t1e_65\">13 486 910 </span><span class=\"S17B1 S1071 S2\" id=\"t1f_65\">Share capital at 31 December 2022 </span><span class=\"S17B2 S1071 S2\" id=\"t1g_65\">27 120 820 </span><span class=\"S17B3 S1071 S2\" id=\"t1h_65\">0.50 </span><span class=\"S17B4 S1071 S2\" id=\"t1i_65\">13 560 410 </span><span class=\"S17B5 S1071 S2\" id=\"t1j_65\">Treasury shares: </span><span class=\"S17B6 S1071 S2\" id=\"t1k_65\">Holdings of treasury shares at 31 December 2020 </span><span class=\"S17B7 S1071 S2\" id=\"t1l_65\">15 666 </span><span class=\"S17B8 S1071 S2\" id=\"t1m_65\">7 833 </span><span class=\"S17B9 S1070 S2\" id=\"t1n_65\">Buy-back of restricted shares </span><span class=\"S17BA S1070 S2\" id=\"t1o_65\">6 306 </span><span class=\"S17BB S1070 S2\" id=\"t1p_65\">0.50 </span><span class=\"S17BC S1070 S2\" id=\"t1q_65\">3 153 </span><span class=\"S17BD S1070 S2\" id=\"t1r_65\">Share options exercised from treasury shares </span><span class=\"S17BE S1070 S2\" id=\"t1s_65\">-7 126 </span><span class=\"S17BF S1070 S2\" id=\"t1t_65\">0.50 </span><span class=\"S17C0 S1070 S2\" id=\"t1u_65\">-3 563 </span><span class=\"S17C1 S1071 S2\" id=\"t1v_65\">Holdings of treasury shares at 31 December 2021 </span><span class=\"S17C2 S1071 S2\" id=\"t1w_65\">14 846 </span><span class=\"S17C3 S1071 S2\" id=\"t1x_65\">7 423 </span><span class=\"S17C4 S1070 S2\" id=\"t1y_65\">Buy-back of restricted shares </span><span class=\"S17C5 S1070 S2\" id=\"t1z_65\">481 </span><span class=\"S17C6 S1070 S2\" id=\"t20_65\">0.50 </span><span class=\"S17C7 S1070 S2\" id=\"t21_65\">241 </span><span class=\"S17C8 S1070 S2\" id=\"t22_65\">Buy-back of treasury shares </span><span class=\"S17C9 S1070 S2\" id=\"t23_65\">36 000 </span><span class=\"S17CA S1070 S2\" id=\"t24_65\">0.50 </span><span class=\"S17CB S1070 S2\" id=\"t25_65\">18 000 </span><span class=\"S17CC S1070 S2\" id=\"t26_65\">Share options exercised from treasury shares </span><span class=\"S17CD S1070 S2\" id=\"t27_65\">-36 205 </span><span class=\"S17CE S1070 S2\" id=\"t28_65\">0.50 </span><span class=\"S17CF S1070 S2\" id=\"t29_65\">-18 103 </span><span class=\"S17D0 S1071 S2\" id=\"t2a_65\">Holdings of treasury shares at 31 December 2022 </span><span class=\"S17D1 S1071 S2\" id=\"t2b_65\">15 122 </span><span class=\"S17D2 S1071 S2\" id=\"t2c_65\">7 561 </span><span class=\"S17D3 S1070 S2\" id=\"t2d_65\">Restricted shares were o\ufb00ered to the employees according to the Board\u2019s discretion. </span><span class=\"S17D4 S1070 S2\" id=\"t2e_65\">The participant received the </span><span class=\"S17D5 S1070 S2\" id=\"t2f_65\">shares in the Company that have been subject to a three years\u2019 lock up period </span><span class=\"S17D6 S1070 S2\" id=\"t2g_65\">All shares have the same voting rights and otherwise the same rights in the Company. Ordinary shares are classi\ufb01ed as equity. </span><span class=\"S17D7 S1070 S2\" id=\"t2h_65\">Expenses that are directly attributable to the issue of ordinary shares are included as a reduction of equity. </span><span class=\"S17D8 S1070 S2\" id=\"t2i_65\">At the General Meeting 28 April 2022, the Board of Directors of Photocure ASA was granted authorisation to issue up to 6.1 million </span><span class=\"S17D9 S1070 S2\" id=\"t2j_65\">shares. Of this authorisation, (a) 5.4 million shares are linked to \ufb01nancing of the Company\u2019s development, while (b) 0.75 million shares </span><span class=\"S17DA S1070 S2\" id=\"t2k_65\">are associated with the issue of shares to the Company\u2019s employees. Subscription of shares under the incentive program shall </span><span class=\"S17DB S1070 S2\" id=\"t2l_65\">be subscribed at the market price with an addition of 10% at the time of allocation of the employee share options. At the General </span><span class=\"S17DC S1070 S2\" id=\"t2m_65\">Meeting the Board of Directors was granted authorisation to purchase treasury shares to 2.7 million shares. The basis for this </span><span class=\"S17DD S1070 S2\" id=\"t2n_65\">authorisation to purchase treasury shares is the desire by the Board of Directors to increase the liquidity of the Company\u2019s shares </span><span class=\"S17DE S1070 S2\" id=\"t2o_65\">and in connection with the incentive schemes. </span>All authorisations are valid up until the Ordinary General Meeting in 2023. Previously issued authorisations have expired<span class=\"S17E0 S1070 S2\" id=\"t4_66\">The table below indicates the status of authorisations at 31 December 2022: </span><span class=\"S17E1 S1071 S2\" id=\"t5_66\">Purchase, </span><span class=\"S17E2 S1071 S2\" id=\"t6_66\">treasury shares </span><span class=\"S17E3 S1071 S2\" id=\"t7_66\">Ordinary </span><span class=\"S17E4 S1071 S2\" id=\"t8_66\">share issue </span><span class=\"S17E5 S1071 S2\" id=\"t9_66\">Employee </span><span class=\"S17E6 S1071 S2\" id=\"ta_66\">share issues </span><span class=\"S17E7 S1070 S2\" id=\"tb_66\">(Figures indicate the number of shares) </span><span class=\"S17E8 S1070 S2\" id=\"tc_66\">Authorisation issued at the General Meeting on 28 April 2022 </span><span class=\"S17E9 S1070 S2\" id=\"td_66\">2 697 657 </span><span class=\"S17EA S1070 S2\" id=\"te_66\">5 395 314 </span><span class=\"S17EB S1070 S2\" id=\"tf_66\">750 000 </span><span class=\"S17EC S1070 S2\" id=\"tg_66\">Share issues after the General Meeting on 28 April 2022 </span><span class=\"S17ED S1070 S2\" id=\"th_66\">0 </span><span class=\"S17EE S1070 S2\" id=\"ti_66\">0 </span><span class=\"S17EF S1070 S2\" id=\"tj_66\">144 250 </span><span class=\"S17F0 S1070 S2\" id=\"tk_66\">Purchase of treasury shares after the General Meeting 28 April 2022 </span><span class=\"S17F1 S1070 S2\" id=\"tl_66\">-36 000 </span><span class=\"S17F2 S1070 S2\" id=\"tm_66\">0 </span><span class=\"S17F3 S1070 S2\" id=\"tn_66\">0 </span><span class=\"S17F4 S1071 S2\" id=\"to_66\">Remaining under authorisations at 31 December 2022 </span><span class=\"S17F5 S1071 S2\" id=\"tp_66\">2 661 657 </span><span class=\"S17F6 S1071 S2\" id=\"tq_66\">5 395 314 </span><span class=\"S17F7 S1071 S2\" id=\"tr_66\">605 750 </span><span class=\"S17F8 S1070 S2\" id=\"ts_66\">1 922 778 share options have been allocated to employees 31 December 2022 (see note 6). </span><span class=\"S17F9 S1070 S2\" id=\"tt_66\">Photocure initiated a buyback of up to 36,000 of its own shares at 1 June 2022. The purpose of the buyback program was to acquire </span><span class=\"S17FA S1070 S2\" id=\"tu_66\">shares which was used as settlement in the Company\u2019s share-based incentive scheme. </span><span class=\"S17FB S1071 S2\" id=\"tv_66\">Ownership structure </span><span class=\"S17FC S1070 S2\" id=\"tw_66\">The major shareholders in Photocure as of 31 December 2022 were: </span><span class=\"S17FD S1071 S2\" id=\"tx_66\">Shares </span><span class=\"S17FE S1071 S2\" id=\"ty_66\">Shareholding </span><span class=\"S17FF S1070 S2\" id=\"tz_66\">Morgan Stanley &amp; Co. LLC </span><span class=\"S1800 S1070 S2\" id=\"t10_66\">4 160 945 </span><span class=\"S1801 S1070 S2\" id=\"t11_66\">15.3 % </span><span class=\"S1802 S1070 S2\" id=\"t12_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1803 S1070 S2\" id=\"t13_66\">1 138 000 </span><span class=\"S1804 S1070 S2\" id=\"t14_66\">4.2 % </span><span class=\"S1805 S1070 S2\" id=\"t15_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1806 S1070 S2\" id=\"t16_66\">1 117 101 </span><span class=\"S1807 S1070 S2\" id=\"t17_66\">4.1 % </span><span class=\"S1808 S1070 S2\" id=\"t18_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1809 S1070 S2\" id=\"t19_66\">720 644 </span><span class=\"S180A S1070 S2\" id=\"t1a_66\">2.7 % </span><span class=\"S180B S1070 S2\" id=\"t1b_66\">RADFORSK INVESTERINGSSTIFTELSE </span><span class=\"S180C S1070 S2\" id=\"t1c_66\">679 619 </span><span class=\"S180D S1070 S2\" id=\"t1d_66\">2.5 % </span><span class=\"S180E S1070 S2\" id=\"t1e_66\">The Bank of New York Mellon SA/NV </span><span class=\"S180F S1070 S2\" id=\"t1f_66\">581 018 </span><span class=\"S1810 S1070 S2\" id=\"t1g_66\">2.1 % </span><span class=\"S1811 S1070 S2\" id=\"t1h_66\">The Bank of New York Mellon SA/NV </span><span class=\"S1812 S1070 S2\" id=\"t1i_66\">515 000 </span><span class=\"S1813 S1070 S2\" id=\"t1j_66\">1.9 % </span><span class=\"S1814 S1070 S2\" id=\"t1k_66\">Nordnet Bank AB </span><span class=\"S1815 S1070 S2\" id=\"t1l_66\">511 441 </span><span class=\"S1816 S1070 S2\" id=\"t1m_66\">1.9 % </span><span class=\"S1817 S1070 S2\" id=\"t1n_66\">RBC Investor services bank S.A. </span><span class=\"S1818 S1070 S2\" id=\"t1o_66\">477 179 </span><span class=\"S1819 S1070 S2\" id=\"t1p_66\">1.8 % </span><span class=\"S181A S1070 S2\" id=\"t1q_66\">The Bank of New York Mellon </span><span class=\"S181B S1070 S2\" id=\"t1r_66\">473 494 </span><span class=\"S181C S1070 S2\" id=\"t1s_66\">1.7 % </span><span class=\"S181D S1070 S2\" id=\"t1t_66\">MP PENSJON PK </span><span class=\"S181E S1070 S2\" id=\"t1u_66\">440 178 </span><span class=\"S181F S1070 S2\" id=\"t1v_66\">1.6 % </span><span class=\"S1820 S1070 S2\" id=\"t1w_66\">The Northern Trust Comp, London Br </span><span class=\"S1821 S1070 S2\" id=\"t1x_66\">439 420 </span><span class=\"S1822 S1070 S2\" id=\"t1y_66\">1.6 % </span><span class=\"S1823 S1070 S2\" id=\"t1z_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1824 S1070 S2\" id=\"t20_66\">417 940 </span><span class=\"S1825 S1070 S2\" id=\"t21_66\">1.5 % </span><span class=\"S1826 S1070 S2\" id=\"t22_66\">Skandinaviska Enskilda Banken AB </span><span class=\"S1827 S1070 S2\" id=\"t23_66\">412 990 </span><span class=\"S1828 S1070 S2\" id=\"t24_66\">1.5 % </span><span class=\"S1829 S1070 S2\" id=\"t25_66\">The Bank of New York Mellon SA/NV </span><span class=\"S182A S1070 S2\" id=\"t26_66\">400 000 </span><span class=\"S182B S1070 S2\" id=\"t27_66\">1.5 % </span><span class=\"S182C S1070 S2\" id=\"t28_66\">JPMorgan Chase Bank, N.A., London </span><span class=\"S182D S1070 S2\" id=\"t29_66\">390 226 </span><span class=\"S182E S1070 S2\" id=\"t2a_66\">1.4 % </span><span class=\"S182F S1070 S2\" id=\"t2b_66\">VERDIPAPIRFONDET EQUINOR AKSJER NO </span><span class=\"S1830 S1070 S2\" id=\"t2c_66\">375 872 </span><span class=\"S1831 S1070 S2\" id=\"t2d_66\">1.4 % </span><span class=\"S1832 S1070 S2\" id=\"t2e_66\">VERDIPAPIRFONDET KLP AKSJENORGE </span><span class=\"S1833 S1070 S2\" id=\"t2f_66\">375 630 </span><span class=\"S1834 S1070 S2\" id=\"t2g_66\">1.4 % </span><span class=\"S1835 S1070 S2\" id=\"t2h_66\">Avanza Bank AB </span><span class=\"S1836 S1070 S2\" id=\"t2i_66\">372 126 </span><span class=\"S1837 S1070 S2\" id=\"t2j_66\">1.4 % </span><span class=\"S1838 S1070 S2\" id=\"t2k_66\">The Bank of New York Mellon </span><span class=\"S1839 S1070 S2\" id=\"t2l_66\">329 888 </span><span class=\"S183A S1070 S2\" id=\"t2m_66\">1.2 % </span><span class=\"S183B S1071 S2\" id=\"t2n_66\">Total of 20 largest shareholders </span><span class=\"S183C S1071 S2\" id=\"t2o_66\">14 328 711 </span><span class=\"S183D S1071 S2\" id=\"t2p_66\">52.8 % </span><span class=\"S183E S1070 S2\" id=\"t2q_66\">Treasury shares </span><span class=\"S183F S1070 S2\" id=\"t2r_66\">15 122 </span><span class=\"S1840 S1070 S2\" id=\"t2s_66\">0.1 % </span><span class=\"S1841 S1070 S2\" id=\"t2t_66\">Total other shareholders </span><span class=\"S1842 S1070 S2\" id=\"t2u_66\">12 776 987 </span><span class=\"S1843 S1070 S2\" id=\"t2v_66\">47.1 % </span><span class=\"S1844 S1071 S2\" id=\"t2w_66\">Total number of shares </span><span class=\"S1845 S1071 S2\" id=\"t2x_66\">27 120 820 </span><span class=\"S1846 S1071 S2\" id=\"t2y_66\">100.0 % </span><span class=\"S1847 S1070 S2\" id=\"t2_67\">Shares owned, directly or indirectly, by members of the Board of Directors, the President and CEO and senior management and their </span><span class=\"S1848 S1070 S2\" id=\"t3_67\">closely related associates as of 31 December 2022: </span><span class=\"S1849 S1071 S2\" id=\"t4_67\">Name </span><span class=\"S184A S1071 S2\" id=\"t5_67\">Position </span><span class=\"S184B S1071 S2\" id=\"t6_67\">No. of </span><span class=\"S184C S1071 S2\" id=\"t7_67\">shares </span><span class=\"S184D S1071 S2\" id=\"t8_67\">No. of share </span><span class=\"S184E S1071 S2\" id=\"t9_67\">options </span><span class=\"S184F SFE S2\" id=\"ta_67\">** </span><span class=\"S1850 S1070 S2\" id=\"tb_67\">Daniel Schneider </span><span class=\"S1851 S1070 S2\" id=\"tc_67\">President &amp; CEO </span><span class=\"S1852 S1070 S2\" id=\"td_67\">99 689 </span><span class=\"S1853 S1070 S2\" id=\"te_67\">325 000 </span><span class=\"S1854 S1070 S2\" id=\"tf_67\">Erik Dahl </span><span class=\"S1855 S1070 S2\" id=\"tg_67\">Chief Financial O\ufb03cer </span><span class=\"S1856 S1070 S2\" id=\"th_67\">32 750 </span><span class=\"S1857 S1070 S2\" id=\"ti_67\">192 500 </span><span class=\"S1858 S1070 S2\" id=\"tj_67\">Geo\ufb00rey Coy </span><span class=\"S1859 S1070 S2\" id=\"tk_67\">VP and General Manager North America </span><span class=\"S185A S1070 S2\" id=\"tl_67\">15 207 </span><span class=\"S185B S1070 S2\" id=\"tm_67\">212 500 </span><span class=\"S185C S1070 S2\" id=\"tn_67\">Susanne Strauss </span><span class=\"S185D S1070 S2\" id=\"to_67\">VP and General Manager Europe </span><span class=\"S185E S1070 S2\" id=\"tp_67\">1 392 </span><span class=\"S185F S1070 S2\" id=\"tq_67\">200 000 </span><span class=\"S1860 S1070 S2\" id=\"tr_67\">Grete Hogstad </span><span class=\"S1861 S1070 S2\" id=\"ts_67\">VP Global Strategic Marketing &amp; BD </span><span class=\"S1862 S1070 S2\" id=\"tt_67\">30 719 </span><span class=\"S1863 S1070 S2\" id=\"tu_67\">112 500 </span><span class=\"S1864 S1070 S2\" id=\"tv_67\">Patricia Kelly </span><span class=\"S1865 S1070 S2\" id=\"tw_67\">VP Global Human Resources </span><span class=\"S1866 S1070 S2\" id=\"tx_67\">- </span><span class=\"S1867 S1070 S2\" id=\"ty_67\">80 000 </span><span class=\"S1868 S1070 S2\" id=\"tz_67\">Anders Neijber </span><span class=\"S1869 S1070 S2\" id=\"t10_67\">VP Global Medical A\ufb00airs and Clinical Development </span><span class=\"S186A S1070 S2\" id=\"t11_67\">- </span><span class=\"S186B S1070 S2\" id=\"t12_67\">88 000 </span><span class=\"S186C S1070 S2\" id=\"t13_67\">Jan H. Egbert </span><span class=\"S186D S1070 S2\" id=\"t14_67\">Chairperson of the board </span><span class=\"S186E S1070 S2\" id=\"t15_67\">14 500 </span><span class=\"S186F S1070 S2\" id=\"t16_67\">1 312 </span><span class=\"S1870 S1070 S2\" id=\"t17_67\">Anders Tuv * </span><span class=\"S1871 S1070 S2\" id=\"t18_67\">Board member </span><span class=\"S1872 S1070 S2\" id=\"t19_67\">679 619 </span><span class=\"S1873 S1070 S2\" id=\"t1a_67\">804 </span><span class=\"S1874 S1070 S2\" id=\"t1b_67\">Anne Wors\u00f8e </span><span class=\"S1875 S1070 S2\" id=\"t1c_67\">Board member </span><span class=\"S1876 S1070 S2\" id=\"t1d_67\">- </span><span class=\"S1877 S1070 S2\" id=\"t1e_67\">804 </span><span class=\"S1878 S1070 S2\" id=\"t1f_67\">Johanna Holldack </span><span class=\"S1879 S1070 S2\" id=\"t1g_67\">Board member </span><span class=\"S187A S1070 S2\" id=\"t1h_67\">- </span><span class=\"S187B S1070 S2\" id=\"t1i_67\">804 </span><span class=\"S187C S1070 S2\" id=\"t1j_67\">Neal Shore </span><span class=\"S187D S1070 S2\" id=\"t1k_67\">Board member </span><span class=\"S187E S1070 S2\" id=\"t1l_67\">- </span><span class=\"S187F S1070 S2\" id=\"t1m_67\">804 </span><span class=\"S1880 S1294 S2\" id=\"t1n_67\">* </span><span class=\"S1881 S1295 S2\" id=\"t1o_67\">Anders Tuv represents RADFORSK Investeringsstiftelse. </span><span class=\"S1882 S1294 S2\" id=\"t1p_67\">** </span><span class=\"S1883 S1295 S2\" id=\"t1q_67\">See note 6 for additional information about the share options. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7144": {
   "value": "<span class=\"S17A7 S1070 S2\" id=\"t15_65\">Registered share capital in Photocure ASA amounted to: </span><span class=\"S17A8 S1071 S2\" id=\"t16_65\">No. of shares </span><span class=\"S17A9 S1071 S2\" id=\"t17_65\">Nominal value </span><span class=\"S17AA S1071 S2\" id=\"t18_65\">per share NOK </span><span class=\"S17AB S1071 S2\" id=\"t19_65\">Share capital </span><span class=\"S17AC S1071 S2\" id=\"t1a_65\">in NOK </span><span class=\"S17AD S1071 S2\" id=\"t1b_65\">Share capital at 31 December 2021 </span><span class=\"S17AE S1071 S2\" id=\"t1c_65\">26 973 820 </span><span class=\"S17AF S1071 S2\" id=\"t1d_65\">0.50 </span><span class=\"S17B0 S1071 S2\" id=\"t1e_65\">13 486 910 </span><span class=\"S17B1 S1071 S2\" id=\"t1f_65\">Share capital at 31 December 2022 </span><span class=\"S17B2 S1071 S2\" id=\"t1g_65\">27 120 820 </span><span class=\"S17B3 S1071 S2\" id=\"t1h_65\">0.50 </span><span class=\"S17B4 S1071 S2\" id=\"t1i_65\">13 560 410 </span><span class=\"S17B5 S1071 S2\" id=\"t1j_65\">Treasury shares: </span><span class=\"S17B6 S1071 S2\" id=\"t1k_65\">Holdings of treasury shares at 31 December 2020 </span><span class=\"S17B7 S1071 S2\" id=\"t1l_65\">15 666 </span><span class=\"S17B8 S1071 S2\" id=\"t1m_65\">7 833 </span><span class=\"S17B9 S1070 S2\" id=\"t1n_65\">Buy-back of restricted shares </span><span class=\"S17BA S1070 S2\" id=\"t1o_65\">6 306 </span><span class=\"S17BB S1070 S2\" id=\"t1p_65\">0.50 </span><span class=\"S17BC S1070 S2\" id=\"t1q_65\">3 153 </span><span class=\"S17BD S1070 S2\" id=\"t1r_65\">Share options exercised from treasury shares </span><span class=\"S17BE S1070 S2\" id=\"t1s_65\">-7 126 </span><span class=\"S17BF S1070 S2\" id=\"t1t_65\">0.50 </span><span class=\"S17C0 S1070 S2\" id=\"t1u_65\">-3 563 </span><span class=\"S17C1 S1071 S2\" id=\"t1v_65\">Holdings of treasury shares at 31 December 2021 </span><span class=\"S17C2 S1071 S2\" id=\"t1w_65\">14 846 </span><span class=\"S17C3 S1071 S2\" id=\"t1x_65\">7 423 </span><span class=\"S17C4 S1070 S2\" id=\"t1y_65\">Buy-back of restricted shares </span><span class=\"S17C5 S1070 S2\" id=\"t1z_65\">481 </span><span class=\"S17C6 S1070 S2\" id=\"t20_65\">0.50 </span><span class=\"S17C7 S1070 S2\" id=\"t21_65\">241 </span><span class=\"S17C8 S1070 S2\" id=\"t22_65\">Buy-back of treasury shares </span><span class=\"S17C9 S1070 S2\" id=\"t23_65\">36 000 </span><span class=\"S17CA S1070 S2\" id=\"t24_65\">0.50 </span><span class=\"S17CB S1070 S2\" id=\"t25_65\">18 000 </span><span class=\"S17CC S1070 S2\" id=\"t26_65\">Share options exercised from treasury shares </span><span class=\"S17CD S1070 S2\" id=\"t27_65\">-36 205 </span><span class=\"S17CE S1070 S2\" id=\"t28_65\">0.50 </span><span class=\"S17CF S1070 S2\" id=\"t29_65\">-18 103 </span><span class=\"S17D0 S1071 S2\" id=\"t2a_65\">Holdings of treasury shares at 31 December 2022 </span><span class=\"S17D1 S1071 S2\" id=\"t2b_65\">15 122 </span><span class=\"S17D2 S1071 S2\" id=\"t2c_65\">7 561 </span><span class=\"S17D3 S1070 S2\" id=\"t2d_65\">Restricted shares were o\ufb00ered to the employees according to the Board\u2019s discretion. </span><span class=\"S17D4 S1070 S2\" id=\"t2e_65\">The participant received the </span><span class=\"S17D5 S1070 S2\" id=\"t2f_65\">shares in the Company that have been subject to a three years\u2019 lock up period </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfTreasurySharesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7387": {
   "value": "2. LOAN TERMS AND REPAYMENT <span class=\"S1885 S1070 S2\" id=\"t1s_67\">(Amounts in NOK 1,000) </span><span class=\"S1886 S1071 S2\" id=\"t1t_67\">Currency </span><span class=\"S1887 S1071 S2\" id=\"t1u_67\">Nominell </span><span class=\"S1888 S1071 S2\" id=\"t1v_67\">interest </span><span class=\"S1889 S1071 S2\" id=\"t1w_67\">rate </span><span class=\"S188A S1071 S2\" id=\"t1x_67\">Year of </span><span class=\"S188B S1071 S2\" id=\"t1y_67\">maturity </span><span class=\"S188C S1071 S2\" id=\"t1z_67\">Loan </span><span class=\"S188D S1071 S2\" id=\"t20_67\">amount </span><span class=\"S188E S1071 S2\" id=\"t21_67\">01.01 </span><span class=\"S188F S1071 S2\" id=\"t22_67\">Instal- </span><span class=\"S1890 S1071 S2\" id=\"t23_67\">ments </span><span class=\"S1891 S1071 S2\" id=\"t24_67\">paid </span><span class=\"S1892 S1071 S2\" id=\"t25_67\">Book value </span><span class=\"S1893 S1071 S2\" id=\"t26_67\">31-Dec-22 </span><span class=\"S1894 S1071 S2\" id=\"t27_67\">1st year </span><span class=\"S1895 S1071 S2\" id=\"t28_67\">instal- </span><span class=\"S1896 S1071 S2\" id=\"t29_67\">ments </span><span class=\"S1897 S1070 S2\" id=\"t2a_67\">Bank loan secured through governmental </span><span class=\"S1898 S1070 S2\" id=\"t2b_67\">guarantee due to Covid-19 </span><span class=\"S1899 S1070 S2\" id=\"t2c_67\">NOK </span><span class=\"S189A S1070 S2\" id=\"t2d_67\">4.80 % </span><span class=\"S189B S1070 S2\" id=\"t2e_67\">2023 </span><span class=\"S189C S1070 S2\" id=\"t2f_67\">37 500 </span><span class=\"S189D S1070 S2\" id=\"t2g_67\">-25 000 </span><span class=\"S189E S1070 S2\" id=\"t2h_67\">12 500 </span><span class=\"S189F S1070 S2\" id=\"t2i_67\">12 500 </span><span class=\"S18A0 S1070 S2\" id=\"t2j_67\">Deferred consideration (Earnout) </span><span class=\"S18A1 S1070 S2\" id=\"t2k_67\">NOK/EUR </span><span class=\"S18A2 S1070 S2\" id=\"t2l_67\">2030 </span><span class=\"S18A3 S1070 S2\" id=\"t2m_67\">139 350 </span><span class=\"S18A4 S1070 S2\" id=\"t2n_67\">-5 714 </span><span class=\"S18A5 S1070 S2\" id=\"t2o_67\">135 333 </span><span class=\"S18A6 S1070 S2\" id=\"t2p_67\">9 100 </span><span class=\"S18A7 S1070 S2\" id=\"t2q_67\">Right-of-use o\ufb03ce contract Norway </span><span class=\"S18A8 S1070 S2\" id=\"t2r_67\">NOK </span><span class=\"S18A9 S1070 S2\" id=\"t2s_67\">3.15 % </span><span class=\"S18AA S1070 S2\" id=\"t2t_67\">2027 </span><span class=\"S18AB S1070 S2\" id=\"t2u_67\">13 052 </span><span class=\"S18AC S1070 S2\" id=\"t2v_67\">-2 193 </span><span class=\"S18AD S1070 S2\" id=\"t2w_67\">11 434 </span><span class=\"S18AE S1070 S2\" id=\"t2x_67\">2 302 </span><span class=\"S18AF S1070 S2\" id=\"t2y_67\">Right-of-use o\ufb03ce contract US </span><span class=\"S18B0 S1070 S2\" id=\"t2z_67\">USD </span><span class=\"S18B1 S1070 S2\" id=\"t30_67\">3.70 % </span><span class=\"S18B2 S1070 S2\" id=\"t31_67\">2028 </span><span class=\"S18B3 S1070 S2\" id=\"t32_67\">10 269 </span><span class=\"S18B4 S1070 S2\" id=\"t33_67\">-1 548 </span><span class=\"S18B5 S1070 S2\" id=\"t34_67\">9 591 </span><span class=\"S18B6 S1070 S2\" id=\"t35_67\">1 598 </span><span class=\"S18B7 S1070 S2\" id=\"t36_67\">Right-of-use o\ufb03ce contract Germany </span><span class=\"S18B8 S1070 S2\" id=\"t37_67\">EUR </span><span class=\"S18B9 S1070 S2\" id=\"t38_67\">1.40 % </span><span class=\"S18BA S1070 S2\" id=\"t39_67\">2026 </span><span class=\"S18BB S1070 S2\" id=\"t3a_67\">5 861 </span><span class=\"S18BC S1070 S2\" id=\"t3b_67\">-1 317 </span><span class=\"S18BD S1070 S2\" id=\"t3c_67\">5 064 </span><span class=\"S18BE S1070 S2\" id=\"t3d_67\">1 422 </span><span class=\"S18BF S1070 S2\" id=\"t3e_67\">Right-of-use o\ufb03ce company car \ufb02eet Germany * </span><span class=\"S18C0 S1070 S2\" id=\"t3f_67\">EUR </span><span class=\"S18C1 S1070 S2\" id=\"t3g_67\">1.40 % </span><span class=\"S18C2 S204 S2\" id=\"t3h_67\">2024 </span><span class=\"S18C3 S1070 S2\" id=\"t3i_67\">460 </span><span class=\"S18C4 S1070 S2\" id=\"t3j_67\">-708 </span><span class=\"S18C5 S1070 S2\" id=\"t3k_67\">949 </span><span class=\"S18C6 S1070 S2\" id=\"t3l_67\">460 </span><span class=\"S18C7 S18E0 S2\" id=\"t3m_67\">Total non-current liabilities </span><span class=\"S18C8 S1071 S2\" id=\"t3n_67\">174 871 </span><span class=\"S18C9 S1071 S2\" id=\"t3o_67\">27 382 </span><span class=\"S18CA S1294 S2\" id=\"t3p_67\">* </span><span class=\"S18CB S1295 S2\" id=\"t3q_67\">There are seperate lease agreements for each lease subject </span><span class=\"S18CC S1070 S2\" id=\"t3r_67\">Hexvix sales, marketing and distribution rights in Europe and other markets previously controlled by Ipsen Pharma SAS (Ipsen), were </span><span class=\"S18CD S1070 S2\" id=\"t3s_67\">acquired by Photocure 1 October 2020. The parties entered into a \ufb01nal agreement were Photocure paid Ipsen EUR 15 million upon </span><span class=\"S18CE S1070 S2\" id=\"t3t_67\">transfer on 1 October 2020. Ipsen receives in addition a deferred consideration 15% of sales (years 1-7 post-transfer) and 7.5% of </span><span class=\"S18CF S1070 S2\" id=\"t3u_67\">sales (years 8-10) in the previous Ipsen major markets. The deferred consideration is paid as quarterly earnout payments in EURO </span><span class=\"S18D0 S1070 S2\" id=\"t3v_67\">after the close of the quarter. </span><span class=\"S18D1 S1070 S2\" id=\"t3w_67\">The fair value of the deferred consideration is driven by future expected sales and is remeasured on a yearly basis. Photocure </span><span class=\"S18D2 S1070 S2\" id=\"t3x_67\">performed a new remeasurement as of 31 December 2022. </span><span class=\"S18D3 S1070 S2\" id=\"t3y_67\">The remeasurement resulted in a fair value of NOK 135.3 re\ufb02ecting </span><span class=\"S18D4 S1070 S2\" id=\"t3z_67\">an increase of fair value of NOK 0.8 million compared to remeasurement adjustment of NOK 17.2 in 2021. The increased fair value </span><span class=\"S18D5 S1070 S2\" id=\"t40_67\">has been recognized in pro\ufb01t or loss as a \ufb01nancial cost. To arrive at the remeasured fair value of NOK 135.3 million, Photocure has </span><span class=\"S18D6 S1070 S2\" id=\"t41_67\">discounted the estimated earnout payments by an IRR at level with the investment project. This IRR has been deemed appropriate </span><span class=\"S18D7 S1070 S2\" id=\"t42_67\">as a discount rate for the earnout payments since the level of the payments will be subject to the same risk factors as the cash </span><span class=\"S18D8 S1070 S2\" id=\"t43_67\">\ufb02ow prognosis for the acquisition as a whole. Future sales, given performance in 2022 and growth opportunities going forward, are </span><span class=\"S18D9 S1070 S2\" id=\"t44_67\">expected to be in line with forecasts prepared in connection with the transaction. </span><span class=\"S18DA S1070 S2\" id=\"t45_67\">Photocure has made the remeasurement of the earnout liability in NOK currency and based the forecasted cash\ufb02ow on a \ufb01xed </span><span class=\"S18DB S1070 S2\" id=\"t46_67\">exchange rate EUR/NOK of 10.2 and this is in line with the prior year remeasurement . </span><span class=\"S18DC S1070 S2\" id=\"t47_67\">The agreement with Ipsen determined a \ufb02oor revenue for the earnout from 2022 to the end of the forecast period and there is no </span><span class=\"S18DD S1070 S2\" id=\"t48_67\">upper cap of revenue. The total undiscounted amount of the earnout may be in the interval of NOK 187 - 306 million depending </span><span class=\"S18DE S1070 S2\" id=\"t49_67\">on revenue and development of the currency exchange rate between EUR and NOK. According to our sensitivity analysis the </span><span class=\"S18DF S1070 S2\" id=\"t4a_67\">corresponding net present value of the liability may decrease or increase by NOK 33 million. </span><span class=\"S18E2 S1071 S2\" id=\"t4_68\">Group </span><span class=\"S18E3 S1071 S2\" id=\"t5_68\">Earnout </span><span class=\"S18E4 S1071 S2\" id=\"t6_68\">liability </span><span class=\"S18E5 S1071 S2\" id=\"t7_68\">Financial </span><span class=\"S18E6 S1071 S2\" id=\"t8_68\">loan bank </span><span class=\"S18E7 S1071 S2\" id=\"t9_68\">O\ufb03ce </span><span class=\"S18E8 S1071 S2\" id=\"ta_68\">Lease </span><span class=\"S18E9 S1071 S2\" id=\"tb_68\">Oslo </span><span class=\"S18EA S1071 S2\" id=\"tc_68\">O\ufb03ce </span><span class=\"S18EB S1071 S2\" id=\"td_68\">Lease </span><span class=\"S18EC S1071 S2\" id=\"te_68\">Princeton </span><span class=\"S18ED S1071 S2\" id=\"tf_68\">O\ufb03ce and </span><span class=\"S18EE S1071 S2\" id=\"tg_68\">car Lease </span><span class=\"S18EF S1071 S2\" id=\"th_68\">Germany </span><span class=\"S18F0 S1071 S2\" id=\"ti_68\">Total </span><span class=\"S18F1 S1071 S2\" id=\"tj_68\">Accumulated 31 December 2020 </span><span class=\"S18F2 S1070 S2\" id=\"tk_68\">149 941 </span><span class=\"S18F3 S1070 S2\" id=\"tl_68\">50 000 </span><span class=\"S18F4 S1070 S2\" id=\"tm_68\">1 970 </span><span class=\"S18F5 S1070 S2\" id=\"tn_68\">1 917 </span><span class=\"S18F6 S1070 S2\" id=\"to_68\">0 </span><span class=\"S18F7 S1070 S2\" id=\"tp_68\">203 828 </span><span class=\"S18F8 S1070 S2\" id=\"tq_68\">Proceeds from loans and borrowing </span><span class=\"S18F9 S1070 S2\" id=\"tr_68\">0 </span><span class=\"S18FA S1070 S2\" id=\"ts_68\">Loan repayment and earnout </span><span class=\"S18FB S1070 S2\" id=\"tt_68\">-3 834 </span><span class=\"S18FC S1070 S2\" id=\"tu_68\">-12 500 </span><span class=\"S18FD S1070 S2\" id=\"tv_68\">-16 334 </span><span class=\"S18FE S1070 S2\" id=\"tw_68\">Payment of lease liabilities </span><span class=\"S18FF S1070 S2\" id=\"tx_68\">-1 970 </span><span class=\"S1900 S1070 S2\" id=\"ty_68\">-839 </span><span class=\"S1901 S1070 S2\" id=\"tz_68\">-1 134 </span><span class=\"S1902 S1070 S2\" id=\"t10_68\">-3 943 </span><span class=\"S1903 S1071 S2\" id=\"t11_68\">Total changes from \ufb01nancing </span><span class=\"S1904 S1071 S2\" id=\"t12_68\">-3 834 </span><span class=\"S1905 S1071 S2\" id=\"t13_68\">-12 500 </span><span class=\"S1906 S1071 S2\" id=\"t14_68\">-1 970 </span><span class=\"S1907 S1071 S2\" id=\"t15_68\">-839 </span><span class=\"S1908 S1071 S2\" id=\"t16_68\">-1 134 </span><span class=\"S1909 S1071 S2\" id=\"t17_68\">-20 277 </span><span class=\"S190A S1070 S2\" id=\"t18_68\">Change in fair value currency </span><span class=\"S190B S1070 S2\" id=\"t19_68\">-15 906 </span><span class=\"S190C S1070 S2\" id=\"t1a_68\">82 </span><span class=\"S190D S1070 S2\" id=\"t1b_68\">-15 824 </span><span class=\"S190E S1070 S2\" id=\"t1c_68\">Remeasurerd liability </span><span class=\"S190F S1070 S2\" id=\"t1d_68\">17 220 </span><span class=\"S1910 S1070 S2\" id=\"t1e_68\">17 220 </span><span class=\"S1911 S1070 S2\" id=\"t1f_68\">New lease liability </span><span class=\"S1912 S1070 S2\" id=\"t1g_68\">13 053 </span><span class=\"S1913 S1070 S2\" id=\"t1h_68\">9 110 </span><span class=\"S1914 S1070 S2\" id=\"t1i_68\">7 455 </span><span class=\"S1915 S1070 S2\" id=\"t1j_68\">29 617 </span><span class=\"S1916 S1070 S2\" id=\"t1k_68\">Interest expense </span><span class=\"S1917 S1070 S2\" id=\"t1l_68\">22 425 </span><span class=\"S1918 S1070 S2\" id=\"t1m_68\">1 065 </span><span class=\"S1919 S1070 S2\" id=\"t1n_68\">157 </span><span class=\"S191A S1070 S2\" id=\"t1o_68\">91 </span><span class=\"S191B S1070 S2\" id=\"t1p_68\">88 </span><span class=\"S191C S1070 S2\" id=\"t1q_68\">23 826 </span><span class=\"S191D S1070 S2\" id=\"t1r_68\">Interest paid </span><span class=\"S191E S1070 S2\" id=\"t1s_68\">-24 985 </span><span class=\"S191F S1070 S2\" id=\"t1t_68\">-1 065 </span><span class=\"S1920 S1070 S2\" id=\"t1u_68\">-157 </span><span class=\"S1921 S1070 S2\" id=\"t1v_68\">-91 </span><span class=\"S1922 S1070 S2\" id=\"t1w_68\">-88 </span><span class=\"S1923 S1070 S2\" id=\"t1x_68\">-26 386 </span><span class=\"S1924 S1071 S2\" id=\"t1y_68\">Total liability related changes </span><span class=\"S1925 S1071 S2\" id=\"t1z_68\">-1 246 </span><span class=\"S1926 S1071 S2\" id=\"t20_68\">0 </span><span class=\"S1927 S1071 S2\" id=\"t21_68\">13 053 </span><span class=\"S1928 S1071 S2\" id=\"t22_68\">9 192 </span><span class=\"S1929 S1071 S2\" id=\"t23_68\">7 455 </span><span class=\"S192A S1071 S2\" id=\"t24_68\">28 453 </span><span class=\"S192B S1070 S2\" id=\"t25_68\">1th year instalments </span><span class=\"S192C S1070 S2\" id=\"t26_68\">-5 750 </span><span class=\"S192D S1070 S2\" id=\"t27_68\">-25 000 </span><span class=\"S192E S1070 S2\" id=\"t28_68\">-2 400 </span><span class=\"S192F S1070 S2\" id=\"t29_68\">-1 549 </span><span class=\"S1930 S1070 S2\" id=\"t2a_68\">-1 882 </span><span class=\"S1931 S1070 S2\" id=\"t2b_68\">-36 581 </span><span class=\"S1932 S1071 S2\" id=\"t2c_68\">Accumulated 31 December 2021 </span><span class=\"S1933 S1070 S2\" id=\"t2d_68\">139 350 </span><span class=\"S1934 S1070 S2\" id=\"t2e_68\">37 500 </span><span class=\"S1935 S1070 S2\" id=\"t2f_68\">13 052 </span><span class=\"S1936 S1070 S2\" id=\"t2g_68\">10 269 </span><span class=\"S1937 S1070 S2\" id=\"t2h_68\">6 322 </span><span class=\"S1938 S1070 S2\" id=\"t2i_68\">206 492 </span><span class=\"S1939 S1070 S2\" id=\"t2j_68\">Proceeds from loans and borrowing </span><span class=\"S193A S1070 S2\" id=\"t2k_68\">0 </span><span class=\"S193B S1070 S2\" id=\"t2l_68\">Loan repayment and earnout instalments </span><span class=\"S193C S1070 S2\" id=\"t2m_68\">-5 714 </span><span class=\"S193D S1070 S2\" id=\"t2n_68\">-25 000 </span><span class=\"S193E S1070 S2\" id=\"t2o_68\">-30 714 </span><span class=\"S193F S1070 S2\" id=\"t2p_68\">Payment of lease liabilities </span><span class=\"S1940 S1070 S2\" id=\"t2q_68\">-2 193 </span><span class=\"S1941 S1070 S2\" id=\"t2r_68\">-1 548 </span><span class=\"S1942 S1070 S2\" id=\"t2s_68\">-1 889 </span><span class=\"S1943 S1070 S2\" id=\"t2t_68\">-5 630 </span><span class=\"S1944 S1071 S2\" id=\"t2u_68\">Total changes from \ufb01nancing </span><span class=\"S1945 S1071 S2\" id=\"t2v_68\">-5 714 </span><span class=\"S1946 S1071 S2\" id=\"t2w_68\">-25 000 </span><span class=\"S1947 S1071 S2\" id=\"t2x_68\">-2 193 </span><span class=\"S1948 S1071 S2\" id=\"t2y_68\">-1 548 </span><span class=\"S1949 S1071 S2\" id=\"t2z_68\">-1 889 </span><span class=\"S194A S1071 S2\" id=\"t30_68\">-36 344 </span><span class=\"S194B S1070 S2\" id=\"t31_68\">Remeasurerd liability </span><span class=\"S194C S1070 S2\" id=\"t32_68\">758 </span><span class=\"S194D S1070 S2\" id=\"t33_68\">574 </span><span class=\"S194E S1070 S2\" id=\"t34_68\">1 245 </span><span class=\"S194F S1070 S2\" id=\"t35_68\">410 </span><span class=\"S1950 S1070 S2\" id=\"t36_68\">2 988 </span><span class=\"S1951 S1070 S2\" id=\"t37_68\">New lease liability </span><span class=\"S1952 S1070 S2\" id=\"t38_68\">-324 </span><span class=\"S1953 S1070 S2\" id=\"t39_68\">1 170 </span><span class=\"S1954 S1070 S2\" id=\"t3a_68\">846 </span><span class=\"S1955 S1070 S2\" id=\"t3b_68\">Interest expense </span><span class=\"S1956 S1070 S2\" id=\"t3c_68\">24 383 </span><span class=\"S1957 S1070 S2\" id=\"t3d_68\">846 </span><span class=\"S1958 S1070 S2\" id=\"t3e_68\">249 </span><span class=\"S1959 S1070 S2\" id=\"t3f_68\">248 </span><span class=\"S195A S1070 S2\" id=\"t3g_68\">79 </span><span class=\"S195B S1070 S2\" id=\"t3h_68\">25 804 </span><span class=\"S195C S1070 S2\" id=\"t3i_68\">Interest paid </span><span class=\"S195D S1070 S2\" id=\"t3j_68\">-23 444 </span><span class=\"S195E S1070 S2\" id=\"t3k_68\">-846 </span><span class=\"S195F S1070 S2\" id=\"t3l_68\">-249 </span><span class=\"S1960 S1070 S2\" id=\"t3m_68\">-298 </span><span class=\"S1961 S1070 S2\" id=\"t3n_68\">-79 </span><span class=\"S1962 S1070 S2\" id=\"t3o_68\">-24 915 </span><span class=\"S1963 S1071 S2\" id=\"t3p_68\">Total liability related changes </span><span class=\"S1964 S1071 S2\" id=\"t3q_68\">1 697 </span><span class=\"S1965 S1071 S2\" id=\"t3r_68\">0 </span><span class=\"S1966 S1071 S2\" id=\"t3s_68\">574 </span><span class=\"S1967 S1071 S2\" id=\"t3t_68\">871 </span><span class=\"S1968 S1071 S2\" id=\"t3u_68\">1 580 </span><span class=\"S1969 S1071 S2\" id=\"t3v_68\">4 723 </span><span class=\"S196A S1071 S2\" id=\"t3w_68\">Accumulated 31 December 2022 </span><span class=\"S196B S1071 S2\" id=\"t3x_68\">135 333 </span><span class=\"S196C S1071 S2\" id=\"t3y_68\">12 500 </span><span class=\"S196D S1071 S2\" id=\"t3z_68\">11 433 </span><span class=\"S196E S1071 S2\" id=\"t40_68\">9 591 </span><span class=\"S196F S1071 S2\" id=\"t41_68\">6 014 </span><span class=\"S1970 S1071 S2\" id=\"t42_68\">174 871 </span><span class=\"S1971 S1070 S2\" id=\"t43_68\">1th year instalments </span><span class=\"S1972 S1070 S2\" id=\"t44_68\">-9 100 </span><span class=\"S1973 S1070 S2\" id=\"t45_68\">-12 500 </span><span class=\"S1974 S1070 S2\" id=\"t46_68\">-2 302 </span><span class=\"S1975 S1070 S2\" id=\"t47_68\">-1 598 </span><span class=\"S1976 S1070 S2\" id=\"t48_68\">-1 882 </span><span class=\"S1977 S1070 S2\" id=\"t49_68\">-27 382 </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfBorrowingsExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7649": {
   "value": "<span class=\"S1447 S106F S2\" id=\"t2_69\">23. ACCOUNTS PAYABLE AND OTHER CURRENT LIABILITIES </span><span class=\"S1979 S1070 S2\" id=\"t3_69\">(Amounts in NOK 1,000) </span><span class=\"S197A S1071 S2\" id=\"t4_69\">Group </span><span class=\"S197B S1071 S2\" id=\"t5_69\">Parent </span><span class=\"S197C S1071 S2\" id=\"t6_69\">31-Dec-22 </span><span class=\"S197D S1071 S2\" id=\"t7_69\">31-Dec-21 </span><span class=\"S197E S1071 S2\" id=\"t8_69\">31-Dec-22 </span><span class=\"S197F S1071 S2\" id=\"t9_69\">31-Dec-21 </span><span class=\"S1980 S1070 S2\" id=\"ta_69\">Accounts payable </span><span class=\"S1981 S1070 S2\" id=\"tb_69\">21 281 </span><span class=\"S1982 S1070 S2\" id=\"tc_69\">23 648 </span><span class=\"S1983 S1070 S2\" id=\"td_69\">12 479 </span><span class=\"S1984 S1070 S2\" id=\"te_69\">15 574 </span><span class=\"S1985 S1070 S2\" id=\"tf_69\">Accounts payable intercompany </span><span class=\"S1986 S1070 S2\" id=\"tg_69\">- </span><span class=\"S1987 S1070 S2\" id=\"th_69\">- </span><span class=\"S1988 S1070 S2\" id=\"ti_69\">3 388 </span><span class=\"S1989 S1070 S2\" id=\"tj_69\">1 444 </span><span class=\"S198A S1071 S2\" id=\"tk_69\">Total </span><span class=\"S198B S1071 S2\" id=\"tl_69\">21 281 </span><span class=\"S198C S1071 S2\" id=\"tm_69\">23 648 </span><span class=\"S198D S1071 S2\" id=\"tn_69\">15 867 </span><span class=\"S198E S1071 S2\" id=\"to_69\">17 018 </span><span class=\"S198F S1070 S2\" id=\"tp_69\">Accrued bonus, holiday pay, salaries </span><span class=\"S1990 S1070 S2\" id=\"tq_69\">30 782 </span><span class=\"S1991 S1070 S2\" id=\"tr_69\">27 426 </span><span class=\"S1992 S1070 S2\" id=\"ts_69\">12 442 </span><span class=\"S1993 S1070 S2\" id=\"tt_69\">13 625 </span><span class=\"S1994 S1070 S2\" id=\"tu_69\">Incurred earnout liability </span><span class=\"S1995 S1070 S2\" id=\"tv_69\">7 376 </span><span class=\"S1996 S1070 S2\" id=\"tw_69\">7 463 </span><span class=\"S1997 S1070 S2\" id=\"tx_69\">7 376 </span><span class=\"S1998 S1070 S2\" id=\"ty_69\">7 463 </span><span class=\"S1999 S1070 S2\" id=\"tz_69\">Short-term payable, intercompany </span><span class=\"S199A S1070 S2\" id=\"t10_69\">- </span><span class=\"S199B S1070 S2\" id=\"t11_69\">- </span><span class=\"S199C S1070 S2\" id=\"t12_69\">14 048 </span><span class=\"S199D S1070 S2\" id=\"t13_69\">5 758 </span><span class=\"S199E S1070 S2\" id=\"t14_69\">Miscellaneous other accrued costs </span><span class=\"S199F S1070 S2\" id=\"t15_69\">12 649 </span><span class=\"S19A0 S1070 S2\" id=\"t16_69\">15 465 </span><span class=\"S19A1 S1070 S2\" id=\"t17_69\">8 142 </span><span class=\"S19A2 S1070 S2\" id=\"t18_69\">9 315 </span><span class=\"S19A3 S1071 S2\" id=\"t19_69\">Total other current liabilities </span><span class=\"S19A4 S1071 S2\" id=\"t1a_69\">50 807 </span><span class=\"S19A5 S1071 S2\" id=\"t1b_69\">50 354 </span><span class=\"S19A6 S1071 S2\" id=\"t1c_69\">42 008 </span><span class=\"S19A7 S1071 S2\" id=\"t1d_69\">36 161 </span><span class=\"S19A8 S1070 S2\" id=\"t1e_69\">The incured earnout liability is for net sales </span><span class=\"S19A9 S1070 S2\" id=\"t1f_69\">in last quarter. </span><span class=\"S19AA S1070 S2\" id=\"t1g_69\">Accrued bonus, holiday pay, salaries include accrual for estimated annual bonus as of 31 December 2022. Final annual bonus for the </span><span class=\"S19AB S1070 S2\" id=\"t1h_69\">Group is to be decided by the Board of Directors. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7650": {
   "value": "<span class=\"S1447 S106F S2\" id=\"t2_69\">23. ACCOUNTS PAYABLE AND OTHER CURRENT LIABILITIES </span><span class=\"S1979 S1070 S2\" id=\"t3_69\">(Amounts in NOK 1,000) </span><span class=\"S197A S1071 S2\" id=\"t4_69\">Group </span><span class=\"S197B S1071 S2\" id=\"t5_69\">Parent </span><span class=\"S197C S1071 S2\" id=\"t6_69\">31-Dec-22 </span><span class=\"S197D S1071 S2\" id=\"t7_69\">31-Dec-21 </span><span class=\"S197E S1071 S2\" id=\"t8_69\">31-Dec-22 </span><span class=\"S197F S1071 S2\" id=\"t9_69\">31-Dec-21 </span><span class=\"S1980 S1070 S2\" id=\"ta_69\">Accounts payable </span><span class=\"S1981 S1070 S2\" id=\"tb_69\">21 281 </span><span class=\"S1982 S1070 S2\" id=\"tc_69\">23 648 </span><span class=\"S1983 S1070 S2\" id=\"td_69\">12 479 </span><span class=\"S1984 S1070 S2\" id=\"te_69\">15 574 </span><span class=\"S1985 S1070 S2\" id=\"tf_69\">Accounts payable intercompany </span><span class=\"S1986 S1070 S2\" id=\"tg_69\">- </span><span class=\"S1987 S1070 S2\" id=\"th_69\">- </span><span class=\"S1988 S1070 S2\" id=\"ti_69\">3 388 </span><span class=\"S1989 S1070 S2\" id=\"tj_69\">1 444 </span><span class=\"S198A S1071 S2\" id=\"tk_69\">Total </span><span class=\"S198B S1071 S2\" id=\"tl_69\">21 281 </span><span class=\"S198C S1071 S2\" id=\"tm_69\">23 648 </span><span class=\"S198D S1071 S2\" id=\"tn_69\">15 867 </span><span class=\"S198E S1071 S2\" id=\"to_69\">17 018 </span><span class=\"S198F S1070 S2\" id=\"tp_69\">Accrued bonus, holiday pay, salaries </span><span class=\"S1990 S1070 S2\" id=\"tq_69\">30 782 </span><span class=\"S1991 S1070 S2\" id=\"tr_69\">27 426 </span><span class=\"S1992 S1070 S2\" id=\"ts_69\">12 442 </span><span class=\"S1993 S1070 S2\" id=\"tt_69\">13 625 </span><span class=\"S1994 S1070 S2\" id=\"tu_69\">Incurred earnout liability </span><span class=\"S1995 S1070 S2\" id=\"tv_69\">7 376 </span><span class=\"S1996 S1070 S2\" id=\"tw_69\">7 463 </span><span class=\"S1997 S1070 S2\" id=\"tx_69\">7 376 </span><span class=\"S1998 S1070 S2\" id=\"ty_69\">7 463 </span><span class=\"S1999 S1070 S2\" id=\"tz_69\">Short-term payable, intercompany </span><span class=\"S199A S1070 S2\" id=\"t10_69\">- </span><span class=\"S199B S1070 S2\" id=\"t11_69\">- </span><span class=\"S199C S1070 S2\" id=\"t12_69\">14 048 </span><span class=\"S199D S1070 S2\" id=\"t13_69\">5 758 </span><span class=\"S199E S1070 S2\" id=\"t14_69\">Miscellaneous other accrued costs </span><span class=\"S199F S1070 S2\" id=\"t15_69\">12 649 </span><span class=\"S19A0 S1070 S2\" id=\"t16_69\">15 465 </span><span class=\"S19A1 S1070 S2\" id=\"t17_69\">8 142 </span><span class=\"S19A2 S1070 S2\" id=\"t18_69\">9 315 </span><span class=\"S19A3 S1071 S2\" id=\"t19_69\">Total other current liabilities </span><span class=\"S19A4 S1071 S2\" id=\"t1a_69\">50 807 </span><span class=\"S19A5 S1071 S2\" id=\"t1b_69\">50 354 </span><span class=\"S19A6 S1071 S2\" id=\"t1c_69\">42 008 </span><span class=\"S19A7 S1071 S2\" id=\"t1d_69\">36 161 </span><span class=\"S19A8 S1070 S2\" id=\"t1e_69\">The incured earnout liability is for net sales </span><span class=\"S19A9 S1070 S2\" id=\"t1f_69\">in last quarter. </span><span class=\"S19AA S1070 S2\" id=\"t1g_69\">Accrued bonus, holiday pay, salaries include accrual for estimated annual bonus as of 31 December 2022. Final annual bonus for the </span><span class=\"S19AB S1070 S2\" id=\"t1h_69\">Group is to be decided by the Board of Directors. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfOtherCurrentLiabilitiesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7651": {
   "value": "<span class=\"S1447 S106F S2\" id=\"t2_69\">23. ACCOUNTS PAYABLE AND OTHER CURRENT LIABILITIES </span><span class=\"S1979 S1070 S2\" id=\"t3_69\">(Amounts in NOK 1,000) </span><span class=\"S197A S1071 S2\" id=\"t4_69\">Group </span><span class=\"S197B S1071 S2\" id=\"t5_69\">Parent </span><span class=\"S197C S1071 S2\" id=\"t6_69\">31-Dec-22 </span><span class=\"S197D S1071 S2\" id=\"t7_69\">31-Dec-21 </span><span class=\"S197E S1071 S2\" id=\"t8_69\">31-Dec-22 </span><span class=\"S197F S1071 S2\" id=\"t9_69\">31-Dec-21 </span><span class=\"S1980 S1070 S2\" id=\"ta_69\">Accounts payable </span><span class=\"S1981 S1070 S2\" id=\"tb_69\">21 281 </span><span class=\"S1982 S1070 S2\" id=\"tc_69\">23 648 </span><span class=\"S1983 S1070 S2\" id=\"td_69\">12 479 </span><span class=\"S1984 S1070 S2\" id=\"te_69\">15 574 </span><span class=\"S1985 S1070 S2\" id=\"tf_69\">Accounts payable intercompany </span><span class=\"S1986 S1070 S2\" id=\"tg_69\">- </span><span class=\"S1987 S1070 S2\" id=\"th_69\">- </span><span class=\"S1988 S1070 S2\" id=\"ti_69\">3 388 </span><span class=\"S1989 S1070 S2\" id=\"tj_69\">1 444 </span><span class=\"S198A S1071 S2\" id=\"tk_69\">Total </span><span class=\"S198B S1071 S2\" id=\"tl_69\">21 281 </span><span class=\"S198C S1071 S2\" id=\"tm_69\">23 648 </span><span class=\"S198D S1071 S2\" id=\"tn_69\">15 867 </span><span class=\"S198E S1071 S2\" id=\"to_69\">17 018 </span><span class=\"S198F S1070 S2\" id=\"tp_69\">Accrued bonus, holiday pay, salaries </span><span class=\"S1990 S1070 S2\" id=\"tq_69\">30 782 </span><span class=\"S1991 S1070 S2\" id=\"tr_69\">27 426 </span><span class=\"S1992 S1070 S2\" id=\"ts_69\">12 442 </span><span class=\"S1993 S1070 S2\" id=\"tt_69\">13 625 </span><span class=\"S1994 S1070 S2\" id=\"tu_69\">Incurred earnout liability </span><span class=\"S1995 S1070 S2\" id=\"tv_69\">7 376 </span><span class=\"S1996 S1070 S2\" id=\"tw_69\">7 463 </span><span class=\"S1997 S1070 S2\" id=\"tx_69\">7 376 </span><span class=\"S1998 S1070 S2\" id=\"ty_69\">7 463 </span><span class=\"S1999 S1070 S2\" id=\"tz_69\">Short-term payable, intercompany </span><span class=\"S199A S1070 S2\" id=\"t10_69\">- </span><span class=\"S199B S1070 S2\" id=\"t11_69\">- </span><span class=\"S199C S1070 S2\" id=\"t12_69\">14 048 </span><span class=\"S199D S1070 S2\" id=\"t13_69\">5 758 </span><span class=\"S199E S1070 S2\" id=\"t14_69\">Miscellaneous other accrued costs </span><span class=\"S199F S1070 S2\" id=\"t15_69\">12 649 </span><span class=\"S19A0 S1070 S2\" id=\"t16_69\">15 465 </span><span class=\"S19A1 S1070 S2\" id=\"t17_69\">8 142 </span><span class=\"S19A2 S1070 S2\" id=\"t18_69\">9 315 </span><span class=\"S19A3 S1071 S2\" id=\"t19_69\">Total other current liabilities </span><span class=\"S19A4 S1071 S2\" id=\"t1a_69\">50 807 </span><span class=\"S19A5 S1071 S2\" id=\"t1b_69\">50 354 </span><span class=\"S19A6 S1071 S2\" id=\"t1c_69\">42 008 </span><span class=\"S19A7 S1071 S2\" id=\"t1d_69\">36 161 </span><span class=\"S19A8 S1070 S2\" id=\"t1e_69\">The incured earnout liability is for net sales </span><span class=\"S19A9 S1070 S2\" id=\"t1f_69\">in last quarter. </span><span class=\"S19AA S1070 S2\" id=\"t1g_69\">Accrued bonus, holiday pay, salaries include accrual for estimated annual bonus as of 31 December 2022. Final annual bonus for the </span><span class=\"S19AB S1070 S2\" id=\"t1h_69\">Group is to be decided by the Board of Directors. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  },
  "f7705": {
   "value": "<span class=\"S19AC S106F S2\" id=\"t1i_69\">24. SUBSEQUENT EVENTS </span><span class=\"S19AD S1070 S2\" id=\"t1j_69\">Post-period, on March 21, 2023, Photocure announced that Karl Storz due to component supply issues will discontinue the </span><span class=\"S19AE S1070 S2\" id=\"t1k_69\">production of its current \ufb02exible BLC equipment in the U.S. Karl Storz plans to service existing customers through the remainder of </span><span class=\"S19AF S1070 S2\" id=\"t1l_69\">the year. Karl Storz will explore the development of a next generation state-of-the-art \ufb02exible blue light system pending a positive </span><span class=\"S19B0 S1070 S2\" id=\"t1m_69\">reclassi\ufb01cation decision by the U.S. Food &amp; Drug Administration (FDA). The impact from a lack of new \ufb02exible BLC installations in FY </span><span class=\"S19B1 S1070 S2\" id=\"t1n_69\">2023 is estimated to be less than 2% of Photocure\u2019s total revenue. </span>",
   "dimensions": {
    "concept": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
    "language": "en",
    "entity": "scheme:5967007LIEEXZXG8OW35",
    "period": "2022-01-01T00:00:00/2023-01-01T00:00:00"
   }
  }
 }
}